"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,GB,A,GB 107487 A,058-809-382-362-702,1917-07-05,1917,GB 1353316 A,1916-09-23,GB 1353316 A,1916-09-23,Improvements in Window Cleaning Appliances.,"107,487. Dodd, E., and Dodd, R. Sept 23, 1916. Cloths stretched over backings.-In a windowcleaning appliance, the duster or the like is secured to the head part, comprising a wooden block b fixed to a metal frame a, by means of pivoted shackles h held in their operative positions by the ends of the bifurcated handle c. The handle is pivoted in the ears e and sprung under the clips g and the lower end may be secured to a long rod.",DODD EDWARD;;DODD ROBERT,DODD EDWARD;;DODD ROBERT,,https://lens.org/058-809-382-362-702,Granted Patent,no,0,1,1,1,0,A47L1/06,A47L1/06,,0,0,,,,EXPIRED
2,US,A,US 4570536 A,001-504-755-571-908,1986-02-18,1986,US 58551884 A,1984-03-02,US 58551884 A,1984-03-02,Electrically actuated can crusher,"An electrically actuated can crusher having a housing, a motor mounted within the housing and a shaft rotatable by the motor and downwardly driven thereby having a crush plate thereon. The housing also includes a bottom crush plate allowing a can to be crushed to be placed in the housing between the crush plates. The housing includes an access door which, when in the open position, deactivates the motor. In this manner, when the door is closed, the motor can be activated to lower the shaft crush plate to crush a can placed therebetween. The shaft crush plate may include a lever movable in a slot in the housing to align the shaft crush plate in its movement and a reversing switch may be provided in the lever and slot to reverse the direction of movement of the shaft crush plate after crushing of a can.",DODD ROBERT N,DODD ROBERT N,DODD NOLAN (1996-12-20);;DODD RONALD L (1993-12-29),https://lens.org/001-504-755-571-908,Granted Patent,yes,11,52,1,1,0,B30B1/18;;B30B1/18;;B30B9/3064;;B30B9/3064;;B30B9/321;;B30B9/321;;Y10S100/902;;Y10S100/902,B30B1/18;;B30B9/30;;B30B9/32,100/53;;100/102;;100/256;;100/268;;100/289;;100/295;;100/902;;221/199,0,0,,,,EXPIRED
3,DE,A1,DE 19830086 A1,036-381-291-923-030,1999-01-14,1999,DE 19830086 A,1998-07-06,US 89149197 A,1997-07-11,Software-gesteuertes Auswahl- und Testsystem,,LORAL SPACE SYSTEMS INC,DODD ROBERT W,,https://lens.org/036-381-291-923-030,Patent Application,no,0,1,3,3,0,G05B13/024;;G05B13/024,G05B13/02;;G05B23/02,,0,0,,,,DISCONTINUED
4,US,A,US 5781456 A,118-503-764-218-477,1998-07-14,1998,US 89149197 A,1997-07-11,US 89149197 A,1997-07-11,Software select and test,"A software-controlled select and test system for use with a spacecraft. The system reduces the assembly, integration, test time and improves performance of the payload and spacecraft by optimizing the performance using standardized algorithms. The system also reduces the DC power required by the spacecraft, and the thermal dissipation, battery size, solar array size and mass of the spacecraft. This is achieved by optimizing traveling wave tube amplifiers for each channel instead of meeting minimum power requirement over the entire range, wherein most channels have excess power. A serial interface adapter performs the optimization functions via software.",LORAL SPACE SYSTEMS INC,DODD ROBERT W,SPACE SYSTEMS/LORAL LLC (1997-07-09),https://lens.org/118-503-764-218-477,Granted Patent,yes,9,8,3,3,0,G05B13/024;;G05B13/024,G05B13/02;;G05B23/02,364/579;;364/481;;330/278,0,0,,,,EXPIRED
5,US,A,US 3065982 A,015-723-822-851-984,1962-11-27,1962,US 10810961 A,1961-05-05,US 10810961 A,1961-05-05,Adjustable scaffold stop,,DODD ROBERT M,DODD ROBERT M,,https://lens.org/015-723-822-851-984,Granted Patent,no,10,15,1,1,0,E04G1/22;;E04G1/22;;Y10S285/902;;Y10S285/902;;Y10T403/32434;;Y10T403/32434,E04G1/22,,0,0,,,,EXPIRED
6,US,A,US 6018703 A,138-649-427-990-949,2000-01-25,2000,US 9915498 A,1998-06-18,US 9915498 A;;US 89149197 A,1997-07-11,Software select and test,"A software-controlled select and test system for use with a spacecraft. The system reduces the assembly, integration, test time and improves performance of the payload and spacecraft by optimizing the performance using standardized algorithms. The system also reduces the DC power required by the spacecraft, and the thermal dissipation, battery size, solar array size and mass of the spacecraft. This is achieved by optimizing traveling wave tube amplifiers for each channel instead of meeting minimum power requirement over the entire range, wherein most channels have excess power. A serial interface adapter performs the optimization functions via software.",LORAL SPACE SYSTEMS INC,DODD ROBERT W,,https://lens.org/138-649-427-990-949,Granted Patent,yes,3,12,3,3,0,G05B13/024;;G05B13/024,G05B13/02;;G05B23/02,702/113;;702/57;;330/278,0,0,,,,EXPIRED
7,US,A,US 5923292 A,074-576-903-428-195,1999-07-13,1999,US 89148497 A,1997-07-11,US 89148497 A,1997-07-11,Dual antenna null elimination,"RF signal nulling and loss of RF lock (i.e., loss of a communications or command link) is resolved by changing the phase of signals derived from first and second (+Z and -Z) antennas so that they add in phase instead of canceling. This is accomplished automatically by using a computer or processor to measure the RF signal level output by a receiver and change the phase of the incoming signal using a phase shifter to achieve the highest level. A squelch circuit in the receiver is used to determine the maximum obtainable RF signal level. The squelch level is compared in a computer to a threshold when the system looks for a higher squelch level. The phase of the phase shifter is changed using a computer to maximize the received signal level. A feedback loop from the receiver through the computer to the phase shifter provides a path to shift the phase of the incoming RF signal in one of the paths so the respective signals add instead of cancel, which eliminates the signal nulling problem.",LORAL SPACE SYSTEMS INC,DODD ROBERT W,SPACE SYSTEMS/LORAL LLC (1997-07-09),https://lens.org/074-576-903-428-195,Granted Patent,yes,3,6,1,1,0,H01Q3/2611;;H01Q3/2611,H01Q3/26,342/383;;342/354;;342/372,0,0,,,,EXPIRED
8,US,A,US 1179615 A,176-001-704-260-394,1916-04-18,1916,US 6651815 A,1915-12-13,US 6651815 A,1915-12-13,BREAST-YOKE.,,DODD ROBERT M,DODD ROBERT M,,https://lens.org/176-001-704-260-394,Granted Patent,no,0,0,1,1,0,B68B5/00;;B68B5/00,,,0,0,,,,EXPIRED
9,GB,A,GB 190420187 A,147-094-815-181-422,1905-07-27,1905,GB 190420187D A,1904-09-19,GB 190420187T A,1904-09-19,A New or Improved Ball or Float Valve,"20,187. Ames. R., Dodd, E., and Dodd, R. P. Sept. 19. B a l l and float valves.-A ball or float valve for regulating liquid supply comprises a casing closed at p by a water-tight cap, and bored at d to receive a valve f, which is seated at e at the top of a bib c. The valve f fits the casing loosely, and is provided with a groove o and, if desired, other grooves leading to a chamber f<1> in which is another valve g, of leather or of metal, operated by a spindle h oE triangular or other section so as to allow liquid to pass downwards freely. The spindle h is actuated by a float lever j, and may or may not be provided with a slotted piece n to retain the lever j in case the valves stick. Liquid enters from the inlet b, passes into the space above the valves, and presses them on to their seats. If the valve g be lifted, fluid pressure is released in the chamber f<1>, and so the main valve is forced open. When the lever j rises, the valve g closes by gravity and the main valve slowly falls, avoiding shock. The facings of the valves are renewable, and may be of leather or of metal.",AMES RICHARD;;DODD EDWARD;;DODD ROBERT PARKER,AMES RICHARD;;DODD EDWARD;;DODD ROBERT PARKER,,https://lens.org/147-094-815-181-422,Patent Application,no,0,1,1,1,0,,,,0,0,,,,DISCONTINUED
10,GB,A,GB 191025090 A,067-920-342-062-643,1911-08-10,1911,GB 191025090D A,1910-10-28,GB 191025090T A,1910-10-28,Improvements relating to Sluice or like Operating Mechanism for Sewage or other Fluid Mains.,"25,090. Dodd, E., Dodd, R., and Wicks, J. T. Oct. 28. Actuating. - In sluice-operating mechanism for sewage or other mains that discharge into tidal water or reservoirs &c. in which the level rises and falls, the mechanism is so operated that the main discharges only during ebb or fall of level in the reservoir. The valve a, Figs. 1 and 2, which controls through pipes c the supply of hydraulic pressure to the operating - mechanism of the sluice t is operated by rack-and-pinion mechanism, which is actuated by a float n only during a portion of the rise and fall thereof. The float n is connected to a counterweight o by a cord m which passes over pulleys l, p. Two wheels f are each mounted through one-way clutches on the shaft g in such a manner that, on the wheel l rotating in one direction, one of the wheels f is rotated, and on the reverse movement the other wheel is rotated. These wheels f engage racks k which are connected to the valve-rod b. Each rack k is of such length that it disengages with the wheel as soon as the valve is completely moved, and at the same time brings the other rack into engagement with the other wheel, the result being that the valve is moved only during the first part of the movement of the float in each direction. To prevent the sluice from being opened when the height of water outside is above that in the sewer, the device shown in Figs. 1 and 9 is provided. A pair of cylinders w, each containing a bell-shaped piston x floating in mercury, are connected by a lever y which operates a valve 3 in the pipe c supplying pressure fluid through the valve a to the sluiceoperating mechanism. The chambers formed by the pistons and cylinders are connected one by the tubes 4 with the well r, and the other by the tube 5 to the sewer. When the tide rises above the level of the water in the sewer, the pressure due to the rise of water in the tube 4 raises the piston and closes the valve 3 until the level of water in the sewer is higher than that in the well r, whereupon the reverse action takes place. Consequently if, at the reversal of the tide, the level in the sewer is below that of the sea, the sluice valve does not open.",DODD EDWARD;;DODD ROBERT;;WICKS JOHN THOMAS,DODD EDWARD;;DODD ROBERT;;WICKS JOHN THOMAS,,https://lens.org/067-920-342-062-643,Patent Application,no,0,1,1,1,0,E02B13/02;;E03F7/02,E02B13/02,,0,0,,,,DISCONTINUED
11,CN,C,CN 100573486 C,102-646-973-288-428,2009-12-23,2009,CN 200480014492 A,2004-05-12,US 44698603 A,2003-05-27,A method and apparatus to improve multi-cpu system performance for accesses to memory,,INTEL CORP,JAMES DODD;;ROBERT MILSTREY,,https://lens.org/102-646-973-288-428,Granted Patent,no,0,0,14,14,0,G06F13/1631;;G06F13/00;;G06F13/1663;;G06F13/1631,G06F13/16,,0,0,,,,INACTIVE
12,EP,A1,EP 1532537 A1,071-647-523-467-826,2005-05-25,2005,EP 03791721 A,2003-08-22,US 0326244 W;;US 22961702 A,2002-08-27,ADDRESS DECODE,,INTEL CORP,DODD JAMES;;MILSTREY ROBERT,,https://lens.org/071-647-523-467-826,Patent Application,yes,0,0,11,11,0,G06F12/06;;G06F12/06;;G06F13/42;;G06F12/02,G06F12/06,,1,0,,,See references of WO 2004021201A1,DISCONTINUED
13,CN,C,CN 100377138 C,035-622-214-117-076,2008-03-26,2008,CN 03824643 A,2003-08-22,US 22961702 A,2002-08-27,Address decode method and system,,INTEL CORP,JAMES DODD;;ROBERT MILSTREY,,https://lens.org/035-622-214-117-076,Granted Patent,no,3,0,11,11,0,G06F12/06;;G06F12/06;;G06F13/42;;G06F12/02,G06F13/42;;G06F12/06,,0,0,,,,EXPIRED
14,WO,A2,WO 2004/107184 A2,055-273-059-447-018,2004-12-09,2004,US 2004/0014807 W,2004-05-12,US 44698603 A,2003-05-27,A METHOD AND APPARATUS TO IMPROVE MULTI-CPU SYSTEM PERFORMANCE FOR ACCESSES TO MEMORY,A flowchart and circuit for tracking memory page accesses in a multi-processor computing system to optimize memory bandwidth utilization.,INTEL CORP,DODD JAMES;;MILSTREY ROBERT,,https://lens.org/055-273-059-447-018,Patent Application,yes,0,3,14,14,0,G06F13/1631;;G06F13/00;;G06F13/1663;;G06F13/1631,G06F13/16,,0,0,,,,PENDING
15,CN,A,CN 1695131 A,078-106-194-016-954,2005-11-09,2005,CN 03824643 A,2003-08-22,US 22961702 A,2002-08-27,Address decode,,INTEL CORP,ROBERT DODD JAMES MILSTREY,,https://lens.org/078-106-194-016-954,Patent Application,no,0,0,11,11,0,G06F12/06;;G06F12/06;;G06F13/42;;G06F12/02,G06F12/06,,0,0,,,,EXPIRED
16,WO,A3,WO 2004/107184 A3,096-458-208-643-652,2005-01-27,2005,US 2004/0014807 W,2004-05-12,US 44698603 A,2003-05-27,A METHOD AND APPARATUS TO IMPROVE MULTI-CPU SYSTEM PERFORMANCE FOR ACCESSES TO MEMORY,A flowchart and circuit for tracking memory page accesses in a multi-processor computing system to optimize memory bandwidth utilization.,INTEL CORP,DODD JAMES;;MILSTREY ROBERT,,https://lens.org/096-458-208-643-652,Search Report,yes,6,0,14,14,0,G06F13/1631;;G06F13/00;;G06F13/1663;;G06F13/1631,G06F13/16,,0,0,,,,PENDING
17,DE,B4,DE 112004000694 B4,060-140-262-272-34X,2018-04-12,2018,DE 112004000694 T,2004-05-12,US 44698603 A;;US 2004/0014807 W,2003-05-27,Ein Verfahren und eine Vorrichtung zur Verbesserung der Multi-CPU-Systemleistung für Speicherzugriffe,"Vorrichtung, umfassend: mehrere CPUs (102, 104), die über einen Speicher-Controller-Hub (106) mit einem DRAM-Speicher (108, 406) mit mehreren Speicherbänken gekoppelt sind, wobei jede der CPUs mehrere DRAM-Verfolgungsregister (204) aufweist; wobei jede der CPUs (102, 104) eingerichtet ist, als Antwort auf Empfangen (302) einer Snoop-Adresse (202) von einer der anderen CPUs (102, 104) oder anderen Agenten die Snoop-Adresse (202) mittels eines Bankdekodierers (208) zu dekodieren (304), um eine der Speicherbänke, auf die die andere CPU zugreift, zu bestimmen, und ferner eingerichtet ist, anhand der bestimmten Speicherbank eines der DRAM-Verfolgungsregister (204) zu bestimmen, mehrere Seitenadressenbits der Snoop-Adresse (202) mittels eines Komparators (210) mit dem Inhalt des DRAM-Verfolgungsregisters (204) zu vergleichen (306), um zu bestimmen, ob eine der Snoop-Adresse (202) entsprechende Seite des DRAM-Speichers (108, 406) geöffnet ist, und, falls keine Übereinstimmung vorliegt, eine geöffnete Seite der Speicherbank zu schließen, eine der Snoop-Adresse (202) entsprechende Seite zu öffnen und die Snoop-Adresse (202) in das DRAM-Verfolgungsregister (204) zu laden; und wobei jede der CPUs (102, 104) ferner eingerichtet ist, Adressen ausgehender Transaktionen in einer Transaktionswarteschlange in DRAM-Verfolgungsregister (204), die den Speicherbänken der Adressen der Transaktionen entsprechen, zu laden und die ausgehenden Transaktionen in der Transaktionswarteschlange anhand bereits geöffneter Seiten zu ordnen.",INTEL CORP,DODD JAMES;;MILSTREY ROBERT,,https://lens.org/060-140-262-272-34X,Granted Patent,no,6,0,14,14,0,G06F13/1631;;G06F13/00;;G06F13/1663;;G06F13/1631,G06F12/02;;G06F13/00;;G06F13/16,,0,0,,,,INACTIVE
18,AU,A1,AU 2003/258322 A1,004-203-268-616-160,2004-03-19,2004,AU 2003/258322 A,2003-08-22,US 22961702 A;;US 0326244 W,2002-08-27,ADDRESS DECODE,,INTEL CORP,MILSTREY ROBERT;;DODD JAMES,,https://lens.org/004-203-268-616-160,Patent Application,no,0,0,11,11,0,G06F12/06;;G06F12/06;;G06F13/42;;G06F12/02,G06F12/06,,0,0,,,,DISCONTINUED
19,KR,A,KR 20050057060 A,067-257-412-742-145,2005-06-16,2005,KR 20057003512 A,2005-02-28,US 22961702 A,2002-08-27,ADDRESS DECODE,"Machine-readable media, methods, and apparatus are described which process memory transactions. In some embodiments, a processor or other external components provide a memory controller with decoded memory addresses. The memory controller then may access the memory with the processor decoded address without decoding the address itself. In other embodiments, a processor or other external components provide a memory controller with partially decoded memory addresses. The memory controller then generates a decoded address from the partially decoded address and may access the memory with the generated decoded address.",INTEL CORP,DODD JAMES;;MILSTREY ROBERT,,https://lens.org/067-257-412-742-145,Patent Application,no,0,0,11,11,0,G06F12/06;;G06F12/06;;G06F13/42;;G06F12/02,G06F12/06,,0,0,,,,INACTIVE
20,CN,A,CN 1795441 A,102-045-572-448-394,2006-06-28,2006,CN 200480014492 A,2004-05-12,US 44698603 A,2003-05-27,A method and apparatus to improve multi-cpu system performance for accesses to memory,,INTEL CORP,ROBERT DODD JAMES MILSTREY,,https://lens.org/102-045-572-448-394,Patent Application,no,0,6,14,14,0,G06F13/1631;;G06F13/00;;G06F13/1663;;G06F13/1631,G06F13/16,,0,0,,,,INACTIVE
21,GB,A,GB 2416055 A,135-863-056-990-330,2006-01-11,2006,GB 0521374 A,2004-05-12,US 2004/0014807 W;;US 44698603 A,2003-05-27,A method and apparatus to improve multi-CPU system performance for accesses to memory,A flowchart and circuit for tracking memory page accesses in a multi-processor computing system to optimize memory bandwidth utilization.,INTEL CORP,DODD JAMES;;MILSTREY ROBERT,,https://lens.org/135-863-056-990-330,Patent Application,no,6,0,14,14,0,G06F13/1631;;G06F13/00;;G06F13/1663;;G06F13/1631,G06F13/16;;G06F13/00,G4A AMB           MB,0,0,,,,INACTIVE
22,GB,B,GB 2416055 B,133-724-421-389-250,2007-03-21,2007,GB 0521374 A,2004-05-12,US 2004/0014807 W;;US 44698603 A,2003-05-27,A method and apparatus to improve multi-CPU system performance for accesses to memory,,INTEL CORP,DODD JAMES;;MILSTREY ROBERT,,https://lens.org/133-724-421-389-250,Granted Patent,no,6,0,14,14,0,G06F13/1631;;G06F13/00;;G06F13/1663;;G06F13/1631,G06F13/16;;G06F13/00,G4A AMB           MB,0,0,,,,INACTIVE
23,DE,T5,DE 112004000694 T5,135-007-620-299-961,2007-07-26,2007,DE 112004000694 T,2004-05-12,US 44698603 A;;US 2004/0014807 W,2003-05-27,Ein Verfahren und eine Vorrichtung zur Verbesserung der Multi-CPU-Systemleistung für Speicherzugriffe,,INTEL CORP,DODD JAMES;;MILSTREY ROBERT,,https://lens.org/135-007-620-299-961,Patent Application,no,0,1,14,14,0,G06F13/1631;;G06F13/00;;G06F13/1663;;G06F13/1631,G06F13/00;;G06F13/16,,0,0,,,,INACTIVE
24,HK,A1,HK 1079311 A1,090-817-336-823-694,2006-03-31,2006,HK 06101054 A,2006-01-24,US 44698603 A;;US 2004/0014807 W,2003-05-27,A method and apparatus to improve multi-cpu systemperformance for accesses to memory,,INTEL CORP,DODD JAMES;;MILSTREY ROBERT,,https://lens.org/090-817-336-823-694,Patent Application,no,0,0,14,14,0,G06F13/1631;;G06F13/00;;G06F13/1663;;G06F13/1631,G06F/;;G06F13/16,,0,0,,,,DISCONTINUED
25,WO,A1,WO 2004/021201 A1,107-804-624-205-914,2004-03-11,2004,US 0326244 W,2003-08-22,US 22961702 A,2002-08-27,ADDRESS DECODE,"Machine-readable media, methods, and apparatus are described which process memory transactions. In some embodiments, a processor or other external components provide a memory controller with decoded memory addresses. The memory controller then may access the memory with the processor decoded address without decoding the address itself. In other embodiments, a processor or other external components provide a memory controller with partially decoded memory addresses. The memory controller then generates a decoded address from the partially decoded address and may access the memory with the generated decoded address.",INTEL CORP,DODD JAMES;;MILSTREY ROBERT,,https://lens.org/107-804-624-205-914,Patent Application,yes,3,1,11,11,0,G06F12/06;;G06F12/06;;G06F13/42;;G06F12/02,G06F12/06,,0,0,,,,PENDING
26,US,A1,US 2004/0042320 A1,021-141-508-786-595,2004-03-04,2004,US 22961702 A,2002-08-27,US 22961702 A,2002-08-27,Address decode,"
   Machine-readable media, methods, and apparatus are described which process memory transactions. In some embodiments, a processor or other external components provide a memory controller with decoded memory addresses. The memory controller then may access the memory with the processor decoded address without decoding the address itself. In other embodiments, a processor or other external components provide a memory controller with partially decoded memory addresses. The memory controller then generates a decoded address from the partially decoded address and may access the memory with the generated decoded address. 
",DODD JAMES M.;;MILSTREY ROBERT,DODD JAMES M;;MILSTREY ROBERT,INTEL CORPORATION (2002-08-20),https://lens.org/021-141-508-786-595,Patent Application,yes,22,13,11,11,0,G06F12/06;;G06F12/06;;G06F13/42;;G06F12/02,G06F12/06,365/230.06;;365/233.5,0,0,,,,EXPIRED
27,GB,A,GB 190023102 A,025-772-841-766-199,1901-10-05,1901,GB 190023102D A,1900-12-18,GB 190023102T A,1900-12-18,"An Alarm to be Attached to the Doors of Traps, Pigeon Lofts and the like.","23,102. Atherton, W. R., and Dodd, W. Dec. 18. Signals, electric-bell.-Relates to an alarm signal for use with traps, cages, and the like, and specially adapted for notifying the return of a homing pigeon. The Figure shows a pigeon loft in which the bolting-wires a are formed with upward cranked extensions a<2>, to support the weighted ends c<1> of levers c so arranged that, when the wires a are moved by a returning bird, contact is made between the ends c<2> of the levers c and a bar e, thus completing an electric-bell circuit. The levers c are mounted on a movable spindle d, provided with an arm f and operated by a handle g so as to raise all the levers c simultaneously and place them in engagement with the extensions a' of the wires a. A spring h is arranged on the spindle d to bring the spindle d back to its normal position.",ATHERTON WILLIAM ROBERT;;DODD WILLIAM,ATHERTON WILLIAM ROBERT;;DODD WILLIAM,,https://lens.org/025-772-841-766-199,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
28,GB,A,GB 190600796 A,180-340-825-568-134,1906-11-29,1906,GB 190600796D A,1906-01-11,GB 190600796T A,1906-01-11,Improvements in Bricks,"796. Callender, W. R., and Dodd, W. Jan. 11. Bricks for walls and partitions are formed with grooves B on their upper and lower surfaces, vertical perforations C and recesses D, adapted to register with similar recesses in adjacent bricks. The bricks are made in two sizes, the smaller size having one perforation C, and are arranged to imitate Flemish bond, the perforations C forming continuous holes in the wall. These holes and the horizontal grooves B are filled with cement. Angle bricks are similarly constructed.",CALLENDER WILLIAM ROBERT;;DODD WILLIAM,CALLENDER WILLIAM ROBERT;;DODD WILLIAM,,https://lens.org/180-340-825-568-134,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
29,US,A,US 3523053 A,161-987-224-511-923,1970-08-04,1970,US 3523053D A,1968-05-14,US 72908368 A,1968-05-14,TAPE APPLICATOR DISPENSER,,JAMES ZBINDEN;;ROBERT E DODD,ZBINDEN JAMES;;DODD ROBERT E,,https://lens.org/161-987-224-511-923,Granted Patent,no,4,27,1,1,0,B65H35/0033;;B65H35/0033;;Y10T156/1348;;Y10T156/1348;;Y10T156/1793;;Y10T156/1793,B65H35/00,156/523,0,0,,,,EXPIRED
30,EP,A1,EP 3779213 A1,194-036-805-497-246,2021-02-17,2021,EP 20020340 A,2020-07-28,GB 201911628 A,2019-08-14,CONNECTION ARRANGEMENT,"A connection arrangement is described comprising a first elongate component 12, a second elongate component 14 and a connector member 22, wherein the first elongate component 12 is provided with a channel 16 of re-entrant form, and the connector member 22 includes a hook 24 receivable within the channel 16, wherein the channel 16 includes a first lip 18 extending towards a plane 20 in which a face of the first component 12 is located, a free edge of the lip 18 being spaced from the said plane 20 by a first spacing D1, and the hook 24 includes a second lip having a height less than or equal to the first spacing D1.
",STALCOM AUTOMOTIVE TECH LIMITED,MUSTARD ROBERT R;;DODD ROBIN,,https://lens.org/194-036-805-497-246,Patent Application,yes,1,0,4,4,0,F16B7/0493;;F16B5/0036,F16B7/04,,0,0,,,,PENDING
31,US,B2,US 6888777 B2,060-098-503-081-522,2005-05-03,2005,US 22961702 A,2002-08-27,US 22961702 A,2002-08-27,Address decode,"Machine-readable media, methods, and apparatus are described which process memory transactions. In some embodiments, a processor or other external components provide a memory controller with decoded memory addresses. The memory controller then may access the memory with the processor decoded address without decoding the address itself. In other embodiments, a processor or other external components provide a memory controller with partially decoded memory addresses. The memory controller then generates a decoded address from the partially decoded address and may access the memory with the generated decoded address.",INTEL CORP,DODD JAMES M;;MILSTREY ROBERT,INTEL CORPORATION (2002-08-20),https://lens.org/060-098-503-081-522,Granted Patent,yes,20,0,11,11,0,G06F12/06;;G06F12/06;;G06F13/42;;G06F12/02,G06F12/06,365/230.06;;365/230.03;;365/230.01,5,0,,,"10/446986-P15754-A Method and Apparatus to Improve Multi-CPU System Performance for Accesses to Memory-Dodd et al.;;10/284596-P15181-Memory Transaction Ordering-Dodd et al.;;10/364280-P15186-Buffered Writes and Memory Page Control-Dodd.;;10/199578-P13911-A system, apparatus, and method for a flexible dram architecture-Dodd et al.;;10/104270-P13913-Memory system with burst length shorter than prefetch length-Dodd et al.",EXPIRED
32,GB,B,GB 2586251 B,027-980-610-351-665,2023-09-27,2023,GB 201911628 A,2019-08-14,GB 201911628 A,2019-08-14,Connection arrangement,,STALCOM AUTOMOTIVE TECH LIMITED,ROBERT R MUSTARD;;ROBIN DODD,,https://lens.org/027-980-610-351-665,Granted Patent,no,5,0,4,4,0,F16B7/0493;;F16B5/0036,F16B5/00,,0,0,,,,ACTIVE
33,GB,A,GB 2586251 A,141-864-217-642-84X,2021-02-17,2021,GB 201911628 A,2019-08-14,GB 201911628 A,2019-08-14,Connection arrangement,"A connection arrangement comprises a first elongate component (12, fig 1), a second elongate component (14, fig 1) and a connector member 22, wherein the first elongate component is provided with a channel 16 of re-entrant form and the connector member includes a hook 24 receivable within the channel, wherein the channel includes a first lip 18 extending towards a plane 20 in which a face of the first component is located, a free edge of the lip being spaced from the said plane by a first spacing D1 and the hook 24 includes a second lip 26 having a height D2 which less than or equal to the first spacing D1. The connector member can include a first planar section (36a, fig 8), at least part which is attachable to the first elongate component and a second planar section (36b, fig 8), at least part of which is attachable to the second elongate component. A third planar section (36c) may also be present.",STALCOM AUTOMOTIVE TECH LIMITED,ROBERT R MUSTARD;;ROBIN DODD,,https://lens.org/141-864-217-642-84X,Patent Application,no,2,0,4,4,0,F16B7/0493;;F16B5/0036,F16B5/00,,0,0,,,,ACTIVE
34,TW,B,TW I240284 B,093-871-407-725-247,2005-09-21,2005,TW 92122743 A,2003-08-19,US 22961702 A,2002-08-27,Address decode,"Machine-readable media, methods, and apparatus are described which process memory transactions. In some embodiments, a processor or other external components provide a memory controller with decoded memory addresses. The memory controller then may access the memory with the processor decoded address without decoding the address itself. In other embodiments, a processor or other external components provide a memory controller with partially decoded memory addresses. The memory controller then generates? a decoded address from the partially decoded address and may access the memory with the generated decoded address.",INTEL CORP,DODD JAMES M;;MILSTREY ROBERT,,https://lens.org/093-871-407-725-247,Granted Patent,no,0,0,11,11,0,G06F12/06;;G06F12/06;;G06F13/42;;G06F12/02,G06F12/06,,0,0,,,,EXPIRED
35,US,A1,US 2004/0243768 A1,098-780-909-093-807,2004-12-02,2004,US 44698603 A,2003-05-27,US 44698603 A,2003-05-27,Method and apparatus to improve multi-CPU system performance for accesses to memory,"
   A flowchart and circuit for tracking memory page accesses in a multi-processor computing system to optimize memory bandwidth utilization. 
",DODD JAMES M.;;MILSTREY ROBERT,DODD JAMES M;;MILSTREY ROBERT,INTEL CORPORATION (2003-07-10),https://lens.org/098-780-909-093-807,Patent Application,yes,7,17,14,14,0,G06F13/1631;;G06F13/00;;G06F13/1663;;G06F13/1631,G06F13/16,711/146;;711/163;;711/158,0,0,,,,EXPIRED
36,TW,A,TW 200419585 A,166-721-085-886-269,2004-10-01,2004,TW 92122743 A,2003-08-19,US 22961702 A,2002-08-27,Address decode,"Machine-readable media, methods, and apparatus are described which process memory transactions. In some embodiments, a processor or other external components provide a memory controller with decoded memory addresses. The memory controller then may access the memory with the processor decoded address without decoding the address itself. In other embodiments, a processor or other external components provide a memory controller with partially decoded memory addresses. The memory controller then generates a decoded address from the partially decoded address and may access the memory with the generated decoded address.",INTEL CORP,DODD JAMES M;;MILSTREY ROBERT,,https://lens.org/166-721-085-886-269,Patent of Addition,no,0,0,11,11,0,G06F12/06;;G06F12/06;;G06F13/42;;G06F12/02,G06F12/06,,0,0,,,,EXPIRED
37,US,B2,US 7404047 B2,016-681-011-372-297,2008-07-22,2008,US 44698603 A,2003-05-27,US 44698603 A,2003-05-27,Method and apparatus to improve multi-CPU system performance for accesses to memory,"Methods and apparatuses for improving processor performance in a multi-processor system by optimizing accesses to memory. Processors can track the state of a memory such that the memory can be efficiently utilized in a multi-processor system including the ability to decode incoming snoop addresses from other processors, comparing them to contents of a memory tracking register(s), and updating tracking register(s) appropriately. Likewise, the transactions from other non-processor bus agents and/or bus mastering devices, such as a bus bridge, memory controller, Input/output (I/O), and graphics could also be tracked.",INTEL CORP,DODD JAMES M;;MILSTREY ROBERT,INTEL CORPORATION (2003-07-10),https://lens.org/016-681-011-372-297,Granted Patent,yes,8,7,14,14,0,G06F13/1631;;G06F13/00;;G06F13/1663;;G06F13/1631,G06F13/14;;G06F13/16,711/147;;711/146;;711/141;;711/5,2,0,,,"Examination Report from GB Application No. GB0521374.9, mailed Feb. 22, 2006, 11 pgs.;;PCT Search Report Dec. 13, 2004.",INACTIVE
38,US,A1,US 2003/0189868 A1,051-294-530-738-843,2003-10-09,2003,US 11991902 A,2002-04-09,US 11991902 A,2002-04-09,Early power-down digital memory device and method,"
   Methods and devices for a memory system are disclosed. A digital memory device can receive power-down commands during the pendency of an active-mode command such as a burst read or write, that is, early. The device shuts down some circuitry, such as address and command registers, immediately upon receipt of the early power-down command. Other device components, e.g., those involved in servicing the burst read or write, remain active at least until their portion of the command has been completed. In some embodiments, the early power-down command can be issued concurrently with an active-mode command as an option to that command, freeing a memory controller from having to schedule and issue power-down commands separately. Significant power savings, as compared to those obtained with prior-art memory device power-down modes, are possible. 
",RIESENMAN ROBERT J.;;DODD JAMES M.,RIESENMAN ROBERT J;;DODD JAMES M,INTEL CORPORATION (2002-04-03),https://lens.org/051-294-530-738-843,Patent Application,yes,6,46,2,2,0,G11C5/143;;G11C7/20;;G11C11/4072;;G11C5/143;;G11C7/20;;G11C11/4072,G11C5/14;;G11C7/20;;G11C11/4072,365/226,0,0,,,,EXPIRED
39,WO,A2,WO 2003/083664 A2,101-324-271-426-795,2003-10-09,2003,US 0307913 W,2003-03-13,US 10441202 A,2002-03-22,MAPPING DATA MASKS IN HARDWARE BY CONTROLLER PROGRAMMING,"A memory controller or other device may be programmed with a data mask mapping scheme. A selection device within the memory controller may be set with the data mask mapping scheme between data and a data mask. In one embodiment, a storage device may be included and programmed with the data mask mapping scheme.",INTEL CORP,RIESENMAN ROBERT;;DODD JAMES;;WILLIAMS MICHAEL,,https://lens.org/101-324-271-426-795,Patent Application,yes,0,0,18,18,0,G06F13/1668;;G06F12/00;;G06F13/16;;G06F13/1668,G06F13/16,,0,0,,,,PENDING
40,HK,A1,HK 1068971 A1,030-255-010-331-771,2005-05-06,2005,HK 04109923 A,2004-12-14,US 0307913 W;;US 10441202 A,2002-03-22,MAPPING DATA MASKS IN HARDWARE BY CONTROLLER PROGRAMMING,"A memory controller or other device may be programmed with a data mask mapping scheme. A selection device within the memory controller may be set with the data mask mapping scheme between data and a data mask. In one embodiment, a storage device may be included and programmed with the data mask mapping scheme.",INTEL CORP,RIESENMAN ROBERT;;DODD JAMES;;WILLIAMS MICHAEL,,https://lens.org/030-255-010-331-771,Patent Application,no,0,0,18,18,0,G06F13/1668;;G06F12/00;;G06F13/16;;G06F13/1668,G06F/;;G06F13/16,,0,0,,,,DISCONTINUED
41,US,A,US 1143893 A,121-628-602-962-081,1915-06-22,1915,US 1914/0847493 A,1914-06-26,US 1914/0847493 A,1914-06-26,PREPARATION OF SEMIPLASTIC MATERIAL FROM THE SOJA BEAN.,,DODD ROBERT;;HUMPHRIES HERBERT BROOKE PERREN,DODD ROBERT;;HUMPHRIES HERBERT BROOKE PERREN,,https://lens.org/121-628-602-962-081,Granted Patent,no,0,0,1,1,0,A23J1/14;;Y10S264/38;;A23J1/14;;Y10S264/38,,,0,0,,,,EXPIRED
42,DE,A1,DE 1474618 A1,182-185-657-959-675,1969-01-30,1969,DE 1474618 A,1965-11-26,DE P0038209 A,1965-11-26,Abwiegemaschine,,PNEUMATIC SCALE CORP,WILLIAM VERGOBBI ROBERT;;LLOYD DODD EDMUND,,https://lens.org/182-185-657-959-675,Patent Application,no,0,0,3,3,0,G01G13/00,G01G13/00,,0,0,,,,EXPIRED
43,AU,A8,AU 2003/214186 A8,073-737-160-428-984,2003-10-13,2003,AU 2003/214186 A,2003-03-13,US 10483702 A;;US 0307915 W,2002-03-22,Obtaining data mask mapping information,"A data mask map may be programmed into a storage device in various ways. In one embodiment, the data mask is hardwired into a selection device to reorder either the data mask bits or the data chunks. In another embodiment, a data mask map is retrieved from a location in memory. In still another embodiment, the data mask map is determined through an algorithm.",INTEL CORP,DODD JAMES;;RIESENMAN ROBERT;;WILLIAMS MICHAEL,,https://lens.org/073-737-160-428-984,Patent Application,no,0,0,22,22,0,G06F12/04;;G06F13/1626;;G06F12/00;;G06F13/16;;G06F12/06;;G06F13/1626;;G06F12/04,G06F12/04;;G06F12/06;;G06F13/16,,0,0,,,,DISCONTINUED
44,DE,D1,DE 60336894 D1,086-717-703-264-693,2011-06-09,2011,DE 60336894 T,2003-03-13,US 10483702 A;;US 0307915 W,2002-03-22,ERFASSUNG VON DATENMASKENABBILDUNGSINFORMATION,"A data mask map may be programmed into a storage device in various ways. In one embodiment, the data mask is hardwired into a selection device to reorder either the data mask bits or the data chunks. In another embodiment, a data mask map is retrieved from a location in memory. In still another embodiment, the data mask map is determined through an algorithm.",INTEL CORP,RIESENMAN ROBERT;;DODD JAMES;;WILLIAMS MICHAEL,,https://lens.org/086-717-703-264-693,Granted Patent,no,0,0,22,22,0,G06F12/04;;G06F13/1626;;G06F12/00;;G06F13/16;;G06F12/06;;G06F13/1626;;G06F12/04,G06F13/16;;G06F12/04;;G06F12/06,,0,0,,,,EXPIRED
45,US,A,US 5292327 A,157-630-656-984-138,1994-03-08,1994,US 95866192 A,1992-10-08,US 95866192 A,1992-10-08,Surgical knot pusher,"A surgical knot pusher for moving a knot along a length of suture material to a remote site includes a rod extending along a longitudinal axis from an engagement end to a grasping end, a notch spaced from said engagement end, a passageway sized to receive surgical thread lying on said longitudinal axis and extending from said engagement end to said notch, and a tapered camming surface positioned to be engaged by said surgical thread and moved to a position where it may be grasped by the surgeon.",DODD JOSEPH T;;GREENLER ROBERT J,DODD JOSEPH T;;GREENLER ROBERT J,,https://lens.org/157-630-656-984-138,Granted Patent,yes,28,121,1,1,0,A61B17/12013;;A61B17/12013;;A61B17/0467;;A61B17/0467;;A61B17/320016;;A61B17/320016;;A61B17/3201;;A61B17/3201;;A61B2017/0474;;A61B2017/0474;;A61B2017/0477;;A61B2017/0477,A61B17/04;;A61B17/12;;A61B17/32,606/148;;606/1.139,1,0,,,"General Surgery & Laparoscopy News, p. 14, Aug. 1992, advertisement for Sharpe ENDO ASSIST Endoscopic Knot Pusher, Sharpe ENDOSURGICAL.",EXPIRED
46,EP,B1,EP 1488321 B1,026-693-227-176-675,2011-04-27,2011,EP 03711594 A,2003-03-13,US 0307915 W;;US 10483702 A,2002-03-22,OBTAINING DATA MASK MAPPING INFORMATION,"A data mask map may be programmed into a storage device in various ways. In one embodiment, the data mask is hardwired into a selection device to reorder either the data mask bits or the data chunks. In another embodiment, a data mask map is retrieved from a location in memory. In still another embodiment, the data mask map is determined through an algorithm.",INTEL CORP,RIESENMAN ROBERT;;DODD JAMES;;WILLIAMS MICHAEL,,https://lens.org/026-693-227-176-675,Granted Patent,yes,3,0,22,22,0,G06F12/04;;G06F13/1626;;G06F12/00;;G06F13/16;;G06F12/06;;G06F13/1626;;G06F12/04,G06F13/16;;G06F12/04;;G06F12/06,,0,0,,,,EXPIRED
47,DE,D1,DE 60329172 D1,100-276-059-156-61X,2009-10-22,2009,DE 60329172 T,2003-03-13,US 10441202 A;;US 0307913 W,2002-03-22,ABBILDUNG VON DATENMASKEN IN HARDWARE DURCH STEUERUNGSPROGRAMMIERUNG,"A memory controller or other device may be programmed with a data mask mapping scheme. A selection device within the memory controller may be set with the data mask mapping scheme between data and a data mask. In one embodiment, a storage device may be included and programmed with the data mask mapping scheme.",INTEL CORP,RIESENMAN ROBERT;;DODD JAMES;;WILLIAMS MICHAEL,,https://lens.org/100-276-059-156-61X,Granted Patent,no,0,0,18,18,0,G06F13/1668;;G06F12/00;;G06F13/16;;G06F13/1668,G06F13/16,,0,0,,,,EXPIRED
48,EP,A2,EP 1488321 A2,135-218-466-878-892,2004-12-22,2004,EP 03711594 A,2003-03-13,US 0307915 W;;US 10483702 A,2002-03-22,OBTAINING DATA MASK MAPPING INFORMATION,"A data mask map may be programmed into a storage device in various ways. In one embodiment, the data mask is hardwired into a selection device to reorder either the data mask bits or the data chunks. In another embodiment, a data mask map is retrieved from a location in memory. In still another embodiment, the data mask map is determined through an algorithm.",INTEL CORP,RIESENMAN ROBERT;;DODD JAMES;;WILLIAMS MICHAEL,,https://lens.org/135-218-466-878-892,Patent Application,yes,0,0,22,22,0,G06F12/04;;G06F13/1626;;G06F12/00;;G06F13/16;;G06F12/06;;G06F13/1626;;G06F12/04,G06F12/04;;G06F12/06;;G06F13/16,,0,0,,,,EXPIRED
49,CN,A,CN 112823363 A,182-391-133-518-761,2021-05-18,2021,CN 202080001949 A,2020-08-28,US 201916556033 A;;CN 2020112084 W,2019-08-29,SYSTEMS AND METHODS FOR COSMETICS PRODUCTS RETAIL DISPLAYS,"A system and method for electronically managing display components for cosmetics products. The system and method increase automation and efficiency in the operations of the computer networks, graphical user interfaces and databases for cosmetics retail displays to be responsive to retail store and customer requirements and increase performance of such systems. The system integrates information from various, often disparate and remotely located systems and databases, involved in the designing, manufacturing, producing, allocating and/or delivering components of cosmetics products retail displays to a diverse set of retail store locations. Customizations of cosmetics retail displays at various retail store locations are automated and facilitated based on cosmetics products retail sales performance at the various retail store locations. Users of such a system are provided information to more efficiently provide cosmetics retail displays and components, and supply updates to such displays according to current product data, inventory and brand or manufacturer requirements.",MEIYUME HOLDING CO LTD;;MEIYUME HONG KONG LTD,BROCKMAN ROBERT;;DODD STEVE;;ATHERTON GRAHAM,,https://lens.org/182-391-133-518-761,Patent Application,no,4,0,7,9,0,G06Q10/043;;G06Q10/0637;;G06Q10/043;;G06Q10/0637;;G06Q10/06315;;G06Q10/10;;A47F7/0021;;G06Q10/0637;;A47F7/0021;;G06Q10/043,G06Q10/00;;G06Q10/08,,0,0,,,,PENDING
50,KR,A,KR 20220053652 A,035-538-474-291-474,2022-04-29,2022,KR 20227010530 A,2020-08-28,US 201916556033 A;;CN 2020112084 W,2019-08-29,화장품 소매 디스플레이 시스템 및 방법,"화장품에 대한 디스플레이 구성요소들을 전자적으로 관리하기 위한 시스템 및 방법이 개시되어 있다. 상기 시스템 및 방법은 소매점 및 고객 요구사항에 응답하고 이러한 시스템의 성능을 증가시키기 위해 화장품 소매 디스플레이를 위한 컴퓨터 네트워크, 그래픽 사용자 인터페이스 및 데이터베이스의 운영의 자동화 및 효율을 증가시킨다. 상기 시스템은 화장품 소매 디스플레이의 구성요소들을 다양한 소매점 위치 세트로 설계, 제조, 생성, 할당 및/또는 배달하는 것과 관련된 개별적이고 원격 위치된 시스템 및 데이터베이스로부터의 정보를 통합한다. 다양한 위치에서의 화장품 소매 디스플레이의 맞춤화는 다양한 소매점 위치에서의 화장품 소매 판매 실적에 기초하여 자동화 및 촉진된다. 이러한 시스템의 사용자에게는 화장품 소매 디스플레이 및 구성 요소를 보다 효율적으로 제공하고 현재 제품 데이터, 재고 및 브랜드 또는 제조업자 요구사항에 따라 이러한 디스플레이에 업데이트를 제공하기 위한 정보가 제공된다.",MEIYUME HOLDINGS B V I LTD;;MEIYUME HONG KONG LTD,BROCKMAN ROBERT;;DODD STEVE;;ATHERTON GRAHAM,,https://lens.org/035-538-474-291-474,Patent Application,no,0,0,7,9,0,G06Q10/043;;G06Q10/0637;;G06Q10/043;;G06Q10/0637;;G06Q10/06315;;G06Q10/10;;A47F7/0021;;G06Q10/0637;;A47F7/0021;;G06Q10/043,G06Q10/04;;A47F7/00;;G06Q10/06;;G06Q10/10,,0,0,,,,PENDING
51,FR,A,FR 474201 A,052-453-023-126-553,1915-02-12,1915,FR 474201D A,1914-06-27,GB 474201X A,1913-07-03,Perfectionnements à la préparation d'une matière semi-plastique au moyen de la fève de soja,,ROBERT DODD;;HERBERT BROOKE PERREN HUMPHRIE,DODD ROBERT;;HUMPHRIES HERBERT BROOKE PERREN,,https://lens.org/052-453-023-126-553,Granted Patent,no,0,0,1,1,0,C08K3/30;;C08K3/013;;C08K2003/3045,C08L89/00,"XIV, 8",0,0,,,,EXPIRED
52,US,A,US 5894567 A,044-641-211-853-158,1999-04-13,1999,US 53610995 A,1995-09-29,US 53610995 A,1995-09-29,Mechanism for enabling multi-bit counter values to reliably cross between clocking domains,"A queue structure for transmitting a multiple-bit signal from a first sub-system operating in a first clocking domain in a computer system to a second sub-system operating in a second clocking domain in the computer system is disclosed. The queue structure comprises a queue data latch having a plurality of storage elements, wherein each of the plurality of storage elements can store the multiple-bit signal from the first sub-system. A load pointer is used for generating a first multiple-bit count indicating one of the plurality of storage element for storing the multiple-bit signal. A synchronization unit is coupled to the load pointer for receiving the first multiple-bit count. The synchronization unit outputs the multiple-bit count at the second sub-system when the multiple-bit signal is ready to be sampled in the second clocking domain.",INTEL CORP,DODD JAMES M;;MURDOCH ROBERT N,INTEL CORPORATION (1995-09-26),https://lens.org/044-641-211-853-158,Granted Patent,yes,3,23,1,1,0,G06F5/06;;G06F13/405;;G06F5/06;;G06F13/405,G06F5/06;;G06F13/40,395/551;;395/558;;395/309,0,0,,,,EXPIRED
53,GB,A,GB 1104301 A,105-635-443-964-009,1968-02-21,1968,GB 4703966 A,1965-11-05,GB 4703966 A,1965-11-05,Weighing machine for filling containers with predetermined weights of material,"1,104,301. Controlling clutches. PNEUMATIC SCALE CORPORATION. 5 Nov., 1965, No. 47039/65. Heading F2L. [Also in Divisions B8 and G1] In a packaging machine the drive means includes a main cam-shaft 58 on which is mounted a one-revolution clutch 68, which includes a ratchet 348 and spring-pressed pawl 350 pivotally mounted in a pawl carrier disc 352 rotating with cam-shaft 58. A pawl stop 354 can disengage the pawl 350, and is connected to compressed-air drive means; if the scales weighing packages in the machine make their weight in time, the pawl stop 354 is retracted and the machine continues to cycle. A roller (364) mounted on arm 360 co-operates with a cut-out (365) on disc 352. If the pawl stop is actuated to cause the clutch to disengage, the roller 364 is urged into the cut-out (365) to stop shaft 58 in a "" zero "" position. When pawl 350 initially engages ratchet 348 a sharp impact is encountered, and to absorb such impact a friction drive assembly is provided including a separate driving arm 386 keyed to shaft 58 and provided with a drive block 388 received in a slot 390. A recess in disc 352 carries an annular friction element 398 against which bears an annular metal member 396, spring-mounted and connected to driving arm 386, so that the impact is taken up frictionally.",PNEUMATIC SCALE CORP,VERGOBBI ROBERT WILLIAM;;DODD EDMUND LLOYD,,https://lens.org/105-635-443-964-009,Granted Patent,no,0,5,1,1,0,B65B1/32;;G01G13/00,B65B1/32;;G01G13/00,B8A AF            AF;;B8A AR13          AF;;B8A AR8           AF;;B8A A1C4D1B       -;;B8A A1C4M5        -;;B8A A1C4S13       -;;B8A A1H12A        -;;B8A A1N           -;;B8C CU10          CU10;;B8C C40B2C1       CU10;;B8C C40B2C2       CU10;;B8C C40B2E        CU10;;B8C C40B2F2       CU10;;F2L L1A           -;;F2L L10U          -;;G1W WA3F          -;;G1W WA3H          -;;G1W WA3J          -;;G1W WA3L          -;;G1W WA3N          -;;G1W WA3P          -;;G1W WA3R          -;;G1W WA3X3         -;;G1W WA4           -;;G1W WG2           -,0,0,,,,EXPIRED
54,WO,A1,WO 2021/037202 A1,158-800-701-169-534,2021-03-04,2021,CN 2020112084 W,2020-08-28,US 201916556033 A,2019-08-29,SYSTEMS AND METHODS FOR COSMETICS PRODUCTS RETAIL DISPLAYS,"A system and method for electronically managing display components for cosmetics products. The system and method increase automation and efficiency in the operations of the computer networks, graphical user interfaces and databases for cosmetics retail displays to be responsive to retail store and customer requirements and increase performance of such systems. The system integrates information from various, often disparate and remotely located systems and databases, involved in the designing, manufacturing, producing, allocating and/or delivering components of cosmetics products retail displays to a diverse set of retail store locations. Customizations of cosmetics retail displays at various retail store locations are automated and facilitated based on cosmetics products retail sales performance at the various retail store locations. Users of such a system are provided information to more efficiently provide cosmetics retail displays and components, and supply updates to such displays according to current product data, inventory and brand or manufacturer requirements.",MEIYUME HOLDINGS B V I LTD;;MEIYUME HONG KONG LTD,BROCKMAN ROBERT;;DODD STEVE;;ATHERTON GRAHAM,,https://lens.org/158-800-701-169-534,Patent Application,yes,6,0,7,9,0,G06Q10/043;;G06Q10/0637;;G06Q10/043;;G06Q10/0637;;G06Q10/06315;;G06Q10/10;;A47F7/0021;;G06Q10/0637;;A47F7/0021;;G06Q10/043,G06Q10/00;;G06Q10/08,,0,0,,,,PENDING
55,US,A,US 955614 A,113-772-387-145-498,1910-04-19,1910,US 1909/0509809 A,1909-07-27,US 1909/0509809 A,1909-07-27,GAS-PRODUCER.,,STONE GEORGE C;;DODD ROBERT H,STONE GEORGE C;;DODD ROBERT H,,https://lens.org/113-772-387-145-498,Granted Patent,no,0,3,1,1,0,F27D3/10;;F27D3/10,,,0,0,,,,EXPIRED
56,AU,A8,AU 2003/218166 A8,124-203-921-686-083,2003-10-13,2003,AU 2003/218166 A,2003-03-13,US 10441202 A;;US 0307913 W,2002-03-22,Mapping data masks in hardware by controller programming,"A memory controller or other device may be programmed with a data mask mapping scheme. A selection device within the memory controller may be set with the data mask mapping scheme between data and a data mask. In one embodiment, a storage device may be included and programmed with the data mask mapping scheme.",INTEL CORP,RIESENMAN ROBERT;;WILLIAMS MICHAEL;;DODD JAMES,,https://lens.org/124-203-921-686-083,Patent Application,no,0,0,18,18,0,G06F13/1668;;G06F12/00;;G06F13/16;;G06F13/1668,G06F13/16,,0,0,,,,DISCONTINUED
57,CN,A,CN 1653435 A,154-844-003-751-390,2005-08-10,2005,CN 03810638 A,2003-03-13,US 0307913 W;;US 10441202 A,2002-03-22,Mapping data masks in hardware by controller programming,"A memory controller or other device may be programmed with a data mask mapping scheme. A selection device within the memory controller may be set with the data mask mapping scheme between data and a data mask. In one embodiment, a storage device may be included and programmed with the data mask mapping scheme.",INTEL CORP,ROBERT RIESENMAN;;JAMES DODD;;MICHAEL WILLIAMS,,https://lens.org/154-844-003-751-390,Patent Application,no,0,2,18,18,0,G06F13/1668;;G06F12/00;;G06F13/16;;G06F13/1668,G06F13/16,,0,0,,,,EXPIRED
58,AU,A1,AU 2003/218166 A1,008-734-947-054-348,2003-10-13,2003,AU 2003/218166 A,2003-03-13,US 10441202 A;;US 0307913 W,2002-03-22,MAPPING DATA MASKS IN HARDWARE BY CONTROLLER PROGRAMMING,"A memory controller or other device may be programmed with a data mask mapping scheme. A selection device within the memory controller may be set with the data mask mapping scheme between data and a data mask. In one embodiment, a storage device may be included and programmed with the data mask mapping scheme.",INTEL CORP,RIESENMAN ROBERT;;DODD JAMES;;WILLIAMS MICHAEL,,https://lens.org/008-734-947-054-348,Patent Application,no,0,0,18,18,0,G06F13/1668;;G06F12/00;;G06F13/16;;G06F13/1668,G06F13/16,,0,0,,,,DISCONTINUED
59,WO,A3,WO 2003/083665 A3,137-719-343-403-959,2003-12-18,2003,US 0307915 W,2003-03-13,US 10483702 A,2002-03-22,OBTAINING DATA MASK MAPPING INFORMATION,"A data mask map may be programmed into a storage device in various ways. In one embodiment, the data mask is hardwired into a selection device to reorder either the data mask bits or the data chunks. In another embodiment, a data mask map is retrieved from a location in memory. In still another embodiment, the data mask map is determined through an algorithm.",INTEL CORP,RIESENMAN ROBERT;;DODD JAMES;;WILLIAMS MICHAEL,,https://lens.org/137-719-343-403-959,Search Report,yes,3,0,22,22,0,G06F12/04;;G06F13/1626;;G06F12/00;;G06F13/16;;G06F12/06;;G06F13/1626;;G06F12/04,G06F12/04;;G06F12/06;;G06F13/16,,0,0,,,,PENDING
60,EP,A2,EP 1488322 A2,178-409-013-906-442,2004-12-22,2004,EP 03714157 A,2003-03-13,US 0307913 W;;US 10441202 A,2002-03-22,MAPPING DATA MASKS IN HARDWARE BY CONTROLLER PROGRAMMING,"A memory controller or other device may be programmed with a data mask mapping scheme. A selection device within the memory controller may be set with the data mask mapping scheme between data and a data mask. In one embodiment, a storage device may be included and programmed with the data mask mapping scheme.",INTEL CORP,RIESENMAN ROBERT;;DODD JAMES;;WILLIAMS MICHAEL,,https://lens.org/178-409-013-906-442,Patent Application,yes,0,0,18,18,0,G06F13/1668;;G06F12/00;;G06F13/16;;G06F13/1668,G06F13/16,,0,0,,,,EXPIRED
61,US,A,US 955615 A,104-491-067-371-886,1910-04-19,1910,US 955615D A,,US 955615T A,,GAS-PRODUCER.,,STONE GEORGE C;;DODD ROBERT H,STONE GEORGE C;;DODD ROBERT H,,https://lens.org/104-491-067-371-886,Granted Patent,no,0,3,1,1,0,F27D3/10;;F27D3/10,,,0,0,,,,EXPIRED
62,US,A,US 1692352 A,162-470-400-935-667,1928-11-20,1928,US 13485526 A,1926-09-11,US 13485526 A,1926-09-11,Mold for musical-instrument mouthpieces,,COLT S MFG CO,SCHMALZ WILLIAM F;;DODD ROBERT E,,https://lens.org/162-470-400-935-667,Granted Patent,no,0,0,1,1,0,B29C33/00;;B29C33/00,B29C33/00,,0,0,,,,EXPIRED
63,US,A,US 2502441 A,183-492-606-859-865,1950-04-04,1950,US 71181046 A,1946-11-22,US 71181046 A,1946-11-22,Phosphate coating of metals,,OAKITE PROD INC,DODD SIDNEY R;;AYRES ROBERT F,,https://lens.org/183-492-606-859-865,Granted Patent,no,9,34,1,1,0,C23C22/42;;C23C22/42,C23C22/42,,0,0,,,,EXPIRED
64,US,B2,US 6781911 B2,181-205-559-900-88X,2004-08-24,2004,US 11991902 A,2002-04-09,US 11991902 A,2002-04-09,Early power-down digital memory device and method,"
    Methods and devices for a memory system are disclosed. A digital memory device can receive power-down commands during the pendency of an active-mode command such as a burst read or write, that is, early. The device shuts down some circuitry, such as address and command registers, immediately upon receipt of the early power-down command. Other device components, e.g., those involved in servicing the burst read or write, remain active at least until their portion of the command has been completed. In some embodiments, the early power-down command can be issued concurrently with an active-mode command as an option to that command, freeing a memory controller from having to schedule and issue power-down commands separately. Significant power savings, as compared to those obtained with prior-art memory device power-down modes, are possible. 
",INTEL CORP,RIESENMAN ROBERT J;;DODD JAMES M,INTEL CORPORATION (2002-04-03),https://lens.org/181-205-559-900-88X,Granted Patent,yes,6,37,2,2,0,G11C5/143;;G11C7/20;;G11C11/4072;;G11C5/143;;G11C7/20;;G11C11/4072,G11C5/14;;G11C7/20;;G11C11/4072,365/226;;365/229;;713/322;;713/323,6,0,,,"Micron Technology, Inc., TN-48-07 Migrating from FPM/EDO to SDRAM, Rev. 5/00, pp.1-3.;;Micron Technology, Inc., TN-48-05 SDRAM Write to Active Command Timing, Rev. 11/00, pp. 1-3.;;Micron Technology, Inc., TN-46-05 General DDR SDRAM Functionality, Rev. A Pub. 7/01, pp. 1-11.;;Micron Technology, Inc., TN-48-01 Examples of Read-Modify-Write Cycles with Synchronous DRAMs, Rev. 2/99, pp. 1-3.;;Micron Technology, Inc., 64Mb: x32 Synchronous DRAM, Rev. 9/00, pp. 1-53.;;Micron Technology, Inc., 512Mb: x4, x8, x16 Double Data Rate(DDR) SDRAM, Rev. B; Pub. 4/01, pp. 1-68.",EXPIRED
65,AT,T1,AT E507528 T1,194-717-875-032-050,2011-05-15,2011,AT 03711594 T,2003-03-13,US 10483702 A;;US 0307915 W,2002-03-22,ERFASSUNG VON DATENMASKENABBILDUNGSINFORMATION,"A data mask map may be programmed into a storage device in various ways. In one embodiment, the data mask is hardwired into a selection device to reorder either the data mask bits or the data chunks. In another embodiment, a data mask map is retrieved from a location in memory. In still another embodiment, the data mask map is determined through an algorithm.",INTEL CORP,RIESENMAN ROBERT;;DODD JAMES;;WILLIAMS MICHAEL,,https://lens.org/194-717-875-032-050,Granted Patent,no,0,0,22,22,0,G06F12/04;;G06F13/1626;;G06F12/00;;G06F13/16;;G06F12/06;;G06F13/1626;;G06F12/04,G06F12/04;;G06F12/06;;G06F13/16,,0,0,,,,EXPIRED
66,AT,B,AT 82806 B,050-015-049-526-755,1921-02-25,1921,AT 82806D A,1914-06-24,GB 82806X A,1913-07-03,Verfahren zur Herstellung einer halbplastischen Masse aus Sojabohnen.,,DODD ROBERT;;HUMPHRIES HERBERT BROOKE PERRE,DODD ROBERT;;HUMPHRIES HERBERT BROOKE PERRE,,https://lens.org/050-015-049-526-755,Granted Patent,no,0,0,1,1,0,,,39B,0,0,,,,EXPIRED
67,US,A,US 3225847 A,065-687-556-942-450,1965-12-28,1965,US 24638262 A,1962-12-21,US 24638262 A,1962-12-21,Weighing machine,,PNEUMATIC SCALE CORP,VERGOBBI ROBERT W;;DODD EDMUND L,,https://lens.org/065-687-556-942-450,Granted Patent,no,16,7,1,1,0,G01G13/00;;G01G13/00,G01G13/00,,0,0,,,,EXPIRED
68,WO,A3,WO 2003/083664 A3,073-413-793-605-054,2003-12-04,2003,US 0307913 W,2003-03-13,US 10441202 A,2002-03-22,MAPPING DATA MASKS IN HARDWARE BY CONTROLLER PROGRAMMING,"A memory controller or other device may be programmed with a data mask mapping scheme. A selection device within the memory controller may be set with the data mask mapping scheme between data and a data mask. In one embodiment, a storage device may be included and programmed with the data mask mapping scheme.",INTEL CORP,RIESENMAN ROBERT;;DODD JAMES;;WILLIAMS MICHAEL,,https://lens.org/073-413-793-605-054,Search Report,yes,3,0,18,18,0,G06F13/1668;;G06F12/00;;G06F13/16;;G06F13/1668,G06F13/16,,0,0,,,,PENDING
69,AT,T1,AT E442626 T1,128-219-518-609-653,2009-09-15,2009,AT 03714157 T,2003-03-13,US 10441202 A;;US 0307913 W,2002-03-22,ABBILDUNG VON DATENMASKEN IN HARDWARE DURCH STEUERUNGSPROGRAMMIERUNG,"A memory controller or other device may be programmed with a data mask mapping scheme. A selection device within the memory controller may be set with the data mask mapping scheme between data and a data mask. In one embodiment, a storage device may be included and programmed with the data mask mapping scheme.",INTEL CORP,RIESENMAN ROBERT;;DODD JAMES;;WILLIAMS MICHAEL,,https://lens.org/128-219-518-609-653,Granted Patent,no,0,0,18,18,0,G06F13/1668;;G06F12/00;;G06F13/16;;G06F13/1668,G06F13/16,,0,0,,,,EXPIRED
70,CN,A,CN 1653434 A,183-991-346-002-254,2005-08-10,2005,CN 03810637 A,2003-03-13,US 10483702 A,2002-03-22,Obtaining data mask mapping information,"A data mask map may be programmed into a storage device in various ways. In one embodiment, the data mask is hardwired into a selection device to reorder either the data mask bits or the data chunks. In another embodiment, a data mask map is retrieved from a location in memory. In still another embodiment, the data mask map is determined through an algorithm.",INTEL CORP,ROBERT RIESENMAN;;JAMES DODD;;MICHAEL WILLIAMS,,https://lens.org/183-991-346-002-254,Patent Application,no,0,2,22,22,0,G06F12/04;;G06F13/1626;;G06F12/00;;G06F13/16;;G06F12/06;;G06F13/1626;;G06F12/04,G06F12/04;;G06F12/06;;G06F13/16,,0,0,,,,EXPIRED
71,US,A1,US 2021/0065122 A1,190-093-396-163-223,2021-03-04,2021,US 202017005336 A,2020-08-28,US 202017005336 A;;US 201916556033 A,2019-08-29,SYSTEMS AND METHODS FOR COSMETICS PRODUCTS RETAIL DISPLAYS,"Technological advancements are disclosed that increase automation and efficiency in the operations of the computer networks, graphical user interfaces and databases for cosmetics retail displays to be responsive to retail store and customer requirements and increase performance of such systems. The system integrates information from various, often disparate and remotely located systems and databases, involved in the designing, manufacturing, producing, allocating and/or delivering components of cosmetics products retail displays to a diverse set of retail store locations. Customizations of cosmetics retail displays at various retail store locations are automated and facilitated based on cosmetics products retail sales performance at the various retail store locations. Users of such a system are provided information to more efficiently provide various services, cosmetics retail displays and components, and supply updates to such displays according to current product data, inventory and brand or manufacturer requirements.",MEIYUME HOLDINGS B V I LTD,BROCKMAN ROBERT;;DODD STEVE;;ATHERTON GRAHAM,MEIYUME HOLDINGS (B.V.I.) LIMITED (2020-08-28),https://lens.org/190-093-396-163-223,Patent Application,yes,0,0,2,9,0,G06Q30/0201;;G06Q10/083;;G06Q10/0875;;G06Q10/06313;;G06Q10/06315;;G06Q10/103;;G06Q10/06375;;G06Q30/04;;H04W12/06;;H04W12/63;;G06Q10/103;;G06Q30/0201;;G06Q10/06375;;G06Q10/06315;;G06K7/10297;;G06Q10/0875;;G06Q10/083;;G06Q10/06313;;H04L63/102;;G06Q30/04,G06Q10/10;;G06K7/10;;G06Q10/06;;G06Q10/08;;G06Q30/02;;G06Q30/04;;H04L29/06,,0,0,,,,ACTIVE
72,US,A,US 4343655 A,067-081-757-497-134,1982-08-10,1982,US 26560981 A,1981-05-20,US 26560981 A;;US 9263179 A,1979-11-08,Insolubilizers for binders for paper coating compositions,"Paper coating compositions contain at least one pigment, at least one binder, and as an insolubilizer for the binder an alkylated product of the reaction of glyoxal and a cyclic urea.",SUN CHEMICAL CORP,DODD JOHN A;;LANE ROBERT L,SEQUA CHEMICALS INC. A DE. CORP (1987-12-16);;SEQUA CORPORATION (1987-05-07),https://lens.org/067-081-757-497-134,Granted Patent,yes,4,29,1,3,0,C08G12/28;;C08G12/28;;D21H19/62;;D21H19/62;;Y10T428/31975;;Y10T428/31975,C08G12/28;;D21H19/62,106/214,1,0,,,"Japanese Laid Open application No. J5 3044-567, Sep. 30, 1976.",EXPIRED
73,EP,B1,EP 1488322 B1,025-371-797-334-868,2009-09-09,2009,EP 03714157 A,2003-03-13,US 0307913 W;;US 10441202 A,2002-03-22,MAPPING DATA MASKS IN HARDWARE BY CONTROLLER PROGRAMMING,"A memory controller or other device may be programmed with a data mask mapping scheme. A selection device within the memory controller may be set with the data mask mapping scheme between data and a data mask. In one embodiment, a storage device may be included and programmed with the data mask mapping scheme.",INTEL CORP,RIESENMAN ROBERT;;DODD JAMES;;WILLIAMS MICHAEL,,https://lens.org/025-371-797-334-868,Granted Patent,yes,3,0,18,18,0,G06F13/1668;;G06F12/00;;G06F13/16;;G06F13/1668,G06F13/16,,0,0,,,,EXPIRED
74,AU,A1,AU 2003/214186 A1,078-012-231-627-029,2003-10-13,2003,AU 2003/214186 A,2003-03-13,US 10483702 A;;US 0307915 W,2002-03-22,OBTAINING DATA MASK MAPPING INFORMATION,"A data mask map may be programmed into a storage device in various ways. In one embodiment, the data mask is hardwired into a selection device to reorder either the data mask bits or the data chunks. In another embodiment, a data mask map is retrieved from a location in memory. In still another embodiment, the data mask map is determined through an algorithm.",INTEL CORP,RIESENMAN ROBERT;;DODD JAMES;;WILLIAMS MICHAEL,,https://lens.org/078-012-231-627-029,Patent Application,no,0,0,22,22,0,G06F12/04;;G06F13/1626;;G06F12/00;;G06F13/16;;G06F12/06;;G06F13/1626;;G06F12/04,G06F12/04;;G06F12/06;;G06F13/16,,0,0,,,,DISCONTINUED
75,CN,B,CN 1653435 B,131-854-986-892-93X,2010-05-26,2010,CN 03810638 A,2003-03-13,US 0307913 W;;US 10441202 A,2002-03-22,"Method, device and system for mapping data masks in hardware","A memory controller or other device may be programmed with a data mask mapping scheme. A selection device within the memory controller may be set with the data mask mapping scheme between data and a data mask. In one embodiment, a storage device may be included and programmed with the data mask mapping scheme.",INTEL CORP,ROBERT RIESENMAN;;MICHAEL WILLIAMS;;JAMES DODD,,https://lens.org/131-854-986-892-93X,Granted Patent,no,0,0,18,18,0,G06F13/1668;;G06F12/00;;G06F13/16;;G06F13/1668,G06F13/16;;G06F12/08,,0,0,,,,EXPIRED
76,WO,A2,WO 2003/083665 A2,018-631-889-437-332,2003-10-09,2003,US 0307915 W,2003-03-13,US 10483702 A,2002-03-22,OBTAINING DATA MASK MAPPING INFORMATION,"A data mask map may be programmed into a storage device in various ways. In one embodiment, the data mask is hardwired into a selection device to reorder either the data mask bits or the data chunks. In another embodiment, a data mask map is retrieved from a location in memory. In still another embodiment, the data mask map is determined through an algorithm.",INTEL CORP,RIESENMAN ROBERT;;DODD JAMES;;WILLIAMS MICHAEL,,https://lens.org/018-631-889-437-332,Patent Application,yes,0,0,22,22,0,G06F12/04;;G06F13/1626;;G06F12/00;;G06F13/16;;G06F12/06;;G06F13/1626;;G06F12/04,G06F12/04;;G06F12/06;;G06F13/16,,0,0,,,,PENDING
77,CN,C,CN 100380351 C,028-546-174-058-925,2008-04-09,2008,CN 03810637 A,2003-03-13,US 10483702 A,2002-03-22,Obtaining data mask mapping information,"A data mask map may be programmed into a storage device in various ways. In one embodiment, the data mask is hardwired into a selection device to reorder either the data mask bits or the data chunks. In another embodiment, a data mask map is retrieved from a location in memory. In still another embodiment, the data mask map is determined through an algorithm.",INTEL CORP,ROBERT RIESENMAN;;JAMES DODD;;MICHAEL WILLIAMS,,https://lens.org/028-546-174-058-925,Granted Patent,no,3,0,22,22,0,G06F12/04;;G06F13/1626;;G06F12/00;;G06F13/16;;G06F12/06;;G06F13/1626;;G06F12/04,G06F13/16;;G06F12/04;;G06F12/06,,0,0,,,,EXPIRED
78,US,B2,US 11334849 B2,116-121-614-407-76X,2022-05-17,2022,US 202017005336 A,2020-08-28,US 202017005336 A;;US 201916556033 A,2019-08-29,Systems and methods for cosmetics products retail displays,"Technological advancements are disclosed that increase automation and efficiency in the operations of the computer networks, graphical user interfaces and databases for cosmetics retail displays to be responsive to retail store and customer requirements and increase performance of such systems. The system integrates information from various, often disparate and remotely located systems and databases, involved in the designing, manufacturing, producing, allocating and/or delivering components of cosmetics products retail displays to a diverse set of retail store locations. Customizations of cosmetics retail displays at various retail store locations are automated and facilitated based on cosmetics products retail sales performance at the various retail store locations. Users of such a system are provided information to more efficiently provide various services, cosmetics retail displays and components, and supply updates to such displays according to current product data, inventory and brand or manufacturer requirements.",MEIYUME HOLDINGS B V I LTD,BROCKMAN ROBERT;;DODD STEVE;;ATHERTON GRAHAM,MEIYUME HOLDINGS (B.V.I.) LIMITED (2020-08-28),https://lens.org/116-121-614-407-76X,Granted Patent,yes,21,0,2,9,0,G06Q30/0201;;G06Q10/083;;G06Q10/0875;;G06Q10/06313;;G06Q10/06315;;G06Q10/103;;G06Q10/06375;;G06Q30/04;;H04W12/06;;H04W12/63;;G06Q10/103;;G06Q30/0201;;G06Q10/06375;;G06Q10/06315;;G06K7/10297;;G06Q10/0875;;G06Q10/083;;G06Q10/06313;;H04L63/102;;G06Q30/04,G06K7/10;;G06Q10/10;;G06Q10/06;;G06Q10/08;;G06Q30/02;;G06Q30/04;;H04L9/40,,3,3,002-239-381-130-164;;094-304-665-947-702;;175-644-551-568-357,10.1016/0022-4359(94)90002-7;;10.3390/s150921114;;pmc4610585;;26343659;;10.1007/s40685-016-0043-6,"Dreze, Xavier, Stephen J. Hoch, and Mary E. Purk. “Shelf management and space elasticity.” Journal of retailing 70.4 (1994): 301-326. (Year: 1994).;;Frontoni, Emanuele, Adriano Mancini, and Primo Zingaretti. “Embedded vision sensor network for planogram maintenance in retail environments.” Sensors 15.9 (2015): 21114-21133. (Year: 2015).;;Hubner et al., Effect of Replenishment and Backroom on Retail Shelf-Space Planning, Business Research (2017), 2017, pp. 123-156, vol. 10.",ACTIVE
79,CA,A,CA 771525 A,132-501-408-374-690,1967-11-14,1967,CA 771525D A,,CA 771525T A,,WEIGHING MACHINE,,PNEUMATIC SCALE CORP,VERGOBBI ROBERT W;;DODD EDMUND L,,https://lens.org/132-501-408-374-690,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
80,GB,A,GB 191315316 A,153-640-895-339-957,1914-06-18,1914,GB 191315316D A,1913-07-03,GB 191315316T A,1913-07-03,Preparation of Plastic Substances and the like from Protein Containing Materials.,"15,316. Dodd, R., and Humphries, H. B. P. July 3. Plastic compositions containing proteins &c. - A composition resembling horn, ivory, corozo nut, &c. is made from the protein matter of the soya bean. The bulk of the oil is removed. and the resulting meal is macerated in water; most of the insoluble and unemulsifiable matter is removed, and a coagulant is added to the liquid. The preferred coagulant is aluminium sulphate with or without an acid, and with or without formalin. In an example, 1 kg. of soya meal is macerated with water. The liquid is filtered or decanted, and warmed to 120‹ F. Colouring-matter is added and then a solution containing 100 grm. of aluminium sulphate and 20 cc. of formalin. The coagulate is strained off and moulded, the articles thus obtained being treated in a weak formaldehyde bath and dried. An alternative coagulant consists of 40 grams of aluminium sulphate, 20 cc. of hydrochloric acid, and 20 cc. of formalin in 250 cc. of water. Filling, hardening, or colouring materials may be introduced at any convenient stage of the process.",DODD ROBERT;;HUMPHRIES HERBERT BROOKE PERRE,DODD ROBERT;;HUMPHRIES HERBERT BROOKE PERRE,,https://lens.org/153-640-895-339-957,Patent Application,no,0,0,1,1,0,C08L99/00;;C08K5/098;;C08K5/30;;C08K2003/3045,C08L89/00,,0,0,,,,DISCONTINUED
81,EP,A1,EP 0148660 A1,151-851-267-902-961,1985-07-17,1985,EP 84402405 A,1984-11-26,FR 8319496 A,1983-12-06,"Beta-carboline derivatives, process for their preparation and medicaments containing them.","La présente invention concerne des dérivés de β-carbolines, des procédés pour leurs préparations et des médicaments les contenant.",CENTRE NAT RECH SCIENT,POTIER PIERRE;;DODD ROBERT;;ROSSIER JEAN-PIERRE,ETABLISSEMENT PUBLIC DIT:  CENTRE NATIONAL DE LA R (1987-02-25),https://lens.org/151-851-267-902-961,Patent Application,yes,1,2,3,3,0,A61P25/08;;A61P25/20;;C07D471/04,A61K31/47;;A61P25/08;;A61P25/20;;C07D471/04,,2,0,,,"CHEMICAL ABSTRACTS, vol. 96, no. 7, 15 février 1982, page 74, no. 46396u, Columbus, Ohio, US; H. CHANDRA et al.: ""Chemical ocelusion of rhesus monkey fallopian tube with 3-amine-9H-pyride(3,4-b)indole"" & MED. SCI.: LIBR. COMPEND. 1981, 9(10), 993;;CHEMICAL ABSTRACTS, vol. 98, no. 13, 28 mars 1983, page 190, no. 102389z, Columbus, Ohio, US; HIROKO TOHDA et al.: ""Actions of amino-beta-carbolines on induction of sister chromatid exchanges IND: DJJ"" & MUTAT. RES. 1983, 116(2), 137-47",DISCONTINUED
82,US,A,US 3698903 A,005-389-521-541-76X,1972-10-17,1972,US 3698903D A,1969-01-24,US 79366569 A,1969-01-24,METHOD OF MAKING A GRADED PHOTO-PRINTING MASTER,,RCA CORP,DODD JOHN A JR;;GESHNER ROBERT A,RCA LICENSING CORPORATION TWO INDEPENDENCE WAY PRINCETON NJ 08540 A CORP. OF DE (1987-12-08),https://lens.org/005-389-521-541-76X,Granted Patent,no,0,4,9,9,0,H01J9/142;;H01J9/142,H01J9/14;;H01J9/227,96/36.1,0,0,,,,EXPIRED
83,GB,A,GB 1276811 A,082-282-382-752-745,1972-06-07,1972,GB 357970 A,1970-01-26,US 79366569 A,1969-01-24,METHOD OF MAKING A GRADED STENCIL,"1276811 Photo-masks R C A CORPORATION 26 Jan 1970 [24 Jan 1969] 3579/70 Headings G2A G2J and G2M [Also in Divisions B6 and H1] Graded stencils (i.e. photo-masks) for use in the manufacture of shadow-mask cathode ray tubes having an array of opaque or transparent areas on a transparent or opaque background respectively, the sizes of the areas having a progressive variation from a maximum at the centre of the array to a minimum at the edges thereof, are prepared by a process comprising (1) exposing a light-sensitive film to a pattern which forms on the film an array of lighted areas of uniform size, the exposure time of at least the areas in the array varying from a maximum at the centre to a minimum at the edges, and (2) developing, specifically a hexagonal pattern of uniformly sized dots is mechanically plotted thus forming a fragmentary positive stencil, which is photographically reduced to form a negative stencil which is photographically reduced and stepped to form a positive stencil having dots whose size is equal to the smallest size required in the shadow mask; the positive stencil is used to form a corresponding negative stencil which is used together with the shutter described below to form either the required graded positive stencil or a negative stencil which is used to form the required graded positive stencil. The exposure may be effected in a single step; alternatively it may consist of a uniform exposure to produce dots of a uniform size and then a radially variable overall exposure. The shutter, Fig. 8 comprises a shutter plate 41 having an aperture 43 especially shaped to produce the required exposure time variation. The plate 41 is fixed above an aperture 46, to an opaque plate 45 rotatably mounted on a support platform 47 via rollers 47 and 51. In use, plate 45 and hence aperture 43 is rotated 465 times to contact expose stationary stencil 25, as described above.",RCA CORP,DODD JOHN ALTON JR;;GESHNER ROBERT ANDREW,,https://lens.org/082-282-382-752-745,Granted Patent,no,0,0,9,9,0,H01J9/142;;H01J9/142,H01J9/14;;H01J9/227,B6J JME           MEEM;;B6J J510          JA6A;;B6J J525          JA6A;;B6J J60Y          JA6A;;B6J J605          JA6A;;G2J J22           J22;;G2X XBX30B        XBX3;;G2X XBX30Y        XBX3;;G2X XNG           XNG;;G2X XN4           XN4;;H1D DAF4          AF4;;H1D D4A4          4C;;H1D D4A7          4C;;H1D D4G8          4C;;H1D D4K4          4C;;H1D D4K7D         4C;;H1D D4K7Y         4C,0,0,,,,EXPIRED
84,FR,A1,FR 2555988 A1,146-371-270-921-094,1985-06-07,1985,FR 8319496 A,1983-12-06,FR 8319496 A,1983-12-06,"DERIVE DE B-CARBOLINES, PROCEDE POUR LEURS PREPARATIONS ET MEDICAMENT LES CONTENANT","<P>LA PRESENTE INVENTION CONCERNE DES DERIVES DE B-CARBOLINES, DES PROCEDES POUR LEURS PREPARATIONS ET DES MEDICAMENTS LES CONTENANT.</P>",CENTRE NAT RECH SCIENT,POTIER PIERRE;;DODD ROBERT;;ROSSIER JEAN PIERRE,,https://lens.org/146-371-270-921-094,Patent Application,no,1,1,3,3,0,A61P25/08;;A61P25/20;;C07D471/04,A61K31/47;;A61P25/08;;A61P25/20;;C07D471/04,,2,0,,,"CHEMICAL ABSTRACTS, vol. 96, 1982, réf. no. 46396u, page 74, Columbus Ohio (US);;CHEMICAL ABSTRACTS, vol. 98, 1983, réf. no. 102389z, page 190, Columbus Ohio (US)",DISCONTINUED
85,SG,A,SG 10201913871U A,063-144-182-485-625,2021-03-30,2021,SG 10201913871U A,2019-12-30,US 201916556033 A,2019-08-29,Systems And Methods For Cosmetics Products Retail Displays,,MEIYUME HOLDINGS BVI LTD,BROCKMAN IV ROBERT;;DODD STEVE;;ATHERTON GRAHAM,,https://lens.org/063-144-182-485-625,Unknown,no,0,0,7,9,0,G06Q10/043;;G06Q10/0637;;G06Q10/043;;G06Q10/0637;;G06Q10/06315;;G06Q10/10;;A47F7/0021;;G06Q10/0637;;A47F7/0021;;G06Q10/043,,,0,0,,,,PENDING
86,GB,A,GB 651318 A,182-395-640-149-719,1951-03-14,1951,GB 2885948 A,1948-11-05,GB 2885948 A,1948-11-05,Improvements in or relating to the production of silver-halide photographic emulsions,"651,318. Photographic emulsions. ILFORD, Ltd. Nov. 5, 1948, No. 28859. Addition to 585,758. [Class 98 (ii)] A photographic emulsion is prepared by forming by double decomposition a suspension of silver halide in an aqueous solution of gelatine and adding thereto, at a low pH value, sufficient of an aromatic sulphonate which is not surfaceactive but has a hydrophobic group in the anion to cause precipitation of the gelatine phase containing the silver halide, separating the so-formed gelatine/aromatic sulphonate complex containing silver halide, washing the separated complex, and redispersing in a predominantly aqueous or predominantly organic liquid medium to form the emulsion. The aromatic sulphonate may be used in admixture with an anion soap. The complex may be used to form a highly concentrated emulsion for drying. The emulsion may be ripened before formation of the complex, and the emulsion formed by re-dispersion may be digested before coating. The aromatic sulphonate may be sodium naphthalene 1- or 2-monosulphonate, disodium naphthalene-1:5-disulphonate, trisodium naphthalene - 1 : 3 : 5 - trisulphonate, a naphthol sulphonate, or a dye such as Tartrazine. In example (1), the pH of a ripened fine-grain silver bromide emulsion is adjusted to 2.0 with sulphuric acid, an aqueous solution of sodium naphthalene-2-monosulphonate is added, the supernatant liquid is decanted from the precipitate, and the latter is dispersed in 40 per cent aqueous alcohol adjusted to pH 5.0 with alkali. The complex is re-precipitated by addition of 98 per cent ethyl alcohol, the supernatant liquid is decanted, the precipitate is soaked in water, and re-dispersed in aqueous gelatine solution. The resulting emulsion is digested and coated. In example (2), the procedure is similar using sodium 2 - naphthol - 6 - sulphonate, and in example (3), the procedure is similar to example (1) using an original emulsion of much greater gelatine strength. Specification 580,504 is referred to.",ILFORD LTD,SMITH ROBERT CHARLES MORRIS;;DODD EDWARD CYRIL,,https://lens.org/182-395-640-149-719,Granted Patent,no,0,0,1,1,0,G03C1/015,G03C1/015,G2C CC19F2        CC19,0,0,,,,EXPIRED
87,US,B2,US 11341448 B2,162-803-724-389-829,2022-05-24,2022,US 201916556033 A,2019-08-29,US 201916556033 A,2019-08-29,Systems and methods for cosmetics products retail displays,"Technological advancements are disclosed that increase automation and efficiency in the operations of the computer networks, graphical user interfaces and databases for cosmetics retail displays to be responsive to retail store and customer requirements and increase performance of such systems. The system integrates information from various, often disparate and remotely located systems and databases, involved in the designing, manufacturing, producing, allocating and/or delivering components of cosmetics products retail displays to a diverse set of retail store locations. Customizations of cosmetics retail displays at various retail store locations are automated and facilitated based on cosmetics products retail sales performance at the various retail store locations. Users of such a system are provided information to more efficiently provide cosmetics retail displays and components, and supply updates to such displays according to current market data, sales, inventory and brand or manufacturer requirements.",MEIYUME HOLDINGS BVI LTD,BROCKMAN IV ROBERT;;DODD STEVE;;ATHERTON GRAHAM,MEIYUME HOLDINGS (BVI) LIMITED (2019-08-06),https://lens.org/162-803-724-389-829,Granted Patent,yes,16,0,7,9,0,G06Q10/043;;G06Q10/0637;;G06Q10/043;;G06Q10/0637;;G06Q10/06315;;G06Q10/10;;A47F7/0021;;G06Q10/0637;;A47F7/0021;;G06Q10/043,G06Q10/06;;A47F7/00;;G06Q10/04,,6,3,175-644-551-568-357;;006-813-951-393-310;;094-304-665-947-702,10.1007/s40685-016-0043-6;;10.1109/vsmm.2010.5665949;;10.3390/s150921114;;pmc4610585;;26343659,"Hubner et al., “Effect of replenishment and backroom on retail shelf-space planning”, Business Research (2017) 10:123-156 (Year: 2017).;;Patel, Kirit. “Pharmacy design, merchandising and stock control.” Pharmacy Business Management (2005): 269. (Year: 2005).;;Guidi, Gabriele, et al. “Virtual reality for retail.” 2010 16th International Conference on Virtual Systems and Multimedia. IEEE, 2010. (Year: 2010).;;Frontoni, Emanuele, Adriano Mancini, and Primo Zingaretti. “Embedded Vision Sensor Network for Planogram Maintenance in Retail Environments.” Sensors 15.9 (2015): 21114-21133. (Year: 2015).;;Non-final Office Action for U.S. Appl. No. 17/005,336, dated Nov. 12, 2021, 16 pages.;;U.S. Appl. No. 17/005,336, filed Aug. 28, 2020.",ACTIVE
88,US,A1,US 2021/0065080 A1,004-968-855-356-943,2021-03-04,2021,US 201916556033 A,2019-08-29,US 201916556033 A,2019-08-29,SYSTEMS AND METHODS FOR COSMETICS PRODUCTS RETAIL DISPLAYS,"Technological advancements are disclosed that increase automation and efficiency in the operations of the computer networks, graphical user interfaces and databases for cosmetics retail displays to be responsive to retail store and customer requirements and increase performance of such systems. The system integrates information from various, often disparate and remotely located systems and databases, involved in the designing, manufacturing, producing, allocating and/or delivering components of cosmetics products retail displays to a diverse set of retail store locations. Customizations of cosmetics retail displays at various retail store locations are automated and facilitated based on cosmetics products retail sales performance at the various retail store locations. Users of such a system are provided information to more efficiently provide cosmetics retail displays and components, and supply updates to such displays according to current market data, sales, inventory and brand or manufacturer requirements.",MEIYUME HOLDINGS BVI LTD,BROCKMAN IV ROBERT;;DODD STEVE;;ATHERTON GRAHAM,MEIYUME HOLDINGS (BVI) LIMITED (2019-08-06),https://lens.org/004-968-855-356-943,Patent Application,yes,0,3,7,9,0,G06Q10/043;;G06Q10/0637;;G06Q10/043;;G06Q10/0637;;G06Q10/06315;;G06Q10/10;;A47F7/0021;;G06Q10/0637;;A47F7/0021;;G06Q10/043,G06Q10/06;;A47F7/00;;G06Q10/04,,0,0,,,,ACTIVE
89,CA,A,CA 914978 A,125-380-315-856-381,1972-11-21,1972,CA 914978D A,,CA 914978T A,,METHOD OF MAKING A GRADED STENCIL,,RCA CORP,DODD JOHN A JR;;GESHNER ROBERT A,,https://lens.org/125-380-315-856-381,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
90,CN,B,CN 1876783 B,049-103-100-655-021,2010-09-15,2010,CN 200510130398 A,2005-06-10,EP 04253487 A,2004-06-11,Detergent additives for lubricating oil compositions,"Use as a detergent in a lubricating oil composition of an oil-soluble hydrocarbyl phenol aldehyde condensate having the following structure: wherein n is 0 to 10, preferably 1 to 8, more preferably 2 to 6, and most preferably 3 to 5; Y is a divalent bridging group, and is preferably a hydrocarbyl group, preferably having from 1 to 4 carbon atoms; and R is a hydrocarbyl group having from 4 to 30,preferably 8 to 18, and most preferably 9 to 15 carbon atoms. The oil-soluble hydrocarbyl phenol aldehyde condensate has a weight average molecular weight (Mw) of 1250 to 1680, as measured by MALDI-TOF (Matrix Assisted Laser Desorption Ionization- Time of Flight) mass spectrometry.",INFINEUM INT LTD,RAYMOND FELLOWS;;JAMES DODD;;ROBERT SHAW;;SIMON CHUNG,,https://lens.org/049-103-100-655-021,Granted Patent,no,0,0,13,16,0,C10M163/00;;C10M165/00;;C10M2207/024;;C10M2207/028;;C10M2219/089;;C10N2030/52;;C10N2040/25;;C10M165/00;;C10M2207/028;;C10M2207/024;;C10M2219/089;;C10M163/00;;C10N2030/52;;C10N2040/25,C10M129/14;;C10M145/18;;C10L1/18;;C10M129/10;;C10M129/24;;C10M129/91;;C10M145/20;;C10M159/12;;C10M163/00;;C10M165/00;;C10M177/00;;C10N20/04;;C10N30/04;;C10N40/25;;C10N70/00,,0,0,,,,INACTIVE
91,JP,A,JP H10194291 A,130-050-644-496-443,1998-07-28,1998,JP 170598 A,1998-01-07,GB 9700242 A,1997-01-08,"PACKAGE FOR FOAMING BEVERAGE, AND PACKAGING METHOD","PROBLEM TO BE SOLVED: To manufacture a package at a low cost by using a hollow insert which can float on a beverage, and efficiently form foam at the time of unsealing by a simple structure by a method wherein a fluid which pressurizes a first chamber of the container is fed from an opening of a second chamber of a hollow insert, and pressurized, and the pressurized gas is jetted into a beverage in the first chamber from an opening. SOLUTION: During a rotating motion of a container 10, a capsule 1 is lifted from a lower position to a rising position, and a narrowed opening 7 is lifted to a sufficient height where the opening 7 can directly communicate with a gas in a head space 15. As the pressure in the head space 15 rises by an evaporation of liquid nitrogen 16, the pressure in a second chamber 3 of the capsule 1 increases in the same manner. Then, when the open top of the container 10 is sealed, the capsule 1 is located at a lowered position, and as a result of the buoyancy balancing adjustment, the direction of the capsule 1 becomes a state wherein the narrowed opening 7 is immersed in a beverage 6, when the package 10 is unsealed, the fluid in the second chamber 3 is jetted from the capsule 1 through the narrowed opening 7.",GUINNESS BREWING WORLDWIDE,DODD CAROLE JANE;;PURDHAM ROBERT;;SARGEANT VIVIEN JANE,,https://lens.org/130-050-644-496-443,Patent Application,no,0,1,18,18,0,B65D85/73;;B65D85/73;;B65B31/00;;B65B31/00,B65D25/02;;B65B31/00;;B65D17/34;;B65D17/347;;B65D17/353;;B65D79/00;;B65D85/73,,0,0,,,,EXPIRED
92,DK,T3,DK 0854089 T3,014-538-034-264-358,2002-07-29,2002,DK 97309758 T,1997-12-03,GB 9700242 A,1997-01-08,"Fremgangsmåde til emballering af en drikkevare, der indeholder gas i opløsning",,GUINNESS LTD,DODD CAROLE JANE;;PURDHAM ROBERT;;SARGEANT VIVIEN JANE,,https://lens.org/014-538-034-264-358,Granted Patent,no,0,0,18,18,0,B65D85/73;;B65D85/73;;B65B31/00;;B65B31/00,B65D25/02;;B65B31/00;;B65D17/34;;B65D17/347;;B65D17/353;;B65D79/00;;B65D85/73,,0,0,,,,EXPIRED
93,US,B2,US 8925178 B2,095-524-179-485-101,2015-01-06,2015,US 28516008 A,2008-09-30,US 28516008 A;;US 96052607 P,2007-10-02,"Two gun tool dolly for firing and inserting three or more nails into plate, header, or footer frame members being attached to wall stud members","A two gun tool dolly which is capable of firing and inserting two, three or four nails into plate, header, or footer frame members at predetermined locations thereof so as to fixedly secure top and bottom plate, header, or footer members to stud frame members of a wall structure or wall panel.",SMITH AUBREY;;FLEMING STEPHEN;;TUCKER ROBERT;;DODD DOUGLAS;;ILLINOIS TOOL WORKS,SMITH AUBREY;;FLEMING STEPHEN;;TUCKER ROBERT;;DODD DOUGLAS,ILLINOIS TOOL WORKS INC (2008-12-15),https://lens.org/095-524-179-485-101,Granted Patent,yes,29,0,3,3,0,B27F7/02;;B27F7/02;;Y10T29/49833;;Y10T29/49833;;Y10T29/49947;;Y10T29/49947;;Y10T29/5168;;Y10T29/5168;;Y10T29/5173;;Y10T29/5173;;Y10T29/5343;;Y10T29/5343,B27F7/02;;B23P11/00,29/525.01;;227/110;;227/111;;227/109;;29/432;;29/54;;29/798,0,0,,,,INACTIVE
94,US,B2,US 7954681 B2,099-079-753-785-006,2011-06-07,2011,US 28515308 A,2008-09-30,US 28515308 A;;US 96052907 P,2007-10-02,Single tool nailing bridge system,"A new and improved nailing bridge system which comprises a single nailing gun which is mounted for movement along a stud frame locus or a seam locus, defined by means of abutting sheets of wall sheathing, covering, paneling, or the like, wherein the single nailing gun can be moved to any one of effectively an infinite number of positions so as to permit nails to be driven into the covering, sheathing, paneling, or the like, in order to fixedly secure the sheathing, covering, paneling, or the like, to underlying stud frame members of a wall structure or wall panel member. Stitcher guns are also mounted upon a separate support beam so as to fixedly secure the sheathing, covering, paneling, or the like, to the upper and lower plate, header, or footer members of the wall structure or wall panel member.",ILLINOIS TOOL WORKS,SMITH AUBREY;;FLEMING STEPHEN;;TUCKER ROBERT;;DODD DOUGLAS,ILLINOIS TOOL WORKS INC (2008-12-15),https://lens.org/099-079-753-785-006,Granted Patent,yes,18,9,3,3,0,B27F7/006;;Y10T408/5612;;Y10T408/94;;Y10T408/91;;Y10T408/93;;Y10T408/561;;Y10T408/5617;;Y10T408/5612;;Y10T408/94;;Y10T408/91;;Y10T408/93;;Y10T408/561;;Y10T408/5617;;B27F7/006,B21J15/10,227/111;;227/107;;227/143;;227/144;;227/145;;91/525;;92/12.1;;408/87;;408/88;;408/234;;408/236;;804/238;;804/91,0,0,,,,INACTIVE
95,CN,B,CN 1740292 B,048-866-143-713-411,2011-01-19,2011,CN 200510106727 A,2005-06-10,EP 04253487 A,2004-06-11,Detergent additive combination for lubricating compositions,"An oil-soluble hydrocarbyl phenol aldehyde condensate having the following structure: wherein n is 0 to 10, preferably 1 to 8, more preferably 2 to 6, and most preferably 3 to 5; Y is a divalent bridging group, and is preferably a hydrocarbyl group, preferably having from 1 to 4 carbon atoms; and R is a hydrocarbyl group having from 4 to 30, preferably 8 to 18, and most preferably 9 to 15 carbon atoms. The oil-soluble hydrocarbyl phenol aldehyde condensate has a weight average molecular weight (Mw) of 1250 to 1680, as measured by MALDI-TOF (Matrix Assisted Laser Desorption Ionization-Time of Flight) mass spectrometry.",INFINEUM INT LTD,RAYMOND FELLOWS;;SIMON CHUNG;;ROBERT SHAW;;JAMES DODD,,https://lens.org/048-866-143-713-411,Granted Patent,no,0,0,13,16,0,C10M163/00;;C10M165/00;;C10M2207/024;;C10M2207/028;;C10M2219/089;;C10N2030/52;;C10N2040/25;;C10M165/00;;C10M2207/028;;C10M2207/024;;C10M2219/089;;C10M163/00;;C10N2030/52;;C10N2040/25,C10M129/14;;C10M129/24;;C10L1/18;;C10M129/10;;C10M129/91;;C10M145/20;;C10M159/12;;C10M163/00;;C10M165/00;;C10M177/00;;C10N20/04;;C10N30/04;;C10N40/25;;C10N70/00,,0,0,,,,INACTIVE
96,DE,D1,DE 69711589 D1,112-641-303-276-751,2002-05-08,2002,DE 69711589 T,1997-12-03,GB 9700242 A,1997-01-08,Verfahren zum Verpacken eines gelöstes Gas enthaltenden Getränkes,,GUINNESS BREWING WORLDWIDE,DODD CAROLE JANE;;PURDHAM ROBERT;;SARGEANT VIVIEN JANE,"GUINNESS LTD., LONDON, GB (2002-10-31)",https://lens.org/112-641-303-276-751,Granted Patent,no,0,0,18,18,0,B65D85/73;;B65D85/73;;B65B31/00;;B65B31/00,B65D25/02;;B65B31/00;;B65D17/34;;B65D17/347;;B65D17/353;;B65D79/00;;B65D85/73,,0,0,,,,EXPIRED
97,EP,A2,EP 0854089 A2,141-623-006-597-674,1998-07-22,1998,EP 97309758 A,1997-12-03,GB 9700242 A,1997-01-08,A method of packaging a beverage containing gas in solution and a beverage package,A method of packaging a beverage having gas in solution and a beverage package has a container 10 containing the beverage 6 to form a headspace 15. Floating on the beverage 6 is a hollow spherical capsule having a restricted aperture 7. During sealing of the container 10 by a top 20 the headspace 15 is pressurised (by a nitrogen dose 16) and during such pressurisation the insert 1 is raised relative to its natural floating position on the beverage 6 to ensure that the aperture 7 communicates with the headspace 15 to pressurise the chamber of that insert. The aforementioned raising of the insert 1 is preferably achieved by subjecting the insert to a centrifugal force during rotation of the container in seaming the top 20 thereto or by magnetic attraction. Following pressurisation of the headspace 15 the insert is lowered to float naturally on the beverage 6 with its aperture 7 submerged. During pressurisation the insert 1 may take in a minimal volume of beverage from the container. When the container is opened by ring pull 25 a pressure differential develops causing fluid under pressure to be ejected from the insert 1 through the aperture 7 into the beverage 6 for liberating gas from solution and the development of froth on the beverage.,GUINNESS BREWING WORLDWIDE,DODD CAROLE JANE;;PURDHAM ROBERT;;SARGEANT VIVIEN JANE,GUINNESS LIMITED (2002-07-01),https://lens.org/141-623-006-597-674,Patent Application,yes,0,2,18,18,0,B65D85/73;;B65D85/73;;B65B31/00;;B65B31/00,B65D25/02;;B65B31/00;;B65D17/34;;B65D17/347;;B65D17/353;;B65D79/00;;B65D85/73,,0,0,,,,EXPIRED
98,EP,B1,EP 1605034 B1,186-791-068-581-008,2012-06-20,2012,EP 05104350 A,2005-05-23,EP 04253487 A;;EP 05104350 A,2004-06-11,Use of detergent additive for lubricating oil compositions,,INFINEUM INT LTD,SHAW ROBERT;;CHUNG SIMON;;DODD JAMES;;FELLOWS RAYMOND,,https://lens.org/186-791-068-581-008,Granted Patent,yes,2,0,3,16,0,C10M129/91;;C10M129/10;;C10M145/20;;C10M163/00;;C10M165/00;;C10M167/00;;C10M2203/06;;C10M2203/1006;;C10M2205/028;;C10M2205/22;;C10M2207/026;;C10M2207/028;;C10M2207/289;;C10M2209/084;;C10M2215/064;;C10M2215/065;;C10M2215/28;;C10M2219/046;;C10M2223/045;;C10N2010/04;;C10N2020/04;;C10N2030/04;;C10N2030/42;;C10N2030/43;;C10N2030/45;;C10N2030/52;;C10N2040/25,C10M145/20;;C10M129/10;;C10M129/16;;C10M129/91;;C10M141/02;;C10M161/00;;C10M163/00;;C10M165/00;;C10M167/00,,1,0,,,"ANONYMOUS: ""Methylene-bridged alkyl phenols"" June 1999 (1999-06), RESEARCH DISCLOSURE, KENNETH MASON PUBLICATIONS, HAMPSHIRE, GB , XP007124476 ISSN: 0374-4353 * the whole document *",ACTIVE
99,DE,B2,DE 1474618 B2,044-939-745-144-93X,1975-02-20,1975,DE 1474618 A,1965-11-26,DE P0038209 A,1965-11-26,DE 1474618 B2,,"PNEUMATIC SCALE CORP., QUINCY, MASS. (V.ST.A.)","VERGOBBI, ROBERT WILLIAM, BRAINTREE;;DODD, EDMUND LLOYD, QUINCY",,https://lens.org/044-939-745-144-93X,Patent Application,no,0,0,3,3,0,G01G13/00,G01G13/00,,0,0,,,,EXPIRED
100,AP,A0,AP 2014007992 A0,168-246-187-752-440,2014-10-31,2014,AP 2014007992 A,2013-05-09,IB 2013053768 W;;US 201261647174 P;;US 201361790967 P,2012-05-15,"Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1",,NOVARTIS AG,DODD STEPHANIE KAY;;GROTZFELD ROBERT MARTIN;;MARZINZIK ANDREAS,,https://lens.org/168-246-187-752-440,Patent Application,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D401/14;;A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D403/10,,0,0,,,,ACTIVE
101,EP,B1,EP 0854089 B1,122-394-330-005-858,2002-04-03,2002,EP 97309758 A,1997-12-03,GB 9700242 A,1997-01-08,A method of packaging a beverage containing gas in solution,,GUINNESS BREWING WORLDWIDE,DODD CAROLE JANE;;PURDHAM ROBERT;;SARGEANT VIVIEN JANE,GUINNESS LIMITED (2002-07-01),https://lens.org/122-394-330-005-858,Granted Patent,yes,3,1,18,18,0,B65D85/73;;B65D85/73;;B65B31/00;;B65B31/00,B65D25/02;;B65B31/00;;B65D17/34;;B65D17/347;;B65D17/353;;B65D79/00;;B65D85/73,,0,0,,,,EXPIRED
102,US,B1,US 6551638 B1,177-942-778-417-666,2003-04-22,2003,US 99934297 A,1997-12-29,GB 9700242 A,1997-01-08,Method of packaging a beverage containing gas in solution and a beverage package,"
    A method of packaging a beverage having gas in solution and a beverage package has a container  10  containing the beverage  6  to form a headspace  15  . Floating on the beverage  6  is a hollow spherical capsule having a restricted aperture  7  . During sealing of the container  10  by a top  20  the headspace  15  is pressurised (by a nitrogen dose  16  ) and during such pressurisation the insert  1  is raised relative to its natural floating position on the beverage  6  to ensure that the aperture  7  communicates with the headspace  15  to pressurise the chamber of that insert. The aforementioned raising of the insert  1  is preferably achieved by subjecting the insert to a centrifugal force during rotation of the container in seaming the top  20  thereto or by magnetic attraction. Following pressurisation of the headspace  15  the insert is lowered to float naturally on the beverage  6  with its aperture  7  submerged. During pressurisation the insert  1  may take in a minimal volume of beverage from the container. When the container is opened by ring pull  25  a pressure differential develops causing fluid under pressure to be ejected from the insert  1  through the aperture  7  into the beverage  6  for liberating gas from solution and the development of froth on the beverage. 
",GUINNESS BREWING WORLDWIDE,DODD CAROLE JANE;;PURDHAM ROBERT;;SARGEANT VIVIEN JANE,GUINNESS BREWING WORLDWIDE LIMITED (1997-12-15),https://lens.org/177-942-778-417-666,Granted Patent,yes,12,17,18,18,0,B65D85/73;;B65D85/73;;B65B31/00;;B65B31/00,B65D25/02;;B65B31/00;;B65D17/34;;B65D17/347;;B65D17/353;;B65D79/00;;B65D85/73,426/106;;426/112;;426/115;;426/118;;426/124;;426/131;;426/394;;426/397;;426/398;;220/501;;220/502;;53/420,0,0,,,,EXPIRED
103,EP,A3,EP 0854089 A3,034-445-745-108-047,1998-12-23,1998,EP 97309758 A,1997-12-03,GB 9700242 A,1997-01-08,A method of packaging a beverage containing gas in solution and a beverage package,A method of packaging a beverage having gas in solution and a beverage package has a container 10 containing the beverage 6 to form a headspace 15. Floating on the beverage 6 is a hollow spherical capsule having a restricted aperture 7. During sealing of the container 10 by a top 20 the headspace 15 is pressurised (by a nitrogen dose 16) and during such pressurisation the insert 1 is raised relative to its natural floating position on the beverage 6 to ensure that the aperture 7 communicates with the headspace 15 to pressurise the chamber of that insert. The aforementioned raising of the insert 1 is preferably achieved by subjecting the insert to a centrifugal force during rotation of the container in seaming the top 20 thereto or by magnetic attraction. Following pressurisation of the headspace 15 the insert is lowered to float naturally on the beverage 6 with its aperture 7 submerged. During pressurisation the insert 1 may take in a minimal volume of beverage from the container. When the container is opened by ring pull 25 a pressure differential develops causing fluid under pressure to be ejected from the insert 1 through the aperture 7 into the beverage 6 for liberating gas from solution and the development of froth on the beverage.,GUINNESS BREWING WORLDWIDE,DODD CAROLE JANE;;PURDHAM ROBERT;;SARGEANT VIVIEN JANE,GUINNESS LIMITED (2002-07-01),https://lens.org/034-445-745-108-047,Search Report,yes,3,0,18,18,0,B65D85/73;;B65D85/73;;B65B31/00;;B65B31/00,B65D25/02;;B65B31/00;;B65D17/34;;B65D17/347;;B65D17/353;;B65D79/00;;B65D85/73,,0,0,,,,EXPIRED
104,FR,B1,FR 2996225 B1,112-303-191-647-519,2014-10-03,2014,FR 1259403 A,2012-10-03,FR 1259403 A,2012-10-03,ANALOGUES DE LA COELENTERAZINE EMETTANT UNE LUMIERE DECALEE VERS LE ROUGE VISANT L'IMAGERIE IN VIVO,,CENTRE NAT RECH SCIENT,DODD ROBERT;;BRULET PHILIPPE;;PICAUD SANDRINE;;GEALAGEAS RONAN,,https://lens.org/112-303-191-647-519,Granted Patent,no,0,0,3,3,0,A61P43/00;;C07D487/04,C07D487/04;;A61K49/00;;A61P43/00;;C07D233/96;;C07D241/06,,0,0,,,,INACTIVE
105,EP,A1,EP 1605034 A1,143-450-066-915-064,2005-12-14,2005,EP 05104350 A,2005-05-23,EP 04253487 A;;EP 05104350 A,2004-06-11,Use of detergent additive for lubricating oil compositions,"Use as a detergent in a lubricating oil composition of an oil-soluble hydrocarbyl phenol aldehyde condensate having the following structure:
   wherein n is 0 to 10, preferably 1 to 8, more preferably 2 to 6, and most preferably 3 to 5; Y is a divalent bridging group, and is preferably a hydrocarbyl group, preferably having from 1 to 4 carbon atoms; and R is a hydrocarbyl group having from 4 to 30, preferably 8 to 18, and most preferably 9 to 15 carbon atoms. The oil-soluble hydrocarbyl phenol aldehyde condensate has a weight average molecular weight (Mw) of 1250 to 1680, as measured by MALDI-TOF (Matrix Assisted Laser Desorption lonization- Time of Flight) mass spectrometry.",INFINEUM INT LTD,SHAW ROBERT;;CHUNG SIMON;;DODD JAMES;;FELLOWS RAYMOND,,https://lens.org/143-450-066-915-064,Patent Application,yes,2,13,3,16,0,C10M129/10;;C10M129/91;;C10M145/20;;C10M163/00;;C10M165/00;;C10M167/00;;C10M2203/06;;C10M2203/1006;;C10M2205/028;;C10M2205/22;;C10M2207/026;;C10M2207/028;;C10M2207/289;;C10M2209/084;;C10M2215/064;;C10M2215/065;;C10M2215/28;;C10M2219/046;;C10M2223/045;;C10N2020/04;;C10N2030/04;;C10N2030/43;;C10N2030/42;;C10N2030/45;;C10N2030/52;;C10N2040/25;;C10N2010/04,C10M129/10;;C10M129/16;;C10M129/91;;C10M141/02;;C10M145/20;;C10M161/00;;C10M163/00;;C10M165/00;;C10M167/00,,1,0,,,"ANONYMOUS: ""Methylene-bridged alkyl phenols"", June 1999, RESEARCH DISCLOSURE, KENNETH MASON PUBLICATIONS, HAMPSHIRE, GB, ISSN: 0374-4353, XP007124476",ACTIVE
106,CA,C,CA 2223602 C,141-562-600-147-899,2003-03-18,2003,CA 2223602 A,1998-01-07,GB 9700242 A,1997-01-08,A METHOD OF PACKAGING A BEVERAGE CONTAINING GAS IN SOLUTION AND A BEVERAGE PACKAGE,A method of packaging a beverage having gas in solution and a beverage package has a container 10 containing the beverage 6 to form a headspace 15. Floating on the beverage 6 is a hollow spherical capsule having a restricted aperture 7. During sealing of the container 10 by a top 20 the headspace 15 is pressurised (by a nitrogen dose 16) and during such pressurisation the insert 1 is raised relative to its natural floating position on the beverage 6 to ensure that the aperture 7 communicates with the headspace 15 to pressurise the chamber of that insert. The aforementioned raising of the insert 1 is preferably achieved by subjecting the insert to a centrifugal force during rotation of the container in seaming the top 20 thereto or by magnetic attraction. Following pressurisation of the headspace 15 the insert is lowered to float naturally on the beverage 6 with its aperture 7 submerged. During pressurisation the insert 1 may take in a minimal volume of beverage from the container. When the container is opened by ring pull 25 a pressure differential develops causing fluid under pressure to be ejected from the insert 1 through the aperture 7 into the beverage 6 for liberating gas from solution and the development of froth on the beverage.,GUINNESS BREWING WORLDWIDE,SARGEANT VIVIEN JANE;;DODD CAROLE JANE;;PURDHAM ROBERT,,https://lens.org/141-562-600-147-899,Granted Patent,no,0,0,18,18,0,B65D85/73;;B65D85/73;;B65B31/00;;B65B31/00,B65D25/02;;B65B31/00;;B65D17/34;;B65D17/347;;B65D17/353;;B65D79/00;;B65D85/73,,0,0,,,,EXPIRED
107,GB,A,GB 785476 A,043-968-510-858-360,1957-10-30,1957,GB 1070355 A,1955-04-13,GB 1070355 A,1955-04-13,Improved casein,"The properties, i.e. opacity, colour, of casein obtained from animal or vegetable sources are improved by alternately washing the precipitated and coagulated protein with water at different temperatures in the presence of a surface-active agent, which may be added prior to the coagulation, so that the coagulate swells during one washing and contracts during the next washing. The coagulate and whey are heated at a rate of increase of temperature not greater than 1 DEG C. per minute to a temperature such that the coagulate may be handled but below that at which the coagulate becomes rubbery or stringy in texture or coagulates into large masses, e.g. 60 DEG C., and is separated from the whey as quickly as possible. The coagulate is then washed with water at 40-50 DEG C., separated from the wash water, washed with water at a temperature below 20 DEG C. and separated therefrom, the sequence being repeated a plurality of times. Suitable surfaceactive agents are anionic, cationic, or non-ionic agents, the latter class being capable of forming water-soluble complexes with calcium and other heavy metals in which the metal is present in a unionized form, e.g. alkylated phenol ethylene oxide condensate, condensates of long-chain fatty alcohols and ethylene oxide which possesses a polyethylene glycol chain.",ERINOID LTD,DODD ROBERT;;JUDD ALBERT ERNEST;;YOUNG GEOFFREY AUSTIN,,https://lens.org/043-968-510-858-360,Granted Patent,no,0,0,1,1,0,D01F4/00,D01F4/00,C3H HJ            HJ;;C3H HK2           HK2,0,0,,,,EXPIRED
108,DE,T2,DE 69711589 T2,175-595-267-719-965,2002-09-26,2002,DE 69711589 T,1997-12-03,GB 9700242 A,1997-01-08,Verfahren zum Verpacken eines gelöstes Gas enthaltenden Getränkes,,GUINNESS LTD,DODD CAROLE JANE;;PURDHAM ROBERT;;SARGEANT VIVIEN JANE,"GUINNESS LTD., LONDON, GB (2002-10-31)",https://lens.org/175-595-267-719-965,Granted Patent,no,0,0,18,18,0,B65D85/73;;B65D85/73;;B65B31/00;;B65B31/00,B65D25/02;;B65B31/00;;B65D17/34;;B65D17/347;;B65D17/353;;B65D79/00;;B65D85/73,,0,0,,,,EXPIRED
109,DE,C3,DE 1474618 C3,091-497-097-716-280,1975-10-23,1975,DE 1474618 A,1965-11-26,DE P0038209 A,1965-11-26,DE 1474618 C3,,"PNEUMATIC SCALE CORP., NORTH QUINCY, MASS. (V.ST.A.)","VERGOBBI, ROBERT WILLIAM, BRAINTREE;;DODD, EDMUND LLOYD, QUINCY",,https://lens.org/091-497-097-716-280,Granted Patent,no,0,0,3,3,0,G01G13/00,G01G13/00,,0,0,,,,EXPIRED
110,CN,A,CN 1256624 A,148-905-919-012-722,2000-06-14,2000,CN 97180171 A,1997-10-23,US 73646996 A;;US 73609396 A;;US 73896496 A;;US 88960797 A;;US 94677097 A;;US 94729997 A;;US 94707697 A;;US 95118597 A,1996-10-24,Compositions for reducing odor on skin,"The present invention relates to an aqueous odor-absorbing composition which is safe for use on human skin comprising from about 0.1 % to about 5 %, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from about 0.5 % to about 30 %, by weight of the composition, of a linear dimethicone having a nominal viscosity of 350 centistokes or less; and an aqueous carrier. The compositions can also comprise one or more of the following optional components: low molecular weight polyols; water-soluble antimicrobial preservatives; zinc salts; water-soluble polymers; soluble carbonate and/or bicarbonate salts; chelating agents; zeolites; activated carbon; and mixtures thereof. The present invention also relates the use of the aforementioned compositions in reducing body, vaginal, and or environmental odors on skin. The composition can be applied directly as a spray, poured from a bottle and applied by hand, or applied via a wipe.",PROCTER & GAMBLE,TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY,,https://lens.org/148-905-919-012-722,Patent Application,no,0,5,15,24,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61K8/891;;A61Q15/00;;A61K8/73;;A61Q15/00,A61K8/02;;A61K8/04;;A61K8/27;;A61K8/44;;A61K8/73;;A61K8/891;;A61Q15/00,,0,0,,,,DISCONTINUED
111,AU,A,AU 1997/048524 A,176-910-917-407-642,1998-07-16,1998,AU 1997/048524 A,1997-12-19,GB 9700242 A,1997-01-08,A method of packaging a beverage containing gas in solution and a beverage package,,GUINNESS LTD,DODD CAROLE JANE;;PURDHAM ROBERT;;SARGEANT VIVIEN JANE,,https://lens.org/176-910-917-407-642,Patent Application,no,0,0,18,18,0,B65D85/73;;B65D85/73;;B65B31/00;;B65B31/00,B65D25/02;;B65B31/00;;B65D17/34;;B65D17/347;;B65D17/353;;B65D79/00;;B65D85/73,,0,0,,,,EXPIRED
112,US,B2,US 8925173 B2,075-062-001-484-815,2015-01-06,2015,US 28515408 A,2008-09-30,US 28515408 A;;US 96052707 P,2007-10-02,Automated three nail gun tool dolly,"A new and improved automated gun tool dolly which comprises a plurality of nail guns, such as, for example, three nail guns, which are mounted upon a horizontally movable carriage assembly in a vertically and horizontally staggered mode so as to be disposed within a diagonal array. Movement of the carriage assembly along horizontally oriented guide rails is automatically controlled, such as, for example, by means of a programmable logic controller (PLC), such that the three nail guns are sequentially and continuously disposed at predetermined firing positions at which the nail guns are sequentially fired so as to insert nails within predetermined regions of 2×4 or 2×6 plate, header, or footer members of a wall panel or wall structure.",SMITH AUBREY;;FLEMING STEPHEN;;TUCKER ROBERT;;DODD DOUGLAS;;ILLINOIS TOOL WORKS,SMITH AUBREY;;FLEMING STEPHEN;;TUCKER ROBERT;;DODD DOUGLAS,ILLINOIS TOOL WORKS INC (2008-12-15),https://lens.org/075-062-001-484-815,Granted Patent,yes,32,2,3,3,0,B27F7/006;;B27F7/006;;Y10T29/49833;;Y10T29/49833;;Y10T29/49947;;Y10T29/49947;;Y10T29/5146;;Y10T29/5146;;Y10T29/5173;;Y10T29/5173;;Y10T29/53013;;Y10T29/53013;;Y10T29/53052;;Y10T29/53052;;Y10T29/5343;;Y10T29/5343,B27F7/02;;B23P11/00;;B27F7/00,29/432;;227/110;;227/111;;227/109;;29/525.01;;29/798;;29/54,0,0,,,,INACTIVE
113,EP,A1,EP 1642956 A1,177-909-082-114-902,2006-04-05,2006,EP 05111664 A,2005-05-23,EP 05104350 A;;EP 04253487 A;;EP 05111664 A,2004-06-11,Detergent additive combination for lubricating compositions,"A lubricating oil composition comprising a major amount of an oil of lubricating viscosity and a detergent composition comprising (A) an overbased metal salt of an organic acid and (B) an oil-soluble hydrocarbyl phenol aldehyde condensate having the following structure:
  
wherein n is 0 to 10, preferably 1 to 8, more preferably 2 to 6, and most preferably 3 to 5; Y is a divalent bridging group, and is preferably a hydrocarbyl group, preferably having from 1 to 4 carbon atoms; and R is a hydrocarbyl group having from 4 to 30, preferably 8 to 18, and most preferably 9 to 15 carbon atoms. The oil-soluble hydrocarbyl phenol aldehyde condensate has a weight average molecular weight (Mw) of 1250 to 1680, as measured by MALDI-TOF (Matrix Assisted Laser Desorption Ionization- Time of Flight) mass spectrometry.",INFINEUM INT LTD,SHAW ROBERT;;CHUNG SIMON;;DODD JAMES;;FELLOWS RAYMOND,,https://lens.org/177-909-082-114-902,Patent Application,yes,6,0,3,16,0,C10M129/10;;C10M129/91;;C10M145/20;;C10M163/00;;C10M165/00;;C10M167/00;;C10M2203/06;;C10M2203/1006;;C10M2205/028;;C10M2205/22;;C10M2207/026;;C10M2207/028;;C10M2207/289;;C10M2209/084;;C10M2215/064;;C10M2215/065;;C10M2215/28;;C10M2219/046;;C10M2223/045;;C10N2020/04;;C10N2030/04;;C10N2030/43;;C10N2030/42;;C10N2030/45;;C10N2030/52;;C10N2040/25;;C10N2010/04,C10M163/00;;C10M129/10;;C10M129/16;;C10M129/91;;C10M141/02;;C10M145/20;;C10M161/00;;C10M165/00;;C10M167/00,,1,0,,,"ANONYMOUS: ""Methylene-bridged alkyl phenols"", RESEARCH DISCLOSURE, MASON PUBLICATIONS, HAMPSHIRE, GB, vol. 422, no. 73, June 1999 (1999-06-01), XP007124476, ISSN: 0374-4353",DISCONTINUED
114,NZ,A,NZ 329388 A,130-012-603-531-049,1998-06-26,1998,NZ 32938897 A,1997-12-10,GB 9700242 A,1997-01-08,"FILLING BEVERAGE CONTAINER INCLUDING GAS FILLED INSERT, WHICH IS CHARGED FROM PRESSURISED GAS IN HEADSPACE",,GUINNESS LTD,DODD CAROLE JANE;;PURDHAM ROBERT;;SARGEANT VIVIEN JANE,,https://lens.org/130-012-603-531-049,Patent Application,no,0,0,18,18,0,B65D85/73;;B65D85/73;;B65B31/00;;B65B31/00,B65D25/02;;B65B31/00;;B65D17/34;;B65D17/347;;B65D17/353;;B65D79/00;;B65D85/73,,0,0,,,,DISCONTINUED
115,AU,B2,AU 730356 B2,000-711-601-414-091,2001-03-08,2001,AU 1997/048524 A,1997-12-19,GB 9700242 A,1997-01-08,A method of packaging a beverage containing gas in solution and a beverage package,,GUINNESS LTD,DODD CAROLE JANE;;PURDHAM ROBERT;;SARGEANT VIVIEN JANE,,https://lens.org/000-711-601-414-091,Granted Patent,no,2,0,18,18,0,B65D85/73;;B65D85/73;;B65B31/00;;B65B31/00,B65D25/02;;B65B31/00;;B65D17/34;;B65D17/347;;B65D17/353;;B65D79/00;;B65D85/73,,0,0,,,,EXPIRED
116,ES,T3,ES 2175288 T3,108-837-968-470-735,2002-11-16,2002,ES 97309758 T,1997-12-03,GB 9700242 A,1997-01-08,PROCEDIMIENTO PARA ENVASAR UNA BEBIDA QUE CONTIENE GAS EN SOLUCION.,"UN PROCEDIMIENTO PARA ENVASAR UNA BEBIDA CON GAS EN SOLUCION Y UN ENVASE DE BEBIDA CONSTA DE UN RECIPIENTE 10 QUE CONTIENE LA BEBIDA 6 PARA FORMAR UN ESPACIO DE AIRE 15. FLOTANDO EN LA BEBIDA 6 HAY UNA CAPSULA ESFERICA HUECA CON UNA ABERTURA LIMITADA 7. DURANTE EL SELLADO DEL RECIPIENTE 10 POR UNA TAPA 20 SE PRESURIZA EL ESPACIO DE AIRE 15 (MEDIANTE UNA DOSIS DE NITROGENO 16), Y DURANTE ESTA PRESURIZACION EL INSERTO 1 SE ELEVA EN RELACION CON SU POSICION LATERAL DE FLOTAMIENTO EN LA BEBIDA 6 PARA ASEGURAR QUE LA ABERTURA 7 SE COMUNICA CON EL ESPACIO DE AIRE 15 CON OBJETO DE PRESURIZAR LA CAMARA DEL INSERTO. ESTA ELEVACION DEL INSERTO 1 SE LOGRA PREFERENTEMENTE SOMETIENDOLO A UNA FUERZA CENTRIFUGA DURANTE LA ROTACION DEL RECIPIENTE AL UNIRLE LA TAPA 20 O POR ATRACCION MAGNETICA. TRAS LA PRESURIZACION DEL ESPACIO DE AIRE 15, SE DESCIENDE EL INSERTO PARA QUE FLOTE DE MANERA NATURAL EN LA BEBIDA 6 CON SU ABERTURA 7 SUMERGIDA. DURANTE LA PRESURIZACION, EL INSERTO 1 PUEDE ADMITIR UN VOLUMEN MINIMO DE BEBIDA DEL RECIPIENTE. CUANDO EL RECIPIENTE SE ABRE TIRANDO DE UN ARO 25 SE DESARROLLA UN DIFERENCIAL DE PRESION HACIENDO QUE EL FLUIDO BAJO PRESION SALGA EXPULSADO DEL INSERTO 1 A TRAVES DE LA ABERTURA 7 A LA BEBIDA 6 PARA LIBERAR GAS DE LA SOLUCION Y FORMANDO ESPUMA EN LA BEBIDA.",GUINNESS LTD,DODD CAROLE JANE;;PURDHAM ROBERT;;SARGEANT VIVIEN JANE,,https://lens.org/108-837-968-470-735,Granted Patent,no,0,0,18,18,0,B65D85/73;;B65D85/73;;B65B31/00;;B65B31/00,B65D25/02;;B65B31/00;;B65D17/34;;B65D17/347;;B65D17/353;;B65D79/00;;B65D85/73,,0,0,,,,EXPIRED
117,CA,A1,CA 2223602 A1,115-698-041-609-144,1998-07-08,1998,CA 2223602 A,1998-01-07,GB 9700242 A,1997-01-08,A METHOD OF PACKAGING A BEVERAGE CONTAINING GAS IN SOLUTION AND A BEVERAGE PACKAGE,A method of packaging a beverage having gas in solution and a beverage package has a container 10 containing the beverage 6 to form a headspace 15. Floating on the beverage 6 is a hollow spherical capsule having a restricted aperture 7. During sealing of the container 10 by a top 20 the headspace 15 is pressurised (by a nitrogen dose 16) and during such pressurisation the insert 1 is raised relative to its natural floating position on the beverage 6 to ensure that the aperture 7 communicates with the headspace 15 to pressurise the chamber of that insert. The aforementioned raising of the insert 1 is preferably achieved by subjecting the insert to a centrifugal force during rotation of the container in seaming the top 20 thereto or by magnetic attraction. Following pressurisation of the headspace 15 the insert is lowered to float naturally on the beverage 6 with its aperture 7 submerged. During pressurisation the insert 1 may take in a minimal volume of beverage from the container. When the container is opened by ring pull 25 a pressure differential develops causing fluid under pressure to be ejected from the insert 1 through the aperture 7 into the beverage 6 for liberating gas from solution and the development of froth on the beverage.,GUINNESS BREWING WORLDWIDE,DODD CAROLE JANE;;SARGEANT VIVIEN JANE;;PURDHAM ROBERT,,https://lens.org/115-698-041-609-144,Patent Application,no,0,0,18,18,0,B65D85/73;;B65D85/73;;B65B31/00;;B65B31/00,B65D25/02;;B65B31/00;;B65D17/34;;B65D17/347;;B65D17/353;;B65D79/00;;B65D85/73,,0,0,,,,EXPIRED
118,FR,A1,FR 2996225 A1,170-122-788-360-589,2014-04-04,2014,FR 1259403 A,2012-10-03,FR 1259403 A,2012-10-03,ANALOGUES DE LA COELENTERAZINE EMETTANT UNE LUMIERE DECALEE VERS LE ROUGE VISANT L'IMAGERIE IN VIVO,"La présente invention concerne un composé de formule générale (I) : dans laquelle : n est un entier compris entre 0 et 4, de préférence entre 0 et 2 ; EDG représente un groupe électrodonneur indépendamment choisi parmi un radical hydroxy (-OH), hydroxyalkyle en C1-C6, alcoxy en C1-C6, amino (-NH2), alkylamino en C1-C6, dialkylamino en C1-C6, thiol (-SH), et alkylthio en C1-C6 ; R représente un radical benzyle, α-styryle ou naphtyle ; X représente un radical hydroxy ou un halogène choisi parmi un atome de chlore, de brome, d'iode ou de fluor ; à condition toutefois que lorsque X représente un radical hydroxy et R un radical benzyle, alors n est égal à 2 et les deux groupes EDG représentent un radical hydroxy, préférentiellement en position 3 et 5 du noyau phényle qui les porte; et à l'exception des composés pour lesquels X représente un atome de fluor ou d'iode, n est égal à 0 et R représente un radical benzyle.",CENTRE NAT RECH SCIENT,DODD ROBERT;;BRULET PHILIPPE;;PICAUD SANDRINE;;GEALAGEAS RONAN,,https://lens.org/170-122-788-360-589,Patent Application,no,0,0,3,3,0,A61P43/00;;C07D487/04,C07D487/04;;A61K49/00;;A61P43/00;;C07D233/96;;C07D241/06,,3,3,032-595-170-017-291;;067-673-741-723-298;;015-867-932-503-975,10.1042/bj2610913;;2803250;;pmc1138916;;10.1016/s0040-4039(98)01115-0;;10.1016/0143-4160(93)90041-4;;8519061,"SHIMOMURA O ET AL: ""SEMI-SYNTHETIC AEQUORINS WITH IMPROVED SENSITIVITY TO CA2+ IONS"", BIOCHEMICAL JOURNAL, THE BIOCHEMICAL SOCIETY, LONDON, GB, vol. 261, no. 3, 1 August 1989 (1989-08-01), pages 913 - 920, XP001007915, ISSN: 0264-6021;;HIRANO T ET AL: ""Bioluminescent Properties of Fluorinated Semi-synthetic Aequorins"", TETRAHEDRON LETTERS, ELSEVIER, AMSTERDAM, NL, vol. 39, no. 31, 30 July 1998 (1998-07-30), pages 5541 - 5544, XP004124111, ISSN: 0040-4039, DOI: 10.1016/S0040-4039(98)01115-0;;SHIMOMURA O ET AL: ""Light-emitting properties of recombinant semisynthetic aequorins and recombinant fluorescein-conjugated aequorin for measuring cellular calcium"", CELL CALCIUM (EDINBURGH), CHURCHILL LIVINGSTONE MEDICAL JOURNALS, EDINBURGH, GB, vol. 14, no. 5, 1 May 1993 (1993-05-01), pages 373 - 378, XP026181845, ISSN: 0143-4160, [retrieved on 19930501], DOI: 10.1016/0143-4160(93)90041-4",INACTIVE
119,US,A1,US 2009/0100663 A1,179-748-445-958-265,2009-04-23,2009,US 28516008 A,2008-09-30,US 28516008 A;;US 96052607 P,2007-10-02,"Two gun tool dolly for firing and inserting three or more nails into plate, header, or footer frame members being attached to wall stud members","A two gun tool dolly which is capable of firing and inserting two, three or four nails into plate, header, or footer frame members at predetermined locations thereof so as to fixedly secure top and bottom plate, header, or footer members to stud frame members of a wall structure or wall panel.",SMITH AUBREY;;FLEMING STEPHEN;;TUCKER ROBERT;;DODD DOUGLAS,SMITH AUBREY;;FLEMING STEPHEN;;TUCKER ROBERT;;DODD DOUGLAS,ILLINOIS TOOL WORKS INC (2008-12-15),https://lens.org/179-748-445-958-265,Patent Application,yes,29,0,3,3,0,B27F7/02;;B27F7/02;;Y10T29/49833;;Y10T29/49833;;Y10T29/49947;;Y10T29/49947;;Y10T29/5168;;Y10T29/5168;;Y10T29/5173;;Y10T29/5173;;Y10T29/5343;;Y10T29/5343,B23Q3/16,29/525.01;;29/50,0,0,,,,INACTIVE
120,WO,A1,WO 2014/053605 A1,054-897-590-134-509,2014-04-10,2014,EP 2013070644 W,2013-10-03,FR 1259403 A,2012-10-03,COELENTERAZINE ANALOGUES EMITTING A RED-SHIFTED LIGHT INTENDED FOR IN VIVO IMAGING,"The present invention concerns a compound of general formula (I) in which: n is a whole number between 0 and 4, preferably between 0 and 2; EDG represents an electron donating group chosen independently from a hydroxy (-OH), C1-C6 hydroxyalkyl, C1-C6 alcoxy, amino (-NH2), C1-C6 alkylamino, C1-C6 dialkylamino, thiol (-SH), and C1-C6 alkylthio radical; R represents a benzyl, α-styryl or naphthyl radical; X represents a hydroxy radical or a halogen chosen from a chlorine, bromine, iodine or fluorine atom; on condition, however, that when X represents a hydroxy radical and R a benzyl radical, n is equal to 2 and the two EDG groups represent a hydroxy radical, preferably in position 3 and 5 of the phenyl ring bearing them; and with the exception of the compounds for which X represents a fluorine or iodine atom, n is equal to 0 and R represents a benzyl radical.",CENTRE NAT RECH SCIENT,DODD ROBERT;;BRULET PHILIPPE;;PICAUD SANDRINE;;GEALAGEAS RONAN,,https://lens.org/054-897-590-134-509,Patent Application,yes,7,5,3,3,0,A61P43/00;;C07D487/04,C07D487/04,,39,36,032-595-170-017-291;;067-673-741-723-298;;015-867-932-503-975;;033-734-619-879-689;;018-227-352-105-931;;019-361-684-548-118;;007-635-694-672-198;;082-273-104-135-400;;029-050-580-451-375;;123-731-962-135-045;;080-180-593-684-455;;128-166-304-138-984;;143-605-281-417-432;;023-950-811-233-953;;015-107-944-377-37X;;049-639-955-600-304;;051-221-675-264-805;;084-150-079-951-475;;051-221-675-264-805;;021-142-375-745-582;;068-197-046-617-647;;083-644-891-365-534;;126-664-296-164-363;;030-110-587-241-466;;046-294-406-192-416;;018-140-447-729-577;;089-283-610-594-646;;036-072-582-604-970;;032-194-289-807-488;;052-089-917-379-05X;;067-673-741-723-298;;032-595-170-017-291;;048-455-683-236-728;;054-766-427-835-217;;008-207-784-933-932;;023-950-811-233-953,10.1042/bj2610913;;2803250;;pmc1138916;;10.1016/s0040-4039(98)01115-0;;10.1016/0143-4160(93)90041-4;;8519061;;10.1002/jcp.1030590302;;13911999;;10.1038/35012659;;10830969;;pmc397733;;10.1073/pnas.82.10.3154;;3858813;;7794244;;10.1006/bbrc.1995.1821;;10.1038/256236a0;;239351;;16371601;;10.1152/physrev.00004.2005;;237461;;10.1146/annurev.bi.44.070175.001351;;10.1021/bi00746a025;;4147978;;10.1016/s0021-9258(17)37872-9;;33174;;9144537;;10.1006/bbrc.1997.6452;;10.1073/pnas.97.13.7260;;10860991;;pmc16533;;pmc2846983;;20305645;;10.1038/nn.2518;;10.1371/journal.pone.0000974;;17912353;;pmc1991622;;10.2310/7290.2006.00033;;17311763;;10.1016/s0040-4039(01)00340-9;;10.2310/7290.2006.00033;;17311763;;pmc3092744;;21589654;;10.1371/journal.pone.0019520;;10.1007/s00216-010-4106-9;;20711766;;10.1039/p19920001607;;10.1246/cl.1993.2149;;10.1016/s0040-4020(97)00812-0;;10.1016/0040-4039(92)89028-b;;10.1016/j.tet.2006.04.044;;10.1246/cl.1998.95;;10.1016/j.ab.2010.08.025;;20800051;;10.1016/s0040-4039(02)00462-8;;10.1016/j.tet.2010.12.001;;10.1016/s0040-4039(98)01115-0;;10.1042/bj2610913;;2803250;;pmc1138916;;10.1042/bj2510405;;3401214;;pmc1149017;;10.1016/j.tet.2003.08.040;;15689515;;pmc2279293;;10.1110/ps.041142905;;10.1073/pnas.97.13.7260;;10860991;;pmc16533,"SHIMOMURA O ET AL: ""SEMI-SYNTHETIC AEQUORINS WITH IMPROVED SENSITIVITY TO CA2+ IONS"", BIOCHEMICAL JOURNAL, THE BIOCHEMICAL SOCIETY, LONDON, GB, vol. 261, no. 3, 1 August 1989 (1989-08-01), pages 913 - 920, XP001007915, ISSN: 0264-6021;;HIRANO T ET AL: ""Bioluminescent Properties of Fluorinated Semi-synthetic Aequorins"", TETRAHEDRON LETTERS, ELSEVIER, AMSTERDAM, NL, vol. 39, no. 31, 30 July 1998 (1998-07-30), pages 5541 - 5544, XP004124111, ISSN: 0040-4039, DOI: 10.1016/S0040-4039(98)01115-0;;SHIMOMURA O ET AL: ""Light-emitting properties of recombinant semisynthetic aequorins and recombinant fluorescein-conjugated aequorin for measuring cellular calcium"", CELL CALCIUM (EDINBURGH), CHURCHILL LIVINGSTONE MEDICAL JOURNALS, EDINBURGH, GB, vol. 14, no. 5, 1 May 1993 (1993-05-01), pages 373 - 378, XP026181845, ISSN: 0143-4160, [retrieved on 19930501], DOI: 10.1016/0143-4160(93)90041-4;;SHIMOMURA, O.; JOHNSON, F. H.; SAIGA, Y., J CELL. COMP. PHYSIOL., vol. 59, 1962, pages 223 - 240;;HEAD, J. F.; INOUYE, S.; TERANISHI, K.; SHIMOMURA, O., NATURE, vol. 405, 2000, pages 372 - 376;;INOUYE, S.; NOGUCHI, M.; SAKAKI, Y.; TAKAGI, Y.; MIYATA, T.; IWANAGA, S.; MIYATA, T.; TSUJI, F. I., PROC. NATL. ACAD. SCI. USA, vol. 82, 1985, pages 3154 - 3158;;SHIMOMURA, O., BIOCHEM. BIOPHYS. RES. COMMUN., vol. 211, 1995, pages 359 - 363;;SHIMOMURA, O.; JOHNSON, F. H., NATURE, vol. 256, 1975, pages 236 - 238;;RIZZUTO, R.; POZZAN, T., PHYSIOL. REV., vol. 86, 2006, pages 369 - 408;;CONNIER, M. J.; LEE, J.; WAMPLER, J. E., ANNU. REV. BIOCHEM., vol. 44, 1975, pages 255 - 272;;HORI, K.; WAMPLER, J. E.; MATTHEWS, J. C.; CORMIER, M. J., BIOCHEMISTRY, vol. 12, 1973, pages 4462 - 4468;;CHARBONNEAU, H.; CORMIER, M. J., J BIOL. CHEM., vol. 254, 1979, pages 769 - 780;;INOUYE, S.; SHIMOMURA, O., BIOCHEM. BIOPHYS. RES. COMMUN., vol. 233, 1997, pages 349 - 353;;BAUBET, V.; LE MOUELLIC, H.; CAMPBELL, A. K.; LUCAS- MEUNIER, E.; FOSSIER, P.; BRÛLET, P., PROC. NATL. ACAD. SEI. USA, vol. 97, 2000, pages 7260 - 7265;;MARTIN, J. R.; ROGERS, K. L.; CHAGNEAU, C.; BRÛLCT, P., PLOSONE, vol. 2, 2007, pages C275;;NAUMANN, E. A.; KAMPFF, A. R.; PROBER, D. A.; SCHIER, A. F.; ENGERT, F., NAT.NEUROSCI., vol. 13, 2010, pages 513 - 520;;ROGERS, K. L.; PICAUD, S.; RONCALI, E.; BOISGARD, R.; COLASANTE, C.; STINNAKRE, J.; TAVITIAN, B.; BRÛLET, P., PLOSONE, vol. 2, 2007, pages E974;;CURIE, T.; ROGERS, K. L.; COLASANTE, C.; BRÛLET, P., MOLECULAR IMAGING, vol. 6, 2007, pages 30 - 42;;WU, C.; NAKAMURA, H.; MURAI, A.; SHIMOMURA, O., TETRAHEDRON LETT., vol. 42, 2001, pages 2997 - 3000;;BAUBET, V.; LE MOUELLIC, H.; CAMPBELL, A. K.; LUCAS-MEUNIER, E.; FOSSIER, P.; BRÛLET, P., PROC. NATL. ACAD. SEI. USA, vol. 97, 2000, pages 7260 - 7265;;CURIE, T.; ROGERS, K.L.; COLASANTC, C.; BRÛLET, P., MOL. IMAGING, vol. 6, 2007, pages 30 - 42;;BAKAYAN A.; VAQUERO C.F.; PICAZO F; LLOPIS J., PLOS ONE, vol. 6, no. 5, 2011, pages E19520;;STEPANYUK, G. A.; UNCH, J.; MALIKOVA, N.; MARKOVA, S. V.; LEE, J.; VYSOTSKI, E. S., ANAL. BIOANAL. CHEM., vol. 398, 2010, pages 1809 - 1817;;QI, C. F.; GOMI, Y.; HIRANO, T.; OHASHI, M.; OHMIYA, Y.; TSUJI, F. I., J CHEM. SOC. PERKIN TRANS., vol. 13, 1992, pages 1607 - 1611;;OHMIYA, Y.; TERANISHI, K.; AKUTAGAWA, M.; OHASHI, M.; TSUJI, F. 1., CHEM. LETT., 1993, pages 2149 - 2152;;HIRANO, T.; NEGISHI, R.; YAMAGUCHI, M.; QI, F. C.; OHMIYA, Y.; TSUJI, F. I.; OHASHI, M., TETRAHEDRON, vol. 53, 1997, pages 12903 - 12916;;HIRANO, T.; GOMI, Y.; TAKAHASHI, T.; KITAHARA, K.; QI, F. C.; MIZOGUCHI, I.; KYUSHIN, S.; OHASHI, M., TETRAHEDRON LETT., vol. 33, 1992, pages 5771 - 5774;;MORI, K.; MAKI, S.; NIWA, H.; IKEDA, H.; HIRANO, T., TETRAHEDRON, vol. 62, 2006, pages 6272 - 6288;;SAITO, R.; HIRANO, T.; NIWA, H.; OHASHI, M., CHEM LETT., 1998, pages 95 - 96;;SAITO, R.; HIRANO, T.; MAKI, S.; NIWA, H.; OHASHI, M., BULL. CHEM. SOC. JPN., vol. 84, 2011, pages 90 - 99;;INOUYE, S.; LIMON, R.; SAHARA, Y.; HISADA, S.; HOSAYA, T., ANAL. BIOCHEM., vol. 407, 2010, pages 247 - 252;;DEVILLERS, 1.; ARRAULT, A.; OLIVE, G.; MARCHAND-BRYNAERT, J., TETRAHEDRON LETT., vol. 43, 2002, pages 3161 - 3164;;PHAKHODEE, W.; TOYODA, M.; CHOU, C.-M.; KHUNNAWUTMANOTHAM, N.; ISOBE, M., TETRAHEDRON, vol. 67, 2011, pages 1150 - 1157;;HIRANO, T.; OHMIYA, Y.; MAKI, S.; NIWA, H.; OHASHI, M., TETRAHEDRON LETT., vol. 39, 1998, pages 5541 - 5544;;SHIMOMURA, O.; MUSICKI, B.; KISHI, Y., BIOCHEM. J., vol. 261, 1989, pages 913 - 920;;SHIMOMURA, O.; MUSICKI, B.; KISHI, Y., BIOCHEM. J, vol. 251, 1988, pages 405 - 410;;ADAMCZYK, M.; AKIREDDY, S. R.; JOHNSON, D. D.; MATTINGLY P. G.; PAN, Y.; REDDY, R. E., TETRAHEDRON, vol. 59, 2003, pages 8129 - 8142;;DENG ET AL., PROTEIN SCI, vol. 14, 2005, pages 663 - 675;;BAUBET; BRÛLET ET AL., PROC NATL ACAD SCI USA, vol. 97, 2000, pages 7260 - 7265",PENDING
121,DE,A1,DE 2002605 A1,151-594-932-015-103,1970-09-03,1970,DE 2002605 A,1970-01-21,US 79366569 A,1969-01-24,Verfahren zur Herstellung einer abgestuften Schablone,,RCA CORP,HADDONFIELD DODD JUN JOHN ALTO;;ANDREW GESHNER ROBERT,,https://lens.org/151-594-932-015-103,Patent Application,no,0,0,9,9,0,H01J9/142;;H01J9/142,H01J9/14;;H01J9/227,,0,0,,,,EXPIRED
122,GB,A,GB 2320383 A,003-862-200-455-615,1998-06-17,1998,GB 8204107 A,1982-02-12,GB 8204107 A;;GB 8106491 A,1981-03-03,Dual polarisation comparator for deriving sum and difference signals,"Four aerial element signals, each having vertically and horizontally polarised components, are applied to the input ports of a square array of square waveguides. Two further square guides are arranged on each of opposite sides of the square array. Signal components in one (vertical) plane are coupled between the four inner guides in azimuth and elevation and signal components in the other (horizontal) plane are coupled out of the inner foul guides and into the outer guides. Selective transference is achieved by rotation of the polarisation planes. Sum and difference signals are thus obtained from the inner guides for one plane of polarisation and from the outer guides for the other.",ELLIOTT BROS,WATSON COLIN JAMES;;DODD ROBERT THOMAS JOSEPH;;SCORER MICHAEL,,https://lens.org/003-862-200-455-615,Patent Application,no,0,0,3,5,0,G01S13/4409,G01S13/44,H4D DFBB          FBB;;H4D D507          FBB;;H4D D533          FBB,0,0,,,,EXPIRED
123,BE,A,BE 785313 A,045-984-400-734-351,1972-12-27,1972,BE 785313 A,1972-06-23,US 15932671 A,1971-07-02,WERKWIJZE TER VERWIJDERING VAN VERONTREINIGINGEN UIT EEN ETHEENSTROOM,,SHELL INT RESEARCH,DODD DELWIN EARL;;LI KUEI-JUNG;;GOLDING ROBERT ALEXANDER,,https://lens.org/045-984-400-734-351,Granted Patent,no,0,0,12,12,0,C07C7/11;;C07C7/11,C07C7/11,,0,0,,,,EXPIRED
124,IT,B,IT 956995 B,075-639-233-701-253,1973-10-10,1973,IT 2647772 A,1972-06-30,US 15932671 A,1971-07-02,PROCESSO PER IL TRATTAMENTO DI UNA CORRENTE ETILENCIA ALLO SCO PO DI ELIMINARE IMPUREZZE,,SHELL INT RESEARCH,DODD DELWIN EARL;;LI KUEI-JUNG;;GOLDING ROBERT ALEXANDER,,https://lens.org/075-639-233-701-253,Granted Patent,no,0,0,12,12,0,C07C7/11;;C07C7/11,C07C7/11,,0,0,,,,EXPIRED
125,NL,C,NL 170844 C,125-990-201-258-090,1983-01-03,1983,NL 7208998 A,1972-06-29,US 15932671 A,1971-07-02,WERKWIJZE TER BEREIDING VAN ETHANOL DOOR KATALYTISCHE HYDRATATIE VAN ETHEEN.,,SHELL INT RESEARCH,DODD DELWIN EARL;;LI KUEI-JUNG;;GOLDING ROBERT ALEXANDER,,https://lens.org/125-990-201-258-090,Granted Patent,no,0,0,12,12,0,C07C7/11;;C07C7/11,C07C7/11,,0,0,,,,EXPIRED
126,DE,C2,DE 2232271 C2,070-450-515-384-224,1987-11-12,1987,DE 2232271 A,1972-06-30,US 15932671 A,1971-07-02,DE 2232271 C2,,SHELL INT RESEARCH,DODD DELWIN EARL;;LI KUEI-JUNG;;GOLDING ROBERT ALEXANDER,,https://lens.org/070-450-515-384-224,Granted Patent,no,0,0,12,12,0,C07C7/11;;C07C7/11,C07C7/11,,0,0,,,,EXPIRED
127,ES,T3,ES 2763374 T3,131-401-358-068-171,2020-05-28,2020,ES 12793078 T,2012-05-30,US 201161492075 P;;US 201161494923 P;;US 2012/0039990 W,2011-06-01,Accionadores de aerosol y conjuntos de aerosol mejorados,"Accionador de aerosol (100), que comprende: un cuerpo (110) que comprende: una abertura de tapa en un extremo del cuerpo; una abertura (117) en por lo menos una parte del cuerpo adyacente a una abertura de tapa; una abertura de recipiente en un extremo opuesto del cuerpo; y una protuberancia realzada (119); una tapa (120); una abertura de colector de descarga definida por la tapa y la abertura (117) del cuerpo; un colector (140) colocado dentro de un interior del cuerpo, comprendiendo el colector: un extremo de entrada (145) colocado en la protuberancia realzada; un extremo de descarga (147) posicionado en la abertura de colector de descarga; y por lo menos un nervio de soporte de colector (144) posicionado entre el extremo de entrada y el extremo de descarga; un disparador (130) colocado de manera pivotante con el cuerpo; y por lo menos un nervio de soporte de disparador (134) que se extiende desde el disparador.",SILGAN DISPENSING SYSTEMS CORP,GOOD ROBERT J;;DEJONG DAVID L;;DODD JOSEPH K,,https://lens.org/131-401-358-068-171,Granted Patent,no,0,0,8,8,0,B65D83/48;;B65D83/206;;B65D83/48;;B65D83/206,B65D83/00;;B65D83/20;;B65D83/48,,0,0,,,,ACTIVE
128,GB,A,GB 1342874 A,153-466-186-998-158,1974-01-03,1974,GB 3070672 A,1972-06-30,US 15932671 A,1971-07-02,PROCESS FOR TREATING AN ETHYLENE STREAM TO REMOVE IMPURITIES,"1342874 Ethanol preparation SHELL INTERNATIONALE RESEARCH MAAT - SCHAPPIJ NV 30 June 1972 [2 July 1971] 30706/72 Heading C2C [Also in Division C5] Ethanol is prepared by hydration, with a supported phosphoric acid catalyst, of ethylene which is purified by a two-stage scrubbing process, by contacting the ethylene with a first absorbent comprising water (e.g. water or aqueous ethanol or diethyl ether) and then with a second absorbent comprising a lean, heavy hydrocarbon.",SHELL INT RESEARCH,DODD DELWIN EARL;;LI KUEI-JUNG;;GOLDING ROBERT ALEXANDER,,https://lens.org/153-466-186-998-158,Granted Patent,no,0,0,12,12,0,C07C7/11;;C07C7/11,C07C7/11,,0,0,,,,EXPIRED
129,AU,A1,AU 2011/211411 A1,135-224-789-812-530,2011-09-01,2011,AU 2011/211411 A,2011-08-12,AU 2008/202600 A;;AU 2011/211411 A,2008-06-12,Electromagnetic interference shielded panel and method of manufacture,ELECTROMAGNETIC INTERFERENCE SHIELDED PANEL AND METHOD OF MANUFACTURE Abstract An electromagnetic interference shielded panel (20) and method of manufacture. The panel (20) includes one or more frame members (24) having a rib (98) adapted to provide sacrificial material when a first skin member is welded to the frame member (24). The first skin member is welded to the frame members (24) of a frame assembly (22) prior to bonding of a core member and a second skin member to the first skin member and frame assembly (22).,AAR CORP,LOUGHRY GREGORY J;;DODD TOMMY E;;SPENCER ROBERT H,,https://lens.org/135-224-789-812-530,Patent Application,no,0,0,2,2,0,,H05K9/00;;E04B1/92,,0,0,,,,INACTIVE
130,US,A,US 3733368 A,155-126-378-996-108,1973-05-15,1973,US 3733368D A,1971-07-02,US 15932671 A,1971-07-02,PROCESS FOR THE SEPARATION OF POLYMERS FROM A RECYCLE STREAM THAT CONTAINS ETHYLENE,,SHELL OIL CO,DODD DELWIN EARL;;LI KUEI-JUNG;;GOLDING ROBERT ALEXANDER,,https://lens.org/155-126-378-996-108,Granted Patent,no,0,5,12,12,0,C07C7/11;;C07C7/11,C07C7/11,260-677   A,0,0,,,,EXPIRED
131,CN,A,CN 103619728 A,054-180-846-527-835,2014-03-05,2014,CN 201280026846 A,2012-05-30,US 2012/0039990 W;;US 201161492075 P;;US 201161494923 P,2011-06-01,Aerosol actuators and improved aerosol assemblies,"According to certain embodiments of the invention, a valve guide or raised boss may be connected to or integral with a base or body of an aerosol actuator. In various embodiments, a valve guide may include a raised boss associated with a grip or body of an aerosol actuator. The valve guide or raised boss may align a manifold with a valve when an aerosol actuator is assembled to a container containing a product. In addition, a valve guide or raised boss may limit the movement of a portion of a manifold in a defined direction or defined plane such that the load on a valve by a manifold is controlled. For example, a valve guide may ensure a top load on a valve during actuation or may minimize side loads on a valve during actuation.",MEADWESTVACO CALMAR INC,GOOD ROBERT J;;DEJONG DAVID L;;DODD JOSEPH K,,https://lens.org/054-180-846-527-835,Patent Application,no,4,4,8,8,0,B65D83/48;;B65D83/206;;B65D83/48;;B65D83/206,B65D83/00,,0,0,,,,ACTIVE
132,NL,A,NL 7208998 A,066-460-172-427-943,1973-01-04,1973,NL 7208998 A,1972-06-29,US 15932671 A,1971-07-02,NL 7208998 A,,SHELL INT RESEARCH,DODD DELWIN EARL;;LI KUEI-JUNG;;GOLDING ROBERT ALEXANDER,,https://lens.org/066-460-172-427-943,Patent Application,no,0,0,12,12,0,C07C7/11;;C07C7/11,C07C7/11,,0,0,,,,EXPIRED
133,US,B2,US 7600319 B2,126-390-888-052-001,2009-10-13,2009,US 77028707 A,2007-06-28,US 77028707 A,2007-06-28,Method of making an electromagnetic interference shielded panel,An electromagnetic interference shielded panel and method of manufacture. The panel includes one or more frame members having a rib adapted to provide sacrificial material when a first skin member is welded to the frame member. The first skin member is welded to the frame members of a frame assembly prior to bonding of a core member and a second skin member to the first skin member and frame assembly.,AAR CORP,LOUGHRY GREGORY J;;SPENCER ROBERT H;;DODD TOMMY E,AAR CORP (2007-06-27),https://lens.org/126-390-888-052-001,Granted Patent,yes,14,1,24,24,0,H05K9/0003;;H05K9/0073;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;H05K9/0073;;H05K9/0003,B21D47/00;;B21K23/00;;B23P17/00,29/897.32;;29/592.1;;29/602.1;;204/192.15;;174/384;;174/394,1,0,,,"HMMWV Shelters, General Dynamics, 2005.",INACTIVE
134,EP,A1,EP 2714545 A1,132-992-023-038-820,2014-04-09,2014,EP 12793078 A,2012-05-30,US 201161492075 P;;US 201161494923 P;;US 2012/0039990 W,2011-06-01,AEROSOL ACTUATORS AND IMPROVED AEROSOL ASSEMBLIES,,MEADWESTVACO CALMAR INC,GOOD ROBERT J;;DEJONG DAVID L;;DODD JOSEPH K,"WESTROCK DISPENSING SYSTEMS, INC. (2017-04-12);;SILGAN DISPENSING SYSTEMS CORPORATION (2017-09-27)",https://lens.org/132-992-023-038-820,Patent Application,yes,0,0,8,8,0,B65D83/48;;B65D83/206;;B65D83/48;;B65D83/206,B65D83/00;;B65D83/20;;B65D83/48,,0,0,,,,ACTIVE
135,NO,L,NO 20082925 L,183-766-339-809-227,2008-12-29,2008,NO 20082925 A,2008-06-25,US 77028707 A,2007-06-28,"Panel for skjerming mot elektromagnetisk pavirkning, og fremgangsmate for fremstilling av samme",Et elektromagnetisk interferensskjermet panel og fremgangsmåte for fremstilling er beskrevet. Panelet omfatter et eller flere rammeelementer med en rib tilpasset for å tilveiebringe offermaterialet når et første hudelement blir sveiset til rammeelementet. Det første hudelement blir sveiset til rammeelementene av en rammesammenstilling før binding av et kjerneelement og et andre hudelement til det første hudelement og rammesammenstilling. I I,AAR CORP,LOUGHRY GREGORY J;;SPENCER ROBERT H;;DODD TOMMY E,,https://lens.org/183-766-339-809-227,Abstract,no,0,0,24,24,0,H05K9/0003;;H05K9/0073;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;H05K9/0073;;H05K9/0003,H05K3/02;;H04M1/32;;H05K5/06,,0,0,,,,DISCONTINUED
136,SG,A1,SG 148929 A1,000-854-057-996-013,2009-01-29,2009,SG 2008039620 A,2008-05-26,US 77028707 A,2007-06-28,ELECTROMAGNETIC INTERFERENCE SHIELDED PANEL AND METHOD OF MANUFACTURE,ELECTROMAGNETIC INTERFERENCE SHIELDED PANEL AND METHOD OF MANUFACTURE An electromagnetic interference shielded panel and method of manufacture. The panel includes one or more frame members having a rib adapted to provide sacrificial material when a first skin member is welded to the frame member. The first skin member is welded to the frame members of a frame assembly prior to bonding of a core member and a second skin member to the first skin member and frame assembly.,AAR CORP,LOUGHRY GREGORY J;;SPENCER ROBERT H;;DODD TOMMY E,,https://lens.org/000-854-057-996-013,Patent Application,no,0,0,24,24,0,H05K9/0003;;H05K9/0073;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;H05K9/0073;;H05K9/0003,,,0,0,,,,PENDING
137,CA,A1,CA 2634102 A1,031-451-659-654-430,2008-12-28,2008,CA 2634102 A,2008-06-06,US 77028707 A,2007-06-28,ELECTROMAGNETIC INTERFERENCE SHIELDED PANEL AND METHOD OF MANUFACTURE,An electromagnetic interference shielded panel and method of manufacture. Th e panel includes one or more frame members having a rib adapted to provide sacrificial material when a first skin member is welded to the frame member. The first skin member is welded to the frame members of a frame assembly prior to bonding of a core member and a second skin member to the first skin member and frame assembly.,AAR CORP,DODD TOMMY E;;LOUGHRY GREGORY J;;SPENCER ROBERT H,,https://lens.org/031-451-659-654-430,Patent Application,no,0,0,24,24,0,H05K9/0003;;H05K9/0073;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;H05K9/0073;;H05K9/0003,H05K9/00;;H05K5/00,,0,0,,,,INACTIVE
138,CA,C,CA 2634102 C,159-945-055-095-991,2012-09-25,2012,CA 2634102 A,2008-06-06,US 77028707 A,2007-06-28,ELECTROMAGNETIC INTERFERENCE SHIELDED PANEL AND METHOD OF MANUFACTURE,An electromagnetic interference shielded panel and method of manufacture. The panel includes one or more frame members having a rib adapted to provide sacrificial material when a first skin member is welded to the frame member. The first skin member is welded to the frame members of a frame assembly prior to bonding of a core member and a second skin member to the first skin member and frame assembly.,AAR CORP,LOUGHRY GREGORY J;;SPENCER ROBERT H;;DODD TOMMY E,,https://lens.org/159-945-055-095-991,Granted Patent,no,0,0,24,24,0,H05K9/0003;;H05K9/0073;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;H05K9/0073;;H05K9/0003,H05K9/00;;H05K5/00,,0,0,,,,INACTIVE
139,US,A1,US 2009/0000819 A1,186-294-474-885-878,2009-01-01,2009,US 77028707 A,2007-06-28,US 77028707 A,2007-06-28,ELECTROMAGNETIC INTERFERENCE SHIELDED PANEL AND METHOD OF MANUFACTURE,An electromagnetic interference shielded panel and method of manufacture. The panel includes one or more frame members having a rib adapted to provide sacrificial material when a first skin member is welded to the frame member. The first skin member is welded to the frame members of a frame assembly prior to bonding of a core member and a second skin member to the first skin member and frame assembly.,AAR CORP A DELAWARE CORP,LOUGHRY GREGORY J;;SPENCER ROBERT H;;DODD TOMMY E,AAR CORP (2007-06-27),https://lens.org/186-294-474-885-878,Patent Application,yes,14,1,24,24,0,H05K9/0003;;H05K9/0073;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;H05K9/0073;;H05K9/0003,B21D47/00;;H05K9/00,174/384;;29/897.32,0,0,,,,INACTIVE
140,AU,B2,AU 2008/202600 B2,015-142-765-830-726,2011-06-09,2011,AU 2008/202600 A,2008-06-12,US 77028707 A,2007-06-28,Electromagnetic interference shielded panel and method of manufacture,,AAR CORP,SPENCER ROBERT H;;DODD TOMMY E;;LOUGHRY GREGORY J,,https://lens.org/015-142-765-830-726,Granted Patent,no,2,0,24,24,0,H05K9/0003;;H05K9/0073;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;H05K9/0073;;H05K9/0003,H05K9/00;;E04B1/92,,0,0,,,,INACTIVE
141,US,A1,US 2003/0182519 A1,107-400-641-681-815,2003-09-25,2003,US 10441202 A,2002-03-22,US 10441202 A,2002-03-22,Mapping data masks in hardware by controller programming,"
   A memory controller or other device may be programmed with a data mask mapping scheme. A selection device within the memory controller may be set with the data mask mapping scheme between data and a data mask. In one embodiment, a storage device may be included and programmed with the data mask mapping scheme. 
",RIESENMAN ROBERT J.;;DODD JAMES M.;;WILLIAMS MICHAEL W.,RIESENMAN ROBERT J;;DODD JAMES M;;WILLIAMS MICHAEL W,INTEL CORPORATION (2002-03-13),https://lens.org/107-400-641-681-815,Patent Application,yes,10,29,18,18,0,G06F13/1668;;G06F12/00;;G06F13/16;;G06F13/1668,G06F13/16,711/154;;711/202,0,0,,,,EXPIRED
142,US,B2,US 7642470 B2,194-966-863-486-765,2010-01-05,2010,US 39244609 A,2009-02-25,US 39244609 A;;US 77028707 A,2007-06-28,Electromagnetic interference shielded panel,An electromagnetic interference shielded panel and method of manufacture. The panel includes one or more frame members having a rib adapted to provide sacrificial material when a first skin member is welded to the frame member. The first skin member is welded to the frame members of a frame assembly prior to bonding of a core member and a second skin member to the first skin member and frame assembly.,AAR CORP,LOUGHRY GREGORY J;;SPENCER ROBERT H;;DODD TOMMY E,,https://lens.org/194-966-863-486-765,Granted Patent,yes,29,1,24,24,0,H05K9/0003;;H05K9/0073;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;H05K9/0073;;H05K9/0003,H05K9/00,174/382;;174/384,1,0,,,"HMMWV Shelters, General Dynamics, 2005.",INACTIVE
143,TW,A,TW 200404204 A,096-363-645-285-839,2004-03-16,2004,TW 92106035 A,2003-03-19,US 10441202 A,2002-03-22,Mapping data masks in hardware by controller programming,"A memory controller or other device may be programmed with a data mask mapping scheme. A selection device within the memory controller may be set with the data mask mapping scheme between data and a data mask. In one embodiment, a storage device may be included and programmed with the data mask mapping scheme.",INTEL CORP,RIESENMAN ROBERT J;;DODD JAMES M;;WILLIAMS MICHAEL W,,https://lens.org/096-363-645-285-839,Patent of Addition,no,0,0,18,18,0,G06F13/1668;;G06F12/00;;G06F13/16;;G06F13/1668,G06F13/16,,0,0,,,,EXPIRED
144,GB,B,GB 2238903 B,175-990-417-278-377,1994-10-19,1994,GB 8927800 A,1989-12-08,GB 8927800 A,1989-12-08,Magnetrons,,EEV LTD,CROOK ARCHIE WATSON;;WEAVER FRANCIS JAMES;;DODD GEOFFREY ROBERT,,https://lens.org/175-990-417-278-377,Granted Patent,no,7,0,3,3,0,H01J23/05,H01J23/05,H1D DK            KC1B;;H1D D16CY         KC1B;;H1D D16C1BX       KC1B;;H1D D16C1BY       KC1B;;H1D D16C1Y        KC1B;;H1D D16M1         KC1B;;H1D D16S7         KC1B;;H1D D16S8         KC1B;;H1D D17AY         KC1B;;H1D D17A2B        KC1B;;H1D D17A2Y        KC1B;;H1D D17B          KC1B;;H1D D46C          KC1B;;H1D D46Y          KC1B,0,0,,,,EXPIRED
145,AU,B2,AU 2011/211411 B2,191-694-788-615-620,2012-08-16,2012,AU 2011/211411 A,2011-08-12,AU 2008/202600 A;;AU 2011/211411 A,2008-06-12,Electromagnetic interference shielded panel and method of manufacture,ELECTROMAGNETIC INTERFERENCE SHIELDED PANEL AND METHOD OF MANUFACTURE Abstract An electromagnetic interference shielded panel (20) and method of manufacture. The panel (20) includes one or more frame members (24) having a rib (98) adapted to provide sacrificial material when a first skin member is welded to the frame member (24). The first skin member is welded to the frame members (24) of a frame assembly (22) prior to bonding of a core member and a second skin member to the first skin member and frame assembly (22).,AAR CORP,LOUGHRY GREGORY J;;DODD TOMMY E;;SPENCER ROBERT H,,https://lens.org/191-694-788-615-620,Granted Patent,no,1,0,2,2,0,,H05K9/00;;E04B1/92,,0,0,,,,INACTIVE
146,US,A1,US 2009/0152000 A1,083-831-256-907-684,2009-06-18,2009,US 39244609 A,2009-02-25,US 39244609 A;;US 77028707 A,2007-06-28,Electromagnetic Interference Shielded Panel,An electromagnetic interference shielded panel and method of manufacture. The panel includes one or more frame members having a rib adapted to provide sacrificial material when a first skin member is welded to the frame member. The first skin member is welded to the frame members of a frame assembly prior to bonding of a core member and a second skin member to the first skin member and frame assembly.,AAR CORP,LOUGHRY GREGORY J;;SPENCER ROBERT H;;DODD TOMMY E,,https://lens.org/083-831-256-907-684,Patent Application,yes,29,6,24,24,0,H05K9/0003;;H05K9/0073;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;H05K9/0073;;H05K9/0003,H05K7/16;;H05K9/00,174/384;;174/350;;361/725;;361/816;;361/818,0,0,,,,INACTIVE
147,CN,B,CN 101336071 B,096-260-708-270-473,2013-06-05,2013,CN 200810129311 A,2008-06-26,US 77028707 A,2007-06-28,Electromagnetic interference shielded panel and method of manufacture,,AAR CORP,SPENCER ROBERT H;;LOUGHRY GREGORY J;;DODD TOMMY E,,https://lens.org/096-260-708-270-473,Granted Patent,no,0,0,24,24,0,H05K9/0003;;H05K9/0073;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;H05K9/0073;;H05K9/0003,H05K9/00,,0,0,,,,INACTIVE
148,US,B2,US 6952367 B2,134-103-948-246-912,2005-10-04,2005,US 70102503 A,2003-11-03,US 70102503 A;;US 10483702 A,2002-03-22,Obtaining data mask mapping information,"A data mask map may be programmed into a storage device in various ways. In one embodiment, the data mask is hardwired into a selection device to reorder either the data mask bits or the data chunks. In another embodiment, a data mask map is retrieved from a location in memory. In still another embodiment, the data mask map is determined through an algorithm.",INTEL CORP,RIESENMAN ROBERT J;;DODD JAMES M;;WILLIAMS MICHAEL W,,https://lens.org/134-103-948-246-912,Granted Patent,yes,6,6,22,22,0,G06F12/04;;G06F13/1626;;G06F12/00;;G06F13/16;;G06F12/06;;G06F13/1626;;G06F12/04,G06F12/04;;G06F12/06;;G06F13/16,365/185.11;;365/230.06,1,0,,,"PCT Search Report mailed Sep. 30, 2003, International Application No. PCT/US03/07915 (6 pages).",EXPIRED
149,KR,B1,KR 950009040 B1,056-157-207-160-616,1995-08-14,1995,KR 890008981 A,1989-06-27,US 21071288 A,1988-06-28,PRESSURE SENSITIVE ADHESIVE TAPES,,MINESOTA MINING MANUFACTUIRN C,MARK DODD PURGETT;;YVAN ADRIEN BOGAERT;;ROBERT REMI LOUIS,,https://lens.org/056-157-207-160-616,Granted Patent,no,0,1,16,16,0,C09J133/08;;C08L21/00;;C08L2666/02;;C08L2666/04;;C08L2666/24;;C09J7/385;;C09J133/20;;C09J151/04;;C09J2301/302,C09J7/00;;C08L21/00;;C09J7/02;;C09J133/04;;C09J133/06;;C09J133/08;;C09J151/04,,0,0,,,,EXPIRED
150,MX,A,MX 2008008473 A,177-214-629-331-716,2009-03-04,2009,MX 2008008473 A,2008-06-27,US 77028707 A,2007-06-28,ELECTROMAGNETIC INTERFERENCE SHIELDED PANEL AND METHOD OF MANUFACTURE.,An electromagnetic interference shielded panel and method of manufacture. The panel includes one or more frame members having a rib adapted to provide sacrificial material when a first skin member is welded to the frame member. The first skin member is welded to the frame members of a frame assembly prior to bonding of a core member and a second skin member to the first skin member and frame assembly.,AAR CORP,LOUGHRY GREGORY J;;SPENCER ROBERT H;;DODD TOMMY E,,https://lens.org/177-214-629-331-716,Patent Application,no,0,0,24,24,0,H05K9/0003;;H05K9/0073;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;H05K9/0073;;H05K9/0003,H05K9/00;;E04B1/00,,0,0,,,,ACTIVE
151,US,B2,US 6801459 B2,190-623-911-114-422,2004-10-05,2004,US 10483702 A,2002-03-22,US 10483702 A,2002-03-22,Obtaining data mask mapping information,"
    A data mask map may be programmed into a storage device in various ways. In one embodiment, the data mask is hardwired into a selection device to reorder either the data mask bits or the data chunks. In another embodiment, a data mask map is retrieved from a location in memory. In still another embodiment, the data mask map is determined through an algorithm. 
",INTEL CORP,RIESENMAN ROBERT J;;DODD JAMES M;;WILLIAMS MICHAEL W,INTEL CORPORATION (2002-03-13),https://lens.org/190-623-911-114-422,Granted Patent,yes,5,17,22,22,0,G06F12/04;;G06F13/1626;;G06F12/00;;G06F13/16;;G06F12/06;;G06F13/1626;;G06F12/04,G06F12/04;;G06F12/06;;G06F13/16,365/189.01;;365/230.06,1,0,,,"PCT Search Report mailed Sep. 30, 2003, International Application No. PCT/US 03/07915 (6 pages).",EXPIRED
152,DE,A1,DE 2232271 A1,193-216-010-724-187,1973-01-18,1973,DE 2232271 A,1972-06-30,US 15932671 A,1971-07-02,VERFAHREN ZUR ENTFERNUNG VON VERUNREINIGUNGEN AUS EINEM AETHYLENSTROM,,SHELL INT RESEARCH,DODD DELWIN EARL;;LI KUEI-JUNG;;GOLDING ROBERT ALEXANDER,,https://lens.org/193-216-010-724-187,Patent Application,no,6,0,12,12,0,C07C7/11;;C07C7/11,C07C7/11,,0,0,,,,EXPIRED
153,IT,A0,IT 8267233 A0,036-801-239-891-631,1982-03-02,1982,IT 6723382 A,1982-03-02,GB 8106491 A,1981-03-03,COMPARATORE IN GUIDA D ONDA,,ELLIOTT BROTHERS LONDON LTD,DODD ROBERT THOMAS JOSEPH;;SCORER MICHAEL;;WATSON COLIN JAMES,,https://lens.org/036-801-239-891-631,Patent Application,no,0,0,2,5,0,,,,0,0,,,,DISCONTINUED
154,CA,A,CA 1063623 A,035-209-849-832-613,1979-10-02,1979,CA 234850 A,1975-09-05,US 50803074 A,1974-09-23,ALCOHOL PROCESS,"A process for the production of alcohols in which in a reaction zone olefins are directly hydrated in the presence of a catalyst, at least a portion of the reaction product is passed from the reaction zone to a scrubbing zone where it is contacted with a lean absorbent, at least a portion of the fresh olefin feed is introduced in the scrubbing zone as a stripping agent for organic impurities,a liquid alcohol-containing product stream and an overhead gas stream are recovered from the scrubbing zone and the said overhead stream is recycled to the reaction zone.",SHELL CANADA LTD,FOSTER ELTON G;;GOLDING ROBERT A;;DODD DELWIN E,,https://lens.org/035-209-849-832-613,Granted Patent,no,0,0,13,13,0,C07C29/76;;C07C29/76;;C07C29/86;;C07C29/86,C07C29/04;;C07C27/00;;C07C29/76;;C07C29/86;;C07C31/02;;C07C67/00,260-639.4,0,0,,,,EXPIRED
155,EP,A2,EP 2009978 A2,093-265-743-039-57X,2008-12-31,2008,EP 08158170 A,2008-06-12,US 77028707 A,2007-06-28,Electromagnetic interference shielded panel and method of manufacture,"An electromagnetic interference shielded panel (20) and method of manufacture. The panel includes one or more frame members (24) having a rib (98) adapted to provide sacrificial material when a first skin member (120) is welded to the frame member. The first skin member is welded to the frame members of a frame assembly (22) prior to bonding of a core member (160) and a second skin member (140) to the first skin member and frame assembly.
",AAR CORP,LOUGHRY GREGORY J;;SPENCER ROBERT H;;DODD TOMMY E,,https://lens.org/093-265-743-039-57X,Patent Application,yes,0,0,24,24,0,H05K9/0003;;H05K9/0073;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;H05K9/0073;;H05K9/0003,H05K9/00,,0,0,,,,DISCONTINUED
156,US,B2,US 7750251 B2,149-325-842-928-163,2010-07-06,2010,US 39248209 A,2009-02-25,US 39248209 A;;US 77028707 A,2007-06-28,Frame member for electromagnetic interference shielded panel,An electromagnetic interference shielded panel and method of manufacture. The panel includes one or more frame members having a rib adapted to provide sacrificial material when a first skin member is welded to the frame member. The first skin member is welded to the frame members of a frame assembly prior to bonding of a core member and a second skin member to the first skin member and frame assembly.,AAR CORP,LOUGHRY GREGORY J;;SPENCER ROBERT H;;DODD TOMMY E,AAR MANUFACTURING INC (2021-08-25),https://lens.org/149-325-842-928-163,Granted Patent,yes,33,4,24,24,0,H05K9/0003;;H05K9/0073;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;H05K9/0073;;H05K9/0003,H05K9/00,174/382;;174/384,2,0,,,"HMMWV Shelters, General Dynamics, 2005.;;Patent Abstract of Japanese Publication No. 2007132035, Published May 31, 2007.",ACTIVE
157,US,A1,US 2003/0179605 A1,165-866-453-164-616,2003-09-25,2003,US 10483702 A,2002-03-22,US 10483702 A,2002-03-22,Obtaining data mask mapping information,"
   A data mask map may be programmed into a storage device in various ways. In one embodiment, the data mask is hardwired into a selection device to reorder either the data mask bits or the data chunks. In another embodiment, a data mask map is retrieved from a location in memory. In still another embodiment, the data mask map is determined through an algorithm. 
",RIESENMAN ROBERT J.;;DODD JAMES M.;;WILLIAMS MICHAEL W.,RIESENMAN ROBERT J;;DODD JAMES M;;WILLIAMS MICHAEL W,INTEL CORPORATION (2002-03-13),https://lens.org/165-866-453-164-616,Patent Application,yes,2,24,22,22,0,G06F12/04;;G06F13/1626;;G06F12/00;;G06F13/16;;G06F12/06;;G06F13/1626;;G06F12/04,G06F12/04;;G06F12/06;;G06F13/16,365/189.01,0,0,,,,EXPIRED
158,GB,B,GB 2320383 B,189-119-027-752-505,1998-09-02,1998,GB 8204107 A,1982-02-12,GB 8204107 A;;GB 8106491 A,1981-03-03,Waveguide comparator,,ELLIOTT BROS,WATSON COLIN JAMES;;DODD ROBERT THOMAS JOSEPH;;SCORER MICHAEL,,https://lens.org/189-119-027-752-505,Granted Patent,no,0,0,3,5,0,G01S13/4409,G01S13/44,H4D DFBB          FBB;;H4D D507          FBB;;H4D D533          FBB,0,0,,,,EXPIRED
159,EP,A1,EP 2387299 A1,015-549-529-505-31X,2011-11-16,2011,EP 11177506 A,2008-06-12,EP 08158170 A;;US 77028707 A,2007-06-28,Frame member for use with a skin member in forming an electromagnetic interference shielded panel,"A frame member (24) for use with a skin member (120) in forming an electromagnetic interference shielded panel. The panel includes one or more frame members having a rib (98) adapted to provide sacrificial material when a first skin member (120) is welded to the frame member (24). The first skin member is welded to the frame members of a frame assembly prior to bonding of a core member and a second skin member to the first skin member and frame assembly.
",AAR CORP,LOUGHRY GREGORY J;;SPENCER ROBERT H;;DODD TOMMY E,,https://lens.org/015-549-529-505-31X,Patent Application,yes,3,0,24,24,0,H05K9/0003;;H05K9/0073;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;H05K9/0073;;H05K9/0003,H05K9/00,,0,0,,,,DISCONTINUED
160,US,B2,US 6957307 B2,095-954-230-132-695,2005-10-18,2005,US 10441202 A,2002-03-22,US 10441202 A,2002-03-22,Mapping data masks in hardware by controller programming,"A memory controller or other device may be programmed with a data mask mapping scheme. A selection device within the memory controller may be set with the data mask mapping scheme between data and a data mask. In one embodiment, a storage device may be included and programmed with the data mask mapping scheme.",INTEL CORP,RIESENMAN ROBERT J;;DODD JAMES M;;WILLIAMS MICHAEL W,INTEL CORPORATION (2002-03-13),https://lens.org/095-954-230-132-695,Granted Patent,yes,12,14,18,18,0,G06F13/1668;;G06F12/00;;G06F13/16;;G06F13/1668,G06F13/16,711/154;;711/155;;711/163;;365/195,1,0,,,"PCT Search Report, International Application No. PCT/US 03/07913, mailed Sep. 25, 2003 (6 pages).",EXPIRED
161,US,A1,US 2004/0093471 A1,155-114-823-685-28X,2004-05-13,2004,US 70102503 A,2003-11-03,US 70102503 A;;US 10483702 A,2002-03-22,Obtaining data mask mapping information,"
   A data mask map may be programmed into a storage device in various ways. In one embodiment, the data mask is hardwired into a selection device to reorder either the data mask bits or the data chunks. In another embodiment, a data mask map is retrieved from a location in memory. In still another embodiment, the data mask map is determined through an algorithm. 
",RIESENMAN ROBERT J.;;DODD JAMES M.;;WILLIAMS MICHAEL W.,RIESENMAN ROBERT J;;DODD JAMES M;;WILLIAMS MICHAEL W,,https://lens.org/155-114-823-685-28X,Patent Application,yes,3,14,22,22,0,G06F12/04;;G06F13/1626;;G06F12/00;;G06F13/16;;G06F12/06;;G06F13/1626;;G06F12/04,G06F12/04;;G06F12/06;;G06F13/16,711/154,0,0,,,,EXPIRED
162,EP,A4,EP 2714545 A4,150-896-446-124-766,2015-04-22,2015,EP 12793078 A,2012-05-30,US 201161492075 P;;US 201161494923 P;;US 2012/0039990 W,2011-06-01,AEROSOL ACTUATORS AND IMPROVED AEROSOL ASSEMBLIES,,MEADWESTVACO CALMAR INC,GOOD ROBERT J;;DEJONG DAVID L;;DODD JOSEPH K,"WESTROCK DISPENSING SYSTEMS, INC. (2017-04-12);;SILGAN DISPENSING SYSTEMS CORPORATION (2017-09-27)",https://lens.org/150-896-446-124-766,Search Report,no,2,0,8,8,0,B65D83/48;;B65D83/206;;B65D83/48;;B65D83/206,B65D83/00;;B65D83/20;;B65D83/48,,0,0,,,,ACTIVE
163,JP,A,JP 2009010377 A,013-615-650-802-308,2009-01-15,2009,JP 2008164709 A,2008-06-24,US 77028707 A,2007-06-28,ELECTROMAGNETIC INTERFERENCE SHIELDED PANEL AND METHOD OF MANUFACTURE THEREFOR,"<P>PROBLEM TO BE SOLVED: To provide an electromagnetic interference shielded panel which shields the content in a case from electromagnetic interference, by shielding electromagnetic waves entering the case to accommodate devices, such as electrical devices that receive adverse effects due to electromagnetic waves, and to provide a manufacturing method for the panel. <P>SOLUTION: A panel 20 comprises one or more frame members, having a rib serving as a sacrifical material, when a first skin member 120 is welded to the frame member. Before a core member 160 and a second skin member 140 are connected to the first skin member and a frame assembly, the first skin member is welded to the frame member of the frame assembly. <P>COPYRIGHT: (C)2009,JPO&INPIT",AAR CORP,LOUGHRY GREGORY J;;SPENCER ROBERT H;;DODD TOMMY E,,https://lens.org/013-615-650-802-308,Patent Application,no,3,1,24,24,0,H05K9/0003;;H05K9/0073;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;H05K9/0073;;H05K9/0003,H05K9/00;;E04B1/92,,0,0,,,,INACTIVE
164,JP,B1,JP S582930 B1,045-221-543-602-430,1983-01-19,1983,JP 6509172 A,1972-06-30,US 15932671 A,1971-07-02,JP S582930 B1,,SHELL INT RESEARCH,DODD DELWIN EARL;;LI KUEI-JUNG;;GOLDING ROBERT ALEXANDER,,https://lens.org/045-221-543-602-430,Patent Application,no,3,2,12,12,0,C07C7/11;;C07C7/11,C07C7/11,,0,0,,,,DISCONTINUED
165,US,A1,US 2009/0151999 A1,057-135-061-331-409,2009-06-18,2009,US 39248209 A,2009-02-25,US 39248209 A;;US 77028707 A,2007-06-28,Frame Member for Electromagnetic Interference Shielded Panel,An electromagnetic interference shielded panel and method of manufacture. The panel includes one or more frame members having a rib adapted to provide sacrificial material when a first skin member is welded to the frame member. The first skin member is welded to the frame members of a frame assembly prior to bonding of a core member and a second skin member to the first skin member and frame assembly.,AAR CORP,LOUGHRY GREGORY J;;SPENCER ROBERT H;;DODD TOMMY E,AAR MANUFACTURING INC (2021-08-25),https://lens.org/057-135-061-331-409,Patent Application,yes,31,0,24,24,0,H05K9/0003;;H05K9/0073;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;H05K9/0073;;H05K9/0003,H05K9/00,174/377;;361/818;;174/384;;361/816,0,0,,,,ACTIVE
166,EP,B1,EP 2714545 B1,067-508-878-998-699,2019-10-02,2019,EP 12793078 A,2012-05-30,US 201161492075 P;;US 201161494923 P;;US 2012/0039990 W,2011-06-01,AEROSOL ACTUATORS AND IMPROVED AEROSOL ASSEMBLIES,,SILGAN DISPENSING SYSTEMS CORP,GOOD ROBERT J;;DEJONG DAVID L;;DODD JOSEPH K,"WESTROCK DISPENSING SYSTEMS, INC. (2017-04-12);;SILGAN DISPENSING SYSTEMS CORPORATION (2017-09-27)",https://lens.org/067-508-878-998-699,Granted Patent,yes,6,0,8,8,0,B65D83/48;;B65D83/206;;B65D83/48;;B65D83/206,B65D83/00;;B65D83/20;;B65D83/48,,0,0,,,,ACTIVE
167,US,B2,US 6925013 B2,127-980-985-545-701,2005-08-02,2005,US 78694004 A,2004-02-24,US 78694004 A;;US 10483702 A,2002-03-22,Obtaining data mask mapping information,"A data mask map may be programmed into a storage device in various ways. In one embodiment, the data mask is hardwired into a selection device to reorder either the data mask bits or the data chunks. In another embodiment, a data mask map is retrieved from a location in memory. In still another embodiment, the data mask map is determined through an algorithm.",INTEL CORP,RIESENMAN ROBERT J;;DODD JAMES M;;WILLIAMS MICHAEL W,,https://lens.org/127-980-985-545-701,Granted Patent,yes,6,0,22,22,0,G06F12/04;;G06F13/1626;;G06F12/00;;G06F13/16;;G06F12/06;;G06F13/1626;;G06F12/04,G06F12/04;;G06F12/06;;G06F13/16,365/189.01;;365/230.06,1,0,,,"PCT Search Report mailed Sep. 30, 2003, International Application No. PCT/US 03/07915 (6 pages).",EXPIRED
168,WO,A1,WO 2012/166793 A1,151-264-377-874-387,2012-12-06,2012,US 2012/0039990 W,2012-05-30,US 201161492075 P;;US 201161494923 P,2011-06-01,AEROSOL ACTUATORS AND IMPROVED AEROSOL ASSEMBLIES,"According to certain embodiments of the invention, a valve guide or raised boss may be connected to or integral with a base or body of an aerosol actuator. In various embodiments, a valve guide may include a raised boss associated with a grip or body of an aerosol actuator. The valve guide or raised boss may align a manifold with a valve when an aerosol actuator is assembled to a container containing a product. In addition, a valve guide or raised boss may limit the movement of a portion of a manifold in a defined direction or defined plane such that the load on a valve by a manifold is controlled. For example, a valve guide may ensure a top load on a valve during actuation or may minimize side loads on a valve during actuation.",MEADWESTVACO CALMAR INC;;GOOD ROBERT J;;DEJONG DAVID L;;DODD JOSEPH K,GOOD ROBERT J;;DEJONG DAVID L;;DODD JOSEPH K,,https://lens.org/151-264-377-874-387,Patent Application,yes,5,6,8,8,0,B65D83/48;;B65D83/206;;B65D83/48;;B65D83/206,B65D83/00,,0,0,,,,PENDING
169,TW,B,TW I297435 B,050-155-034-742-839,2008-06-01,2008,TW 92106183 A,2003-03-20,US 10483702 A,2002-03-22,Method and machine readable medium for obtaining data mask mapping information,"A data mask map may be programmed into a storage device in various ways. In one embodiment, the data mask is hardwired into a selection device to reorder either the data mask bits or the data chunks. In another embodiment, a data mask map is retrieved from a location in memory. In still another embodiment, the data mask map is determined through an algorithm.",INTEL CORP,ROBERT J RIESENMAN;;JAMES M DODD;;MICHAEL W WILLIAMS,,https://lens.org/050-155-034-742-839,Granted Patent,no,0,0,22,22,0,G06F12/04;;G06F13/1626;;G06F12/00;;G06F13/16;;G06F12/06;;G06F13/1626;;G06F12/04,G06F12/06,,0,0,,,,EXPIRED
170,FR,B1,FR 2150691 B1,041-543-737-566-825,1977-08-05,1977,FR 7223750 A,1972-06-30,US 15932671 A,1971-07-02,FR 2150691 B1,,SHELL INT RESEARCH,DODD DELWIN EARL;;LI KUEI-JUNG;;GOLDING ROBERT ALEXANDER,,https://lens.org/041-543-737-566-825,Granted Patent,no,0,0,12,12,0,C07C7/11;;C07C7/11,C07C7/11,,0,0,,,,EXPIRED
171,GB,A,GB 2238903 A,112-657-183-919-340,1991-06-12,1991,GB 8927800 A,1989-12-08,GB 8927800 A,1989-12-08,Magnetron cathode,"A magnetron includes a cathode 1, coaxially disposed within anode 2, having end regions 10 and 11 which are electron emissive during operation and a central region 12 which is substantially non-emissive. Such an arrangement has been found to give improved performance. The non-emissive region preferably occupies less than one third of the total axial extent of the cathode. In various other cathode configurations disclosed, Figs. 2-7 (not shown), a plurality of symmetrically disposed non-emissive regions may be provided, or the cathode surface may be grooved with some of the grooves filled with emissive material, the remaining grooves being left empty or filled with non-emissive material. <IMAGE>",EEV LTD,CROOK ARCHIE WATSON;;WEAVER FRANCIS JAMES;;DODD GEOFFREY ROBERT,,https://lens.org/112-657-183-919-340,Patent Application,no,7,3,3,3,0,H01J23/05,H01J23/05,H1D DK            KC1B;;H1D D16CY         KC1B;;H1D D16C1BX       KC1B;;H1D D16C1BY       KC1B;;H1D D16C1Y        KC1B;;H1D D16M1         KC1B;;H1D D16S7         KC1B;;H1D D16S8         KC1B;;H1D D17AY         KC1B;;H1D D17A2B        KC1B;;H1D D17A2Y        KC1B;;H1D D17B          KC1B;;H1D D46C          KC1B;;H1D D46Y          KC1B,0,0,,,,EXPIRED
172,US,A1,US 2004/0165446 A1,109-973-539-976-642,2004-08-26,2004,US 78694004 A,2004-02-24,US 78694004 A;;US 10483702 A,2002-03-22,Obtaining data mask mapping information,"
   A data mask map may be programmed into a storage device in various ways. In one embodiment, the data mask is hardwired into a selection device to reorder either the data mask bits or the data chunks. In another embodiment, a data mask map is retrieved from a location in memory. In still another embodiment, the data mask map is determined through an algorithm. 
",RIESENMAN ROBERT J.;;DODD JAMES M.;;WILLIAMS MICHAEL W.,RIESENMAN ROBERT J;;DODD JAMES M;;WILLIAMS MICHAEL W,,https://lens.org/109-973-539-976-642,Patent Application,yes,3,12,22,22,0,G06F12/04;;G06F13/1626;;G06F12/00;;G06F13/16;;G06F12/06;;G06F13/1626;;G06F12/04,G06F12/04;;G06F12/06;;G06F13/16,365/189.01,0,0,,,,EXPIRED
173,TW,A,TW 200402628 A,141-751-755-122-55X,2004-02-16,2004,TW 92106183 A,2003-03-20,US 10483702 A,2002-03-22,Obtaining data mask mapping information,"A data mask map may be programmed into a storage device in various ways. In one embodiment, the data mask is hardwired into a selection device to reorder either the data mask bits or the data chunks. In another embodiment, a data mask map is retrieved from a location in memory. In still another embodiment, the data mask map is determined through an algorithm.",INTEL CORP,RIESENMAN ROBERT J;;DODD JAMES M;;WILLIAMS MICHAEL W,,https://lens.org/141-751-755-122-55X,Patent of Addition,no,0,6,22,22,0,G06F12/04;;G06F13/1626;;G06F12/00;;G06F13/16;;G06F12/06;;G06F13/1626;;G06F12/04,G06F12/16;;G06F12/04;;G06F12/06;;G06F13/16;;G11C16/04,,0,0,,,,EXPIRED
174,AU,A1,AU 2008/202600 A1,145-586-987-447-125,2009-01-15,2009,AU 2008/202600 A,2008-06-12,US 77028707 A,2007-06-28,Electromagnetic interference shielded panel and method of manufacture,,AAR CORP,SPENCER ROBERT H;;DODD TOMMY E;;LOUGHRY GREGORY J,,https://lens.org/145-586-987-447-125,Patent Application,no,0,0,24,24,0,H05K9/0003;;H05K9/0073;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;H05K9/0073;;H05K9/0003,H05K9/00;;E04B1/92,,0,0,,,,INACTIVE
175,US,A,US 4003952 A,163-527-334-634-364,1977-01-18,1977,US 50803074 A,1974-09-23,US 50803074 A,1974-09-23,Direct hydration of olefins to alcohols,"An improvement in the process for producing alcohols by the direct hydration of olefins in the presence of a catalyst, where the reactor effluent is scrubbed with water in a scrubbing zone and where the olefin feed is introduced in the lower portion of the scrubbing zone to strip out the organic impurities found in the aqueous alcohol product stream.",SHELL OIL CO,FOSTER ELTON GORDON;;GOLDING ROBERT A;;DODD DELWIN E,,https://lens.org/163-527-334-634-364,Granted Patent,yes,4,5,13,13,0,C07C29/76;;C07C29/76;;C07C29/86;;C07C29/86,C07C29/04;;C07C27/00;;C07C29/76;;C07C29/86;;C07C31/02;;C07C67/00,260/641,0,0,,,,EXPIRED
176,FR,A1,FR 2150691 A1,122-720-213-633-805,1973-04-13,1973,FR 7223750 A,1972-06-30,US 15932671 A,1971-07-02,FR 2150691 A1,,SHELL INT RESEARCH,DODD DELWIN EARL;;LI KUEI-JUNG;;GOLDING ROBERT ALEXANDER,,https://lens.org/122-720-213-633-805,Patent Application,no,0,0,12,12,0,C07C7/11;;C07C7/11,C07C7/11,,0,0,,,,EXPIRED
177,EP,A3,EP 2009978 A3,141-992-347-531-917,2010-04-21,2010,EP 08158170 A,2008-06-12,US 77028707 A,2007-06-28,Electromagnetic interference shielded panel and method of manufacture,"An electromagnetic interference shielded panel (20) and method of manufacture. The panel includes one or more frame members (24) having a rib (98) adapted to provide sacrificial material when a first skin member (120) is welded to the frame member. The first skin member is welded to the frame members of a frame assembly (22) prior to bonding of a core member (160) and a second skin member (140) to the first skin member and frame assembly.
",AAR CORP,LOUGHRY GREGORY J;;SPENCER ROBERT H;;DODD TOMMY E,,https://lens.org/141-992-347-531-917,Search Report,yes,3,0,24,24,0,H05K9/0003;;H05K9/0073;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;Y10T29/4902;;Y10T29/49002;;Y10T29/49629;;H05K9/0073;;H05K9/0003,H05K9/00,,0,0,,,,DISCONTINUED
178,TW,B,TW I260496 B,174-170-662-262-053,2006-08-21,2006,TW 92106035 A,2003-03-19,US 10441202 A,2002-03-22,Mapping data masks in hardware by controller programming,"A memory controller or other device may be programmed with a data mask mapping scheme. A selection device within the memory controller may be set with the data mask mapping scheme between data and a data mask. In one embodiment, a storage device may be included and programmed with the data mask mapping scheme.",INTEL CORP,RIESENMAN ROBERT J;;DODD JAMES M;;WILLIAMS MICHAEL W,,https://lens.org/174-170-662-262-053,Granted Patent,no,0,0,18,18,0,G06F13/1668;;G06F12/00;;G06F13/16;;G06F13/1668,G06F12/00;;G06F13/16,,0,0,,,,EXPIRED
179,DE,A1,DE 2542203 A1,043-523-540-394-569,1976-04-08,1976,DE 2542203 A,1975-09-22,US 50803074 A,1974-09-23,VERFAHREN ZUR HERSTELLUNG VON ALKOHOLEN,,SHELL INT RESEARCH,FOSTER ELTON GORDON;;GOLDING ROBERT ALEXANDER;;DODD DELWIN EARL,,https://lens.org/043-523-540-394-569,Patent Application,no,0,1,13,13,0,C07C29/76;;C07C29/76;;C07C29/86;;C07C29/86,C07C29/04;;C07C27/00;;C07C29/76;;C07C29/86;;C07C31/02;;C07C67/00,,1,0,,,NICHTS-ERMITTELT,EXPIRED
180,US,A,US 5208216 A,059-998-183-746-334,1993-05-04,1993,US 90656092 A,1992-06-30,US 90656092 A;;US 71466691 A,1991-06-13,Acrylamide terpolymer shale stabilizing additive for low viscosity oil and gas drilling operations,"A low viscosity drilling fluid and method for stabilizing a downhole shale formation are disclosed. The fluid comprises an aqueous solution of a partialy transamidated hydrolyzed acrylamide copolymer, potassium chloride, a weighting agent and an optional viscosifying agent. The copolymer comprises from about 50 to about 98 mole percent primary amide functionality, from about 0.1 to about 15 mole percent secondary amide functionality and from about 2 to about 50 mole percent of the acrylate salt. The drilling fluid has a density out from about 8 to about 18 pounds per gallon and a viscosity of from about 5 to about 30 centistokes.",NALCO CHEMICAL CO,WILLIAMSON C DARWIN;;FONG DODD W;;GABEL ROBERT K,NALCO/ EXXON ENERGY CHEMICALS L.P (1994-09-01);;NALCO CHEMICAL COMPANY (1992-06-29),https://lens.org/059-998-183-746-334,Granted Patent,yes,6,101,1,1,0,C09K8/24;;C09K8/24,C09K8/24,507/120,6,1,147-634-672-722-256,10.2118/10100-pa,"G. M. Bol, IADC/SPE 14802, 1986.;;R. P. Steiger, Journal of Petroleum Technology, pp. 1661 1670, Aug. 1982.;;R. K. Clark et al., Journal of Petroleum Technology, pp. 719 727, Jun., 1976.;;J. J. Sheu et al., Society of Petroleum Engineers (SPE) 18033, 1988.;;J. A. Wingrave, et al., SPE 166787, 1987.;;B. G. Chesser, International Association of Drilling Contractors/Society of Petroleum Engineers (IADC/SPE) 14757, 1986.",EXPIRED
181,US,A1,US 2014/0110440 A1,124-672-456-333-427,2014-04-24,2014,US 201214122293 A,2012-05-30,US 201214122293 A;;US 201161492075 P;;US 201161494923 P;;US 2012/0039990 W,2011-06-01,AEROSOL ACTUATORS AND IMPROVED AEROSOL ASSEMBLIES,"According to certain embodiments of the invention, a valve guide or raised boss may be connected to or integral with a base or body of an aerosol actuator. In various embodiments, a valve guide may include a raised boss associated with a grip or body of an aerosol actuator. The valve guide or raised boss may align a manifold with a valve when an aerosol actuator is assembled to a container containing a product. In addition, a valve guide or raised boss may limit the movement of a portion of a manifold in a defined direction or defined plane such that the load on a valve by a manifold is controlled. For example, a valve guide may ensure a top load on a valve during actuation or may minimize side loads on a valve during actuation.",GOOD ROBERT J;;DEJONG DAVID L;;DODD JOSEPH K;;MEADWESTVACO CALMAR INC,GOOD ROBERT J;;DEJONG DAVID L;;DODD JOSEPH K,SILGAN DISPENSING SYSTEMS CORPORATION (2011-06-06),https://lens.org/124-672-456-333-427,Patent Application,yes,23,14,8,8,0,B65D83/48;;B65D83/206;;B65D83/48;;B65D83/206,B65D83/00,222/402.13,0,0,,,,DISCONTINUED
182,US,B2,US 8516765 B2,074-904-845-095-82X,2013-08-27,2013,US 52777808 A,2008-11-05,US 52777808 A;;US 10893908 P;;US 2008/0082476 W,2008-10-28,"Foamed building panel, clip and system for installation","A building panel has a unitary foamed core, and a unitary cover layer of resinous polymeric material covering the core and covering a bottom edge or drip edge and an upper edge of the panel. A system for installation of adjacent panels includes the adjacent panels having vertical clip-receiving grooves slidably receiving narrow edges of a clip. The clip holds adjacent panels in coplanar abutting relationship to minimize movement while installed on a wall of a building.",SHAW ROBERT;;BECK DAVID;;STUCKY DAVID;;STEELE DAVID;;DODD ROBERT;;VALENTINE JAMIE;;CERTAIN TEED CORP,SHAW ROBERT;;BECK DAVID;;STUCKY DAVID;;STEELE DAVID;;DODD ROBERT;;VALENTINE JAMIE,CERTAINTEED CORPORATION (2009-09-22),https://lens.org/074-904-845-095-82X,Granted Patent,yes,70,29,3,3,0,B32B5/18;;E04F13/0841;;E04F13/18;;B32B7/12;;B32B27/065;;B32B27/20;;B32B27/281;;B32B27/286;;B32B27/30;;B32B27/32;;B32B27/34;;B32B27/36;;B32B27/365;;B32B27/40;;B32B3/02;;B32B2262/101;;B32B2266/0235;;B32B2266/025;;B32B2270/00;;B32B2307/4026;;B32B2307/41;;B32B2307/712;;B32B2307/718;;B32B2419/00;;E04F13/18;;E04F13/0841;;B32B5/18;;B32B3/02;;B32B27/20;;B32B2307/4026;;B32B27/365;;B32B2266/0235;;B32B2307/718;;B32B2307/712;;B32B27/30;;B32B27/36;;B32B27/40;;B32B2419/00;;B32B27/32;;B32B27/281;;B32B27/34;;B32B2262/101;;B32B27/065;;B32B2270/00;;B32B2307/41;;B32B27/286;;B32B2266/025;;B32B7/12,E04D1/00,52/553;;52/489.1,2,0,,,"U.S. Appl. No. 11/588,577, filed Oct. 27, 2006.;;International Search Report and Written Opinion dated Dec. 24, 2008, in PCT/US08/82476.",ACTIVE
183,US,A1,US 2010/0281801 A1,079-921-142-193-243,2010-11-11,2010,US 52777808 A,2008-11-05,US 52777808 A;;US 10893908 P;;US 2008/0082476 W,2008-10-28,"Foamed Building Panel, Clip and System for Installation","A building panel has a unitary foamed core, and a unitary cover layer of resinous polymeric material covering the core and covering a bottom edge or drip edge and an upper edge of the panel. A system for installation of adjacent panels includes the adjacent panels having vertical clip-receiving grooves slidably receiving narrow edges of a clip. The clip holds adjacent panels in coplanar abutting relationship to minimize movement while installed on a wall of a building.",CERTAIN TEED CORP,SHAW ROBERT;;BECK DAVID;;STUCKY DAVID;;STEELE DAVID;;DODD ROBERT;;VALENTINE JAMIE,CERTAINTEED CORPORATION (2009-09-22),https://lens.org/079-921-142-193-243,Patent Application,yes,71,34,3,3,0,B32B5/18;;E04F13/0841;;E04F13/18;;B32B7/12;;B32B27/065;;B32B27/20;;B32B27/281;;B32B27/286;;B32B27/30;;B32B27/32;;B32B27/34;;B32B27/36;;B32B27/365;;B32B27/40;;B32B3/02;;B32B2262/101;;B32B2266/0235;;B32B2266/025;;B32B2270/00;;B32B2307/4026;;B32B2307/41;;B32B2307/712;;B32B2307/718;;B32B2419/00;;E04F13/18;;E04F13/0841;;B32B5/18;;B32B3/02;;B32B27/20;;B32B2307/4026;;B32B27/365;;B32B2266/0235;;B32B2307/718;;B32B2307/712;;B32B27/30;;B32B27/36;;B32B27/40;;B32B2419/00;;B32B27/32;;B32B27/281;;B32B27/34;;B32B2262/101;;B32B27/065;;B32B2270/00;;B32B2307/41;;B32B27/286;;B32B2266/025;;B32B7/12,E04B1/38;;E04B2/44;;E04B1/70;;E04C2/38,52/302.1;;52/588.1;;52/582.1;;52/506.05,0,0,,,,ACTIVE
184,DE,C3,DE 2002605 C3,133-119-806-156-401,1974-09-05,1974,DE 2002605 A,1970-01-21,US 79366569 A,1969-01-24,DE 2002605 C3,,"RCA CORP., NEW YORK, N.Y. (V.ST.A.)","DODD JUN., JOHN ALTON, HADDONFIELD;;GESHNER, ROBERT ANDREW, CHERRY HILL",,https://lens.org/133-119-806-156-401,Granted Patent,no,0,0,9,9,0,H01J9/142;;H01J9/142,H01J9/14;;H01J9/227,,0,0,,,,EXPIRED
185,DE,B2,DE 2002605 B2,136-372-576-639-501,1974-02-14,1974,DE 2002605 A,1970-01-21,US 79366569 A,1969-01-24,DE 2002605 B2,,"RCA CORP., NEW YORK, N.Y. (V.ST.A.)","DODD JUN., JOHN ALTON, HADDONFIELD;;GESHNER, ROBERT ANDREW, CHERRY HILL",,https://lens.org/136-372-576-639-501,Patent Application,no,0,0,9,9,0,H01J9/142;;H01J9/142,H01J9/14;;H01J9/227,,0,0,,,,EXPIRED
186,CN,A,CN 115668399 A,021-466-060-666-91X,2023-01-31,2023,CN 202180026646 A,2021-06-01,US 202063034257 P;;US 2021/0035233 W,2020-06-03,Glucose measurement prediction using stacked machine learning models,"Glucose measurements and glucose impact event prediction using a stack of machine learning models are described. The CGM platform includes stacked machine learning models such that an output generated by one of the machine learning models may be provided as an input to another of the machine learning models. The plurality of machine learning models includes at least one model trained to generate a glucose measurement prediction and another model trained to generate an event prediction for an upcoming time interval. Each machine learning model of the stacked machine learning models is configured to generate a respective output when provided as input at least one of a glucose measurement provided by a CGM system worn by the user or additional data describing user behavior or affecting other aspects of future glucose of the person. The predictions may then be output, such as by transmitting and/or displaying notifications regarding the corresponding predictions.",DEXCOM INC,DEREZINSKI MICHAEL;;LINDEN JOSTVANDER;;DODD ROBERT;;JEPPSSON LARS;;ACCIAROL GIUSEPPE,,https://lens.org/021-466-060-666-91X,Patent Application,no,0,0,7,7,0,A61B5/0022;;A61B5/14532;;A61B5/7225;;A61B5/7267;;A61B5/7275;;A61B5/6833;;G16H50/70;;G16H50/20;;G06N20/20;;G06N3/08;;G06N3/044;;A61B5/14532;;A61B5/6801;;A61B5/7275;;A61B5/0022;;A61B5/7267;;A61B5/74;;A61B5/0004;;A61B5/7225,G16H50/70;;A61B5/145,,0,0,,,,PENDING
187,GB,A8,GB 2386748 A8,181-568-405-466-307,2005-01-25,2005,GB 0206240 A,2002-03-16,GB 0206240 A,2002-03-16,Coaxial output arrangement for a magnetron,"A magnetron output arrangement includes a coaxial output adapted to be coupled in an endfire configuration to a rectangular waveguide. The waveguide has a flange for mating with the magnetron output arrangement. The coaxial output includes a central conductor. The output arrangement further includes a plate located in a predetermined position with respect to the central conductor. The plane of the plate is arranged to be substantially perpendicular to the axis of the coaxial output. The plate is located a predetermined distance from the end of the central conductor, such that the coaxial output in use couples with the plate so that the output coupling is substantially the same regardless of the type of waveguide flange employed.",MARCONI APPLIED TECHN LTD,BRADY MICHAEL BARRY CLIVE;;DODD GEOFFREY ROBERT;;EDWARDS MARTIN BERNARD,,https://lens.org/181-568-405-466-307,Patent Application,no,0,0,16,16,0,H01J23/54;;H01J25/50;;H01J25/587;;H01P5/103;;H01J23/48;;H01P5/103;;H01J25/50;;H01J25/587;;H01P5/103;;H01J23/54,H01J23/40;;H01J23/54;;H01J25/50;;H01J25/587;;H01P5/103,H1D DKJF          KJF;;H1D D18AY         KJF;;H1D D18A1BY       KJF;;H1D D18A1B2B      KJF;;H1D D18A1B2Y      KJF;;H1D D18A1Y        KJF;;H1D D18A3A        KJF;;H1D D18A3B        KJF;;H1D D18A3Y        KJF;;H1D D46C          KJF,0,0,,,,EXPIRED
188,US,S,US D0616735 S,118-551-582-734-004,2010-06-01,2010,US 33256009 F,2009-02-19,US 33256009 F,2009-02-19,Installation clip for a siding panel,,CERTAIN TEED CORP,SHAW ROBERT;;BECK DAVID;;STUCKY DAVID;;STEELE DAVID;;DODD ROBERT;;VALENTINE JAMES JAMIE,CERTAINTEED CORPORATION (2009-01-20),https://lens.org/118-551-582-734-004,Design Right,no,0,3,1,1,0,,,0808;;D 8382,0,0,,,,ACTIVE
189,WO,A1,WO 2005/002473 A1,066-408-107-223-233,2005-01-13,2005,GB 2004002861 W,2004-07-02,GB 0315543 A,2003-07-02,PROSTHESIS WITH ARTIFICIAL LIGAMENT,"A prosthetic device comprising a bearing component (2, 4) for connection to a bone (3, 6), the bearing component (2, 4) replacing part or all of a human or animal joint, and a prosthetic ligament (8) which is connected to or passes through the bearing component (2, 4). Preferably, the joint comprises a human knee joint and the first and second bearing components comprise a tibial bearing component (4) and a femoral bearing component (2) respectively, and the prosthetic ligament (8) at one end is connected to or passes through the tibial component (4) and at the other end is connected to or passes through the femoral component (2). The present invention can be used with a fixed bearing prosthetic knee or a mobile bearing knee using a meniscal component (10).",BIOMET MERCK LTD;;GOODFELLOW JOHN;;O'CONNOR JOHN;;MURRAY DAVID;;DODD CHRISTOPHER;;SCOTT ROBERT,GOODFELLOW JOHN;;O'CONNOR JOHN;;MURRAY DAVID;;DODD CHRISTOPHER;;SCOTT ROBERT,,https://lens.org/066-408-107-223-233,Patent Application,yes,9,22,3,3,0,A61F2/08;;A61F2/3836,A61F2/08;;A61F2/38,,0,0,,,,PENDING
190,WO,A1,WO 2010/050994 A1,047-551-314-025-822,2010-05-06,2010,US 2008/0082476 W,2008-11-05,US 10893908 P,2008-10-28,"FOAMED BUILDING PANEL, CLIP AND SYSTEM FOR INSTALLATION","A building panel has a unitary foamed core, and a unitary cover layer of resinous polymeric material covering the core and covering a bottom edge or drip edge and an upper edge of the panel. A system for installation of adjacent panels includes the adjacent panels having vertical clip-receiving grooves slidably receiving narrow edges of a clip. The clip holds adjacent panels in coplanar abutting relationship to minimize movement while installed on a wall of a building.",CERTAIN TEED CORP;;SHAW ROBERT D;;BECK DAVID;;STUCKY DAVID;;STEELE DAVID;;DODD ROBERT;;VALENTINE JAMIE,SHAW ROBERT D;;BECK DAVID;;STUCKY DAVID;;STEELE DAVID;;DODD ROBERT;;VALENTINE JAMIE,,https://lens.org/047-551-314-025-822,Patent Application,yes,4,5,3,3,0,B32B5/18;;E04F13/0841;;E04F13/18;;B32B7/12;;B32B27/065;;B32B27/20;;B32B27/281;;B32B27/286;;B32B27/30;;B32B27/32;;B32B27/34;;B32B27/36;;B32B27/365;;B32B27/40;;B32B3/02;;B32B2262/101;;B32B2266/0235;;B32B2266/025;;B32B2270/00;;B32B2307/4026;;B32B2307/41;;B32B2307/712;;B32B2307/718;;B32B2419/00;;E04F13/18;;E04F13/0841;;B32B5/18;;B32B3/02;;B32B27/20;;B32B2307/4026;;B32B27/365;;B32B2266/0235;;B32B2307/718;;B32B2307/712;;B32B27/30;;B32B27/36;;B32B27/40;;B32B2419/00;;B32B27/32;;B32B27/281;;B32B27/34;;B32B2262/101;;B32B27/065;;B32B2270/00;;B32B2307/41;;B32B27/286;;B32B2266/025;;B32B7/12,E04B2/00,,0,0,,,,PENDING
191,US,S,US D0663047 S,046-306-735-580-079,2012-07-03,2012,US 33256109 F,2009-02-19,US 33256109 F,2009-02-19,Siding panel having grooved ends,,SHAW ROBERT;;BECK DAVID;;STUCKY DAVID;;STEELE DAVID;;DODD ROBERT;;VALENTINE JAMES JAMIE;;CERTAIN TEED CORP,SHAW ROBERT;;BECK DAVID;;STUCKY DAVID;;STEELE DAVID;;DODD ROBERT;;VALENTINE JAMES JAMIE,CERTAINTEED CORPORATION (2005-02-12),https://lens.org/046-306-735-580-079,Design Right,no,0,4,1,1,0,,,2501;;D25/139,0,0,,,,ACTIVE
192,US,A,US 5928743 A,197-127-630-504-856,1999-07-27,1999,US 89984797 A,1997-07-24,US 89984797 A,1997-07-24,Pressurized gas vessel having internal chemical surface,"A pressurized vessel filled with a high purity gas, said vessel having a polymeric coating covering its internal surfaces; said high purity gases selected from the group consisting of hydrogen chloride, tungsten hexafluoride, chlorine, hydrogen bromide, nitrogen trifluoride, silanes and boron trichloride; said vessel filled with gas pressure from about 200 psig to about 6,000 psig; and the material for said polymeric coating selected from the group of polyperfluoroalkoxyethylene, copolymer of ethylene and chlorotrifluoroethylene and copolymer of ethylene and tetrafluoroethylene.",PUREPAK TECHNOLOGY CORP,BEALKY ROBERT J;;DODD MICHAEL A;;MOYERS II THOMAS J,PUREPAK TECHNOLOGY CORPORATION (1997-07-22),https://lens.org/197-127-630-504-856,Granted Patent,yes,14,15,1,1,0,B65D85/84;;B65D85/84;;B65D90/04;;B65D90/04;;F17C1/10;;F17C1/10;;F17C2203/0604;;F17C2203/0604;;F17C2203/066;;F17C2203/066;;F17C2209/2145;;F17C2209/2145;;F17C2209/232;;F17C2209/232;;F17C2221/03;;F17C2221/03;;F17C2221/037;;F17C2221/037;;F17C2221/05;;F17C2221/05;;F17C2223/036;;F17C2223/036;;F17C2260/053;;F17C2260/053;;F17C2270/0745;;F17C2270/0745;;Y02E60/32;;Y02E60/32;;Y10T428/1355;;Y10T428/1355;;Y10T428/1393;;Y10T428/1393;;Y10T428/3154;;Y10T428/3154;;Y10T428/31544;;Y10T428/31544,B65D85/84;;B65D90/04;;F17C1/10,428/35.8;;428/36.91;;428/421;;428/422;;206/6;;206/524.3;;206/524.5;;220/581;;220/586;;215/12.2,5,0,,,"Du Pont, Tefzel HT 2190 fluoropolymer resin, Product Information Brochure, dated Dec. 1996.;;Du Pont, Tefzel fluoropolymer resin, Technical Information Brochure, dated Aug. 1995.;;Du Pont, Tefzel fluoropolymer, Properties Handbook, dated Jun. 1994.;;Du Pont, Tefzel ETFE fluoropolymer MSDS, dated Feb. 25, 1996.;;Sang A Flontec Co., Ltd., Teflon Product Brochure, no date.",EXPIRED
193,GB,A,GB 2403416 A,059-910-803-794-267,2005-01-05,2005,GB 0315543 A,2003-07-02,GB 0315543 A,2003-07-02,Prosthesis with artificial ligament,"A prosthetic device comprising a bearing component 2, 4 for connection to a bone 3, 6, the bearing component 2, 4 replacing part or all of a human or animal joint, and a prosthetic ligament 8 which is connected to or passes through the bearing component 2, 4. The bearing component 2,4 may be provided with a peg or bollard 10 to which the prosthetic ligament 8 is attached. Preferably, the joint comprises a human knee joint and the first and second bearing components comprise a tibial bearing component 4 and a femoral bearing component 2 respectively, and the prosthetic ligament 8 at one end is connected to or passes through the tibial component 4 and at the other end is connected to or passes through the femoral component 2. The present invention can be used with a fixed bearing prosthetic knee or a mobile bearing knee using a meniscal component (40).",BIOMET MERCK LTD,SCOTT ROBERT;;O'CONNOR JOHN;;DODD CHRISTOPHER;;MURRAY DAVID;;GOODFELLOW JOHN,,https://lens.org/059-910-803-794-267,Patent Application,no,5,103,3,3,0,A61F2/08;;A61F2/3836,A61F2/08;;A61F2/38,A5R RAK           RAK;;A5R RAM           RAM,0,0,,,,DISCONTINUED
194,BR,A2,BR 112013023679 A2,070-219-896-082-972,2016-12-13,2016,BR 112013023679 A,2012-03-16,US 2012/0029468 W;;US 201113068875 A;;US 201113285576 A,2011-03-15,conectores de tubo de impressão e sistemas de bomba utilizando os mesmos,,MEADWESTVACO CALMAR INC,DODD JOSEPH K;;GOOD ROBERT J;;KELLY;;KRESTINE JOSEPH R,,https://lens.org/070-219-896-082-972,Patent Application,no,0,0,27,27,0,B05B11/0037;;B05B15/30;;B05B11/0044;;B05B11/1011;;B05B11/0044;;B05B11/0037;;B05B15/30;;B05B11/1011;;B05B11/1045;;B05B11/1047;;B05B11/0089,B05B11/00,,0,0,,,,DISCONTINUED
195,GB,A,GB 2386748 A,081-440-208-954-231,2003-09-24,2003,GB 0206240 A,2002-03-16,GB 0206240 A,2002-03-16,Coaxial output arrangement for a magnetron,"A magnetron 10 has a co-axial output13 which comprises a central conductor 14 and terminates in a probe 16. Power is transmitted from the magnetron 10, via the coaxial line 13, to a rectangular waveguide 17. The co-axial output 13 further comprises a plate member19 located in a predetermined position with respect to the central conductor 14. The plate member 19 has an aperture (22, figure 4) with an edge 20 arranged to overlap approximately half of the probe 16 in a spaced relationship (figure 4), such that the waveguide 17 and coaxial line 13 are arranged in an 'end-fire' configuration. This arrangement allows the coupling to be optimised as the distance between the end of the probe 16 and the plate member 19 is fixed. Additionally the arrangement may be provided with a tuning stub (23, figure 5) for tuning the magnetron output.",MARCONI APPLIED TECHN LTD,BRADY MICHAEL BARRY CLIVE;;DODD GEOFFREY ROBERT;;EDWARDS MARTIN BERNARD,,https://lens.org/081-440-208-954-231,Patent Application,no,4,0,16,16,0,H01J23/54;;H01J25/50;;H01J25/587;;H01P5/103;;H01J23/48;;H01P5/103;;H01J25/50;;H01J25/587;;H01P5/103;;H01J23/54,H01J23/40;;H01J23/54;;H01J25/50;;H01J25/587;;H01P5/103,H1D DKJF          KJF;;H1D D18AY         KJF;;H1D D18A1BY       KJF;;H1D D18A1B2B      KJF;;H1D D18A1B2Y      KJF;;H1D D18A1Y        KJF;;H1D D18A3A        KJF;;H1D D18A3B        KJF;;H1D D18A3Y        KJF;;H1D D46C          KJF,0,0,,,,EXPIRED
196,WO,A1,WO 2003/079393 A1,111-645-405-578-330,2003-09-25,2003,GB 0301106 W,2003-03-17,GB 0206240 A,2002-03-16,MAGNETRON ARRANGEMENTS,"A magnetron arrangement has a coaxial output (13) including a central conductor (14). The output further comprises a plate (19) located in a predetermined position with respect to the central conductor. The plate optimises the coupling of energy between the magnetron (11) and a rectangular waveguide (17). Previously, the central conductor of the coaxial output was arranged in a predetermined position with respect to a wall of the waveguide, but it was found that the amount of coupling thus produced was dependent on the type of end flange fused at the end of the waveguide.",E2V TECH UK LTD;;BRADY MICHAEL BARRY CLIVE;;DODD GEOFFREY ROBERT;;EDWARDS MARTIN BERNARD,BRADY MICHAEL BARRY CLIVE;;DODD GEOFFREY ROBERT;;EDWARDS MARTIN BERNARD,,https://lens.org/111-645-405-578-330,Patent Application,yes,5,0,16,16,0,H01J23/54;;H01J25/50;;H01J25/587;;H01P5/103;;H01J23/48;;H01P5/103;;H01J25/50;;H01J25/587;;H01P5/103;;H01J23/54,H01J23/40;;H01J23/54;;H01J25/50;;H01J25/587;;H01P5/103,,2,0,,,"PATENT ABSTRACTS OF JAPAN vol. 013, no. 243 (E - 768) 7 June 1989 (1989-06-07);;PATENT ABSTRACTS OF JAPAN vol. 2000, no. 25 12 April 2001 (2001-04-12)",PENDING
197,AU,A1,AU 2003/212530 A1,106-724-933-014-971,2003-09-29,2003,AU 2003/212530 A,2003-03-17,GB 0206240 A;;GB 0301106 W,2002-03-16,MAGNETRON ARRANGEMENTS,"A magnetron output arrangement includes a coaxial output adapted to be coupled in an endfire configuration to a rectangular waveguide. The waveguide has a flange for mating with the magnetron output arrangement. The coaxial output includes a central conductor. The output arrangement further includes a plate located in a predetermined position with respect to the central conductor. The plane of the plate is arranged to be substantially perpendicular to the axis of the coaxial output. The plate is located a predetermined distance from the end of the central conductor, such that the coaxial output in use couples with the plate so that the output coupling is substantially the same regardless of the type of waveguide flange employed.",E2V TECH UK LTD,BRADY MICHAEL BARRY CLIVE;;DODD GEOFFREY ROBERT;;EDWARDS MARTIN BERNARD,,https://lens.org/106-724-933-014-971,Patent Application,no,0,0,16,16,0,H01J23/54;;H01J25/50;;H01J25/587;;H01P5/103;;H01J23/48;;H01P5/103;;H01J25/50;;H01J25/587;;H01P5/103;;H01J23/54,H01J23/40;;H01J23/54;;H01J25/50;;H01J25/587;;H01P5/103,,0,0,,,,DISCONTINUED
198,WO,A1,WO 2017/042233 A1,157-693-800-755-072,2017-03-16,2017,EP 2016071115 W,2016-09-07,EP 15306378 A,2015-09-09,AZETIDINIMINES AS CARBAPENEMASES INHIBITORS,The present application relates to novel azetidinimine of formula (I). Wherein R 1 -R 6 are as defined in claim 1. The azetidinimine of the invention are useful as antibiotics and as inhibitors of a carbapenemases. The present invention thus further relates totheir use in antibiotic therapies and their methods of synthesis.,CENTRE NAT DE LA RECH SCIENT (CNRS),DODD ROBERT;;CARIOU KEVIN;;MINARD CORINNE;;IORGA BOGDAN-IULIU;;NAAS THIERRY,,https://lens.org/157-693-800-755-072,Patent Application,yes,0,1,8,8,0,C07D401/04;;C07D205/085;;A61K31/397;;C07D205/06;;A61P31/04;;A61P43/00;;A61K45/06;;Y02A50/30;;C07D205/085;;C07D401/04;;A61K31/397;;A61K45/06;;C07D205/06,C07D205/085,,12,8,087-635-969-474-441;;080-541-830-098-304;;126-257-701-746-327;;013-505-049-775-153;;040-772-807-251-179;;089-597-139-310-067;;114-339-696-334-152;;018-702-847-708-937,10.1002/anie.200503936;;16570331;;10.1021/jo00391a020;;10.1246/nikkashi.1975.1524;;10.1021/ol201947b;;21848304;;pmc3170467;;23718841;;pmc3732456;;10.1021/jo400960e;;10.1016/s0040-4039(00)77413-2;;10.1016/s0040-4039(96)02054-0;;24962338;;10.1002/anie.201402767,"GOSPODOVA, TZ.; RASHKOVA, J. R.; VITEVA, L. Z.: ""Stereocontrolled intramolecular cyclization of anti-.beta.-aminonitriles. Convenient access to trans-azetidin-2-imines"", BULGARIAN ACADEMY OF SCIENCES, vol. 40, no. 4, 6 March 2008 (2008-03-06), pages 568 - 571, XP009186964;;MATTHEW WHITING ET AL: ""Copper-Catalyzed Reaction Cascade: Direct Conversion of Alkynes intoN-Sulfonylazetidin-2-imines"", ANGEWANDTE CHEMIE INTERNATIONAL EDITION, vol. 45, no. 19, 5 May 2006 (2006-05-05), DE, pages 3157 - 3161, XP055224270, ISSN: 1433-7851, DOI: 10.1002/anie.200503936;;PERST H ED - THIEME: ""Product Class 17 : Ketenimines"", 1 January 2006, SCIENCE OF SYNTHESIS: HOUBEN-WEYL METHODS OF MOLECULAR TRANSFORMATIONS, DE, PAGE(S) 781 - 838, ISBN: 978-1-58890-200-9, XP009099064;;BARBARO GAETANO ET AL: ""Periselectivity in cycloadditions to vinylmethylketene and structurally related vinylketene imines"", THE JOURNAL OF ORGANIC CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 52, no. 15, 1 January 1987 (1987-01-01), pages 3289 - 3296, XP009097792, ISSN: 0022-3263, DOI: 10.1021/JO00391A020;;MOSTOWICZ, DANUTA; ABRAMS KI, WOJCIECH; PIOTROWSKA, KRYSTYNA; BELZECKI, CZESLAW: ""A new approach to the synthesis of chiral .beta.-lactam derivatives"", POLI SH JOURNAL OF CHEMISTRY, vol. 57, no. 1-3, 1 January 1983 (1983-01-01), pages 297 - 9, XP009186971;;MITSURU ODANAKA ET AL, NIPPON KAGAKU KAISHI: JOURNAL OF THE CHEMICAL SOCIETY OF JAPAN., no. 9, 1 January 1975 (1975-01-01), JP, pages 1524 - 1529, XP055224787, ISSN: 0369-4577, DOI: 10.1246/nikkashi.1975.1524;;KYLE A. DEKORVER ET AL: ""Introducing a New Class of N- Phosphoryl Ynamides via Cu(I)-Catalyzed Amidations of Alkynyl Bromides"", ORGANIC LETTERS, vol. 13, no. 18, 16 September 2011 (2011-09-16), US, pages 4862 - 4865, XP055225572, ISSN: 1523-7060, DOI: 10.1021/ol201947b;;XIAO-NA WANG ET AL: ""Synthesis of Cyclopentenimines from N -Allyl Ynamides via a Tandem Aza-Claisen Rearrangement-Carbocyclization Sequence"", THE JOURNAL OF ORGANIC CHEMISTRY, vol. 78, no. 12, 21 June 2013 (2013-06-21), US, pages 6233 - 6244, XP055224271, ISSN: 0022-3263, DOI: 10.1021/jo400960e;;VAN CAMP, A.; GOOSSENS, D.; MOYA-PORTUGUEZ, M.; MARCHAND-BRYNAERT, J.; GHOSEZ, L., TETRAHEDRON LETT., vol. 21, 1980, pages 3081 - 3084;;ALAJARDIN, M.; MOLINA, P.; VIDAL, A., TETRAHEDRON LETT., vol. 37, 1996, pages 8945 - 8948;;HENTZ, A.; RETAILLEAU, P.; GANDON, V.; CARIOU, K.; DODD, R. H, ANGEW. CHEM. INT. ED., vol. 53, 2014, pages 8333 - 8337;;TETRAHEDRON LETT., vol. 47, 2006, pages 8109",PENDING
199,US,A1,US 2005/0084668 A1,042-077-368-433-306,2005-04-21,2005,US 68684103 A,2003-10-16,US 68684103 A,2003-10-16,Nanoclustered magnetic materials for high moment write pole applications,The present invention includes magnetic write elements with portions formed a nanophase high magnetic moment material to enable further increases in areal density in magnetic recording. The nanophase deposited high magnetic moment material comprises coated nanoclusters and nanolaminated cluster films that are deposited to form nanophase high magnetic moment material portions of a write pole and SUL layer in perpendicular recording media. The nanophase write poles exhibit high magnetic moments and are generally compatible with conventional writer head fabrication techniques.,SEAGATE TECHNOLOGY LLC,LAMBERTON ROBERT W;;MACKEN DECLAN;;DODD PAUL M;;O'KANE WILLIAM J,SEAGATE TECHNOLOGY LLC (2003-10-07),https://lens.org/042-077-368-433-306,Patent Application,yes,7,7,2,2,0,B82Y25/00;;G11B5/1278;;G11B5/187;;G11B5/313;;G11B5/74;;G11B2005/0029;;H01F10/007;;G11B5/1274;;G11B5/133;;Y10T428/115;;Y10T428/256;;Y10T428/32;;Y10T428/1171;;Y10T428/115;;Y10T428/256;;Y10T428/32;;Y10T428/1171;;B82Y25/00;;G11B5/313;;H01F10/007;;G11B5/74;;G11B5/1278;;G11B2005/0029;;G11B5/187;;G11B5/1274;;G11B5/133,G11B5/00;;G11B5/127;;G11B5/187;;G11B5/31;;G11B5/74;;H01F10/00,428/328;;360/86,0,0,,,,EXPIRED
200,US,B2,US 9078874 B2,037-344-906-714-985,2015-07-14,2015,US 201013392044 A,2010-08-24,US 201013392044 A;;EP 09290643 A;;US 23662509 P;;IB 2010053796 W,2009-08-25,Composition and method for treating cognitive impairments in down syndrom subjects,"Compounds having inverse agonist functional selectivity for GABA A receptors containing the α5 subunit for use as a medicament in the treatment of cognitive impairments in subjects suffering from Down syndrome. The use of these compounds is disclosed. Pharmaceutical compositions for such treatment can comprise these compounds or suitable pharmaceutically acceptable salt thereof, a polyethoxylated castor oil and dimethyl sulfoxide (DMSO). Methods are disclosed for enhancing cognitive function, or treating or lessening the severity of cognitive impairments, in subjects suffering from Down syndrome by administering to a subject in need thereof a pharmaceutically effective amount of one or more of these compounds.",POTIER MARIE-CAUDE;;DODD ROBERT;;DELATOUR BENOÎT;;BRAUDEAU JÉRÔME;;HERAULT YANN;;CT NAT DE LA RECH SCIENTIFIQUE—CNRS,POTIER MARIE-CAUDE;;DODD ROBERT;;DELATOUR BENOÎT;;BRAUDEAU JÉRÔME;;HERAULT YANN,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS (2012-05-02),https://lens.org/037-344-906-714-985,Granted Patent,yes,6,0,9,9,0,A61K31/381;;A61K31/381;;A61K9/0019;;A61K9/0019;;A61K31/4162;;A61K31/4162;;A61K31/502;;A61K31/502;;A61K31/5517;;A61K31/5517;;A61P25/28,A61P25/28;;A61K9/00;;A61K31/381;;A61K31/4162;;A61K31/502;;A61K31/5517,,35,33,154-343-665-077-504;;089-420-127-197-948;;040-534-170-038-608;;041-232-737-795-339;;005-074-622-484-972;;098-720-474-380-035;;003-632-473-817-358;;022-089-074-878-863;;142-315-311-170-556;;060-009-701-841-759;;042-314-133-748-828;;021-707-881-253-13X;;004-155-602-279-291;;106-382-788-443-157;;086-719-788-823-333;;033-352-116-089-50X;;022-729-270-383-334;;040-603-513-769-741;;051-751-371-773-377;;031-073-229-390-222;;035-549-067-065-596;;158-769-816-284-513;;027-138-178-894-577;;008-720-605-756-043;;114-046-413-750-465;;030-795-134-474-798;;005-151-061-459-887;;110-411-283-383-413;;036-504-079-856-464;;075-834-160-316-752;;046-511-954-625-540;;005-003-378-275-766;;121-223-221-497-870,pmc2783207;;10.1016/j.bbr.2009.08.034;;19720087;;10.1021/jm011082k;;12061884;;10.1016/j.neuropharm.2006.04.018;;17046030;;19770002;;10.1016/j.pharmthera.2009.09.001;;18936916;;10.1007/s00213-008-1357-7;;10.1152/jn.00626.2006;;17093127;;15537339;;10.1021/jm040863t;;10.1021/jm040863t.s001;;16633803;;10.1007/s00213-006-0361-z;;20026436;;12097508;;pmc6758233;;10.1523/jneurosci.22-13-05572.2002;;10.1016/j.neulet.2005.03.031;;15925111;;10.1016/j.lfs.2006.07.004;;16904699;;16326923;;10.1124/jpet.105.092320;;10.1016/s0166-4328(97)81111-4;;9021073;;19576998;;10.1016/j.drudis.2009.06.009;;8584244;;10.1016/0304-3940(95)12052-6;;17322876;;10.1038/nn1860;;10.1037/e496052006-010;;8341361;;15371516;;10.1523/jneurosci.1766-04.2004;;pmc6729789;;11296070;;10.1001/archpedi.155.4.442;;10.1016/j.neuropharm.2007.08.008;;17888460;;10.1016/j.neuron.2007.07.025;;pmc8055171;;17785178;;7550346;;10.1038/ng1095-177;;10.1016/j.neulet.2007.12.039;;18226451;;15918586;;10.2741/3118;;10.1016/j.mehy.2005.06.018;;16125326;;10.1002/mrdd.20157;;17910090;;9517425;;10.1016/s0028-3908(97)00157-3;;10608287;;10.1016/s0028-3908(99)00083-0;;9284055;;10.1016/s0306-4522(97)00146-2;;10.1021/jm031076j.s001;;15084116;;10.1021/jm031076j;;10.1124/mol.54.5.928;;9804628;;10.1038/321864a0;;3724846,"A. C. Costa et al., ""Behavioral validation of the Ts65Dn mouse model for Down syndrome of a genetic background free of the retinal degeneration mutation Pdeb(rd1)"", Behav. Brain Res. 206, 52-62 (2010).;;A. El Hadri et al., ""N-Substituted 4-Amino-3,3-dipropyl-2(3H)-furanones: New Positive Allosteric Modulators of the GABA(A) Receptor Sharing Electrophysiological Properties with the Anticonvulsant Loreclezole"", J. Med. Chem. 45, 2824-2831 (2002).;;Atack et al., ""L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for alpha5-containing GABA(A) receptors"", Neuropharmacology, 51:1023-1029 (2006).;;Atack, J. R.; ""Preclinical and clinical pharmacology of the GABA(A) receptor alpha5 subtype-selective inverse agonist alpha5IA"", Pharmacol. Ther. 125(1):11-26 (2010).;;Ballard et al., ""RO4938581, a novel congnitive enhancer acting at GABA(A) alpha5 subunit-containing receptors"", Psychopharmacology, 202:207-223 (2009).;;Best, T. K. et al. ""Ts65Dn, a Mouse Model of Down Syndrome, Exhibits Increased GABA(B)-Induced Potassium Current"", J. Neurophysiol. 97, 892-900 (2007).;;Chambers et al., ""An Orally Bioavailable, Functionally Selective Inverse Agonist at the Benzodiazepine Site of GABA(A) alpha5 Receptors with Cognition Enhancing Properties"", J. Med. Chem., 47:5829-5832 (2004).;;Collinson et al., ""An inverse agonist selective for alpha5 subunit-containing GABA(A) receptors improves encoding and recall but not consolidation in the Morris water maze"", Psychopharmacology, 188:619-628 (2006).;;Collinson et al., ""Enhanced Learning and Memory and Altered GABAergic Synaptic Transmission in Mice Lacking the alpha5 Subunit of the GABA(A) Receptor"", J. Neurosci., 22(13):5572-5580 (2002).;;Costa A. C. S. et al., ""Deficits in hippocampal CA1 LTP induced by TBS but not HFS in the Ts65Dn mouse: A model of Down syndrome"", Neurosci. Lett., vol. 382, No. 3, pp. 317-322 (2005).;;D. J. Moura et al., ""Effects of beta-carboline alkaloids on the object recognition task in mice"", Life Sci. 79, 2099-2104 (2006).;;Dawson et al., ""An Inverse Agonist Selective for alpha5 Subunit-Containing GABA(A) Receptors Enhances Cognition"", The Journal of Pharmacology and Experimental Therapeutics, 316(3):1335-1345 (2006).;;Demas, G. E. et at, ""Spatial memory deficits in segmental trisomic Ts65Dn mice"", Behav. Brain Res., 82, 85-92 (1996).;;D'Hulst, C. et al., ""The complexity of the GABA(A) receptor shapes unique pharmacological profiles"", Drug Discov. Today, 14(17/18), 866-875 (2009).;;Escorihuela. R. M. et al., ""A behavioral assessment of Ts65Dn mice: a putative Down syndrome model.""Neurosci. Lett., 199, 143-146 (1995).;;F. Fernandez et al., ""Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome,"" Nature Neuroscience, 10(4):411-413 (2007).;;Hoffman, G. E. et al., ""C-Fos and Fos-Related Antigens as Markers for Neuronal Activity: Perspectives From Neuroendocrine Systems"" NIDA Res. Monogr, 125, 117-133 (1993).;;International Search Report dated Nov. 19, 2010 issued in International Patent Application No. PCT/IB2010/053796.;;Kleschevnikov A. M., et al., ""Hippocampal Long-Term Potentiation Suppressed by Increased Inhibition in the Ts65Dn Mouse, a Genetic Model of Down Syndrome"", The Journal of Neuroscience, 24(37):8153-8160 (2004).;;Lobaugh N. J. et al., ""Piracetam Therapy Does Not Enhance Cognitive Functioning In Children With Down Syndrome"", Arch. Pediatr. Adolesc. Med.; 155(4):442-448 (2001).;;McNamara R. K. et al., ""Benzodiazepine receptor antagonists flumazenil and CGS 8216 and inverse-agonist beta-CCM enhance spatial learning in the rat: Dissociation from anxiogenic actions"", Psychobiology, 21(2):101-108 (1993).;;Nutt D. J. et al., ""Blockade of alcohol's amnestic activity in humans by an alpha5 subtype benzodiazepine receptor inverse agonist"", Neuropharmacology, 53:810-820 (2007).;;Palop et al., ""Aberrant Excitatory Neuronal Activity and Compensatory Remodeling of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer's Disease."" Neuron. 55(5):697-711 (2007).;;Reeves et al., ""A mouse model for Down syndrome exhibits learning and baviour deficits"", Nature Genetics, 11(2):177-184 (1995).;;Rueda, N. et al., ""Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome"", Neurosci. Lett. 433, 22-27 (2008).;;S. A. Merschman et al., ""Characterization of the solubility of a poorly soluble hydroxylated metabolite in human urine and its implications for potential renal toxicity"", Pharmazie 60, 359-363 (2005).;;S. M. Hoelter et al., ""Sighted C3H' mice-a tool for analysing the influence of vision on mouse behaviour?"" Front Biosci. 13, 5810-5823 (2008).;;Schmitt, ""Neuro-modulation, aminergic neuro-disinhibition and neuro-degeneration. Draft of a comprehensive theory for Alzheimer disease"", Med. Hypotheses.;65(6):1106-1119 (2005).;;Sherman, S. L. et al., ""Epidemiology of Down Syndrome"", Ment. Retard. Dev. Disabil. Res. Rev. 13, 221-227 (2007).;;Siarey, R. J. et. al, ""Altered Long-term Potentiation in the Young and Old Ts65Dn Mouse, a Model for Down Syndrome"", Neuropharmacology 36, 1549-1554 (1997).;;Siarey, R.J. et al., ""Increased synaptic depression in the Ts65Dn mouse, a model for mental retardation in Down syndrome"", Neuropharmacology, 38, 1917-1920 (1999).;;Sperk, G. et al., ""GABA(A) Receptor Subunits in the Rat Hippocampus I: Immunocytochemical Distribution of 13 Subunits"", Neuroscience 80, 987-1000 (1997).;;Sternfeld et al., ""Selective, Orally Active Gamma-Aminobutyric Acid(A) alpha5 Receptor Inverse Agonists as Cognition Enhancers"", J. Med. Chem., 47:2176-2179 (2004).;;Sur, C. et al., ""Rat and Human Hippocampal alpha5 Subunit-Containing gamma-Aminobutyric Acid(A) Receptors Have alpha5beta3gamma2 Pharmacological Characteristics"", Mol. Pharmacol. 54: 928-933 (1998).;;Venault et al., ""Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks"", Nature, 321(6073):864-866 (1986).",ACTIVE
201,EP,A1,EP 3347343 A1,115-783-425-867-667,2018-07-18,2018,EP 16760758 A,2016-09-07,EP 15306378 A;;EP 2016071115 W,2015-09-09,AZETIDINIMINES AS CARBAPENEMASES INHIBITORS,,CENTRE NAT RECH SCIENT,DODD ROBERT;;CARIOU KEVIN;;MINARD CORINNE;;IORGA BOGDAN-IULIU;;NAAS THIERRY,,https://lens.org/115-783-425-867-667,Patent Application,yes,0,0,8,8,0,C07D401/04;;C07D205/085;;A61K31/397;;C07D205/06;;A61P31/04;;A61P43/00;;A61K45/06;;Y02A50/30;;C07D205/085;;C07D401/04;;A61K31/397;;A61K45/06;;C07D205/06,C07D205/085,,0,0,,,,ACTIVE
202,EP,A1,EP 0991401 A1,159-557-839-852-394,2000-04-12,2000,EP 98926413 A,1998-06-08,US 9811812 W;;US 87116697 A;;US 87179197 A,1997-06-09,METHODS FOR CONTROLLING ENVIRONMENTAL ODORS ON THE BODY USING COMPOSITIONS COMPRISING UNCOMPLEXED CYCLODEXTRINS AND PERFUME,,PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY,,https://lens.org/159-557-839-852-394,Patent Application,yes,0,0,17,18,0,A61K8/0208;;A61K8/738;;A61Q13/00;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61K8/738;;A61Q13/00;;A61K8/0208;;A61Q15/00,A61K8/02;;A61K8/00;;A61K8/18;;A61K8/25;;A61K8/27;;A61K8/34;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61Q13/00;;A61Q15/00;;C08L83/10,,0,0,,,,DISCONTINUED
203,FR,A1,FR 2969150 A1,156-017-924-495-719,2012-06-22,2012,FR 1060825 A,2010-12-20,FR 1060825 A,2010-12-20,NOUVELLES MOLECULES INDOLIQUES DEMONTRANT DES ACTIVITES ANTIBACTERIENNES DANS UNE VARIETE DE BACTERIES A GRAM-NEGATIF ET POSITIF DONT DES BACTERIES MULTIDROGUES-RESISTANTES,"L'invention concerne des dérivés indoliques répondant à la formule générale I dans laquelle : > - R représente un atome d'hydrogène, un atome d'halogène, un groupe alkyle en C à C linéaire ou ramifié ou un groupe aryle et en particulier phényle, ou encore un groupe arylalkyle en C à C - R représente un atome d'hydrogène, un atome d'halogène, un groupe alkyle en C à C linéaire ou ramifié, un radical hydroxy, un groupe alkoxy en C à C , un groupe aryle, alkylaryloxy, arylalkyloxy, aryloxy en particulier benzyloxy, ou encore un groupement NO ; - n = 1, 2 ou 3 ; - Ar représente un radical aryle mono- ou polycyclique éventuellement substitué par un ou plusieurs atome (s) d'halogène, ou groupa (s) alkyle en C à C , ou par des groupes alkoxy en à C ou encore un groupe aryle tel que phényle, en particulier des radicaux choisis parmi les radicaux phényle, naphtyle et phénantrényle ; > - R R représentent indépendamment l'un de l'autre un atome d'hydrogène ou un groupe alkyle en C à C linéaire ramifié, ou un groupe alkoxy en C à C ; ainsi que leurs sels avec des acides pharmaceutiquement acceptables sous forme d'un mélange racémique, de mélanges d'isomères optiques dans lesquels l'isomère R est prépondérant, ou de son isomère R optiquement pur, à l exception toutefois du composé de formule I sous forme racémique dans lequel : - R = R = R = H - R = F et Ar = naphtyle et à l'exception également du composé de formule I sous toutes ses formes énantiomériques dans laquelle : - R = R = R = R = H et - Ar = naphtyle.",CENTRE NAT RECH SCIENT;;UNIV AIX MARSEILLE II,DODD ROBERT;;BEAUMARD FLORIANE;;KIEFER LIONEL;;PAGES JEAN-MARIE;;CHEVALIER JACQUELINE,,https://lens.org/156-017-924-495-719,Patent Application,no,3,0,3,3,0,A61P31/00;;A61P31/04;;C07D209/14,C07D209/14;;A61K31/404;;A61P31/00,,2,2,046-923-402-893-513;;011-496-568-024-680,10.1016/s0960-894x(04)00412-3;;10.1016/j.bmcl.2004.03.056;;15149704;;10.1002/ardp.19943270209;;8135641,"KESSLER A ET AL: ""N<2>-Benzyl-N<1>-(1-(1-naphthyl)ethyl)-3-phenylpropane-1,2-diamines and conformationally restrained indole analogues: development of calindol as a new calcimimetic acting at the calcium sensing receptor"", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, ELSEVIER SCIENCE, GB, vol. 14, no. 12, 21 June 2004 (2004-06-21), pages 3345 - 3349, XP004841403, ISSN: 0960-894X, DOI: DOI:10.1016/J.BMCL.2004.03.056;;MAHBOOBI S ET AL: ""ANTIMYKOBAKTERIELL WIRKSAME INDOLDERIVATIVE. INDOLE DERIVATIVES WITH ANTIMYCOBACTERIAL ACTIVITY"", ARCHIV DER PHARMAZIE, WILEY - VCH VERLAG GMBH & CO. KGAA, DE, vol. 327, no. 2, 1 January 1994 (1994-01-01), pages 105 - 114, XP002045437, ISSN: 0365-6233",INACTIVE
204,KR,A,KR 20010013612 A,125-373-204-916-622,2001-02-26,2001,KR 19997011622 A,1997-06-08,US 87116697 A;;US 87179197 A;;US 9811812 W,1997-06-09,METHODS FOR CONTROLLING ENVIRONMENTAL ODORS ON THE BODY USING COMPOSITIONS COMPRISING UNCOMPLEXED CYCLODEXTRINS AND PERFUME,"The present invention encompasses the use of oder absorbing compositions for controlling environmental malodors on skin wherein the odor absorbing composition comprises uncomplexed cyclodextrin, an aqueous carrier, hydrophilic volatile perfume, and optionally an oil phase and one or more surfactants.",PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY,,https://lens.org/125-373-204-916-622,Patent Application,no,0,1,17,18,0,A61K8/0208;;A61K8/738;;A61Q13/00;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61K8/738;;A61Q13/00;;A61K8/0208;;A61Q15/00,A61K8/00;;A61K8/02;;A61K8/18;;A61K8/25;;A61K8/27;;A61K8/34;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61Q13/00;;A61Q15/00;;C08L83/10,,0,0,,,,DISCONTINUED
205,EP,B1,EP 3347343 B1,189-299-499-834-913,2023-09-27,2023,EP 16760758 A,2016-09-07,EP 15306378 A;;EP 2016071115 W,2015-09-09,AZETIDINIMINES AS CARBAPENEMASES INHIBITORS,,CENTRE NAT RECH SCIENT,DODD ROBERT;;CARIOU KEVIN;;MINARD CORINNE;;IORGA BOGDAN-IULIU;;NAAS THIERRY,,https://lens.org/189-299-499-834-913,Granted Patent,yes,0,0,8,8,0,C07D401/04;;C07D205/085;;A61K31/397;;C07D205/06;;A61P31/04;;A61P43/00;;A61K45/06;;Y02A50/30;;C07D205/085;;C07D401/04;;A61K31/397;;A61K45/06;;C07D205/06,C07D205/085;;A61K31/397;;A61K45/06;;A61P31/04;;A61P43/00;;C07D205/06;;C07D401/04,,2,2,055-269-292-321-84X;;024-278-790-062-57X,10.1016/j.tetlet.2013.11.091;;21442670;;10.1002/chem.201100447,"OHASHI KAZUHIRO ET AL: ""Synthesis of 1-haloethenamides from ynamide through halotrimethylsilane-mediated hydrohalogenation"", TETRAHEDRON LETTERS, ELSEVIER LTD, AMSTERDAM, NL, vol. 55, no. 3, 28 November 2013 (2013-11-28), pages 632 - 635, XP028549445, ISSN: 0040-4039, DOI: 10.1016/J.TETLET.2013.11.091;;MARIANNA PIZZETTI ET AL: ""Microwave-Assisted Aminocarbonylation of Ynamides by Using Catalytic [Fe 3 (CO) 12 ] at Low Pressures of Carbon Monoxide"", CHEMISTRY - A EUROPEAN JOURNAL, vol. 17, no. 16, 11 April 2011 (2011-04-11), DE, pages 4523 - 4528, XP055675570, ISSN: 0947-6539, DOI: 10.1002/chem.201100447",ACTIVE
206,CA,A1,CA 2997851 A1,044-499-369-130-211,2017-03-16,2017,CA 2997851 A,2016-09-07,EP 15306378 A;;EP 2016071115 W,2015-09-09,AZETIDINIMINES AS CARBAPENEMASES INHIBITORS,The present application relates to novel azetidinimine of formula (I) below: Wherein R1-R6 are as disclosed herein. The azetidinimine of the invention are useful as antibiotics and as inhibitors of a carbapenemases. The present invention thus further relates to their use in antibiotic therapies and their methods of synthesis.,CENTRE NAT RECH SCIENT,DODD ROBERT;;CARIOU KEVIN;;MINARD CORINNE;;IORGA BOGDAN-IULIU;;NAAS THIERRY,,https://lens.org/044-499-369-130-211,Patent Application,no,0,0,8,8,0,C07D401/04;;C07D205/085;;A61K31/397;;C07D205/06;;A61P31/04;;A61P43/00;;A61K45/06;;Y02A50/30;;C07D205/085;;C07D401/04;;A61K31/397;;A61K45/06;;C07D205/06,C07D205/085,,0,0,,,,PENDING
207,EP,A1,EP 2470176 A1,036-594-532-986-462,2012-07-04,2012,EP 10763011 A,2010-08-24,US 23662509 P;;EP 09290643 A;;IB 2010053796 W;;EP 10763011 A,2009-08-25,COMPOSITION AND METHOD FOR TREATING COGNITIVE IMPAIRMENTS IN DOWN SYNDROM SUBJECTS,,CENTRE NAT RECH SCIENT,POTIER MARIE-CLAUDE;;DODD ROBERT;;DELATOUR BENOIT;;BRAUDEAU JEROME;;HERAULT YANN,,https://lens.org/036-594-532-986-462,Patent Application,yes,0,0,9,9,0,A61K31/381;;A61K31/381;;A61K9/0019;;A61K9/0019;;A61K31/4162;;A61K31/4162;;A61K31/502;;A61K31/502;;A61K31/5517;;A61K31/5517;;A61P25/28,A61K31/381;;A61K31/4162;;A61K31/502;;A61K31/5517;;A61P25/28,,1,0,,,See references of WO 2011024115A1,INACTIVE
208,FR,B1,FR 2969150 B1,044-341-646-438-063,2013-07-26,2013,FR 1060825 A,2010-12-20,FR 1060825 A,2010-12-20,NOUVELLES MOLECULES INDOLIQUES DEMONTRANT DES ACTIVITES ANTIBACTERIENNES DANS UNE VARIETE DE BACTERIES A GRAM-NEGATIF ET POSITIF DONT DES BACTERIES MULTIDROGUES-RESISTANTES,,CENTRE NAT RECH SCIENT;;UNIV AIX MARSEILLE II,DODD ROBERT;;BEAUMARD FLORIANE;;KIEFER LIONEL;;PAGES JEAN-MARIE;;CHEVALIER JACQUELINE,,https://lens.org/044-341-646-438-063,Granted Patent,no,0,0,3,3,0,A61P31/00;;A61P31/04;;C07D209/14,C07D209/14;;A61K31/404;;A61P31/00,,0,0,,,,INACTIVE
209,BR,A,BR 9809995 A,155-793-794-391-115,2000-08-01,2000,BR 9809995 A,1998-06-08,US 87116697 A;;US 87179197 A;;US 9811812 W,1997-06-09,Métodos para o controle de odores ambientais sobre o corpo usando-se composições compreendendo ciclodextrinas não-complexadas e perfume,"Patente de Invenção: <B>""MéTODOS PARA O CONTROLE DE ODORES AMBIENTAIS SOBRE O CORPO USANDO-SE COMPOSIçõES COMPREENDENDO CICLODEXTRINAS NãO-COMPLEXADAS E PERFUME""<D>. A presente invenção inclui o uso de composições de absorção de odor para o controle de maus odores ambientais sobre a pele, em que a composição de absorção de odor compreende ciclodextrina não-complexada, um veículo aquoso, perfume volátil hidrofílico e, opcionalmente, uma fase oleosa e um ou mais tensoativos.",PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY,,https://lens.org/155-793-794-391-115,Patent Application,no,0,0,17,18,0,A61K8/0208;;A61K8/738;;A61Q13/00;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61K8/738;;A61Q13/00;;A61K8/0208;;A61Q15/00,A61K8/00;;A61K8/02;;A61K8/18;;A61K8/25;;A61K8/27;;A61K8/34;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61Q13/00;;A61Q15/00;;C08L83/10,,0,0,,,,DISCONTINUED
210,US,A,US 5928631 A,185-959-066-992-030,1999-07-27,1999,US 87185497 A,1997-06-09,US 87185497 A;;US 87185797 A;;US 87186097 A;;US 9811787 W,1997-06-09,Methods for controlling environmental odors on the body using compositions comprising uncomplexed cyclodextrins,"The present invention encompasses a method of controlling environmental malodors on the body comprising the application to the skin of a composition comprising from about 0.1% to about 5%, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from about 0.1% to about 36%, by weight of the composition, of an oil phase selected from the group consisting of emollients, moisturizers, and skin protectants; one or more surfactants each having a hydrophilic/lipophilic balance of about 8 to 18 and wherein each surfactant, when combined with an aqueous cyclodextrin solution, provides no less than 25% of odor capture as an aqueous cyclodextrin solution; and an aqueous carrier. The compositions can be applied directly as a spray, poured from a bottle and applied by hand, or applied via a wipe.",PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY,PROCTER & GAMBLE COMPANY THE (1997-06-09),https://lens.org/185-959-066-992-030,Granted Patent,yes,30,95,16,18,0,A61K8/19;;A61K8/27;;A61K8/347;;A61K8/37;;A61K8/39;;A61K8/44;;A61K8/4973;;A61K8/738;;A61K8/891;;A61K8/90;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61K8/39;;A61K8/37;;A61K8/90;;A61Q15/00;;A61K8/891;;A61K8/27;;A61K8/44;;A61K8/347;;A61K8/19;;A61K8/738;;A61K8/4973,A61K8/00;;A47K7/00;;A61K8/18;;A61K8/19;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/34;;A61K8/37;;A61K8/44;;A61K8/49;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;C08L83/10,424/65;;424/67;;424/69;;424/78.03;;424/401;;424/405;;424/642;;424/715;;424/717;;422/5,30,0,,,"Hashimoto, H., Studies on the Industrial Production and Application of Cyclodextrins , Starch Science, vol. 36, No. 1 (1989), pp. 35 42.;;Hashimoto, H., Application of Cyclodextrins to Foods, Toiletries and Other Products in Japan , Ensuiko Sugar Refining Co., Ltd., pp. 13 46.;;U.S. application No. 08/736,469, Trinh et al., filed Oct. 24, 1996.;;U.S. application No. 08/736,093, Trinh et al., filed Oct. 24, 1996.;;U.S. application No. 08/889,607, Trinh et al., filed Jul. 8, 1997.;;U.S. application No. 08/736,471, Lucas et al., filed Oct. 24, 1996.;;U.S. application No. 08/736,470, Lucas et al., filed Oct. 24, 1996.;;U.S. application No. 08/738,964, Dodd et al., filed Oct. 24, 1996.;;U.S. application No. 08/736,838, Peterson et al., filed Oct. 28, 1996.;;U.S. application No. 08/739,091, Peterson et al., filed Oct. 28, 1996.;;U.S. application No. 08/871,166, Lucas et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,791, Dodd et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,855, Trinh et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,853, Lucas et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,857, Lucas et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,790, Peterson et al., filed Jun. 9,1997.;;U.S. application No. 08/871,856, Peterson et al., filed Jun. 9, 1997;;U.S. application No. 08/871,858, Lucas et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,577, Lucas et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,860, Lucas et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,861, Peterson et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,092, Peterson et al., filed Jun. 9, 1997.;;U.S. application No. 08/289,732, Trinh et al., filed Aug. 12, 1994.;;U.S. application No. 08/289,733, Trinh et al., filed Aug. 12, 1994.;;U.S. application No. 08/289,734, Cappel et al., filed Aug. 12, 1994.;;U.S. application No. 08/289,735, Cappel et al., filed Aug. 12, 1994.;;U.S. application No. 08/289,969, Pilosof et al., filed Aug. 12, 1997.;;U.S. application No. 08/871,576, Woo et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,119, Woo et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,042, Woo et al., filed Jun. 9, 1997.",EXPIRED
211,CO,A1,CO 4940386 A1,053-028-124-221-073,2000-07-24,2000,CO 98032880 A,1998-06-09,US 87185497 A;;US 87185797 A;;US 87186097 A,1997-06-09,COMPOSICIONES EN DOS FASES LIBRES DE PERFUME Y METODOS PARA PRODUCIR EL OLOR CORPORAL Y AMBIENTAL,"La presente invención se relaciona con una composiciónabsorbente de olor que contiene: a) desde 0.1% hasta 5% en peso de la composición de ciclodextrina no complexada, soluble en agua solubilizada; b) desde 0.1% hasta 36% en peso de la composición de una fase de aceite seleccionada del grupo consistente e emolientes, humectantes y protectores para la piel; c) uno o más surfactantes que tienen un equilibrio hidrófilo/lipófilo de 8 a 18 y donde cada surfactante cuando se combina con una solución acuosa de ciclodextrina, provee no menos que 25% de un nivel de captura de olor como solución acuosa de ciclodextrina; y d) un portador acuoso; donde la composición es segura para uso sobre la piel. Adicionalmente se relaciona también con métodos para reducir el olor que comprende la aplicación a la piel de la anterior composición, depositada sobre un medio dispensador flexible.",PROCTER & GAMBLE,LUCAS JULIET MARIE;;TOAN TRINH;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY,,https://lens.org/053-028-124-221-073,Patent Application,no,0,0,16,18,0,A61K8/19;;A61K8/27;;A61K8/347;;A61K8/37;;A61K8/39;;A61K8/44;;A61K8/4973;;A61K8/738;;A61K8/891;;A61K8/90;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61K8/39;;A61K8/37;;A61K8/90;;A61Q15/00;;A61K8/891;;A61K8/27;;A61K8/44;;A61K8/347;;A61K8/19;;A61K8/738;;A61K8/4973,A47K7/00;;A61K8/00;;A61K8/18;;A61K8/19;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/34;;A61K8/37;;A61K8/44;;A61K8/49;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;C08L83/10,,0,0,,,,PENDING
212,WO,A1,WO 2011/024115 A1,010-142-685-804-577,2011-03-03,2011,IB 2010053796 W,2010-08-24,US 23662509 P;;EP 09290643 A,2009-08-25,COMPOSITION AND METHOD FOR TREATING COGNITIVE IMPAIRMENTS IN DOWN SYNDROM SUBJECTS,"This application relates to compounds having inverse agonist functional selectivity for GABA A receptors containing the α5 subunit for use as a medicament in the treatment of cognitive impairments in subjects suffering from Down syndrome. The present application also relates to the use of compounds having inverse agonist functional selectivity for GABA A receptors containing the α5 subunit for the preparation of a medicament in the treatment of cognitive impairments in subjects suffering from Down syndrome. The application further relates to pharmaceutical compositions for treating cognitive impairments in subjects suffering from Down syndrome comprising a compound having inverse agonist functional selectivity for GABA A receptors containing the α5 subunit, or suitable pharmaceutically acceptable salt thereof, a polyethoxylated castor oil and dimethyl sulfoxide (DMSO). The present application also describes methods for enhancing cognitive function, or treating or lessening the severity of cognitive impairments, in subjects suffering from Down syndrome by administering to a subject in need thereof a pharmaceutically effective amount of one or more compounds having inverse agonist functional selectivity for GABA A receptors containing the α5 subunit. More particularly, the present application is concerned with the treatment of cognitive impairments, such as impairment in memory, learning capacity or both, in subjects suffering from Down syndrome.",CENTRE NAT RECH SCIENT;;POTIER MARIE-CLAUDE;;DODD ROBERT;;DELATOUR BENOIT;;BRAUDEAU JEROME;;HERAULT YANN,POTIER MARIE-CLAUDE;;DODD ROBERT;;DELATOUR BENOIT;;BRAUDEAU JEROME;;HERAULT YANN,,https://lens.org/010-142-685-804-577,Patent Application,yes,5,8,9,9,0,A61K31/381;;A61K31/381;;A61K9/0019;;A61K9/0019;;A61K31/4162;;A61K31/4162;;A61K31/502;;A61K31/502;;A61K31/5517;;A61K31/5517;;A61P25/28,A61K31/381;;A61K31/4162;;A61K31/502;;A61K31/5517;;A61P25/28,,47,39,005-074-622-484-972;;046-511-954-625-540;;003-632-473-817-358;;051-751-371-773-377;;158-769-816-284-513;;040-603-513-769-741;;033-352-116-089-50X;;121-223-221-497-870;;005-074-622-484-972;;040-534-170-038-608;;046-511-954-625-540;;021-707-881-253-13X;;031-073-229-390-222;;030-795-134-474-798;;035-549-067-065-596;;007-364-858-655-289;;033-352-116-089-50X;;030-725-264-212-91X;;003-632-473-817-358;;142-315-311-170-556;;022-089-074-878-863;;030-795-134-474-798;;005-151-061-459-887;;098-720-474-380-035;;027-138-178-894-577;;005-003-378-275-766;;075-834-160-316-752;;110-411-283-383-413;;114-046-413-750-465;;154-343-665-077-504;;041-232-737-795-339;;042-314-133-748-828;;089-420-127-197-948;;041-232-737-795-339;;106-382-788-443-157;;004-155-602-279-291;;086-719-788-823-333;;022-729-270-383-334;;036-504-079-856-464,18936916;;10.1007/s00213-008-1357-7;;10.1021/jm031076j.s001;;15084116;;10.1021/jm031076j;;15537339;;10.1021/jm040863t;;10.1021/jm040863t.s001;;11296070;;10.1001/archpedi.155.4.442;;7550346;;10.1038/ng1095-177;;15371516;;10.1523/jneurosci.1766-04.2004;;pmc6729789;;17322876;;10.1038/nn1860;;10.1038/321864a0;;3724846;;18936916;;10.1007/s00213-008-1357-7;;10.1016/j.neuropharm.2006.04.018;;17046030;;10.1021/jm031076j.s001;;15084116;;10.1021/jm031076j;;16326923;;10.1124/jpet.105.092320;;10.1016/j.neuropharm.2007.08.008;;17888460;;10.1016/j.mehy.2005.06.018;;16125326;;10.1016/j.neuron.2007.07.025;;pmc8055171;;17785178;;10.1002/jps.2600660104;;833720;;17322876;;10.1038/nn1860;;10.1203/00006450-199904020-00100;;15537339;;10.1021/jm040863t;;10.1021/jm040863t.s001;;20026436;;12097508;;pmc6758233;;10.1523/jneurosci.22-13-05572.2002;;16633803;;10.1007/s00213-006-0361-z;;10.1016/j.mehy.2005.06.018;;16125326;;10.1002/mrdd.20157;;17910090;;10.1152/jn.00626.2006;;17093127;;10.1016/j.neulet.2007.12.039;;18226451;;10.1124/mol.54.5.928;;9804628;;9284055;;10.1016/s0306-4522(97)00146-2;;9517425;;10.1016/s0028-3908(97)00157-3;;10.2741/3118;;pmc2783207;;10.1016/j.bbr.2009.08.034;;19720087;;19770002;;10.1016/j.pharmthera.2009.09.001;;10.1016/j.lfs.2006.07.004;;16904699;;10.1021/jm011082k;;12061884;;19770002;;10.1016/j.pharmthera.2009.09.001;;19576998;;10.1016/j.drudis.2009.06.009;;10.1016/s0166-4328(97)81111-4;;9021073;;8584244;;10.1016/0304-3940(95)12052-6;;10.1037/e496052006-010;;8341361;;10608287;;10.1016/s0028-3908(99)00083-0,"THERESA M BALLARD ET AL: ""RO4938581, a novel cognitive enhancer acting at GABAA alpha-5 subunit-containing receptors"", PSYCHOPHARMACOLOGY, SPRINGER, BERLIN, DE, vol. 202, no. 1-3, 21 October 2008 (2008-10-21), pages 207 - 223, XP019702240, ISSN: 1432-2072;;F.STERNFELD, R.W.CARLING, R.A.JELLEY, T.LADDUWAHETTY, K.J.MERCHANT, K.W.MOORE, A.J.REEVE, L.J.STREET, D.O'CONNOR, AND M. MACLEOD: ""Selective, Orally Active gamma-Aminobutyric AcidA alpha-5 Receptor Inverse Agonists as Cognition Enhancers"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 47, 27 March 2004 (2004-03-27), pages 2176 - 2179, XP002550720;;M.CHAMBERS, J.ATACK, R.CARLING, N.COLLINSON, S.COOK, G.DAWSON, P.FERRIS, S.HOBBS, D.O'CONNOR, W.RYCROFT, AND A.MACLEOD: ""An Orally Bioavailable, Functionally Selective Inverse Agonist at the Benzodiazepine Site of GABA-A alpha-5 Receptors with Cognition Enhancing Properties"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 47, 16 October 2004 (2004-10-16), pages 5829 - 5832, XP002550721;;ARCHIVES OF PED AND ADOL MED, vol. 155, no. 4, April 2001 (2001-04-01), pages 442 - 448;;REEVES ET AL., NATURE GENETICS, vol. 11, no. 2, 1995, pages 177 - 84;;KLESCHEVNIKOV ET AL., THE JOURNAL OF NEUROSCIENCE, vol. 24, no. 37, 2004, pages 8153 - 8160;;F. FERNANDEZ ET AL.: ""Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome"", NATURE NEUROSCIENCE, 25 February 2007 (2007-02-25);;NOGRADY: ""Medicinal Chemistry A Biochemical Aprroach"", 1985, OXFORD UNIVERSITY PRESS, pages: 388 - 392;;MCNAMARA; SKELTON, PSYCHOBIOLOGY, vol. 21, no. 2, 2002, pages 101 - 108;;VENAULT ET AL., NATURE, vol. 321, no. 6073, 1986, pages 864 - 866;;BALLARD ET AL., PSYCHOPHARMACOLOGY, vol. 202, 2009, pages 207 - 223;;ATACK ET AL., NEUROPHARMACOLOGY, vol. 51, 2006, pages 1023 - 1029;;STERNFELD ET AL., J. MED. CHEM., vol. 47, 2004, pages 2176 - 2179;;DAWSON ET AL., THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, vol. 316, no. 3, 2006, pages 1335 - 1345;;NUTT ET AL., NEUROPHARMACOLOGY, vol. 53, 2007, pages 810 - 820;;SCHMITT: ""Neuro-modulation, aminergic neuro-disinhibition and neuro- degeneration. Draft of a comprehensive theory for Alzheimer disease"", MED HYPOTHESES., vol. 65, no. 6, 2005, pages 1106 - 19;;PALOP ET AL.: ""Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease"", NEURON, vol. 55, no. 5, 6 September 2007 (2007-09-06), pages 697 - 711;;MCNAMARA; SKELTON, PSYCHOBIOLOGY, vol. 21, pages 101 - 108;;S. M. BERGE ET AL., J. PHARMACEUTICAL SCIENCES, vol. 66, 1977, pages 1 - 19;;""Remington's Pharmaceutical Sciences"", 1975, MACK PUBLISHING COMPANY;;F. FERNANDEZ ET AL.: ""Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome"", NATURE NEUROSCIENCE, vol. 10, 2007, pages 411 - 413;;LOBAUGH NJ ET AL.: ""Piracetam does not enhance cognitive abilities in moderate to high-functioning 7 to 13 year-old children with Down syndrome"", PRESENTED AT THE PAS/SPR MEETING, 3 May 1999 (1999-05-03);;STERNFELD ET AL., J MED. CHEM., vol. 47, 2004, pages 2176 - 2179;;DAWSON ET AL., THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTALTHERAPEUTICS, vol. 316, no. 3, 2006, pages 1335 - 1345;;CHAMBERS ET AL., J MED. CHEM., vol. 47, 2004, pages 5829 - 5832;;COLLINSON ET AL., J. NEUROSCI., vol. 22, 2002, pages 5572 - 5580;;COLLINSON ET AL., PSYCHPHARMACOLOGY, vol. 188, 2006, pages 619 - 628;;SCHMITT ET AL.: ""Neuro-modulation, aminergic neuro-disinhibition and neuro- degeneration. Draft of a comprehensive theory for Alzheimer disease"", MED HYPOTHESES, vol. 65, no. 6, 2005, pages 1106 - 19;;PALOP ET AL.: ""Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease"", NEURON., vol. 55, no. 5, 6 September 2007 (2007-09-06), pages 697 - 711;;SHERMAN, S.L.; ALLEN, E.G.; BEAN, L.H.; FREEMAN, S.B., MENT RETARD DEV DISABIL RES REV, vol. 13, 2007, pages 221 - 227;;BEST, T.K.; SIAREY, R.J.; GALDZICKI, Z., J NEUROPHYSIOL, vol. 97, 2007, pages 892 - 900;;RUEDA, N.; FLOREZ, J.; MARTINEZ-CUE, C., NEUROSCI LETT, vol. 433, 2008, pages 22 - 27;;SUR, C.; QUIRK, K.; DEWAR, D.; ATACK, J.; MCKERNAN, R., MOL PHARMACOL, vol. 54, 1998, pages 928 - 933;;SPERK, G.; SCHWARZER, C.; TSUNASHIMA, K.; FUCHS, K.; SIEGHART, W., NEUROSCIENCE, vol. 80, 1997, pages 987 - 1000;;SIAREY, R.J.; STOLL, J.; RAPOPORT, S.I.; GALDZICKI, Z., NEUROPHARMACOLOGY, vol. 36, 1997, pages 1549 - 1554;;S. M. HOELTER ET AL., FRONT BIOSCI, vol. 13, 2008, pages 5810;;A. C. COSTA; M. R. STASKO; C. SCHMIDT; M. T. DAVISSON, BEHAV BRAIN RES, vol. 206, 2010, pages 52;;J. R. ATACK, PHARMACOL THER, vol. 125, 2010, pages 11;;S. A. MERSCHMAN ET AL., PHARMAZIE, vol. 60, 2005, pages 359;;D. J. MOURA ET AL., LIFE SCI, vol. 79, 2006, pages 2099;;A.EL HADRI, J. MED. CHEM., vol. 45, 2002, pages 2824 - 2831;;ATACK, J.R.: ""Preclinical and clinical pharmacology of the GABA(A) receptor alpha5 subtype-selective inverse agonist alpha5IA"", PHARMACOL THER., vol. 125, no. 1, January 2010 (2010-01-01), pages 11 - 26;;D'HULST, C.; ATACK, J.R.; KOOY, R.F.: ""The complexity of the GABAA receptor shapes unique pharmacological profiles"", DRUG DISCOV TODAY, vol. 14, 2009, pages 866 - 875;;DEMAS, G.E.; NELSON, R.J.; KRUEGER, B.K.; YAROWSKY, P.J.: ""Spatial memory deficits in segmental trisomic Ts65Dn mice"", BEHAV BRAIN RES, vol. 82, 1996, pages 85 - 92;;ESCORIHUELA, R.M.; FERNANDEZ-TERUEL, A.; VALLINA, I.F.; BAAMONDE, C.; LUMBRERAS, M.A.; DIERSSEN, M.; TOBENA, A.; FLOREZ, J.: ""A behavioral assessment of Ts65Dn mice: a putative Down syndrome model"", NEUROSCI LETT, vol. 199, 1995, pages 143 - 146;;HOFFMAN, G.E.; LEE, W.S.; SMITH, M.S.; ABBUD, R.; ROBERTS, M.M.; ROBINSON, A.G.; VERBALIS, J.G.: ""c-Fos and Fos-related antigens as markers for neuronal activity: perspectives from neuroendocrine systems"", NIDA RES MONOGR, vol. 125, 1993, pages 117 - 133;;SIAREY, R.J.; CARLSON, E.J.; EPSTEIN, C.J.; BALBO, A.; RAPOPORT, S.I.; GALDZICKI, Z.: ""Increased synaptic depression in the Ts65Dn mouse, a model for mental retardation in Down syndrome"", NEUROPHARMACOLOGY, vol. 38, 1999, pages 1917 - 1920",PENDING
213,GB,B,GB 2136123 B,077-483-904-735-302,1986-10-29,1986,GB 8405603 A,1984-03-02,GB 8405603 A;;GB 8306055 A,1983-03-04,DISSOLUTION TESTING MACHINE,,NOORMOHAMMADI AKBAR;;BECKETT ARNOLD HEYWORTH;;GREEVES GRAHAME KENNETH;;DODD ROBERT EDWARD,NOORMOHAMMADI AKBAR;;BECKETT ARNOLD HEYWORTH;;GREEVES GRAHAME KENNETH;;DODD ROBERT EDWARD,,https://lens.org/077-483-904-735-302,Granted Patent,no,0,0,3,12,0,G01N13/00;;G01N33/15;;G01N2013/006;;B01F21/221;;B01F31/24;;B01F2101/23,B01F1/00;;B01F11/00;;G01N13/00;;G01N33/15,G1BBG;;G1BCD;;U1S1310;;U1S1463;;U1SG1B,0,0,,,,EXPIRED
214,US,B2,US 7128986 B2,189-309-257-501-004,2006-10-31,2006,US 68684103 A,2003-10-16,US 68684103 A,2003-10-16,Nanoclustered magnetic materials for high moment write pole applications,The present invention includes magnetic write elements with portions formed a nanophase high magnetic moment material to enable further increases in areal density in magnetic recording. The nanophase deposited high magnetic moment material comprises coated nanoclusters and nanolaminated cluster films that are deposited to form nanophase high magnetic moment material portions of a write pole and SUL layer in perpendicular recording media. The nanophase write poles exhibit high magnetic moments and are generally compatible with conventional writer head fabrication techniques.,SEAGATE TECHNOLOGY LLC,LAMBERTON ROBERT W;;MACKEN DECLAN;;DODD PAUL M;;O'KANE WILLIAM J,SEAGATE TECHNOLOGY LLC (2003-10-07),https://lens.org/189-309-257-501-004,Granted Patent,yes,11,12,2,2,0,B82Y25/00;;G11B5/1278;;G11B5/187;;G11B5/313;;G11B5/74;;G11B2005/0029;;H01F10/007;;G11B5/1274;;G11B5/133;;Y10T428/115;;Y10T428/256;;Y10T428/32;;Y10T428/1171;;Y10T428/115;;Y10T428/256;;Y10T428/32;;Y10T428/1171;;B82Y25/00;;G11B5/313;;H01F10/007;;G11B5/74;;G11B5/1278;;G11B2005/0029;;G11B5/187;;G11B5/1274;;G11B5/133,G11B5/127;;G11B5/00;;G11B5/187;;G11B5/31;;G11B5/74;;H01F10/00,428/812;;428/815;;428/692.1,13,12,049-666-834-763-290;;124-025-511-500-072;;013-518-861-907-690;;164-773-470-295-619;;165-418-901-242-528;;002-977-185-709-771;;120-394-066-680-981;;041-778-889-901-342;;003-883-929-556-907;;091-489-408-095-216;;000-832-075-267-394;;061-676-596-102-713,10.1063/1.344689;;10.1109/20.951149;;10.1109/tmag.2002.802126;;10.1109/tmag.2002.802668;;10.1016/s0304-8853(02)00090-2;;10.1016/s0304-8853(00)01349-4;;10.1063/1.1304868;;10.1103/physrevb.59.6373;;10.1103/physrevb.52.15070;;9980853;;10.1016/s0009-2614(02)00024-6;;10.1088/0022-3727/30/5/003;;10.1088/1367-2630/4/1/398,"Kong et al. (Mag. Conf, 2002, INTERMAG Europe 2002, Digest Papers).;;Komuro et al. (J. Appl. Phys., 67(9), May 1990, 5126-5130).;;Pan et al. (IEEE Trans. Mag., 37(4) 2001, 2284-2287).;;Yu et al. (IEEE Trans. Mag., 38(5), 2002, 3030-3032).;;Katada et al. (IEEE Trans. Mag., 38(5), 2002, 2225-2227).;;S.H. Baker, C. Binns, K.W. Edmonds, M.J. Maher, S.C. Thornton, S. Louch, S.S. Dhesi, Enhancements in magnetic moments of exposed and Co-coated Fe nanoclusters as a function of cluster size, Jan. 17, 2002, pp. 19-25.;;K.W. Edmonds, C. Binns, S.H. Baker, M.J. Maher, S.C. Thornton, O. Tjernberg, N.B. Brookes, Size dependence of the magnetic moments of exposed nanoscale iron particles; Oct. 3, 2000, pp. 113-119.;;S.H. Baker, S.C. Thornton, K.W. Edmonds, M.J. Maher, C. Norris, and C. Binns, The construction of a gas aggregation source for the preparation of size-selected nanoscale transition metal clusters, Apr. 24, 2000, pp. 3178-3183.;;A.M.N. Niklasson and B. Johansson, Interface magnetism of 3d transition metals, Jul. 22, 1998, pp. 6373-6382.;;S. Mirbt, O. Eriksson, and B. Johansson, Magnetic coupling in 3 d transition-metal monolayers and bilayers on bcc (100) iron, Jul. 19, 1995, pp. 15070-15073.;;Mark B. Knickelbein, Adsorbate-induced enhancement of the magnetic moments of iron clusters; Chemical Physics Letters; Feb. 19, 2002; pp. 221-225.;;A Perez, P Melinon, V Dupuis, P Jensen, B Prevel, J Tuaillon, L Bardotti, C Martet, M Treilleux, M Broyer, M Pellarin, J L Vaille, B Palant, and J Lerme, Cluster assembled materials: a novel class of nanostructured solids with original structures and properties; J. Phys. D: Appl. Phys. 1997; pp. 709-721.;;J T Lau, A Fohlisch, M Marins, R Nietubyc, M Reif and W Wurth; Spin and orbital magnetic moments of deposited small iron clusters studied by x-ray magnetic circular dichroism spectroscopy; New Journal of Physics; Published Dec. 12, 2002; pp. 98.1-98.12.",EXPIRED
215,US,B2,US 11174226 B2,008-208-063-422-66X,2021-11-16,2021,US 201615759084 A,2016-09-07,EP 15306378 A;;EP 2016071115 W,2015-09-09,Azetidinimines as carbapenemases inhibitors,The present application relates to novel azetidinimine of formula (I). Wherein R 1 -R 6 are as defined in claim 1 . The azetidinimine of the invention are useful as antibiotics and as inhibitors of a carbapenemases. The present invention thus further relates to their use in antibiotic therapies and their methods of synthesis.,CENTRE NAT RECH SCIENT,DODD ROBERT;;CARIOU KEVIN;;MINARD CORINNE;;IORGA BOGDAN-IULIU;;NAAS THIERRY,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (2018-06-12),https://lens.org/008-208-063-422-66X,Granted Patent,yes,0,0,8,8,0,C07D401/04;;C07D205/085;;A61K31/397;;C07D205/06;;A61P31/04;;A61P43/00;;A61K45/06;;Y02A50/30;;C07D205/085;;C07D401/04;;A61K31/397;;A61K45/06;;C07D205/06,C07D205/06;;A61K31/397;;A61K45/06;;C07D205/085;;C07D401/04,,19,13,165-533-825-286-740;;087-635-969-474-441;;080-541-830-098-304;;126-257-701-746-327;;013-505-049-775-153;;040-772-807-251-179;;055-269-292-321-84X;;024-278-790-062-57X;;013-520-917-983-231;;112-407-928-681-17X;;000-406-605-597-939;;023-551-389-428-633;;112-183-574-106-812,10.1111/j.1349-7006.2003.tb01343.x;;10.1002/anie.200503936;;16570331;;10.1021/jo00391a020;;10.1246/nikkashi.1975.1524;;10.1021/ol201947b;;21848304;;pmc3170467;;23718841;;pmc3732456;;10.1021/jo400960e;;10.1016/j.tetlet.2013.11.091;;21442670;;10.1002/chem.201100447;;10.5012/bkcs.2010.31.03.570;;23734901;;10.1021/ol4013298;;10.1016/j.tetlet.2008.01.073;;10.1139/v88-362;;10.1021/jo00902a007,"STN Registry entry for CAS RN 55268-38-7, Entered STN Nov. 16, 1984, Accessed Mar. 26, 2019.;;Ito et al. in Cancer Science 94(1), 3-8 (2003).;;STN Registry database entry for CAS RN 123134-51-0, Entered STN Oct. 13, 1989, Accessed Jul. 22, 2019.;;Gospodova, Tz. et al., Stereocontrolled intramolecular cyclization of anti-beta-aminonitriles. Convenient access to trans-azetidin-2-imines, Bulgarian Chemical Communications, 2008, vol. 40, No. 4, pp. 568-571.;;Whiting, M. et al., Copper-Catalyzed Reaction Cascade: Direct Conversion of Alkynes into N-Sulfonylazetidin-2-imines, Angew. Chem. Int. Ed., 2006, vol. 45, pp. 3157-3161.;;Perst, H., Product Class 17: Ketenimines, Science of Synthesis: Houben-Weyl Methods of Molecular Transformation, 2006, pp. 781-839.;;Barbaro, G. et al., Periselectivity in Cycloadditions to Vinylmethylketene and Structurally Related Vinylketene Imines, J. Org. Chem., 1987, vol. 52, pp. 3289-3296.;;Mostowicz, D. et al., A New Approach to the Synthesis of Chiral Beta-Lactam Derivatives, Polish Journal of Chemistry, 1983, vol. 57, pp. 297-299.;;Odanaka, M. et al, Nippon Kagaku Kaishi: Journal of the Chemical Society of Japan, 1975, No. 9, pp. 1524-1529.;;DeKorver, K. et al., Introducing a New Class of N-Phosphoryl Ynamides via Cu(I)-Catalyzed Amidations of Alkynyl Bromides, Organic Letters, 2011, vol. 13, No. 18, pp. 4862-4865.;;Wang, Xiao-Na et al., Synthesis of Cyclopentenimines from N-Allyl Ynamides via a Tandem Aza-Claisen Rearrangement-Carbocyclization Sequence, J Org. Chem, 2013, vol. 78, pp. 6233-6244.;;Kazuhiro et al. “Synthesis of 1-haloethenamides from ynamide through halotrimethylsilane-mediated hydrohalogenation”. Tetrahedrom Letters 55 (2014) 632-635.;;Pizzetti et al. “Microwave-Assited Animocarbonylation of Ynamides by Using Catalytic [Fe3(CO)12] at Low Pressures of Carbon Monoxide” Chem. Eur. J. 2011, 17, 4523-4528.;;Sato et al. “Radical Additions of Arenethiols to Ynamides for the Selective Synthesis of N-[(Z)-2-(Arylsulfanyl)-1-alkenyl]amides” Bull. Korean Chem. Soc. 2010; vol. 31; No. 3; pp. 570-576.;;Gati et al. “Intramolecular Carbocupration of N-Aryl-ynamides: A Modular Indole Synthesis” Organic Letters; Jun. 2013; 15(12): 3122-3125.;;Kim et al. “Highly efficient synthesis of a-amino amidines from ynamides by the Cu-catalyzed three-component coupling reactions” Tetrahedron Letters; 49 (2008) 1745-1749.;;Schwan et al. “The synthesis and unimolecular decomposition of four novel D1-1,2,4-triazolines1”. Department of Chemistry, McMaster University, Hamilton, Ont., Canada L85 4M1. Can. J. Chem, 66, 2285 (1988).;;Crandall et al. “Reaction of N-Isopropylallenimine with organic azides”. J. Org. Chem. vol. 40, No. 14, 1975 2045-2047.;;Tlili “Synthesis and Reactivity of Diaza-1,2 Spiropentanes”Journal of the Chemical Society of Tunisia, vol. III—n° 8—Dec. 1988.",ACTIVE
216,WO,A1,WO 1998/056341 A1,026-557-071-946-744,1998-12-17,1998,US 9811812 W,1998-06-08,US 87116697 A;;US 87179197 A,1997-06-09,METHODS FOR CONTROLLING ENVIRONMENTAL ODORS ON THE BODY USING COMPOSITIONS COMPRISING UNCOMPLEXED CYCLODEXTRINS AND PERFUME,"The present invention encompasses the use of oder absorbing compositions for controlling environmental malodors on skin wherein the odor absorbing composition comprises uncomplexed cyclodextrin, an aqueous carrier, hydrophilic volatile perfume, and optionally an oil phase and one or more surfactants.",PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY,,https://lens.org/026-557-071-946-744,Patent Application,yes,2,15,17,18,0,A61K8/0208;;A61K8/738;;A61Q13/00;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61K8/738;;A61Q13/00;;A61K8/0208;;A61Q15/00,A61K8/02;;A61K8/00;;A61K8/18;;A61K8/25;;A61K8/27;;A61K8/34;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61Q13/00;;A61Q15/00;;C08L83/10,,1,1,117-288-143-743-628,10.1002/star.19820341106,"SZEJTLI, J.: ""CYCLODEXTRINS IN FOOD, COSMETICS AND TOILETRIES"", STÄRKE, vol. 34, no. 11, November 1982 (1982-11-01), WEINHEIM, DEUTSCHLAND, pages 382, XP002079064",PENDING
217,CA,A1,CA 2293417 A1,051-229-075-589-32X,1998-12-17,1998,CA 2293417 A,1998-06-08,US 87116697 A;;US 87179197 A;;US 9811812 W,1997-06-09,METHODS FOR CONTROLLING ENVIRONMENTAL ODORS ON THE BODY USING COMPOSITIONS COMPRISING UNCOMPLEXED CYCLODEXTRINS AND PERFUME,"The present invention encompasses the use of oder absorbing compositions for controlling environmental malodors on skin wherein the odor absorbing composition comprises uncomplexed cyclodextrin, an aqueous carrier, hydrophilic volatile perfume, and optionally an oil phase and one or more surfactants.",PROCTER & GAMBLE,LUCAS JULIET M;;DODD MICHAEL THOMAS;;TRINH TOAN;;BARTOLO ROBERT GREGORY,,https://lens.org/051-229-075-589-32X,Patent Application,no,0,0,17,18,0,A61K8/0208;;A61K8/738;;A61Q13/00;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61K8/738;;A61Q13/00;;A61K8/0208;;A61Q15/00,A61K8/00;;A61K8/02;;A61K8/18;;A61K8/25;;A61K8/27;;A61K8/34;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61Q13/00;;A61Q15/00;;C08L83/10,,0,0,,,,DISCONTINUED
218,WO,A1,WO 2012/084971 A1,046-299-238-547-451,2012-06-28,2012,EP 2011073437 W,2011-12-20,FR 1060825 A,2010-12-20,INDOLE DERIVATIVES AS AGENTS AGAINST GRAM-NEGATIVE AND GRAM-POSITIVE BACTERIA,"The invention relates to indole derivatives corresponding to general formula (I) and also the salts thereof with pharmaceutically acceptable acids, in the form of a racemic mixture, of mixtures of optical isomers in which the R isomer is predominant, or of the optically pure R isomer thereof, and to the use thereof as antibiotic agents.",CENTRE NAT RECH SCIENT;;UNIV AIX MARSEILLE II;;DODD ROBERT;;BEAUMARD FLORIANE;;KIEFER LIONEL;;PAGES JEAN-MARIE;;CHEVALIER JACQUELINE,DODD ROBERT;;BEAUMARD FLORIANE;;KIEFER LIONEL;;PAGES JEAN-MARIE;;CHEVALIER JACQUELINE,,https://lens.org/046-299-238-547-451,Patent Application,yes,4,8,3,3,0,A61P31/00;;A61P31/04;;C07D209/14,C07D209/14;;A01P1/00;;A61K31/404;;A61P31/04,,3,3,046-923-402-893-513;;011-496-568-024-680;;046-923-402-893-513,10.1016/s0960-894x(04)00412-3;;10.1016/j.bmcl.2004.03.056;;15149704;;10.1002/ardp.19943270209;;8135641;;10.1016/s0960-894x(04)00412-3;;10.1016/j.bmcl.2004.03.056;;15149704,"KESSLER A ET AL: ""N<2>-Benzyl-N<1>-(1-(1-naphthyl)ethyl)-3-phenylpropane-1,2-diamines and conformationally restrained indole analogues: development of calindol as a new calcimimetic acting at the calcium sensing receptor"", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, ELSEVIER SCIENCE, GB, vol. 14, no. 12, 21 June 2004 (2004-06-21), pages 3345 - 3349, XP004841403, ISSN: 0960-894X, DOI: DOI:10.1016/J.BMCL.2004.03.056;;MAHBOOBI S ET AL: ""ANTIMYKOBAKTERIELL WIRKSAME INDOLDERIVATIVE. INDOLE DERIVATIVES WITH ANTIMYCOBACTERIAL ACTIVITY"", ARCHIV DER PHARMAZIE, WILEY - VCH VERLAG GMBH & CO. KGAA, DE, vol. 327, no. 2, 1 January 1994 (1994-01-01), pages 105 - 114, XP002045437, ISSN: 0365-6233;;DODD ET AL., BIOORG. MED. CHEM. LETT., vol. 14, 2004, pages 3345 - 3349",PENDING
219,US,B1,US 6386401 B1,065-756-276-164-398,2002-05-14,2002,US 71475200 A,2000-11-16,US 71475200 A;;US 49472300 A,2000-01-31,Dispenser for extrudable material,"
    A hand dispenser for dispensing an extrudable material includes a housing for holding the extrudable material, along with a pistol grip handle. A trigger member is mounted adjacent the pistol grip handle for movement in a path toward and away therefrom to incrementally effect a metered dispensing of the extrudable material. An adjustable stop cam is mounted in the path of movement of the trigger member. The stop cam has different cam portions engageable by the trigger member and is effective to limit movement of the trigger member to different degrees and, thereby, vary the metered amount of dispensed material. A piston rod has a series of ratcheting teeth on at least two different sides of the rod engageable by a drive pawl operatively associated with the trigger member. The ratcheting teeth in one series thereof has a spacing different from the spacing of the ratcheting teeth in the other series thereof. Therefore, the multiple series of ratcheting teeth provide multiple settings of the dispenser for each setting of the adjustable stop cam. 
",PRINCE CASTLE INC,DODD ROBERT E;;ELLENWOOD JR WILLIAM R;;GORMAN DARRELL C E,MARMON FOODSERVICE TECHNOLOGIES INC (2020-12-28);;PRINCE CASTLE LLC (2009-12-01),https://lens.org/065-756-276-164-398,Granted Patent,yes,6,29,1,1,0,B05C17/01;;B05C17/01,B05C17/01,222/391,0,0,,,,EXPIRED
220,US,B2,US 10513621 B2,086-648-329-438-035,2019-12-24,2019,US 201615552832 A,2016-02-29,US 201615552832 A;;US 201562121898 P;;US 2016/0020073 W,2015-02-27,Ink and method of conducting an examination,"An ink and method of conducting an examination suitable for reducing the likelihood that the students' answers on paper-based examinations may be changed at a later time prior to being graded. The ink includes a solution of marking particles, a suspension material, and a preserving material. A mark made with the ink is initially erasable for a predetermined period of time after the mark is formed and after the expiration of the predetermined period of time the mark is not erasable. The method of conducting an examination includes providing an ink to an individual, and then providing questions to an individual wherein the individual indicates answers to the questions by producing marks with the ink.",PURDUE RESEARCH FOUNDATION,BOUDOURIS BRYAN WILLIAM;;DODD ROBERT RANDELL;;SARGENT JESSICA L;;ALCORACE EMILY,PURDUE RESEARCH FOUNDATION (2019-09-12),https://lens.org/086-648-329-438-035,Granted Patent,yes,14,1,3,3,0,B43K8/04;;B43K8/06;;C09D11/17;;C09D11/17;;C09D11/16;;C09D11/20,C09D11/17;;B43K8/04;;B43K8/06;;C09D11/16;;C09D11/20,,1,0,,,"International Search Report, PCT/US16/020073, dated Jul. 25, 2016.",ACTIVE
221,EP,B1,EP 2470176 B1,084-149-872-395-63X,2014-12-10,2014,EP 10763011 A,2010-08-24,US 23662509 P;;EP 09290643 A;;IB 2010053796 W;;EP 10763011 A,2009-08-25,COMPOSITION AND METHOD FOR TREATING COGNITIVE IMPAIRMENTS IN DOWN SYNDROM SUBJECTS,,CENTRE NAT RECH SCIENT,POTIER MARIE-CLAUDE;;DODD ROBERT;;DELATOUR BENOÎT;;BRAUDEAU JÉRÔME;;HERAULT YANN,,https://lens.org/084-149-872-395-63X,Granted Patent,yes,0,0,9,9,0,A61K31/381;;A61K31/381;;A61K9/0019;;A61K9/0019;;A61K31/4162;;A61K31/4162;;A61K31/502;;A61K31/502;;A61K31/5517;;A61K31/5517;;A61P25/28,A61K31/381;;A61K31/4162;;A61K31/502;;A61K31/5517;;A61P25/28,,2,2,038-572-956-119-536;;077-302-801-429-729,10.1155/2012/412536;;22844278;;pmc3400297;;10.1038/nrneurol.2012.40;;22410580,"ELIZABETH HEAD ET AL: ""Aging and Down Syndrome"", CURRENT GERONTOLOGY AND GERIATRICS RESEARCH, vol. 379, no. 1, 1 January 2012 (2012-01-01), pages 1 - 7, XP055098036, ISSN: 1687-7063, DOI: 10.1002/ajmg.a.34114;;COSTA A C: ""Alzheimer disease: Treatment of Alzheimer disease in Down syndrome"", NATURE REVIEWS NEUROLOGY 2012 NATURE PUBLISHING GROUP GBR, vol. 8, no. 4, April 2012 (2012-04-01), pages 182 - 184, ISSN: 1759-4758",INACTIVE
222,PE,A1,PE 98399 A1,102-628-408-035-138,1999-11-19,1999,PE 00048198 A,1998-06-09,US 87116697 A;;US 87179197 A,1997-06-09,METODOS PARA CONTROLAR OLORES AMBIENTALES SOBRE EL CUERPO USANDO COMPUESTOS QUE COMPRENDEN CICLODEXTRINAS NO COMPLEJAS Y PERFUME,"QUE COMPRENDE LA APLICACION A LA PIEL DE UNA COMPOSICION COMPUESTA POR: A) DE 0,1% A 5% APROXIMADAMENTE, EN PESO DE LA COMPOSICION DE CICLODEXTRINA NO COMPLEJA, HIDROSOLUBLE , SOLUBILIZADA; B) UN VEHICULO ACUOSO; C) DE 0,1% A 36% APROXIMADAMENTE, EN PESO DE LA COMPOSICION DE UNA FASE OLEOSA SELECCIONADA DE: EMULSIFICANTES HUMECTANTES Y PROTECTORES DE LA PIEL; D) UNO O MAS SURFACTANTES; Y E) DE 0,004% A 2%, APROXIMADAMENTE, EN PESO DE LA COMPOSICION DE UNA MEZCLA DE PERFUMES VOLATILES HIDROFILICOS, ADICIONALMENTE LA COMPOSICION PUEDE COMPRENDER: POLIOLES DE BAJO PESO MOLECULAR, ANTIMICROBIANOS HIDROFOBICOS, SALES DE ZINC, POLIMEROS HIDROSOLUBLES, SALES SOLUBLES DE CARBONATO Y/O BICARBONATO, AGENTES QUELANTES, ZEOLITAS, PRESERVANTES ANTIMICROBIANOS HIDROSOLUBLES, Y MEZCLAS DE ELLOS",PROCTER & GAMBLE,DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;TRINH TOAN,,https://lens.org/102-628-408-035-138,Patent Application,no,0,0,17,18,0,A61K8/0208;;A61K8/738;;A61Q13/00;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61K8/738;;A61Q13/00;;A61K8/0208;;A61Q15/00,A61K8/00;;A61K8/02;;A61K8/18;;A61K8/25;;A61K8/27;;A61K8/34;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61Q13/00;;A61Q15/00;;C08L83/10,,0,0,,,,DISCONTINUED
223,AU,A,AU 1998/078257 A,158-225-701-241-534,1998-12-30,1998,AU 1998/078257 A,1998-06-08,US 87116697 A;;US 87179197 A;;US 9811812 W,1997-06-09,Methods for controlling environmental odors on the body using compositions comprising uncomplexed cyclodextrins and perfume,,PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY,,https://lens.org/158-225-701-241-534,Patent Application,no,0,0,17,18,0,A61K8/0208;;A61K8/738;;A61Q13/00;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61K8/738;;A61Q13/00;;A61K8/0208;;A61Q15/00,A61K8/00;;A61K8/02;;A61K8/18;;A61K8/25;;A61K8/27;;A61K8/34;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61Q13/00;;A61Q15/00;;C08L83/10,,0,0,,,,DISCONTINUED
224,DE,D1,DE 60011462 D1,135-205-116-913-114,2004-07-15,2004,DE 60011462 T,2000-11-08,FR 9914050 A;;FR 0003104 W,1999-11-09,"ARALKYL-1,2-DIAMINEN MIT CALCIMIMETISCHER WIRKUNG UND VERFAHREN ZU IHRER HERSTELLUNG","The invention concerns compounds of general formula (I) wherein: X represents a SO2 or CH2 group; R1 represents a hydrogen or halogen atom or an alkoxy, aryl aralkyl group or an alkyl group substituted or not with one or several halogen atoms, n is equal to 0, 1 or 2, and R2 represents a hydrogen or halogen atom or an alkyl or alkoxy group, and their salt with a pharmaceutically acceptable acid. The invention also concerns the method for preparing said compounds, pharmaceutical compositions containing them and their use as modulator of CaSR activity and as medicine particularly designed for treating diseases or physiological disorders involving modulation of CaSR activity.",CENTRE NAT RECH SCIENT,RUAT MARTIAL;;POTIER JEAN-PAUL;;DODD ROBERT;;DAUBAN MARCEL;;FAURE VERONIQUE,,https://lens.org/135-205-116-913-114,Granted Patent,no,0,0,10,10,0,C07C211/27;;C07C311/18;;C07C311/29;;C07D333/34;;A61P1/04;;A61P13/12;;A61P19/10;;A61P25/28;;A61P3/00;;A61P3/14;;A61P35/00;;A61P5/00;;A61P5/22;;A61P9/10,A61P1/04;;A61K31/132;;A61K31/18;;A61P3/00;;A61P3/14;;A61P5/00;;A61P5/22;;A61P9/10;;A61P13/12;;A61P19/10;;A61P25/28;;A61P35/00;;C07C211/27;;C07C217/08;;C07C311/05;;C07C311/16;;C07C311/18;;C07C311/29;;C07C311/38;;C07D333/34;;C07F7/08,,0,0,,,,EXPIRED
225,ES,T3,ES 2531983 T3,127-324-979-352-22X,2015-03-23,2015,ES 10763011 T,2010-08-24,US 23662509 P;;EP 09290643 A;;IB 2010053796 W,2009-08-25,Composición y método de tratamiento de deficiencias cognitivas en individuos con síndrome de Down,"Un compuesto que tiene selectividad funcional de agonista inverso para receptores GABAA que contienen la subunidad α5 para utilización como medicamento para el tratamiento o alivio de la gravedad de deficiencias cognitivas en individuos que padecen síndrome de Down, en donde el compuesto tiene una de las estructuras siguientes:**Fórmula** o una sal farmacéuticamente aceptable o un éster escindible in vivo o un conjugado de glucósido enzimáticamente lábil o uno de sus ésteres de aminoácido.",CENTRE NAT RECH SCIENT,POTIER MARIE-CLAUDE;;DODD ROBERT;;DELATOUR BENOÎT;;BRAUDEAU JÉRÔME;;HERAULT YANN,,https://lens.org/127-324-979-352-22X,Granted Patent,no,0,0,9,9,0,A61K31/381;;A61K31/381;;A61K9/0019;;A61K9/0019;;A61K31/4162;;A61K31/4162;;A61K31/502;;A61K31/502;;A61K31/5517;;A61K31/5517;;A61P25/28,A61K31/381;;A61K31/4162;;A61K31/502;;A61K31/5517;;A61P25/28,,0,0,,,,ACTIVE
226,US,A1,US 2019/0055194 A1,129-589-135-437-73X,2019-02-21,2019,US 201615759084 A,2016-09-07,EP 15306378 A;;EP 2016071115 W,2015-09-09,Azetidinimines as Carbapenemases Inhibitors,The present application relates to novel azetidinimine of formula (I). Wherein R 1 -R 6 are as defined in claim 1 . The azetidinimine of the invention are useful as antibiotics and as inhibitors of a carbapenemases. The present invention thus further relates to their use in antibiotic therapies and their methods of synthesis.,CENTRE NAT RECH SCIENT,DODD ROBERT;;CARIOU KEVIN;;MINARD CORINNE;;IORGA BOGDAN-IULIU;;NAAS THIERRY,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (2018-06-12),https://lens.org/129-589-135-437-73X,Patent Application,yes,0,0,8,8,0,C07D401/04;;C07D205/085;;A61K31/397;;C07D205/06;;A61P31/04;;A61P43/00;;A61K45/06;;Y02A50/30;;C07D205/085;;C07D401/04;;A61K31/397;;A61K45/06;;C07D205/06,A61K31/397;;C07D205/06;;A61K45/06,,0,0,,,,ACTIVE
227,GB,A,GB 2136123 A,099-883-513-981-013,1984-09-12,1984,GB 8405603 A,1984-03-02,GB 8405603 A;;GB 8306055 A,1983-03-04,Dissolution Testing Machine,"A dissolution testing machine has a container for a liquid and a holder for pellets, means supporting the holder within the container and drive means enabling the holder to be reciprocated via its support means so that solvent flushes into and out of the holder. The holder may be a mesh tube, or a solid walled tube, closed at both ends by an apertured member. A set of containers may receive the holder successively, each container containing a solvent of the same or different characteristics. The container or containers may be supported in a temperature-controlled bath.",NOORMOHAMMADI AKBAR;;BECKETT ARNOLD HEYWORTH;;GREEVES GRAHAME KENNETH;;DODD ROBERT EDWARD,NOORMOHAMMADI AKBAR;;BECKETT ARNOLD HEYWORTH;;GREEVES GRAHAME KENNETH;;DODD ROBERT EDWARD,,https://lens.org/099-883-513-981-013,Patent Application,no,0,10,3,12,0,G01N13/00;;G01N33/15;;G01N2013/006;;B01F21/221;;B01F31/24;;B01F2101/23,B01F1/00;;B01F11/00;;G01N13/00;;G01N33/15,G1B BBG           BG;;G1B BCD           CD;;U1S S1310;;U1S S1463,0,0,,,,EXPIRED
228,US,A,US 5942214 A,153-453-053-888-753,1999-08-24,1999,US 87116697 A,1997-06-09,US 87116697 A;;US 87179197 A;;US 9811812 W,1997-06-09,Methods for controlling environmental odors on the body using compositions comprising uncomplexed cyclodextrins and perfume,"The present invention encompasses a method of controlling environmental odors on the body comprising the application to the skin of a composition comprising from about 0.1% to about 5%, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from about 0.1% to about 36%, by weight of the composition, of an oil phase selected from the group consisting of emollients, moisturizers, and skin protectants; one or more surfactants; from about 0.004% to about 2%, by weight of the composition, of a hydrophilic, volatile perfume composition; and an aqueous carrier. The compositions can be applied directly as a spray, poured from a bottle and applied by hand, or applied via a wipe.",PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY,PROCTER & GAMBLE COMPANY THE (1997-06-19),https://lens.org/153-453-053-888-753,Granted Patent,yes,32,31,17,18,0,A61K8/0208;;A61K8/738;;A61Q13/00;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61K8/738;;A61Q13/00;;A61K8/0208;;A61Q15/00,A61K8/02;;A61K8/18;;A61K8/25;;A61K8/27;;A61K8/34;;A61K8/00;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61Q13/00;;A61Q15/00;;C08L83/10,424/65;;422/5;;424/67;;424/69;;424/76.1;;424/76.2;;424/76.21;;424/76.4;;424/76.8;;424/78.03;;424/405;;424/642;;424/715;;424/717,32,1,090-441-333-592-541,10.3109/03639049209040853,"T. Loftsson, et al. Interactions Between Preservatives and 2 Hydroxypropl Cyclodextrin , Drug Development and Industrial Pharmacy, 18(13), 1992, pp. 1477 1484.;;Hashimoto, H., Studies on the Industrial Production and Application of Cyclodextrins , Starch Science, vol. 36, No. 1 (1989), pp. 35 42.;;H. Matsuda, et al., Application of 2 Hydroxypropyl Cyclodextrin to Perfumes and Cosmetics , The 7th International Cyclodextrins Symposium, Tokyo, Japan, Apr. 25 28, 1994, pp. 516 519.;;Hashimoto, H., Application of Cyclodextrins to Foods, Toiletries and Other Products in Japan , Ensuiko Sugar Refining Co., Ltd., pp. 13 46, No date.;;U.S. application No. 08/736,469, Trinh et al., filed Oct. 24, 1996.;;U.S. application No. 08/736,093, Trinh et al., filed Oct. 24, 1996.;;U.S. application No. 08/889,607, Trinh et al., filed Jul. 8, 1997.;;U.S. application No. 08/736,471, Lucas et al., filed Oct. 24, 1996.;;U.S. application No. 08/736,470, Lucas et al., filed Oct. 24, 1996.;;U.S. application No. 08/738,964, Dodd et al., filed Oct. 24, 1996.;;U.S. application No. 08/736,838, Peterson et al., filed Oct. 28, 1996.;;U.S. application No. 08/739,091, Peterson et al., filed Oct. 28, 1996.;;U.S. application No. 08/871,854, Lucas et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,791, Dodd et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,855, Trinh et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,853, Lucas et al., filed Jun. 1997.;;U.S. application No. 08/871,857, Lucas et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,790, Peterson et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,856, Peterson et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,858, Lucas et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,577, Lucas et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,860, Lucas et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,861, Peterson et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,092, Peterson et al., filed Jun. 9, 1997.;;U.S. application No. 08/289,732, Trinh et al., filed Aug. 12, 1994.;;U.S. application No. 08/289,733, Trinh et al., filed Aug. 12, 1994.;;U.S. application No. 08/289,734, Cappel et al., filed Aug. 12, 1994.;;U.S. application No. 08/289,735, Cappel et al., filed Aug. 12, 1994.;;U.S. application No. 08/289,969, Pilsof et al., filed Aug. 12, 1994.;;U.S. application No. 08/871,576, Woo et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,119, Woo et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,042, Woo et al., filed Jun. 9, 1997.",EXPIRED
229,NO,D0,NO 996055 D0,171-698-002-607-26X,1999-12-08,1999,NO 996055 A,1999-12-08,US 87116697 A;;US 87179197 A;;US 9811812 W,1997-06-09,"Fremgangsmåte for å kontrollere omgivelseslukt på legemet, ved anvendelse av blandinger omfattende ikke-komplekserte cyklodekstriner og parfyme",,PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY,,https://lens.org/171-698-002-607-26X,Patent Application,no,0,0,17,18,0,A61K8/0208;;A61K8/738;;A61Q13/00;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61K8/738;;A61Q13/00;;A61K8/0208;;A61Q15/00,A61K8/02;;A61K8/00;;A61K8/18;;A61K8/25;;A61K8/27;;A61K8/34;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61Q13/00;;A61Q15/00;;C08L83/10,,0,0,,,,DISCONTINUED
230,CZ,A3,CZ 441399 A3,003-112-538-578-951,2000-05-17,2000,CZ 441399 A,1998-06-08,CZ 441399 A,1998-06-08,Preparation absorbing bad smells containing elementary cyclodextrins and perfumes,,PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY,,https://lens.org/003-112-538-578-951,Patent Application,no,0,0,1,1,0,,A61K8/02;;A61K8/73;;A61Q13/00;;A61Q15/00,,0,0,,,,PENDING
231,EP,A1,EP 2298296 A1,080-475-645-154-850,2011-03-23,2011,EP 09290643 A,2009-08-25,EP 09290643 A,2009-08-25,Composition and method for treating cognitive impairments in down syndrome subjects,"This application relates to compounds having inverse agonist functional selectivity for GABA A  receptors containing the α5 subunit for use as a medicament in the treatment of cognitive impairments in subjects suffering from Down syndrome. The present application also relates to the use of compounds having inverse agonist functional selectivity for GABA A  receptors containing the α5 subunit for the preparation of a medicament in the treatment of cognitive impairments in subjects suffering from Down syndrome. The application further relates to pharmaceutical compositions for treating cognitive impairments in subjects suffering from Down syndrome comprising a compounds having inverse agonist functional selectivity for GABA A  receptors containing the α5 subunit, or suitable pharmaceutically acceptable salt thereof, a polyethoxylated castor oil and dimethyl sulfoxide (DMSO). The present application also describes methods for enhancing cognitive function, or treating or lessening the severity of cognitive impairments, in subjects suffering from Down syndrome by administering to a subject in need thereof a pharmaceutically effective amount of one or more compounds having inverse agonist functional selectivity for GABA A  receptors containing the α5 subunit. More particularly, the present application is concerned with the treatment of cognitive impairments, such as impairment in memory, learning capacity or both, in subjects suffering from Down syndrome.",CENTRE NAT RECH SCIENT,POTIER MARIE-CLAUDE;;DODD ROBERT;;DELATOUR BENOIT;;BRAUDEAU JEROME;;HERAULT YANN,,https://lens.org/080-475-645-154-850,Patent Application,yes,5,9,9,9,0,A61K31/381;;A61K31/381;;A61K9/0019;;A61K9/0019;;A61K31/4162;;A61K31/4162;;A61K31/502;;A61K31/502;;A61K31/5517;;A61K31/5517;;A61P25/28,A61K31/381;;A61K31/4162;;A61K31/502;;A61K31/5517;;A61P25/28,,29,23,005-074-622-484-972;;046-511-954-625-540;;003-632-473-817-358;;051-751-371-773-377;;158-769-816-284-513;;040-603-513-769-741;;033-352-116-089-50X;;121-223-221-497-870;;005-074-622-484-972;;040-534-170-038-608;;046-511-954-625-540;;021-707-881-253-13X;;031-073-229-390-222;;030-795-134-474-798;;035-549-067-065-596;;007-364-858-655-289;;040-603-513-769-741;;033-352-116-089-50X;;046-511-954-625-540;;003-632-473-817-358;;142-315-311-170-556;;022-089-074-878-863;;030-795-134-474-798,18936916;;10.1007/s00213-008-1357-7;;10.1021/jm031076j.s001;;15084116;;10.1021/jm031076j;;15537339;;10.1021/jm040863t;;10.1021/jm040863t.s001;;11296070;;10.1001/archpedi.155.4.442;;7550346;;10.1038/ng1095-177;;15371516;;10.1523/jneurosci.1766-04.2004;;pmc6729789;;17322876;;10.1038/nn1860;;10.1038/321864a0;;3724846;;18936916;;10.1007/s00213-008-1357-7;;10.1016/j.neuropharm.2006.04.018;;17046030;;10.1021/jm031076j.s001;;15084116;;10.1021/jm031076j;;16326923;;10.1124/jpet.105.092320;;10.1016/j.neuropharm.2007.08.008;;17888460;;10.1016/j.mehy.2005.06.018;;16125326;;10.1016/j.neuron.2007.07.025;;pmc8055171;;17785178;;10.1002/jps.2600660104;;833720;;15371516;;10.1523/jneurosci.1766-04.2004;;pmc6729789;;17322876;;10.1038/nn1860;;10.1021/jm031076j.s001;;15084116;;10.1021/jm031076j;;15537339;;10.1021/jm040863t;;10.1021/jm040863t.s001;;20026436;;12097508;;pmc6758233;;10.1523/jneurosci.22-13-05572.2002;;16633803;;10.1007/s00213-006-0361-z;;10.1016/j.mehy.2005.06.018;;16125326,"THERESA M BALLARD ET AL: ""RO4938581, a novel cognitive enhancer acting at GABAA alpha-5 subunit-containing receptors"", PSYCHOPHARMACOLOGY, SPRINGER, BERLIN, DE, vol. 202, no. 1-3, 21 October 2008 (2008-10-21), pages 207 - 223, XP019702240, ISSN: 1432-2072;;F.STERNFELD, R.W.CARLING, R.A.JELLEY, T.LADDUWAHETTY, K.J.MERCHANT, K.W.MOORE, A.J.REEVE, L.J.STREET, D.O'CONNOR, AND M. MACLEOD: ""Selective, Orally Active gamma-Aminobutyric AcidA alpha-5 Receptor Inverse Agonists as Cognition Enhancers"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 47, 27 March 2004 (2004-03-27), pages 2176 - 2179, XP002550720;;M.CHAMBERS, J.ATACK, R.CARLING, N.COLLINSON, S.COOK, G.DAWSON, P.FERRIS, S.HOBBS, D.O'CONNOR, W.RYCROFT, AND A.MACLEOD: ""An Orally Bioavailable, Functionally Selective Inverse Agonist at the Benzodiazepine Site of GABA-A alpha-5 Receptors with Cognition Enhancing Properties"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 47, 16 October 2004 (2004-10-16), pages 5829 - 5832, XP002550721;;ARCHIVES OF PED AND ADOL MED, vol. 155, no. 4, April 2001 (2001-04-01), pages 442 - 448;;REEVES ET AL., NATURE GENETICS, vol. 11, no. 2, 1995, pages 177 - 84;;KLESCHEVNIKOV ET AL., THE JOURNAL OF NEUROSCIENCE, vol. 24, no. 37, 2004, pages 8153 - 8160;;F. FERNANDEZ ET AL.: ""Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome"", NATURE NEUROSCIENCE, ADVANCE ONLINE PUBLICATION, 25 February 2007 (2007-02-25);;NOGRADY: ""Medicinal Chemistry A Biochemical Aprroach"", 1985, OXFORD UNIVERSITY PRESS, pages: 388 - 392;;MCNAMARA; SKELTON, PSYCHOBIOLOGY, vol. 21, no. 2, 2002, pages 101 - 108;;VENAULT ET AL., NATURE, vol. 321, no. 6073, 1986, pages 864 - 866;;BALLARD ET AL., PSYCHOPHARMACOLOGY, vol. 202, 2009, pages 207 - 223;;ATACK ET AL., NEUROPHARMACOLOGY, vol. 51, 2006, pages 1023 - 1029;;STERNFELD ET AL., J. MED. CHEM., vol. 47, 2004, pages 2176 - 2179;;DAWSON ET AL., THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, vol. 316, no. 3, 2006, pages 1335 - 1345;;NUTT ET AL., NEUROPHARMACOLOGY, vol. 53, 2007, pages 810 - 820;;SCHMITT: ""Neuro-modulation, aminergic neuro-disinhibition and neuro- degeneration. Draft of a comprehensive theory for Alzheimer disease"", MED HYPOTHESES, vol. 65, no. 6, 2005, pages 1106 - 19;;PALOP ET AL.: ""Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease"", NEURON, vol. 55, no. 5, 6 September 2007 (2007-09-06), pages 697 - 711;;MCNAMARA; SKELTON, PSYCHOBIOLOGY, vol. 21, pages 101 - 108;;S. M. BERGE ET AL., J. PHARMACEUTICAL SCIENCES, vol. 66, 1977, pages 1 - 19;;""Remington's Pharmaceutical Sciences"", 1975, MACK PUBLISHING COMPANY;;KLESCHEVNIKOV, THE JOURNAL OF NEURSCIENCE, vol. 24, no. 37, 2004, pages 8153 - 8160;;F. FERNANDEZ ET AL.: ""Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome"", NATURE NEUROSCIENCE, 25 February 2007 (2007-02-25);;LOBAUGH NJ ET AL.: ""PAS/SPR meeting in San Francisco"", ARCHIVES OF PED AND ADOL MED, vol. 155, no. 4, 3 May 1999 (1999-05-03), pages 442 - 448;;STERNFELD; 2004 ET AL., J. MED. CHEM., vol. 47, pages 2176 - 2179;;DAWSON ET AL., THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTALTHERAPEUTICS, vol. 316, no. 3, 2006, pages 1335 - 1345;;CHAMBERS ET AL., J. MED. CHEM., vol. 47, 2004, pages 5829 - 5832;;COLLINSON ET AL., J. NEUROSCI., vol. 22, 2002, pages 5572 - 5580;;COLLINSON ET AL., PSYCHPHARMACOLOGY, vol. 188, 2006, pages 619 - 628;;SCHMITT ET AL.: ""Neuro-modulation, aminergic neuro-disinhibition and neuro- degeneration. Draft of a comprehensive theory for Alzheimer disease"", MED HYPOTHESES, vol. 65, no. 6, 2005, pages 1106 - 19",DISCONTINUED
232,US,A1,US 2018/0030294 A1,083-750-013-886-650,2018-02-01,2018,US 201615552832 A,2016-02-29,US 201615552832 A;;US 201562121898 P;;US 2016/0020073 W,2015-02-27,INK AND METHOD OF CONDUCTING AN EXAMINATION,"An ink and method of conducting an examination suitable for reducing the likelihood that the students' answers on paper-based examinations may be changed at a later time prior to being graded. The ink includes a solution of marking particles, a suspension material, and a preserving material. A mark made with the ink is initially erasable for a predetermined period of time after the mark is formed and after the expiration of the predetermined period of time the mark is not erasable. The method of conducting an examination includes providing an ink to an individual, and then providing questions to an individual wherein the individual indicates answers to the questions by producing marks with the ink.",PURDUE RESEARCH FOUNDATION,BOUDOURIS BRYAN WILLIAM;;DODD ROBERT RANDELL;;SARGENT JESSICA L;;ALCORACE EMILY,PURDUE RESEARCH FOUNDATION (2019-09-12),https://lens.org/083-750-013-886-650,Patent Application,yes,11,0,3,3,0,B43K8/04;;B43K8/06;;C09D11/17;;C09D11/17;;C09D11/16;;C09D11/20,C09D11/17,,0,0,,,,ACTIVE
233,US,A,US 5861147 A,143-752-797-557-524,1999-01-19,1999,US 87179197 A,1997-06-09,US 87179197 A,1997-06-09,Methods for controlling environmental odors on the body using compositions comprising uncomplexed cyclodextrins and perfume,"The present invention encompasses methods of controlling environmental malodors on skin comprising the application to the skin of a composition comprising from about 0.1% to about 5%, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from about 0.004% to about 2%, by weight of the composition, of a hydrophilic, volatile perfume composition comprising at least about 50% by weight of one or more hydrophilic, volatile perfume ingredients wherein each ingredient has a boiling point of about 260.degree. or lower, and a ClogP of less than about 3.5, and an aqueous carrier. The compositions can be applied directly as a spray, poured from a bottle and applied by hand, or applied via a wipe.",PROCTER & GAMBLE,DODD MICHAEL THOMAS;;TRINH TOAN;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE,PROCTER & GAMBLE COMPANY THE (1997-06-09),https://lens.org/143-752-797-557-524,Granted Patent,yes,54,18,1,18,0,A61K8/738;;A61K8/738;;A61K8/0208;;A61K8/0208;;A61Q13/00;;A61Q13/00;;A61Q15/00;;A61Q15/00,A61K8/02;;A61K8/73;;A61Q13/00;;A61Q15/00,424/65;;422/5;;424/67;;424/69;;424/76.1;;424/76.2;;424/76.21;;424/76.4;;424/76.8;;424/78.03;;424/405;;424/642;;424/715;;424/717,4,1,090-441-333-592-541,10.3109/03639049209040853,"Hashimoto, H., Studies on the Industrial Production and Application of Cyclodextrins , Starch Science, vol. 36, No. 1 (1989), pp. 35 42.;;H. Matsuda, et al., Application of 2 Hydroxypropyl Cyclodextrin to Perfumes and Cosmetics , The 7th International Cyclodextrins Symposium, Tokyo, Japan, Apr. 25 28, 1994, pp. 516 519.;;Hashimoto, H., Application of Cyclodextrins to Foods, Toiletries and Other Products in Japan , Ensuiko Sugar Refining Co., Ltd., pp. 13 46.;;T. Loftsson, et al. Interactions Between Preservatives and 2 Hydroxypropyl Cyclodextrin , Drug Development and Industrial Pharmacy, 18(13), 1992, pp. 1477 1484.",EXPIRED
234,TR,T2,TR 199903041 T2,038-565-793-601-663,2000-06-21,2000,TR 9903041 T,1998-06-08,US 87116697 A;;US 87179197 A,1997-06-09,Komplekslenmemis siklodekstrinler ve parfüm içeren bilesimler kullanilarak vücut üzerindeki çevre kokularinin kontrol edilmesi için yöntemler.,"Bu bulus, deri üzerinde kötü çevre kokularinin kontrol edilmesi için koku sogurucu bilesimlerin kullanimini kapsamaktadir, koku sogurucu bilesim, komplekslenmemis siklodekstrin, bir sulu tasiyici madde, hidrofilik uçucu parfüm ve istege göre bir yag fazi ve bir ya da daha çok sürfaktani içermektedir.",PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY,,https://lens.org/038-565-793-601-663,Patent Application,no,0,0,17,18,0,A61K8/0208;;A61K8/738;;A61Q13/00;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61K8/738;;A61Q13/00;;A61K8/0208;;A61Q15/00,A61K8/02;;A61K8/00;;A61K8/18;;A61K8/25;;A61K8/27;;A61K8/34;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61Q13/00;;A61Q15/00;;C08L83/10,,0,0,,,,PENDING
235,HU,A2,HU P0004525 A2,069-293-092-796-443,2001-06-28,2001,HU P0004525 A,1998-06-08,US 87116697 A;;US 87179197 A;;US 9811812 W,1997-06-09,METHODS FOR CONTROLLING ENVIRONMENTAL ODORS ON THE BODY USING COMPOSITIONS COMPRISING UNCOMPLEXED CYCLODEXTRINS AND PERFUME,"A találmány tárgya olyan, a bőrön lévő környezeti szagokabszorbeálására alkalmas készítmények alkalmazása, amelyek 0,5-5 t%nem komplex ciklodextrint, egy vizes hordozót, 0,004-2 t% hidrofilparfümöt és, adott esetben, 0,1-36 t% olajfázist és egy vagy többfelületaktív anyagot tartalmaznak. A találmány szerinti készítmények abőrre vagy a hajra alkalmazhatók közvetlenül spray formában, önthetőkpalackból, alkalmazhatók kézzel vagy a készítménnyel előre átitatottés az alkalmazáskor nedves törlővel. A találmány tárgyát képezi aflexibilis szétosztó eszközbe csomagolt találmány szerintikészítmények előállítási eljárása is. Ó",PROCTER & GAMBLE,BARTOLO ROBERT GREGORY;;DODD MICHAEL THOMAS;;LUCAS JULIET MARIE;;TRINH TOAN,,https://lens.org/069-293-092-796-443,Patent Application,no,0,0,17,18,0,A61K8/0208;;A61K8/738;;A61Q13/00;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61K8/738;;A61Q13/00;;A61K8/0208;;A61Q15/00,A61K8/02;;A61K8/00;;A61K8/18;;A61K8/25;;A61K8/27;;A61K8/34;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61Q13/00;;A61Q15/00;;C08L83/10,,0,0,,,,PENDING
236,US,A1,US 2012/0283248 A1,161-569-763-356-844,2012-11-08,2012,US 201013392044 A,2010-08-24,US 201013392044 A;;EP 09290643 A;;US 23662509 P;;IB 2010053796 W,2009-08-25,COMPOSITION AND METHOD FOR TREATING COGNITIVE IMPAIRMENTS IN DOWN SYNDROM SUBJECTS,"Compounds having inverse agonist functional selectivity for GABA A receptors containing the α5 subunit for use as a medicament in the treatment of cognitive impairments in subjects suffering from Down syndrome. The use of these compounds is disclosed. Pharmaceutical compositions for such treatment can comprise these compounds or suitable pharmaceutically acceptable salt thereof, a polyethoxylated castor oil and dimethyl sulfoxide (DMSO). Methods are disclosed for enhancing cognitive function, or treating or lessening the severity of cognitive impairments, in subjects suffering from Down syndrome by administering to a subject in need thereof a pharmaceutically effective amount of one or more of these compounds.",POTIER MARIE-CLAUDE;;DODD ROBERT;;DELATOUR BENOIT;;BRAUDEAU JEROME;;HERAULT YANN;;CENTRE NAT RECH SCIENT,POTIER MARIE-CLAUDE;;DODD ROBERT;;DELATOUR BENOIT;;BRAUDEAU JEROME;;HERAULT YANN,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS (2012-05-02),https://lens.org/161-569-763-356-844,Patent Application,yes,2,2,9,9,0,A61K31/381;;A61K31/381;;A61K9/0019;;A61K9/0019;;A61K31/4162;;A61K31/4162;;A61K31/502;;A61K31/502;;A61K31/5517;;A61K31/5517;;A61P25/28,A61K31/551;;A61K31/427;;A61K31/5025;;A61P25/28;;C07D417/04;;C07D487/04;;C07D487/14,514/219;;544/234;;548/204;;540/494;;540/555;;514/248;;514/365,0,0,,,,ACTIVE
237,CO,A1,CO 4940387 A1,185-235-412-977-260,2000-07-24,2000,CO 98032877 A,1998-06-09,US 87116697 A;;US 87179197 A,1997-06-09,METODOS PARA CONTROLAR OLORES AMBIENTALES EN EL CUERPO USAN- DO COMPOSICIONES QUE CONTIENEN CICLODEXTRINA NO COMPLEXADA Y PERFUME,"La presente invención se relaciona con una composición paracontrolar malos olores ambientales sobre la piel, dicha composición comprende: a) desde 0.1% hasta 5% en peso de la composición de ciclodextrina no complexada, soluble en agua, solubilizada; b) un portador acuoso; c) desde O.1% hasta 36% en peso de la composición de una fase de aceite seleccionada del grupo consistente de emolientes, humectantes y protectores para la piel; d) uno o más surfactantes; y e) desde O.OO4% hasta 2% en peso de la composición de una composición de perfume volátil hidrofila, con un ingrediente activo para controlar malos olores ambientales sobre la piel por medio de aplicar la composición a la piel.",PROCTER & GAMBLE,LUCAS JULIET MARIE;;TOAN TRINH;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY,,https://lens.org/185-235-412-977-260,Patent Application,no,0,0,17,18,0,A61K8/0208;;A61K8/738;;A61Q13/00;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61K8/738;;A61Q13/00;;A61K8/0208;;A61Q15/00,A61K8/00;;A61K8/02;;A61K8/18;;A61K8/25;;A61K8/27;;A61K8/34;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61Q13/00;;A61Q15/00;;C08L83/10,,0,0,,,,PENDING
238,NO,L,NO 996055 L,180-472-933-259-86X,2000-02-04,2000,NO 996055 A,1999-12-08,US 87116697 A;;US 87179197 A;;US 9811812 W,1997-06-09,"Fremgangsmåte for å kontrollere omgivelseslukt på legemet, ved anvendelse av blandinger omfattende ikke-komplekserte cyklodekstriner og parfyme","Foreliggende oppfinnelse omfatter bruken av lukt- absorberende blandinger for å kontrollere omgivende, dårlig lukt på huden hvor den luktabsorberende blandingen omfatter ikke-komplekst syklodekstrin, en vandig bærer, hydrofil, flyktig parfyme, og valgfritt en oljefase og et eller flere overflateaktive stoffer.",PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY,,https://lens.org/180-472-933-259-86X,Abstract,no,0,0,17,18,0,A61K8/0208;;A61K8/738;;A61Q13/00;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61K8/738;;A61Q13/00;;A61K8/0208;;A61Q15/00,A61K8/02;;A61K8/00;;A61K8/18;;A61K8/25;;A61K8/27;;A61K8/34;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61Q13/00;;A61Q15/00;;C08L83/10,,0,0,,,,DISCONTINUED
239,WO,A1,WO 2016/138521 A1,195-704-601-097-459,2016-09-01,2016,US 2016/0020073 W,2016-02-29,US 201562121898 P,2015-02-27,INK AND METHOD OF CONDUCTING AN EXAMINATION,"An ink and method of conducting an examination suitable for reducing the likelihood that the students' answers on paper-based examinations may be changed at a later time prior to being graded. The ink includes a solution of marking particles, a suspension material, and a preserving material. A mark made with the ink is initially erasable for a predetermined period of time after the mark is formed and after the expiration of the predetermined period of time the mark is not erasable. The method of conducting an examination includes providing an ink to an individual, and then providing questions to an individual wherein the individual indicates answers to the questions by producing marks with the ink.",PURDUE RESEARCH FOUNDATION,BOUDOURIS BRYAN WILLIAM;;DODD ROBERT RANDELL;;SARGENT JESSICA L;;ALCORACE EMILY,,https://lens.org/195-704-601-097-459,Patent Application,yes,5,0,3,3,0,B43K8/04;;B43K8/06;;C09D11/17;;C09D11/17;;C09D11/16;;C09D11/20,C09D11/16;;B43K8/04;;C09D11/18;;C09D11/20,,0,0,,,,PENDING
240,US,B1,US 7825933 B1,034-419-000-679-436,2010-11-02,2010,US 36178906 A,2006-02-24,US 36178906 A,2006-02-24,Managing primitive program vertex attributes as per-attribute arrays,"Systems and methods for compiling high-level primitive programs are used to generate primitive program micro-code for execution by a primitive processor. A compiler is configured to produce micro-code for a specific target primitive processor based on the target primitive processor's capabilities. The compiler supports features of the high-level primitive program by providing conversions for different applications programming interface conventions, determining output primitive types, initializing attribute arrays based on primitive input profile modifiers, and determining vertex set lengths from specified primitive input types.",NVIDIA CORP,KILGARD MARK J;;EVERITT CASS W;;DODD CHRISTOPHER T;;GLANVILLE ROBERT STEVEN,NVIDIA CORPORATION (2006-02-23),https://lens.org/034-419-000-679-436,Granted Patent,yes,19,9,1,1,0,G06F8/447;;G06T15/005;;G06T15/005;;G06F8/447,G06T15/00,345/522;;345/440,7,2,062-305-667-671-045;;170-122-876-842-465,10.1145/383259.383275;;10.1145/1198555.1198567,"Barenburg, et al. System for Adaptive Resampling in Texture Mapping, (WO 2005/010826 A1) Feb. 3, 2005.;;Randi J. Rost, ""OpenGL Shading Language"", second edition, 25, Jan. 2006, Addison Wesley Professional.;;Kilgard, et al. ""A System for Programming Graphics Hardware in a C-like Language"", University of Texas at Austin and NVIDIA Corp., 2003.;;""OpenGL Performer Programmer's Guide"", Techpubs library, Dec. 7, 2007.;;Kekoa, et al. ""A Real-Time Procedural Shading Program for Programmable Graphics Hardware,"" ACM SIGGRAPH, Aug. 2001.;;Shreiner, et al. ""An Interactive Introduction to Open GL Programming"", SIGGRAPH, 2002, (SIGGRAPH.pdf).;;John Douglas Owens, ""Computer Graphics on Stream Architecture"", Nov. 2002, (Owens 2003.pdf).",ACTIVE
241,AU,A,AU 1992/013423 A,051-164-083-765-675,1992-08-27,1992,AU 1992/013423 A,1992-01-24,US 64579691 A,1991-01-25,RUST PREVENTIVE MATERIAL AND METHOD OF APPLICATION,,INT LEAD ZINC RES,CARR DODD S;;POWERS RODNEY G;;LANGLEY ROBERT M;;LASA IVAN R,,https://lens.org/051-164-083-765-675,Patent Application,no,0,0,3,3,0,C23F13/06,C23F13/06,,0,0,,,,PENDING
242,DE,D1,DE 60208435 D1,080-449-177-389-624,2006-02-02,2006,DE 60208435 T,2002-10-30,US 292001 A;;US 0234770 W,2001-11-15,RASIERER UND RASIERKASSETTEN,,GILLETTE CO,BRANDT KLAUS;;DAVIS M;;DODD T;;PARENT ROBERT;;SZCZEPANOWSKI ANDREW;;WOODNORTH J,,https://lens.org/080-449-177-389-624,Granted Patent,no,0,0,26,26,0,B26B21/40;;B26B21/4025;;B26B21/4087;;B26B21/48;;B26B21/4087;;B26B21/40;;B26B21/48;;B26B21/4025,B26B21/40;;B26B21/48;;B26B21/52,,0,0,,,,EXPIRED
243,US,A1,US 2010/0127425 A1,100-339-844-478-775,2010-05-27,2010,US 68364110 A,2010-01-07,US 68364110 A;;US 22700905 A;;US 45205903 A,2003-06-02,"Process of and Apparatus for Making a Shingle, and Shingle Made Thereby","A process and apparatus for making a shingle, together with the shingle made thereby, is provided, in which one or more thermoplastic materials are extruded or co-extruded to form an extrudate, with the extrudate being cut into a preliminary shingle shape, which is allowed to dissipate heat, and then is delivered to a compression mold, wherein the preliminary shingle shape is compression molded to substantially its final dimensions and is then discharged from the mold and allowed to cool.",CERTAIN TEED CORP,MACKINNON THOMAS KEVIN;;DODD ROBERT E;;KIM JOONG YOUN;;WYLIE DOUGLAS H,,https://lens.org/100-339-844-478-775,Patent Application,yes,39,2,6,15,0,B32B27/12;;B32B27/12;;B32B27/20;;B32B27/20;;E04D1/20;;E04D1/20;;Y10T428/24355;;Y10T428/24355,B28B5/04;;B32B27/12;;B32B27/20;;E04D1/20,264/297.5,0,0,,,,EXPIRED
244,DE,T2,DE 60208435 T2,070-641-636-706-439,2006-08-24,2006,DE 60208435 T,2002-10-30,US 292001 A;;US 0234770 W,2001-11-15,RASIERER UND RASIERKASSETTEN,,GILLETTE CO,BRANDT KLAUS;;DAVIS M;;DODD T;;PARENT ROBERT;;SZCZEPANOWSKI ANDREW;;WOODNORTH J,,https://lens.org/070-641-636-706-439,Granted Patent,no,0,2,26,26,0,B26B21/40;;B26B21/4025;;B26B21/4087;;B26B21/48;;B26B21/4087;;B26B21/40;;B26B21/48;;B26B21/4025,B26B21/40;;B26B21/48;;B26B21/52,,0,0,,,,EXPIRED
245,CA,C,CA 2509735 C,115-617-367-791-241,2012-09-25,2012,CA 2509735 A,2005-06-09,EP 04253487 A,2004-06-11,DETERGENT ADDITIVES FOR LUBRICATING OIL COMPOSITIONS,"Use as a detergent in a lubricating oil composition of an oil-soluble hydrocarbyl phenol aldehyde condensate having the following structure: (see above formula) wherein n is 0 to 10, preferably 1 to 8, more preferably 2 to 6, and most preferably 3 to 5; Y is a divalent bridging group, and is preferably a hydrocarbyl group, preferably having from 1 to 4 carbon atoms; and R is a hydrocarbyl group having from 4 to 30, preferably 8 to 18, and most preferably 9 to 15 carbon atoms. The oil-soluble hydrocarbyl phenol aldehyde condensate has a weight average molecular weight (Mw) of 1250 to 1680, as measured by MALDI-TOF (Matrix Assisted Laser Desorption Ionization- Time of Flight) mass spectrometry.",INFINEUM INT LTD,SHAW ROBERT WILLIAM;;CHUNG SIMON SIU MING;;DODD JAMES CHRISTIAN;;FELLOWS RAYMOND,,https://lens.org/115-617-367-791-241,Granted Patent,no,0,0,13,16,0,C10M163/00;;C10M165/00;;C10M2207/024;;C10M2207/028;;C10M2219/089;;C10N2030/52;;C10N2040/25;;C10M165/00;;C10M2207/028;;C10M2207/024;;C10M2219/089;;C10M163/00;;C10N2030/52;;C10N2040/25,C10L1/18;;C10M129/14;;C10M129/10;;C10M129/24;;C10M129/91;;C10M145/20;;C10M159/12;;C10M163/00;;C10M165/00;;C10M177/00;;C10N20/04;;C10N30/04;;C10N40/25;;C10N70/00,,0,0,,,,INACTIVE
246,JP,A,JP 2005350676 A,167-015-301-216-584,2005-12-22,2005,JP 2005171257 A,2005-06-10,EP 04253487 A,2004-06-11,CLEANING ADDITIVE FOR LUBRICATION OIL COMPOSITION,"<P>PROBLEM TO BE SOLVED: To provide a new cleaning additive that is free from sulfur and metals(mineral content in other words). <P>SOLUTION: As a cleaning agent in a lubricant oil composition are, is used an oil soluble hydrocarbyl phenol aldehyde condensate having a structure of the formula (wherein n is 0 to 10, Y is a divalent crosslinking group and the R is a 4 to 30 C hydrocarbyl). The weight average molecular weight (Mw) of this oil-soluble hydrocarbyl phenol-aldehyde condensate is 1250 to 1680 that is measured according to the MARDI-TOF (Matrix Assisted Laser Desorption Ionization-Time of Flight) mass analysis. <P>COPYRIGHT: (C)2006,JPO&NCIPI",INFINEUM INT LTD,SHAW ROBERT WILLIAM;;CHUNG SIMON SIU MING;;DODD JAMES CHRISTIAN;;FELLOWS RAY,,https://lens.org/167-015-301-216-584,Patent Application,no,2,3,13,16,0,C10M163/00;;C10M165/00;;C10M2207/024;;C10M2207/028;;C10M2219/089;;C10N2030/52;;C10N2040/25;;C10M165/00;;C10M2207/028;;C10M2207/024;;C10M2219/089;;C10M163/00;;C10N2030/52;;C10N2040/25,C10L1/18;;C10M129/10;;C10M129/24;;C10M129/91;;C10M145/20;;C10M159/12;;C10M163/00;;C10M165/00;;C10M177/00;;C10N20/04;;C10M129/14;;C10N30/04;;C10N40/25;;C10N70/00,,0,0,,,,INACTIVE
247,WO,A1,WO 1992/013116 A1,028-305-367-615-233,1992-08-06,1992,US 9200624 W,1992-01-24,US 64579691 A,1991-01-25,RUST PREVENTIVE MATERIAL AND METHOD OF APPLICATION,"Perforated sheets (13) of rolled zinc, held against steel reinforced concrete highway piers (11) in seawater intertidal zones (30), provide sacrificial cathodic protection to the embedded steel (12). Unique grooved, recycled plastic/wood composite extrusions (14) press the perforated zinc sheets firmly against the four faces of the concrete piers by means of durable stainless steel binding strips (16).",INT LEAD ZINC RES,CARR DODD S;;POWERS RODNEY G;;LANGLEY ROBERT M;;LASA IVAN R,,https://lens.org/028-305-367-615-233,Patent Application,yes,10,3,3,3,0,C23F13/06,C23F13/06,,2,0,,,"APOSTOLOS et al., STATE OF CALIFORNIA DEPARTMENT OF TRANSPORTATION REPORT, ""Development Testing & Field Application of Metallized Cathodic Protection Coatings on Reinforced Concrete Substructures"", pages 28-41.;;WHITING et al., NATIONAL COOPERATIVE HIGHWAY RESEARCH PROGRAM REPORT 234, ""Gelvanic Cathodic Protection for Reinforced Concrete Bridge Decks"", June 1981, pages 1-63.",PENDING
248,SG,A1,SG 135057 A1,044-432-178-334-004,2007-09-28,2007,SG 2006009443 A,2005-06-10,EP 04253487 A,2004-06-11,DETERGENT ADDITIVES FOR LUBRICATING OIL COMPOSITIONS,,INFINEUM INT LTD,SHAW ROBERT WILLIAM;;CHUNG SIMON SIU MING;;DODD JAMES CHRISTIAN;;FELLOWS RAYMOND,,https://lens.org/044-432-178-334-004,Patent Application,no,0,0,13,16,0,C10M163/00;;C10M165/00;;C10M2207/024;;C10M2207/028;;C10M2219/089;;C10N2030/52;;C10N2040/25;;C10M165/00;;C10M2207/028;;C10M2207/024;;C10M2219/089;;C10M163/00;;C10N2030/52;;C10N2040/25,C10M129/14;;C10L1/18;;C10M129/10;;C10M129/24;;C10M129/91;;C10M145/20;;C10M159/12;;C10M163/00;;C10M165/00;;C10M177/00;;C10N20/04;;C10N30/04;;C10N40/25;;C10N70/00,,0,0,,,,PENDING
249,US,A,US 5011662 A,042-848-822-328-390,1991-04-30,1991,US 7014587 A,1987-07-02,US 7014587 A;;GB 8306055 A;;US 58539484 A,1983-03-04,Dissolution testing machine,"A dissolution testing machine has a container for a liquid and a holder for pellets, a support for supporting the holder within the container and a drive enabling the holder to be reciprocated via its support so that solvent flushes into and out of the holder. The holder may be a mesh tube, or a solid walled tube, closed at both ends by an apertured member. A set of containers may receive the holder successively, each container containing a solvent of the same or different characteristics.",NOORMOHAMMADI AKBAR;;DODD ROBERT E;;BECKETT ARNOLD H;;GEEVES GRAHAME K J,NOORMOHAMMADI AKBAR;;DODD ROBERT E;;BECKETT ARNOLD H;;GEEVES GRAHAME K J,,https://lens.org/042-848-822-328-390,Granted Patent,yes,17,22,1,12,0,G01N13/00;;G01N33/15;;G01N2013/006;;B01F21/221;;B01F21/00;;B01F31/24;;B01F2101/23;;G01N33/15;;G01N13/00;;G01N2013/006;;B01F21/00;;B01F21/221;;B01F31/24;;B01F2101/23,B01F1/00;;B01F11/00;;G01N13/00;;G01N33/15,422/68.1;;73/432.1;;134/135;;134/137;;134/157;;366/240;;366/256;;366/332;;422/64;;422/65,0,0,,,,EXPIRED
250,US,A1,US 2012/0232946 A1,087-046-779-243-452,2012-09-13,2012,US 201213412060 A,2012-03-05,US 201213412060 A;;US 201161450455 P,2011-03-08,Methods and Systems for a Multi-Party Customizable Calendar,"A method and system for a real time multi-person scheduling system for creating and tracking the availability of persons, places, or things which may be required for an appointment. The scheduling system where an appointment can be created and tracked in real time and the system is configured to allow for remote access and amendments to an appointment through data transmission protocols. The scheduling system further providing for the tracking of persons, places, or things, such that parties to the appointment may track their hours and pay an attendee of an appointment or bill a client for the time expended.",COCANOUGHER CHARLES DANIEL;;COCANOUGHER ROBERT ALLEN;;CHAMBERS STEPHEN FORD;;DODD BRADLEY ALLEN,COCANOUGHER CHARLES DANIEL;;COCANOUGHER ROBERT ALLEN;;CHAMBERS STEPHEN FORD;;DODD BRADLEY ALLEN,365 SCHEDULE LTD (2012-04-26),https://lens.org/087-046-779-243-452,Patent Application,yes,13,14,1,1,0,G06Q10/109;;G06Q10/109,G06Q10/10,705/7.19,1,0,,,"""Skeds website Au 2009"" (selected pages from the skeds.com website between 8/06/2009 and 8/31/2009",DISCONTINUED
251,US,B2,US 7785510 B2,178-899-791-076-726,2010-08-31,2010,US 22700905 A,2005-09-15,US 22700905 A;;US 45205903 A,2003-06-02,"Process of and apparatus for making a shingle, and shingle made thereby","A process and apparatus for making a shingle, together with the shingle made thereby, is provided, in which one or more thermoplastic materials are extruded or co-extruded to form an extrudate, with the extrudate being cut into a preliminary shingle shape, which is allowed to dissipate heat, and then is delivered to a compression mold, wherein the preliminary shingle shape is compression molded to substantially its final dimensions and is then discharged from the mold and allowed to cool.",CERTAIN TEED CORP,MACKINNON THOMAS KEVIN;;DODD ROBERT E;;KIM JOONG YOUN;;WYLIE DOUGLAS H,CERTAINTEED CORPORATION (2005-08-10),https://lens.org/178-899-791-076-726,Granted Patent,yes,32,12,6,15,0,B32B27/12;;B32B27/12;;B32B27/20;;B32B27/20;;E04D1/20;;E04D1/20;;Y10T428/24355;;Y10T428/24355,B29C47/00;;B29C45/73;;B29C47/06;;B32B27/12;;B32B27/20;;D01D5/12;;E04D1/20,264/148;;264/151;;264/160;;264/173.15;;264/173.16;;264/177.17;;264/210.2;;264/210.5;;264/211.12;;264/294;;264/297.5;;264/320;;264/327,0,0,,,,INACTIVE
252,WO,A1,WO 2012/059568 A1,043-201-440-617-823,2012-05-10,2012,EP 2011069385 W,2011-11-04,FR 1059156 A,2010-11-05,"NOVEL WATER-SOLUBLE INDOLOBENZAZEPINE MOLECULES DEMONSTRATING ANTIMITOTIC, ANTIVASCULAR, AND ANTITUMOR ACTIVITIES IN VIVO","The present patent application relates to indolobenzazepine derivatives having an antitumor activity, to the synthesis thereof, and to the use thereof. In particular, the present patent application relates to the stereocontrolled synthesis of C5-substituted indolobenzazepinones enabling only one of the two possible C5 isomers to be obtained, as well as water-soluble analogs making it possible to demonstrate the very high effectiveness of said molecules in reducing the size of tumors in vivo .",CENTRE NAT RECH SCIENT;;DODD ROBERT;;BAKALA JOANNA;;LIU JIANMIAO;;BIGNON JEROME;;PONS VALERIE;;BEAUMONT STEPHANE,DODD ROBERT;;BAKALA JOANNA;;LIU JIANMIAO;;BIGNON JEROME;;PONS VALERIE;;BEAUMONT STEPHANE,,https://lens.org/043-201-440-617-823,Patent Application,yes,0,0,2,2,0,A61P35/00;;C07D487/04;;C07F9/6561,C07D487/04;;A61K31/55;;A61K31/661;;A61P35/00;;C07F9/6561,,25,19,074-272-709-032-581;;076-806-375-838-273;;077-295-491-167-117;;018-057-544-697-186;;116-588-718-564-582;;081-499-776-547-120;;110-627-034-802-835;;062-680-494-492-667;;050-819-521-791-08X;;010-462-726-429-383;;034-478-367-075-807;;148-953-524-448-982;;019-019-914-754-133;;111-487-862-838-213;;015-255-592-779-184;;001-736-794-972-707;;023-271-933-937-663;;074-272-709-032-581;;086-179-079-459-642,18503262;;10.1021/jm701466p;;19743863;;10.1021/jm900476c;;10.1002/0471220574;;10.1002/prot.10465;;12910460;;11848977;;10.1021/cr9800199;;9443934;;10.1124/mol.53.1.77;;14704692;;10.1038/nbt0104-15;;10.1051/medsci/200218121227;;14593726;;560248;;10.1016/s0300-9084(98)80004-7;;9615861;;10.1038/nrc1628;;15928673;;10466764;;12499266;;10.1016/s0360-3016(02)03922-6;;12459377;;9157969;;10.1007/bf00046365;;2292139;;18503262;;10.1021/jm701466p;;10.1248/cpb.36.2248,"LAURENT KELLER ET AL: ""New C5-alkylated indolobenzazepinones acting as inhibitors of tubulin polymerization: cytotoxic and antitumor activities"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 51, no. 12, 2008, pages 3414 - 3421, XP002629763;;AURÉLIEN PUTEY ET AL: ""Indolobenzazepin-7-ones and 6-, 8-, and 9-membered ring derivatives as tubulin polymerization inhibitors: synthesis and structure-activity relationship studies"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 52, no. 19, 2009, pages 5916 - 5925, XP002629764;;GREENE: ""Protective Groups in Organic Synthesis"", 2007, WILEY;;HARRISON ET AL.: ""Compendium of Synthetic Organic Methods"", vol. 1-8, 1971, J. WILEY & SONS;;PAUL LLOYD-WILLIAMS, FERNANDO ALBERICIO, ERNEST GIRALT: ""Chemical Approaches to the Synthesis of Peptides and Proteins"", 1997, CRC PRESS;;HOUBEN-WEYL: ""Methods of Organic Chemistry, Synthesis of Peptides and Peptidomimetics"", vol. E 22A,, 2002, GEORG THIEME VERLAG;;VERDONK ET AL., PROTEINS, vol. 52, 2003, pages 609 - 623;;RAJSKI, S. R., WILLIAMS, R. M., CHEM. REV., vol. 98, 1998, pages 2723 - 2795;;BAILLY, C., COLSON P. ET AL., MOL. PHARMACOL., vol. 53, 1998, pages 77 - 87;;THYSS, A., PIVOT, X.: ""Traitements médicaux des cancers"", 1998, MASSON, pages: 96 - 113;;BECKER, J, NATURE BIOTECHNOLOGY, vol. 22, 2004, pages 15 - 18;;JORDAN, M. A., WILSON, L., NATURE REV. CANCER, vol. 4, 2004, pages 253 - 266;;ARNAL, I., SASSOON, I., TOURNEBIZE, R., MED SCI. (PARIS, vol. 18, 2002, pages 1227 - 1235;;HADFIELD, J. A., DUCKI, S., HIRST, N., MCGOWAN, A. T., PROG. CELL CYCLE RES., vol. 5, 2003, pages 309 - 325;;BAUDOIN, O., GUÉRITTE, F.: ""Studies in Natural Product Chemistry, Vol. 29, Bioactive Natural Products (Part J"", vol. 29, 2003, ELSEVIER;;WANG, R. W.-J., REBHUN, L. I., KUPCHAN, S. M., CANCER RES., vol. 37, 1977, pages 3071 - 3079;;IMBERT, T. F., BIOCHIMIE, vol. 80, 1998, pages 207 - 222;;TOZER, G. M., KANTHOU, C., BAGULEY, B. C., NAT. REV. CANCER, vol. 5, 2005, pages 423 - 435;;CHAPLIN, D. J., DOUGHERTY, G., J. BR. J CANCER, vol. 80, no. 1, 1999, pages 57 - 64;;DAVIS, P. D., DOUGHERTY, G. J. ET AL., CANCER RES., vol. 62, 2002, pages 7247 - 7253;;BLAKEY, D. C., ASHTON, S. E., WESTWOOD, F. R., WALKER, M., RYAN, A., J INT. J. RADIAT. ONCOL. BIOL. PHYS., vol. 54, 2002, pages 1497 - 1502;;DARK, G. G., HILL, S. A. ET AL., CANCER RES., vol. 57, 1997, pages 1829 - 1834;;DENEKAMP, J., CANCER METASTASIS REV., vol. 9, 1990, pages 267 - 282;;L. KELLER, S. BEAUMONT, J.-M. LIU, S. THORET, J. S. BIGNON, J. WDZIECZAK-BAKALA, P. DAUBAN, R. H. DODD, J MED CHEM., vol. 51, 2008, pages 3414 - 3421;;SAKAMOTO T., NAGANO T., KONDO Y., YAMANAKA H., CHEM. PHARM. BULL., vol. 36, 1988, pages 2248 - 2252",PENDING
253,US,A1,US 2006/0029775 A1,050-662-104-676-432,2006-02-09,2006,US 22700905 A,2005-09-15,US 22700905 A;;US 45205903 A,2003-06-02,"Process of and apparatus for making a shingle, and shingle made thereby","A process and apparatus for making a shingle, together with the shingle made thereby, is provided, in which one or more thermoplastic materials are extruded or co-extruded to form an extrudate, with the extrudate being cut into a preliminary shingle shape, which is allowed to dissipate heat, and then is delivered to a compression mold, wherein the preliminary shingle shape is compression molded to substantially its final dimensions and is then discharged from the mold and allowed to cool.",MACKINNON THOMAS KEVIN;;DODD ROBERT E;;KIM JOONG Y;;WYLIE DOUGLAS H,MACKINNON THOMAS KEVIN;;DODD ROBERT E;;KIM JOONG Y;;WYLIE DOUGLAS H,CERTAINTEED CORPORATION (2005-08-10),https://lens.org/050-662-104-676-432,Patent Application,yes,32,68,6,15,0,B32B27/12;;B32B27/12;;B32B27/20;;B32B27/20;;E04D1/20;;E04D1/20;;Y10T428/24355;;Y10T428/24355,E04D1/00;;B32B27/12;;B32B27/20;;E04D1/20,428/141;;264/210.2;;264/320;;425/131.1;;425/308,0,0,,,,EXPIRED
254,US,A1,US 2005/0277559 A1,170-804-342-507-521,2005-12-15,2005,US 14946905 A,2005-06-09,EP 04253487 A,2004-06-11,Detergent additives for lubricating oil compositions,"An oil-soluble hydrocarbyl phenol aldehyde condensate having the following structure: wherein n is 0 to 10, preferably 1 to 8, more preferably 2 to 6, and most preferably 3 to 5; Y is a divalent bridging group, and is preferably a hydrocarbyl group, preferably having from 1 to 4 carbon atoms; and R is a hydrocarbyl group having from 4 to 30, preferably 8 to 18, and most preferably 9 to 15 carbon atoms. The oil-soluble hydrocarbyl phenol aldehyde condensate has a weight average molecular weight (Mw) of 1250 to 1680, as measured by MALDI-TOF (Matrix Assisted Laser Desorption Ionization-Time of Flight) mass spectrometry.",SHAW ROBERT W;;CHUNG SIMON S M;;DODD JAMES C;;FELLOWS RAYMOND,SHAW ROBERT W;;CHUNG SIMON S M;;DODD JAMES C;;FELLOWS RAYMOND,INFINEUM INTERNATIONAL LIMITED (2005-07-22),https://lens.org/170-804-342-507-521,Patent Application,yes,6,12,13,16,0,C10M163/00;;C10M165/00;;C10M2207/024;;C10M2207/028;;C10M2219/089;;C10N2030/52;;C10N2040/25;;C10M165/00;;C10M2207/028;;C10M2207/024;;C10M2219/089;;C10M163/00;;C10N2030/52;;C10N2040/25,C10L1/18;;C10M129/10;;C10M129/14;;C10M129/24;;C10M129/91;;C10M145/20;;C10M159/12;;C10M163/00;;C10M165/00;;C10M177/00;;C10N20/04;;C10N30/04;;C10N40/25;;C10N70/00,508/585,0,0,,,,INACTIVE
255,JP,A,JP 2006117951 A,090-014-903-621-433,2006-05-11,2006,JP 2005357693 A,2005-12-12,EP 04253487 A,2004-06-11,LUBRICATING OIL COMPOSITIONS,"<P>PROBLEM TO BE SOLVED: To obtain a lubricating oil composition of an oil-soluble hydrocarbyl phenol aldehyde condensate as a detergent. <P>SOLUTION: This lubricating oil composition comprising a major amount of an oil of lubricating viscosity and a detergent composition comprising (A) an overbased metal salt of an organic acid and (B) an oil-soluble hydrocarbyl phenol aldehyde condensate having the structure of formula (1): wherein (n) is 0 to 10, preferably 1 to 8, more preferably 2 to 6, and most preferably 3 to 5; Y is a divalent bridging group, and is preferably a hydrocarbyl group, preferably having from 1 to 4 carbon atoms; and R is a hydrocarbyl group having from 4 to 30, preferably 8 to 18, and most preferably 9 to 15 carbon atoms. <P>COPYRIGHT: (C)2006,JPO&NCIPI",INFINEUM INT LTD,SHAW ROBERT WILLIAM;;CHUNG SIMON SIU MING;;DODD JAMES CHRISTIAN;;FELLOWS RAY,,https://lens.org/090-014-903-621-433,Patent Application,no,2,3,13,16,0,C10M163/00;;C10M165/00;;C10M2207/024;;C10M2207/028;;C10M2219/089;;C10N2030/52;;C10N2040/25;;C10M165/00;;C10M2207/028;;C10M2207/024;;C10M2219/089;;C10M163/00;;C10N2030/52;;C10N2040/25,C10M129/14;;C10L1/18;;C10M169/04;;C10M129/10;;C10M129/24;;C10M129/91;;C10M145/20;;C10M159/12;;C10M159/20;;C10M159/22;;C10M159/24;;C10M163/00;;C10M165/00;;C10M177/00;;C10N10/02;;C10N10/04;;C10N20/04;;C10N30/04;;C10N40/25;;C10N70/00,,0,0,,,,DISCONTINUED
256,US,B2,US 7851421 B2,105-616-255-680-320,2010-12-14,2010,US 14946905 A,2005-06-09,EP 04253487 A,2004-06-11,Detergent additives for lubricating oil compositions,"An oil-soluble hydrocarbyl phenol aldehyde condensate having the following structure: wherein n is 0 to 10, preferably 1 to 8, more preferably 2 to 6, and most preferably 3 to 5; Y is a divalent bridging group, and is preferably a hydrocarbyl group, preferably having from 1 to 4 carbon atoms; and R is a hydrocarbyl group having from 4 to 30, preferably 8 to 18, and most preferably 9 to 15 carbon atoms. The oil-soluble hydrocarbyl phenol aldehyde condensate has a weight average molecular weight (Mw) of 1250 to 1680, as measured by MALDI-TOF (Matrix Assisted Laser Desorption Ionization-Time of Flight) mass spectrometry.",INFINEUM INT LTD,SHAW ROBERT W;;CHUNG SIMON S M;;DODD JAMES C;;FELLOWS RAYMOND,INFINEUM INTERNATIONAL LIMITED (2005-07-22),https://lens.org/105-616-255-680-320,Granted Patent,yes,6,3,13,16,0,C10M163/00;;C10M165/00;;C10M2207/024;;C10M2207/028;;C10M2219/089;;C10N2030/52;;C10N2040/25;;C10M165/00;;C10M2207/028;;C10M2207/024;;C10M2219/089;;C10M163/00;;C10N2030/52;;C10N2040/25,C08K5/13;;C10L1/18;;C10M129/14;;C10M105/72;;C10M129/10;;C10M129/24;;C10M129/91;;C10M145/20;;C10M159/12;;C10M163/00;;C10M165/00;;C10M177/00;;C10N20/04;;C10N30/04;;C10N40/25;;C10N70/00,508/585;;508/568,1,0,,,"XP007124476 ""Methylene-bridged alkyl phenols"", Anonymous, Jun. 1999 Research Disclosure, Kenneth Mason Publications, Hampshire, GB.",INACTIVE
257,SG,A1,SG 118366 A1,182-719-977-715-905,2006-01-27,2006,SG 200503728 A,2005-06-10,EP 04253487 A,2004-06-11,Detergent additives for lubricating oil compositions,,INFINEUM INT LTD,ROBERT WILLIAM SHAW;;SIMON SIU MING CHUNG;;JAMES CHRISTIAN DODD;;RAYMOND FELLOWS,,https://lens.org/182-719-977-715-905,Patent Application,no,0,0,13,16,0,C10M163/00;;C10M165/00;;C10M2207/024;;C10M2207/028;;C10M2219/089;;C10N2030/52;;C10N2040/25;;C10M165/00;;C10M2207/028;;C10M2207/024;;C10M2219/089;;C10M163/00;;C10N2030/52;;C10N2040/25,C10M129/14;;C10L1/18;;C10M129/10;;C10M129/24;;C10M129/91;;C10M145/20;;C10M159/12;;C10M163/00;;C10M165/00;;C10M177/00;;C10N20/04;;C10N30/04;;C10N40/25;;C10N70/00,,0,0,,,,PENDING
258,US,A1,US 2010/0159053 A1,135-083-623-253-357,2010-06-24,2010,US 71835110 A,2010-03-05,US 71835110 A;;US 22700905 A;;US 45205903 A,2003-06-02,"Apparatus for Making a Shingle, and Shingle Made Thereby","An apparatus for making a shingle, together with the shingle made thereby, is provided, in which one or more thermoplastic materials are extruded or co-extruded to form an extrudate, with the extrudate being cut into a preliminary shingle shape, which is allowed to dissipate heat, and then is delivered to a compression mold, wherein the preliminary shingle shape is compression molded to substantially its final dimensions and is then discharged from the mold and allowed to cool.",CERTAIN TEED CORP,MACKINNON THOMAS KEVIN;;DODD ROBERT E;;KIM JOONG YOUN;;WYLIE DOUGLAS H,,https://lens.org/135-083-623-253-357,Patent Application,yes,46,2,6,15,0,B32B27/12;;B32B27/12;;B32B27/20;;B32B27/20;;E04D1/20;;E04D1/20;;Y10T428/24355;;Y10T428/24355,B29C47/06;;B32B27/12;;B32B27/20;;E04D1/20,425/131.1,0,0,,,,EXPIRED
259,CA,A1,CA 2553186 A1,102-716-433-954-152,2007-03-15,2007,CA 2553186 A,2006-07-18,US 22700905 A,2005-09-15,"PROCESS OF AND APPARATUS FOR MAKING A SHINGLE, AND SHINGLE MADE THEREBY","A process and apparatus for making a shingle, together with the shingle ma de thereby, is provided, in which one or more thermoplastic materials are extruded or co-extruded to form an extrudate, with the extrudate being cut into a preliminary shingle shape, which is allowed to dissipate heat, and then is delivered to a compression mold, wherein the preliminary shingle shape is compression molded to substantially its final dimensions and is then discharged from the mold and allowed to cool.",CERTAIN TEED CORP,MACKINNON THOMAS KEVIN;;KIM JOONG YOUN;;DODD ROBERT E;;WYLIE DOUGLAS H,,https://lens.org/102-716-433-954-152,Patent Application,no,0,1,2,15,0,,B29C69/00;;B29C47/06;;E04D1/20,,0,0,,,,INACTIVE
260,CN,A,CN 113336177 A,157-653-770-664-420,2021-09-03,2021,CN 202110232653 A,2021-03-02,US 202062983879 P,2020-03-02,FLUID FILLING SYSTEM,"Systems and methods are provided for transferring fluid between a container and a reservoir. In an embodiment, a system may include a container having an interior volume configured to hold a volume of fluid. An adapter may be associated with the container for providing fluid communication with the volume of fluid. A receiver may be configured to be fluidly coupled with a reservoir. The receiver may be configured to releasably engage the adapter, and may include a valve configured to be opened when the adapter is engaged with the receiver to allow fluid transfer between the container and the reservoir.",FNA GROUP INC,CHRISTOPHER C ALEXANDER;;RICHARD J GILPATRICK;;ROBERT E DODD;;SHAWN M MULKINS,,https://lens.org/157-653-770-664-420,Patent Application,no,0,0,3,3,0,B67D7/04;;B67D7/78;;B67D7/06;;F02F7/006;;F04B53/16;;B65D75/5883;;B65D47/248;;B65D33/16;;B65D41/0414;;B67D7/04,B67D7/04;;B67D7/06;;B67D7/78;;F02F7/00;;F04B53/16,,0,0,,,,PENDING
261,CN,A,CN 1545452 A,132-553-958-061-634,2004-11-10,2004,CN 01823563 A,2001-09-06,US 88339801 A,2001-06-19,Compact ink jet printhead,一种紧凑的热喷墨打印头，包括：打印头基底(11)，形成于打印头基底中的多个并排的墨滴发生器(40)柱状阵列(61)，形成于打印头基底中的用于激发每个墨滴发生器的驱动电路(85)。该打印头基底具有每平方毫米至少为10.43个墨滴发生器的墨滴发生器组装密度。,HEWLETT PACKARD CO,BROWNING ROBERT N K;;BAKKOM ANGELA W;;DODD SIMON;;MACKENZIE MARK H,,https://lens.org/132-553-958-061-634,Patent Application,no,0,3,23,23,0,B41J2/14072;;B41J2/15;;B41J2/145;;B41J2/14072;;B41J2/15,B41J2/05;;B41J2/14;;B41J2/15;;B41J2/175,,0,0,,,,DISCONTINUED
262,US,B2,US 8017052 B2,147-788-488-848-117,2011-09-13,2011,US 68364110 A,2010-01-07,US 68364110 A;;US 22700905 A;;US 45205903 A,2003-06-02,"Process of and apparatus for making a shingle, and shingle made thereby","A process and apparatus for making a shingle, together with the shingle made thereby, is provided, in which one or more thermoplastic materials are extruded or co-extruded to form an extrudate, with the extrudate being cut into a preliminary shingle shape, which is allowed to dissipate heat, and then is delivered to a compression mold, wherein the preliminary shingle shape is compression molded to substantially its final dimensions and is then discharged from the mold and allowed to cool.",CERTAIN TEED CORP,MACKINNON THOMAS KEVIN;;DODD ROBERT E;;KIM JOONG YOUN;;WYLIE DOUGLAS H,,https://lens.org/147-788-488-848-117,Granted Patent,yes,39,4,6,15,0,B32B27/12;;B32B27/12;;B32B27/20;;B32B27/20;;E04D1/20;;E04D1/20;;Y10T428/24355;;Y10T428/24355,B29C47/00;;B29C45/73;;B29C47/06;;B32B27/12;;B32B27/20;;D01D5/12;;E04D1/20,264/148;;264/151;;264/160;;264/173.15;;264/173.16;;264/177.17;;264/210.2;;264/210.5;;264/211.12;;264/294;;264/297.5;;264/320;;264/327,0,0,,,,EXPIRED
263,FR,A1,FR 2967159 A1,013-816-187-546-568,2012-05-11,2012,FR 1059156 A,2010-11-05,FR 1059156 A,2010-11-05,"NOUVELLES MOLECULES INDOLOBENZAZEPINIQUES HYDROSOLUBLES DEMONTRANT DES ACTIVITES ANTIMITOTIQUES, ANTIVASCULAIRES ET ANTITUMORALES IN VIVO","L'objet de la présente demande de brevet concerne des dérivés indolobenzazépiniques à activité antitumorale, leur synthèse, et leur utilisation. En particulier, l'objet de la présente demande de brevet concerne une synthèse stéréocontrôlée de indolobenzazépinones substitués en C5 permettant d'obtenir uniquement l'un ou l'autre des deux isomères possibles en C5 ainsi que des analogues hydrosolubles permettant de démontrer la très grande efficacité de ces molécules à diminuer in vivo la taille de tumeurs.",CENTRE NAT RECH SCIENT,DODD ROBERT;;BAKALA JOANNA;;LIU JIANMIAO;;BIGNON JEROME;;PONS VALERIE;;BAUMONT STEPHANE,,https://lens.org/013-816-187-546-568,Patent Application,no,0,0,2,2,0,A61P35/00;;C07D487/04;;C07F9/6561,C07D487/04;;A61K31/55;;A61P35/00;;C07D209/08;;C07D223/16,,2,2,074-272-709-032-581;;076-806-375-838-273,18503262;;10.1021/jm701466p;;19743863;;10.1021/jm900476c,"LAURENT KELLER ET AL: ""New C5-alkylated indolobenzazepinones acting as inhibitors of tubulin polymerization: cytotoxic and antitumor activities"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 51, no. 12, 2008, pages 3414 - 3421, XP002629763;;AURÉLIEN PUTEY ET AL: ""Indolobenzazepin-7-ones and 6-, 8-, and 9-membered ring derivatives as tubulin polymerization inhibitors: synthesis and structure-activity relationship studies"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 52, no. 19, 2009, pages 5916 - 5925, XP002629764",PENDING
264,AT,T1,AT E378179 T1,034-205-853-706-383,2007-11-15,2007,AT 01968656 T,2001-09-07,US 77318201 A,2001-01-30,SCHMALER TINTENSTRAHLDRUCKKOPF,,HEWLETT PACKARD CO,TORGERSON JOSEPH;;BROWNING ROBERT;;MACKENZIE MARK;;MILLER MICHAEL;;BAKKOM ANGELA;;DODD SIMON,,https://lens.org/034-205-853-706-383,Granted Patent,no,0,0,34,34,0,B41J2/14072;;B41J2/15;;B41J2/14072;;B41J2/15,B41J2/05;;B41J2/15,,0,0,,,,EXPIRED
265,US,A1,US 2014/0278653 A1,061-219-456-681-377,2014-09-18,2014,US 201414208940 A,2014-03-13,US 201414208940 A;;US 201361783909 P;;US 201361784023 P,2013-03-14,Method And System For Optimizing Field Service Appoint Scheduling,"A system and method for allowing a dispatcher and/or a service technician to achieve an optimized schedule for a few or a large number of service technicians performing repairs in the field based on an analysis of past data, methodologies and formulas, wherein a scheduling program is displayed to the dispatcher on a monitor of a computer or any other processing device, using the scheduling program the dispatcher calls up or accesses the current schedule of all the technicians, and the technicians can simultaneously view their entire current schedule and agree to a proposed appointment, even placing blocks on dates and times that they are not available for scheduling so that optimized or near optimized schedules are obtained quickly and economically.",COCANOUGHER CHARLES D;;COCANOUGHER ROBERT A;;CHAMBERS STEPHEN F;;DODD BRADLEY A,COCANOUGHER CHARLES D;;COCANOUGHER ROBERT A;;CHAMBERS STEPHEN F;;DODD BRADLEY A,FIELDLOCATE (2014-10-24),https://lens.org/061-219-456-681-377,Patent Application,yes,17,10,1,1,0,G06Q10/063116;;G06Q10/063116,G06Q10/06,705/7.16,0,0,,,,DISCONTINUED
266,US,B2,US 8337188 B2,112-059-218-065-462,2012-12-25,2012,US 71835110 A,2010-03-05,US 71835110 A;;US 22700905 A;;US 45205903 A,2003-06-02,"Apparatus for making a shingle, and shingle made thereby","An apparatus for making a shingle, together with the shingle made thereby, is provided, in which one or more thermoplastic materials are extruded or co-extruded to form an extrudate, with the extrudate being cut into a preliminary shingle shape, which is allowed to dissipate heat, and then is delivered to a compression mold, wherein the preliminary shingle shape is compression molded to substantially its final dimensions and is then discharged from the mold and allowed to cool.",MACKINNON THOMAS KEVIN;;DODD ROBERT E;;KIM JOONG YOUN;;WYLIE DOUGLAS H;;CERTAIN TEED CORP,MACKINNON THOMAS KEVIN;;DODD ROBERT E;;KIM JOONG YOUN;;WYLIE DOUGLAS H,,https://lens.org/112-059-218-065-462,Granted Patent,yes,46,2,6,15,0,B32B27/12;;B32B27/12;;B32B27/20;;B32B27/20;;E04D1/20;;E04D1/20;;Y10T428/24355;;Y10T428/24355,B29C47/00;;B29C45/73;;B29C47/06;;B29C51/02;;B32B27/12;;B32B27/20;;D01D5/12;;E04D1/20,425/131.1;;425/112;;425/253;;425/308;;264/148;;264/151;;264/160;;264/173.15;;264/173.16;;264/177.17;;264/210.2;;264/210.5;;264/211.12;;264/294;;264/297.5;;264/320;;264/321;;264/327;;52/540,0,0,,,,INACTIVE
267,AT,T1,AT E409496 T1,191-033-834-339-738,2008-10-15,2008,AT 99962827 T,1999-11-22,US 19793398 A;;US 32129299 A,1998-11-23,HAUTDESODORIERENDE UND DESINFIZIERENDE ZUBEREITUNG,The present invention relates to aqueous compositions comprising an odor controlling agent and select sanitizing agents for deodorizing and sanitizing skin surfaces. Articles of manufacture and methods of deodorizing and sanitizing the skin using disclosed compositions are also disclosed.,PROCTER & GAMBLE,DODD MICHAEL;;WEI KARL;;TRINH TOAN;;SINE MARK;;BARTOLO ROBERT;;JAKUBOVIC DAVID,,https://lens.org/191-033-834-339-738,Granted Patent,no,0,0,3,21,0,A61K8/0208;;A61K8/27;;A61K8/347;;A61K8/40;;A61K8/416;;A61K8/43;;A61K8/4973;;A61K8/738;;A61K8/8147;;A61Q15/00;;A61Q17/005;;A61Q17/005;;A61K8/347;;A61K8/8147;;A61K8/0208;;A61K8/40;;A61K8/43;;A61K8/738;;A61Q15/00;;A61K8/4973;;A61K8/416;;A61K8/27,A61K8/02;;A61K8/27;;A61K8/34;;A61K8/40;;A61K8/41;;A61K8/43;;A61K8/49;;A61K8/73;;A61K8/81;;A61Q15/00;;A61Q17/00,,0,0,,,,EXPIRED
268,US,B1,US 8171461 B1,000-828-311-276-662,2012-05-01,2012,US 36176906 A,2006-02-24,US 36176906 A,2006-02-24,Primitive program compilation for flat attributes with provoking vertex independence,"Systems and methods for compiling high-level primitive programs are used to generate primitive program micro-code for execution by a primitive processor. A compiler is configured to produce micro-code for a specific target primitive processor based on the target primitive processor's capabilities. The compiler supports features of the high-level primitive program by providing conversions for different applications programming interface conventions, determining output primitive types, initializing attribute arrays based on primitive input profile modifiers, and determining vertex set lengths from specified primitive input types.",KILGARD MARK J;;EVERITT CASS W;;DODD CHRISTOPHER T;;GLANVILLE ROBERT STEVEN;;NVIDIA COPORATION,KILGARD MARK J;;EVERITT CASS W;;DODD CHRISTOPHER T;;GLANVILLE ROBERT STEVEN,NVIDIA CORPORATION (2006-02-23),https://lens.org/000-828-311-276-662,Granted Patent,yes,35,25,1,1,0,G06F8/4441;;G06F8/4441,G06F15/16;;G06F9/45,717/136;;717/141;;717/151;;709/232,18,2,062-305-667-671-045;;170-122-876-842-465,10.1145/383259.383275;;10.1145/1198555.1198567,"Franziska Roesner, User-Driven Access Control: A New Model for Granting Permissions in Modern Operating Systems [online], Apr. 19, 2011 [retrieved on Dec. 22, 2011], pp. 1-21 . Retrieved from the internet: .;;David Luebke & Mark Harris, GPGPU: General Purpose Computer on Graphics Hardware [online], 2004 [retrieved on Dec. 22, 2011], pp. 1-289. Retrieved from the internet: .;;Barenburg, et al. System for Adaptive Resampling in Texture Mapping, (WO 2005/010826 A1) Feb. 3, 2005.;;Randi J. Rost, ""OpenGL Shading Language"", second edition, Jan. 25, 2006, Addison Wesley Professional.;;Kilgard, et al. ""A System for Programming Graphics Hardware in a C-like Language"", University of Texas at Austin and NVIDIA Corp., 2003.;;""OpenGL Performer Programmer's Guide"", Techpubs library, Dec. 7, 2007.;;Kekoa, et al. ""A Real-Time Procedural Shading Program for Programmable Graphics Hardware,"" ACM SIGGRAPH, Aug. 2001.;;Shreiner, et al. ""An Interactive Introduction to Open GL Programming"", SIGGRAPH, 2002, (SIGGRAPH.pdf).;;John Douglas Owens, ""Computer Graphics on Stream Architecture"", Nov. 2002, (Owens 2003.pdf).;;Office Action. U.S. Appl. No. 11/361,597, Dated Jul. 9, 2009.;;Office Action. U.S. Appl. No. 11/361,789. Dated Jun. 24, 2009.;;Office Action. U.S. Appl. No: 11/361,789 dtd. Dec. 28, 2009.;;Kilgard, Mark J. ""Cg in Two Pages,"" NVIDIA Corporation, Jan. 16, 2003, pp. 1-2.;;Rost, Randi, J. ""OpenGL Shading Language,"" 2nd Edition, Jan. 25, 2006.;;Kilgard, et al. ""A System for Programming Graphics Hardware in a C-like Language,"" Univ. of Texas at Austin and NVIDIA Corp., 2003.;;Office Action, U.S. Appl. No. 11/361,597, dated May 21, 2010.;;Final Office Action, U.S. Appl. No. 11/361,597, dated Oct. 13, 2010.;;Office Action, U.S. Appl. No. 11/361,769, dated Apr. 25, 2011.",ACTIVE
269,US,B1,US 8006236 B1,120-293-971-169-70X,2011-08-23,2011,US 36159706 A,2006-02-24,US 36159706 A,2006-02-24,System and method for compiling high-level primitive programs into primitive program micro-code,"Systems and methods for compiling high-level primitive programs are used to generate primitive program micro-code for execution by a primitive processor. A compiler is configured to produce micro-code for a specific target primitive processor based on the target primitive processor's capabilities. The compiler supports features of the high-level primitive program by providing conversions for different applications programming interface conventions, determining output primitive types, initializing attribute arrays based on primitive input profile modifiers, and determining vertex set lengths from specified primitive input types.",NVIDIA CORP,KILGARD MARK J;;EVERITT CASS W;;DODD CHRISTOPHER T;;GLANVILLE ROBERT STEVEN,NVIDIA CORPORATION (2006-02-23),https://lens.org/120-293-971-169-70X,Granted Patent,yes,27,18,1,1,0,G06F8/443;;G06F8/443,G06F9/45,717/136;;345/419;;345/581,10,2,062-305-667-671-045;;170-122-876-842-465,10.1145/383259.383275;;10.1145/1198555.1198567,"Barenbrug; System for Adaptive resampling in texture mapping, (WO 2005/010826 A1), Feb. 3, 2005, (WO 2005010826 A1.pdf.;;Randi J. Rost, OpenGL Shading Language, second edition, Jan. 25, 2006, Addison Wesley Professional, (Randi.pdf).;;Kilgard et al. A system for programming graphics hardware in a C-like language, University of Texas at Austin and NVIDIA Corp., 2003, (Kilgard-Mark.pdf).;;OpenGL Performer Programmer's Guide, Techpubs library, Dec. 7, 2004, (sgi.pdf).;;Kekoa et al., A real-time procedural shading program for programmable graphics hardware, ACM SIGGRAPH, Aug. 2001, (Kekoa.pdf).;;Shreiner et al., An Interactive Introduction to Open GL Programming, SIGGRAPH, 2002, (SIGGRAPH.pdf).;;John Douglas Owens, Computer Graphics on Stream Architecture, Nov. 2002, (Owens2003.pdf).;;Mark J. Kilgard, ""Cg in Two Pages"", NVIDIA Corporation, Jan. 16, 2003, pp. 1-2.;;Office Action. U.S. Appl. No. 11/361,789, Dated Jun. 24, 2009.;;Office Action. U.S. Appl. No. 11/361,789 dtd. Dec. 28, 2009.",ACTIVE
270,AT,T1,AT E557002 T1,122-688-202-428-681,2012-05-15,2012,AT 01938319 T,2001-05-23,FR 0006619 A;;FR 0101599 W,2000-05-24,VERBINDUNGEN MIT CALCIMIMETISCHER WIRKUNG,,CENTRE NAT RECH SCIENT,RUAT MARTIAL;;DODD ROBERT;;FAURE HELENE;;DAUBAN PHILIPPE;;KESSLER ALBANE;;POTIER PIERRE,,https://lens.org/122-688-202-428-681,Granted Patent,no,0,0,11,11,0,C07D209/14;;C07D209/42;;A61P1/00;;A61P1/04;;A61P13/12;;A61P19/10;;A61P25/00;;A61P25/28;;A61P35/00;;A61P43/00;;A61P5/00;;A61P5/18;;A61P5/20;;A61P9/00;;C07D209/42;;C07D209/14,A61K31/4045;;A61P1/04;;A61P5/00;;A61P5/18;;A61P9/00;;A61P13/12;;A61P19/10;;A61P25/00;;A61P35/00;;A61P43/00;;C07D209/14;;C07D209/42,,0,0,,,,EXPIRED
271,CA,A1,CA 2509735 A1,180-385-279-548-927,2005-12-11,2005,CA 2509735 A,2005-06-09,EP 04253487 A,2004-06-11,DETERGENT ADDITIVES FOR LUBRICATING OIL COMPOSITIONS,"Use as a detergent in a lubricating oil composition of an oil-soluble hydrocarbyl phenol aldehyde condensate having the following structure: (see formula I) wherein n is 0 to 10, preferably 1 to 8, more preferably 2 to 6, and most preferably 3 to 5; Y is a divalent bridging group, and is preferably a hydrocarbyl group, preferably having from 1 to 4 carbon atoms; and R is a hydrocarbyl group having from 4 to 30, preferably 8 to 18, and most preferably 9 to 15 carbon atoms. The oil-soluble hydrocarbyl phenol aldehyde condensate has a weight average molecular weight (Mw) of 1250 to 1680, as measured by MALDI-TOF (Matrix Assisted Laser Desorption Ionization- Time of Flight) mass spectrometry.",INFINEUM INT LTD,CHUNG SIMON SIU MING;;DODD JAMES CHRISTIAN;;SHAW ROBERT WILLIAM;;FELLOWS RAYMOND,,https://lens.org/180-385-279-548-927,Patent Application,no,0,1,13,16,0,C10M163/00;;C10M165/00;;C10M2207/024;;C10M2207/028;;C10M2219/089;;C10N2030/52;;C10N2040/25;;C10M165/00;;C10M2207/028;;C10M2207/024;;C10M2219/089;;C10M163/00;;C10N2030/52;;C10N2040/25,C10M129/14;;C10L1/18;;C10M129/10;;C10M129/24;;C10M129/91;;C10M145/20;;C10M159/12;;C10M163/00;;C10M165/00;;C10M177/00;;C10N20/04;;C10N30/04;;C10N40/25;;C10N70/00,,0,0,,,,INACTIVE
272,CA,A1,CA 2101251 A1,180-431-460-667-685,1992-07-26,1992,CA 2101251 A,1992-01-24,US 64579691 A,1991-01-25,RUST PREVENTIVE MATERIAL AND METHOD OF APPLICATION,"2101251 9213116 PCTABS00014 Perforated sheets (13) of rolled zinc, held against steel reinforced concrete highway piers (11) in seawater intertidal zones (30), provide sacrificial cathodic protection to the embedded steel (12). Unique grooved, recycled plastic/wood composite extrusions (14) press the perforated zinc sheets firmly against the four faces of the concrete piers by means of durable stainless steel binding strips (16).",INT LEAD ZINC RES,CARR DODD S;;POWERS RODNEY G;;LANGLEY ROBERT M;;LASA IVAN R,,https://lens.org/180-431-460-667-685,Patent Application,no,0,1,3,3,0,C23F13/06,C23F13/06,,0,0,,,,DISCONTINUED
273,CA,C,CA 2553186 C,083-283-135-062-094,2015-02-03,2015,CA 2553186 A,2006-07-18,US 22700905 A,2005-09-15,"PROCESS OF AND APPARATUS FOR MAKING A SHINGLE, AND SHINGLE MADE THEREBY","A process and apparatus for making a shingle, together with the shingle made thereby, is provided, in which one or more thermoplastic materials are extruded or co-extruded to form an extrudate, with the extrudate being cut into a preliminary shingle shape, which is allowed to dissipate heat, and then is delivered to a compression mold, wherein the preliminary shingle shape is compression molded to substantially its final dimensions and is then discharged from the mold and allowed to cool.",CERTAIN TEED CORP,MACKINNON THOMAS KEVIN;;DODD ROBERT E;;KIM JOONG YOUN;;WYLIE DOUGLAS H,,https://lens.org/083-283-135-062-094,Granted Patent,no,0,0,2,15,0,,B29C69/00;;B29C47/06;;E04D1/20,,0,0,,,,INACTIVE
274,AU,A,AU 1974/066033 A,101-837-898-614-240,1975-08-28,1975,AU 1974/066033 A,1974-02-26,US 33596873 A,1973-02-26,TRANSFER APPARATUS,,DENNIS DALE JONES;;GEORGE EDWARD MARSHALL;;DONALD HARRY FISHER;;COLIN ROBERT DODD,JONES DENNIS DALE;;MARSHALL GEORGE EDWARD;;FISHER DONALD HARRY;;DODD COLIN ROBERT,,https://lens.org/101-837-898-614-240,Patent Application,no,0,0,15,15,0,G03G15/169;;G03G15/169,G03G15/16,,0,0,,,,DISCONTINUED
275,DE,D1,DE 60325561 D1,120-482-945-378-21X,2009-02-12,2009,DE 60325561 T,2003-03-17,GB 0206240 A;;GB 0301106 W,2002-03-16,AUSKOPPELSTRUKTUR FÜR EIN MAGNETRON,"A magnetron output arrangement includes a coaxial output adapted to be coupled in an endfire configuration to a rectangular waveguide. The waveguide has a flange for mating with the magnetron output arrangement. The coaxial output includes a central conductor. The output arrangement further includes a plate located in a predetermined position with respect to the central conductor. The plane of the plate is arranged to be substantially perpendicular to the axis of the coaxial output. The plate is located a predetermined distance from the end of the central conductor, such that the coaxial output in use couples with the plate so that the output coupling is substantially the same regardless of the type of waveguide flange employed.",E2V TECH UK LTD,BRADY MICHAEL BARRY;;DODD GEOFFREY ROBERT;;EDWARDS MARTIN BERNARD;;MULCAHY BERNARD RICHARD,,https://lens.org/120-482-945-378-21X,Granted Patent,no,0,0,16,16,0,H01J23/54;;H01J25/50;;H01J25/587;;H01P5/103;;H01J23/48;;H01P5/103;;H01J25/50;;H01J25/587;;H01P5/103;;H01J23/54,H01J23/40;;H01J23/54;;H01J25/50;;H01J25/587;;H01P5/08;;H01P5/103,,0,0,,,,EXPIRED
276,AT,T1,AT E40748 T1,131-603-643-020-201,1989-02-15,1989,AT 84301406 T,1984-03-02,EP 84301406 A;;GB 8306055 A,1983-03-04,VORRICHTUNG ZUR AUFLOESUNGSUNTERSUCHUNG.,"A tester comprises a container to hold liquid and a pellet holder supported in the container and with a reciprocating drive so that the liquid flushes in and out of the holder. There is pref. a set of tubular containers in a temp. controlled bath and the holder can be located successively in each container. The holder is pref. a tube with a solid or a mesh wall and top and bottom apertured closures, the bottom of the holder being soft/or resilient so that the pellets are not abraded. The container may be in a row or a circle, with a movable frame above the containers and carrying holder and drive. For pharmaceutical tablets or chemicals, providing with reproducible manual or automatic testing free from concentration gradients in the solvent.",NOORMOHAMMADI AKBAR;;BECKETT ARNOLD HEYWORTH;;GEEVES GRAHAME KENNETH JOHN;;DODD ROBERT EDWARD,NOORMOHAMMADI AKBAR;;BECKETT ARNOLD HEYWORTH;;GEEVES GRAHAME KENNETH JOHN;;DODD ROBERT EDWARD,,https://lens.org/131-603-643-020-201,Granted Patent,no,0,0,8,12,0,G01N13/00;;G01N33/15;;G01N2013/006;;B01F21/221;;B01F21/00;;B01F31/24;;B01F2101/23,B01F1/00;;B01F11/00;;G01N13/00;;G01N33/15,,0,0,,,,DISCONTINUED
277,EP,A1,EP 0586526 A1,000-209-889-582-997,1994-03-16,1994,EP 92912278 A,1992-05-29,FR 9106453 A,1991-05-29,AZA-6-INDOLE-DERIVED COMPOUNDS AS BENZODIAZEPINE RECEPTOR LIGANDS AND DRUGS CONTAINING SAME.,"L'invention concerne des dérivés des aza-6-indoles, ligands du récepteur des benzodiazépines ayant un effet agoniste inverse vis-à-vis des benzodiazépine de formule (I), R1 est H, alcoxyméthyle, ou un groupe (II), R2 est hydrocarbyloxy, R3, R4 est alkyle. L'invention concerne également des médicaments constitués de ces composés pour traiter notamment les troubles nerveux.",CENTRE NAT RECH SCIENT,DODD ROBERT H;;POTIER PIERRE;;DOISY XAVIER;;ROSSIER JEAN;;PRADO DE CARVALHO LIA,,https://lens.org/000-209-889-582-997,Patent Application,yes,0,0,7,7,0,C07D471/04;;A61P25/00;;A61P25/28;;C07D471/04,A61K31/435;;A61P25/00;;A61P25/28;;C07D471/04,,0,0,,,,DISCONTINUED
278,GB,B,GB 2253108 B,048-749-029-308-428,1995-01-18,1995,GB 9125219 A,1991-11-27,GB 9026037 A,1990-11-30,Motion detector unit,"PCT No. PCT/GB91/02099 Sec. 371 Date Jul. 29, 1992 Sec. 102(e) Date Jul. 29, 1992 PCT Filed Nov. 27, 1991 PCT Pub. No. WO92/09905 PCT Pub. Date Jun. 11, 1992.A unit for detecting a moving person or object by means of doppler frequency shift. The unit comprises a microwave circuit board (1) accommodating an oscillator and a mixer, and an antenna board (2) carrying transmit (8) and receive (9) patch arrays. In the assembled unit the two boards (1,2) are disposed adjacent one another. Coupling between the microwave circuit and the antenna arrays is achieved by two slots (6,11) resonant at the oscillator fundamental frequency and formed in a ground plane (5) on the microwave board (1). Feed striplines (7,10,12) on the two boards (1,2) lie orthogonal to the slots (6,11) and are terminated in T-sections (15,14). The stripline/slot arrangement suppresses emission at the oscillator second harmonic frequency. The antenna board (2) has no electrical connection to the microwave circuit, enabling the radiated beam shape to be changed by simply replacing the antenna board with one having a different patch array pattern.",MARCONI GEC LTD,ALDRED IAN RICHARD;;DODD ROBERT THOMAS JOSEPH;;HUMPHRYES REGINALD FREDERICK;;PHILPOTT ANDREW GUY,,https://lens.org/048-749-029-308-428,Granted Patent,no,3,0,16,16,0,G01S7/032;;G01S13/56;;H01Q9/0457;;H03D9/0633;;E05F15/73;;H01P5/028;;H01Q1/247;;H01Q23/00;;G01S13/56;;H01Q9/0457;;G01S13/56;;H03D9/0633;;G01S7/032;;E05F15/73;;H01P5/028;;H01Q23/00;;H01Q1/247,G01S7/03;;G01S7/28;;G01S13/50;;G01S13/56;;H01Q9/04;;H01Q23/00;;H03D9/06,H1Q QBX           BX;;H1Q QHX           HX;;H3R RMB           RMB;;H4D DRPA          RPA;;H4D DSH           SH;;H4D D265          RPA;;H4D D265          SH;;H4D D360          RPA;;H4D D360          SH;;H4D D366          DRPA;;H4D D366          SH;;H4D D396          RPA;;H4D D396          SH;;U1S S2188,0,0,,,,EXPIRED
279,US,A,US 3225294 A,056-824-580-856-482,1965-12-21,1965,US 14192161 A,1961-09-29,US 14192161 A,1961-09-29,Method and apparatus for measuring the space between surfaces or objects,,MCCLUNG ROBERT W;;DODD CAIUS V;;ALLEN JR JOHN W;;NANCE ROY A,MCCLUNG ROBERT W;;DODD CAIUS V;;ALLEN JR JOHN W;;NANCE ROY A,,https://lens.org/056-824-580-856-482,Granted Patent,no,2,11,1,1,0,G01B7/14;;G01B7/14;;G01B7/13;;G01B7/13;;G21C17/06;;G21C17/06;;Y02E30/30,G01B7/13;;G01B7/14;;G21C17/06,,0,0,,,,EXPIRED
280,GB,B,GB 2386748 B,080-549-323-156-414,2006-02-08,2006,GB 0206240 A,2002-03-16,GB 0206240 A,2002-03-16,Magnetron arrangements,"A magnetron output arrangement includes a coaxial output adapted to be coupled in an endfire configuration to a rectangular waveguide. The waveguide has a flange for mating with the magnetron output arrangement. The coaxial output includes a central conductor. The output arrangement further includes a plate located in a predetermined position with respect to the central conductor. The plane of the plate is arranged to be substantially perpendicular to the axis of the coaxial output. The plate is located a predetermined distance from the end of the central conductor, such that the coaxial output in use couples with the plate so that the output coupling is substantially the same regardless of the type of waveguide flange employed.",MARCONI APPLIED TECHN LTD;;E2V TECH,BRADY MICHAEL BARRY CLIVE;;DODD GEOFFREY ROBERT;;EDWARDS MARTIN BERNARD;;MULCAHY BERNARD RICHARD,,https://lens.org/080-549-323-156-414,Granted Patent,no,9,0,16,16,0,H01J23/54;;H01J25/50;;H01J25/587;;H01P5/103;;H01J23/48;;H01P5/103;;H01J25/50;;H01J25/587;;H01P5/103;;H01J23/54,H01J23/40;;H01J23/48;;H01J23/54;;H01J25/50;;H01J25/587;;H01P5/103,H1D DKJF          KJF;;H1D D18AY         KJF;;H1D D18A1BY       KJF;;H1D D18A1B2B      KJF;;H1D D18A1B2Y      KJF;;H1D D18A1Y        KJF;;H1D D18A3A        KJF;;H1D D18A3B        KJF;;H1D D18A3Y        KJF;;H1D D46C          KJF,0,0,,,,EXPIRED
281,WO,A1,WO 1992/021680 A1,120-361-238-611-456,1992-12-10,1992,FR 9200480 W,1992-05-29,FR 9106453 A,1991-05-29,AZA-6-INDOLE-DERIVED COMPOUNDS AS BENZODIAZEPINE RECEPTOR LIGANDS AND DRUGS CONTAINING SAME,"Aza-6-indole derivatives as benzodiazepine receptor ligands having a reverse agonist effect relative to the benzodiazepines of formula (I), wherein R1 is H, alkoxymethyl or a group (II); R2 is hydrocarbyloxy; and R3 and R4 are alkyl. Drugs consisting of said compounds and designed particularly to treat nervous disorders are also provided.",CENTRE NAT RECH SCIENT,DODD ROBERT H;;POTIER PIERRE;;DOISY XAVIER;;ROSSIER JEAN;;PRADO DE CARVALHO LIA,,https://lens.org/120-361-238-611-456,Patent Application,yes,1,2,7,7,0,C07D471/04;;A61P25/00;;A61P25/28;;C07D471/04,A61P25/00;;A61P25/28;;A61K31/435;;C07D471/04,,0,0,,,,PENDING
282,CA,A1,CA 2110299 A1,161-337-087-141-334,1992-12-10,1992,CA 2110299 A,1992-05-29,FR 9106453 A,1991-05-29,"COMPOUNDS DERIVES FROM AZA-6-INDOLES, BENZODIAZEPINE RECEPTOR LIGANDS AND DRUGS CONTAINING SAME","2110299 9221680 L'invention concerne des dérivés des aza-6-indoles, ligands du récepteur des benzodiazépines ayant un effet agoniste inverse vis-à-vis des benzodiazépine de formule (I), R1 est H, alcoxyméthyle, ou un groupe (II), R2 est hydrocarbyloxy, R3, R4 est alkyle. L'invention concerne également des médicaments constitués de ces composés pour traiter notamment les troubles nerveux.",CENTRE NAT RECH SCIENT,DODD ROBERT H;;POTIER PIERRE;;DOISY XAVIER;;ROSSIER JEAN;;PRADO DE CARVALHO LIA,,https://lens.org/161-337-087-141-334,Patent Application,no,0,0,7,7,0,C07D471/04;;A61P25/00;;A61P25/28;;C07D471/04,A61K31/435;;A61P25/00;;A61P25/28;;C07D471/04,,0,0,,,,DISCONTINUED
283,FR,B1,FR 2677024 B1,000-549-967-156-258,1995-03-03,1995,FR 9106453 A,1991-05-29,FR 9106453 A,1991-05-29,"COMPOSES DERIVES DES AZA-6-INDOLES, LIGANDS DU RECEPTEUR DES BENZODIAZEPINES ET MEDICAMENTS LES CONTENANT.",,CENTRE NAT RECH SCIENT,DODD ROBERT H;;POTIER PIERRE;;DOISY XAVIER;;ROSSIER JEAN;;CARVALHO LIA PRADO DE,,https://lens.org/000-549-967-156-258,Granted Patent,no,0,0,7,7,0,C07D471/04;;A61P25/00;;A61P25/28;;C07D471/04,A61K31/435;;A61P25/00;;A61P25/28;;C07D471/04,,0,0,,,,EXPIRED
284,GB,A,GB 2253108 A,059-158-418-819-20X,1992-08-26,1992,GB 9125219 A,1991-11-27,GB 9026037 A,1990-11-30,MOTION DETECTOR UNIT,"PCT No. PCT/GB91/02099 Sec. 371 Date Jul. 29, 1992 Sec. 102(e) Date Jul. 29, 1992 PCT Filed Nov. 27, 1991 PCT Pub. No. WO92/09905 PCT Pub. Date Jun. 11, 1992.A unit for detecting a moving person or object by means of doppler frequency shift. The unit comprises a microwave circuit board (1) accommodating an oscillator and a mixer, and an antenna board (2) carrying transmit (8) and receive (9) patch arrays. In the assembled unit the two boards (1,2) are disposed adjacent one another. Coupling between the microwave circuit and the antenna arrays is achieved by two slots (6,11) resonant at the oscillator fundamental frequency and formed in a ground plane (5) on the microwave board (1). Feed striplines (7,10,12) on the two boards (1,2) lie orthogonal to the slots (6,11) and are terminated in T-sections (15,14). The stripline/slot arrangement suppresses emission at the oscillator second harmonic frequency. The antenna board (2) has no electrical connection to the microwave circuit, enabling the radiated beam shape to be changed by simply replacing the antenna board with one having a different patch array pattern.",MARCONI GEC LTD,ALDRED IAN RICHARD;;DODD ROBERT THOMAS JOSEPH;;HUMPHRYES REGINALD FREDERICK;;PHILPOTT ANDREW GUY,,https://lens.org/059-158-418-819-20X,Patent Application,no,2,5,16,16,0,G01S7/032;;G01S13/56;;H01Q9/0457;;H03D9/0633;;E05F15/73;;H01P5/028;;H01Q1/247;;H01Q23/00;;G01S13/56;;H01Q9/0457;;G01S13/56;;H03D9/0633;;G01S7/032;;E05F15/73;;H01P5/028;;H01Q23/00;;H01Q1/247,G01S7/03;;G01S7/28;;G01S13/50;;G01S13/56;;H01Q9/04;;H01Q23/00;;H03D9/06,H1Q QBX           BX;;H1Q QHX           HX;;H3R RMB           RMB;;H4D DRPA          RPA;;H4D DSH           SH;;H4D D265          RPA;;H4D D265          SH;;H4D D360          RPA;;H4D D360          SH;;H4D D366          DRPA;;H4D D366          SH;;H4D D396          RPA;;H4D D396          SH;;U1S S2188,0,0,,,,EXPIRED
285,EP,A1,EP 0513287 A1,177-978-681-974-620,1992-11-19,1992,EP 91920526 A,1991-11-27,GB 9102099 W;;GB 9026037 A,1990-11-30,MOTION DETECTOR UNIT.,"PCT No. PCT/GB91/02099 Sec. 371 Date Jul. 29, 1992 Sec. 102(e) Date Jul. 29, 1992 PCT Filed Nov. 27, 1991 PCT Pub. No. WO92/09905 PCT Pub. Date Jun. 11, 1992.A unit for detecting a moving person or object by means of doppler frequency shift. The unit comprises a microwave circuit board (1) accommodating an oscillator and a mixer, and an antenna board (2) carrying transmit (8) and receive (9) patch arrays. In the assembled unit the two boards (1,2) are disposed adjacent one another. Coupling between the microwave circuit and the antenna arrays is achieved by two slots (6,11) resonant at the oscillator fundamental frequency and formed in a ground plane (5) on the microwave board (1). Feed striplines (7,10,12) on the two boards (1,2) lie orthogonal to the slots (6,11) and are terminated in T-sections (15,14). The stripline/slot arrangement suppresses emission at the oscillator second harmonic frequency. The antenna board (2) has no electrical connection to the microwave circuit, enabling the radiated beam shape to be changed by simply replacing the antenna board with one having a different patch array pattern.",MARCONI GEC LTD,PHILPOTT ANDREW GUY;;ALDRED IAN RICHARD;;DODD ROBERT THOMAS JOSEPH;;HUMPHRYES REGINALD FREDERICK,BAE SYSTEMS ELECTRONICS LTD. TRANSFER- MICROWAVE S (2002-05-15);;BAE SYSTEMS ELECTRONICS LIMITED;MARCONI ELECTRONIC (2001-07-02);;MICROWAVE SOLUTIONS LIMITED (2002-07-01),https://lens.org/177-978-681-974-620,Patent Application,yes,0,0,16,16,0,G01S7/032;;G01S13/56;;H01Q9/0457;;H03D9/0633;;E05F15/73;;H01P5/028;;H01Q1/247;;H01Q23/00;;G01S13/56;;H01Q9/0457;;G01S13/56;;H03D9/0633;;G01S7/032;;E05F15/73;;H01P5/028;;H01Q23/00;;H01Q1/247,G01S7/03;;G01S7/28;;G01S13/50;;G01S13/56;;H01Q9/04;;H01Q23/00;;H03D9/06,,0,0,,,,EXPIRED
286,US,B2,US 7199524 B2,124-924-379-882-200,2007-04-03,2007,US 50774605 A,2005-09-16,GB 0206240 A;;GB 0301106 W,2002-03-16,Magnetron arrangements,"A magnetron output arrangement includes a coaxial output adapted to be coupled in an endfire configuration to a rectangular waveguide. The waveguide has a flange for mating with the magnetron output arrangement. The coaxial output includes a central conductor. The output arrangement further includes a plate located in a predetermined position with respect to the central conductor. The plane of the plate is arranged to be substantially perpendicular to the axis of the coaxial output. The plate is located a predetermined distance from the end of the central conductor, such that the coaxial output in use couples with the plate so that the output coupling is substantially the same regardless of the type of waveguide flange employed.",E2V TECH UK LTD,BRADY MICHAEL BARRY CLIVE;;DODD GEOFFREY ROBERT;;EDWARDS MARTIN BERNARD;;MULCAHY BERNARD RICHARD,TELEDYNE UK LIMITED (2004-12-04),https://lens.org/124-924-379-882-200,Granted Patent,yes,13,0,16,16,0,H01J23/54;;H01J25/50;;H01J25/587;;H01P5/103;;H01J23/48;;H01P5/103;;H01J25/50;;H01J25/587;;H01P5/103;;H01J23/54,H01J23/40;;H01J23/46;;H01J23/54;;H01J25/50;;H01J25/587;;H01P5/103,315/39.51;;315/39.53;;315/39.67,0,0,,,,EXPIRED
287,FR,A1,FR 2677024 A1,140-213-760-833-482,1992-12-04,1992,FR 9106453 A,1991-05-29,FR 9106453 A,1991-05-29,"COMPOSES DERIVES DES AZA-6-INDOLES, LIGANDS DU RECEPTEUR DES BENZODIAZEPINES ET MEDICAMENTS LES CONTENANT.","Aza-6-indole derivatives as benzodiazepine receptor ligands having a reverse agonist effect relative to the benzodiazepines of formula (I), wherein R1 is H, alkoxymethyl or a group (II); R2 is hydrocarbyloxy; and R3 and R4 are alkyl. Drugs consisting of said compounds and designed particularly to treat nervous disorders are also provided.",CENTRE NAT RECH SCIENT,DODD ROBERT H;;PIERRE POTIER;;XAVIER DOISY;;JEAN ROSSIER;;LIA PRADO DE CARVALHO,,https://lens.org/140-213-760-833-482,Patent Application,no,1,0,7,7,0,C07D471/04;;A61P25/00;;A61P25/28;;C07D471/04,A61K31/435;;A61P25/00;;A61P25/28;;C07D471/04,,1,1,024-902-488-475-791,10.1016/s0040-4020(01)85462-4,"TETRAHEDRON, (INCL. TETRAHEDRON REPORTS), vol. 46. no. 9, 1990, Oxford, GB, pages 3245-3266; R.H. DOOD et al.: ""Synthesis of beta-carboline-benzodiazepine hybrid molecules and their ""amputated"" analoques as novel ligands of the benzodiazepine receptor"" * page 3263, alinéa 3, composé 34 *",EXPIRED
288,ES,T3,ES 2318114 T3,143-879-942-942-065,2009-05-01,2009,ES 03708350 T,2003-03-17,GB 0206240 A,2002-03-16,DISPOSITIVOS DE MEGNETRONES.,"A magnetron output arrangement includes a coaxial output adapted to be coupled in an endfire configuration to a rectangular waveguide. The waveguide has a flange for mating with the magnetron output arrangement. The coaxial output includes a central conductor. The output arrangement further includes a plate located in a predetermined position with respect to the central conductor. The plane of the plate is arranged to be substantially perpendicular to the axis of the coaxial output. The plate is located a predetermined distance from the end of the central conductor, such that the coaxial output in use couples with the plate so that the output coupling is substantially the same regardless of the type of waveguide flange employed.",E2V TECH UK LTD,BRADY MICHAEL BARRY CLIVE;;DODD GEOFFREY ROBERT;;EDWARDS MARTIN BERNARD;;MULCAHY BERNARD RICHARD,,https://lens.org/143-879-942-942-065,Granted Patent,no,0,0,16,16,0,H01J23/54;;H01J25/50;;H01J25/587;;H01P5/103;;H01J23/48;;H01P5/103;;H01J25/50;;H01J25/587;;H01P5/103;;H01J23/54,H01J23/40;;H01J23/54;;H01J25/50;;H01J25/587;;H01P5/08;;H01P5/103,,0,0,,,,EXPIRED
289,US,A,US 5262783 A,199-067-257-365-296,1993-11-16,1993,US 91611192 A,1992-07-29,GB 9026037 A,1990-11-30,Motion detector unit,"A unit for detecting a moving person or object by means of doppler frequency shift. The unit comprises a microwave circuit board (1) accommodating an oscillator and a mixer, and an antenna board (2) carrying transmit (8) and receive (9) patch arrays. In the assembled unit the two boards (1,2) are disposed adjacent one another. Coupling between the microwave circuit and the antenna arrays is achieved by two slots (6,11) resonant at the oscillator fundamental frequency and formed in a ground plane (5) on the microwave board (1). Feed striplines (7,10,12) on the two boards (1,2) lie orthogonal to the slots (6,11) and are terminated in T-sections (15,14). The stripline/slot arrangement suppresses emission at the oscillator second harmonic frequency. The antenna board (2) has no electrical connection to the microwave circuit, enabling the radiated beam shape to be changed by simply replacing the antenna board with one having a different patch array pattern.",MARCONI GEC LTD,PHILPOTT ANDREW G;;ALDRED IAN R;;DODD ROBERT T J;;HUMPHRYES REGINALD F,G4C-MARCONI LIMITED (1992-10-14);;MICROWAVE SOLUTIONS LIMITED (2002-01-30);;BAE SYSTEMS ELECTRONICS LIMITED (2000-02-23),https://lens.org/199-067-257-365-296,Granted Patent,yes,8,66,16,16,0,G01S7/032;;G01S13/56;;H01Q9/0457;;H03D9/0633;;E05F15/73;;H01P5/028;;H01Q1/247;;H01Q23/00;;G01S13/56;;H01Q9/0457;;G01S13/56;;H03D9/0633;;G01S7/032;;E05F15/73;;H01P5/028;;H01Q23/00;;H01Q1/247,G01S7/03;;G01S7/28;;G01S13/50;;G01S13/56;;H01Q9/04;;H01Q23/00;;H03D9/06,342/28;;342/114;;455/327,0,0,,,,EXPIRED
290,EP,B1,EP 0513287 B1,155-005-152-858-65X,1996-02-28,1996,EP 91920526 A,1991-11-27,GB 9102099 W;;GB 9026037 A,1990-11-30,MOTION DETECTOR UNIT,"PCT No. PCT/GB91/02099 Sec. 371 Date Jul. 29, 1992 Sec. 102(e) Date Jul. 29, 1992 PCT Filed Nov. 27, 1991 PCT Pub. No. WO92/09905 PCT Pub. Date Jun. 11, 1992.A unit for detecting a moving person or object by means of doppler frequency shift. The unit comprises a microwave circuit board (1) accommodating an oscillator and a mixer, and an antenna board (2) carrying transmit (8) and receive (9) patch arrays. In the assembled unit the two boards (1,2) are disposed adjacent one another. Coupling between the microwave circuit and the antenna arrays is achieved by two slots (6,11) resonant at the oscillator fundamental frequency and formed in a ground plane (5) on the microwave board (1). Feed striplines (7,10,12) on the two boards (1,2) lie orthogonal to the slots (6,11) and are terminated in T-sections (15,14). The stripline/slot arrangement suppresses emission at the oscillator second harmonic frequency. The antenna board (2) has no electrical connection to the microwave circuit, enabling the radiated beam shape to be changed by simply replacing the antenna board with one having a different patch array pattern.",MARCONI GEC LTD,PHILPOTT ANDREW GUY;;ALDRED IAN RICHARD;;DODD ROBERT THOMAS JOSEPH;;HUMPHRYES REGINALD FREDERICK,BAE SYSTEMS ELECTRONICS LTD. TRANSFER- MICROWAVE S (2002-05-15);;BAE SYSTEMS ELECTRONICS LIMITED;MARCONI ELECTRONIC (2001-07-02);;MICROWAVE SOLUTIONS LIMITED (2002-07-01),https://lens.org/155-005-152-858-65X,Granted Patent,yes,4,0,16,16,0,G01S7/032;;G01S13/56;;H01Q9/0457;;H03D9/0633;;E05F15/73;;H01P5/028;;H01Q1/247;;H01Q23/00;;G01S13/56;;H01Q9/0457;;G01S13/56;;H03D9/0633;;G01S7/032;;E05F15/73;;H01P5/028;;H01Q23/00;;H01Q1/247,G01S7/03;;G01S7/28;;G01S13/50;;G01S13/56;;H01Q9/04;;H01Q23/00;;H03D9/06,,1,0,,,"PATENT ABSTRACTS OF JAPAN vol. 6, no. 62 (P-111)(940) 21 April 1982 & JP-A-57 003 061",EXPIRED
291,EP,A1,EP 1485932 A1,181-428-070-307-763,2004-12-15,2004,EP 03708350 A,2003-03-17,GB 0301106 W;;GB 0206240 A,2002-03-16,MAGNETRON ARRANGEMENTS,"A magnetron output arrangement includes a coaxial output adapted to be coupled in an endfire configuration to a rectangular waveguide. The waveguide has a flange for mating with the magnetron output arrangement. The coaxial output includes a central conductor. The output arrangement further includes a plate located in a predetermined position with respect to the central conductor. The plane of the plate is arranged to be substantially perpendicular to the axis of the coaxial output. The plate is located a predetermined distance from the end of the central conductor, such that the coaxial output in use couples with the plate so that the output coupling is substantially the same regardless of the type of waveguide flange employed.",E2V TECH UK LTD,BRADY MICHAEL BARRY CLIVE;;DODD GEOFFREY ROBERT;;EDWARDS MARTIN BERNARD;;MULCAHY BERNARD RICHARD,"TELEDYNE UK LIMITED (2020-02-12);;TELEDYNE UK LIMITED; GB (2020-05-13);;TELEDYNE E2V (UK) LIMITED (2018-02-20);;TELEDYNE E2V (UK) LIMITED, GB (2018-04-10);;TELEDYNE E2V (UK) LIMITED; GB (2017-12-08)",https://lens.org/181-428-070-307-763,Patent Application,yes,0,0,16,16,0,H01J23/54;;H01J25/50;;H01J25/587;;H01P5/103;;H01J23/48;;H01P5/103;;H01J25/50;;H01J25/587;;H01P5/103;;H01J23/54,H01J23/40;;H01J23/54;;H01J25/50;;H01J25/587;;H01P5/103,,0,0,,,,EXPIRED
292,ES,T3,ES 2083599 T3,071-728-214-334-629,1996-04-16,1996,ES 91920526 T,1991-11-27,GB 9026037 A,1990-11-30,UNIDAD DETECTORA DE MOVIMIENTO.,"PCT No. PCT/GB91/02099 Sec. 371 Date Jul. 29, 1992 Sec. 102(e) Date Jul. 29, 1992 PCT Filed Nov. 27, 1991 PCT Pub. No. WO92/09905 PCT Pub. Date Jun. 11, 1992.A unit for detecting a moving person or object by means of doppler frequency shift. The unit comprises a microwave circuit board (1) accommodating an oscillator and a mixer, and an antenna board (2) carrying transmit (8) and receive (9) patch arrays. In the assembled unit the two boards (1,2) are disposed adjacent one another. Coupling between the microwave circuit and the antenna arrays is achieved by two slots (6,11) resonant at the oscillator fundamental frequency and formed in a ground plane (5) on the microwave board (1). Feed striplines (7,10,12) on the two boards (1,2) lie orthogonal to the slots (6,11) and are terminated in T-sections (15,14). The stripline/slot arrangement suppresses emission at the oscillator second harmonic frequency. The antenna board (2) has no electrical connection to the microwave circuit, enabling the radiated beam shape to be changed by simply replacing the antenna board with one having a different patch array pattern.",MARCONI GEC LTD,PHILPOTT ANDREW GUY;;ALDRED IAN RICHARD;;DODD ROBERT THOMAS JOSEPH;;HUMPHRYES REGINALD FREDERICK,,https://lens.org/071-728-214-334-629,Granted Patent,no,0,1,16,16,0,G01S7/032;;G01S13/56;;H01Q9/0457;;H03D9/0633;;E05F15/73;;H01P5/028;;H01Q1/247;;H01Q23/00;;G01S13/56;;H01Q9/0457;;G01S13/56;;H03D9/0633;;G01S7/032;;E05F15/73;;H01P5/028;;H01Q23/00;;H01Q1/247,G01S7/03;;G01S7/28;;G01S13/50;;G01S13/56;;H01Q9/04;;H01Q23/00;;H03D9/06,,0,0,,,,EXPIRED
293,EP,B1,EP 1485932 B1,187-561-159-718-05X,2008-12-31,2008,EP 03708350 A,2003-03-17,GB 0301106 W;;GB 0206240 A,2002-03-16,MAGNETRON ARRANGEMENTS,"A magnetron output arrangement includes a coaxial output adapted to be coupled in an endfire configuration to a rectangular waveguide. The waveguide has a flange for mating with the magnetron output arrangement. The coaxial output includes a central conductor. The output arrangement further includes a plate located in a predetermined position with respect to the central conductor. The plane of the plate is arranged to be substantially perpendicular to the axis of the coaxial output. The plate is located a predetermined distance from the end of the central conductor, such that the coaxial output in use couples with the plate so that the output coupling is substantially the same regardless of the type of waveguide flange employed.",E2V TECH UK LTD,BRADY MICHAEL BARRY CLIVE;;DODD GEOFFREY ROBERT;;EDWARDS MARTIN BERNARD;;MULCAHY BERNARD RICHARD,"TELEDYNE UK LIMITED (2020-02-12);;TELEDYNE UK LIMITED; GB (2020-05-13);;TELEDYNE E2V (UK) LIMITED (2018-02-20);;TELEDYNE E2V (UK) LIMITED, GB (2018-04-10);;TELEDYNE E2V (UK) LIMITED; GB (2017-12-08)",https://lens.org/187-561-159-718-05X,Granted Patent,yes,5,0,16,16,0,H01J23/54;;H01J25/50;;H01J25/587;;H01P5/103;;H01J23/48;;H01P5/103;;H01J25/50;;H01J25/587;;H01P5/103;;H01J23/54,H01J23/40;;H01J23/54;;H01J25/50;;H01J25/587;;H01P5/08;;H01P5/103,,2,0,,,"PATENT ABSTRACTS OF JAPAN vol. 013, no. 243 (E-768), 7 June 1989 (1989-06-07) & JP 01 045043 A (TOSHIBA CORP), 17 February 1989 (1989-02-17);;PATENT ABSTRACTS OF JAPAN vol. 2000, no. 25, 12 April 2001 (2001-04-12) & JP 2001 229840 A (TOSHIBA CORP), 24 August 2001 (2001-08-24)",EXPIRED
294,AT,T1,AT E134774 T1,021-298-481-875-226,1996-03-15,1996,AT 91920526 T,1991-11-27,GB 9026037 A,1990-11-30,GERÄT FÜR BEWEGUNGSDETEKTION,"PCT No. PCT/GB91/02099 Sec. 371 Date Jul. 29, 1992 Sec. 102(e) Date Jul. 29, 1992 PCT Filed Nov. 27, 1991 PCT Pub. No. WO92/09905 PCT Pub. Date Jun. 11, 1992.A unit for detecting a moving person or object by means of doppler frequency shift. The unit comprises a microwave circuit board (1) accommodating an oscillator and a mixer, and an antenna board (2) carrying transmit (8) and receive (9) patch arrays. In the assembled unit the two boards (1,2) are disposed adjacent one another. Coupling between the microwave circuit and the antenna arrays is achieved by two slots (6,11) resonant at the oscillator fundamental frequency and formed in a ground plane (5) on the microwave board (1). Feed striplines (7,10,12) on the two boards (1,2) lie orthogonal to the slots (6,11) and are terminated in T-sections (15,14). The stripline/slot arrangement suppresses emission at the oscillator second harmonic frequency. The antenna board (2) has no electrical connection to the microwave circuit, enabling the radiated beam shape to be changed by simply replacing the antenna board with one having a different patch array pattern.",MARCONI GEC LTD,PHILPOTT ANDREW GUY;;ALDRED IAN RICHARD;;DODD ROBERT THOMAS JOSEPH;;HUMPHRYES REGINALD FREDERICK,,https://lens.org/021-298-481-875-226,Granted Patent,no,0,0,16,16,0,G01S7/032;;G01S13/56;;H01Q9/0457;;H03D9/0633;;E05F15/73;;H01P5/028;;H01Q1/247;;H01Q23/00;;G01S13/56;;H01Q9/0457;;G01S13/56;;H03D9/0633;;G01S7/032;;E05F15/73;;H01P5/028;;H01Q23/00;;H01Q1/247,G01S7/03;;G01S7/28;;G01S13/50;;G01S13/56;;H01Q9/04;;H01Q23/00;;H03D9/06,,0,0,,,,EXPIRED
295,PT,E,PT 1485932 E,055-151-652-363-08X,2009-03-17,2009,PT 03708350 T,2003-03-17,GB 0206240 A,2002-03-16,MAGNETRON ARRANGEMENTS,"A magnetron output arrangement includes a coaxial output adapted to be coupled in an endfire configuration to a rectangular waveguide. The waveguide has a flange for mating with the magnetron output arrangement. The coaxial output includes a central conductor. The output arrangement further includes a plate located in a predetermined position with respect to the central conductor. The plane of the plate is arranged to be substantially perpendicular to the axis of the coaxial output. The plate is located a predetermined distance from the end of the central conductor, such that the coaxial output in use couples with the plate so that the output coupling is substantially the same regardless of the type of waveguide flange employed.",E2V TECH UK LTD,BRADY MICHAEL BARRY CLIVE;;DODD GEOFFREY ROBERT;;EDWARDS MARTIN BERNARD;;MULCAHY BERNARD RICHARD,,https://lens.org/055-151-652-363-08X,Granted Patent,no,0,0,16,16,0,H01J23/54;;H01J25/50;;H01J25/587;;H01P5/103;;H01J23/48;;H01P5/103;;H01J25/50;;H01J25/587;;H01P5/103;;H01J23/54,H01J23/40;;H01J23/54;;H01J23/00;;H01J25/00;;H01J25/50;;H01J25/587;;H01P5/08;;H01P5/10;;H01P5/103,,0,0,,,,EXPIRED
296,KR,B1,KR 100220145 B1,128-872-820-233-118,1999-09-01,1999,KR 920701813 A,1992-07-30,GB 9026037 A;;GB 9102099 W,1990-11-30,MOTION DETECTOR UNIT,"PCT No. PCT/GB91/02099 Sec. 371 Date Jul. 29, 1992 Sec. 102(e) Date Jul. 29, 1992 PCT Filed Nov. 27, 1991 PCT Pub. No. WO92/09905 PCT Pub. Date Jun. 11, 1992.A unit for detecting a moving person or object by means of doppler frequency shift. The unit comprises a microwave circuit board (1) accommodating an oscillator and a mixer, and an antenna board (2) carrying transmit (8) and receive (9) patch arrays. In the assembled unit the two boards (1,2) are disposed adjacent one another. Coupling between the microwave circuit and the antenna arrays is achieved by two slots (6,11) resonant at the oscillator fundamental frequency and formed in a ground plane (5) on the microwave board (1). Feed striplines (7,10,12) on the two boards (1,2) lie orthogonal to the slots (6,11) and are terminated in T-sections (15,14). The stripline/slot arrangement suppresses emission at the oscillator second harmonic frequency. The antenna board (2) has no electrical connection to the microwave circuit, enabling the radiated beam shape to be changed by simply replacing the antenna board with one having a different patch array pattern.",MARCONI ELECTRONIC SYST LTD,ANDREW GUY PHILPOTT;;IAN RICHARD ALDRED;;ROBERT THOMAS JOSEPH DODD;;REGINALD FREDERICK HUMPHRYES,,https://lens.org/128-872-820-233-118,Granted Patent,no,0,0,16,16,0,G01S7/032;;G01S13/56;;H01Q9/0457;;H03D9/0633;;E05F15/73;;H01P5/028;;H01Q1/247;;H01Q23/00;;G01S13/56;;H01Q9/0457;;G01S13/56;;H03D9/0633;;G01S7/032;;E05F15/73;;H01P5/028;;H01Q23/00;;H01Q1/247,G01S7/03;;G01S7/28;;G01S13/50;;G01S13/56;;H01Q9/04;;H01Q23/00;;H03D9/06,,0,0,,,,EXPIRED
297,WO,A1,WO 1992/009905 A1,120-463-007-115-655,1992-06-11,1992,GB 9102099 W,1991-11-27,GB 9026037 A,1990-11-30,MOTION DETECTOR UNIT,"A unit for detecting a moving person or object by means of doppler frequency shift. The unit comprises a microwave circuit board (1) accommodating an oscillator and a mixer, and an antenna board (2) carrying transmit (8) and receive (7) patch arrays. In the assembled unit the two boards (1, 2) are intimately secured together. Coupling between the microwave circuit and the antenna arrays is achieved by two slots (5, 6) resonant at the oscillator fundamental frequency, formed in the ground plane (4) of the microwave board (1). Feed striplines (9, 10, 17, 19) on the two boards lie orthogonal to and sandwich the slots (5, 6). The stripline/slot arrangement suppresses emission at the oscillator second harmonic frequency.",MARCONI GEC LTD,PHILPOTT ANDREW GUY;;ALDRED IAN RICHARD;;DODD ROBERT THOMAS JOSEPH;;HUMPHRYES REGINALD FREDERICK,,https://lens.org/120-463-007-115-655,Patent Application,yes,4,7,16,16,0,G01S7/032;;G01S13/56;;H01Q9/0457;;H03D9/0633;;E05F15/73;;H01P5/028;;H01Q1/247;;H01Q23/00;;G01S13/56;;H01Q9/0457;;G01S13/56;;H03D9/0633;;G01S7/032;;E05F15/73;;H01P5/028;;H01Q23/00;;H01Q1/247,G01S7/03;;G01S7/28;;G01S13/50;;G01S13/56;;H01Q9/04;;H01Q23/00;;H03D9/06,,1,0,,,"PATENT ABSTRACTS OF JAPAN ; vol. 6, no. 62 (P-111)(940) 21 April 1982 ; & JP,A,57 003 061 ( HITACHI SEISAKUSHO ) 8 January 1982 see abstract",PATENTED
298,DE,D1,DE 69117495 D1,074-456-440-042-344,1996-04-04,1996,DE 69117495 T,1991-11-27,GB 9026037 A;;GB 9102099 W,1990-11-30,GERÄT FÜR BEWEGUNGSDETEKTION,"PCT No. PCT/GB91/02099 Sec. 371 Date Jul. 29, 1992 Sec. 102(e) Date Jul. 29, 1992 PCT Filed Nov. 27, 1991 PCT Pub. No. WO92/09905 PCT Pub. Date Jun. 11, 1992.A unit for detecting a moving person or object by means of doppler frequency shift. The unit comprises a microwave circuit board (1) accommodating an oscillator and a mixer, and an antenna board (2) carrying transmit (8) and receive (9) patch arrays. In the assembled unit the two boards (1,2) are disposed adjacent one another. Coupling between the microwave circuit and the antenna arrays is achieved by two slots (6,11) resonant at the oscillator fundamental frequency and formed in a ground plane (5) on the microwave board (1). Feed striplines (7,10,12) on the two boards (1,2) lie orthogonal to the slots (6,11) and are terminated in T-sections (15,14). The stripline/slot arrangement suppresses emission at the oscillator second harmonic frequency. The antenna board (2) has no electrical connection to the microwave circuit, enabling the radiated beam shape to be changed by simply replacing the antenna board with one having a different patch array pattern.",MARCONI GEC LTD,PHILPOTT ANDREW GUY;;ALDRED IAN RICHARD;;DODD ROBERT THOMAS JOSEPH;;HUMPHRYES REGINALD FREDERICK,,https://lens.org/074-456-440-042-344,Granted Patent,no,0,0,16,16,0,G01S7/032;;G01S13/56;;H01Q9/0457;;H03D9/0633;;E05F15/73;;H01P5/028;;H01Q1/247;;H01Q23/00;;G01S13/56;;H01Q9/0457;;G01S13/56;;H03D9/0633;;G01S7/032;;E05F15/73;;H01P5/028;;H01Q23/00;;H01Q1/247,G01S7/03;;G01S7/28;;G01S13/50;;G01S13/56;;H01Q9/04;;H01Q23/00;;H03D9/06,,0,0,,,,EXPIRED
299,US,A,US 5484793 A,148-184-559-448-719,1996-01-16,1996,US 14248993 A,1993-11-29,FR 9106453 A;;FR 9200480 W,1991-05-29,Compounds derived from 6-azaindoles as ligands of the benzodiazepine receptor and medicaments containing them,"New 6-azaindole derivatives as ligands of the benzodiazepine receptor, pharmaceutical compositions containing these compounds, processes for producing these compounds and also compounds which are useful in particular as intermediates in the processes of preparation.",CENTRE NAT RECH SCIENT,DODD ROBERT H;;POTIER PIERRE;;DOISY XAVIER;;ROSSIER JEAN;;DE CARVALHO LIA P,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (1993-11-23),https://lens.org/148-184-559-448-719,Granted Patent,yes,1,1,7,7,0,C07D471/04;;A61P25/00;;A61P25/28;;C07D471/04,A61K31/435;;A61P25/00;;A61P25/28;;C07D471/04,514/300;;546/113,14,12,024-902-488-475-791;;024-902-488-475-791;;001-702-237-730-590;;041-524-863-214-181;;022-217-134-734-102;;018-029-877-886-34X;;028-157-053-517-663;;121-223-221-497-870;;085-910-008-951-211;;061-220-662-842-483;;119-872-048-045-552;;041-164-015-462-725,10.1016/s0040-4020(01)85462-4;;10.1016/s0040-4020(01)85462-4;;10.1016/0304-3940(83)90092-7;;6314204;;2448430;;10.1523/jneurosci.08-01-00289.1988;;pmc6569358;;10.1021/jm00128a024;;2754707;;1977911;;10.1021/jm00173a031;;10.1021/jm00106a025;;1847429;;10.1038/321864a0;;3724846;;2844205;;10.1016/0166-4328(88)90005-8;;10.1016/0361-9230(87)90104-3;;3676858;;10.1007/bf00207229;;2829267;;2469147;;10.1016/0166-2236(88)90042-2,"Tetrahedron, vol. 46, No. 9, 1990, pp. 3245 3266.;;Dellouve Courillon, Synthesis of B Carboline Benzodiazepine . . . , Tetrahedron, vol. 46, No. 9, pp. 3245 3266, 1990.;;Smart, Synthesis of Functional . . . , Neuroscience Letters, vol. 40, pp. 55 59, 1983.;;Sigel, Allosteric Modulation by Benzodiazepine Receptor . . . , Journal of Neuroscience, vol. 8(1), pp. 289 295, 1988.;;Shutske, 9 Amino 1,2,3,4 tetrahydroacridin 1 osl: Synthesis . . . , J. Med. Chem., vol. 32, pp. 1805 1813, 1989.;;Kawakubo, Potent Anticonflict Activity . . . , J. Med. Chem., vol. 33, pp. 3110 3116, 1990.;;Sasaki, Synthesis and Anticonvulsant Activity . . . , J. Med. Chem., vol. 34, pp. 628 633, 1991.;;Venault, Benzodiazepine Impairs and . . . , reprinted from Nature, vol. 321, No. 6073, pp. 864 866, 1986.;;File, Low and High Doses . . . , Behavioural Brain Research, vol. 30, pp. 31 36, 1988.;;Jensen, Bidirectional Effects of . . . , Brain Research Bulletin, vol. 19, pp. 359 364, 1987.;;Duka, Human Studies on the Benzodiazepine Receptor . . . , Psychopharmacology, vol. 93, pp. 421 427, 1987.;;Sarter, Treatment Strategies for Senile Dementia . . . , TINS, vol. 11, No. 1, pp. 13 16, 1988.;;Hendrickson, James B., Organic Chemistry, third edition, pp. 403 404, 504 506 and 515, 1970.;;Solomons, T. W. Graham, Organic Chemistry, foruth edition, pp. 837 838 and 862, 1988.",EXPIRED
300,WO,A1,WO 2019/055395 A1,107-139-850-117-413,2019-03-21,2019,US 2018/0050424 W,2018-09-11,US 201715701558 A,2017-09-12,CHILD RESISTANT AEROSOL ACTUATOR,"The actuator includes a shroud adapted to be situated on an aerosol container over the stem and an actuation member mounted on and moveable within the shroud to depress the stem by the application of an external force applied to the top surface of the actuation member. The actuation member includes a nozzle and a conduit for connecting the stem and the nozzle. A hood is normally positioned to block the actuation member from being moved to depress the stem. A locking member normally intersects the path of movement of the hood to lock the hood in its blocking position. The locking member has two sections both of which must be simultaneously moved to a position remote from the path of hood movement such that the hood may be moved from its blocking position, allowing the actuation member to be moved to depress the stem.",WD 40 MFG COMPANY,STARZMAN MICHAEL;;FREUDENBERG JOHN;;BATES KEVIN;;KRUPP BENJAMIN;;STATES ROBERT;;PARROT DAVID;;GOOD ROBERT;;DODD JOSEPH;;FALCON SARA,,https://lens.org/107-139-850-117-413,Patent Application,yes,1,0,21,21,0,B05B1/1645;;B05B11/0094;;B65D83/303;;B65D83/20;;B65D83/22;;B05B1/1645;;B65D83/22;;B05B11/1059;;B65D83/20;;B65D83/22;;B65D83/24;;B65D83/30;;B65D50/046;;B65D2215/02;;B05B1/1645;;B05B11/0094;;B65D83/303;;B05B11/1059,B05B11/00;;B65D83/20;;B65D50/04;;B65D83/22;;B65D83/24;;B65D83/30,,0,0,,,,PENDING
301,FR,B1,FR 2812875 B1,013-195-389-982-158,2003-12-12,2003,FR 0010427 A,2000-08-08,FR 0010427 A,2000-08-08,NOUVELLES DIAMINES POSSEDANT UNE ACTIVITE MODULATRICE DES CASR ET LEUR MODE DE PREPARATION,,CENTRE NAT RECH SCIENT,DAUBAN PHILIPPE MARCEL;;DODD ROBERT;;FAURE HELENE VERONIQUE;;RUAT MARTIAL;;POTIER PIERRE JEAN PAUL,,https://lens.org/013-195-389-982-158,Granted Patent,no,0,0,9,9,0,A61P19/10;;A61P29/00;;A61P35/00;;C07C311/29;;C07C311/29;;C07B2200/07;;C07B2200/07;;C07C211/36;;C07C211/36;;C07C311/20;;C07C311/20;;C07C2601/14;;C07C2601/14;;C07D203/26;;C07D203/26,A61P19/10;;A61K31/18;;A61P29/00;;A61P35/00;;C07B53/00;;C07B55/00;;C07C209/60;;C07C211/36;;C07C303/40;;C07C311/20;;C07C311/29;;C07D203/26,,0,0,,,,EXPIRED
302,EP,B1,EP 0499527 B1,125-894-775-419-711,1997-05-02,1997,EP 92400351 A,1992-02-11,FR 9101595 A,1991-02-12,"Beta-carboline derivatives, ligands of benzodiazepine receptors with inverse agonist and benzodiazepine antagonist effects and medicaments containing them",,CENTRE NAT RECH SCIENT,DODD ROBERT;;POTIER PIERRE;;ROSSIER JEAN;;DOREY GILBERT;;DUBOIS LAURENT;;PRADO DE CARVALHO LIA,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS (1997-03-26);;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (1993-03-17),https://lens.org/125-894-775-419-711,Granted Patent,yes,0,0,13,13,0,C07D405/04;;C07D471/14;;C07D491/14;;A61P25/20;;C07D405/04;;C07D471/14;;C07D491/14,A61K31/435;;A61K31/55;;A61P25/20;;C07D405/04;;C07D471/14;;C07D491/14;;C07D491/147;;C07D495/14,,3,0,,,"European Journal of Pharmacology, vol. 76, 1981, pages 281-284;;Journal of Medicinal Chemistry, vol. 32, 1989, pages 1989-1802;;Heterocycles, vol. 20, 1983, pages 1295-1313",EXPIRED
303,WO,A8,WO 2019/055395 A8,149-711-295-898-537,2020-03-26,2020,US 2018/0050424 W,2018-09-11,US 201715701558 A,2017-09-12,CHILD RESISTANT AEROSOL ACTUATOR,"The actuator includes a shroud adapted to be situated on an aerosol container over the stem and an actuation member mounted on and moveable within the shroud to depress the stem by the application of an external force applied to the top surface of the actuation member. The actuation member includes a nozzle and a conduit for connecting the stem and the nozzle. A hood is normally positioned to block the actuation member from being moved to depress the stem. A locking member normally intersects the path of movement of the hood to lock the hood in its blocking position. The locking member has two sections both of which must be simultaneously moved to a position remote from the path of hood movement such that the hood may be moved from its blocking position, allowing the actuation member to be moved to depress the stem.",WD 40 MFG COMPANY,STARZMAN MICHAEL;;FREUDENBERG JOHN;;BATES KEVIN;;KRUPP BENJAMIN;;STATES ROBERT;;PARROTT DAVID;;GOOD ROBERT;;DODD JOSEPH;;FALCON SARA,,https://lens.org/149-711-295-898-537,Amended Application,yes,0,0,21,21,0,B05B1/1645;;B05B11/0094;;B65D83/303;;B65D83/20;;B65D83/22;;B05B1/1645;;B65D83/22;;B05B11/1059;;B65D83/20;;B65D83/22;;B65D83/24;;B65D83/30;;B65D50/046;;B65D2215/02;;B05B1/1645;;B05B11/0094;;B65D83/303;;B05B11/1059,B65D83/20;;B05B11/00;;B65D50/04;;B65D83/22;;B65D83/24;;B65D83/30,,0,0,,,,PENDING
304,FR,B1,FR 2672602 B1,155-500-672-201-406,1993-06-04,1993,FR 9101595 A,1991-02-12,FR 9101595 A,1991-02-12,COMPOSES DERIVES DES BETA-CARBOLINES LIGANDS DU RECEPTEUR DES BENZODIAZEPINES AYANT UN EFFET AGONISTE INVERSE ET ANTAGONISTE VIS-A-VIS DES BENZODIAZEPINES ET MEDICAMENTS LES CONTENANT.,,CENTRE NAT RECH SCIENT,ROBERT DODD;;PIERRE POTIER;;JEAN ROSSIER;;GILBERT DOREY;;LAURENT DUBOIS;;LIA PRADO DE CARVALHO,,https://lens.org/155-500-672-201-406,Granted Patent,no,0,0,13,13,0,C07D405/04;;C07D471/14;;C07D491/14;;A61P25/20;;C07D405/04;;C07D471/14;;C07D491/14,A61K31/435;;A61K31/55;;A61P25/20;;C07D405/04;;C07D471/14;;C07D491/14;;C07D491/147;;C07D495/14,,0,0,,,,EXPIRED
305,EP,A2,EP 2279566 A2,168-726-483-407-898,2011-02-02,2011,EP 09743289 A,2009-04-28,US 2009/0042001 W;;US 5095408 P,2008-05-06,SINGLE CABLE ANTENNA MODULE FOR LAPTOP COMPUTER AND MOBILE DEVICES,,RAYSPAN CORP;;ACHOUR MAHA,ACHOUR MAHA;;POILASNE GREGORY;;GUMMALLA AJAY;;PATHAK VANEET;;BARTSCH RYAN ROBERT;;DODD ANGELA MAE,"ACHOUR, MAHA (2011-12-21);;HOLLINWORTH FUND , L.L.C. (2011-12-21)",https://lens.org/168-726-483-407-898,Patent Application,yes,0,0,8,22,0,H01Q1/2266;;H01Q1/38;;H01P1/213;;H01Q9/42;;H01Q5/357;;H01Q5/378;;H01Q1/38;;H01Q1/2266;;H01P1/213;;H01Q9/42;;H01Q5/378;;H01Q5/357,H01Q5/00;;H01P1/213;;H01Q1/22;;H01Q1/38;;H01Q5/10;;H01Q9/42,,0,0,,,,DISCONTINUED
306,DK,T3,DK 0499527 T3,196-239-292-984-091,1997-11-03,1997,DK 92400351 T,1992-02-11,FR 9101595 A,1991-02-12,"Beta-carbolinderivater, som er ligander for benzodiazepinreceptoren og har en omvendt agonistvirkning og en antagonistvirkning over for benzodiazepiner, og lægemidler, som indeholder dem",,CENTRE NAT RECH SCIENT,POTIER PIERRE;;DODD ROBERT;;ROSSIER JEAN;;DOREY GILBERT;;DUBOIS LAURENT;;PRADO DE CARVALHO LIA,,https://lens.org/196-239-292-984-091,Granted Patent,no,0,0,13,13,0,C07D405/04;;C07D471/14;;C07D491/14;;A61P25/20;;C07D405/04;;C07D471/14;;C07D491/14,A61K31/435;;A61K31/55;;A61P25/20;;C07D405/04;;C07D471/14;;C07D491/14;;C07D491/147;;C07D495/14,,0,0,,,,EXPIRED
307,CN,A,CN 111356643 A,026-615-571-600-371,2020-06-30,2020,CN 201880072968 A,2018-09-11,US 201715701558 A;;US 2018/0050424 W,2017-09-12,CHILD RESISTANT AEROSOL ACTUATOR,"The actuator includes a shroud adapted to be situated on an aerosol container over the stem and an actuation member mounted on and moveable within the shroud to depress the stem by the application ofan external force applied to the top surface of the actuation member. The actuation member includes a nozzle and a conduit for connecting the stem and the nozzle. A hood is normally positioned to block the actuation member from being moved to depress the stem. A locking member normally intersects the path of movement of the hood to lock the hood in its blocking position. The locking member has twosections both of which must be simultaneously moved to a position remote from the path of hood movement such that the hood may be moved from its blocking position, allowing the actuation member to bemoved to depress the stem.",WD 40 MFG COMPANY,STARZMAN MICHAEL;;FREUDENBERG JOHN;;BATES KEVIN;;KRUPP BENJAMIN;;STATES ROBERT;;PARROT DAVID;;GOOD ROBERT;;DODD JOSEPH;;FALCON SARA,,https://lens.org/026-615-571-600-371,Patent Application,no,10,0,21,21,0,B05B1/1645;;B05B11/0094;;B65D83/303;;B65D83/20;;B65D83/22;;B05B1/1645;;B65D83/22;;B05B11/1059;;B65D83/20;;B65D83/22;;B65D83/24;;B65D83/30;;B65D50/046;;B65D2215/02;;B05B1/1645;;B05B11/0094;;B65D83/303;;B05B11/1059,B65D83/20;;B05B11/00;;B65D50/04;;B65D83/22;;B65D83/24;;B65D83/30,,0,0,,,,ACTIVE
308,WO,A3,WO 2009/137302 A3,138-445-986-522-709,2010-03-04,2010,US 2009/0042001 W,2009-04-28,US 5095408 P,2008-05-06,SINGLE CABLE ANTENNA MODULE FOR LAPTOP COMPUTER AND MOBILE DEVICES,"Implementations and examples of wireless communication systems based on multi-frequency antennas each operating at different frequency bands for wireless communications, including multi-frequency antennas based on metamaterial structures.",RAYSPAN CORP;;POILASNE GREGORY;;ACHOUR MAHA;;GUMMALLA AJAY;;PATHAK VANEET;;BARTSCH RYAN ROBERT;;DODD ANGELA MAE,POILASNE GREGORY;;ACHOUR MAHA;;GUMMALLA AJAY;;PATHAK VANEET;;BARTSCH RYAN ROBERT;;DODD ANGELA MAE,,https://lens.org/138-445-986-522-709,Search Report,yes,6,0,8,22,0,H01Q1/2266;;H01Q1/38;;H01P1/213;;H01Q9/42;;H01Q5/357;;H01Q5/378;;H01Q1/38;;H01Q1/2266;;H01P1/213;;H01Q9/42;;H01Q5/378;;H01Q5/357,H01Q5/10;;H04B1/40,,0,0,,,,PENDING
309,US,B2,US 9588611 B2,199-820-625-139-418,2017-03-07,2017,US 201514599708 A,2015-01-19,US 201514599708 A,2015-01-19,System and method for guarding emergency and critical touch targets,A touch screen system and method that (1) renders a critical button in a visually distinguishable manner and (2) provides an intuitive multi-step activation process that effectively guards the button from unintentional activation is provided.,HONEYWELL INT INC,LANCASTER JEFF;;DE MERS ROBERT E;;DODD SONIA R;;NELSON ERIK T;;ALMQUIST JESSAMY,HONEYWELL INTERNATIONAL INC (2015-01-14),https://lens.org/199-820-625-139-418,Granted Patent,yes,15,0,3,3,0,G06F3/04842;;G06F3/0488;;Y02P90/02;;G06F3/04842;;Y02P90/02;;G06F3/0412;;G06F3/0488;;G06F2203/04104,G06F3/041;;G06F3/0484;;G06F3/0488,,5,0,,,"Alapetite, A., et al.; A Deported View Concept for Touch Interaction, ACHI 2013 : The Sixth International Conference on Advances in Computer-Human Interactions; Copyright (c) IARIA, 2013. ISBN: 978-1-61208-250-9.;;Voelker, S., et al.; An Evaluation of State Switching Methods for Indirect Touch Systems, Session: Tables and Floors CHI 2013: Changing Perspectives, Paris, France, 2013.;;Sorrill, S.L.; What Safety Initiatives Have Been Introduced in Response to; Southern Illinois University Carbondale Open SIUC, 2013.;;Thurber, M.; Garmin G5000 Adds Vision to Learjet Cockpit, Business Aviation, Oct. 3, 2012.;;Extended EP Search Report for Application No. 15194178.8-1507 dated Nov. 5, 2011.",ACTIVE
310,WO,A2,WO 2009/137302 A2,098-833-128-364-658,2009-11-12,2009,US 2009/0042001 W,2009-04-28,US 5095408 P,2008-05-06,SINGLE CABLE ANTENNA MODULE FOR LAPTOP COMPUTER AND MOBILE DEVICES,"Implementations and examples of wireless communication systems based on multi-frequency antennas each operating at different frequency bands for wireless communications, including multi-frequency antennas based on metamaterial structures.",RAYSPAN CORP;;POILASNE GREGORY;;ACHOUR MAHA;;GUMMALLA AJAY;;PATHAK VANEET;;BARTSCH RYAN ROBERT;;DODD ANGELA MAE,POILASNE GREGORY;;ACHOUR MAHA;;GUMMALLA AJAY;;PATHAK VANEET;;BARTSCH RYAN ROBERT;;DODD ANGELA MAE,,https://lens.org/098-833-128-364-658,Patent Application,yes,0,1,8,22,0,H01Q1/2266;;H01Q1/38;;H01P1/213;;H01Q9/42;;H01Q5/357;;H01Q5/378;;H01Q1/38;;H01Q1/2266;;H01P1/213;;H01Q9/42;;H01Q5/378;;H01Q5/357,H01Q5/10;;H04B1/40,,0,0,,,,PENDING
311,GR,T3,GR 3024291 T3,041-016-225-951-047,1997-10-31,1997,GR 970401940 T,1997-07-30,FR 9101595 A,1991-02-12,"Beta-carboline derivatives, ligands of benzodiazepine receptors with inverse agonist and benzodiazepine antagonist effects and medicaments containing them",,CENTRE NAT RECH SCIENT,DODD ROBERT;;POTIER PIERRE;;ROSSIER JEAN;;DOREY GILBERT;;DUBOIS LAURENT;;PRADO DE CARVALHO LIA,,https://lens.org/041-016-225-951-047,Granted Patent,no,0,0,13,13,0,C07D405/04;;C07D471/14;;C07D491/14;;A61P25/20;;C07D405/04;;C07D471/14;;C07D491/14,A61K31/435;;A61K31/55;;A61P25/20;;C07D405/04;;C07D471/14;;C07D491/14;;C07D491/147;;C07D495/14,,0,0,,,,EXPIRED
312,US,B2,US 11285133 B2,108-028-117-876-606,2022-03-29,2022,US 201816492502 A,2018-03-08,EP 17305257 A;;EP 2018055820 W,2017-03-09,2- or 3-imidazolines as carbapenemases inhibitors,"The present application relates to novel 3-imidazolines of formula (I′) and (I) below: (I′) (I) Wherein Ar 1 , Ar 2 , Ar 3 , and R 1 to R 6 are as defined in the claims. The 3-imidazolines of the invention are useful in antibiotic therapies, in particular as inhibitors of carbapenemases. They are also useful as antibiotics themselves. The present invention also concerns a method for preparing more specifically the 3-imidazolines of formula (I). The present invention further relates to conjugates of said compounds with known antibiotics.",CENTRE NAT RECH SCIENT;;UNIV PARIS SUD;;ASSIST PUBLIQUE—HOPITAUX DE PARIS,CARIOU KEVIN;;DODD ROBERT;;ROMERO EUGÉNIE;;BENCHEKROUN MOHAMED;;IORGA BOGDAN;;NAAS THIERRY;;OUESLATI SAOUSSEN,UNIVERSITÉ PARIS-SUD (2019-09-03);;ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (2019-09-02);;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (2019-09-02);;UNIVERSITE PARIS-SACLAY (2022-01-12),https://lens.org/108-028-117-876-606,Granted Patent,yes,5,0,9,9,0,C07D233/20;;A61P31/04;;A61K47/552;;A61K31/407;;A61K31/4164;;C07D233/06;;C07D233/22;;C07D233/24,C07D233/06;;A61K31/407;;A61K31/4164;;A61K47/55;;C07D233/22;;C07D233/24,,9,5,053-755-959-589-328;;033-005-058-351-875;;006-306-488-334-645;;053-755-959-589-328;;006-306-488-334-645,23252919;;10.1021/ol303302r;;10.1016/j.bmc.2004.08.039;;15498657;;27955926;;10.1016/j.bmc.2016.11.051;;23252919;;10.1021/ol303302r;;27955926;;10.1016/j.bmc.2016.11.051,"Hui Chen et al., Org. Letters (2013) vol. 15(1) pp. 212-215.;;Venkatesan et al. (BioOrg & Med Chem'2004). pp. 5807-5817.;;Zhao et al. (BioOrg & Med Chem'2017)pp. 750-758.;;Vippagunta et al. (2001).;;International Search Report dated Apr. 20, 2018 in International Application No. PCT/EP2018/055820.;;Chen, et al., “Copper-Catalyzed Aliphatic C—H Amination with an Amidine Moiety”, 2013, pp. 212-215, vol. 15, No. 1, Organic Letters.;;Aranapakam, et al., “Novel imidazole substituted 6-methylidene-penems as broad-spectrum β-lactamase inhibitors”, 2004, pp. 5807-5817, vol. 12, Bioorganic & Medicinal Chemistry.;;DONGMEI ZHAO, SHIZHEN ZHAO, LIYU ZHAO, XIANGQIAN ZHANG, PENG WEI, CHUNCHI LIU, CHENZHOU HAO, BIN SUN, XIN SU, MAOSHENG CHENG: ""Discovery of biphenyl imidazole derivatives as potent antifungal agents: Design, synthesis, and structure-activity relationship studies"", BIOORGANIC & MEDICINAL CHEMISTRY, 1 January 2017 (2017-01-01), pages 750 - 758, XP055465906, Retrieved from the Internet <URL:http://www.heteroletters.org/issue43/PDF/Paper-13.pdf> DOI: 10.1016/j.bmc.2016.11.051;;Dabholkar, Vijay V. et al., “Chemistry of Novel Biphenyl Imidazole—Their Synthesis & Microbial Evaluation”, Heterocyclic Letters, vol. 4: (2) 409-415 (2014).",ACTIVE
313,ES,T3,ES 2103904 T3,123-854-541-634-989,1997-10-01,1997,ES 92400351 T,1992-02-11,FR 9101595 A,1991-02-12,COMPUESTOS DERIVADOS DE LAS BETA-CARBOLINAS LIGANTES DEL RECEPTOR DE LAS BENZODIACEPINAS QUE TIENEN UN EFECTO AGONISTA INVERSO Y ANTAGONISTA CON RESPECTO A LAS BENZODIACEPINAS Y MEDICAMENTOS QUE LOS CONTIENEN.,"LA INVENCION SE REFIERE A NUEVOS COMPUESTOS DERIVADOS DE LAS (BETA)-CARBOLINAS Y QUE SON LIGANDOS DEL RECEPTOR DE LAS BENZODIACEPINAS QUE TIENEN UN EFECTO AGONISTA INVERSO Y ANTAGONISTA RESPECTO DE LAS BENZODIACEPINAS. ESTOS COMPUESTOS RESPONDEN A LAS FORMULAS (I), (II): EN LAS QUE: X ES O, S, O REPRESENTA EL RADICAL -N(R SUB 6)-C(=O)-CH SUB 2-X, R SUB 1 ES UN RADICAL HIDROXI, ALCOXI, ALQUIL SUSTITUIDO POR UN RADICAL HIDROXI O ALCOXI, R SUB 2 ES UN ATOMO DE HIDROGENO O UN RADICAL ALQUIL, HIDROXI, ALCOXI, BENCILOXI, PUDIENDO DICHOS RADICALES ESTAR EVENTUALMENTE SUSTITUIDOS, R SUB 3, R SUB 4, R SUB 5 Y R SUB 6 SON ELEGIDOS ENTRE EL ATOMO DE HIDROGENO O UN RADICAL ALQUILO EVENTUALMENTE SUSTITUIDO POR UN RADICAL HIDROXI, ALCOXI, ALCOXI-CARBONILMETILO, ASI COMO A LOS DERIVADOS TETRAHIDRO DE (BETA)-CARBOLINA CORRESPONDIENTES Y A LAS SALES O DERIVADOS DE AMONIO CUATERNARIOS DE ESTOS COMPUESTOS FARMACEUTICAMENTE ACEPTABLES.",CENTRE NAT RECH SCIENT,DODD ROBERT;;POTIER PIERRE;;ROSSIER JEAN;;DOREY GILBERT;;DUBOIS LAURENT;;PRADO DE CARVALHO LIA,,https://lens.org/123-854-541-634-989,Granted Patent,no,0,0,13,13,0,C07D405/04;;C07D471/14;;C07D491/14;;A61P25/20;;C07D405/04;;C07D471/14;;C07D491/14,A61K31/435;;A61K31/55;;A61P25/20;;C07D405/04;;C07D471/14;;C07D491/14;;C07D491/147;;C07D495/14,,0,0,,,,EXPIRED
314,CN,A,CN 115263925 A,187-319-392-969-423,2022-11-01,2022,CN 202210340100 A,2022-04-01,US 202117245671 A,2021-04-30,Liquid metal bearing structure with enhanced sealing structure,"The invention relates to a liquid metal bearing structure with an enhanced sealing structure. The invention provides a bearing arrangement for an X-ray tube, the bearing arrangement comprising a journal bearing shaft having a radially projecting thrust bearing encased within a sleeve. The structure of the sleeve forms enlarged wells or voids in the sleeve that are disposed adjacent to various rotating anti-wetting seals/sealing surfaces formed between the sleeve and the shaft. The geometry of the trap is formed to retain the liquid metal/lubricating fluid within the gap defined by the bearing assembly and direct the liquid metal to flow outwardly from the gap defined between the sleeve and the shaft away from the rotating anti-wetting seal and back into the gap. This geometry allows centrifugal forces exerted on the liquid metal by rotation of the bearing structure to move the flowing-out liquid metal away from the rotating dampproof seal, thereby significantly reducing contact of the liquid metal with the seal.",GE PRECISION MEDICINE LLC,HUNTER IAN STRIDER;;DODD JAMES;;BERNDT KENNETH R;;LOUBAR ERIC;;TRISCARI ANDREW;;DANN ROBERT,,https://lens.org/187-319-392-969-423,Patent Application,no,0,0,6,6,0,F16C33/103;;F16C33/1065;;F16C33/106;;F16C17/26;;H01J35/104;;F16C2380/16;;H01J35/104;;H01J2235/106;;H01J2235/1066;;F16C2380/16;;F16C2210/08;;F16C17/02;;F16C33/106;;F16C33/103;;F16C33/1085;;F16C33/74;;F16C17/026;;F16C2223/00;;F16C33/109;;H01J35/104;;H01J2235/1053;;H01J2235/1066;;H01J2235/1086,F16C33/10;;F16C17/26;;H01J35/10,,0,0,,,,PENDING
315,DE,T2,DE 69219379 T2,177-761-545-259-596,1997-12-11,1997,DE 69219379 T,1992-02-11,FR 9101595 A,1991-02-12,"Beta-carbolinderivate, Ligande für Benzodiazepinrezeptoren mit agonistischer Inverse und Benzodiazepinantasonistische Wirkungen und diese enthaltende Arzneimittel",,CENTRE NAT RECH SCIENT,DODD ROBERT;;POTIER PIERRE;;ROSSIER JEAN;;DOREY GILBERT;;DUBOIS LAURENT;;PRADO DE CARVALHO LIA,,https://lens.org/177-761-545-259-596,Granted Patent,no,0,0,13,13,0,C07D405/04;;C07D471/14;;C07D491/14;;A61P25/20;;C07D405/04;;C07D471/14;;C07D491/14,A61K31/435;;A61K31/55;;A61P25/20;;C07D405/04;;C07D471/14;;C07D491/14;;C07D491/147;;C07D495/14,,0,0,,,,EXPIRED
316,FR,A1,FR 2812875 A1,194-607-989-002-928,2002-02-15,2002,FR 0010427 A,2000-08-08,FR 0010427 A,2000-08-08,NOUVELLES DIAMINES POSSEDANT UNE ACTIVITE MODULATRICE DES CASR ET LEUR MODE DE PREPARATION,"<P>La présente invention concerne donc les diamines de formule générale (I) : (CF DESSIN DANS BOPI) dans laquelle : A représente un groupe A1 ou A2 de formule générale suivante : (CF DESSIN DANS BOPI) B représente un groupe B1 ou B2 de formule générale suivante : (CF DESSIN DANS BOPI) X représente un groupe SO2 , CH2 , C=O ou COO, (CF DESSIN DANS BOPI) représente un groupe deformule CH (R25) -CH (R26) ou CH (R27) =CH (R28) et R1 à R28, identiques ou différents, représentent, indépendamment l'un de l'autre, un atome d'hydrogène oud'halogène ou un groupe alkyle, cycloalkyle, CN, NO2 , hydroxy, aryle, aralkyle, alcoxy, aryloxy, amino, alkylamino, dialkylamino, cycloalkylamino, arylamino, arylalkylamino, diarylamino, diarylalkylamino, trihalogénoalkyle ou trihalogénoalcoxy, à la condition que dans le groupe A1, au moins un des radicaux R1, R2, R3, R4 ou R5 représente l'atome d'hydrogène lorsque les quatre autres ne représentent pas l'atome d'hydrogène et dans le groupe B1, au moins un des radicaux R13, R14, R15, R16 ou R17 représente l'atome d'hydrogène lorsque les quatre autres ne représentent pas l'atome d'hydrogène, et leurs sels avec un acide pharmaceutiquement acceptable, sous forme de mélange racémique ou de leurs isomères optiquement purs.Elle concerne également leur préparation, les compositions pharmaceutiques les comprenant et leur utilisation comme modulateur de l'activité CaSR et comme médicament destiné de préférence au traitement des maladies ou des désordres physiologiques faisant intervenir la modulation de l'activité des CaSR.</P>",CENTRE NAT RECH SCIENT,DAUBAN PHILIPPE MARCEL;;DODD ROBERT;;FAURE HELENE VERONIQUE;;RUAT MARTIAL;;POTIER PIERRE JEAN PAUL,,https://lens.org/194-607-989-002-928,Patent Application,no,3,0,9,9,0,A61P19/10;;A61P29/00;;A61P35/00;;C07C311/29;;C07C311/29;;C07B2200/07;;C07B2200/07;;C07C211/36;;C07C211/36;;C07C311/20;;C07C311/20;;C07C2601/14;;C07C2601/14;;C07D203/26;;C07D203/26,A61P19/10;;A61K31/18;;A61P29/00;;A61P35/00;;C07B53/00;;C07B55/00;;C07C209/60;;C07C211/36;;C07C303/40;;C07C311/20;;C07C311/29;;C07D203/26,,5,5,018-469-980-911-127;;016-159-301-798-016;;080-106-548-907-87X;;067-172-220-793-586;;074-724-826-995-461,10.1016/s0957-4166(00)80266-9;;10.1002/ardp.19933260711;;10.1002/hlca.19970800407;;10.1016/s0040-4039(97)01589-x;;10.1016/0040-4020(95)00999-x,"W.H. SCHLICHTER, ET AL.: ""Novel, enantioselective synthesis of vicinal cyclohexanediamines as key-intermediates for highly selective opioid kappa and sigma agonists"", TETRAHEDRON: ASYMMETRY, vol. 3, no. 3, 1992, Elsevier Science Publishers, Amsterdam, NL, pages 329 - 333, XP000992877, ISSN: 0957-4166;;W.H. SCHLICHTER, ET AL.: ""Asymmetric reductive amination of cycloakanones, XIII. Enantioselective amidoamination: a new regiospecific strategy for the synthesis of chiral cyclohexane-1,2-diamino-derivatives"", ARCHIV DER PHARMAZIE, vol. 326, no. 7, 1993, VCH Verlagsgesellschaft, Weinheim, DE, pages 429 - 436, XP000992867, ISSN: 0365-6233;;I. NÄGELI, ET AL.: ""Rhodium(II)-catalysed CH insertions with {[(4-nitrophenyl)sulphonyl]imino}phenyl-lambda3-iodane"", HELVETICA CHIMICA ACTA, vol. 80, no. 4, 30 June 1997 (1997-06-30), Verlag Helvetica Chimica Acta, Bâle, CH, pages 1087 - 1105, XP002165375, ISSN: 0018-019X;;M.J. SODERGREN, ET AL.: ""Preparation and evaluation of nitrene precursors (PhI=NOS2Ar) for the copper-catalysed aziridination of olefins"", TETRAHEDRON LETTERS, vol. 38, no. 39, 29 September 1997 (1997-09-29), Elsevier Science Publishers, Amsterdam, NL, pages 6897 - 6900, XP004090314, ISSN: 0040-4039;;P. MÜLLER, ET AL.: ""A method for rhodium(II)-catalysed aziridination of olefins"", TETRAHEDRON LETTERS, vol. 52, no. 5, 29 January 1996 (1996-01-29), Elsevier Science Publishers, Amsterdam, NL, pages 1543 - 1548, XP004104459, ISSN: 0040-4039",EXPIRED
317,DE,T8,DE 69731237 T8,148-120-946-066-347,2006-08-24,2006,DE 69731237 T,1997-10-23,US 73647196 A;;US 73647096 A;;US 94707597 A;;US 95118497 A;;US 9718954 W,1996-10-24,VERFAHREN ZUR VERMINDERUNG VON KÖRPERGERUCH,"The present invention relates to an odor absorbing composition, which is safe for use on human skin, comprising from 0.1 % to 5 %, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from 0.1 % to 36 %, by weight of the composition, of an oil phase selected from the group consisting of emollients, moisturizers, and skin protectants; an emulsifier; and an aqueous carrier. The odor absorbing compositions of the present invention may also contain an effective amount of hydrophobic antimicrobials. The present invention also relates to the use of cyclodextrin-containing compositions for the manufacture of an odor absorbing composition, which is safe for use on skin, for controlling environmental malodors on skin and for reducing body odor and/or vaginal odor.",PROCTER & GAMBLE,TRINH TOAH;;DODD THOMAS;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;BUCKNER YAGER;;KAJS MARIE,,https://lens.org/148-120-946-066-347,Amended Patent,no,0,0,24,28,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61Q15/00;;D06M13/005;;A61K8/73;;A61Q15/00,A61K8/00;;A61K8/73;;A61K8/02;;A61K8/04;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/44;;A61Q15/00;;D06M13/00,,0,0,,,,EXPIRED
318,TW,B,TW I446731 B,007-586-339-327-105,2014-07-21,2014,TW 98114614 A,2009-05-01,US 5095408 P;;US 43168909 A;;US 2009/0042001 W,2008-05-06,Single cable antenna module for laptop computer and mobile devices,,HOLLINWORTH FUND L L C,POILASNE GREGORY;;ACHOUR MAHA;;GUMMALLA AJAY;;PATHAK VANEET;;BARTSCH RYAN ROBERT;;DODD ANGELA MAE,,https://lens.org/007-586-339-327-105,Granted Patent,no,0,0,8,22,0,H01Q1/2266;;H01Q1/38;;H01P1/213;;H01Q9/42;;H01Q5/357;;H01Q5/378;;H01Q1/38;;H01Q1/2266;;H01P1/213;;H01Q9/42;;H01Q5/378;;H01Q5/357,H01Q5/10,,0,0,,,,INACTIVE
319,US,B2,US 9129243 B2,132-781-723-218-670,2015-09-08,2015,US 13189108 A,2008-06-02,US 13189108 A;;US 94157607 P,2007-06-01,Apparatus and methods for strategic planning by utilizing roadmapping,"A system for performing strategic planning. At least one processor and memory are configured to, based on user input, provide a plurality of roadmaps, and link a data point of a first roadmap to a data point of a second roadmap to integrate at least portions of the first and second roadmaps. “Intelligent” roadmapping can be provided wherein the system scans relationships in data from different sources and loads related categories and data points onto a combined roadmap.",BUSHELL DONALD K;;MAKI ROBERT L;;DODD LEE;;HREN MICHAEL S;;HINSON JANICE L;;BOEING CO,BUSHELL DONALD K;;MAKI ROBERT L;;DODD LEE;;HREN MICHAEL S;;HINSON JANICE L,THE BOEING COMPANY (2008-10-22),https://lens.org/132-781-723-218-670,Granted Patent,yes,28,3,2,2,0,G06Q10/0633;;G06Q10/0633;;G06Q10/06;;G06Q10/06;;G06Q10/06316;;G06Q10/06316;;G06Q10/0637;;G06Q10/0637;;G06Q10/067;;G06Q10/067,G06Q10/06,,12,4,074-703-064-299-714;;070-521-369-383-973;;017-800-207-958-439;;063-231-896-914-124,10.1109/edoc.2006.60;;10.1109/iemc.2002.1038558;;10.1016/j.compind.2003.10.001;;10.1016/j.techfore.2003.10.002,"Troux Technologies, ""Corporate Fact Sheet,"" Obtained via archives of May 13, 2006 from the Wayback Machine.;;Ernst, ""Tool Support for Enterprise Architecture Management-Strengths and Weaknesses,"" 2006, Proc. of the 10th IEEE Int'l Enterprise Distributed Object Computing Conference.;;Computas website, 2004, http://www.computas.com/, retrieved from Internet archive.;;Trouxmetis website, Apr. 18, 2006, http://www.computas.com/, retrieved from Internet archive.;;Dragstra, ""Enterprise Architecture,"" Apr. 2005, Master's Thesis, Department of Mathematics and Computing Science, retrieved from http://alexandria.tue.nl/extra2/afstversl/wsk-i/dragstra2005.pdf.;;Dragstra, ""Enterprise Architecture,"" Apr. 2005, Master's Thesis, Department of Mathematics and Computing Science, available at http://alexandria.tue.nl/extra2/afstversl/wsk-i/dragstra2005.pdf.;;Duckles, ""Purdue's Center for Technology Roadmapping: A Resource for Research and Education in Technology Roadmapping,"" 2002, Engineering Management Conference, IEMC '02, vol. 2, pp. 900-904.;;""The Learning Trust"" website, http://www.learningtrust.com, dated Mar. 19, 2003 and Apr. 17, 2003, from the Internet Archive.;;van der Aalst, ""Process mining: a research agenda,"" 2004, Computers in Industry, vol. 53, pp. 231-244.;;Rinne, ""Technology roadmaps: Infrastructure for innovation,"" 2004, Technological Forecasting & Social Change, vol. 71, pp. 67-80.;;Vision Strategist is the currently recognized Enterprise System for Roadmapping. The website is http://www.alignent.com/products/visionstrategist/ , 2008.;;Lee Sherman, ""Enterprise Modeling Tools-Map business operations to enterprise infrastructure using architectural models"", Enterprise Architect, May 4, 2007, 6 pages.",INACTIVE
320,FR,A1,FR 2672602 A1,136-915-203-931-209,1992-08-14,1992,FR 9101595 A,1991-02-12,FR 9101595 A,1991-02-12,COMPOSES DERIVES DES BETA-CARBOLINES LIGANDS DU RECEPTEUR DES BENZODIAZEPINES AYANT UN EFFET AGONISTE INVERSE ET ANTAGONISTE VIS-A-VIS DES BENZODIAZEPINES ET MEDICAMENTS LES CONTENANT.,"<P>L'invention se rapporte à de nouveaux composés dérivés des beta -carbolines et qui sont des ligands du récepteur des benzodiazépines ayant un effet agoniste inverse et antagoniste vis-à-vis des benzodiazépines. Ces composés répondent aux formules: <BR/>(CF DESSIN DANS BOPI)<BR/> <BR/> dans lesquelles: <BR/>(CF DESSIN DANS BOPI)<BR/> <BR/> R1 est un radical hydroxy, alcoxy, alkyl substitué par un radical hydroxy ou alcoxy, <BR/> R2 est un atome d'hydrogène ou un radical alkyl, hydroxy, alcoxy, acyloxy, benzyloxy, lesdits radicaux pouvant être éventuellement substitués, <BR/> R3 , R4 , R5 et R6 sont choisis parmi l'atome d'hydrogène ou un radical alkyle éventuellement substitué par un radical hydroxy, alcoxy, alkoxycarbonylméthyle, <BR/> ainsi que les dérivés tétrahydro de beta-carboline correspondants et les sels ou dérivés d'ammonium quaternaires de ces composés pharmaceutiquement acceptables.</P>",CENTRE NAT RECH SCIENT,ROBERT DODD;;PIERRE POTIER;;JEAN ROSSIER;;GILBERT DOREY;;LAURENT DUBOIS;;LIA PRADO DE CARVALHO,,https://lens.org/136-915-203-931-209,Patent Application,no,1,0,13,13,0,C07D405/04;;C07D471/14;;C07D491/14;;A61P25/20;;C07D405/04;;C07D471/14;;C07D491/14,A61K31/435;;A61K31/55;;A61P25/20;;C07D405/04;;C07D471/14;;C07D491/14;;C07D491/147;;C07D495/14,,0,0,,,,EXPIRED
321,EP,A1,EP 0499527 A1,052-723-181-059-525,1992-08-19,1992,EP 92400351 A,1992-02-11,FR 9101595 A,1991-02-12,"Beta-carboline derivatives, ligands of benzodiazepine receptors with inverse agonist and benzodiazepine antagonist effects and medicaments containing them.","L'invention se rapporte à de nouveaux composés dérivés des β-carbolines et qui sont des ligands du récepteur des benzodiazépines ayant un effet agoniste inverse et antagoniste vis-à-vis des benzodiazépines. Ces composés répondent aux formules :
  
 dans lesquelles : 
X est O, S,
  
 ou bien
  
 représente le radical -N(R₆)-C(=O)-CH₂-X, 
R₁ est un radical hydroxy, alcoxy, alkyl substitué par un radical hydroxy ou alcoxy, 
R₂ est un atome d'hydrogène ou un radical alkyl, hydroxy, alcoxy, acyloxy, benzyloxy, lesdits radicaux pouvant être éventuellement substitués, 
R₃, R₄, R₅ et R₆ sont choisis parmi l'atome d'hydrogène ou un radical alkyle éventuellement substitué par un radical hydroxy, alcoxy, alkoxy-carbonylmethyle, 
ainsi que les dérivés tétrahydro de β-carboline correspondants et les sels ou dérivés d'ammonium quaternaires de ces composés pharmaceutiquement acceptables.",CENTRE NAT RECH SCIENT,DODD ROBERT;;POTIER PIERRE;;ROSSIER JEAN;;DOREY GILBERT;;DUBOIS LAURENT;;PRADO DE CARVALHO LIA,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS (1997-03-26);;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (1993-03-17),https://lens.org/052-723-181-059-525,Patent Application,yes,1,2,13,13,0,C07D405/04;;C07D471/14;;C07D491/14;;A61P25/20;;C07D405/04;;C07D471/14;;C07D491/14,A61K31/435;;A61K31/55;;A61P25/20;;C07D405/04;;C07D471/14;;C07D491/14;;C07D491/147;;C07D495/14,,0,0,,,,EXPIRED
322,US,A1,US 2009/0316612 A1,090-273-766-961-808,2009-12-24,2009,US 43168909 A,2009-04-28,US 43168909 A;;US 5095408 P,2008-05-06,Single Cable Antenna Module for Laptop Computer and Mobile Devices,"Implementations and examples of wireless communication systems based on multi-frequency antennas each operating at different frequency bands for wireless communications, including multi-frequency antennas based on metamaterial structures.",RAYSPAN CORP,POILASNE GREGORY;;ACHOUR MAHA;;GUMMALLA AJAY;;PATHAK VANEET;;BARTSCH RYAN ROBERT;;DODD ANGELA MAE,HOLLINWORTH FUND L.L.C (2011-09-26);;RAYSPAN CORPORATION (2009-04-27),https://lens.org/090-273-766-961-808,Patent Application,yes,9,41,8,22,0,H01Q1/2266;;H01Q1/38;;H01P1/213;;H01Q9/42;;H01Q5/357;;H01Q5/378;;H01Q1/38;;H01Q1/2266;;H01P1/213;;H01Q9/42;;H01Q5/378;;H01Q5/357,H01Q5/10;;H04L5/00;;H04W4/00,370/297;;370/329,0,0,,,,DISCONTINUED
323,EP,A4,EP 2279566 A4,120-531-860-190-267,2015-01-21,2015,EP 09743289 A,2009-04-28,US 2009/0042001 W;;US 5095408 P,2008-05-06,SINGLE CABLE ANTENNA MODULE FOR LAPTOP COMPUTER AND MOBILE DEVICES,,HOLLINWORTH FUND L L C;;ACHOUR MAHA,ACHOUR MAHA;;POILASNE GREGORY;;GUMMALLA AJAY;;PATHAK VANEET;;BARTSCH RYAN ROBERT;;DODD ANGELA MAE,"ACHOUR, MAHA (2011-12-21);;HOLLINWORTH FUND , L.L.C. (2011-12-21)",https://lens.org/120-531-860-190-267,Search Report,no,6,0,8,22,0,H01Q1/2266;;H01Q1/38;;H01P1/213;;H01Q9/42;;H01Q5/357;;H01Q5/378;;H01Q1/38;;H01Q1/2266;;H01P1/213;;H01Q9/42;;H01Q5/378;;H01Q5/357,H01Q5/00;;H01P1/213;;H01Q1/22;;H01Q1/38;;H01Q5/10;;H01Q9/42,,1,1,049-269-743-702-477,10.1002/0471754323,"""Electromagnetic Metamaterials"", 11 November 2005, JOHN WILEY & SONS, Hoboken, NJ, USA, ISBN: 978-0-47-166985-2, article CHRISTOPHE CALOZ ET AL: ""ELECTROMAGNETIC METAMATERIALS: TRANSMISSION LINE THEORY AND MICROWAVE APPLICATIONS The Engineering Approach"", XP055155260",DISCONTINUED
324,US,A,US 5258385 A,152-175-764-008-042,1993-11-02,1993,US 83439992 A,1992-02-12,FR 9101595 A,1991-02-12,"beta -Carboline-derived compounds, lamchart benzodiazepine-receptor ligands, having an inverse agonist and antagonist effect on benzodiazepines, and drugs containing them","The invention relates to novel .beta.-carboline-derived compounds which are benzodiazepine-receptor ligands having an inverse agonist and antagonist effect on benzodiazepines. These compounds are of the formulae: ##STR1## in which: X is O, S, ##STR2## or alternatively, ##STR3## represents the radical --N(R.sub.6)--C(=O)--CH.sub.2 --X, R.sub.1 is a hydroxyl, alkoxy or alkyl radical substituted by a hydroxyl or alkoxy radical, R.sub.2 is a hydrogen atom or an alkyl, hydroxyl, alkoxy, acyloxy or benzyloxy radical, it being possible for said radicals to be optionally substituted, R.sub.3, R.sub.4, R.sub.5 and R.sub.6 are chosen from a hydrogen atom or an alkyl radical optionally substituted by a hydroxyl, alkoxy or alkoxycarbonylmethyl radical, as well as the corresponding tetrahydro derivatives of .beta.-carboline and the quaternary ammonium salts or derivatives of these pharmaceutically acceptable compounds.",CENTRE NAT RECH SCIENT,DODD ROBERT;;POTIER PIERRE;;ROSSIER JEAN;;DOREY GILBERT;;DUBOIS LAURENT;;PRADO DE CARVALHO LIA,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (1992-01-21),https://lens.org/152-175-764-008-042,Granted Patent,yes,2,4,13,13,0,C07D405/04;;C07D471/14;;C07D491/14;;A61P25/20;;C07D405/04;;C07D471/14;;C07D491/14,A61K31/55;;A61P25/20;;C07D405/04;;A61K31/435;;C07D471/14;;C07D491/14;;C07D491/147;;C07D495/14,514/287;;546/64,1,0,,,"Mann et al., J. of Chem. Soc., Part XIII, pp. 3830 3833, 1959.",EXPIRED
325,US,A1,US 2009/0048882 A1,176-503-659-187-449,2009-02-19,2009,US 13189108 A,2008-06-02,US 13189108 A;;US 94157607 P,2007-06-01,APPARATUS AND METHODS FOR STRATEGIC PLANNING,"A system for performing strategic planning. At least one processor and memory are configured to, based on user input, provide a plurality of roadmaps, and link a data point of a first roadmap to a data point of a second roadmap to integrate at least portions of the first and second roadmaps. “Intelligent” roadmapping can be provided wherein the system scans relationships in data from different sources and loads related categories and data points onto a combined roadmap.",BUSHELL DONALD K;;MAKI ROBERT L;;DODD LEE;;HREN MICHAEL S;;HINSON JANICE L,BUSHELL DONALD K;;MAKI ROBERT L;;DODD LEE;;HREN MICHAEL S;;HINSON JANICE L,THE BOEING COMPANY (2008-10-22),https://lens.org/176-503-659-187-449,Patent Application,yes,28,5,2,2,0,G06Q10/0633;;G06Q10/0633;;G06Q10/06;;G06Q10/06;;G06Q10/06316;;G06Q10/06316;;G06Q10/0637;;G06Q10/0637;;G06Q10/067;;G06Q10/067,G06Q10/00,705/7,9,4,074-703-064-299-714;;070-521-369-383-973;;017-800-207-958-439;;063-231-896-914-124,10.1109/edoc.2006.60;;10.1109/iemc.2002.1038558;;10.1016/j.compind.2003.10.001;;10.1016/j.techfore.2003.10.002,"Dragstra, ""Enterprise Architecture,"" April 2005, Master's Thesis, Department of Mathematics and Computing Science, retrieved from http://alexandria.tue.nl/extra2/afstversl/wsk-i/dragstra2005.pdf;;Ernst, ""Tool Support for Enterprise Architecture Management - Strengths and Weaknesses,"" 2006, Proc. of the 10th IEEE Int'l Enterprise Distributed Object Computing Conference;;Computas website, 2004, http://www.computas.com/, retrieved from Internet archive;;Trouxmetis website, 4/18/06, http://www.computas.com/, retrieved from Internet archive;;Dragstra, ""Enterprise Architecture,"" April 2005, Master's Thesis, Department of Mathematics and Computing Science, available at http://alexandria.tue.nl/extra2/afstversl/wsk-i/dragstra2005.pdf;;Duckles, ""Purdue's Center for Technology Roadmapping: A Resource for Research and Education in Technology Roadmapping,"" 2002, Engineering Management Conference, IEMC '02, Vol. 2, pp. 900-904;;""The Learning Trust"" website, http://www.learningtrust.com, dated 3/19/03 and 4/17/03, from the Internet Archive;;van der Aalst, ""Process mining: a research agenda,"" 2004, Computers in Industry, Vol. 53, pp. 231-244;;Rinne, ""Technology roadmaps: Infrastructure for innovation,"" 2004, Technological Forecasting & Social Change, Vol. 71, pp. 67-80",INACTIVE
326,AT,T1,AT E152452 T1,013-967-782-473-402,1997-05-15,1997,AT 92400351 T,1992-02-11,FR 9101595 A,1991-02-12,"BETA-CARBOLINDERIVATE, LIGANDE FÜR BENZODIAZEPINREZEPTOREN MIT AGONISTISCHER INVERSE UND BENZODIAZEPINANTASONISTISCHE WIRKUNGEN UND DIESE ENTHALTENDE ARZNEIMITTEL",,CENTRE NAT RECH SCIENT,DODD ROBERT;;POTIER PIERRE;;ROSSIER JEAN;;DOREY GILBERT;;DUBOIS LAURENT;;PRADO DE CARVALHO LIA,,https://lens.org/013-967-782-473-402,Granted Patent,no,0,0,13,13,0,C07D405/04;;C07D471/14;;C07D491/14;;A61P25/20;;C07D405/04;;C07D471/14;;C07D491/14,A61K31/435;;A61K31/55;;A61P25/20;;C07D405/04;;C07D471/14;;C07D491/14;;C07D491/147;;C07D495/14,,0,0,,,,DISCONTINUED
327,DE,D1,DE 69219379 D1,077-872-478-588-934,1997-06-05,1997,DE 69219379 T,1992-02-11,FR 9101595 A,1991-02-12,"Beta-carbolinderivate, Ligande für Benzodiazepinrezeptoren mit agonistischer Inverse und Benzodiazepinantasonistische Wirkungen und diese enthaltende Arzneimittel",,CENTRE NAT RECH SCIENT,DODD ROBERT;;POTIER PIERRE;;ROSSIER JEAN;;DOREY GILBERT;;DUBOIS LAURENT;;PRADO DE CARVALHO LIA,,https://lens.org/077-872-478-588-934,Granted Patent,no,0,0,13,13,0,C07D405/04;;C07D471/14;;C07D491/14;;A61P25/20;;C07D405/04;;C07D471/14;;C07D491/14,A61K31/435;;A61K31/55;;A61P25/20;;C07D405/04;;C07D471/14;;C07D491/14;;C07D491/147;;C07D495/14,,0,0,,,,EXPIRED
328,DE,D1,DE 69731237 D1,102-167-789-257-316,2004-11-18,2004,DE 69731237 T,1997-10-23,US 73647196 A;;US 73647096 A;;US 94707597 A;;US 95118497 A;;US 9718954 W,1996-10-24,VERFAHREN ZUR VERMINDERUNG VON KÖRPERGERUCH,"The present invention relates to an odor absorbing composition, which is safe for use on human skin, comprising from 0.1 % to 5 %, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from 0.1 % to 36 %, by weight of the composition, of an oil phase selected from the group consisting of emollients, moisturizers, and skin protectants; an emulsifier; and an aqueous carrier. The odor absorbing compositions of the present invention may also contain an effective amount of hydrophobic antimicrobials. The present invention also relates to the use of cyclodextrin-containing compositions for the manufacture of an odor absorbing composition, which is safe for use on skin, for controlling environmental malodors on skin and for reducing body odor and/or vaginal odor.",PROCTER & GAMBLE,TRINH TOAN;;DODD THOMAS;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;BUCKNER YAGER;;KAJS MARIE,,https://lens.org/102-167-789-257-316,Granted Patent,no,0,0,24,28,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61Q15/00;;D06M13/005;;A61K8/73;;A61Q15/00,A61K8/00;;A61K8/02;;A61K8/04;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/44;;A61K8/73;;A61Q15/00;;D06M13/00,,0,0,,,,EXPIRED
329,TW,A,TW 200950363 A,114-728-838-774-129,2009-12-01,2009,TW 98114614 A,2009-05-01,US 5095408 P;;US 43168909 A;;US 2009/0042001 W,2008-05-06,Single cable antenna module for laptop computer and mobile devices,"Implementations and examples of wireless communication systems based on multi-frequency antennas each operating at different frequency bands for wireless communications, including multi-frequency antennas based on metamaterial structures.",RAYSPAN CORP,POILASNE GREGORY;;ACHOUR MAHA;;GUMMALLA AJAY;;PATHAK VANEET;;BARTSCH RYAN ROBERT;;DODD ANGELA MAE,,https://lens.org/114-728-838-774-129,Patent of Addition,no,0,3,8,22,0,H01Q1/2266;;H01Q1/38;;H01P1/213;;H01Q9/42;;H01Q5/357;;H01Q5/378;;H01Q1/38;;H01Q1/2266;;H01P1/213;;H01Q9/42;;H01Q5/378;;H01Q5/357,H04B1/38;;H01Q1/38;;H01Q5/10,,0,0,,,,INACTIVE
330,US,A1,US 2016/0209969 A1,143-914-547-673-388,2016-07-21,2016,US 201514599708 A,2015-01-19,US 201514599708 A,2015-01-19,SYSTEM AND METHOD FOR GUARDING EMERGENCY AND CRITICAL TOUCH TARGETS,A touch screen system and method that (1) renders a critical button in a visually distinguishable manner and (2) provides an intuitive multi-step activation process that effectively guards the button from unintentional activation is provided.,HONEYWELL INT INC,LANCASTER JEFF;;DE MERS ROBERT E;;DODD SONIA R;;NELSON ERIK T;;ALMQUIST JESSAMY,HONEYWELL INTERNATIONAL INC (2015-01-14),https://lens.org/143-914-547-673-388,Patent Application,yes,4,5,3,3,0,G06F3/04842;;G06F3/0488;;Y02P90/02;;G06F3/04842;;Y02P90/02;;G06F3/0412;;G06F3/0488;;G06F2203/04104,G06F3/041;;G06F3/0488,,0,0,,,,ACTIVE
331,WO,A4,WO 2009/137302 A4,181-642-227-176-026,2010-04-22,2010,US 2009/0042001 W,2009-04-28,US 5095408 P,2008-05-06,SINGLE CABLE ANTENNA MODULE FOR LAPTOP COMPUTER AND MOBILE DEVICES,"Implementations and examples of wireless communication systems based on multi-frequency antennas each operating at different frequency bands for wireless communications, including multi-frequency antennas based on metamaterial structures.",RAYSPAN CORP;;POILASNE GREGORY;;ACHOUR MAHA;;GUMMALLA AJAY;;PATHAK VANEET;;BARTSCH RYAN ROBERT;;DODD ANGELA MAE,POILASNE GREGORY;;ACHOUR MAHA;;GUMMALLA AJAY;;PATHAK VANEET;;BARTSCH RYAN ROBERT;;DODD ANGELA MAE,,https://lens.org/181-642-227-176-026,Patent Application,yes,0,0,8,22,0,H01Q1/2266;;H01Q1/38;;H01P1/213;;H01Q9/42;;H01Q5/357;;H01Q5/378;;H01Q1/38;;H01Q1/2266;;H01P1/213;;H01Q9/42;;H01Q5/378;;H01Q5/357,H01Q5/10;;H04B1/40,,0,0,,,,PENDING
332,US,A1,US 2021/0128530 A1,014-510-036-420-102,2021-05-06,2021,US 201816492502 A,2018-03-08,EP 17305257 A;;EP 2018055820 W,2017-03-09,2- OR 3-IMIDAZOLINES AS CARBAPENEMASES INHIBITORS,"The present application relates to novel 3-imidazolines of formula (I′) and (I) below: (I′) (I) Wherein Ar 1 , Ar 2 , Ar 3 , and R 1 to R 6 are as defined in the claims. The 3-imidazolines of the invention are useful in antibiotic therapies, in particular as inhibitors of carbapenemases. They are also useful as antibiotics themselves. The present invention also concerns a method for preparing more specifically the 3-imidazolines of formula (I). The present invention further relates to conjugates of said compounds with known antibiotics.",CENTRE NAT RECH SCIENT;;UNIV PARIS SUD;;HOPITAUX PARIS ASSIST PUBLIQUE,CARIOU KEVIN;;DODD ROBERT;;ROMERO EUGÉNIE;;BENCHEKROUN MOHAMED;;IORGA BOGDAN;;NAAS THIERRY;;OUESLATI SAOUSSEN,UNIVERSITÉ PARIS-SUD (2019-09-03);;ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (2019-09-02);;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (2019-09-02);;UNIVERSITE PARIS-SACLAY (2022-01-12),https://lens.org/014-510-036-420-102,Patent Application,yes,0,0,9,9,0,C07D233/20;;A61P31/04;;A61K47/552;;A61K31/407;;A61K31/4164;;C07D233/06;;C07D233/22;;C07D233/24,A61K31/4164;;A61K31/407;;A61K47/55;;C07D233/06;;C07D233/22;;C07D233/24,,0,0,,,,ACTIVE
333,DE,T2,DE 69731237 T2,037-332-001-377-20X,2006-02-02,2006,DE 69731237 T,1997-10-23,US 73647196 A;;US 73647096 A;;US 94707597 A;;US 95118497 A;;US 9718954 W,1996-10-24,VERFAHREN ZUR VERMINDERUNG VON KÖRPERGERUCH,"The present invention relates to an odor absorbing composition, which is safe for use on human skin, comprising from 0.1 % to 5 %, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from 0.1 % to 36 %, by weight of the composition, of an oil phase selected from the group consisting of emollients, moisturizers, and skin protectants; an emulsifier; and an aqueous carrier. The odor absorbing compositions of the present invention may also contain an effective amount of hydrophobic antimicrobials. The present invention also relates to the use of cyclodextrin-containing compositions for the manufacture of an odor absorbing composition, which is safe for use on skin, for controlling environmental malodors on skin and for reducing body odor and/or vaginal odor.",PROCTER & GAMBLE,TRINH TOAN;;DODD THOMAS;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;BUCKNER YAGER;;KAJS MARIE,,https://lens.org/037-332-001-377-20X,Granted Patent,no,0,2,24,28,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61Q15/00;;D06M13/005;;A61K8/73;;A61Q15/00,A61K8/00;;A61K8/02;;A61K8/04;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/44;;A61K8/73;;A61Q15/00;;D06M13/00;;D06M15/03,,0,0,,,,EXPIRED
334,CA,A1,CA 2061065 A1,038-041-099-797-152,1992-08-13,1992,CA 2061065 A,1992-02-12,FR 9101595 A,1991-02-12,"COMPOUNDS DERIVED OF BETA-CARBOLINES ACTING AS LIGAND OF BENZODIAZEP INE RECEPTORS, HAVING AN INVERSE AGAINST EFFECT AND AN ANTAGONIST EFFECT WITH BENZODIAZEPINES AND DRUGS CONTAINING THEM","BREVET D'INVENTION COMPOSES DERIVES DES .beta.-CARBOLINES LIGANDS DU RECEPTEUR DES BENZODIAZEPINES AYANT UN EFFET AGONISTE INVERSE ET ANTAGONISTE VIS-A-VIS DES BENZODIAZEPINES ET MEDICAMENTS LES CONTENANT Inventeurs: Robert DODD, Pierre POTIER, Jean ROSSIER, Gilbert DOREY, Laurent DUBOIS, Lia PRADO DE CARVALHO CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) L'invention se rapporte a de nouveaux composés dérivés des .beta.-carbolines et qui sont des ligands du récepteur des benzodiazépines ayant un effet agoniste inverse et antagoniste vis-à-vis des benzodiazépines. Ces composés répondent aux formules: I II dans lesquelles: X est O, 5, ou bien représente le radical -N(R6)-C(=O)-CH2-X, R1 est un radical hydroxy, alcoxy, alkyl substitué par un radical hydroxy ou alcoxy, R2 est un atome d'hydrogène ou un radical alkyl, hydroxy, alcoxy, acyloxy, benzyloxy, lesdits radicaux pouvant être éventuellement substitués, R3, R4, R5 et R6 sont choisis parmi l'atome d'hydrogène ou un radical alkyle éventuellement substitué par un radical hydroxy, alcoxy, alkoxycarbonylmethyle, ainsi que les dérives tétrahydro de .beta.-carboline correspondants et les sels ou dérivés d'ammonium quaternaires de ces composés pharmaceutiquement acceptables.",CENTRE NAT RECH SCIENT,DODD ROBERT;;POTIER PIERRE;;ROSSIER JEAN;;DOREY GILBERT;;DUBOIS LAURENT;;PRADO DE CARVALHO LIA,,https://lens.org/038-041-099-797-152,Patent Application,no,0,0,13,13,0,C07D405/04;;C07D471/14;;C07D491/14;;A61P25/20;;C07D405/04;;C07D471/14;;C07D491/14,A61K31/435;;A61K31/55;;A61P25/20;;C07D405/04;;C07D471/14;;C07D491/14;;C07D491/147;;C07D495/14,,0,0,,,,DISCONTINUED
335,FR,A1,FR 2800735 A1,059-774-216-164-830,2001-05-11,2001,FR 9914050 A,1999-11-09,FR 9914050 A,1999-11-09,"NOUVELLES ARALKYLE-1,2-DIAMINES POSSEDANT UNE ACTIVITE CALCIMIMETIQUE ET LEUR MODE DE PREPARATION","The invention concerns compounds of general formula (I) wherein: X represents a SO2 or CH2 group; R1 represents a hydrogen or halogen atom or an alkoxy, aryl aralkyl group or an alkyl group substituted or not with one or several halogen atoms, n is equal to 0, 1 or 2, and R2 represents a hydrogen or halogen atom or an alkyl or alkoxy group, and their salt with a pharmaceutically acceptable acid. The invention also concerns the method for preparing said compounds, pharmaceutical compositions containing them and their use as modulator of CaSR activity and as medicine particularly designed for treating diseases or physiological disorders involving modulation of CaSR activity.",CENTRE NAT RECH SCIENT,RUAT MARTIAL;;POTIER PIERRE JEAN PAUL;;DODD ROBERT;;DAUBAN PHILIPPE MARCEL;;FAURE HELENE VERONIQUE,,https://lens.org/059-774-216-164-830,Patent Application,no,1,0,10,10,0,C07C211/27;;C07C311/18;;C07C311/29;;C07D333/34;;A61P1/04;;A61P13/12;;A61P19/10;;A61P25/28;;A61P3/00;;A61P3/14;;A61P35/00;;A61P5/00;;A61P5/22;;A61P9/10,A61K31/132;;A61K31/18;;A61P3/00;;A61P3/14;;A61P5/00;;A61P5/22;;A61P9/10;;A61P1/04;;A61P13/12;;A61P19/10;;A61P25/28;;A61P35/00;;C07C211/27;;C07C217/08;;C07C311/05;;C07C311/16;;C07C311/18;;C07C311/29;;C07C311/38;;C07D333/34;;C07F7/08,,1,1,016-040-059-645-549,10.1016/s0040-4039(97)01157-x,"P. E. MALIGRES ET AL, TETRAHEDRON LETT., vol. 38, no. 30, 1997, pages 5253 - 5256, XP004083291",EXPIRED
336,EP,A1,EP 3046010 A1,030-312-079-055-830,2016-07-20,2016,EP 15194178 A,2015-11-11,US 201514599708 A,2015-01-19,SYSTEM AND METHOD FOR GUARDING EMERGENCY AND CRITICAL TOUCH TARGETS,"A touch screen system and method that (1) renders a critical button in a visually distinguishable manner and (2) provides an intuitive multi-step activation process that effectively guards the button from unintentional activation is provided.
",HONEYWELL INT INC,LANCASTER JEFF;;DE MERS ROBERT E;;DODD SONIA R;;NELSON ERIK T;;ALMQUIST JESSAMY,,https://lens.org/030-312-079-055-830,Patent Application,yes,3,0,3,3,0,G06F3/04842;;G06F3/0488;;Y02P90/02;;G06F3/04842;;Y02P90/02;;G06F3/0412;;G06F3/0488;;G06F2203/04104,G06F3/041;;G05B19/409,,0,0,,,,DISCONTINUED
337,FR,B1,FR 2800735 B1,171-074-112-225-929,2002-02-01,2002,FR 9914050 A,1999-11-09,FR 9914050 A,1999-11-09,"NOUVELLES ARALKYLE-1,2-DIAMINES POSSEDANT UNE ACTIVITE CALCIMIMETIQUE ET LEUR MODE DE PREPARATION","The invention concerns compounds of general formula (I) wherein: X represents a SO2 or CH2 group; R1 represents a hydrogen or halogen atom or an alkoxy, aryl aralkyl group or an alkyl group substituted or not with one or several halogen atoms, n is equal to 0, 1 or 2, and R2 represents a hydrogen or halogen atom or an alkyl or alkoxy group, and their salt with a pharmaceutically acceptable acid. The invention also concerns the method for preparing said compounds, pharmaceutical compositions containing them and their use as modulator of CaSR activity and as medicine particularly designed for treating diseases or physiological disorders involving modulation of CaSR activity.",CENTRE NAT RECH SCIENT,RUAT MARTIAL;;POTIER PIERRE JEAN PAUL;;DODD ROBERT;;DAUBAN PHILIPPE MARCEL;;FAURE HELENE VERONIQUE,,https://lens.org/171-074-112-225-929,Granted Patent,no,0,0,10,10,0,C07C211/27;;C07C311/18;;C07C311/29;;C07D333/34;;A61P1/04;;A61P13/12;;A61P19/10;;A61P25/28;;A61P3/00;;A61P3/14;;A61P35/00;;A61P5/00;;A61P5/22;;A61P9/10,A61K31/132;;A61K31/18;;A61P3/00;;A61P3/14;;A61P5/00;;A61P5/22;;A61P1/04;;A61P9/10;;A61P13/12;;A61P19/10;;A61P25/28;;A61P35/00;;C07C211/27;;C07C217/08;;C07C311/05;;C07C311/16;;C07C311/18;;C07C311/29;;C07C311/38;;C07D333/34;;C07F7/08,,0,0,,,,EXPIRED
338,CA,A1,CA 2390880 A1,144-934-767-134-241,2001-05-17,2001,CA 2390880 A,2000-11-08,FR 9914050 A;;FR 0003104 W,1999-11-09,"ARALKYL-1,2-DIAMINES HAVING CALCIMIMETIC ACTIVITY AND PREPARATION MODE","The invention concerns compounds of general formula (I) wherein: X represents a SO2 or CH2 group; R1 represents a hydrogen or halogen atom or an alkoxy, aryl aralkyl group or an alkyl group substituted or not with one or several halogen atoms, n is equal to 0, 1 or 2, and R2 represents a hydrogen or halogen atom or an alkyl or alkoxy group, and their salt with a pharmaceutically acceptable acid. The invention also concerns the method for preparing said compounds, pharmaceutical compositions containing them and their use as modulator of CaSR activity and as medicine particularly designed for treating diseases or physiological disorders involving modulation of CaSR activity.",CENTRE NAT RECH SCIENT,RUAT MARTIAL;;POTIER PIERRE JEAN-PAUL SERGE;;DODD ROBERT;;FAURE HELENE VERONIQUE;;DAUBAN PHILIPPE MARCEL,,https://lens.org/144-934-767-134-241,Patent Application,no,0,0,10,10,0,C07C211/27;;C07C311/18;;C07C311/29;;C07D333/34;;A61P1/04;;A61P13/12;;A61P19/10;;A61P25/28;;A61P3/00;;A61P3/14;;A61P35/00;;A61P5/00;;A61P5/22;;A61P9/10,A61P1/04;;A61K31/132;;A61K31/18;;A61P3/00;;A61P3/14;;A61P5/00;;A61P5/22;;A61P9/10;;A61P13/12;;A61P19/10;;A61P25/28;;A61P35/00;;C07C211/27;;C07C217/08;;C07C311/05;;C07C311/16;;C07C311/18;;C07C311/29;;C07C311/38;;C07D333/34;;C07F7/08,,0,0,,,,DISCONTINUED
339,GB,A,GB 2140596 A,034-901-873-964-469,1984-11-28,1984,GB 8417055 A,1983-11-14,US 44190182 A;;US 8301772 W,1982-11-15,DETECTION OF SEQUENTIAL DATA STREAM,"A method for detection of a sequential data stream which can be performed in a data storage subsystem without host computer (10) intervention featuring examination of the channel program processed during a read operation for signals indicative that the data is not part of a sequential data stream, for example, embedded seek instructions. If a particular channel program does not contain such indications, the successive record or records may then be stated to a faster access memory device such as a solid- state cache (22). The invention is described in a plug-compatible, software-transparent configuration. <IMAGE>",STORAGE TECHNOLOGY CORP,DODD P DAVID;;BLICKENSTAFF RONALD L;;COULSON RICHARD L;;MORENO ROBERT J;;TREDE BRIAN E,,https://lens.org/034-901-873-964-469,Patent Application,no,0,0,11,11,0,G06F12/0802;;G06F12/0862;;G06F12/0866;;G06F12/0888;;G06F2212/6026;;G06F2212/6028;;G11B20/18;;G11B20/1883;;G11B2020/10916;;G11B2220/20;;G06F12/0802;;G06F2212/6028;;G11B2220/20;;G06F12/0888;;G11B2020/10916;;G11B20/18;;G06F2212/6026;;G06F12/0866;;G11B20/1883;;G06F12/0862,G06F12/08;;G11B20/18,G4A AMC           MC,0,0,,,,EXPIRED
340,EP,A1,EP 1235797 A1,041-536-780-909-824,2002-09-04,2002,EP 00976121 A,2000-11-08,FR 0003104 W;;FR 9914050 A,1999-11-09,"ARALKYL-1,2-DIAMINES HAVING CALCIMIMETIC ACTIVITY AND PREPARATION MODE","The invention concerns compounds of general formula (I) wherein: X represents a SO2 or CH2 group; R1 represents a hydrogen or halogen atom or an alkoxy, aryl aralkyl group or an alkyl group substituted or not with one or several halogen atoms, n is equal to 0, 1 or 2, and R2 represents a hydrogen or halogen atom or an alkyl or alkoxy group, and their salt with a pharmaceutically acceptable acid. The invention also concerns the method for preparing said compounds, pharmaceutical compositions containing them and their use as modulator of CaSR activity and as medicine particularly designed for treating diseases or physiological disorders involving modulation of CaSR activity.",CENTRE NAT RECH SCIENT,RUAT MARTIAL;;POTIER PIERRE JEAN-PAUL SERGE;;DODD ROBERT;;DAUBAN PHILIPPE MARCEL;;FAURE HELENE VERONIQUE,,https://lens.org/041-536-780-909-824,Patent Application,yes,0,2,10,10,0,C07C211/27;;C07C311/18;;C07C311/29;;C07D333/34;;A61P1/04;;A61P13/12;;A61P19/10;;A61P25/28;;A61P3/00;;A61P3/14;;A61P35/00;;A61P5/00;;A61P5/22;;A61P9/10,A61P1/04;;A61K31/132;;A61K31/18;;A61P3/00;;A61P3/14;;A61P5/00;;A61P5/22;;A61P9/10;;A61P13/12;;A61P19/10;;A61P25/28;;A61P35/00;;C07C211/27;;C07C217/08;;C07C311/05;;C07C311/16;;C07C311/18;;C07C311/29;;C07C311/38;;C07D333/34;;C07F7/08,,0,0,,,,EXPIRED
341,CN,A,CN 111533700 A,074-840-726-049-919,2020-08-14,2020,CN 202010428693 A,2020-05-20,CN 202010428693 A,2020-05-20,5-substituted uracil derivative as well as preparation method and application thereof,"The invention relates to a 5-substituted uracil derivative as well as a preparation method and application thereof. The compound is synthesized for the first time, has certain activity of inhibiting human colon cancer cells (SW480 and HCT116), and has potential value in the aspects of anti-tumor drug development and application; meanwhile, alpha-glucosidase inhibitory activity testing is performedon the synthesized compound, and the result shows that the compound also has certain alpha-glucosidase inhibitory activity, which shows that the compound also has broad prospects in development and application of drugs for treating diabetes mellitus.",UNIV TIANJIN SCIENCE & TECH,SUN HUA;;YU PENG;;WANG CHAOXIN;;JIN ZONGXIN;;ZHANG MENGDI;;DODD HUGH ROBERT;;WANG DONG,,https://lens.org/074-840-726-049-919,Patent Application,no,6,0,2,2,0,C07D239/54;;C07D239/553;;A61P35/00;;A61P3/10;;Y02P20/55,C07D239/54;;A61K31/513;;A61P3/10;;A61P35/00;;C07D239/553,,1,1,080-388-496-881-273,10.1039/d0ob01548b;;32936186,"ZHAOXIN WANG, ET AL.: ""Rhodium-catalyzed iminoiodane-mediated oxyamidation studies of 5-vinyluracil derivatives using aryl and alkyl sulfamates"", 《ORGANIC & BIOMOLECULAR CHEMISTRY》",ACTIVE
342,US,A,US 4503501 A,117-085-180-348-563,1985-03-05,1985,US 44179182 A,1982-11-15,US 44179182 A;;US 32535181 A,1981-11-27,Adaptive domain partitioning of cache memory space,A method of operation of a memory array for storage of records of differing predetermined sizes is disclosed which features division of the array into domains which are substantially integral multiples of the predetermined record sizes. In a preferred embodiment the domain allocation may be varied adaptively in accordance with usage so as to enable more efficient use of the array.,STORAGE TECHNOLOGY CORP,COULSON RICHARD L;;BLICKENSTAFF RONALD L;;DODD P DAVID;;MORENO ROBERT J;;KINARD DEAN P,STORAGE TECHNOLOGY CORPORATION A CORP. OF DEL (1982-11-09),https://lens.org/117-085-180-348-563,Granted Patent,yes,14,112,7,8,0,G06F12/0866;;G06F2212/312;;G06F2212/601;;G06F12/0866;;G06F2212/601;;G06F2212/312,G06F12/08,364/300;;364/200,0,0,,,,EXPIRED
343,EP,B1,EP 0109309 B1,114-683-751-558-574,1990-03-07,1990,EP 83306969 A,1983-11-15,US 44190182 A,1982-11-15,METHOD OF OPERATING A COMPUTER SYSTEM,,STORAGE TECHNOLOGY CORPORATION,"DODD, P. DAVID;;BLICKENSTAFF, RONALD L.;;COULSON, RICHARD L.;;MORENO, ROBERT J.;;TREDE, BRIAN E.",,https://lens.org/114-683-751-558-574,Granted Patent,yes,0,0,11,11,0,G06F12/0802;;G06F12/0862;;G06F12/0866;;G06F12/0888;;G06F2212/6026;;G06F2212/6028;;G11B20/18;;G11B20/1883;;G11B2020/10916;;G11B2220/20;;G06F12/0802;;G06F2212/6028;;G11B2220/20;;G06F12/0888;;G11B2020/10916;;G11B20/18;;G06F2212/6026;;G06F12/0866;;G11B20/1883;;G06F12/0862,G06F12/08;;G11B20/18,,1,0,,,"IBM Technical Disclosure Bulletin, Vol 15, No 4, Sept 1972, pp 1100-1101",EXPIRED
344,EP,A2,EP 0080876 A2,037-495-516-789-672,1983-06-08,1983,EP 82306313 A,1982-11-26,US 32535081 A,1981-11-27,Cache control method and apparatus.,"A host computer (10) is backed up by long term secondary magnetic disk storage means (14) coupled to the computer by channels (12), a storage director (16) and a control module (18). A cache memory (22) with an associated cache manager (24) are also connected to the storage director (16) for storing data which the host computer (10) is likely to require. In order to allow automatic transfer to the cache memory (22) of only that data which is likely to be required, the storage director (16) and cache manager (24) determine when accessed data from the disk storage means (14) appears to be part of sequential data because it lacks indications to the contrary, such as embedded SEEK instructions. When data lacks such counter indications, automatic transfers to the cache memory (22) occur a track at a time.",STORAGE TECHNOLOGY CORP,DODD DAVID P;;BLICKENSTAFF RONALD L;;COULSON RICHARD L;;MORENO ROBERT J;;TREDE BRIAN E,,https://lens.org/037-495-516-789-672,Patent Application,yes,0,4,7,7,0,G06F12/0866;;G06F12/0866;;G06F12/0862;;G06F12/0862;;G06F2212/6026;;G06F2212/6026;;G06F2212/6028;;G06F2212/6028,G06F13/10;;G06F3/06;;G06F12/08,,0,0,,,,EXPIRED
345,CA,A,CA 1203320 A,150-438-063-608-335,1986-04-15,1986,CA 441192 A,1983-11-15,US 44190182 A,1982-11-15,DETECTION OF SEQUENTIAL DATA STREAM,"STC-159 A method for detection of a sequential data stream which can be performed in a data storage subsystem without host computer intervention is disclosed featuring examination of the channel program processed during a read operation for signals indicative that the data is not part of a sequential data stream, for example, embedded seek instructions. If a particular channel program for does not contain such indications, the successive record or records may then be staged to a faster access memory device such as a solid-state cache. The invention is described in a plug-compatible, softwaretransparent configuration.",STORAGE TECHNOLOGY CORP,DODD P DAVID;;BLICKENSTAFF RONALD L;;COULSON RICHARD L;;MORENO ROBERT J;;TREDE BRIAN E,,https://lens.org/150-438-063-608-335,Granted Patent,no,0,0,11,11,0,G06F12/0802;;G06F12/0862;;G06F12/0866;;G06F12/0888;;G06F2212/6026;;G06F2212/6028;;G11B20/18;;G11B20/1883;;G11B2020/10916;;G11B2220/20;;G06F12/0802;;G06F2212/6028;;G11B2220/20;;G06F12/0888;;G11B2020/10916;;G11B20/18;;G06F2212/6026;;G06F12/0866;;G11B20/1883;;G06F12/0862,G06F12/08;;G11B20/18,354-246,0,0,,,,EXPIRED
346,ZA,B,ZA 894320 B,110-300-462-748-228,1991-02-27,1991,ZA 894320 A,1989-06-07,US 21071288 A,1988-06-28,PRESSURE-SENSITIVE ADHESIVE TAPES,,MINNESOTA MINING & MFG,PURGETT MARK DODD;;MARK DODD PURGETT;;SMOLDERS ROBERT REMI LOUIS;;ROBERT REMI LOUIS SMOLDERS;;BOGAERT YVAN ADRIEN;;YVAN ADRIEN BOGAERT;;KINNING DAVID JOHN;;DAVID JOHN KINNING;;EVERAERTS ALBERT IVO;;ALBERT IVO EVERAERTS,,https://lens.org/110-300-462-748-228,Granted Patent,no,0,0,16,16,0,C09J133/08;;C08L21/00;;C08L2666/02;;C08L2666/04;;C08L2666/24;;C09J7/385;;C09J133/20;;C09J151/04;;C09J2301/302,C09J7/00;;C08L21/00;;C09J7/02;;C09J133/04;;C09J133/06;;C09J133/08;;C09J151/04,,0,0,,,,EXPIRED
347,WO,A1,WO 2018/162670 A1,027-949-146-575-626,2018-09-13,2018,EP 2018055820 W,2018-03-08,EP 17305257 A,2017-03-09,2- OR 3-IMIDAZOLINES AS CARBAPENEMASES INHIBITORS,"The present application relates tonovel 3-imidazolinesof formula (I')and (I)below: (I') (I) Wherein Ar 1 , Ar 2 , Ar 3 , and R 1 to R 6 are as defined in the claims. The 3-imidazolines of the invention are useful in antibiotic therapies, in particular as inhibitors of carbapenemases. They are also useful as antibiotics themselves. The present invention also concerns a method for preparing more specifically the 3-imidazolines of formula (I). The present invention further relates to conjugates of said compounds with known antibiotics.",CENTRE NAT RECH SCIENT;;UNIV PARIS SUD;;HOPITAUX PARIS ASSIST PUBLIQUE,CARIOU KEVIN;;DODD ROBERT H;;ROMERO EUGÉNIE;;BENCHEKROUN MOHAMED;;IORGA BOGDAN;;NAAS THIERRY;;OUESLATI SAOUSSEN,,https://lens.org/027-949-146-575-626,Patent Application,yes,5,0,9,9,0,C07D233/20;;A61P31/04;;A61K47/552;;A61K31/407;;A61K31/4164;;C07D233/06;;C07D233/22;;C07D233/24,C07D233/20;;A61K31/4164;;A61P31/04,,10,8,033-005-058-351-875;;006-306-488-334-645;;053-755-959-589-328;;048-535-446-899-405;;020-823-935-425-112;;017-232-510-994-253;;179-164-399-785-199;;023-607-489-483-584,10.1016/j.bmc.2004.08.039;;15498657;;27955926;;10.1016/j.bmc.2016.11.051;;23252919;;10.1021/ol303302r;;10.1002/jlac.19596250114;;10.1002/cber.19801130234;;10.1002/anie.200905817;;20354981;;10.1016/s0040-4020(01)00599-3;;pmc6245275;;18463586;;10.3390/molecules13040841,"VENKATESAN A M ET AL: ""Novel imidazole substituted 6-methylidene-penems as broad-spectrum @b-lactamase inhibitors"", BIOORGANIC & MEDICINAL CHEMISTRY, PERGAMON, GB, vol. 12, no. 22, 15 November 2004 (2004-11-15), pages 5807 - 5817, XP004604955, ISSN: 0968-0896, DOI: 10.1016/J.BMC.2004.08.039;;DONGMEI ZHAO ET AL: ""Discovery of biphenyl imidazole derivatives as potent antifungal agents: Design, synthesis, and structure-activity relationship studies"", BIOORGANIC & MEDICINAL CHEMISTRY, 1 January 2017 (2017-01-01), pages 750 - 758, XP055465906, Retrieved from the Internet <URL:http://www.heteroletters.org/issue43/PDF/Paper-13.pdf> DOI: 10.1016/j.bmc.2016.11.051;;HUI CHEN ET AL: ""Copper-Catalyzed Aliphatic C-H Amination with an Amidine Moiety"", ORGANIC LETTERS , 14(23), 6012-6015 CODEN: ORLEF7; ISSN: 1523-7052, vol. 15, no. 1, 4 January 2013 (2013-01-04), pages 212 - 215, XP055465910, ISSN: 1523-7060, DOI: 10.1021/ol303302r;;KIRCHNER ET AL., JUSTUS LIEBIGS ANN. CHEM., vol. 625, 1959, pages 98 - 103;;STEGLICH ET AL., CHEM. BER., vol. 113, 1980, pages 770 - 786;;EVANO ET AL., ANGEW. CHEM. INT. ED., vol. 49, 2010, pages 2840 - 2859;;POZO ET AL., TETRAHEDRON, vol. 57, 2001, pages 6209 - 6214;;LEE ET AL., CURRENT BIOLOGY, vol. 2, no. 4, 1995, pages 223 - 227;;YANG ET AL., E.LIFE, vol. 4, 2015, pages e10206;;BLAU ET AL., MOLECULES, vol. 13, 2008, pages 841 - 854",PENDING
348,EP,B1,EP 1235797 B1,072-190-671-304-761,2004-06-09,2004,EP 00976121 A,2000-11-08,FR 0003104 W;;FR 9914050 A,1999-11-09,"ARALKYL-1,2-DIAMINES HAVING CALCIMIMETIC ACTIVITY AND PREPARATION MODE","The invention concerns compounds of general formula (I) wherein: X represents a SO2 or CH2 group; R1 represents a hydrogen or halogen atom or an alkoxy, aryl aralkyl group or an alkyl group substituted or not with one or several halogen atoms, n is equal to 0, 1 or 2, and R2 represents a hydrogen or halogen atom or an alkyl or alkoxy group, and their salt with a pharmaceutically acceptable acid. The invention also concerns the method for preparing said compounds, pharmaceutical compositions containing them and their use as modulator of CaSR activity and as medicine particularly designed for treating diseases or physiological disorders involving modulation of CaSR activity.",CENTRE NAT RECH SCIENT,RUAT MARTIAL;;POTIER PIERRE JEAN-PAUL SERGE;;DODD ROBERT;;DAUBAN PHILIPPE MARCEL;;FAURE HELENE VERONIQUE,,https://lens.org/072-190-671-304-761,Granted Patent,yes,1,1,10,10,0,C07C211/27;;C07C311/18;;C07C311/29;;C07D333/34;;A61P1/04;;A61P13/12;;A61P19/10;;A61P25/28;;A61P3/00;;A61P3/14;;A61P35/00;;A61P5/00;;A61P5/22;;A61P9/10,A61P1/04;;A61K31/132;;A61K31/18;;A61P3/00;;A61P3/14;;A61P5/00;;A61P5/22;;A61P9/10;;A61P13/12;;A61P19/10;;A61P25/28;;A61P35/00;;C07C211/27;;C07C217/08;;C07C311/05;;C07C311/16;;C07C311/18;;C07C311/29;;C07C311/38;;C07D333/34;;C07F7/08,,1,0,,,"P. E. MALIGRES ET AL: TETRAHEDRON LETT., vol. 38, no. 30, 1997, pages 5253-5256, XP004083291",EXPIRED
349,US,A,US 4468730 A,085-321-018-774-436,1984-08-28,1984,US 32535081 A,1981-11-27,US 32535081 A,1981-11-27,Detection of sequential data stream for improvements in cache data storage,"A method for detection of a sequential data stream which can be performed without host computer intervention is disclosed featuring examination of a data record and channel program during read operations for signals indicative that the data is not part of a sequential data stream, for example, embedded seek instructions. If a particular sought for record does not contain such indications, the successive record or records may then be staged to a faster access memory device such as a solid-state cache. The invention is described in a plug-compatible, software-transparent configuration.",STORAGE TECHNOLOGY CORP,DODD P DAVID;;BLICKENSTAFF RONALD L;;COULSON RICHARD L;;MORENO ROBERT J;;TREDE BRIAN E,STORAGE TECHNOLOGY CORPORATION (1981-11-24),https://lens.org/085-321-018-774-436,Granted Patent,yes,7,98,7,7,0,G06F12/0866;;G06F12/0866;;G06F12/0862;;G06F12/0862;;G06F2212/6026;;G06F2212/6026;;G06F2212/6028;;G06F2212/6028,G06F13/10;;G06F3/06;;G06F12/08,364/200,0,0,,,,EXPIRED
350,EP,A3,EP 0109309 A3,092-970-293-447-548,1986-06-18,1986,EP 83306969 A,1983-11-15,US 44190182 A,1982-11-15,COMPUTER SYSTEM AND METHOD OF OPERATION,"When data is called from a disk memory by a host computer, the data is examined to detect embedded commands which would indicate that the data is not part of a sequential data stream. When such negative indicators are absent (NO STAGE INDICATORS OFF, 86) and provided the total amount of requested data is not large (88), one track is staged (90) into a cache memory in anticipation of a future request. If record 1 on the track was read (92) to the host, it is likely that the request is one of a sequence of requests and a flag is set (94) to indicate this. If then it is possible to de-allocate from the cache the track having the current address less two it is known that three consecutively addressed tracks have been read and an additional track is pre-staged into the cache in anticipation of continuation of the sequence.",STORAGE TECHNOLOGY CORPORATION,"DODD, P. DAVID;;BLICKENSTAFF, RONALD L.;;COULSON, RICHARD L.;;MORENO, ROBERT J.;;TREDE, BRIAN E.",,https://lens.org/092-970-293-447-548,Search Report,yes,1,0,11,11,0,G06F12/0802;;G06F12/0862;;G06F12/0866;;G06F12/0888;;G06F2212/6026;;G06F2212/6028;;G11B20/18;;G11B20/1883;;G11B2020/10916;;G11B2220/20;;G06F12/0802;;G06F2212/6028;;G11B2220/20;;G06F12/0888;;G11B2020/10916;;G11B20/18;;G06F2212/6026;;G06F12/0866;;G11B20/1883;;G06F12/0862,G06F12/08;;G11B20/18,,4,0,,,"ELECTRONIC DESIGN, vol. 28, no. 22, 25th October 1980, pages 38-40, Rochelle Park, New Jersey, US; T. WILLIAMS: ""Cache memory makes a hit processing I/O data quickly"";;COMPUTER DESIGN, vol. 21, no. 3, March 1982, pages 42,47, Winchester, Massachussetts, US; ""Intelligent disk/cache control unit reduces sequential file-disk response"";;IBM TECHNICAL DISCLOSURE BULLETIN, vol. 25, no. 3A, August 1982, page 1285, New York, US; G.C. DRISCOLL et al.: ""Staging length table - a means of minimizing cache memory misses using variable length cache lines"";;IBM TECHNICAL DISCLOSURE BULLETIN, vol. 24, no. 3, August 1981, pages 1559-1562, New York, US; B.T. BENNETT et al.: ""Improving performance of buffered DASD to which some reference are sequential""",EXPIRED
351,AR,A1,AR 036061 A1,110-711-933-531-268,2004-08-04,2004,AR P020102282 A,2002-06-18,US 88339801 A,2001-06-19,CABEZAL DE IMPRESION DE INYECCION DE TINTA,"Un cabezal de impresión por inyección de tinta térmico compacto, que comprende un sustrato de cabezal de impresión (11), una pluralidad de matrices columnares paralelas (61) de generadores de gotas de tinta (40) formados en el sustrato del cabezal de impresión, y circuitos de mando (85) formados en el sustrato del cabezal de impresión para energizar cada uno de los generadores de gota de tinta. El sustrato del cabezal de impresión presenta una densidad de agrupamiento de generadores de gotas de tinta de por lo menos 10,43 generadores de gotas de tinta por mm2.",HEWLETT PACKARD CO,TORGERSON JOSEPH M;;BROWNING ROBERT N;;MCKENZIE ISABELLE;;MILLER WILLIAM;;BAKKOM ANGELA W;;DODD SIMON,,https://lens.org/110-711-933-531-268,Patent Application,no,0,0,23,23,0,B41J2/14072;;B41J2/15;;B41J2/145;;B41J2/14072;;B41J2/15,B41J2/05;;B41J2/14;;B41J2/15;;B41J2/175,,0,0,,,,EXPIRED
352,WO,A1,WO 1984/002013 A1,128-905-007-064-372,1984-05-24,1984,US 8301773 W,1983-11-14,US 44179182 A,1982-11-15,ADAPTIVE DOMAIN PARTITIONING OF CACHE MEMORY SPACE,A method of operation of a memory array for storage of records of differing predetermined sizes (Fig. 4) which features division of the array into domains which are substantially integral multiples of the predetermined record sizes. In a preferred embodiment the domain allocation may be varied adaptively in accordance with usage so as to enable more efficient use of the array (Fig. 3).,STORAGE TECHNOLOGY CORP,COULSON RICHARD L;;BLICKENSTAFF RONALD L;;DODD P DAVID;;MORENO ROBERT J;;KINARD DEAN P,,https://lens.org/128-905-007-064-372,Patent Application,yes,10,4,7,8,0,G06F12/0866;;G06F2212/312;;G06F2212/601;;G06F12/0866;;G06F2212/601;;G06F2212/312,G06F12/08,G4A AKB           KB,0,0,,,,PENDING
353,GB,A,GB 2140597 A,016-936-713-584-587,1984-11-28,1984,GB 8417056 A,1983-11-14,US 44179182 A;;US 8301773 W,1982-11-15,ADAPTIVE DOMAIN PARTITIONING OF CACHE MEMORY SPACE,A method of operation of a memory array for storage of records of differing predetermined sizes (Fig. 4) which features division of the array into domains which are substantially integral multiples of the predetermined record sizes. In a preferred embodiment the domain allocation may be varied adaptively in accordance with usage so as to enable more efficient use of the array (Fig. 3).,STORAGE TECHNOLOGY CORP,COULSON RICHARD L;;BLICKENSTAFF RONALD L;;DODD P DAVID;;MORENO ROBERT J;;KINARD DEAN P,,https://lens.org/016-936-713-584-587,Patent Application,no,0,0,7,8,0,G06F12/0866;;G06F2212/312;;G06F2212/601;;G06F12/0866;;G06F2212/601;;G06F2212/312,G06F12/08,G4A AKB           KB;;G4A AKB1          KB1,0,0,,,,EXPIRED
354,EP,A2,EP 0109309 A2,021-736-040-692-982,1984-05-23,1984,EP 83306969 A,1983-11-15,US 44190182 A,1982-11-15,Method of operating a computer system.,"When data is called from a disk memory by a host computer, the data is examined to detect embedded commands which would indicate that the data is not part of a sequential data stream. When such negative indicators are absent (NO STAGE INDICATORS OFF, 86) and provided the total amount of requested data is not large (88), one track is staged (90) into a cache memory in anticipation of a future request. If record 1 on the track was read (92) to the host, it is likely that the request is one of a sequence of requests and a flag is set (94) to indicate this. If then it is possible to de-allocate from the cache the track having the current address less two it is known that three consecutively addressed tracks have been read and an additional track is pre-staged into the cache in anticipation of continuation of the sequence.",STORAGE TECHNOLOGY CORP,DODD P DAVID;;BLICKENSTAFF RONALD L;;COULSON RICHARD L;;MORENO ROBERT J;;TREDE BRIAN E,,https://lens.org/021-736-040-692-982,Patent Application,yes,0,19,11,11,0,G06F12/0802;;G06F12/0862;;G06F12/0866;;G06F12/0888;;G06F2212/6026;;G06F2212/6028;;G11B20/18;;G11B20/1883;;G11B2020/10916;;G11B2220/20;;G06F12/0802;;G06F2212/6028;;G11B2220/20;;G06F12/0888;;G11B2020/10916;;G11B20/18;;G06F2212/6026;;G06F12/0866;;G11B20/1883;;G06F12/0862,G06F12/08;;G11B20/18,,0,0,,,,EXPIRED
355,AU,A,AU 2001/084113 A,051-319-631-397-185,2002-02-18,2002,AU 2001/084113 A,2001-08-07,FR 0010427 A;;FR 0102562 W,2000-08-08,Novel diamines having a CASR modulating activity,,CENTRE NAT RECH SCIENT,DAUBAN PHILIPPE MARCEL;;DODD ROBERT HUGH;;FAURE HELENE VERONIQUE;;RUAT MARTIAL;;POTIER PIERRE JEAN-PAUL,,https://lens.org/051-319-631-397-185,Patent Application,no,0,0,9,9,0,A61P19/10;;A61P29/00;;A61P35/00;;C07C311/29;;C07C311/29;;C07B2200/07;;C07B2200/07;;C07C211/36;;C07C211/36;;C07C311/20;;C07C311/20;;C07C2601/14;;C07C2601/14;;C07D203/26;;C07D203/26,A61P19/10;;A61K31/18;;A61P29/00;;A61P35/00;;C07B53/00;;C07B55/00;;C07C209/60;;C07C211/36;;C07C303/40;;C07C311/20;;C07C311/29;;C07D203/26,,0,0,,,,PENDING
356,CA,A1,CA 3055471 A1,106-241-483-289-540,2018-09-13,2018,CA 3055471 A,2018-03-08,EP 17305257 A;;EP 2018055820 W,2017-03-09,2- OR 3-IMIDAZOLINES AS CARBAPENEMASES INHIBITORS,"The present application relates tonovel 3-imidazolinesof formula (I')and (I)below: (I') (I) Wherein Ar1, Ar2, Ar3, and R1 to R6 are as defined in the claims. The 3-imidazolines of the invention are useful in antibiotic therapies, in particular as inhibitors of carbapenemases. They are also useful as antibiotics themselves. The present invention also concerns a method for preparing more specifically the 3-imidazolines of formula (I). The present invention further relates to conjugates of said compounds with known antibiotics.",CENTRE NAT RECH SCIENT;;UNIV PARIS SUD;;HOPITAUX PARIS ASSIST PUBLIQUE,CARIOU KEVIN;;DODD ROBERT H;;ROMERO EUGENIE;;BENCHEKROUN MOHAMED;;IORGA BOGDAN;;NAAS THIERRY;;OUESLATI SAOUSSEN,,https://lens.org/106-241-483-289-540,Patent Application,no,0,0,9,9,0,C07D233/20;;A61P31/04;;A61K47/552;;A61K31/407;;A61K31/4164;;C07D233/06;;C07D233/22;;C07D233/24,C07D233/20;;A61K31/4164;;A61P31/04,,0,0,,,,PENDING
357,GB,B,GB 2140597 B,111-688-801-530-929,1986-11-12,1986,GB 8417056 A,1983-11-14,US 44179182 A;;US 8301773 W,1982-11-15,ADAPTIVE DOMAIN PARTITIONING OF CACHE MEMORY SPACE,,STORAGE TECHNOLOGY CORP,COULSON RICHARD L;;BLICKENSTAFF RONALD L;;DODD P DAVID;;MORENO ROBERT J;;KINARD DEAN P,,https://lens.org/111-688-801-530-929,Granted Patent,no,0,0,7,8,0,G06F12/0866;;G06F2212/312;;G06F2212/601;;G06F12/0866;;G06F2212/601;;G06F2212/312,G06F12/08,G4AKB,0,0,,,,EXPIRED
358,EP,B1,EP 3592733 B1,115-128-254-377-258,2021-10-20,2021,EP 18709593 A,2018-03-08,EP 17305257 A;;EP 2018055820 W,2017-03-09,2- OR 3-IMIDAZOLINES AS CARBAPENEMASES INHIBITORS,,CENTRE NAT RECH SCIENT;;UNIV PARIS SACLAY;;HOPITAUX PARIS ASSIST PUBLIQUE,CARIOU KEVIN;;DODD ROBERT H;;ROMERO EUGÉNIE;;BENCHEKROUN MOHAMED;;IORGA BOGDAN;;NAAS THIERRY;;OUESLATI SAOUSSEN,"UNIVERSITE PARIS-SACLAY, FR (2022-11-03);;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS (2021-12-22);;ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (2021-12-22);;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE -, FR (2022-11-03);;UNIVERSITE PARIS-SACLAY (2021-12-22);;ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS, FR (2022-11-03)",https://lens.org/115-128-254-377-258,Granted Patent,yes,2,0,9,9,0,C07D233/20;;A61P31/04;;A61K47/552;;A61K31/407;;A61K31/4164;;C07D233/06;;C07D233/22;;C07D233/24,C07D233/20;;A61K31/4164;;A61P31/04,,3,0,,,"VENKATESAN A M ET AL: ""Novel imidazole substituted 6-methylidene-penems as broad-spectrum @b-lactamase inhibitors"", BIOORGANIC & MEDICINAL CHEMISTRY, PERGAMON, GB, vol. 12, no. 22, 15 November 2004 (2004-11-15), pages 5807-5817, XP004604955, ISSN: 0968-0896, DOI: 10.1016/J.BMC.2004.08.039;;Dongmei Zhao ET AL: ""Discovery of biphenyl imidazole derivatives as potent antifungal agents: Design, synthesis, and structure-activity relationship studies"", Bioorganic & Medicinal Chemistry, 1 January 2017 (2017-01-01), pages 750-758, XP055465906, DOI: 10.1016/j.bmc.2016.11.051 Retrieved from the Internet: URL:http://www.heteroletters.org/issue43/P DF/Paper-13.pdf;;HUI CHEN ET AL: ""Copper-Catalyzed Aliphatic C-H Amination with an Amidine Moiety"", ORGANIC LETTERS , 14(23), 6012-6015 CODEN: ORLEF7; ISSN: 1523-7052, vol. 15, no. 1, 4 January 2013 (2013-01-04), pages 212-215, XP055465910, ISSN: 1523-7060, DOI: 10.1021/ol303302r",ACTIVE
359,CA,A,CA 1203633 A,120-639-541-742-188,1986-04-22,1986,CA 441191 A,1983-11-15,US 44179182 A,1982-11-15,ADAPTIVE DOMAIN PARTITIONING OF CACHE MEMORY SPACE,A method of operation of a memory array for storage of records of differing predetermined sizes is disclosed which features division of the array into domains which are substantially integral multiples of the predetermined record sizes. In a preferred embodiment the domain allocation may be varied adaptively in accordance with usage so as to enable more efficient use of the array.,STORAGE TECHNOLOGY CORP,COULSON RICHARD L;;BLICKENSTAFF RONALD L;;DODD P DAVID;;MORENO ROBERT J;;KINARD DEAN P,,https://lens.org/120-639-541-742-188,Granted Patent,no,0,0,7,8,0,G06F12/0866;;G06F2212/312;;G06F2212/601;;G06F12/0866;;G06F2212/601;;G06F2212/312,G06F12/08,354-246,0,0,,,,EXPIRED
360,EP,B1,EP 0080876 B1,131-170-542-986-225,1989-02-01,1989,EP 82306313 A,1982-11-26,US 32535081 A,1981-11-27,CACHE CONTROL METHOD AND APPARATUS,,STORAGE TECHNOLOGY CORPORATION,"DODD, DAVID P.;;BLICKENSTAFF, RONALD L.;;COULSON, RICHARD L.;;MORENO, ROBERT J.;;TREDE, BRIAN E.",,https://lens.org/131-170-542-986-225,Granted Patent,yes,0,0,7,7,0,G06F12/0866;;G06F12/0866;;G06F12/0862;;G06F12/0862;;G06F2212/6026;;G06F2212/6026;;G06F2212/6028;;G06F2212/6028,G06F13/10;;G06F3/06;;G06F12/08,,1,0,,,"Ralston, Meek: ""Encyclopedia of Computer Science"", 1976, pp. 171,172,389,1027,1028",EXPIRED
361,US,A,US 4430712 A,128-379-623-150-410,1984-02-07,1984,US 32535181 A,1981-11-27,US 32535181 A,1981-11-27,Adaptive domain partitioning of cache memory space,A method of operation of a memory array for storage of records of differing predetermined sizes is disclosed which features division of the array into domains which are substantially integral multiples of the predetermined record sizes. In a preferred embodiment the domain allocation may be varied adaptively in accordance with usage so as to enable more fully efficient use of the array.,STORAGE TECHNOLOGY CORP,COULSON RICHARD L;;BLICKENSTAFF RONALD L;;DODD P DAVID;;MORENO ROBERT J;;KINARD DEAN P,STORAGE TECHNOLOGY CORPORATION (1981-11-24),https://lens.org/128-379-623-150-410,Granted Patent,yes,13,69,5,5,0,G06F12/0866;;G06F2212/312;;G06F2212/601;;G06F12/0866;;G06F2212/312;;G06F2212/601;;Y10S707/99956,G06F3/06;;G06F12/08,364/300;;364/200,0,0,,,,EXPIRED
362,EP,A1,EP 3372587 A1,160-879-063-375-03X,2018-09-12,2018,EP 17305257 A,2017-03-09,EP 17305257 A,2017-03-09,3-IMIDAZOLINES AS CARBAPENEMASES INHIBITORS,"The present application relates to novel 3-imidazolines of formula (I') and (I) below:
  Wherein Ar 1 , Ar 2 , Ar 3 , and R 1  to R 6  are as defined in the claims. The 3-imidazolines of the invention are useful in antibiotic therapies, in particular as inhibitors of carbapenemases. They are also useful as antibiotics themselves. The present invention also concerns a method for preparing more specifically the 3-imidazolines of formula (I). The present invention further relates to conjugates of said compounds with known antibiotics.",CENTRE NAT RECH SCIENT;;UNIV PARIS SUD;;HOPITAUX PARIS ASSIST PUBLIQUE,CARIOU KEVIN;;DODD ROBERT H;;ROMERO EUGÉNIE;;BENCHEKROUN MOHAMED;;IORGA BOGDAN;;NAAS THIERRY;;OUESLATI SAOUSSEN,,https://lens.org/160-879-063-375-03X,Patent Application,yes,5,0,9,9,0,C07D233/20;;A61P31/04;;A61K47/552;;A61K31/407;;A61K31/4164;;C07D233/06;;C07D233/22;;C07D233/24,C07D233/20;;A61K31/4164;;A61P31/04,,8,6,033-005-058-351-875;;048-535-446-899-405;;020-823-935-425-112;;017-232-510-994-253;;179-164-399-785-199;;023-607-489-483-584,10.1016/j.bmc.2004.08.039;;15498657;;10.1002/jlac.19596250114;;10.1002/cber.19801130234;;10.1002/anie.200905817;;20354981;;10.1016/s0040-4020(01)00599-3;;pmc6245275;;18463586;;10.3390/molecules13040841,"VENKATESAN A M ET AL: ""Novel imidazole substituted 6-methylidene-penems as broad-spectrum @b-lactamase inhibitors"", BIOORGANIC & MEDICINAL CHEMISTRY, PERGAMON, GB, vol. 12, no. 22, 15 November 2004 (2004-11-15), pages 5807 - 5817, XP004604955, ISSN: 0968-0896, DOI: 10.1016/J.BMC.2004.08.039;;KIRCHNER ET AL., JUSTUS LIEBIGS ANN. CHEM., vol. 625, 1959, pages 98 - 103;;STEGLICH ET AL., CHEM. BER., vol. 113, 1980, pages 770 - 786;;EVANO ET AL., ANGEW. CHEM. INT. ED, vol. 49, 2010, pages 2840 - 2859;;DEL POZO ET AL., TETRAHEDRON, vol. 57, 2001, pages 6209 - 6214;;LEE ET AL., CURRENT BIOLOGY, vol. 2, no. 4, 1995, pages 223 - 227;;YANG ET AL., E.LIFE, vol. 4, 2015, pages E10206;;BLAU ET AL., MOLECULES, vol. 13, 2008, pages 841 - 854",DISCONTINUED
363,WO,A1,WO 1984/002014 A1,172-189-664-630-099,1984-05-24,1984,US 8301772 W,1983-11-14,US 44190182 A,1982-11-15,DETECTION OF SEQUENTIAL DATA STREAM,"A method for detection of a sequential data stream which can be performed in a data storage subsystem without host computer (10) intervention featuring examination of the channel program processed during a read operation for signals indicative that the data is not part of a sequential data stream, for example, embedded seek instructions. If a particular channel program does not contain such indications, the successive record or records may then be stated to a faster access memory device such as a solid-state cache (22). The invention is described in a plug-compatible, software-transparent configuration.",STORAGE TECHNOLOGY CORP,DODD P DAVID;;BLICKENSTAFF RONALD L;;COULSON RICHARD L;;MORENO ROBERT J;;TREDE BRIAN E,,https://lens.org/172-189-664-630-099,Patent Application,yes,4,0,11,11,0,G06F12/0802;;G06F12/0862;;G06F12/0866;;G06F12/0888;;G06F2212/6026;;G06F2212/6028;;G11B20/18;;G11B20/1883;;G11B2020/10916;;G11B2220/20;;G06F12/0802;;G06F2212/6028;;G11B2220/20;;G06F12/0888;;G11B2020/10916;;G11B20/18;;G06F2212/6026;;G06F12/0866;;G11B20/1883;;G06F12/0862,G06F12/08;;G11B20/18,G4A AMC           MC,1,0,,,"IBM Technical Disclosure, issued 8/81, B.T. Bennett et al:, Improving Performance of Buffered DASD to which Some References are Sequential, Vol. 24, No. 3",PENDING
364,AU,A,AU 2001/014008 A,185-498-587-515-740,2001-06-06,2001,AU 2001/014008 A,2000-11-08,FR 9914050 A;;FR 0003104 W,1999-11-09,"Aralkyl-1,2-diamines having calcimimetic activity and preparation mode","The invention concerns compounds of general formula (I) wherein: X represents a SO2 or CH2 group; R1 represents a hydrogen or halogen atom or an alkoxy, aryl aralkyl group or an alkyl group substituted or not with one or several halogen atoms, n is equal to 0, 1 or 2, and R2 represents a hydrogen or halogen atom or an alkyl or alkoxy group, and their salt with a pharmaceutically acceptable acid. The invention also concerns the method for preparing said compounds, pharmaceutical compositions containing them and their use as modulator of CaSR activity and as medicine particularly designed for treating diseases or physiological disorders involving modulation of CaSR activity.",CENTRE NAT RECH SCIENT,RUAT MARTIAL;;POTIER PIERRE JEAN-PAUL SERGE;;DODD ROBERT;;DAUBAN PHILIPPE MARCEL;;FAURE HELENE VERONIQUE,,https://lens.org/185-498-587-515-740,Patent Application,no,0,0,10,10,0,C07C211/27;;C07C311/18;;C07C311/29;;C07D333/34;;A61P1/04;;A61P13/12;;A61P19/10;;A61P25/28;;A61P3/00;;A61P3/14;;A61P35/00;;A61P5/00;;A61P5/22;;A61P9/10,A61P1/04;;A61K31/132;;A61K31/18;;A61P3/00;;A61P3/14;;A61P5/00;;A61P5/22;;A61P9/10;;A61P13/12;;A61P19/10;;A61P25/28;;A61P35/00;;C07C211/27;;C07C217/08;;C07C311/05;;C07C311/16;;C07C311/18;;C07C311/29;;C07C311/38;;C07D333/34;;C07F7/08,,0,0,,,,DISCONTINUED
365,GB,A,GB 2321042 A,015-435-784-688-250,1998-07-15,1998,GB 9700242 A,1997-01-08,GB 9700242 A,1997-01-08,Packaging a beverage to incorporate a floatable froth producing insert,"A method of packaging a beverage, especially beer, to incorporate a floatable froth producing insert comprises charging an open topped container 10 with beverage 6 to form a headspace 15 and including a hollow insert 1 that floats on the beverage. The insert has at last one restricted aperture 7, and is ballasted so that the aperture is submerged in the beverage when floating naturally. The container is then sealed, and the headspace pressurised to a pressure greater than atmospheric. During the pressurisation stage, the insert is preferably raised so that the aperture is above the level of the liquid, so that it becomes filled with gas at the same pressure as the headspace. The insert may be raised during pressurisation by rotating the container to subject the insert to a centrifugal force so that it abuts against the container wall, or it may be raised by a magnetic force. Alternatively, the insert may be kept at a raised position on the container wall using adhesive. The insert is then lowered so that it floats naturally on the beverage with the aperture submerged. When the container is opened, the gas in the insert is jetted out of the aperture into the beverage to develop froth. Beverage packages are also disclosed that include inserts with one aperture so arranged as to cause rotation of the insert during the jetting of the gas, or with two apertures arranged so that rotation of the insert is restricted during the jetting. An insert is additionally disclosed with a spherical outer surface and a wall of varying thickness serving to ballast the insert with the aperture below the beverage.",GUINNESS BREWING WORLDWIDE,PURDHAM ROBERT;;DODD CAROL JANE;;SARGEANT VIVIEN JANE;;WALTERS FREDERICK JAMES;;FOREMAN NIGEL;;HARVEY NEAL,,https://lens.org/015-435-784-688-250,Patent Application,no,4,0,18,18,0,B65D85/73;;B65D85/73;;B65B31/00;;B65B31/00,B65D25/02;;B65B31/00;;B65D17/34;;B65D17/347;;B65D17/353;;B65D79/00;;B65D85/73,B8D DSC1          DSC1,0,0,,,,EXPIRED
366,DE,D1,DE 3279426 D1,132-458-508-367-26X,1989-03-09,1989,DE 3279426 T,1982-11-26,US 32535081 A,1981-11-27,CACHE CONTROL METHOD AND APPARATUS,,STORAGE TECHNOLOGY CORP,DODD DAVID P;;BLICKENSTAFF RONALD L;;COULSON RICHARD L;;MORENO ROBERT J;;TREDE BRIAN E,,https://lens.org/132-458-508-367-26X,Granted Patent,no,0,0,7,7,0,G06F12/0866;;G06F12/0866;;G06F12/0862;;G06F12/0862;;G06F2212/6026;;G06F2212/6026;;G06F2212/6028;;G06F2212/6028,G06F13/10;;G06F3/06;;G06F12/08,,0,0,,,,EXPIRED
367,DE,D1,DE 3381298 D1,177-679-165-058-482,1990-04-12,1990,DE 3381298 T,1983-11-15,US 44190182 A,1982-11-15,BETRIEBSVERFAHREN FUER EINE RECHNERANORDNUNG.,,STORAGE TECHNOLOGY CORP,DODD P DAVID;;BLICKENSTAFF RONALD L;;COULSON RICHARD L;;MORENO ROBERT J;;TREDE BRIAN E,,https://lens.org/177-679-165-058-482,Granted Patent,no,0,0,11,11,0,G06F12/0802;;G06F12/0862;;G06F12/0866;;G06F12/0888;;G06F2212/6026;;G06F2212/6028;;G11B20/18;;G11B20/1883;;G11B2020/10916;;G11B2220/20;;G06F12/0802;;G06F2212/6028;;G11B2220/20;;G06F12/0888;;G11B2020/10916;;G11B20/18;;G06F2212/6026;;G06F12/0866;;G11B20/1883;;G06F12/0862,G06F12/08;;G11B20/18,,0,0,,,,EXPIRED
368,EP,A2,EP 0080877 A2,016-510-621-991-398,1983-06-08,1983,EP 82306314 A,1982-11-26,US 32535181 A,1981-11-27,Memory system and organization for host computer.,"A host computer (10) is backed up by magnetic disk stores (14) which may be of different types having different track lengths. The host computer is conventionally coupled tothe disk stores by channels (12), a storage director (16) and disk control modules (18). A solid-state cache memory array (22) with an associated cache manager (22) are connected to the storage director for storing tracks of data likely to be required by the host computer. In order to provide efficient utilisation of the cache memory array (22) it is arranged in domains having a length which is substantially an integral multiple of all the different track lengths. The domains are assigned to the different classes of disk storage devices (14) and reallocation is effected from time to time on the basis of actual usage.",STORAGE TECHNOLOGY CORP,COULSON RICHARD L;;BLICKENSTAFF RONALD L;;DODD DAVID P;;MORENO ROBERT J;;KINARD DEAN P,,https://lens.org/016-510-621-991-398,Patent Application,yes,0,3,5,5,0,G06F12/0866;;G06F2212/312;;G06F2212/601;;G06F12/0866;;G06F2212/312;;G06F2212/601;;Y10S707/99956,G06F3/06;;G06F12/08,,0,0,,,,DISCONTINUED
369,US,A1,US 2002/0104014 A1,073-010-581-810-527,2002-08-01,2002,US 6636702 A,2002-01-31,US 6636702 A;;US 26551901 P,2001-01-31,Method and system for configuring and scheduling security audits of a computer network,"
   Managing the selection and scheduling of security audits run on a computing network. The computer network is surveyed by a security audit system to determine the function and relative importance of the elements in the network. Based on function and priority, a more thorough type of security audit is selected to run against each of the network elements by the security audit system. The security audit can also be automatically scheduled based on the information gathered from the survey. Once the system runs the security audit, a vulnerability assessment can be calculated for each element in the network. The vulnerability assessment can be presented in a format that facilitates interpretation and response by someone operating the system. The vulnerability assessment can also be used to configure and schedule future security audits. 
",INTERNET SECURITY SYSTEMS INC,ZOBEL ROBERT DAVID;;DODD TIMOTHY DAVID;;MILLAR SHARON A;;NESFEDER DAVID GERALD;;SINGER CHRISTOPHER S,FINJAN BLUE INC (2018-06-29);;INTERNET SECURITY SYSTEMS INC (2002-01-28);;INTERNATIONAL BUSINESS MACHINES CORPORATION (2007-09-28);;TREND MICRO INCORPORATED (2010-03-31),https://lens.org/073-010-581-810-527,Patent Application,yes,99,185,11,11,0,G06F21/577;;G06F2221/2101;;H04L63/1425;;H04L63/1433;;H04L63/1425;;G06F2221/2101;;G06F21/577;;H04L63/1433,G06F21/00;;H04L29/06,7132,0,0,,,,EXPIRED
370,EP,A3,EP 0080877 A3,063-122-601-374-78X,1985-06-26,1985,EP 82306314 A,1982-11-26,US 32535181 A,1981-11-27,MEMORY SYSTEM AND ORGANIZATION FOR HOST COMPUTER,"A host computer (10) is backed up by magnetic disk stores (14) which may be of different types having different track lengths. The host computer is conventionally coupled tothe disk stores by channels (12), a storage director (16) and disk control modules (18). A solid-state cache memory array (22) with an associated cache manager (22) are connected to the storage director for storing tracks of data likely to be required by the host computer. In order to provide efficient utilisation of the cache memory array (22) it is arranged in domains having a length which is substantially an integral multiple of all the different track lengths. The domains are assigned to the different classes of disk storage devices (14) and reallocation is effected from time to time on the basis of actual usage.",STORAGE TECHNOLOGY CORPORATION,"COULSON, RICHARD L.;;BLICKENSTAFF, RONALD L.;;DODD, DAVID P.;;MORENO, ROBERT J.;;KINARD, DEAN P.",,https://lens.org/063-122-601-374-78X,Search Report,yes,2,0,5,5,0,G06F12/0866;;G06F2212/312;;G06F2212/601;;G06F12/0866;;G06F2212/312;;G06F2212/601;;Y10S707/99956,G06F3/06;;G06F12/08,,1,0,,,"PROCEEDINGS OF THE COMP-CON FALL 80: DISTRIBUTED COMPUTING, September 23-25, 1980, Capital Hilton Hotel, WASHINGTON, D.C. (US). pages 412-416, IEEE, NEW YORK, (US). T. TOKUNAGA et al.: ""Integrated disk cache system with file adaptive control"".",DISCONTINUED
371,CA,A,CA 1198813 A,181-950-180-950-831,1985-12-31,1985,CA 416383 A,1982-11-25,US 32535181 A,1981-11-27,ADAPTIVE DOMAIN PARTITIONING OF CACHE MEMORY SPACE,A method of operation of a memory array for storage of records of differing predetermined sizes is disclosed which features division of the array into domains which are substantially integral multiples of the predetermined record sizes. In a preferred embodiment the domain allocation may be varied adaptively in accordance with usage so as to enable more fully efficient use of the array.,STORAGE TECHNOLOGY CORP,COULSON RICHARD L;;BLICKENSTAFF RONALD L;;DODD P DAVID;;MORENO ROBERT J;;KINARD DEAN P,,https://lens.org/181-950-180-950-831,Granted Patent,no,0,0,5,5,0,G06F12/0866;;G06F2212/312;;G06F2212/601;;G06F12/0866;;G06F2212/312;;G06F2212/601;;Y10S707/99956,G06F3/06;;G06F12/08,352-21.21,0,0,,,,EXPIRED
372,EP,A1,EP 3592733 A1,186-452-860-981-201,2020-01-15,2020,EP 18709593 A,2018-03-08,EP 17305257 A;;EP 2018055820 W,2017-03-09,2- OR 3-IMIDAZOLINES AS CARBAPENEMASES INHIBITORS,,CENTRE NAT RECH SCIENT;;UNIV PARIS SUD;;HOPITAUX PARIS ASSIST PUBLIQUE,CARIOU KEVIN;;DODD ROBERT H;;ROMERO EUGÉNIE;;BENCHEKROUN MOHAMED;;IORGA BOGDAN;;NAAS THIERRY;;OUESLATI SAOUSSEN,"UNIVERSITE PARIS-SACLAY, FR (2022-11-03);;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS (2021-12-22);;ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (2021-12-22);;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE -, FR (2022-11-03);;UNIVERSITE PARIS-SACLAY (2021-12-22);;ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS, FR (2022-11-03)",https://lens.org/186-452-860-981-201,Patent Application,yes,0,0,9,9,0,C07D233/20;;A61P31/04;;A61K47/552;;A61K31/407;;A61K31/4164;;C07D233/06;;C07D233/22;;C07D233/24,C07D233/20;;A61K31/4164;;A61P31/04,,0,0,,,,ACTIVE
373,US,A,US 5742982 A,183-907-646-874-092,1998-04-28,1998,US 75632096 A,1996-11-25,US 75632096 A,1996-11-25,Cable strain relief apparatus,"A clamp assembly (10) is provided which can include first and second clamp halves (16, 18) with a base (50) mounted in each clamp path. The base has a cylindrical inner surface (54) which can clamp a cable thereto for strain relief. Alternatively, a flexible insert (86) having a plurality of cylindrical cavities (102) opening through the outer surface (100) thereof can receive a number of cables (12) to be clamped in the clamp assembly for strain relief. In another version, a plurality of nested inserts (106-116) can be provided on each base (50) allowing the selection of a particular insert dimension suitable the cable to be secured.",SIECOR CORP,DODD JOSEPH K;;HARVEY J D;;WALTERS MARK D;;MORGAN KEVIN L;;DENNIS ROBERT W,SIECOR CORPORATION (1996-11-22);;SIECOR TECHNOLOGY INC (1998-07-16),https://lens.org/183-907-646-874-092,Granted Patent,yes,21,190,1,1,0,F16G11/00;;F16L3/22;;G02B6/4471;;Y10T24/44538;;Y10T24/14;;Y10T24/44538;;Y10T24/14;;F16L3/22;;G02B6/4471;;F16G11/00,F16G11/00;;F16L3/22;;G02B6/44,G2J JGEA15        JGEA15,1,0,,,"AT&T 636 299 110 4, 12A2 Cable Clamp Installation for Nonmetallic Sheath Lightguide Cables, AT&T Practice Instruction Sheet; COMCODE 846 530 780; 1 page. Apr. 1994.",EXPIRED
374,AT,T1,AT E268752 T1,028-293-349-290-222,2004-06-15,2004,AT 00976121 T,2000-11-08,FR 9914050 A;;FR 0003104 W,1999-11-09,"ARALKYL-1,2-DIAMINEN MIT CALCIMIMETISCHER WIRKUNG UND VERFAHREN ZU IHRER HERSTELLUNG","The invention concerns compounds of general formula (I) wherein: X represents a SO2 or CH2 group; R1 represents a hydrogen or halogen atom or an alkoxy, aryl aralkyl group or an alkyl group substituted or not with one or several halogen atoms, n is equal to 0, 1 or 2, and R2 represents a hydrogen or halogen atom or an alkyl or alkoxy group, and their salt with a pharmaceutically acceptable acid. The invention also concerns the method for preparing said compounds, pharmaceutical compositions containing them and their use as modulator of CaSR activity and as medicine particularly designed for treating diseases or physiological disorders involving modulation of CaSR activity.",CENTRE NAT RECH SCIENT,RUAT MARTIAL;;POTIER PIERRE JEAN-PAUL SERGE;;DODD ROBERT;;DAUBAN PHILIPPE MARCEL;;FAURE HELENE VERONIQUE,,https://lens.org/028-293-349-290-222,Granted Patent,no,0,0,10,10,0,C07C211/27;;C07C311/18;;C07C311/29;;C07D333/34;;A61P1/04;;A61P13/12;;A61P19/10;;A61P25/28;;A61P3/00;;A61P3/14;;A61P35/00;;A61P5/00;;A61P5/22;;A61P9/10,A61P1/04;;A61K31/132;;A61K31/18;;A61P3/00;;A61P3/14;;A61P5/00;;A61P5/22;;A61P9/10;;A61P13/12;;A61P19/10;;A61P25/28;;A61P35/00;;C07C211/27;;C07C217/08;;C07C311/05;;C07C311/16;;C07C311/18;;C07C311/29;;C07C311/38;;C07D333/34;;C07F7/08,,0,0,,,,DISCONTINUED
375,US,A,US 4536836 A,087-002-207-257-168,1985-08-20,1985,US 44190182 A,1982-11-15,US 44190182 A;;US 32535081 A,1981-11-27,Detection of sequential data stream,"A method for detection of a sequential data stream which can be performed in a data storge subsystem without host computer intervention is disclosed featuring examination of the channel program processed during a read operation for signals indicative that the data is not part of a sequential data stream, for example, embedded seek instructions. If a particular channel program for does not contain such indications, the successive record or records may then be staged to a faster access memory device such as a solid-state cache. The invention is described in a plug-compatible, software-transparent configuration.",STORAGE TECHNOLOGY CORP,DODD P DAVID;;BLICKENSTAFF RONALD L;;COULSON RICHARD L;;MORENO ROBERT J;;TREDE BRIAN E,STORAGE TECHNOLOGY CORPORATION P.O. BOX 98 LOUISVILLE CO. 80028 A CORP (1982-11-09),https://lens.org/087-002-207-257-168,Granted Patent,yes,4,53,11,11,0,G06F12/0802;;G06F12/0862;;G06F12/0866;;G06F12/0888;;G06F2212/6026;;G06F2212/6028;;G11B20/18;;G11B20/1883;;G11B2020/10916;;G11B2220/20;;G06F12/0802;;G06F2212/6028;;G11B2220/20;;G06F12/0888;;G11B2020/10916;;G11B20/18;;G06F2212/6026;;G06F12/0866;;G11B20/1883;;G06F12/0862,G06F12/08;;G11B20/18,364/200,1,0,,,"B. T. Bennett et al., Improving Performance of Buffered DASD To Which Some References are Sequential , IBM Technical Disclosure Bulletin, vol. 24, No. 3, Aug., 1981.",EXPIRED
376,WO,A1,WO 2001/034562 A1,130-952-033-311-22X,2001-05-17,2001,FR 0003104 W,2000-11-08,FR 9914050 A,1999-11-09,"ARALKYL-1,2-DIAMINES HAVING CALCIMIMETIC ACTIVITY AND PREPARATION MODE","The invention concerns compounds of general formula (I) wherein: X represents a SO2 or CH2 group; R1 represents a hydrogen or halogen atom or an alkoxy, aryl aralkyl group or an alkyl group substituted or not with one or several halogen atoms, n is equal to 0, 1 or 2, and R2 represents a hydrogen or halogen atom or an alkyl or alkoxy group, and their salt with a pharmaceutically acceptable acid. The invention also concerns the method for preparing said compounds, pharmaceutical compositions containing them and their use as modulator of CaSR activity and as medicine particularly designed for treating diseases or physiological disorders involving modulation of CaSR activity.",CENTRE NAT RECH SCIENT;;RUAT MARTIAL;;POTIER PIERRE JEAN PAUL SERGE;;DODD ROBERT;;DAUBAN PHILIPPE MARCEL;;FAURE HELENE VERONIQUE,RUAT MARTIAL;;POTIER PIERRE JEAN-PAUL SERGE;;DODD ROBERT;;DAUBAN PHILIPPE MARCEL;;FAURE HELENE VERONIQUE,,https://lens.org/130-952-033-311-22X,Patent Application,yes,1,38,10,10,0,C07C211/27;;C07C311/18;;C07C311/29;;C07D333/34;;A61P1/04;;A61P13/12;;A61P19/10;;A61P25/28;;A61P3/00;;A61P3/14;;A61P35/00;;A61P5/00;;A61P5/22;;A61P9/10,A61K31/132;;A61K31/18;;A61P3/00;;A61P3/14;;A61P5/00;;A61P1/04;;A61P5/22;;A61P9/10;;A61P13/12;;A61P19/10;;A61P25/28;;A61P35/00;;C07C211/27;;C07C217/08;;C07C311/05;;C07C311/16;;C07C311/18;;C07C311/29;;C07C311/38;;C07D333/34;;C07F7/08,,1,1,016-040-059-645-549,10.1016/s0040-4039(97)01157-x,"P. E. MALIGRES ET AL, TETRAHEDRON LETT., vol. 38, no. 30, 1997, pages 5253 - 5256, XP004083291",PATENTED
377,WO,A1,WO 2002/012181 A1,014-321-853-288-858,2002-02-14,2002,FR 0102562 W,2001-08-07,FR 0010427 A,2000-08-08,NOVEL DIAMINES HAVING A CASR MODULATING ACTIVITY,"The invention concerns diamines of general formula (I), wherein: A represents a group A1 or A2 of general formula (II); B represents a group B1 or B2 of general formula (III); X represents a SO2, CH2, C=O or COO; Y------Z represents a group of formula CH(R25)-CH(R26) or CH(R27)=CH(R28),and R1 to R28, identical or different, represent independently of one another, a hydrogen or halogen atom or an alkyl, cycloalkyl, CN, NO2, hydroxy, aryl, aralkyl, alkoxy, aryloxy, amino, alkylamino, dialkylamino, cycloalkylamino, arylamino, arylalkylamino, diarylamino diarylalkylamino, trihalogenoalkyl or trihalogenoalkoxy group, provided that in the group A1, at least one of the radicals R1, R2, R3, R4 or R5 represents the hydrogen atom when the other four do not represent the hydrogen atom and in the group B1, at least one of the radicals R13, R14, R15, R16 or R17 represents the hydrogen atom when the other four do not represent the hydrogen atom, and their salts with a pharmaceutically acceptable acid, in the form of racemic mixture or their optically pure isomers. The invention also concerns their preparation, pharmaceutical compositions comprising them and their use as CaSR activity modulator and as medicine particularly designed for the treatment of psychological diseases and disorders involving CaSR activity modulation.",CENTRE NAT RECH SCIENT;;DAUBAN PHILIPPE MARCEL;;DODD ROBERT HUGH;;FAURE HELENE VERONIQUE;;RUAT MARTIAL;;POTIER PIERRE JEAN PAUL,DAUBAN PHILIPPE MARCEL;;DODD ROBERT HUGH;;FAURE HELENE VERONIQUE;;RUAT MARTIAL;;POTIER PIERRE JEAN-PAUL,,https://lens.org/014-321-853-288-858,Patent Application,yes,3,36,9,9,0,A61P19/10;;A61P29/00;;A61P35/00;;C07C311/29;;C07C311/29;;C07B2200/07;;C07B2200/07;;C07C211/36;;C07C211/36;;C07C311/20;;C07C311/20;;C07C2601/14;;C07C2601/14;;C07D203/26;;C07D203/26,A61P19/10;;A61K31/18;;A61P29/00;;A61P35/00;;C07B53/00;;C07B55/00;;C07C209/60;;C07C211/36;;C07C303/40;;C07C311/20;;C07C311/29;;C07D203/26,,2,2,018-469-980-911-127;;016-159-301-798-016,10.1016/s0957-4166(00)80266-9;;10.1002/ardp.19933260711,"W.H. SCHLICHTER, ET AL.: ""Novel, enantioselective synthesis of vicinal cyclohexanediamines as key-intermediates for highly selective opioid kappa and sigma agonists"", TETRAHEDRON: ASYMMETRY, vol. 3, no. 3, 1992, Elsevier Science Publishers, Amsterdam, NL, pages 329 - 333, XP000992877, ISSN: 0957-4166;;W.H. SCHLICHTER, ET AL.: ""Asymmetric reductive amination of cycloakanones, XIII. Enantioselective amidoamination: a new regiospecific strategy for the synthesis of chiral cyclohexane-1,2-diamino-derivatives"", ARCHIV DER PHARMAZIE, vol. 326, no. 7, 1993, VCH Verlagsgesellschaft, Weinheim, DE, pages 429 - 436, XP000992867, ISSN: 0365-6233",PENDING
378,CA,A,CA 1180466 A,159-914-029-413-763,1985-01-02,1985,CA 416382 A,1982-11-25,US 32535081 A,1981-11-27,DETECTION OF SEQUENTIAL DATA STREAM,"A method for detection of a sequential data stream which can be performed without host computer intervention is disclosed featuring examination of a data record and channel program during read operations for signals indicative that the data is not part of a sequential data stream, for example, embedded seek instructions. If a particular sought for record does not contain such indications, the successive record or records may then be staged to a faster access memory device such as a solid-state cache. The invention is described in a plug-compatible, software-transparent configuration.",STORAGE TECHNOLOGY CORP,DODD P DAVID;;BLICKENSTAFF RONALD L;;COULSON RICHARD L;;MORENO ROBERT J;;TREDE BRIAN E,,https://lens.org/159-914-029-413-763,Granted Patent,no,0,0,7,7,0,G06F12/0866;;G06F12/0866;;G06F12/0862;;G06F12/0862;;G06F2212/6026;;G06F2212/6026;;G06F2212/6028;;G06F2212/6028,G06F13/10;;G06F3/06;;G06F12/08,354-246,0,0,,,,EXPIRED
379,GB,B,GB 2140596 B,197-122-671-071-185,1987-06-03,1987,GB 8417055 A,1983-11-14,US 44190182 A;;US 8301772 W,1982-11-15,DETECTION OF SEQUENTIAL DATA STREAM,,STORAGE TECHNOLOGY CORP,DODD P DAVID;;BLICKENSTAFF RONALD L;;COULSON RICHARD L;;MORENO ROBERT J;;TREDE BRIAN E,,https://lens.org/197-122-671-071-185,Granted Patent,no,0,0,11,11,0,G06F12/0802;;G06F12/0862;;G06F12/0866;;G06F12/0888;;G06F2212/6026;;G06F2212/6028;;G11B20/18;;G11B20/1883;;G11B2020/10916;;G11B2220/20;;G06F12/0802;;G06F2212/6028;;G11B2220/20;;G06F12/0888;;G11B2020/10916;;G11B20/18;;G06F2212/6026;;G06F12/0866;;G11B20/1883;;G06F12/0862,G06F12/08;;G11B20/18,G4AMC,0,0,,,,EXPIRED
380,GB,B,GB 2321042 B,199-994-082-251-525,2001-03-28,2001,GB 9700242 A,1997-01-08,GB 9700242 A,1997-01-08,A method of packaging a beverage containing gas in solution and a beverage package,,GUINNESS BREWING WORLDWIDE,PURDHAM ROBERT;;DODD CAROL JANE;;SARGEANT VIVIEN JANE;;WALTERS FREDERICK JAMES;;FOREMAN NIGEL;;HARVEY NEAL,,https://lens.org/199-994-082-251-525,Granted Patent,no,4,0,18,18,0,B65D85/73;;B65D85/73;;B65B31/00;;B65B31/00,B65D25/02;;B65B31/00;;B65D17/34;;B65D17/347;;B65D17/353;;B65D79/00;;B65D85/73,B8D DSC1          DSC1,0,0,,,,EXPIRED
381,EP,A3,EP 0080876 A3,023-133-673-872-473,1985-07-10,1985,EP 82306313 A,1982-11-26,US 32535081 A,1981-11-27,COMPUTER SYSTEM AND METHOD OF OPERATION,"A host computer (10) is backed up by long term secondary magnetic disk storage means (14) coupled to the computer by channels (12), a storage director (16) and a control module (18). A cache memory (22) with an associated cache manager (24) are also connected to the storage director (16) for storing data which the host computer (10) is likely to require. In order to allow automatic transfer to the cache memory (22) of only that data which is likely to be required, the storage director (16) and cache manager (24) determine when accessed data from the disk storage means (14) appears to be part of sequential data because it lacks indications to the contrary, such as embedded SEEK instructions. When data lacks such counter indications, automatic transfers to the cache memory (22) occur a track at a time.",STORAGE TECHNOLOGY CORPORATION,"DODD, DAVID P.;;BLICKENSTAFF, RONALD L.;;COULSON, RICHARD L.;;MORENO, ROBERT J.;;TREDE, BRIAN E.",,https://lens.org/023-133-673-872-473,Search Report,yes,2,0,7,7,0,G06F12/0866;;G06F12/0866;;G06F12/0862;;G06F12/0862;;G06F2212/6026;;G06F2212/6026;;G06F2212/6028;;G06F2212/6028,G06F13/10;;G06F3/06;;G06F12/08,,2,0,,,"PROCEEDINGS OF THE COMPCON FALL 80, Washington DC, (US), 23-25 September 1980, pages 412-416, IEEE, NEW YORK, (US). T. TOKUNAGA et al.: ""Integrated disk cache system with file adaptive control"".;;IBM TECHNICAL DISCLOSURE BULLETIN, Vol. 24, No. 3, August 1981, pages 1559-1562, NEW YORK, (US). B.T. BENNETT et al.: ""Improving performance of buffered dasd to wich some references are sequential"".",EXPIRED
382,DE,D1,DE 69717847 D1,075-789-273-560-92X,2003-01-23,2003,DE 69717847 T,1997-10-23,US 73646996 A;;US 73609396 A;;US 73896496 A;;US 88960797 A;;US 94677097 A;;US 94729997 A;;US 94707697 A;;US 95118597 A;;US 9718852 W,1996-10-24,HAUTGERUCHSREDUZIERUNGSKOMPOSITIONEN,"The present invention relates to an aqueous odor-absorbing composition which is safe for use on human skin comprising from about 0.1 % to about 5 %, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from about 0.5 % to about 30 %, by weight of the composition, of a linear dimethicone having a nominal viscosity of 350 centistokes or less; and an aqueous carrier. The compositions can also comprise one or more of the following optional components: low molecular weight polyols; water-soluble antimicrobial preservatives; zinc salts; water-soluble polymers; soluble carbonate and/or bicarbonate salts; chelating agents; zeolites; activated carbon; and mixtures thereof. The present invention also relates the use of the aforementioned compositions in reducing body, vaginal, and or environmental odors on skin. The composition can be applied directly as a spray, poured from a bottle and applied by hand, or applied via a wipe.",PROCTER & GAMBLE,TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;BUCKNER YAGER;;KAJS MARIE,,https://lens.org/075-789-273-560-92X,Granted Patent,no,0,0,15,24,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61K8/891;;A61Q15/00;;A61K8/73;;A61Q15/00,A61K8/02;;A61K8/04;;A61K8/27;;A61K8/44;;A61K8/73;;A61K8/891;;A61Q15/00,,0,0,,,,EXPIRED
383,AU,A,AU 2001/064012 A,086-732-782-792-931,2001-12-03,2001,AU 2001/064012 A,2001-05-23,FR 0006619 A;;FR 0101599 W,2000-05-24,Novel calcium receptor active molecules and method for preparing same,,CENTRE NAT RECH SCIENT,RUAT MARTIAL;;DODD ROBERT;;FAURE HELENE VERONIQUE;;DAUBAN PHILIPPE MARCEL;;KESSLER ALBANE;;POTIER PIERRE JEAN-PAUL,,https://lens.org/086-732-782-792-931,Patent Application,no,0,0,11,11,0,C07D209/14;;C07D209/42;;A61P1/00;;A61P1/04;;A61P13/12;;A61P19/10;;A61P25/00;;A61P25/28;;A61P35/00;;A61P43/00;;A61P5/00;;A61P5/18;;A61P5/20;;A61P9/00;;C07D209/42;;C07D209/14,A61K31/4045;;A61P1/04;;A61P5/00;;A61P5/18;;A61P9/00;;A61P13/12;;A61P19/10;;A61P25/00;;A61P35/00;;A61P43/00;;C07D209/14;;C07D209/42,,0,0,,,,PENDING
384,AU,B2,AU 614623 B2,129-801-260-140-316,1991-09-05,1991,AU 1989/036254 A,1989-06-09,US 21071288 A,1988-06-28,PRESSURE-SENSITIVE ADHESIVE TAPES,,MINNESOTA MINING & MFG,PURGETT MARK DODD;;BOGAERT YVAN ADRIEN;;SMOLDERS ROBERT REMI LOUIS;;EVERAERTS ALBERT IVO;;KINNING DAVID JOHN,,https://lens.org/129-801-260-140-316,Granted Patent,no,1,4,16,16,0,C09J133/08;;C08L21/00;;C08L2666/02;;C08L2666/04;;C08L2666/24;;C09J7/385;;C09J133/20;;C09J151/04;;C09J2301/302,C09J7/00;;C08L21/00;;C09J7/02;;C09J133/04;;C09J133/06;;C09J133/08;;C09J151/04,,0,0,,,,EXPIRED
385,ES,T3,ES 2252529 T3,048-632-770-638-471,2006-05-16,2006,ES 02789325 T,2002-10-30,US 292001 A,2001-11-15,MAQUINILLAS DE AFEITAR Y CARTUCHOS DE MAQUINILLA DE AFEITAR.,"Una maquinilla de afeitar que comprende: un mango, una cabeza, montada sobre el mango, y dentro de la cabeza, un material de cambio de fase.",GILLETTE CO,BRANDT KLAUS;;DAVIS STUART M;;DODD KENNETH T;;PARENT CHARLES ROBERT;;SZCZEPANOWSKI ANDREW;;WOODNORTH DOUGLAS J,,https://lens.org/048-632-770-638-471,Granted Patent,no,0,0,26,26,0,B26B21/40;;B26B21/4025;;B26B21/4087;;B26B21/48;;B26B21/4087;;B26B21/40;;B26B21/48;;B26B21/4025,B26B21/40;;B26B21/48;;B26B21/52,,0,0,,,,EXPIRED
386,US,A1,US 2005/0192317 A1,181-307-431-788-849,2005-09-01,2005,US 34414604 A,2004-01-16,FR 0010427 A;;FR 0102562 W,2000-08-08,Novel diamines having a casr modulating activity,"The invention concerns diamines of general formula (I), wherein: A represents a group A1 or A2 of general formula (II); B represents a group B1 or B2 of general formula (III); X represents a SO 2 , CH 2 , C═O or COO; Y Z represents a group of formula CH(R25)—CH(R26) or CH(R27)═(R28), and R1 to R28, identical or different, represent independently of one another, a hydrogen or halogen atom or an alkyl, cycloalkyl, CN, NO 2 , hydroxy, aryl, aralkyl, alkoxy, aryloxy, amino, alkylamino, dialkylamino, cycloalkylamino, arylamino, arylalkylamino, diarylamino diarylalkylamino, trihalogenoalkyl or trihalogenoalkoxy group, provided that in the group A1, at least one of the radicals R1, R2, R3, R4 or R5 represents the hydrogen atom when the other four do not represent the hydrogen atom and in the group B1, at least one of the radicals R13, R14, R15, R16 or R17 represents the hydrogen atom when the other four do not represent the hydrogen atom, and their salts with a pharmaceutically acceptable acid, in the form of racemic mixture or their optically pore isomers. The invention also concerns their preparation, pharmaceutical compositions comprising them and their use as CaSR activity modulator and as medicine particularly designed for the treatment of psychological diseases and disorders involving CaSR activity modulation.",DAUBAN PHILIPPE M.;;DODD ROBERT H.;;FAURE HELENE V.;;RUAT MARTIAL;;POTIER PIERRE J.;;KESSLER ALBANE,DAUBAN PHILIPPE M;;DODD ROBERT H;;FAURE HELENE V;;RUAT MARTIAL;;POTIER PIERRE J;;KESSLER ALBANE,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (2003-12-19),https://lens.org/181-307-431-788-849,Patent Application,yes,0,3,9,9,0,A61P19/10;;A61P29/00;;A61P35/00;;C07C311/29;;C07C311/29;;C07B2200/07;;C07B2200/07;;C07C211/36;;C07C211/36;;C07C311/20;;C07C311/20;;C07C2601/14;;C07C2601/14;;C07D203/26;;C07D203/26,A61P19/10;;A61K31/18;;A61P29/00;;A61P35/00;;C07B53/00;;C07B55/00;;C07C209/60;;C07C211/36;;C07C303/40;;C07C311/20;;C07C311/29;;C07D203/26,514/317;;514/319;;546/205;;546/231,0,0,,,,EXPIRED
387,AU,A1,AU 2002/243763 A1,053-432-216-204-54X,2002-08-12,2002,AU 2002/243763 A,2002-01-31,US 26551901 P;;US 0202917 W,2001-01-31,Method and system for configuring and scheduling security audits of a computer network,,INTERNET SECURITY SYSTEMS INC,ZOBEL ROBERT DAVID;;DODD TIMOTHY DAVID;;MILLAR SHARON A;;NESFEDER DAVID GERALD JR;;SINGER CHRISTOPHER S,,https://lens.org/053-432-216-204-54X,Patent Application,no,0,0,11,11,0,G06F21/577;;G06F2221/2101;;H04L63/1425;;H04L63/1433;;H04L63/1425;;G06F2221/2101;;G06F21/577;;H04L63/1433,G06F21/00;;H04L29/06,,0,0,,,,DISCONTINUED
388,DE,D1,DE 69130437 D1,069-867-534-146-449,1998-12-10,1998,DE 69130437 T,1991-07-03,US 54795890 A,1990-07-03,Gerät mit neuronalen Netzwerken zur Detektion und Behandlung von Arrythmien,,TELECTRONICS NV,NICKOLLS PETER;;DRANE GEOFF;;FLOWER BARRY;;LUNSMANN PAUL;;DODD ROBERT;;BASSIN DAVID;;WICKHAM JOHN;;MURPHY TONY,,https://lens.org/069-867-534-146-449,Granted Patent,no,0,0,6,7,0,A61N1/36514;;A61N1/36514;;A61N1/39622;;A61N1/39622,A61B5/0245;;A61B5/0452;;A61B10/00;;A61N1/365;;A61N1/39,,0,0,,,,EXPIRED
389,AT,T1,AT E314180 T1,079-531-019-837-265,2006-01-15,2006,AT 02789325 T,2002-10-30,US 292001 A;;US 0234770 W,2001-11-15,RASIERER UND RASIERKASSETTEN,,GILLETTE CO,BRANDT KLAUS;;DAVIS STUART M;;DODD KENNETH T;;PARENT CHARLES ROBERT;;SZCZEPANOWSKI ANDREW;;WOODNORTH DOUGLAS J,,https://lens.org/079-531-019-837-265,Granted Patent,no,0,0,26,26,0,B26B21/40;;B26B21/4025;;B26B21/4087;;B26B21/48;;B26B21/4087;;B26B21/40;;B26B21/48;;B26B21/4025,B26B21/40;;B26B21/48;;B26B21/52,,0,0,,,,EXPIRED
390,WO,A2,WO 2002/061544 A2,164-620-609-461-371,2002-08-08,2002,US 0202917 W,2002-01-31,US 26551901 P,2001-01-31,METHOD AND SYSTEM FOR CONFIGURING AND SCHEDULING SECURITY AUDITS OF A COMPUTER NETWORK,A method/apparatus (100) for managing (121/122) the selection and scheduling (122) of security audits by surveying an audit system (115) to determine function and relative importance of elements (121).,INTERNET SECURITY SYSTEMS INC,ZOBEL ROBERT DAVID;;DODD TIMOTHY DAVID;;MILLAR SHARON A;;NESFEDER DAVID GERALD JR;;SINGER CHRISTOPHER S,,https://lens.org/164-620-609-461-371,Patent Application,yes,0,0,11,11,0,G06F21/577;;G06F2221/2101;;H04L63/1425;;H04L63/1433;;H04L63/1425;;G06F2221/2101;;G06F21/577;;H04L63/1433,G06F21/00;;H04L29/06,,0,0,,,,PENDING
391,US,B2,US 7084167 B2,181-830-962-311-237,2006-08-01,2006,US 29628803 A,2003-04-24,FR 0006619 A;;FR 0101599 W,2000-05-24,Calcium receptor active molecules and method for preparing same,"The invention concerns compounds of general formula (I) wherein: the group X represents a —NR4, —CH═N or —CHR5-NR4-group; the group Y represents an oxygen or sulphur atom or a NR, —CR5, —CHR5-, —CR5=CR6- or —CHR5-CHR6 group provided that when group X represents the —CH═N— or —CHR5-NR4-group, group Y represents an oxygen or a sulphur atom or a Nr, —CR5 or —CHR group; the group R represents a hydrogen atom or an alkyl, aryl or aralkyl group; the groups R1, R5 and R6, identical or different, represent each a hydrogen or halogen atom or an alkyl or alkoxy group; the group R2 represents a hydrogen atom or an alkyl group; the group R3 represents an aryl group; and the group R4 represents a hydrogen atom, an alkyl, aryl, aralkyl, alkylsulphonamide, arylsulphonamide or aralkylsulphonamide group; and their salt with a pharmaceutically acceptable acid, in the form of a racemic mixture and their optically pure isomer. The invention also concerns their preparation, pharmaceutical compositions containing them and their use as CaSR activity modulator and as medicine for preferably treating diseases or physiological disorders involving the intervention of CaSR activity modulation.",CENTRE NAT RECH SCIENT,RUAT MARTIAL;;DODD ROBERT;;FAURE HELENE VERONIQUE;;DAUBAN PHILIPPE MARCEL;;KESSLER ALBANE;;POTIER PIERRE JEAN-PAUL,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (2003-01-21),https://lens.org/181-830-962-311-237,Granted Patent,yes,10,20,11,11,0,C07D209/14;;C07D209/42;;A61P1/00;;A61P1/04;;A61P13/12;;A61P19/10;;A61P25/00;;A61P25/28;;A61P35/00;;A61P43/00;;A61P5/00;;A61P5/18;;A61P5/20;;A61P9/00;;C07D209/42;;C07D209/14,A61K31/404;;A61K31/4045;;A61P1/04;;A61P5/00;;A61P5/18;;A61P9/00;;A61P13/12;;A61P19/10;;A61P25/00;;A61P35/00;;A61P43/00;;C07D209/04;;C07D209/10;;C07D209/14;;C07D209/42,514/415;;514/418;;548/484;;548/491;;548/504,33,17,163-349-537-445-61X;;006-374-663-346-34X;;034-674-846-789-178;;094-439-806-281-288;;004-752-590-588-841;;098-127-415-391-554;;074-856-483-758-679;;036-473-270-821-164;;025-738-507-876-844;;027-230-470-821-73X;;067-739-378-974-664;;095-490-749-475-288;;031-816-227-505-983;;034-610-992-769-789;;013-717-031-758-659;;031-780-820-022-390;;090-024-401-699-280,3224706;;10.1006/bbrc.1997.7401;;9325183;;10.1016/s1043-2760(98)00119-2;;10322397;;9067864;;10.1002/(sici)1097-4547(19970301)47:5<547::aid-jnr10>3.0.co;2-v;;10.1046/j.1523-1755.1998.00735.x;;9453023;;10.1046/j.1523-1755.1998.00782.x;;9461105;;10.1172/jci119851;;pmc508509;;9399943;;10.1056/nejm199711203372104;;9366582;;9509247;;10.1146/annurev.med.49.1.15;;8255296;;10.1038/366575a0;;pmc19959;;9520489;;10.1073/pnas.95.7.4040;;7874174;;10.1038/ng1194-303;;07874174;;10.1073/pnas.92.8.3161;;7724534;;pmc42125;;10.1074/jbc.271.11.5972;;8626377;;07916660;;10.1016/0092-8674(93)90617-y;;7916660;;8854047;;10.1210/edrv-17-4-289;;10.1210/er.17.4.289;;10.1007/bf00906089,"Cruces, et al., ""Acetylenic and Allenic Derivatives of 2-(1-methylindolyl)methylamine As Selective Inhibitors of the Monoamine Oxidases A and B,"" Farmaco, Edizione Scientifica, vol. 43, Iss. 7-8, p. 567-73 (1988).;;Cherqaoui et al.; Structure-selectivity relationship of MAO inhibitors using neural networks; Models in Chemistry 135 (1-2), pp. 79-91 (1998).;;Ferry et al.; Effects of divalent cations and of a calcimimetic on adrenocorticotropic hormone release in pituitary cells, Biochem. and Biophys. Res. Comm. 238, pp. 866-873 (1997).;;Nemeth et al.; Calcimimetic compounds: a direct approach to controlling plasma levels of parathyroid hormone in hyperparathyroidism, TEM, vol. 10, No. 9, pp. 66-71 (1999).;;Ye et al.; Amyloid-62 proteins activate CA<SUP>2+ </SUP>permeable channels through calcium-sensing receptors, J. Neuroscience Res. 47:547-554 (1997).;;Antonsen et al.; A cacimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure; Kidney International, 53:223-227 (1998).;;Wada et al.; NPS R-568 halts or reverses osteitis fibrosa I uremic rats; Kidney International 53:448-453 (1998).;;Wada et al.; The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency; INIST CNRS 2977-2983 (2002).;;Silverberg et al.; Short-term inhibition of parathyroid hormone secretion by a calcium receptor agonist in patients with primary hyperparathyroidism, New England Journal of Medicine, 1506-1510 (1997).;;Brown et al.; The extracellular calcium-sensing receptor: Its role in health and disease; Annu. Rev. Med. 49:15-29 (1998).;;Brown et al.; Cloning and characterization of an extracellular CA2+ sensing receptor from bovine parathyroid; Nature 366:575-580 (1993).;;Nemeth et al.; Calcimimetics with potent and selective activity on the parathyroid calcium receptor, PNAS 95:4040-4045 (1998).;;Pollak et al.; Autosomal dominant hypocalcaemia caused by a CA2+ sensing receptor gene mutation, Nature Genetics, 8:303-307 (1994).;;Ruat et al.; Calcium sensing receptor: Molecular cloning in rat and localization to nerve terminals; PNAS 92:3161-3165 (1995).;;Ruat et al.;Cloned and expressed rat CA2+ sensing receptor; J. Biol. Chem., 271:5972-5975 (1996).;;Pollak et al.; Mutations in the human CA2+ sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism, Cell, 75:1297-1303 (1993).;;Chattopadhyay et al.; The calcium-sension receptor: A window into the physiology and pathophysiology of mineral ion metabolism; Endocrine 17(4):289-307 (1996).;;Gavela et al.; Preparacion de derivados acetilenicos y alenicos de 2-indolilmetilaminas y resultdos preliminaries de su estudio como inhibidores selectivos para las monoaminooxidasaas AYB; 82:129-120 (1986).;;Nogradi, Thomas; Untersuchungen uber rauwolfia-alkaloid-modelle II; 2-substituierte indole, tetrahydrocarbolin und hexadehydro-yohimban-derivate; Monatshefte fur Chemie. Bd. 88(6) 1088-1094 (1957).;;6001 Chemical Abstracts, Columbus, Ohio; XP-002161450 (1987).;;6001 Chemical Abstracts, Columbus, Ohio; XP-002161408 (1996).;;6001 Chemical Abstracts, Columbus, Ohio; XP-002161449 (1986).;;6001 Chemical Abstracts, Columbus, Ohio; XP-002161453 (1996).;;6001 Chemical Abstracts, Columbus, Ohio; XP-002161448 (1998).;;6001 Chemical Abstracts, Columbus, Ohio; XP-002161454 (1998).;;6001 Chemical Abstracts, Columbus, Ohio; XP-002161455 (1986).;;6001 Chemical Abstracts, Columbus, Ohio; XP-002161456 (1985).;;6001 Chemical Abstracts, Columbus, Ohio; XP-002161451 (1958).;;6001 Chemical Abstracts, Columbus, Ohio; XP-002161457 (1958).;;6001 Chemical Abstracts, Columbus, Ohio; XP-002161464 (1989).;;6001 Chemical Abstracts, Columbus, Ohio; XP-002161465 (1989).;;6001 Chemical Abstracts, Columbus, Ohio; XP-002161452 (1978).;;6001 Chemical Abstracts, Columbus, Ohio; XP-002161458 (1978).",EXPIRED
392,PL,A1,PL 368646 A1,028-773-673-985-803,2005-04-04,2005,PL 36864602 A,2002-10-30,US 292001 A,2001-11-15,SHAVING RAZORS AND RAZOR CARTRIDGES,,GILLETTE CO,BRANDT KLAUS;;DAVIS STUART M;;DODD KENNETH T;;PARENT CHARLES ROBERT;;SZCZEPANOWSKI ANDREW;;WOODNORTH DOUGLAS J,,https://lens.org/028-773-673-985-803,Patent Application,no,0,0,26,26,0,B26B21/40;;B26B21/4025;;B26B21/4087;;B26B21/48;;B26B21/4087;;B26B21/40;;B26B21/48;;B26B21/4025,B26B21/40;;B26B21/48;;B26B21/52,,0,0,,,,EXPIRED
393,BR,A,BR 9713276 A,043-380-331-603-330,2000-03-21,2000,BR 9713276 A,1997-10-23,US 73647096 A;;US 73647196 A;;US 94707597 A;;US 95118497 A;;US 9718954 W,1996-10-24,Processos e composições para redução do odor corpóreo,"The present invention relates to an odor absorbing composition, which is safe for use on human skin, comprising from 0.1 % to 5 %, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from 0.1 % to 36 %, by weight of the composition, of an oil phase selected from the group consisting of emollients, moisturizers, and skin protectants; an emulsifier; and an aqueous carrier. The odor absorbing compositions of the present invention may also contain an effective amount of hydrophobic antimicrobials. The present invention also relates to the use of cyclodextrin-containing compositions for the manufacture of an odor absorbing composition, which is safe for use on skin, for controlling environmental malodors on skin and for reducing body odor and/or vaginal odor.",PROCTER & GAMBLE,TRINH TOAN;;DODD MICHAEL THOMAS;;GREGORYBARTOLO ROBERT;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/043-380-331-603-330,Patent Application,no,0,0,24,28,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61Q15/00;;D06M13/005;;A61K8/73;;A61Q15/00,A61K8/00;;A61K8/02;;A61K8/04;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/44;;A61K8/73;;A61Q15/00;;D06M13/00,,0,0,,,,DISCONTINUED
394,US,A1,US 2003/0088984 A1,049-672-251-447-350,2003-05-15,2003,US 292001 A,2001-11-15,US 292001 A,2001-11-15,Shaving razors and razor cartridges,"
   Shaving razors and cartridges are provided that impart warmth to a user's skin during shaving. The razors and cartridges include a phase change material. 
",BRANDT KLAUS;;DAVIS STUART M.;;DODD KENNETH T.;;PARENT CHARLES ROBERT;;SZCZEPANOWSKI ANDREW;;WOODNORTH DOUGLAS J.,BRANDT KLAUS;;DAVIS STUART M;;DODD KENNETH T;;PARENT CHARLES ROBERT;;SZCZEPANOWSKI ANDREW;;WOODNORTH DOUGLAS J,GILLETTE COMPANY THE (2001-10-31);;THE GILLETTE COMPANY LLC (2016-09-01),https://lens.org/049-672-251-447-350,Patent Application,yes,0,27,26,26,0,B26B21/40;;B26B21/4025;;B26B21/4087;;B26B21/48;;B26B21/4087;;B26B21/40;;B26B21/48;;B26B21/4025,B26B21/40;;B26B21/48;;B26B21/52,30/34.05,0,0,,,,EXPIRED
395,AU,A,AU 1989/036254 A,113-250-919-738-860,1990-01-04,1990,AU 1989/036254 A,1989-06-09,US 21071288 A,1988-06-28,PRESSURE-SENSITIVE ADHESIVE TAPES,,MINNESOTA MINING & MFG,PURGETT MARK DODD;;BOGAERT YVAN ADRIEN;;SMOLDERS ROBERT REMI LOUIS;;EVERAERTS ALBERT IVO;;KINNING DAVID JOHN,,https://lens.org/113-250-919-738-860,Patent Application,no,0,0,16,16,0,C09J133/08;;C08L21/00;;C08L2666/02;;C08L2666/04;;C08L2666/24;;C09J7/385;;C09J133/20;;C09J151/04;;C09J2301/302,C09J7/00;;C08L21/00;;C09J7/02;;C09J133/04;;C09J133/06;;C09J133/08;;C09J151/04,,0,0,,,,EXPIRED
396,WO,B1,WO 2001/090069 B1,120-989-701-309-843,2002-04-11,2002,FR 0101599 W,2001-05-23,FR 0006619 A,2000-05-24,NOVEL CALCIUM RECEPTOR ACTIVE MOLECULES AND METHOD FOR PREPARING SAME,"The invention concerns compounds of general formula (I) wherein: the group X represents a -NR4, -CH = N or -CHR5-NR4- group; the group Y represents an oxygen or sulphur atom or a NR, -CR5, -CHR5-, -CR5=CR6- or -CHR5-CHR6 group provided that when group X represents the -CH=N- or -CHR5-NR4- group, group Y represents an oxygen or a sulphur atom or a Nr, -CR5 or -CHR group; the group R represents a hydrogen atom or an alkyl, aryl or aralkyl group; the groups R1, R5 and R6, identical or different, represent each a hydrogen or halogen atom or an alkyl or alkoxy group; the group R2 represents a hydrogen atom or an alkyl group; the group R3 represents an aryl group; and the group R4 represents a hydrogen atom, an alkyl, aryl, aralkyl, alkylsulphonamide, arylsulphonamide or aralkylsulphonamide group; and their salt with a pharmaceutically acceptable acid, in the form of a racemic mixture and their optically pure isomer. The invention also concerns their preparation, pharmaceutical compositions containing them and their use as CaSR activity modulator and as medicine for preferably treating diseases or physiological disorders involving the intervention of CaSR activity modulation.",CENTRE NAT RECH SCIENT;;RUAT MARTIAL;;DODD ROBERT;;FAURE HELENE VERONIQUE;;DAUBAN PHILIPPE MARCEL;;KESSLER ALBANE;;POTIER PIERRE JEAN PAUL,RUAT MARTIAL;;DODD ROBERT;;FAURE HELENE VERONIQUE;;DAUBAN PHILIPPE MARCEL;;KESSLER ALBANE;;POTIER PIERRE JEAN-PAUL,,https://lens.org/120-989-701-309-843,Patent Application,no,0,0,11,11,0,C07D209/14;;C07D209/42;;A61P1/00;;A61P1/04;;A61P13/12;;A61P19/10;;A61P25/00;;A61P25/28;;A61P35/00;;A61P43/00;;A61P5/00;;A61P5/18;;A61P5/20;;A61P9/00;;C07D209/42;;C07D209/14,A61K31/4045;;A61P1/04;;A61P5/00;;A61P5/18;;A61P9/00;;A61P13/12;;A61P19/10;;A61P25/00;;A61P35/00;;A61P43/00;;C07D209/14;;C07D209/42,,0,0,,,,PENDING
397,PL,B1,PL 205097 B1,110-488-220-395-113,2010-03-31,2010,PL 36864602 A,2002-10-30,US 292001 A,2001-11-15,SHAVING RAZORS AND RAZOR CARTRIDGES,,GILLETTE CO,BRANDT KLAUS;;DAVIS STUART M;;DODD KENNETH T;;PARENT CHARLES ROBERT;;SZCZEPANOWSKI ANDREW;;WOODNORTH DOUGLAS J,,https://lens.org/110-488-220-395-113,Granted Patent,no,0,0,26,26,0,B26B21/40;;B26B21/4025;;B26B21/4087;;B26B21/48;;B26B21/4087;;B26B21/40;;B26B21/48;;B26B21/4025,B26B21/40;;B26B21/48;;B26B21/52,,0,0,,,,EXPIRED
398,WO,A1,WO 2003/043791 A1,126-652-307-098-35X,2003-05-30,2003,US 0234770 W,2002-10-30,US 292001 A,2001-11-15,SHAVING RAZORS AND RAZOR CARTRIDGES,Shaving razors and cartridges are provided that impart warmth to a user's skin during shaving. The razors and cartridges include a phase change material.,GILLETTE CO;;BRANDT KLAUS;;DAVIS STUART M;;DODD KENNETH T;;PARENT CHARLES ROBERT;;SZCZEPANOWSKI ANDREW;;WOODNORTH DOUGLAS J,BRANDT KLAUS;;DAVIS STUART M;;DODD KENNETH T;;PARENT CHARLES ROBERT;;SZCZEPANOWSKI ANDREW;;WOODNORTH DOUGLAS J,,https://lens.org/126-652-307-098-35X,Patent Application,yes,4,0,26,26,0,B26B21/40;;B26B21/4025;;B26B21/4087;;B26B21/48;;B26B21/4087;;B26B21/40;;B26B21/48;;B26B21/4025,B26B21/40;;B26B21/48;;B26B21/52,,0,0,,,,PATENTED
399,CN,A,CN 1589192 A,082-714-607-987-999,2005-03-02,2005,CN 02822725 A,2002-10-30,US 292001 A;;US 0234770 W,2001-11-15,Shaving razors and razor cartridges,,GILLETTE CO,KLAUS BRANDT;;DAVIS STUART M;;DODD KENNETH T;;ROBERT PARENT CHARLES;;ANDREW SZCZEPANOWSKI;;WOODNORTH DOUGLAS J,,https://lens.org/082-714-607-987-999,Patent Application,no,0,6,26,26,0,B26B21/40;;B26B21/4025;;B26B21/4087;;B26B21/48;;B26B21/4087;;B26B21/40;;B26B21/48;;B26B21/4025,B26B21/40;;B26B21/48;;B26B21/52,,0,0,,,,EXPIRED
400,WO,A1,WO 2001/090069 A1,100-454-099-467-569,2001-11-29,2001,FR 0101599 W,2001-05-23,FR 0006619 A,2000-05-24,NOVEL CALCIUM RECEPTOR ACTIVE MOLECULES AND METHOD FOR PREPARING SAME,"The invention concerns compounds of general formula (I) wherein: the group X represents a -NR4, -CH = N or -CHR5-NR4- group; the group Y represents an oxygen or sulphur atom or a NR, -CR5, -CHR5-, -CR5=CR6- or -CHR5-CHR6 group provided that when group X represents the -CH=N- or -CHR5-NR4- group, group Y represents an oxygen or a sulphur atom or a Nr, -CR5 or -CHR group; the group R represents a hydrogen atom or an alkyl, aryl or aralkyl group; the groups R1, R5 and R6, identical or different, represent each a hydrogen or halogen atom or an alkyl or alkoxy group; the group R2 represents a hydrogen atom or an alkyl group; the group R3 represents an aryl group; and the group R4 represents a hydrogen atom, an alkyl, aryl, aralkyl, alkylsulphonamide, arylsulphonamide or aralkylsulphonamide group; and their salt with a pharmaceutically acceptable acid, in the form of a racemic mixture and their optically pure isomer. The invention also concerns their preparation, pharmaceutical compositions containing them and their use as CaSR activity modulator and as medicine for preferably treating diseases or physiological disorders involving the intervention of CaSR activity modulation.",CENTRE NAT RECH SCIENT;;RUAT MARTIAL;;DODD ROBERT;;FAURE HELENE VERONIQUE;;DAUBAN PHILIPPE MARCEL;;KESSLER ALBANE;;POTIER PIERRE JEAN PAUL,RUAT MARTIAL;;DODD ROBERT;;FAURE HELENE VERONIQUE;;DAUBAN PHILIPPE MARCEL;;KESSLER ALBANE;;POTIER PIERRE JEAN-PAUL,,https://lens.org/100-454-099-467-569,Patent Application,yes,6,39,11,11,0,C07D209/14;;C07D209/42;;A61P1/00;;A61P1/04;;A61P13/12;;A61P19/10;;A61P25/00;;A61P25/28;;A61P35/00;;A61P43/00;;A61P5/00;;A61P5/18;;A61P5/20;;A61P9/00;;C07D209/42;;C07D209/14,A61K31/4045;;A61P1/04;;A61P5/00;;A61P5/18;;A61P9/00;;A61P13/12;;A61P19/10;;A61P25/00;;A61P35/00;;A61P43/00;;C07D209/14;;C07D209/42,,7,0,,,"CHEMICAL ABSTRACTS, vol. 125, no. 21, 18 November 1996, Columbus, Ohio, US; abstract no. 275909y, KOJIMA, KOICHI ET AL.: ""Preparation of hexahydropyrazinoquinoline derivatives exhibiting excellent serotonin 5-HT1a receptor agonist effects."" XP002161408;;CHEMICAL ABSTRACTS, vol. 129, no. 18, 2 November 1998, Columbus, Ohio, US; abstract no. 225222f, CHERQAOUI, DRISS ET AL.: ""Structure-selectivity relationships of MAO inhibitors using neural networks"" XP002161448;;CHEMICAL ABSTRACTS, vol. 107, no. 3, 20 July 1987, Columbus, Ohio, US; abstract no. 23198n, ALVAREZ GAVELA, L. ET AL.: ""Preparation of acetylenic and allenic derivatives of 2-indolylmethylamines and preliminary results of their study as selective inhibitors for the monoamine oxidases A and B."" XP002161449;;CHEMICAL ABSTRACTS, vol. 106, no. 5, 2 February 1987, Columbus, Ohio, US; abstract no. 32831v, FERNANDEZ ALVAREZ, ELDIBERTO ET AL.: ""2-((Alkynylamino)methyl)indoles."" XP002161450;;CHEMICAL ABSTRACTS, vol. 52, no. 13, 10 July 1958, Columbus, Ohio, US; abstract no. 11039d, TAMAS NOGRADI: ""Rauwolfia alkaloid models. II. 2-Substituted indole, tetrahydrocarboline, and hexahydroyohimban derivatives."" XP002161451;;CHEMICAL ABSTRACTS, vol. 115, no. 5, 5 August 1991, Columbus, Ohio, US; abstract no. 49399u, FERNANDEZ ALVAREZ, ELDIBERTO ET AL.: ""Preparation of acetylenic and allenic derivatives of 2-aminomethyl-1-methylindoles as momoamine oxidase (MAO) inhibitors."" XP002161464;;CHEMICAL ABSTRACTS, vol. 89, no. 3, 17 July 1978, Columbus, Ohio, US; abstract no. 21597t, VASIL'EVA V. F. ET AL.: ""Substituted 1,2,3,4-tetrahydroquinolines. V. N-Carboxamidines and guanidines. Synthesis and pharmacological properties."" XP002161452",PENDING
401,US,B2,US 7350493 B2,135-672-818-763-942,2008-04-01,2008,US 42746106 A,2006-06-29,GB 0513318 A,2005-07-01,Distributor for engine with laser ignition,"A distributor is described for a multi-cylinder laser ignited internal combustion engine. The distributor includes a shaft rotatable by the engine and a plurality of flat reflective surfaces on the shaft. The surfaces lie in planes normal to the axis of rotation of the shaft and are axially staggered from one another along the length of the shaft. An optical transmitter directs light from a laser source to impinge at an angle sequentially on the reflective surfaces as the shaft rotates, and a plurality of optical receivers spaced from one another each receive the light reflected from a respective one of the mirror surfaces and direct the reflected light to a respective one of the engine cylinders.",FORD GLOBAL TECH LLC,SCARISBRICK ANDY;;CARROLL STEPHAN;;DODD ROBERT;;SHENTON TOM;;DEARDEN GEOFF;;KEEN STEVE;;CLISSOLD ROY;;MCCULLOCH JOHN,FORD GLOBAL TECHNOLOGIES LLC (2006-08-30);;FORD MOTOR COMPANY (2006-07-14),https://lens.org/135-672-818-763-942,Granted Patent,yes,9,9,7,7,0,F02P23/04;;H01S3/0071;;F02P7/03;;F02P23/04;;G02B6/3512;;G02B26/08;;F02P23/04;;H01S3/0071,F02P23/04,123143B,0,0,,,,ACTIVE
402,EP,B1,EP 1284963 B1,153-244-543-961-780,2012-05-09,2012,EP 01938319 A,2001-05-23,FR 0101599 W;;FR 0006619 A,2000-05-24,NOVEL CALCIUM RECEPTOR ACTIVE MOLECULES AND METHOD FOR PREPARING SAME,,CENTRE NAT RECH SCIENT,RUAT MARTIAL;;DODD ROBERT;;FAURE HELENE VERONIQUE;;DAUBAN PHILIPPE MARCEL;;KESSLER ALBANE;;POTIER PIERRE JEAN-PAUL,,https://lens.org/153-244-543-961-780,Granted Patent,yes,6,0,11,11,0,C07D209/14;;C07D209/42;;A61P1/00;;A61P1/04;;A61P13/12;;A61P19/10;;A61P25/00;;A61P25/28;;A61P35/00;;A61P43/00;;A61P5/00;;A61P5/18;;A61P5/20;;A61P9/00;;C07D209/42;;C07D209/14,A61K31/4045;;C07D209/14;;A61P1/04;;A61P5/00;;A61P5/18;;A61P9/00;;A61P13/12;;A61P19/10;;A61P25/00;;A61P35/00;;A61P43/00;;C07D209/42,,7,0,,,"CHEMICAL ABSTRACTS, vol. 125, no. 21, 18 novembre 1996 (1996-11-18) Columbus, Ohio, US; abstract no. 275909y, KOJIMA, KOICHI ET AL.: ""Preparation of hexahydropyrazinoquinoline derivatives exhibiting excellent serotonin 5-HT1a receptor agonist effects."" XP002161408 -& DATABASE CHEMICAL ABSTRACTS [en ligne] CA 125:275909, XP002161453 & WO 96 23789 A (SANKYO CO., LTD.) 8 août 1996 (1996-08-08);;CHEMICAL ABSTRACTS, vol. 129, no. 18, 2 novembre 1998 (1998-11-02) Columbus, Ohio, US; abstract no. 225222f, CHERQAOUI, DRISS ET AL.: ""Structure-selectivity relationships of MAO inhibitors using neural networks"" XP002161448 & ACH- MODELS CHEM., vol. 135, no. 1-2, - 1998 pages 79-91, -& DATABASE CHEMICAL ABSTRACTS [en ligne] 129:225222, XP002161454;;CHEMICAL ABSTRACTS, vol. 107, no. 3, 20 juillet 1987 (1987-07-20) Columbus, Ohio, US; abstract no. 23198n, ALVAREZ GAVELA, L. ET AL.: ""Preparation of acetylenic and allenic derivatives of 2-indolylmethylamines and preliminary results of their study as selective inhibitors for the monoamine oxidases A and B."" XP002161449 & AN. QUIM., SER C, vol. 82, no. 2, - 1982 pages 129-134, -& DATABASE CHEMICAL ABSTRACTS [en ligne] CA 107:23198, XP002161455;;CHEMICAL ABSTRACTS, vol. 106, no. 5, 2 février 1987 (1987-02-02) Columbus, Ohio, US; abstract no. 32831v, FERNANDEZ ALVAREZ, ELDIBERTO ET AL.: ""2-((Alkynylamino)methyl)indoles."" XP002161450 & ES 542 696 A (CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS) 16 avril 1985 (1985-04-16) -& DATABASE CHEMICAL ABSTRACTS [en ligne] CA 106:32831, XP002161456;;CHEMICAL ABSTRACTS, vol. 52, no. 13, 10 juillet 1958 (1958-07-10) Columbus, Ohio, US; abstract no. 11039d, TAMAS NOGRADI: ""Rauwolfia alkaloid models. II. 2-Substituted indole, tetrahydrocarboline, and hexahydroyohimban derivatives."" XP002161451 & MONATSH. CHEM., vol. 88, - 1958 pages 1087-1094, -& DATABASE CHEMICAL ABSTRACTS [en ligne] 52:11039, XP002161457;;CHEMICAL ABSTRACTS, vol. 115, no. 5, 5 août 1991 (1991-08-05) Columbus, Ohio, US; abstract no. 49399u, FERNANDEZ ALVAREZ, ELDIBERTO ET AL.: ""Preparation of acetylenic and allenic derivatives of 2-aminomethyl-1-methylindoles as momoamine oxidase (MAO) inhibitors."" XP002161464 & ES 2 010 406 A (CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS) 1 novembre 1989 (1989-11-01) -& DATABASE CHEMICAL ABSTRACTS [en ligne] CA 115:49399, XP002161465;;CHEMICAL ABSTRACTS, vol. 89, no. 3, 17 juillet 1978 (1978-07-17) Columbus, Ohio, US; abstract no. 21597t, VASIL'EVA V. F. ET AL.: ""Substituted 1,2,3,4-tetrahydroquinolines. V. N-Carboxamidines and guanidines. Synthesis and pharmacological properties."" XP002161452 & KHIM.-FARM. ZH., vol. 12, no. 8, - 1978 pages 40-45, -& DATABASE CHEMICAL ABSTRACTS [en ligne] CA 89:21579, XP002161458",EXPIRED
403,FR,B1,FR 2809396 B1,028-980-753-312-889,2005-10-14,2005,FR 0006619 A,2000-05-24,FR 0006619 A,2000-05-24,NOUVELLES MOLECULES POSSEDANT UNE ACTIVITE CALCIMIMETIQUE ET LEUR MODE DE PREPARATION,,CENTRE NAT RECH SCIENT,RUAT MARTIAL;;DODD ROBERT;;FAURE HELENE VERONIQUE;;DAUBAN PHILIPPE MARCEL;;KESSLER ALBANE;;POTIER PIERRE JEAN PAUL,,https://lens.org/028-980-753-312-889,Granted Patent,no,0,0,11,11,0,C07D209/14;;C07D209/42;;A61P1/00;;A61P1/04;;A61P13/12;;A61P19/10;;A61P25/00;;A61P25/28;;A61P35/00;;A61P43/00;;A61P5/00;;A61P5/18;;A61P5/20;;A61P9/00;;C07D209/42;;C07D209/14,A61K31/4045;;A61P1/04;;A61P5/00;;A61P5/18;;A61P9/00;;A61P13/12;;A61P19/10;;A61P25/00;;A61P35/00;;A61P43/00;;C07D209/14;;C07D209/42,,0,0,,,,EXPIRED
404,FR,A1,FR 2809396 A1,027-157-664-680-033,2001-11-30,2001,FR 0006619 A,2000-05-24,FR 0006619 A,2000-05-24,NOUVELLES MOLECULES POSSEDANT UNE ACTIVITE CALCIMIMETIQUE ET LEUR MODE DE PREPARATION,"The invention concerns compounds of general formula (I) wherein: the group X represents a -NR4, -CH = N or -CHR5-NR4- group; the group Y represents an oxygen or sulphur atom or a NR, -CR5, -CHR5-, -CR5=CR6- or -CHR5-CHR6 group provided that when group X represents the -CH=N- or -CHR5-NR4- group, group Y represents an oxygen or a sulphur atom or a Nr, -CR5 or -CHR group; the group R represents a hydrogen atom or an alkyl, aryl or aralkyl group; the groups R1, R5 and R6, identical or different, represent each a hydrogen or halogen atom or an alkyl or alkoxy group; the group R2 represents a hydrogen atom or an alkyl group; the group R3 represents an aryl group; and the group R4 represents a hydrogen atom, an alkyl, aryl, aralkyl, alkylsulphonamide, arylsulphonamide or aralkylsulphonamide group; and their salt with a pharmaceutically acceptable acid, in the form of a racemic mixture and their optically pure isomer. The invention also concerns their preparation, pharmaceutical compositions containing them and their use as CaSR activity modulator and as medicine for preferably treating diseases or physiological disorders involving the intervention of CaSR activity modulation.",CENTRE NAT RECH SCIENT,RUAT MARTIAL;;DODD ROBERT;;FAURE HELENE VERONIQUE;;DAUBAN PHILIPPE MARCEL;;KESSLER ALBANE;;POTIER PIERRE JEAN PAUL,,https://lens.org/027-157-664-680-033,Patent Application,no,4,0,11,11,0,C07D209/14;;C07D209/42;;A61P1/00;;A61P1/04;;A61P13/12;;A61P19/10;;A61P25/00;;A61P25/28;;A61P35/00;;A61P43/00;;A61P5/00;;A61P5/18;;A61P5/20;;A61P9/00;;C07D209/42;;C07D209/14,A61K31/4045;;A61P1/04;;A61P5/00;;A61P5/18;;A61P9/00;;A61P13/12;;A61P19/10;;A61P25/00;;A61P35/00;;A61P43/00;;C07D209/14;;C07D209/42,,7,0,,,"CHEMICAL ABSTRACTS, vol. 125, no. 21, 18 November 1996, Columbus, Ohio, US; abstract no. 275909y, KOJIMA, KOICHI ET AL.: ""Preparation of hexahydropyrazinoquinoline derivatives exhibiting excellent serotonin 5-HT1a receptor agonist effects."" XP002161408;;CHEMICAL ABSTRACTS, vol. 129, no. 18, 2 November 1998, Columbus, Ohio, US; abstract no. 225222f, CHERQAOUI, DRISS ET AL.: ""Structure-selectivity relationships of MAO inhibitors using neural networks"" XP002161448;;CHEMICAL ABSTRACTS, vol. 107, no. 3, 20 July 1987, Columbus, Ohio, US; abstract no. 23198n, ALVAREZ GAVELA, L. ET AL.: ""Preparation of acetylenic and allenic derivatives of 2-indolylmethylamines and preliminary results of their study as selective inhibitors for the monoamine oxidases A and B."" XP002161449;;CHEMICAL ABSTRACTS, vol. 106, no. 5, 2 February 1987, Columbus, Ohio, US; abstract no. 32831v, FERNANDEZ ALVAREZ, ELDIBERTO ET AL.: ""2-((Alkynylamino)methyl)indoles."" XP002161450;;CHEMICAL ABSTRACTS, vol. 52, no. 13, 10 July 1958, Columbus, Ohio, US; abstract no. 11039d, TAMAS NOGRADI: ""Rauwolfia alkaloid models. II. 2-Substituted indole, tetrahydrocarboline, and hexahydroyohimban derivatives."" XP002161451;;CHEMICAL ABSTRACTS, vol. 115, no. 5, 5 August 1991, Columbus, Ohio, US; abstract no. 49399u, FERNANDEZ ALVAREZ, ELDIBERTO ET AL.: ""Preparation of acetylenic and allenic derivatives of 2-aminomethyl-1-methylindoles as momoamine oxidase (MAO) inhibitors."" XP002161464;;CHEMICAL ABSTRACTS, vol. 89, no. 3, 17 July 1978, Columbus, Ohio, US; abstract no. 21597t, VASIL'EVA V. F. ET AL.: ""Substituted 1,2,3,4-tetrahydroquinolines. V. N-Carboxamidines and guanidines. Synthesis and pharmacological properties."" XP002161452",EXPIRED
405,US,A1,US 2007/0250935 A1,060-639-995-308-63X,2007-10-25,2007,US 82119407 A,2007-06-21,US 82119407 A;;US 6636702 A;;US 26551901 P,2001-01-31,Method and system for configuring and scheduling security audits of a computer network,"Managing the selection and scheduling of security audits run on a computing network. The computer network is surveyed by a security audit system to determine the function and relative importance of the elements in the network. Based on function and priority, a more thorough type of security audit is selected to run against each of the network elements by the security audit system. The security audit can also be automatically scheduled based on the information gathered from the survey. Once the system runs the security audit, a vulnerability assessment can be calculated for each element in the network. The vulnerability assessment can be presented in a format that facilitates interpretation and response by someone operating the system. The vulnerability assessment can also be used to configure and schedule future security audits.",ZOBEL ROBERT D;;DODD TIMOTHY D;;MILLAR SHARON A;;NESFEDER DAVID G JR;;SINGER CHRISTOPHER S,ZOBEL ROBERT D;;DODD TIMOTHY D;;MILLAR SHARON A;;NESFEDER DAVID G JR;;SINGER CHRISTOPHER S,INTERNATIONAL BUSINESS MACHINES CORPORATION (2007-09-28),https://lens.org/060-639-995-308-63X,Patent Application,yes,99,21,11,11,0,G06F21/577;;G06F2221/2101;;H04L63/1425;;H04L63/1433;;H04L63/1425;;G06F2221/2101;;G06F21/577;;H04L63/1433,G06F21/00;;G06F11/30;;H04L29/06,726/26,0,0,,,,EXPIRED
406,CA,C,CA 2464706 C,111-510-600-097-454,2007-12-11,2007,CA 2464706 A,2002-10-30,US 292001 A;;US 0234770 W,2001-11-15,SHAVING RAZORS AND RAZOR CARTRIDGES,Shaving razors and cartridges are provided that impart warmth to a user's sk in during shaving. The razors and cartridges include a phase change material.</ SDOAB>,GILLETTE CO,BRANDT KLAUS;;WOODNORTH DOUGLAS J;;DAVIS STUART M;;DODD KENNETH T;;PARENT CHARLES ROBERT;;SZCZEPANOWSKI ANDREW,,https://lens.org/111-510-600-097-454,Granted Patent,no,0,0,26,26,0,B26B21/40;;B26B21/4025;;B26B21/4087;;B26B21/48;;B26B21/4087;;B26B21/40;;B26B21/48;;B26B21/4025,B26B21/40;;B26B21/48;;B26B21/52,,0,0,,,,EXPIRED
407,BR,A,BR 0214002 A,130-626-840-021-786,2004-11-03,2004,BR 0214002 A,2002-10-30,US 292001 A;;US 0234770 W,2001-11-15,"Aparelho de barbear, cartucho de aparelho de barbear e método de barbear","""APARELHO DE BARBEAR, CARTUCHO DE APARELHO DE BARBEAR E MéTODO DE BARBEAR"". São descritos aparelhos e cartuchos de barbear que conferem calor à pele de um usuário durante o barbear. Os aparelhos e cartuchos incluem um material de mudança de fase.",GILLETTE CO,BRANDT KLAUS;;DAVIS STUART M;;DODD KENNETH T;;PARENT CHARLES ROBERT;;SZCZEPANOWSKI ANDREW;;WOODNORTH DOUGLAS J,,https://lens.org/130-626-840-021-786,Patent Application,no,0,0,26,26,0,B26B21/40;;B26B21/4025;;B26B21/4087;;B26B21/48;;B26B21/4087;;B26B21/40;;B26B21/48;;B26B21/4025,B26B21/40;;B26B21/48;;B26B21/52,,0,0,,,,EXPIRED
408,EP,A2,EP 0465241 A2,186-897-562-528-507,1992-01-08,1992,EP 91306051 A,1991-07-03,US 54795890 A,1990-07-03,Apparatus and method for the detection and treatment of arrhythmias using a neural network.,"An apparatus and method for the detection and treatment of arrhythmias using a processor having a neural network (21) with a hierarchical arrangement including a first lower level (21A) for classifying individual waveforms, a second higher level (21B) for diagnosing detected arrhythmias and a third higher level (21C) for the application of therapy in response to a diagnosed arrhythmia. The neural network (21) may be a back propogation neural network or an associative memory type neural network. The arrhythmias detected may be at least one of bradycardia, tachycardia and fibrillation. The apparatus may include a cardioverting/defibrillating packmaker (15). In general, the apparatus acquires physiological signals representative of heart activity in a patient. A neural network (21) receives the physiological signals and determines if any arrhythmia is present, and if present, selects therapy to be applied to the heart. A therapy generator then applies the therapy selected by the neural network (21). The physioligical signals may be processed or unprocessed ECG signal, signals indicative of the properties of the blood, and blood flow signals or signals representative of ventricular wall impedance or ventricular volume.",TELECTRONICS NV,NICKOLLS PETER;;DRANE GEOFF;;FLOWER BARRY;;LUNSMANN PAUL;;DODD ROBERT;;BASSIN DAVID;;WICKHAM JOHN;;MURPHY TONY,,https://lens.org/186-897-562-528-507,Patent Application,yes,0,28,6,7,0,A61N1/36514;;A61N1/36514;;A61N1/39622;;A61N1/39622,A61B5/0245;;A61B5/0452;;A61B10/00;;A61N1/365;;A61N1/39,,0,0,,,,EXPIRED
409,US,B2,US 7712138 B2,030-956-125-199-67X,2010-05-04,2010,US 82119407 A,2007-06-21,US 82119407 A;;US 6636702 A;;US 26551901 P,2001-01-31,Method and system for configuring and scheduling security audits of a computer network,"Managing the selection and scheduling of security audits run on a computing network. The computer network is surveyed by a security audit system to determine the function and relative importance of the elements in the network. Based on function and priority, a more thorough type of security audit is selected to run against each of the network elements by the security audit system. The security audit can also be automatically scheduled based on the information gathered from the survey. Once the system runs the security audit, a vulnerability assessment can be calculated for each element in the network. The vulnerability assessment can be presented in a format that facilitates interpretation and response by someone operating the system. The vulnerability assessment can also be used to configure and schedule future security audits.",IBM,ZOBEL ROBERT DAVID;;DODD TIMOTHY DAVID;;MILLAR SHARON A;;NESFEDER JR DAVID GERALD;;SINGER CHRISTOPHER S,INTERNATIONAL BUSINESS MACHINES CORPORATION (2007-09-28),https://lens.org/030-956-125-199-67X,Granted Patent,yes,114,34,11,11,0,G06F21/577;;G06F2221/2101;;H04L63/1425;;H04L63/1433;;H04L63/1425;;G06F2221/2101;;G06F21/577;;H04L63/1433,G06F12/14;;G06F21/00;;H04L29/06,726/25;;726/22;;726/23;;726/24;;713/188;;709/224;;709/225,99,18,090-071-506-277-668;;065-258-553-829-49X;;027-816-612-288-028;;125-027-089-149-672;;038-340-557-706-933;;005-364-428-355-339;;010-961-486-471-799;;115-192-727-768-90X;;019-857-952-759-763;;043-753-890-505-226;;068-702-276-464-337;;096-442-581-304-695;;071-936-515-547-560;;110-454-069-963-118;;083-993-908-337-720;;089-657-905-928-117;;098-584-601-059-778;;003-983-493-319-713,10.1109/csac.1998.738575;;10.1109/discex.2000.824979;;10.1109/ndss.1995.390642;;10.1109/cds.1996.509364;;10.1145/174613.174614;;10.1109/infcom.1996.493354;;10.1109/iccl.1988.13047;;10.1109/pccc.1996.493637;;10.1109/65.598458;;10.1145/65000.65002;;10.1109/secpri.1996.502681;;10.1109/pccc.1990.101684;;10.1145/122572.122573;;10.1145/191177.191183;;10.1109/tsmc.1982.4308849;;10.1109/tsmc.1984.6313315;;10.1109/tsmc.1986.289253;;10.1109/52.605929,"Essex, David, E-Sleuths Make Net Safe for E-Commerce, Computerworld, Jun. 2000, pp. 1-2.;;Newman, David, Intrusion Detection Systems, Data Communications, 1998, pp. 1-9.;;International Search Report for PCT/US02/17161 of Dec. 31, 2002.;;Hyland, et al., Concentric Supervision of Security Applications: A New Security Management Paradigm Computer Security Applications Conference, 1998, pp. 59-68.;;Koilpillai et al., Recon-A Tool for Incident Detection, Tracking and Response, Darpa Information Survivability Conference and Exposition, 2000, pp. 199-206.;;Alves-Foss, J., An Overview of SNIF: A Tool for Surveying Network Information Flow, Network and Distributed System Security, 1995, pp. 94-101.;;Mansouri-Samani et al., A Configurable Event Service for Distributed Systems Configurable Distributed Systems, 1996, pp. 210-217.;;International Search Report for PCT/US01/13769 of Mar. 8, 2002.;;Jagannathan et al., System Design Document: Next-Generation Intrusion Detection Expert Systems (NIDES), Internet Citation, Mar. 9, 1993, XP002136082, pp. 1-66.;;Koilpillai, Adaptive Network Security Management, DARPA NGI PI Conference, Oct. 1998, pp. 1-27.;;Hiverworld Continuous Adaptive Risk Management, Hiverworld, Inc., 1999-2000, pp. 1-14.;;International Search Report for PCT/US02/04989of Sep. 19, 2002.;;International Search Report for PCT/US02/02917 of Aug. 8, 2002.;;International Search Report for PCT/US03/00155 of May 15, 2003.;;NXI Communications, Inc., White Paper, NTS Security Issues, Oct. 15, 2001, pp. 1-12.;;Mounji et al., Distributed Audit Trail Analysis, Proceedings of the Symposium of Network and Distributed System Security, San Diego, CA, Feb. 16-17, 1995, pp. 102-112.;;Wobber et al., Authentication in the Taos Operating System, ACM Transactions on Computer Systems, vol. 12, No. 1, Feb. 1994, pp. 3-32.;;Mayer et al., The Design of the Trusted Workstation: A True Infosec Product, 13th National Computer Security Conference, Washing, DC, Oct. 1-4, 1990, pp. 827-839.;;Dawson, Intrusion Protection for Networks, Byte, Apr. 1995, pp. 171-172.;;Buhkan, Checkpoint Charlie, PC Week Network, Nov. 27, 1995, pp. N1, N6-N7.;;Process Software Technical Support Page, found on http://www.process.com/techsupport/whitesec.html, printed off of the Process Software website on Feb. 26, 2003, pp. 1-5.;;Ganesan, BAfirewall: A Modern Firewall Design, Proceedings Internet Society Symposium on Network and Distributed System Security 1994, Internet Soc., 1994, pp. 99-108.;;Lee, Trusted Systems, Chapter II-1-6 of Handbook of Information Security Management, Ed. Zella G. Ruthberg and Harold F. Tipton, Auerbach, Boston and New York, 1993, pp. 345-362.;;Lunt, Automated Intrusion Detection, Chapter II-4-4 of Handbook of Information Security Management, Ed. Zella G. Ruthberg and Harold F. Tipton, Auerbach, Boston and New York, 1993, pp. 551-563.;;Guha et al., Network Security via Reverse Engineering of TCP Code: Vulnerability Analysis and Proposed Solution, IEEE, Mar. 1996, pp. 603-610.;;Garg et al., High Level Communication Primitives for Concurrent Systems, IEEE, 1988, pp. 92-99.;;Hastings et al., TCP/IP Spoofing Fundamentals, IEEE, May 1996, pp. 218-224.;;Snapp, Signature Analysis and Communication Issues in a Distributed Intrusion Detection System, Master Thesis, University of California, Davis, California, 1991, pp. 1-40.;;Guha et al., Network Security via Reverse Engineering of TCP Code: Vulnerability Analysis and Proposed Solutions, IEEE, Jul. 1997, pp. 40-48.;;Djahandari et al., An MBone for an Application Gateway Firewall, IEEE, Nov. 1997, pp. 72-81.;;Kim et al., Implementing a Secure Login Environment: A Case Study of Using a Secure Network Layer Protocol, Department of Computer Science, University of Alabama, Jun. 1995, pp. 1-9.;;Satyanarayanan, Integrating Security in a Large Distributed System, Acm Transaction on Computer Systems, vol. 7, No. 3, Aug. 1989, pp. 47-280.;;Sammons, Nathaniel, ""Multi-platform Interrogation and Reporting with Rscan,"" The Ninth Systems Administration Conference, LISA 1995, Monterrey, California, Sep. 17-22, 1995, pp. 75-87.;;Dean et al., ""Java Security: From HotJava to Netscape and Beyond,"" Proceedings of the 1996 IEEE Symposium on Security and Privacy, May 6-8, 1996, Oakland, California, pp. 190-200.;;Fisch et al., ""The Design of an Audit Trail Analysis Tool,"" Proceedings of the 10th Annual Computer Security Applications Conference, Dec. 5-9, 1994, Orlando, Florida, pp. 126-132.;;Safford et al., ""The TAMU Security Package: An Ongoing Response to Internet Intruders in an Academic Environment,"" USENIX Symposium Proceedings, UNIX Security IV, Oct. 4-6, 1993, Santa Clara, California, pp. 91-118.;;Sugawara, Toshiharu, ""A Cooperative LAN Diagnostic and Observation Expert System,"" Ninth Annual Phoenix Conference on Computers and Communications, 1990 Conference Proceedings, Mar. 21-23, 1990, Scottsdale, Arizona, pp. 667-674.;;Casella, Karen A., ""Security Administration in an Open Networking Environment,"" The Ninth Systems Administration Conference, LISA 1995, Monterrey, California, Sep. 17-22, 1995, pp. 67-73.;;Burchell, Jonathan, ""Vi-SPY: Universal NIM?"" Virus Bulletin, Jan. 1995, pp. 20-22.;;Benzel et al., ""Identification of Subjects and Objects in a Trusted Extensible Client Server Architecture,"" 18th National Information Systems Security Conference, Oct. 10-13, 1995, Baltimore, Maryland, pp. 83-99.;;Epstein et al., ""Component Architectures for Trusted Netware,"" 18th National Information Systems Security Conference, Oct. 10-13, 1995, Baltimore, Maryland, pp. 455-463.;;Varadharajan, Vijay, ""Design and Management of a Secure Networked Administration System: A Practical Approach,"" 19th National Information Systems Security Conference, Oct. 22-25, 1996, Baltimore, Maryland, pp. 570-580.;;Snapp et al., ""DIDS (Distributed Intrusion Detection System)-Motivation, Architecture, and An Early Prototype,"" 14th National Computer Security Conference, Oct. 1-4, 1991, Washington, DC, pp. 167-176.;;Broner et al., ""IntelligentI/O Rule-Based Input/Output Processing for Operating Systems,"" Operating Systems Review, vol. 25, No. 3, Jul. 1991, pp. 10-26.;;Drews et al., ""Special Delivery-Automatic Software Distribution Can Make You a Hero,"" Network Computing, Aug. 1, 1994, pp. 80, 82-86, 89, 91-95.;;Morrissey, Peter, ""Walls,"" Network Computing, Feb. 15, 1996, pp. 55-59, 65-67.;;Harlander, Dr. Magnus, ""Central System Administration in a Heterogenous Unix Environment: GeNUAdmin,"" Proceedings of the Eighth Systems Administration Conference (LISA VIII), Sep. 19-23, 1994, San Diego, California, pp. 1-8.;;Shaddock et al., ""How to Upgrade 1500 Workstations on Saturday, and Still Have Time to Mow the Yard on Sunday,"" The Ninth Systems Administration Conference LISA '95, Sep. 17-22, 1995, Monterrey, California, pp. 59-65.;;Anderson, Paul, ""Towards a High-Level Machine Configuration System,"" Proceedings of the Eighth Systems Administration Conference (LISA VIII), Sep. 19-23, 1994, San Diego, California, pp. 19-26.;;Cooper, Michael A., ""Overhauling Rdist for the '90s,"" Proceedings of the Sixth Systems Administration Conference (LISA VI), Oct. 19-23, 1992, Long Beach, California, pp. 175-188.;;Vangala et al., ""Software Distribution and Management in a Networked Environment,"" Proceedings of the Sixth Systems Administration Conference, Oct. 19-23, 1992, Long Beach, California, pp. 163-170.;;Kim et al., ""The Design and Implementation of Tripwire: A File System Integrity Checker,"" 2nd ACM Conference on Computer and Communications Security, Nov. 2-4, 1994, Fairfax, Virginia, pp. 18-29.;;Winn Schwartau, ""e.Security(TM)-Solving 'Dumb Days' With Security Visualization,"" e-Security, Inc., Naples, FL 34103, 2000.;;Anita D'Amico, Ph.D., ""Assessment of Open e-Security Platform(TM): Vendor-Independent Central Management of Computer Security Resources,"" Applied Visions, Inc., 1999.;;""e.Security(TM)-Open Enterprise Security Management: Delivering an integrated, automated, centrally Managed Solution You Can Leverage Today and Tomorrow,"" e-Security, Inc., Naples, FL 34102, 1999.;;""e.Security(TM)-Vision,"" e-Security, Inc., Naples, FL, 1999.;;""e.Security(TM)-Administrator Workbench(TM),"" e-Security, Inc. Naples, FL, 1999.;;""e.Security(TM)-Fact Sheet,"" e-Security, Inc., Naples, FL, 1999.;;""e.Security(TM)-Open e-Security Platform(TM),"" e-Security, Inc. Naples, FL, 1999.;;Babcock, ""E-Security Tackles The Enterprise,"" Jul. 28, 1999; Inter@ctive Week, www.Zdnet.com.;;Kay Blough, ""In Search of More-Secure Extranets,"" Nov. 1, 1999, www.InformationWeek.com.;;Paul H. Desmond, ""Making Sense of Your Security Tools,"" Software Magazine and Wiesner Publishing, www.softwaremag.com, 1999.;;Kay Blough, ""Extra Steps Can Protect Extranets,"" Nov. 1, 1999, www. InformationWeek.com.;;Sean Hao, ""Software protects e-commerce-e-Security's product alerts networks when hackers attack,"" Florida Today, Florida.;;Scott Weiss, ""Security Strategies-E-Security, Inc.,"" product brief, Hurwitz Group, Inc., Mar. 24, 2000.;;Sean Adee, CISA, ""Managed Risk, Enhanced Response-The Positive Impact of Real-Time Security Awareness,"" Information Systems Control Journal, vol. 2, 2000.;;""Reprint Review-The Information Security Portal-Open e-Security Platform Version 1.0"", Feb. 2000, West Coast Publishing, SC Magazine, 1999.;;e.Security-""Introducing the First Integrated, Automated, and Centralized Enterprise Security Management System,"" white paper, e-Security, Inc., Naples, FL 34102, 1999.;;Ann Harrison, ""Computerworld-Integrated Security Helps Zap Bugs,"" Feb. 21, 2000, Computerworld, vol. 34, No. 8, Framingham, MA.;;Shruti Daté, ""Justice Department Will Centrally Monitor Its Systems For Intrusions,"" Apr. 3, 2000, Post-Newsweek Business Information, Inc., www.gcn.com.;;e.Security(TM), website pages (pp. 1-83), www.esecurityinc.com, e-Security, Inc., Naples, FL 34103, Sep. 14, 2000.;;Peter Sommer, ""Intrusion Detection Systems as Evidence,"" Computer Security Research Centre, United Kingdom.;;Musman et al., System or Security Managers Adaptive Response Tool, DARPA Information Survivability Conference and Exposition, Jan. 25, 2000, pp. 56-68.;;Gibson Research Corporation Web Pages, Shields Up!-Internet Connection Security Analysis, grc.com/default.htm, Laguna Hills, California, 2000.;;Rouse et al., Design and Evaluation of an Onboard Computer-Based Information System fro Aircraft, IEEE Transactions of Systems, Man, and Cybernetics, vol. SMC-12, No. 4, Jul./Aug. 1982, pp. 451-463.;;Hammer, An Intelligent Flight-Management Aid for Procedure Execution, IEEE Transactions on Systems, Man, and Cybernetics, vol. SMC-14, No. 6, Nov./Dec. 1984, pp. 885-888.;;Mann et al., Analysis of User Procedural Compliance in Controlling a Simulated Process, IEEE Transactions on Systems, Man, and Cybernetics, vol. SMC-16, No. 4, Jul./Aug. 1986.;;Todd, Signed and Delivered: An Introduction to Security and Authentication, Find Out How the Jave Security API Can Help you Secure your Code, Javaworld, Web Publishing, Inc., San Francisco, Dec. 1, 1998, pp. 1-5.;;Arvind, Secure This. Inform, Association for Information and Image Management, Silver Spring, Sep./Oct. 1999, pp. 1-4.;;Stevens, TCP/IP Illustrated, vol. 1, 1994, pp. 247.;;Lee et al., A Generic Virus Detection Agent on the Internet, IEEE, 30th Annual Hawaii International Conference on System Sciences, 1997, vol. 4.;;Cutler, Inside Windows NT, 1993, Microsoft Press.;;Duncan, Advanced MS-Dos, 1986, Microsoft Press.;;McDaniel, IBM Dictionary of Computing, 1994, International Business Machines Corporation.;;Burd, Systems Architecture, 1998, Course Technology, Second Edition.;;Programmer's Guide PowerJ, 1997, Sybase.;;Swimmer et al., Dynamic detection and classification of computer viruses using general behavior patterns, 1995, Proceedings of the Fifth International Virus Bulletin Conference, Boston.;;Advanced Virus Detection Technology for the Next Millennium, Aug. 1999, Network Associates, A Network Associates Executive White Paper, pp. 1-14.;;Enterprise-Grade Anti-Virus Automation in the 21st Century, Jun. 2000, Symantec, Technology Brief, pp. 1-17.;;Kephart et al., Blueprint for a Computer Immune System, 1997, Retrieved from Internet, URL: http//www.research.ibm.com/antivirus/scipapers/kephart/VB97, pp. 1-15.;;Richardson, Enterprise Antivirus Software, Feb. 2000, Retrieved from Internet, URL: http://www.networkmagazine.com/article/nmg20000426S0006, pp. 1-6.;;Understanding and Managing Polymorphic Viruses, 1996, Symantec, The Symantec Enterprise Papers, vol. XXX, pp. 1-13.;;Gong, JavaTM Security Architecture (JDK1.2), Oct. 2, 1998, Sun Microsystems, Inc., Version 1.0, pp. i-iv, 1-62.;;Softworks Limited VBVM Whitepaper, Nov. 3, 1998, Retrieved from the Internet, URL: http://web.archive.org/web/19981203105455/http://softworksltd.com/vbvm.html, pp. 1-4.;;Kephart, A Biologically Inspired Immune System for Computers, 1994, Artificial Life IV, pp. 130-139.;;International Search Report for PCT/US01/26804 of Mar. 21, 2002.;;Kosoresow et al., Intrusion Detection via System Call Traces, IEEE Software, pp. 35-42, Sep./Oct. 1997.;;Veldman, Heuristic Anti-Virus Technology, Proceedings, 3rd International Virus Bulletin Conference, pp. 67-76, Sep. 1993.;;Symantec, Understanding Heuristics: Symantec's Bloodhound Technology, Symantec White Paper Series, vol. XXXIV, pp. 1-14, Sep. 1997.",EXPIRED
410,US,A,US 5251626 A,097-711-717-959-260,1993-10-12,1993,US 91893492 A,1992-07-22,US 91893492 A;;US 54795890 A;;US 75960391 A,1990-07-03,Apparatus and method for the detection and treatment of arrhythmias using a neural network,"An apparatus and method for the detection and treatment of arrhythmias using a processor having a neural network with a hierarchical arrangement including a first lower level for classifying individual waveforms, a second higher level for diagnosing detected arrhythmias and a third higher level for the application of therapy in response to a diagnosed arrhythmia. The neural network may be a back propogation neural network or an associative memory type neural network. The arrhythmias detected may be at least one of bradycardia, tachycardia and fibrillation. The apparatus may include a cardioverting/defibrillating pacemaker. In general, the apparatus acquires physiological signals representative of heart activity in a patient. A neural network receives the physiological signals and determines if any arrhythmia is present, and if present, selects therapy to be applied to the heart. A therapy generator then applies the therapy selected by the neural network. The physiological signals may be processed or unprocessed ECG signal, signals indicative of the properties of the blood including the presence of gases, blood temperature, and blood flow signals or signals representative of ventricular wall impedance or ventricular volume.",TELECTRONICS PACING SYST,NICKOLLS PETER;;DRANE GEOFF;;FLOWER BARRY;;LUNSMANN PAUL;;DODD ROBERT;;BASSIN DAVID;;WICKHAM JOHN;;MURPHY TONY,PACESETTER INC (1996-11-29),https://lens.org/097-711-717-959-260,Granted Patent,yes,21,136,1,7,0,A61N1/36514;;Y10S128/925;;A61N1/36514;;Y10S128/925,A61N1/365;;A61N1/39,607/14,1,1,096-628-612-891-42X,10.1109/6.4520,"Robert Hecht Nielsen, Neurocomputing: Picking the Human Brain , IEEE Spectrum, Mar. 1988, pp. 36 41.",EXPIRED
411,CA,A1,CA 2464706 A1,143-845-418-892-991,2003-05-30,2003,CA 2464706 A,2002-10-30,US 292001 A;;US 0234770 W,2001-11-15,SHAVING RAZORS AND RAZOR CARTRIDGES,Shaving razors and cartridges are provided that impart warmth to a user's sk in during shaving. The razors and cartridges include a phase change material.</ SDOAB>,GILLETTE CO,PARENT CHARLES ROBERT;;DODD KENNETH T;;DAVIS STUART M;;SZCZEPANOWSKI ANDREW;;WOODNORTH DOUGLAS J;;BRANDT KLAUS,,https://lens.org/143-845-418-892-991,Patent Application,no,0,0,26,26,0,B26B21/40;;B26B21/4025;;B26B21/4087;;B26B21/48;;B26B21/4087;;B26B21/40;;B26B21/48;;B26B21/4025,B26B21/40;;B26B21/48;;B26B21/52,,0,0,,,,EXPIRED
412,US,A1,US 2003/0199497 A1,114-226-825-948-548,2003-10-23,2003,US 29628803 A,2003-04-24,FR 0006619 A;;FR 0101599 W,2000-05-24,Novel calcium receptor active molecules and method for preparing same,"
    The invention concerns compounds of general formula (I) wherein: 

   the group X represents a NR4, CHN or CHR5-NR4-group; the group Y represents an oxygen or sulphur atom or a NR, CR5, CHR5-, CR5CR6- or CHR5-CHR6 group provided that when group X represents the CHN or CHR5-NR4-group, group Y represents an oxygen or a sulphur atom or a Nr, CR5 or CHR group; the group R represents a hydrogen atom or an alkyl, aryl or aralkyl group; the groups R1, R5 and R6, identical or different, represent each a hydrogen or halogen atom or an alkyl or alkoxy group; the group R2 represents a hydrogen atom or an alkyl group; the group R3 represents an aryl group; and the group R4 represents a hydrogen atom, an alkyl, aryl, aralkyl, alkylsulphonamide, arylsulphonamide or aralkyl sulphonamide group; and their salt with a pharmaceutically acceptable acid, in the form of a racemic mixture and their optically pure isomer. The invention also concerns their preparation, pharmaceutical compositions containing them and their use as CaSR activity modulator and as medicine for preferably treating diseases or physiological disorders involving the intervention of CaSR activity modulation. 
",RUAT MARTIAL;;DODD ROBERT;;FAURE HELENE VERONIQUE;;DAUBAN PHILIPPE MARCEL;;KESSLER ALBANE;;POTIER PIERRE JEAN-PAUL,RUAT MARTIAL;;DODD ROBERT;;FAURE HELENE VERONIQUE;;DAUBAN PHILIPPE MARCEL;;KESSLER ALBANE;;POTIER PIERRE JEAN-PAUL,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (2003-01-21),https://lens.org/114-226-825-948-548,Patent Application,yes,2,30,11,11,0,C07D209/14;;C07D209/42;;A61P1/00;;A61P1/04;;A61P13/12;;A61P19/10;;A61P25/00;;A61P25/28;;A61P35/00;;A61P43/00;;A61P5/00;;A61P5/18;;A61P5/20;;A61P9/00;;C07D209/42;;C07D209/14,A61K31/4045;;A61P1/04;;A61P5/00;;A61P5/18;;A61P9/00;;A61P13/12;;A61P19/10;;A61P25/00;;A61P35/00;;A61P43/00;;C07D209/14;;C07D209/42,514/224.2;;514/230.5;;X51431;;514/266.1;;514/367;;514/394;;514/375;;X544 5;;X544 9;;544/283;;546/139;;548/152;;548/217;;548/304.4,0,0,,,,EXPIRED
413,EP,A1,EP 1446269 A1,044-221-678-328-217,2004-08-18,2004,EP 02789325 A,2002-10-30,US 0234770 W;;US 292001 A,2001-11-15,SHAVING RAZORS AND RAZOR CARTRIDGES,,GILLETTE CO,BRANDT KLAUS;;DAVIS STUART M;;DODD KENNETH T;;PARENT CHARLES ROBERT;;SZCZEPANOWSKI ANDREW;;WOODNORTH DOUGLAS J,"THE GILLETTE COMPANY LLC (N. D. GES. D. STAATE, US (2016-12-28)",https://lens.org/044-221-678-328-217,Patent Application,yes,0,0,26,26,0,B26B21/40;;B26B21/4025;;B26B21/4087;;B26B21/48;;B26B21/4087;;B26B21/40;;B26B21/48;;B26B21/4025,B26B21/40;;B26B21/48;;B26B21/52,,0,0,,,,EXPIRED
414,BR,B1,BR 0214002 B1,052-842-708-555-43X,2014-01-07,2014,BR 0214002 A,2002-10-30,US 292001 A;;US 0234770 W,2001-11-15,"APARELHO DE BARBEAR, CARTUCHO DE APARELHO DE BARBEAR E MÉTODO DE BARBEAR",,,BRANDT KLAUS;;DAVIS STUART M;;DODD KENNETH T;;PARENT CHARLES ROBERT;;SZCZEPANOWSKI ANDREW;;WOODNORTH DOUGLAS J,,https://lens.org/052-842-708-555-43X,Granted Patent,no,0,0,26,26,0,B26B21/40;;B26B21/4025;;B26B21/4087;;B26B21/48;;B26B21/4087;;B26B21/40;;B26B21/48;;B26B21/4025,B26B21/40;;B26B21/48;;B26B21/52,,0,0,,,,EXPIRED
415,CN,A,CN 113530738 A,167-331-164-361-164,2021-10-22,2021,CN 202110232637 A,2021-03-02,US 202062983889 P,2020-03-02,ENGINE STARTING SYSTEM,"An electric starting system is provided for an engine. The electric starting system may include a self-contained housing configured to be mounted between an engine and a tool driven by the engine. The electric starting system may also include an electric motor mounted to the housing, the electric motor configured rotationally engage an output shaft of the engine to effectuate starting of the engine.",FNA GROUP INC,ALEXANDER GUS;;CHRISTOPHER C ALEXANDER;;RICHARD J GILPATRICK;;SKRZYPCHAK JOSHUA;;SHAWN M MULKINS;;ROBERT E DODD,,https://lens.org/167-331-164-361-164,Patent Application,no,0,0,4,4,0,F02N11/00;;F02N11/0862;;F02N11/087;;F02N15/02;;F02N15/023;;F02N15/02;;F02N15/006;;F02N11/00;;F16H57/021;;F16H2057/02034;;H02K7/1004;;H02K7/116;;F02N11/0862;;B60K17/28;;F02N11/0851;;F02B65/00;;B60K17/06,F02N11/00;;F02N11/08;;F02N15/02,,0,0,,,,DISCONTINUED
416,EP,A1,EP 1284963 A1,163-252-886-099-793,2003-02-26,2003,EP 01938319 A,2001-05-23,FR 0101599 W;;FR 0006619 A,2000-05-24,NOVEL CALCIUM RECEPTOR ACTIVE MOLECULES AND METHOD FOR PREPARING SAME,,CENTRE NAT RECH SCIENT,RUAT MARTIAL;;DODD ROBERT;;FAURE HELENE VERONIQUE;;DAUBAN PHILIPPE MARCEL;;KESSLER ALBANE;;POTIER PIERRE JEAN-PAUL,,https://lens.org/163-252-886-099-793,Patent Application,yes,0,2,11,11,0,C07D209/14;;C07D209/42;;A61P1/00;;A61P1/04;;A61P13/12;;A61P19/10;;A61P25/00;;A61P25/28;;A61P35/00;;A61P43/00;;A61P5/00;;A61P5/18;;A61P5/20;;A61P9/00;;C07D209/42;;C07D209/14,A61K31/4045;;A61P1/04;;A61P5/00;;A61P5/18;;A61P9/00;;A61P13/12;;A61P19/10;;A61P25/00;;A61P35/00;;A61P43/00;;C07D209/14;;C07D209/42,,0,0,,,,EXPIRED
417,US,A1,US 2007/0000465 A1,050-467-814-810-612,2007-01-04,2007,US 42746106 A,2006-06-29,GB 0513318 A,2005-07-01,DISTRIBUTOR FOR ENGINE WITH LASER IGNITION,"A distributor is described for a multi-cylinder laser ignited internal combustion engine. The distributor includes a shaft rotatable by the engine and a plurality of flat reflective surfaces on the shaft. The surfaces lie in planes normal to the axis of rotation of the shaft and are axially staggered from one another along the length of the shaft. An optical transmitter directs light from a laser source to impinge at an angle sequentially on the reflective surfaces as the shaft rotates, and a plurality of optical receivers spaced from one another each receive the light reflected from a respective one of the mirror surfaces and direct the reflected light to a respective one of the engine cylinders.",SCARISBRICK ANDY;;CARROLL STEPH;;DODD ROBERT;;SHENTON TOM;;DEARDEN GEOFF;;KEEN STEVE;;CLISSOLD ROY;;MCCULLOCH JOHN,SCARISBRICK ANDY;;CARROLL STEPH;;DODD ROBERT;;SHENTON TOM;;DEARDEN GEOFF;;KEEN STEVE;;CLISSOLD ROY;;MCCULLOCH JOHN,FORD GLOBAL TECHNOLOGIES LLC (2006-08-30);;FORD MOTOR COMPANY (2006-07-14),https://lens.org/050-467-814-810-612,Patent Application,yes,5,9,7,7,0,F02P23/04;;H01S3/0071;;F02P7/03;;F02P23/04;;G02B6/3512;;G02B26/08;;F02P23/04;;H01S3/0071,F02P23/04;;F02B19/00,12314300B,0,0,,,,ACTIVE
418,WO,A3,WO 2002/061544 A3,049-589-451-072-891,2002-10-10,2002,US 0202917 W,2002-01-31,US 26551901 P,2001-01-31,METHOD AND SYSTEM FOR CONFIGURING AND SCHEDULING SECURITY AUDITS OF A COMPUTER NETWORK,A method/apparatus (100) for managing (121/122) the selection and scheduling (122) of security audits by surveying an audit system (115) to determine function and relative importance of elements (121).,INTERNET SECURITY SYSTEMS INC,ZOBEL ROBERT DAVID;;DODD TIMOTHY DAVID;;MILLAR SHARON A;;NESFEDER DAVID GERALD JR;;SINGER CHRISTOPHER S,,https://lens.org/049-589-451-072-891,Search Report,yes,3,0,11,11,0,G06F21/577;;G06F2221/2101;;H04L63/1425;;H04L63/1433;;H04L63/1425;;G06F2221/2101;;G06F21/577;;H04L63/1433,G06F21/00;;H04L29/06,,0,0,,,,PENDING
419,EP,A3,EP 0465241 A3,069-139-527-887-622,1994-06-29,1994,EP 91306051 A,1991-07-03,US 54795890 A,1990-07-03,APPARATUS AND METHOD FOR THE DETECTION AND TREATMENT OF ARRHYTHMIAS USING A NEURAL NETWORK,"An apparatus and method for the detection and treatment of arrhythmias using a processor having a neural network (21) with a hierarchical arrangement including a first lower level (21A) for classifying individual waveforms, a second higher level (21B) for diagnosing detected arrhythmias and a third higher level (21C) for the application of therapy in response to a diagnosed arrhythmia. The neural network (21) may be a back propogation neural network or an associative memory type neural network. The arrhythmias detected may be at least one of bradycardia, tachycardia and fibrillation. The apparatus may include a cardioverting/defibrillating packmaker (15). In general, the apparatus acquires physiological signals representative of heart activity in a patient. A neural network (21) receives the physiological signals and determines if any arrhythmia is present, and if present, selects therapy to be applied to the heart. A therapy generator then applies the therapy selected by the neural network (21). The physioligical signals may be processed or unprocessed ECG signal, signals indicative of the properties of the blood, and blood flow signals or signals representative of ventricular wall impedance or ventricular volume.",TELECTRONICS NV,NICKOLLS PETER;;DRANE GEOFF;;FLOWER BARRY;;LUNSMANN PAUL;;DODD ROBERT;;BASSIN DAVID;;WICKHAM JOHN;;MURPHY TONY,,https://lens.org/069-139-527-887-622,Search Report,yes,4,0,6,7,0,A61N1/36514;;A61N1/36514;;A61N1/39622;;A61N1/39622,A61B5/0245;;A61B5/0452;;A61B10/00;;A61N1/365;;A61N1/39,,0,0,,,,EXPIRED
420,EP,B1,EP 1446269 B1,091-609-070-709-412,2005-12-28,2005,EP 02789325 A,2002-10-30,US 0234770 W;;US 292001 A,2001-11-15,SHAVING RAZORS AND RAZOR CARTRIDGES,,GILLETTE CO,BRANDT KLAUS;;DAVIS STUART M;;DODD KENNETH T;;PARENT CHARLES ROBERT;;SZCZEPANOWSKI ANDREW;;WOODNORTH DOUGLAS J,"THE GILLETTE COMPANY LLC (N. D. GES. D. STAATE, US (2016-12-28)",https://lens.org/091-609-070-709-412,Granted Patent,yes,1,0,26,26,0,B26B21/40;;B26B21/4025;;B26B21/4087;;B26B21/48;;B26B21/4087;;B26B21/40;;B26B21/48;;B26B21/4025,B26B21/40;;B26B21/48;;B26B21/52,,0,0,,,,EXPIRED
421,US,B2,US 6868610 B2,145-681-889-052-731,2005-03-22,2005,US 292001 A,2001-11-15,US 292001 A,2001-11-15,Shaving razors and razor cartridges,Shaving razors and cartridges are provided that impart warmth to a user's skin during shaving. The razors and cartridges include a phase change material.,GILLETTE CO,BRANDT KLAUS;;DAVIS STUART M;;DODD KENNETH T;;PARENT CHARLES ROBERT;;SZCZEPANOWSKI ANDREW;;WOODNORTH DOUGLAS J,GILLETTE COMPANY THE (2001-10-31);;THE GILLETTE COMPANY LLC (2016-09-01),https://lens.org/145-681-889-052-731,Granted Patent,yes,27,46,26,26,0,B26B21/40;;B26B21/4025;;B26B21/4087;;B26B21/48;;B26B21/4087;;B26B21/40;;B26B21/48;;B26B21/4025,B26B21/40;;B26B21/48;;B26B21/52,30/41;;30/34.05;;30/140,0,0,,,,EXPIRED
422,AU,A1,AU 2002/353925 A1,159-305-684-352-692,2003-06-10,2003,AU 2002/353925 A,2002-10-30,US 292001 A;;US 0234770 W,2001-11-15,SHAVING RAZORS AND RAZOR CARTRIDGES,,GILLETTE CO,BRANDT KLAUS;;DAVIS STUART M;;DODD KENNETH T;;PARENT CHARLES ROBERT;;SZCZEPANOWSKI ANDREW;;WOODNORTH DOUGLAS J,,https://lens.org/159-305-684-352-692,Patent Application,no,0,0,26,26,0,B26B21/40;;B26B21/4025;;B26B21/4087;;B26B21/48;;B26B21/4087;;B26B21/40;;B26B21/48;;B26B21/4025,B26B21/40;;B26B21/48;;B26B21/52,,0,0,,,,EXPIRED
423,US,B2,US 7340776 B2,013-974-277-581-280,2008-03-04,2008,US 6636702 A,2002-01-31,US 6636702 A;;US 26551901 P,2001-01-31,Method and system for configuring and scheduling security audits of a computer network,"Managing the selection and scheduling of security audits run on a computing network. The computer network is surveyed by a security audit system to determine the function and relative importance of the elements in the network. Based on function and priority, a more thorough type of security audit is selected to run against each of the network elements by the security audit system. The security audit can also be automatically scheduled based on the information gathered from the survey. Once the system runs the security audit, a vulnerability assessment can be calculated for each element in the network. The vulnerability assessment can be presented in a format that facilitates interpretation and response by someone operating the system. The vulnerability assessment can also be used to configure and schedule future security audits.",IBM,ZOBEL ROBERT DAVID;;DODD TIMOTHY DAVID;;MILLAR SHARON A;;NESFEDER JR DAVID GERALD;;SINGER CHRISTOPHER S,FINJAN BLUE INC (2018-06-29);;INTERNET SECURITY SYSTEMS INC (2002-01-28);;INTERNATIONAL BUSINESS MACHINES CORPORATION (2007-09-28);;TREND MICRO INCORPORATED (2010-03-31),https://lens.org/013-974-277-581-280,Granted Patent,yes,115,276,11,11,0,G06F21/577;;G06F2221/2101;;H04L63/1425;;H04L63/1433;;H04L63/1425;;G06F2221/2101;;G06F21/577;;H04L63/1433,G06F12/14;;G06F21/00;;H04L29/06,726/24;;726/22;;726/23;;713/188,99,16,065-258-553-829-49X;;125-027-089-149-672;;038-340-557-706-933;;005-364-428-355-339;;010-961-486-471-799;;115-192-727-768-90X;;019-857-952-759-763;;043-753-890-505-226;;068-702-276-464-337;;096-442-581-304-695;;071-936-515-547-560;;110-454-069-963-118;;083-993-908-337-720;;089-657-905-928-117;;098-584-601-059-778;;003-983-493-319-713,10.1109/discex.2000.824979;;10.1109/cds.1996.509364;;10.1145/174613.174614;;10.1109/infcom.1996.493354;;10.1109/iccl.1988.13047;;10.1109/pccc.1996.493637;;10.1109/65.598458;;10.1145/65000.65002;;10.1109/secpri.1996.502681;;10.1109/pccc.1990.101684;;10.1145/122572.122573;;10.1145/191177.191183;;10.1109/tsmc.1982.4308849;;10.1109/tsmc.1984.6313315;;10.1109/tsmc.1986.289253;;10.1109/52.605929,"International Search Report dated Aug. 8, 2002.;;International Search Report dated Sep. 19, 2002.;;Koilpillai et al., Recon-A Tool for Incident Detection, Tracking and Response, Darpa Information Survivability Conference and Exposition, 2000, pp. 199-206.;;Alves-Foss, J., A Overview of SNIF: A Tool for Surveying Network Information Flow, Network and Distributed System Security, 1995, pp. 94-101.;;Mansouri-Samani et al., A Configurable Event Service for Distributed Systems Configurable Distributed Systems, 1996, pp. 210-217.;;International Search Report for PCT/US01/13769 of Mar. 8, 2002.;;Jagannathan et al., System Design Document: Next-Generation Intrusion Detection Expert Systems (NIDES), Internet Citation, Mar. 9, 1993, XP002136082, pp. 1-66.;;Koilpillai, Adaptive Network Security Management DARPA NGI PI Conference, Oct. 1998, pp. 1-27.;;Hiverworld Continuous Adaptive Risk Management, Hiverworld, Inc., 1999-2000, pp. 1-14.;;International Search Report for PCT/US02/04989of Sep. 19, 2002.;;International Search Report for PCT/US02/02917 of Aug. 8, 2002.;;International Search Report for PCT/US03/00155 of Mar 15, 2003.;;NXI Communications, Inc., White Paper, NTS Security Issues, Oct. 15, 2001, pp. 1-12.;;Mounji et al., Distributed Audit Trail Analysis, Proceedings of the Symposium of Network and Distributed System Security, San Diego, CA, Feb. 16-17, 1995, pp. 102-112.;;Wobber et al., Authentication in the Taos Operating System, ACM Transactions on Computer Systems, vol. 12, No. 1, Feb. 1994, pp. 3-32.;;Mayer et al., The Design of the Trusted Workstation: A True Infosec Product, 13<SUP>th </SUP>National Computer Security Conference, Washing, DC, Oct. 1-4, 1990, pp. 827-839.;;Dawson, Intrusion Protection for Networks, Byte, Apr. 1995, pp. 171-172.;;Buhkan, Checkpoint Charlie, PC Week Networks, Nov. 27, 1995, pp. N1, N6-N7.;;Process Software Technical Support Page, found on http://www.process.com/techsupport/whitesec.html, printed off of the Process Software website on Feb. 26, 2003, pp. 1-5.;;Ganesan, BAfirewall: A Modern Firewall Design, Proceedings Internet Society Symposium on Network and Distributed System Security 1994, Internet Soc., 1994, pp. 99-108.;;Lee, Trusted Systems, Chapter II-1-6 of Handbook of Information Security Management, Ed. Zella G. Ruthberg and Harold F. Tipton, Auerbach, Boston and New York, 1993, pp. 345-362.;;Lunt, Automated Intrusion Detection, Chapter II-4-4 of Handbook of Information Security Management, Ed. Zella G. Ruthberg and Harold F. Tipton, Auerbach, Boston and New York, 1993, pp. 551-563.;;Guha et al., Network Security via Reverse Engineering of TCP Code: Vulnerability Analysis and Proposed Solution, IEEE, Mar. 1996, pp. 603-610.;;Garg et al., High Level Communication Primitives for Concurrent Systems, IEEE, 1988, pp. 92-99.;;Hastings et al., TCP/IP Spoofing Fundamentals, IEEE, May 1996, pp. 218-224.;;Snapp, Signature Analysis and Communication Issues in a Distributed Intrusion Detection System, Master Thesis, University of California, Davis, California, 1991, pp. 1-40.;;Guha et al., Network Security via Reverse Engineering of TCP Code: Vulnerability Analysis and Proposed Solutions, IEEE, Jul. 1997, pp. 40-48.;;Djahandari et al., An MBone for an Application Gateway Firewall, IEEE, Nov. 1997, pp. 72-81.;;Kim et al., Implementing a Secure Login Environment: A Case Study of Using a Secure Network Layer Protocol, Department of Computer Science, University of Alabama, Jun. 1995, pp. 1-9.;;Satyanarayanan, Integrating Security in a Large Distributed System, Acm Transaction on Computer Systems, vol. 7, No. 3, Aug. 1989, pp. 47-280.;;Sammons, Nathaniel, ""Multi-platform Interrogation and Reporting with Rscan,"" The Ninth Systems Administration Conference, LISA 1995, Monterrey, California, Sep. 17-22, 1995, pp. 75-87.;;Dean et al., ""Java Security: From HotJava to Netscape and Beyond,"" Proceedings of the 1996 IEEE Symposium on Security and Privacy, May 6-8, 1996, Oakland, California, pp. 190-200.;;Fisch et al., ""The Design of an Audit Trail Analysis Tool,"" Proceedings of the 10<SUP>th </SUP>Annual Computer Security Applications Conference, Dec. 5-9, 1994, Orlando, Florida, pp. 126-132.;;Safford et al., ""The TAMU Security Package: An Ongoing Response to Internet Intruders in an Academic Environment,"" USENIX Symposium Proceedings, UNIX Security IV, Oct. 4-6, 1993, Santa Clara, California, pp. 97-118.;;Sugawara Toshiharu, ""A Cooperative LAN Diagnostic and Observation Expert System,"" Ninth Annual Phoenix Conference on Computers and Communications, 1990 Conference Proceedings, Mar. 21-23, 1990, Scottsdale, Arizona, pp. 667-674.;;Casella, Karen A., ""Security Administration in an Open Networking Environment,"" The Ninth Systems Administration Conference, LISA 1995, Monterrey, California, Sep. 17-22, 1995, pp. 67-73.;;Burchell, Jonathan, ""Vi-SPY: Universal NIM?"" Virus Bulletin, Jan. 1995, pp. 20-22.;;Benzel et al., ""Identification of Subjects and Objects in a Trusted Extensible Client Server Architecture,"" 18<SUP>th </SUP>National Information Systems Security Conference, Oct. 10-13, 1995, Baltimore, Maryland, pp. 83-99.;;Epstein et al., ""Component Architectures for Trusted Netware,"" 18<SUP>th </SUP>National Information Systems Security Conference, Oct. 10-13, 1995, Baltimore, Maryland, pp. 455-463.;;Varadharajan, Vijay, ""Design and Management of a Secure Networked Administration System: A Practical Approach,"" 19<SUP>th </SUP>National Information Systems Security Conference, Oct. 22-25, 1996, Baltimore, Maryland, pp. 570-580.;;Snapp et al., ""DIDS (Distributed Intrusion Detection System)-Motivation, Architecture, and An Early Prototype,""14<SUP>th </SUP>National Computer Security Conference, Oct. 1-4, 1991, Washington, DC, pp. 167-176.;;Broner et al., ""IntelligentI/O Rule-Based Input/Output Processing for Operating Systems,"" Operating Systems Review, vol. 25, No. 3, Jul. 1991, pp. 10-26.;;Drews et al., ""Special Delivery-Automatic Software Distribution Can Make You a Hero,"" Network Computing, Aug. 1, 1994, pp. 80, 82-86, 89, 91-95.;;Morrissey, Peter, ""Walls,"" Network Computing, Feb. 15, 1996, pp. 55-59, 65-67.;;Harlander, Dr. Magnus, ""Central System Administration in a Heterogenous Unix Environment: GeNU Admin,"" Proceedings of the Eighth Systems Administration Conference (LISA VIII), Sep. 19-23, 1994, San Diego, California, pp. 1-8.;;Shaddock et al., ""How to Upgrade 1500 Workstations on Saturday, and Still Have Time to Mow the Yard on Sunday,"" The Ninth Systems Administration Conference LISA '95, Sep. 17-22, 1995, Monterrey, California, pp. 59-65.;;Anderson, Paul, ""Towards a High-Level Machine Configuration System,"" Proceedings of the Eighth Systems Administration Conference (LISA VIII), Sep. 19-23, 1994, San Diego, California, pp. 19-26.;;Cooper, Michael A., "" Overhauling Rdist for the '90s,"" Proceedings of the Sixth Systems Administration Conference (LISA VI), Oct. 19-23, 1992, Long Beach, California, pp. 175-188.;;Vangala et al., ""Software Distribution and Management in a Networked Environment,"" Proceedings of the Sixth Systems Administration Conference, Oct. 19-23, 1992, Long Beach, California, pp. 163-170.;;Kim et al., ""The Design and Implementation of Tripwire: A File System Integrity Checker,"" 2<SUP>nd </SUP>ACM Conference on Computer and Communications Security, Nov. 2-4, 1994, Fairfax, Virginia, pp. 18-29.;;Winn Schwartau, ""e.Security(TM) -Solving 'Dumb Days' With Security Visualization,"" e-Security, Inc., Naples, FL 34103, 2000.;;Anita D'Amico, Ph.D., ""Assessment of Open e-Security Platform(TM) : Vendor-Independent Central Management of Computer Security Resources,"" Applied Visions, Inc., 1999.;;""e.Security(TM) -Open Enterprise Security Management: Delivering an integrated, automated, centrally Managed Solution You Can Leverage Today and Tomorrow,"" e-Security, Inc., Naples, FL 34102, 1999.;;""e.Security(TM) -Vision,"" e-Security, Inc., Naples, FL, 1999.;;""e.Security(TM) -Administrator Workbench(TM),"" e-Security, Inc. Naples, FL, 1999.;;""e.Security(TM) -Fact Sheet,"" e-Security, Inc., Naples, FL, 1999.;;""e.Security(TM) -Open e-Security Platform(TM),"" e-Security, Inc. Naples, FL, 1999.;;Babcock, ""E-Security Tackles The Enterprise,"" Jul. 28, 1999; Inter@ctive Week, www.Zdnet.com.;;Kay Blough, ""In Search of More-Secure Extranets,"" Nov. 1, 1999, www.InformationWeek.com.;;Paul H. Desmond, ""Making Sense of Your Security Tools,"" Software Magazine and Wiesner Publishing, www.softwaremag.com, 1999.;;Kay Blough, ""Extra Steps Can Protect Extranets,"" Nov. 1, 1999, www.InformationWeek.com.;;Sean Hao, ""Software protects e-commerce-e-Security's product alerts networks when hackers attack,"" Florida Today, Florida.;;Scott Weiss, ""Security Strategies-E-Security, Inc., "" product brief, Hurwitz Group, Inc., Mar. 24, 2000.;;Sean Adee, CISA, ""Managed Risk, Enhanced Response-The Positive Impact of Real-Time Security Awareness,"" Information Systems Control Journal, vol. 2, 2000.;;""Reprint Review-The Information Security Portal-Open e-Security Platform Version 1.0"", Feb. 2000, West Coast Publishing, SC Magazine, 1999.;;""e.Security-Introducing the First Integrated, Automated, and Centralized Enterprise Security Management System,"" white paper, e-Security, Inc., Naples, FL 34102, 1999.;;Ann Harrison, ""Computerworld-Integrated Security Helps Zap Bugs,"" Feb. 21, 2000, Computerworld, vol. 34, No. 8, Framingham, MA.;;Shruti Daté, ""Justice Department Will Centrally Monitor Its Systems For Intrusions,"" Apr. 3, 2000, Post-Newsweek Business Information, Inc., www.gcn.com.;;e.Security(TM), website pages (pp. 1-83), www.esecurityinc.com, e-Security, Inc., Naples, FL 34103, Sep. 14, 2000.;;Peter Sommer, ""Intrusion Detection Systems as Evidence,"" Computer Security Research Centre, United Kingdom.;;Musman et al., System or Security Managers Adaptive Response Tool, DARPA Information Survivability Conference and Exposition, Jan. 25, 2000, pp. 56-68.;;Gibson Research Corporation Web Pages, Shields Up!-Internet Connection Security Analysis, grc.com/default.htm, Laguna Hills, California, 2000.;;Rouse et al., Design and Evaluation of an Onboard Computer-Based Information System fro Aircraft, IEEE Transactions of Systems, Man, and Cybernetics, vol. SMC-12, No. 4, Jul./Aug. 1982, pp. 451-463.;;Hammer, An Intelligent Flight-Management Aid for Procedure Execution, IEEE Transactions on Systems, Man, and Cybernetics, vol. SMC-14, No. 6, Nov./Dec. 1984, pp. 885-888.;;Mann et al., Analysis of User Procedural Compliance in Controlling a Simulated Process, IEEE Transactions on Systems, Man, and Cybernetics, vol. SMC-16, No. 4, Jul./Aug. 1986.;;Todd, Signed and Delivered: An Introduction to Security and Authentication, Find Out How the Jave Security API Can Help you Secure your Code, Javaworld, Web Publishing, Inc., San Francisco, Dec. 1, 1998, pp. 1-5.;;Arvind, Secure This. Inform, Association for Information and Image Management, Silver Spring, Sep./Oct. 1999, pp. 1-4.;;Stevens, TCP/IP Illustrated, vol. 1, 1994, pp. 247.;;Lee et al., A Generic Virus Detection Agent on the Internet, IEEE 30<SUP>th </SUP>Annual Hawaii International Conference on System Sciences, 1997, vol. 4.;;Cutler, Inside Windows NT, 1993, Microsoft Press.;;Duncan, Advanced MS-Doc, 1986, Microsoft Press.;;McDaniel, IBM Dictionary of Computing, 1994, International Business Machines Corporation.;;Burd, Systems Architecture, 1998, Course Technology, Second Edition.;;Programmer's Guide PowerJ, 1997, Sybase.;;Swimmer et al., Dynamic detection and classification of computer viruses using general behavior patterns, 1995, Proceedings of the Fifth International Virus Bulletin Conference, Boston.;;Advanced Virus Detection Technology for the Next Millunnium, Aug. 1999, Network Associates, A Network Associates Executive White Paper, pp. 1-14.;;Enterprise-Grade Anti-Virus Automation in the 21<SUP>st </SUP>Century, Jun. 2000, Symantec, Technology Brief, pp. 1-17.;;Kephart et al., Blueprint for a Computer Immune System, 1997, Retrieved from Internet, URL: http//www.research.ibm.com/antivirus/scipapers/kephart/VB97, pp. 1-15.;;Richardson, Enterprise Antivirus Software, Feb. 2000, Retrieved from Internet, URL: http://www.networkmagazine.com/article/nmg20000426S0006, pp. 1-6.;;Understanding and Managing Polymorphic Viruses, 1996, Symantec, The Symantec Enterprise Papers, vol. XXX, pp. 1-13.;;Gong, JavaTM Security Architecture (JDK1.0), Oct. 2, 1998, Sun Microsystems, Inc., Version 1.0, pp. i-iv, 1-62.;;Softworks Limited VBVM Whitepaper, Nov. 3, 1998, Retrieved from the Internet, URL: http://web.archive.org/web/19981203105455/http://softworksltd.com/vbvm.html, pp. 1-4.;;Kephart, A Biologically Inspired Immune System for Computers, 1994, Artificial Life IV, pp. 130-139.;;International Search Report for PCT/US01/26804 of Mar. 21, 2002.;;Kosoresow et al., Intrusion Detection via System Call Traces, IEEE Software, pp. 35-42, Sep./Oct. 1997.;;Veldman, Heuristic Anti-Virus Technology, Proceedings 3<SUP>rd </SUP>International Virus Bulletin Conference, pp. 67-76, Sep. 1993.;;Symantec, Understanding Heuristics: Symantec's Bloodhound Technology, Symantec White Paper Series, vol. XXXIV, pp. 1-14, Sep. 1997.;;Nachenberg, A New Technique for Detecting Polymorphic Computer Viruses, A thesis submitted in partial satisfaction of the requirements for the degree Master of Science in Computer Science, University of California Los Angeles, pp. 1-127, 1995.;;Microsoft P-Code Technology, http://msdn.microsoft.com/archive/default.asp?url=/archive/en-us/dnarvc/html/msdn<SUB>-</SUB>c7pcode2.asp, pp. 1-6, Apr. 1992.",ACTIVE
424,AU,B2,AU 2002/353925 B2,080-522-765-170-109,2007-12-13,2007,AU 2002/353925 A,2002-10-30,US 292001 A;;US 0234770 W,2001-11-15,Shaving razors and razor cartridges,,GILLETTE CO,WOODNORTH DOUGLAS J;;DAVIS STUART M;;PARENT CHARLES ROBERT;;BRANDT KLAUS;;DODD KENNETH T;;SZCZEPANOWSKI ANDREW,,https://lens.org/080-522-765-170-109,Granted Patent,no,0,0,26,26,0,B26B21/40;;B26B21/4025;;B26B21/4087;;B26B21/48;;B26B21/4087;;B26B21/40;;B26B21/48;;B26B21/4025,B26B21/40;;B26B21/48;;B26B21/52,,0,0,,,,EXPIRED
425,EP,B1,EP 0465241 B1,131-917-704-699-652,1998-11-04,1998,EP 91306051 A,1991-07-03,US 54795890 A,1990-07-03,Apparatus for the detection and treatment of arrhythmias using neural networks,,TELECTRONICS NV,NICKOLLS PETER;;DRANE GEOFF;;FLOWER BARRY;;LUNSMANN PAUL;;DODD ROBERT;;BASSIN DAVID;;WICKHAM JOHN;;MURPHY TONY,,https://lens.org/131-917-704-699-652,Granted Patent,yes,4,25,6,7,0,A61N1/36514;;A61N1/36514;;A61N1/39622;;A61N1/39622,A61B5/0245;;A61B5/0452;;A61B10/00;;A61N1/365;;A61N1/39,,0,0,,,,EXPIRED
426,DE,T2,DE 69130437 T2,178-840-040-439-606,1999-05-12,1999,DE 69130437 T,1991-07-03,US 54795890 A,1990-07-03,Gerät mit neuronalen Netzwerken zur Detektion und Behandlung von Arrythmien,,TELECTRONICS NV,NICKOLLS PETER;;DRANE GEOFF;;FLOWER BARRY;;LUNSMANN PAUL;;DODD ROBERT;;BASSIN DAVID;;WICKHAM JOHN;;MURPHY TONY,,https://lens.org/178-840-040-439-606,Granted Patent,no,0,1,6,7,0,A61N1/36514;;A61N1/36514;;A61N1/39622;;A61N1/39622,A61B5/0245;;A61B5/0452;;A61B10/00;;A61N1/365;;A61N1/39,,0,0,,,,EXPIRED
427,DE,T2,DE 60003941 T2,016-490-777-691-820,2004-05-06,2004,DE 60003941 T,2000-10-20,FR 9913232 A;;FR 0002927 W,1999-10-22,N-SUBSTITUIERTE 1-(BUTYROLACTON)-ISOCHINOLINE ZUR BEHANDLUNG VON NERVENSTÖRUNGEN,"The invention concerns compounds of general formula (I) wherein: Z represents a sulphur or oxygen atom, NH, N-alkyl or Nboc; group R', identical or different, represent each a hydrogen atom, a OCH3 group or a OCH2O group; group R'' represents a hydrogen or a CH3 group; group X represents a carbonyl, sulphonyl or CO2 group; and group R represents an alkyl, aryl, alkenyl or aralkyl group. The invention also concerns the preparation of said compounds, pharmaceutical compositions containing them and their use for stimulating gamma-amino-butyric acid activity and as medicine for treating nervous disorders.",CENTRE NAT RECH SCIENT;;INNOVATIONSAGENTUR GMBH BU TEC;;UNIV BERNE BERN,DODD ROBERT;;RAZET RODOLPHE;;POTIER JEAN-PAUL;;SIEGHART WERNER;;JURSKY FRANTISEK;;FURTMULLER ROMAN;;SIGEL ERWIN;;THOMET URS,,https://lens.org/016-490-777-691-820,Granted Patent,no,0,0,12,12,0,C07D401/04;;C07D405/04;;C07D409/04;;A61P21/02;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/28;;A61P25/32;;A61P43/00;;C07D401/04;;C07D405/04;;C07D409/04,C07D491/056;;A61K31/4725;;A61K31/4741;;A61P21/02;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/28;;A61P25/32;;A61P43/00;;C07D401/04;;C07D405/04;;C07D409/04,,0,0,,,,EXPIRED
428,ID,A,ID 23044 A,081-434-945-329-347,2000-01-13,2000,ID 990238 A,1997-10-23,US 73647196 A;;US 73647096 A;;US 94707597 A;;US 95118497 A,1996-10-24,METODA-METODA DAN KOMPOSISI-KOMPOSISI UNTUK MENGURANGI BAU BADAN,"The present invention relates to an odor absorbing composition, which is safe for use on human skin, comprising from 0.1 % to 5 %, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from 0.1 % to 36 %, by weight of the composition, of an oil phase selected from the group consisting of emollients, moisturizers, and skin protectants; an emulsifier; and an aqueous carrier. The odor absorbing compositions of the present invention may also contain an effective amount of hydrophobic antimicrobials. The present invention also relates to the use of cyclodextrin-containing compositions for the manufacture of an odor absorbing composition, which is safe for use on skin, for controlling environmental malodors on skin and for reducing body odor and/or vaginal odor.",PROCTER & GAMBLE,TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GRAGORY;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/081-434-945-329-347,Patent Application,no,0,0,24,28,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61Q15/00;;D06M13/005;;A61K8/73;;A61Q15/00,A61K8/02;;A61K8/04;;A61K8/00;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/44;;A61K8/73;;A61Q15/00;;D06M13/00,,0,0,,,,PENDING
429,NO,L,NO 991897 L,129-746-774-263-090,1999-06-22,1999,NO 991897 A,1999-04-21,US 73647096 A;;US 73647196 A;;US 94707597 A;;US 95118497 A;;US 9718954 W,1996-10-24,FremgangsmÕter og blandinger for Õ nedsette kroppslukt,"The present invention relates to an odor absorbing composition, which is safe for use on human skin, comprising from 0.1 % to 5 %, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from 0.1 % to 36 %, by weight of the composition, of an oil phase selected from the group consisting of emollients, moisturizers, and skin protectants; an emulsifier; and an aqueous carrier. The odor absorbing compositions of the present invention may also contain an effective amount of hydrophobic antimicrobials. The present invention also relates to the use of cyclodextrin-containing compositions for the manufacture of an odor absorbing composition, which is safe for use on skin, for controlling environmental malodors on skin and for reducing body odor and/or vaginal odor.",PROCTER & GAMBLE,TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/129-746-774-263-090,Abstract,no,0,0,24,28,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61Q15/00;;D06M13/005;;A61K8/73;;A61Q15/00,A61K8/02;;A61K8/00;;A61K8/04;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/44;;A61K8/73;;A61Q15/00;;D06M13/00,,0,0,,,,DISCONTINUED
430,PE,A1,PE 98499 A1,137-102-838-500-160,1999-11-20,1999,PE 00048298 A,1998-06-09,US 87185597 A;;US 87185397 A;;US 87185897 A;;US 87157797 A,1997-06-09,COMPOSICION DE PERFUME DE UNA Y DOS FASES PARA REDUCIR EL OLOR CORPORAL Y SU PROCESO DE PREPARACION,"QUE COMPRENDEN DE 0,1% A 5%, APROXIMADAMENTE, EN PESO DE LA COMPOSICION, DE CICLODEXTRINA SIN COMPLEJAR SOLUBILIZADA, SOLUBLE EN AGUA; DE 0,004% A 2%, APROXIMADAMENTE, EN PESO DE LA COMPOSICION, DE UNA COMPOSICION DE PERFUME; Y UN PORTADOR ACUOSO. LAS COMPOSICIONES TAMBIEN PUEDEN COMPRENDER UNA DIMETICONA DE BAJO PESO MOLECULAR O UNA FASE DE ACEITE QUE SE SELECCIONA DEL GRUPO QUE CONSISTE DE EMOLIENTES, HUMEDECEDORES, PROTECTORES DE LA PIEL, Y MEZCLAS DE ESTOS Y UNO O MAS SURFACTANTES. TAMBIEN PUEDEN CONTENER, PREFERIBLEMENTE, UNA CANTIDAD EFICAZ DE AGENTES ANTIMICROBIANOS HIFROFOBOS Y/O SOLUBLES EN AGUA. SE REFIERE TAMBIEN A UN PROCESO PARA HACER UNA COMPOSICION ABSORBENTE DE OLOR QUE COMPRENDE LOS PASOS DE: A) MEZCLAR UNO O MAS SURFACTANTES, UNA FASE DE ACEITE, UNA COMPOSICION DE PERFUME, Y UNA FASE ACUOSA HASTA QUE LA MEZCLA SEA HOMOGENEA; B) REALIZAR UNA SEGUNDA MEZCLA ANADIENDO CICLODEXTRINA A LA MEZCLA ANTERIOR MEZCLANDO HASTA QUE LA CICLODEXTRINA SE DISUELVA Y LA MEZCLA SEA HOMOGENEA",PROCTER & GAMBLE,LUCAS JULIET MARIE;;DODD MICHAEL THOMAS;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE;;TRINH TOAN;;BARTOLO ROBERT GREGORY,,https://lens.org/137-102-838-500-160,Patent Application,no,0,0,15,21,0,A61K8/0208;;A61K8/19;;A61K8/27;;A61K8/347;;A61K8/37;;A61K8/44;;A61K8/4973;;A61K8/738;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61Q15/00;;A61K8/891;;A61K8/19;;A61K8/347;;A61K8/738;;A61K8/27;;A61K8/44;;A61K8/90;;A61K8/4973;;A61K8/37;;A61K8/0208;;A61Q13/00,A61K8/00;;A61K8/02;;A61K8/19;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/34;;A61K8/37;;A61K8/44;;A61K8/49;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;A61Q19/00;;C08L83/04;;C08L83/12,,0,0,,,,EXPIRED
431,BR,A,BR 9810427 A,196-786-150-785-233,2000-09-05,2000,BR 9810427 A,1998-06-08,US 87157797 A;;US 87185397 A;;US 87185897 A;;US 87185597 A;;US 9811814 W,1997-06-09,Composições perfumadas e em duas fases para redução do odor corporal e métodos de uso das mesmas,"Patente de Invenção: <B>""COMPOSIçõES PERFUMADAS E EM DUAS FASES PARA REDUçãO DO ODOR CORPORAL E MéTODOS DE USO DAS MESMAS""<D>. A presente invenção se refere a composições para absorção de odor e a seu uso sobre a pele. As composições compreendem de cerca de 0,1% a 5% em peso da composição de ciclodextrina não-complexada solubilizada solúvel em água; de cerca de 0,004% a cerca de 2% em peso da composição de uma composição de perfume; e um veículo aquoso. As composições também podem compreender ou uma dimeticona de baixo peso molecular ou uma fase oleosa selecionada do grupo consistindo em emolientes, umidificadores, protetores da pele e misturas dos mesmos e um ou mais tensoativos. As composições para absorção de odor da presente invenção também podem, de preferência, conter uma quantidade efetiva de antimicrobianos solúveis em água e/ou hidrofóbicos. A presente invenção também se refere às composições para absorção de odor depositadas sobre um dispositivo flexível de dispersão.",PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/196-786-150-785-233,Patent Application,no,0,0,15,21,0,A61K8/0208;;A61K8/19;;A61K8/27;;A61K8/347;;A61K8/37;;A61K8/44;;A61K8/4973;;A61K8/738;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61Q15/00;;A61K8/891;;A61K8/19;;A61K8/347;;A61K8/738;;A61K8/27;;A61K8/44;;A61K8/90;;A61K8/4973;;A61K8/37;;A61K8/0208;;A61Q13/00,A61K8/00;;A61K8/02;;A61K8/19;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/34;;A61K8/37;;A61K8/44;;A61K8/49;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;A61Q19/00;;C08L83/04;;C08L83/12,,0,0,,,,DISCONTINUED
432,US,A,US 5874070 A,021-991-045-814-027,1999-02-23,1999,US 87185597 A,1997-06-09,US 87185597 A,1997-06-09,Compositions for reducing body odor,"The present invention relates to a perfumed aqueous, odor absorbing composition comprising from about 0.1% to about 5%, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from about 0.5% to about 30%, by weight of the composition, of a linear dimethicone having a nominal viscosity of 350 centistokes or less; from about 0.004% to about 2%, by weight of the composition, of a perfume composition; and an aqueous carrier; wherein the perfume composition is safe for use on skin. The odor absorbing compositions of the present invention may also contain an effective amount of solubilized, water-soluble, antimicrobial.",PROCTER & GAMBLE,TRINH TOAN;;LUCAS JULIET MARIE;;BARTOLO ROBERT GREGORY;;DODD MICHAEL THOMAS;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,PROCTER & GAMBLE COMPANY THE (1997-06-09),https://lens.org/021-991-045-814-027,Granted Patent,yes,33,22,1,21,0,A61Q15/00;;A61Q15/00;;A61K8/0208;;A61K8/0208;;A61K8/19;;A61K8/19;;A61K8/27;;A61K8/27;;A61K8/347;;A61K8/347;;A61K8/37;;A61K8/37;;A61K8/44;;A61K8/44;;A61K8/4973;;A61K8/4973;;A61K8/738;;A61K8/738;;A61K8/891;;A61K8/891;;A61K8/90;;A61K8/90;;A61Q13/00;;A61Q13/00,A61K8/02;;A61K8/19;;A61K8/27;;A61K8/34;;A61K8/37;;A61K8/44;;A61K8/49;;A61K8/73;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00,424/65;;422/5;;424/67;;424/69;;424/76.1;;424/76.2;;424/76.21;;424/76.4;;424/76.8;;424/78.03;;424/405;;424/642;;424/715;;424/717,31,0,,,"H. Matsuda, et al., Application of 2 Hydroxypropyl Cyclodextrin to Perfumes and Cosmetics , The 7th International Cyclodextrins Symposium, Tokyo, Japan, Apr. 25 28, 1994, pp. 516 19.;;Hashimoto, H., Studies on the Industrial Production and Application of Cyclodextrins , Starch Science, vol. 36, No. 1 (1989), pp. 35 42.;;Hashimoto, H., Application of Cyclodextrins to Foods, Toiletries and Other Products in Japan , Ensuiko Sugar Refining Co., Ltd., pp. 13 46 No Date.;;U.S. application No. 08/736,469, Trinh, et al., filed Oct. 24, 1996.;;U.S. application No. 08/736,093, Trinh, et al., filed Oct. 24, 1996.;;U.S. application No. 08/889,607, Trinh, et al., filed Jul. 8, 1997.;;U.S. application No. 08/736,471, Lucas, et al., filed Oct. 24, 1996.;;U.S. application No. 08/736,470, Lucas, et al., filed Oct. 24, 1996.;;U.S. application No. 08/738,964, Dodd, et al., filed Oct. 24, 1996.;;U.S. application No. 08/736,838, Peterson, et al., filed Oct. 28, 1996.;;U.S. application No. 08/739,091, Peterson, et al., filed Oct. 28, 1996.;;U.S. application No. 08/871,166, Lucas et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,854, Lucas, et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,791, Dodd, et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,853, Lucas, et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,857, Lucas, et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,790, Peterson, et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,856, Peterson, et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,858, Lucas, et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,577, Lucas, et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,860, Lucas, et al., Jun. 9, 1997.;;U.S. application No. 08/871,861, Peterson, et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,092, Peterson, et al., filed Jun. 9, 1997.;;U.S. application No. 08/289,732, Trinh, et al., filed Aug. 12, 1994.;;U.S. application No. 08/289,733, Trinh, et al., filed Aug. 12, 1994.;;U.S. application No. 08/289,734, Cappel, et al., filed Aug. 12, 1994.;;U.S. application No. 08/289,735, Cappel, et al., filed Aug. 12, 1994.;;U.S. application No. 08/289,969, Pilosof, et al., filed Aug. 12, 1994.;;U.S. application No. 08/871,576, Woo, et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,119, Woo et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,042, Woo et al., filed Jun. 9, 1997.",EXPIRED
433,CA,A1,CA 2269808 A1,058-826-285-709-465,1998-04-30,1998,CA 2269808 A,1997-10-23,US 73647196 A;;US 73647096 A;;US 94707597 A;;US 95118497 A;;US 9718954 W,1996-10-24,METHODS AND COMPOSITIONS FOR REDUCING BODY ODOR,"The present invention relates to an odor absorbing composition, which is safe for use on human skin, comprising from 0.1 % to 5 %, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from 0.1 % to 36 %, by weight of the composition, of an oil phase selected from the group consisting of emollients, moisturizers, and skin protectants; an emulsifier; and an aqueous carrier. The odor absorbing compositions of the present invention may also contain an effective amount of hydrophobic antimicrobials. The present invention also relates to the use of cyclodextrincontaining compositions for the manufacture of an odor absorbing composition, which is safe for use on skin, for controlling environmental malodors on skin and for reducing body odor and/or vaginal odor.",PROCTER & GAMBLE,TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE;;LUCAS JULIET MARIE,,https://lens.org/058-826-285-709-465,Patent Application,no,0,0,24,28,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61Q15/00;;D06M13/005;;A61K8/73;;A61Q15/00,A61K8/00;;A61K8/02;;A61K8/04;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/44;;A61K8/73;;A61Q15/00;;D06M13/00,,0,0,,,,EXPIRED
434,EP,A1,EP 0939614 A1,080-761-707-874-931,1999-09-08,1999,EP 97911792 A,1997-10-23,US 9718852 W;;US 73646996 A;;US 73609396 A;;US 73896496 A;;US 88960797 A;;US 94677097 A;;US 94729997 A;;US 94707697 A;;US 95118597 A,1996-10-24,COMPOSITIONS FOR REDUCING ODOR ON SKIN,"The present invention relates to an aqueous odor-absorbing composition which is safe for use on human skin comprising from about 0.1 % to about 5 %, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from about 0.5 % to about 30 %, by weight of the composition, of a linear dimethicone having a nominal viscosity of 350 centistokes or less; and an aqueous carrier. The compositions can also comprise one or more of the following optional components: low molecular weight polyols; water-soluble antimicrobial preservatives; zinc salts; water-soluble polymers; soluble carbonate and/or bicarbonate salts; chelating agents; zeolites; activated carbon; and mixtures thereof. The present invention also relates the use of the aforementioned compositions in reducing body, vaginal, and or environmental odors on skin. The composition can be applied directly as a spray, poured from a bottle and applied by hand, or applied via a wipe.",PROCTER & GAMBLE,TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/080-761-707-874-931,Patent Application,yes,0,0,15,24,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61K8/891;;A61Q15/00;;A61K8/73;;A61Q15/00,A61K8/02;;A61K8/04;;A61K8/27;;A61K8/44;;A61K8/73;;A61K8/891;;A61Q15/00,,0,0,,,,EXPIRED
435,AT,T1,AT E229316 T1,107-356-198-364-456,2002-12-15,2002,AT 97911792 T,1997-10-23,US 73646996 A;;US 73609396 A;;US 73896496 A;;US 88960797 A;;US 94677097 A;;US 94729997 A;;US 94707697 A;;US 95118597 A;;US 9718852 W,1996-10-24,HAUTGERUCHSREDUZIERUNGSKOMPOSITIONEN,"The present invention relates to an aqueous odor-absorbing composition which is safe for use on human skin comprising from about 0.1 % to about 5 %, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from about 0.5 % to about 30 %, by weight of the composition, of a linear dimethicone having a nominal viscosity of 350 centistokes or less; and an aqueous carrier. The compositions can also comprise one or more of the following optional components: low molecular weight polyols; water-soluble antimicrobial preservatives; zinc salts; water-soluble polymers; soluble carbonate and/or bicarbonate salts; chelating agents; zeolites; activated carbon; and mixtures thereof. The present invention also relates the use of the aforementioned compositions in reducing body, vaginal, and or environmental odors on skin. The composition can be applied directly as a spray, poured from a bottle and applied by hand, or applied via a wipe.",PROCTER & GAMBLE,TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/107-356-198-364-456,Granted Patent,no,0,0,15,24,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61K8/891;;A61Q15/00;;A61K8/73;;A61Q15/00,A61K8/02;;A61K8/04;;A61K8/27;;A61K8/44;;A61K8/73;;A61K8/891;;A61Q15/00,,0,0,,,,DISCONTINUED
436,EP,A1,EP 1131044 A1,090-278-967-592-052,2001-09-12,2001,EP 99962825 A,1999-11-22,US 9927684 W;;US 10950098 P;;US 32129299 A,1998-11-23,SKIN DEODORIZING AND SANITIZING COMPOSITIONS,,PROCTER & GAMBLE,DODD MICHAEL THOMAS;;WEI KARL SHIQING;;TRINH TOAN;;SINE MARK RICHARD;;BARTOLO ROBERT GREGORY;;JAKUBOVIC DAVID ANDREW,,https://lens.org/090-278-967-592-052,Patent Application,yes,0,2,5,21,0,A61Q17/005;;A61K8/0208;;A61K8/27;;A61K8/347;;A61K8/40;;A61K8/416;;A61K8/43;;A61K8/4973;;A61K8/738;;A61K8/8147;;A61Q15/00,A61K8/00;;A61K8/02;;A61K8/27;;A61K8/34;;A61K8/40;;A61K8/41;;A61K8/43;;A61K8/49;;A61K8/73;;A61K8/81;;A61Q15/00;;A61Q17/00,,1,0,,,See references of WO 0030599A1,DISCONTINUED
437,ZA,B,ZA 869591 B,107-778-271-916-123,1988-07-27,1988,ZA 869591 A,1986-12-19,US 81123385 A,1985-12-20,"SUBSTITUTED 5,6-DIALKOXYQUINAZOLINE DERIVATIVES",,ORTHO PHARMA CORP,BANDURCO VICTOR T;;BELL STANLEY C;;DODD JOHN H;;FALTICO ROBERT;;SCHWENDER CHARLES F;;TOBIA ALFONSO J,,https://lens.org/107-778-271-916-123,Granted Patent,no,0,0,8,8,0,C07D239/95;;A61P9/04;;C07D239/95,A61K31/505;;A61K31/517;;C07D239/84;;A61P9/04;;C07D239/88;;C07D239/90;;C07D239/95,,0,0,,,,EXPIRED
438,AU,A,AU 2000/019187 A,183-939-205-988-584,2000-06-13,2000,AU 2000/019187 A,1999-11-22,US 10950098 P;;US 32129299 A;;US 9927684 W,1998-11-23,Skin deodorizing and sanitizing compositions,,PROCTER & GAMBLE,DODD MICHAEL THOMAS;;WEI KARL SHIQING;;TRINH TOAN;;SINE MARK RICHARD;;BARTOLO ROBERT GREGORY;;JAKUBOVIC DAVID ANDREW,,https://lens.org/183-939-205-988-584,Patent Application,no,0,0,5,21,0,A61Q17/005;;A61K8/0208;;A61K8/27;;A61K8/347;;A61K8/40;;A61K8/416;;A61K8/43;;A61K8/4973;;A61K8/738;;A61K8/8147;;A61Q15/00,A61K8/00;;A61K8/02;;A61K8/27;;A61K8/34;;A61K8/40;;A61K8/41;;A61K8/43;;A61K8/49;;A61K8/73;;A61K8/81;;A61Q15/00;;A61Q17/00,,0,0,,,,DISCONTINUED
439,EP,A1,EP 0988026 A1,186-358-456-321-913,2000-03-29,2000,EP 98928923 A,1998-06-08,US 9811787 W;;US 87185497 A;;US 87185797 A;;US 87186097 A,1997-06-09,PERFUME-FREE TWO PHASE COMPOSITIONS AND METHODS FOR REDUCING BODY AND ENVIRONMENTAL ODOR,,PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/186-358-456-321-913,Patent Application,yes,0,0,16,18,0,A61K8/19;;A61K8/27;;A61K8/347;;A61K8/37;;A61K8/39;;A61K8/44;;A61K8/4973;;A61K8/738;;A61K8/891;;A61K8/90;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61K8/39;;A61K8/37;;A61K8/90;;A61Q15/00;;A61K8/891;;A61K8/27;;A61K8/44;;A61K8/347;;A61K8/19;;A61K8/738;;A61K8/4973,A61K8/00;;A47K7/00;;A61K8/18;;A61K8/19;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/34;;A61K8/37;;A61K8/44;;A61K8/49;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;C08L83/10,,0,0,,,,DISCONTINUED
440,EP,A1,EP 1131045 A1,022-943-120-781-211,2001-09-12,2001,EP 99962826 A,1999-11-22,US 9927685 W;;US 10960298 P;;US 32129299 A,1998-11-23,SKIN DEODORIZING COMPOSITIONS,,PROCTER & GAMBLE,DODD MICHAEL THOMAS;;WEI KARL SHIQING;;TRINH TOAN;;SINE MARK RICHARD;;BARTOLO ROBERT GREGORY;;JAKUBOVIC DAVID ANDREW,,https://lens.org/022-943-120-781-211,Patent Application,yes,0,0,6,21,0,A61K8/0208;;A61K8/042;;A61K8/27;;A61K8/347;;A61K8/40;;A61K8/416;;A61K8/43;;A61K8/4973;;A61K8/732;;A61K8/738;;A61K8/8147;;A61Q15/00;;A61Q17/005;;A61Q17/005;;A61Q15/00;;A61K8/40;;A61K8/738;;A61K8/4973;;A61K8/0208;;A61K8/8147;;A61K8/347;;A61K8/43;;A61K8/27;;A61K8/416;;A61K8/042;;A61K8/732,A61K8/02;;A61K8/27;;A61K8/00;;A61K8/34;;A61K8/35;;A61K8/37;;A61K8/40;;A61K8/41;;A61K8/43;;A61K8/49;;A61K8/73;;A61K8/81;;A61Q15/00;;A61Q17/00,,0,0,,,,DISCONTINUED
441,NO,D0,NO 991896 D0,030-282-747-666-57X,1999-04-21,1999,NO 991896 A,1999-04-21,US 73609396 A;;US 73646996 A;;US 73896496 A;;US 88960797 A;;US 94607697 A;;US 94677097 A;;US 94729997 A;;US 95118597 A;;US 9718852 W,1996-10-24,Blandinger for Õ nedsette lukt pÕ huden,,PROCTER & GAMBLE,TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/030-282-747-666-57X,Patent Application,no,0,0,2,24,0,,A61K/,,0,0,,,,DISCONTINUED
442,WO,A1,WO 1998/056339 A1,028-469-249-851-615,1998-12-17,1998,US 9811787 W,1998-06-08,US 87185497 A;;US 87185797 A;;US 87186097 A,1997-06-09,PERFUME-FREE TWO PHASE COMPOSITIONS AND METHODS FOR REDUCING BODY AND ENVIRONMENTAL ODOR,"The present invention relates to an aqueous odor-absorbing composition which is safe for use on human skin comprising solubilized, water-soluble, uncomplexed cyclodextrin; an oil phase selected from the group consisting of emollients, moisturizers, skin protectants, and mixtures thereof; one or more surfactants each having hydrophilic/lipophilic balance of about 8-18, and wherein each surfactant, when combined with an aqueous cyclodextrin solution, provides no less than about 25 % a level of odor capture as an aqueous cyclodextrin solution; and an aqueous carrier. The present invention also encompasses methods of controlling body and environmental odors on skin comprising the application to skin of these compositions.",PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/028-469-249-851-615,Patent Application,yes,2,1,16,18,0,A61K8/19;;A61K8/27;;A61K8/347;;A61K8/37;;A61K8/39;;A61K8/44;;A61K8/4973;;A61K8/738;;A61K8/891;;A61K8/90;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61K8/39;;A61K8/37;;A61K8/90;;A61Q15/00;;A61K8/891;;A61K8/27;;A61K8/44;;A61K8/347;;A61K8/19;;A61K8/738;;A61K8/4973,A61K8/00;;A47K7/00;;A61K8/18;;A61K8/19;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/34;;A61K8/37;;A61K8/44;;A61K8/49;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;C08L83/10,,1,1,117-288-143-743-628,10.1002/star.19820341106,"SZEJTLI, J.: ""CYCLODEXTRINS IN FOOD, COSMETICS AND TOILETRIES"", STÄRKE, vol. 34, no. 11, November 1982 (1982-11-01), WEINHEIM, DEUTSCHLAND, pages 382, XP002079165",PENDING
443,WO,A1,WO 2000/030599 A1,097-160-366-930-301,2000-06-02,2000,US 9927684 W,1999-11-22,US 10950098 P;;US 32129299 A,1998-11-23,SKIN DEODORIZING AND SANITIZING COMPOSITIONS,The present invention relates to aqueous compositions comprising an odor controlling agent and select sanitizing agents for deodorizing and sanitizing skin surfaces. Articles of manufacture and methods of deodorizing and sanitizing the skin using disclosed compositions are also disclosed.,PROCTER & GAMBLE,DODD MICHAEL THOMAS;;WEI KARL SHIQING;;TRINH TOAN;;SINE MARK RICHARD;;BARTOLO ROBERT GREGORY;;JAKUBOVIC DAVID ANDREW,,https://lens.org/097-160-366-930-301,Patent Application,yes,12,7,5,21,0,A61Q17/005;;A61K8/0208;;A61K8/27;;A61K8/347;;A61K8/40;;A61K8/416;;A61K8/43;;A61K8/4973;;A61K8/738;;A61K8/8147;;A61Q15/00,A61K8/00;;A61K8/02;;A61K8/27;;A61K8/34;;A61K8/40;;A61K8/41;;A61K8/43;;A61K8/49;;A61K8/73;;A61K8/81;;A61Q15/00;;A61Q17/00,,1,0,,,"MATSUDA, H., ITO, K.: ""Body deodorants containing hydroxyalkylated cyclodextrins"", STN INTERNATIONAL; FILE CA, AN 116:158589, XP002133010",PENDING
444,US,B2,US 7716123 B2,122-620-354-159-694,2010-05-11,2010,US 3660501 A,2001-12-21,US 3660501 A,2001-12-21,"Systems and methods for automatic submission, audit and adjustment of mortgage insurance claims","Systems and methods are described for automatically processing mortgage insurance claims. In one described system, a central server computer receives inputs from, and provides outputs to, a servicer terminal connected into a network. The servicer terminal captures data from a servicer submitting a mortgage insurance claim. A claims database is connected into the network, containing data relating to the mortgage insurance claim. A claim audit rulebase is connected into the network, for automatically performing an audit and adjustment of the submitted mortgage insurance claim. The system automatically provides results of the audit and adjustment to the servicer at the servicer terminal, and presents the servicer with an option to interact with a claim representative to resolve any issues.",GE MORTGAGE HOLDINGS LLC,DODD NANCY J;;PARKER CHARLA M;;POPE ALLISON N;;STEWART JOANNE A;;WHITNEY TRACI L;;JOHNSTON ROBERT,GENWORTH MORTGAGE HOLDINGS LLC (2001-12-13),https://lens.org/122-620-354-159-694,Granted Patent,yes,6,5,2,2,0,G06Q20/10;;G06Q40/02;;G06Q40/08;;G06Q40/03;;G06Q40/02;;G06Q20/10;;G06Q40/08;;G06Q40/03,G06Q20/10,705/38;;705/39,2,0,,,"Enhanced Claims Processing Capabilities Bolster First American Default Management Solutions, PR Newswire, New York, Nov. 21, 2001, p. 1, found on http://proquest,umi.com.;;Gwendolyn Glenn; ""Loan Management Software Gets Warm Reception"", Real Estate Finance Today, Feb. 8, 1999. vol. 16, Iss.5; p. 6.",INACTIVE
445,ID,A,ID 23848 A,165-417-931-654-545,2000-05-25,2000,ID 991559 A,1998-06-08,US 87157797 A;;US 87185397 A;;US 8715597 A;;US 87185897 A,1997-06-09,KOMPOSISI-KOMPOSISI SATU DAN DUA FASA PEWANGI UNTUK MENURUNKAN BAU BADAN DAN METODE-METODE PENGGUNAANNYA,,PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/165-417-931-654-545,Patent Application,no,0,0,1,21,0,,,,0,0,,,,PENDING
446,CA,A1,CA 2293633 A1,169-191-471-881-259,1998-12-17,1998,CA 2293633 A,1998-06-08,US 87185497 A;;US 87185797 A;;US 87186097 A;;US 9811787 W,1997-06-09,PERFUME-FREE TWO PHASE COMPOSITIONS AND METHODS FOR REDUCING BODY AND ENVIRONMENTAL ODOR,"The present invention relates to an aqueous odor-absorbing composition which is safe for use on human skin comprising solubilized, water-soluble, uncomplexed cyclodextrin; an oil phase selected from the group consisting of emollients, moisturizers, skin protectants, and mixtures thereof; one or more surfactants each having hydrophilic/lipophilic balance of about 8-18, and wherein each surfactant, when combined with an aqueous cyclodextrin solution, provides no less than about 25 % a level of odor capture as an aqueous cyclodextrin solution; and an aqueous carrier. The present invention also encompasses methods of controlling body and environmental odors on skin comprising the application to skin of these compositions.",PROCTER & GAMBLE,BARTOLO ROBERT GREGORY;;KAJS THERESA MARIE;;BUCKNER ROBIN YAGER;;DODD MICHAEL THOMAS;;TRINH TOAN;;LUCAS JULIET MARIE,,https://lens.org/169-191-471-881-259,Patent Application,no,0,0,16,18,0,A61K8/19;;A61K8/27;;A61K8/347;;A61K8/37;;A61K8/39;;A61K8/44;;A61K8/4973;;A61K8/738;;A61K8/891;;A61K8/90;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61K8/39;;A61K8/37;;A61K8/90;;A61Q15/00;;A61K8/891;;A61K8/27;;A61K8/44;;A61K8/347;;A61K8/19;;A61K8/738;;A61K8/4973,A47K7/00;;A61K8/00;;A61K8/18;;A61K8/19;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/34;;A61K8/37;;A61K8/44;;A61K8/49;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;C08L83/10,,0,0,,,,DISCONTINUED
447,CZ,B6,CZ 289379 B6,189-804-818-670-43X,2002-01-16,2002,CZ 145099 A,1997-10-23,US 73647196 A;;US 73647096 A;;US 94707597 A;;US 95118497 A,1996-10-24,"Odor absorbing aqueous composition, a pre-formed odor absorbing wipe and process for preparing such odor absorbing aqueous composition","In the present invention there is disclosed an aqueous odor absorbing composition comprising: (a) from 0.1 to 5 percent by weight of the composition, of solubilized, water soluble, uncomplexed cyclodextrin; (b) an aqueous carrier; (c) from 0.1 to 36 percent by weight of the composition, of an oil phase being selected from the group consisting of softening agents, moistening agents, and akin protectants; and (d) an emulsifier, wherein the aqueous composition is safe for use on human skin. In the present invention there is also claimed a pre-formed, odor absorbing wipe that contains the aqueous composition according to the invention deposited on the wipe which further comprises a flexible dispensing means for release of the deposited aqueous composition. A process for making an aqueous odor absorbing composition comprises the steps of: (a) making a mixture by mixing an emulsifier, an oil phase, and an aqueous phase until the mixture is homogenous; (b) making a second mixture by adding cyclodextrin to the mixture of step (a) with mixing until the cyclodextrin dissolves and the resulting mixture is homogenous.",PROCTER & GAMBLE,TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/189-804-818-670-43X,Granted Patent,no,0,0,24,28,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61Q15/00;;D06M13/005;;A61K8/73;;A61Q15/00,A61K8/00;;A61K8/02;;A61K8/04;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/44;;A61K8/73;;A61Q15/00;;D06M13/00,,0,0,,,,EXPIRED
448,US,B2,US 6656456 B2,013-104-499-438-616,2003-12-02,2003,US 44342099 A,1999-11-19,US 44342099 A;;US 32129299 A;;US 10960298 P,1998-11-23,Skin deodorizing compositions,"
    The present invention relates to aqueous gel compositions comprising an odor controlling agent for deodorizing skin surfaces. Articles of manufacture and methods of deodorizing the skin using disclosed compositions are also disclosed. 
",PROCTER & GAMBLE,DODD MICHAEL THOMAS;;TRINH TOAN;;BARTOLO ROBERT GREGORY;;WEI KARL SHIQING;;SINE MARK RICHARD;;JAKUBOVIC DAVID ANDREW,PROCTER & GAMBLE COMPANY THE (2000-03-02),https://lens.org/013-104-499-438-616,Granted Patent,yes,20,27,6,21,0,A61K8/0208;;A61K8/042;;A61K8/27;;A61K8/347;;A61K8/40;;A61K8/416;;A61K8/43;;A61K8/4973;;A61K8/732;;A61K8/738;;A61K8/8147;;A61Q15/00;;A61Q17/005;;A61Q17/005;;A61Q15/00;;A61K8/40;;A61K8/738;;A61K8/4973;;A61K8/0208;;A61K8/8147;;A61K8/347;;A61K8/43;;A61K8/27;;A61K8/416;;A61K8/042;;A61K8/732,A61K8/02;;A61K8/00;;A61K8/27;;A61K8/34;;A61K8/35;;A61K8/37;;A61K8/40;;A61K8/41;;A61K8/43;;A61K8/49;;A61K8/73;;A61K8/81;;A61Q15/00;;A61Q17/00,424/67;;424/401;;424/400;;424/65;;424/78.02;;424/78.03;;424/78.08;;424/78.17,0,0,,,,EXPIRED
449,EP,B1,EP 1133274 B1,027-091-453-362-087,2008-10-01,2008,EP 99962827 A,1999-11-22,US 9927688 W;;US 19793398 A;;US 32129299 A,1998-11-23,SKIN DEODORIZING AND SANITIZING COMPOSITIONS,,PROCTER & GAMBLE,DODD MICHAEL THOMAS;;WEI KARL SHIQING;;TRINH TOAN;;SINE MARK RICHARD;;BARTOLO ROBERT GREGORY;;JAKUBOVIC DAVID ANDREW,,https://lens.org/027-091-453-362-087,Granted Patent,yes,3,0,7,21,0,A61Q17/005;;A61K8/0208;;A61K8/27;;A61K8/347;;A61K8/40;;A61K8/416;;A61K8/43;;A61K8/4973;;A61K8/738;;A61K8/8147;;A61Q15/00,A61K8/00;;A61L9/01;;A61K8/02;;A61K8/26;;A61K8/27;;A61K8/33;;A61K8/34;;A61K8/35;;A61K8/37;;A61K8/40;;A61K8/41;;A61K8/43;;A61K8/49;;A61K8/73;;A61K8/81;;A61K8/97;;A61Q15/00;;A61Q17/00;;A61Q19/10,,6,0,,,"ISHII, K. ET AL.: ""Perfumes containing saccharides and organic substances with specified inorganic organic balance (IOB)"" STN INTERNATIONAL; FILE CA, AN 125:177036, XP002132584 & JP 08 176587 A (SHISEIDO CO LTD, JAPAN) 9 July 1996 (1996-07-09);;ISHIMARU,T., ARIMURA, A.: ""Antiseptic skin cleansers containing cyclodextrin"" STN INTERNATIONAL; FILE CA, AN 131:277024, XP002132585 & JP 11 279084 A (LION CORP., JAPAN) 12 October 1999 (1999-10-12);;KOLLARIK, R. ET AL.: ""Deodorant aerosol spray containing cyclodextrin complexes"" STN INTERNATIONAL; FILE CA, AN 118:27254, XP002132586 & HU 60 127 A (SZIASZ SZOLGALTATO ES IPARI ALTALANOS KISSZOVETKEZET, HUNG.) 28 August 1992 (1992-08-28);;DATABASE WPI Section Ch, Week 198816 Derwent Publications Ltd., London, GB; Class D22, AN 1988-110044 XP002132589 & JP 63 059962 A (OKURA KOSAN KK), 15 March 1988 (1988-03-15);;MATSUKA, H., ITO, K.: ""Body deodorants containing hydroxyalkylated cyclodextrins"" STN INTERNATIONAL; FILE CA, AN 116:158589, XP002133010 & JP 03 284616 A (SHISEIDO CO., LTD., JAPAN) 16 December 1991 (1991-12-16);;CHEN, W.: ""Underarm or foot deodorant"" STN INTERNATIONAL ; FILE CA, AN 128:196489, XP002132588 & CN 1 141 162 A 29 January 1997 (1997-01-29)",EXPIRED
450,DE,D1,DE 69939661 D1,041-024-769-191-752,2008-11-13,2008,DE 69939661 T,1999-11-22,US 19793398 A;;US 32129299 A;;US 9927688 W,1998-11-23,HAUTDESODORIERENDE UND DESINFIZIERENDE ZUBEREITUNG,The present invention relates to aqueous compositions comprising an odor controlling agent and select sanitizing agents for deodorizing and sanitizing skin surfaces. Articles of manufacture and methods of deodorizing and sanitizing the skin using disclosed compositions are also disclosed.,PROCTER & GAMBLE,DODD MICHAEL THOMAS;;WEI KARL SHIQING;;TRINH TOAN;;SINE MARK RICHARD;;BARTOLO ROBERT GREGORY;;JAKUBOVIC DAVID ANDREW,,https://lens.org/041-024-769-191-752,Granted Patent,no,0,0,3,21,0,A61K8/0208;;A61K8/27;;A61K8/347;;A61K8/40;;A61K8/416;;A61K8/43;;A61K8/4973;;A61K8/738;;A61K8/8147;;A61Q15/00;;A61Q17/005;;A61Q17/005;;A61K8/347;;A61K8/8147;;A61K8/0208;;A61K8/40;;A61K8/43;;A61K8/738;;A61Q15/00;;A61K8/4973;;A61K8/416;;A61K8/27,A61L9/01;;A61K8/02;;A61K8/26;;A61K8/27;;A61K8/34;;A61K8/40;;A61K8/41;;A61K8/43;;A61K8/49;;A61K8/73;;A61K8/81;;A61Q15/00;;A61Q17/00,,0,0,,,,EXPIRED
451,EP,A1,EP 2448523 A1,057-641-793-199-222,2012-05-09,2012,EP 10732762 A,2010-06-30,US 2010/0001878 W;;US 49568809 A;;US 49565709 A;;US 49561109 A;;US 49553409 A,2009-06-30,MULTI-PHASIC IMPLANT DEVICE FOR THE REPAIR OR REPLACEMENT OF CARTILAGE TISSUE,,KENSEY NASH CORP,CASTIGLIONE-DODD EMME M;;BRADICA GINO;;EBRAHIMI ALI;;RINGEISEN TIMOTHY A;;WATTENGEL WILLIAM CHRISTIAN;;MCDADE ROBERT L,,https://lens.org/057-641-793-199-222,Patent Application,yes,3,0,6,12,0,A61F2/28;;A61F2/30756;;A61F2002/30014;;A61F2002/30028;;A61F2002/30031;;A61F2002/30052;;A61F2002/30088;;A61F2002/30332;;A61F2002/3092;;A61F2002/30971;;A61F2002/4495;;A61F2210/008;;A61F2220/0033;;A61F2250/0018;;A61F2250/0043;;A61F2250/0051;;A61F2250/0056;;A61F2310/00365;;A61L27/24;;A61L27/48;;A61L27/50;;A61L27/52;;A61L27/56;;A61L2430/06,A61F2/28;;A61F2/00;;A61F2/30,,1,0,,,See also references of WO 2011002511A1,DISCONTINUED
452,WO,A1,WO 2000/030601 A1,130-015-395-264-727,2000-06-02,2000,US 9927688 W,1999-11-22,US 19793398 A;;US 32129299 A,1998-11-23,SKIN DEODORIZING AND SANITIZING COMPOSITIONS,The present invention relates to aqueous compositions comprising an odor controlling agent and select sanitizing agents for deodorizing and sanitizing skin surfaces. Articles of manufacture and methods of deodorizing and sanitizing the skin using disclosed compositions are also disclosed.,PROCTER & GAMBLE,DODD MICHAEL THOMAS;;WEI KARL SHIQING;;TRINH TOAN;;SINE MARK RICHARD;;BARTOLO ROBERT GREGORY;;JAKUBOVIC DAVID ANDREW,,https://lens.org/130-015-395-264-727,Patent Application,yes,3,9,7,21,0,A61Q17/005;;A61K8/0208;;A61K8/27;;A61K8/347;;A61K8/40;;A61K8/416;;A61K8/43;;A61K8/4973;;A61K8/738;;A61K8/8147;;A61Q15/00,A61K8/00;;A61K8/02;;A61K8/27;;A61K8/33;;A61K8/34;;A61K8/35;;A61K8/37;;A61K8/40;;A61K8/41;;A61K8/43;;A61K8/49;;A61K8/73;;A61K8/81;;A61K8/97;;A61Q15/00;;A61Q17/00;;A61Q19/10,,6,0,,,"ISHII, K. ET AL.: ""Perfumes containing saccharides and organic substances with specified inorganic organic balance (IOB)"", STN INTERNATIONAL; FILE CA, AN 125:177036, XP002132584;;ISHIMARU,T., ARIMURA, A.: ""Antiseptic skin cleansers containing cyclodextrin"", STN INTERNATIONAL; FILE CA, AN 131:277024, XP002132585;;KOLLARIK, R. ET AL.: ""Deodorant aerosol spray containing cyclodextrin complexes"", STN INTERNATIONAL; FILE CA, AN 118:27254, XP002132586;;DATABASE WPI Section Ch Week 198816, Derwent World Patents Index; Class D22, AN 1988-110044, XP002132589;;MATSUKA, H., ITO, K.: ""Body deodorants containing hydroxyalkylated cyclodextrins"", STN INTERNATIONAL; FILE CA, AN 116:158589, XP002133010;;CHEN, W.: ""Underarm or foot deodorant"", STN INTERNATIONAL ; FILE CA, AN 128:196489, XP002132588",PENDING
453,DK,D0,DK 615186 D0,186-320-708-477-575,1986-12-18,1986,DK 615186 A,1986-12-18,US 81123385 A,1985-12-20,"SUBSTITUEREDE 5,6-DIALKOXYQUINAZOLINDERIVATER",,ORTHO PHARMA CORP,BANDURCO VICTOR T;;BELL STANLEY C;;DODD JOHN H;;FALOTICO ROBERT;;SCHWENDER CHARLES F;;TOBIA ALFONSO J,,https://lens.org/186-320-708-477-575,Patent Application,no,0,0,8,8,0,C07D239/95;;A61P9/04;;C07D239/95,A61K31/505;;A61K31/517;;C07D239/84;;A61P9/04;;C07D239/88;;C07D239/90;;C07D239/95,,0,0,,,,DISCONTINUED
454,HU,A2,HU P0002716 A2,012-713-088-494-004,2000-12-28,2000,HU P0002716 A,1998-06-08,US 87185897 A,1997-06-09,PERFUMED ONE AND TWO PHASE COMPOSITIONS FOR REDUCING BODY ODOR AND METHODS OF USE THEREOF,"A találmány tárgyát szagot abszorbeáló készítmények és azoknak a bőrrevaló alkalmazása képezi. A készítmények, a készítmény tömegérevonatkoztatva körülbelül 0,1-5% oldhatóvá tett, vízben oldódó nemkomplexált ciklodextrint, körülbelül 0,004-2% parfümkészítményt, ésvizes hordozóanyagot tartalmaznak. A készítmények vagy kismolekulatömegű dimetikont, vagy bőrpuhító szerek, nedvesítőszerek,bőrvédő szerek által alkotott csoportból és ezek keverékei közülkiválasztott olajos fázist, és egy vagy több felületaktív anyagot istartalmazhatnak. A találmány szerinti szagot abszorbeáló készítményekelőnyösen hatékony mennyiségű, vízben oldódó és/vagy hidrofóbmikróbaellenes szereket szintén tartalmazhatnak. A találmány tárgyátképezik a rugalmas adagolóeszközre lerakódott, szagot abszorbeálókészítmények is. Ó",The Procter & Gamble Co.,BARTOLO ROBERT GREGORY;;BUCKNER ROBIN YAGER;;DODD MICHAEL THOMAS;;KAJS THERESA MARIE;;LUCAS JULIET MARIE;;TRINH TOAN,,https://lens.org/012-713-088-494-004,Patent Application,no,0,0,3,21,0,A61K8/0208;;A61K8/19;;A61K8/27;;A61K8/347;;A61K8/37;;A61K8/44;;A61K8/4973;;A61K8/738;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;A61Q15/00;;A61K8/347;;A61K8/891;;A61K8/90;;A61K8/19;;A61K8/37;;A61K8/44;;A61K8/4973;;A61K8/27;;A61K8/738;;A61K8/0208;;A61Q13/00,A61K8/02;;A61K8/19;;A61K8/27;;A61K8/34;;A61K8/37;;A61K8/44;;A61K8/49;;A61K8/73;;A61K8/891;;A61K8/90;;A61K33/30;;A61Q13/00;;A61Q15/00,,0,0,,,,PENDING
455,EP,A2,EP 0227450 A2,022-997-470-373-940,1987-07-01,1987,EP 86309957 A,1986-12-19,US 81123385 A,1985-12-20,"Substituted 5,6-Dialkoxyquinazoline Derivatives.","Quinazoline derivatives having an oxy substituent in 5 and 6 positions are described. The novel quinazoline derivatives are useful as cardiotonic agents.  ",ORTHO PHARMA CORP,BANDURCO VICTOR T;;DODD JOHN H;;BELL STALEY C;;FALOTICO ROBERT;;SCHWENDER CHARLES F;;TOBIA ALFONSO J,,https://lens.org/022-997-470-373-940,Patent Application,yes,0,18,8,8,0,C07D239/95;;A61P9/04;;C07D239/95,A61K31/505;;A61K31/517;;C07D239/84;;A61P9/04;;C07D239/88;;C07D239/90;;C07D239/95,,0,0,,,,DISCONTINUED
456,EP,A1,EP 1133274 A1,136-772-358-041-141,2001-09-19,2001,EP 99962827 A,1999-11-22,US 9927688 W;;US 19793398 A;;US 32129299 A,1998-11-23,SKIN DEODORIZING AND SANITIZING COMPOSITIONS,,PROCTER & GAMBLE,DODD MICHAEL THOMAS;;WEI KARL SHIQING;;TRINH TOAN;;SINE MARK RICHARD;;BARTOLO ROBERT GREGORY;;JAKUBOVIC DAVID ANDREW,,https://lens.org/136-772-358-041-141,Patent Application,yes,0,0,7,21,0,A61Q17/005;;A61K8/0208;;A61K8/27;;A61K8/347;;A61K8/40;;A61K8/416;;A61K8/43;;A61K8/4973;;A61K8/738;;A61K8/8147;;A61Q15/00,A61K8/00;;A61L9/01;;A61K8/02;;A61K8/26;;A61K8/27;;A61K8/33;;A61K8/34;;A61K8/35;;A61K8/37;;A61K8/40;;A61K8/41;;A61K8/43;;A61K8/49;;A61K8/73;;A61K8/81;;A61K8/97;;A61Q15/00;;A61Q17/00;;A61Q19/10,,1,0,,,See references of WO 0030601A1,EXPIRED
457,DE,D1,DE 60131412 D1,130-990-614-625-611,2007-12-27,2007,DE 60131412 T,2001-09-07,US 77318201 A;;US 0128081 W,2001-01-30,SCHMALER TINTENSTRAHLDRUCKKOPF,,HEWLETT PACKARD CO,TORGERSON JOSEPH M;;BROWNING ROBERT N;;MACKENZIE MARK H;;MILLER MICHAEL D;;BAKKOM ANGELA WHITE;;DODD SIMON,"HEWLETT-PACKARD DEVELOPMENT CO., L.P. (N.D.GES, US (2008-05-29)",https://lens.org/130-990-614-625-611,Granted Patent,no,0,0,34,34,0,B41J2/14072;;B41J2/15;;B41J2/14072;;B41J2/15,B41J2/05;;B41J2/15,,0,0,,,,EXPIRED
458,BR,A,BR 9810744 A,179-272-131-736-95X,2000-09-19,2000,BR 9810744 A,1998-06-08,US 87185497 A;;US 87185797 A;;US 87186097 A;;US 9811787 W,1997-06-09,Composições de duas fases isentas de perfume e processos para redução de odor corpóreo e ambiental,"Patente de Invenção: <B>""COMPOSIçõES DE DUAS FASES ISENTAS DE PERFUME E PROCESSOS PARA REDUçãO DE ODOR CORPóREO E AMBIENTAL""<D>. A presente invenção refere-se a uma composição aquosa absorvente de odor, que é segura para uso sobre pele humana, compreendendo: ciclodextrina não-complexada, solúvel em água, solubilizada; uma fase oleosa selecionada do grupo consistindo em emolientes, umidificadores, protetores de pele e as suas misturas; um ou mais tensoativos, cada um deles tendo um equilíbrio hidrofílico/lipofílico de cerca de 8 - 18, e em que cada tensoativo, quando combinado com uma solução aquosa de ciclodextrina, proporciona não menos do que cerca de um nível de 25% de captura de odor, como uma solução aquosa de ciclodextrina; e um transportador aquoso. A presente invenção também abrange processos de controle de odores corpóreos e ambientais sobre a pele, compreendendo a aplicação à pele dessas composições.",PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/179-272-131-736-95X,Patent Application,no,0,0,16,18,0,A61K8/19;;A61K8/27;;A61K8/347;;A61K8/37;;A61K8/39;;A61K8/44;;A61K8/4973;;A61K8/738;;A61K8/891;;A61K8/90;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61K8/39;;A61K8/37;;A61K8/90;;A61Q15/00;;A61K8/891;;A61K8/27;;A61K8/44;;A61K8/347;;A61K8/19;;A61K8/738;;A61K8/4973,A47K7/00;;A61K8/00;;A61K8/18;;A61K8/19;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/34;;A61K8/37;;A61K8/44;;A61K8/49;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;C08L83/10,,0,0,,,,DISCONTINUED
459,ID,A,ID 26590 A,001-722-096-362-744,2001-01-18,2001,ID 991558 A,1998-06-08,US 87185497 A;;US 87185797 A;;US 87186097 A,1997-06-09,KOMPOSISI-KOMPOSISI DUA FASA BEBAS PEWANGI DAN METODE-METODE UNTUK MENURUNKAN BAU BADAN DAN LINGKUNGAN,,PROCTER & GAMBLE,LUCAS LULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/001-722-096-362-744,Patent Application,no,0,0,16,18,0,A61K8/19;;A61K8/27;;A61K8/347;;A61K8/37;;A61K8/39;;A61K8/44;;A61K8/4973;;A61K8/738;;A61K8/891;;A61K8/90;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61K8/39;;A61K8/37;;A61K8/90;;A61Q15/00;;A61K8/891;;A61K8/27;;A61K8/44;;A61K8/347;;A61K8/19;;A61K8/738;;A61K8/4973,A61K8/00;;A47K7/00;;A61K8/18;;A61K8/19;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/34;;A61K8/37;;A61K8/44;;A61K8/49;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;C08L83/10,,0,0,,,,PENDING
460,NO,L,NO 991896 L,055-160-711-118-645,1999-06-21,1999,NO 991896 A,1999-04-21,US 73609396 A;;US 73646996 A;;US 73896496 A;;US 88960797 A;;US 94607697 A;;US 94677097 A;;US 94729997 A;;US 95118597 A;;US 9718852 W,1996-10-24,Blandinger for Õ nedsette lukt pÕ huden,"Vandig luktabsorberende sammensetning som er sikker å bruke på menneskets hud, omfattende 0,1-5% solubilisert, vann- løselig, ikke-kompleksdannet cyklodekstrin, beregnet på vekten av sammensetningen; 0,5-30% lineært dimethicon som har en nominell viskositet på 350 cSt eller mindre, bereg- net på vekten av sammensetningen; og en vandig bærer. Sam- mensetningene kan også omfatte en eller flere av de føl- gende valgfrie komponenter: polyoler med lav molekylvekt, vannløselige antimikrobielle konserveringsmidler, sink- salter, vannløselige polymerer, løselige karbonat- og/eller bikarbonatsalter, chelateringsmidler, zeolitter, aktivert karbon og blandinger derav. Også anvendelse av de oven- nevnte sammensetninger ved nedsettelse av kroppslukt, vagi- nal lukt og/eller miljølukt på huden. Sammensetningen kan påføres direkte i form av en spray, helles fra en flaske og påføres med hånden, eller påføres ved hjelp av en serviett.",PROCTER & GAMBLE,TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/055-160-711-118-645,Abstract,no,0,0,2,24,0,,A61K/,,0,0,,,,DISCONTINUED
461,NO,D0,NO 996053 D0,101-607-360-443-079,1999-12-08,1999,NO 996053 A,1999-12-08,US 87157797 A;;US 87185397 A;;US 87185597 A;;US 87185897 A;;US 9811814 W,1997-06-09,"Parfymerte en- og to-fase blandinger for å redusere kroppslukt, samt fremgangsmåte ved anvendelse derav",,PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/101-607-360-443-079,Patent Application,no,0,0,15,21,0,A61K8/0208;;A61K8/19;;A61K8/27;;A61K8/347;;A61K8/37;;A61K8/44;;A61K8/4973;;A61K8/738;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61Q15/00;;A61K8/891;;A61K8/19;;A61K8/347;;A61K8/738;;A61K8/27;;A61K8/44;;A61K8/90;;A61K8/4973;;A61K8/37;;A61K8/0208;;A61Q13/00,A61K8/02;;A61K8/19;;A61K8/00;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/34;;A61K8/37;;A61K8/44;;A61K8/49;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;A61Q19/00;;C08L83/04;;C08L83/12,,0,0,,,,DISCONTINUED
462,BR,A,BR 9712657 A,097-782-132-449-028,1999-10-26,1999,BR 9712657 A,1997-10-23,US 73609396 A;;US 73646996 A;;US 73896496 A;;US 88960797 A;;US 94677097 A;;US 94707697 A;;US 94729997 A;;US 95118597 A;;US 9718852 W,1996-10-24,Composições para reduzir o odor na pele,"The present invention relates to an aqueous odor-absorbing composition which is safe for use on human skin comprising from about 0.1 % to about 5 %, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from about 0.5 % to about 30 %, by weight of the composition, of a linear dimethicone having a nominal viscosity of 350 centistokes or less; and an aqueous carrier. The compositions can also comprise one or more of the following optional components: low molecular weight polyols; water-soluble antimicrobial preservatives; zinc salts; water-soluble polymers; soluble carbonate and/or bicarbonate salts; chelating agents; zeolites; activated carbon; and mixtures thereof. The present invention also relates the use of the aforementioned compositions in reducing body, vaginal, and or environmental odors on skin. The composition can be applied directly as a spray, poured from a bottle and applied by hand, or applied via a wipe.",PROCTER & GAMBLE,TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/097-782-132-449-028,Patent Application,no,0,0,15,24,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61K8/891;;A61Q15/00;;A61K8/73;;A61Q15/00,A61K8/02;;A61K8/04;;A61K8/27;;A61K8/44;;A61K8/73;;A61K8/891;;A61Q15/00,,0,0,,,,DISCONTINUED
463,HU,A2,HU P9904570 A2,157-892-792-167-458,2000-05-28,2000,HU P9904570 A,1997-10-23,US 95118597 A,1997-10-15,COMPOSITION FOR REDUCING ODOR ON SKIN,"An aqueous odour absorbing composition comprises: (a) 0.1-5 wt.% of solubilised, water-soluble, uncomplexed cyclodextrin; (b) 0.5-30 wt.% of a linear dimethicone having a nominal viscosity of 350 centistokes or less; optionally (c) an effective amount of solubilised, water-soluble, antimicrobial preservative; and (d) an aqueous carrier. The composition is safe for use on skin. Also claimed is a pre-formed wipe composition where the claimed composition is deposited on a wipe, which comprises a flexible dispensing means.",The Procter and Gamble Company,BARTOLO ROBERT GREGORY;;BUCKNER ROBIN YAGER;;DODD MICHAEL THOMAS;;KAJS THERESA MARIE;;LUCAS JULIET MARIE;;TRINH TOAN,,https://lens.org/157-892-792-167-458,Patent Application,no,0,0,2,24,0,,D06M15/03,,0,0,,,,PENDING
464,DE,T2,DE 60131412 T2,198-236-075-575-231,2008-10-30,2008,DE 60131412 T,2001-09-07,US 77318201 A;;US 0128081 W,2001-01-30,SCHMALER TINTENSTRAHLDRUCKKOPF,,HEWLETT PACKARD DEVELOPMENT CO,TORGERSON JOSEPH M;;BROWNING ROBERT N;;MACKENZIE MARK H;;MILLER MICHAEL D;;BAKKOM ANGELA WHITE;;DODD SIMON,"HEWLETT-PACKARD DEVELOPMENT CO., L.P. (N.D.GES, US (2008-05-29)",https://lens.org/198-236-075-575-231,Granted Patent,no,0,0,34,34,0,B41J2/14072;;B41J2/15;;B41J2/14072;;B41J2/15,B41J2/05;;B41J2/15,,0,0,,,,EXPIRED
465,CA,A1,CA 2269816 A1,023-442-545-792-97X,1998-04-30,1998,CA 2269816 A,1997-10-23,US 73646996 A;;US 73609396 A;;US 73896496 A;;US 88960797 A;;US 94677097 A;;US 94729997 A;;US 94707697 A;;US 95118597 A;;US 9718852 W,1996-10-24,COMPOSITIONS FOR REDUCING ODOR ON SKIN,"The present invention relates to an aqueous odor-absorbing composition which is safe for use on human skin comprising from about 0.1 % to about 5 %, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from about 0.5 % to about 30 %, by weight of the composition, of a linear dimethicone having a nominal viscosity of 350 centistokes or less; and an aqueous carrier. The compositions can also comprise one or more of the following optional components: low molecular weight polyols; water-soluble antimicrobial preservatives; zinc salts; water-soluble polymers; soluble carbonate and/or bicarbonate salts; chelating agents; zeolites; activated carbon; and mixtures thereof. The present invention also relates the use of the aforementioned compositions in reducing body, vaginal, and or environmental odors on skin. The composition can be applied directly as a spray, poured from a bottle and applied by hand, or applied via a wipe.",PROCTER & GAMBLE,TRINH TOAN;;BUCKNER ROBIN YAGER;;DODD MICHAEL THOMAS;;KAJS THERESA MARIE;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE,,https://lens.org/023-442-545-792-97X,Patent Application,no,0,0,15,24,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61K8/891;;A61Q15/00;;A61K8/73;;A61Q15/00,A61K8/02;;A61K8/04;;A61K8/27;;A61K8/44;;A61K8/73;;A61K8/891;;A61Q15/00,,0,0,,,,DISCONTINUED
466,NO,D0,NO 991897 D0,016-832-028-813-218,1999-04-21,1999,NO 991897 A,1999-04-21,US 73647096 A;;US 73647196 A;;US 94707597 A;;US 95118497 A;;US 9718954 W,1996-10-24,FremgangsmÕter og blandinger for Õ nedsette kroppslukt,"The present invention relates to an odor absorbing composition, which is safe for use on human skin, comprising from 0.1 % to 5 %, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from 0.1 % to 36 %, by weight of the composition, of an oil phase selected from the group consisting of emollients, moisturizers, and skin protectants; an emulsifier; and an aqueous carrier. The odor absorbing compositions of the present invention may also contain an effective amount of hydrophobic antimicrobials. The present invention also relates to the use of cyclodextrin-containing compositions for the manufacture of an odor absorbing composition, which is safe for use on skin, for controlling environmental malodors on skin and for reducing body odor and/or vaginal odor.",PROCTER & GAMBLE,TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/016-832-028-813-218,Patent Application,no,0,0,24,28,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61Q15/00;;D06M13/005;;A61K8/73;;A61Q15/00,A61K8/02;;A61K8/00;;A61K8/04;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/44;;A61K8/73;;A61Q15/00;;D06M13/00,,0,0,,,,DISCONTINUED
467,AU,A,AU 1998/080610 A,055-473-571-199-021,1998-12-30,1998,AU 1998/080610 A,1998-06-08,US 87185497 A;;US 87185797 A;;US 87186097 A;;US 9811787 W,1997-06-09,Perfume-free two phase compositions and methods for reducing body and environmental odor,,PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/055-473-571-199-021,Patent Application,no,0,0,16,18,0,A61K8/19;;A61K8/27;;A61K8/347;;A61K8/37;;A61K8/39;;A61K8/44;;A61K8/4973;;A61K8/738;;A61K8/891;;A61K8/90;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61K8/39;;A61K8/37;;A61K8/90;;A61Q15/00;;A61K8/891;;A61K8/27;;A61K8/44;;A61K8/347;;A61K8/19;;A61K8/738;;A61K8/4973,A47K7/00;;A61K8/00;;A61K8/18;;A61K8/19;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/34;;A61K8/37;;A61K8/44;;A61K8/49;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;C08L83/10,,0,0,,,,DISCONTINUED
468,AU,A1,AU 2016/201883 A1,117-776-876-715-926,2016-04-21,2016,AU 2016/201883 A,2016-03-24,AU 2016/201883 A;;AU 2010/266713 A;;US 49561109 A;;US 49568809 A;;US 49553409 A;;US 49565709 A;;US 2010/0001878 W,2009-06-30,Multi-phasic implant device for the repair or replacement of cartilage tissue,"H:sxd\lnterwoven\NRPortbl\DCC\SXD\9883489 1docx-24/03/2016 Tissue implants prepared for the repair of tissues, especially avascular tissues such as cartilage. One embodiment presents an electric potential capable of receiving and accumulating desirable factors or molecules from surrounding fluid when exposed to dynamic loading. In another embodiment the implant promotes tissue conduction by retarding, restricting and controlling cellular invasion through use of gradients until competent tissue forms. Further embodiments of the tissue implants may be formed into a multi-phasic device that provides deep tissue mechanical stimulus by conduction of mechanical and fluid forces experienced at the surface of the implant. Fig. 3 Fig. 4",KENSEY NASH CORP,CASTIGLIONE-DODD EMME M;;BRADICA GINO;;EBRAHIMI ALI;;RINGEISEN TIMOTHY A;;WATTENGEL WILLIAM CHRISTIAN;;MCDADE ROBERT L,DSM IP ASSETS B.V. (2017-11-02),https://lens.org/117-776-876-715-926,Patent Application,no,0,0,6,12,0,A61F2/28;;A61F2/30756;;A61F2002/30014;;A61F2002/30028;;A61F2002/30031;;A61F2002/30052;;A61F2002/30088;;A61F2002/30332;;A61F2002/3092;;A61F2002/30971;;A61F2002/4495;;A61F2210/008;;A61F2220/0033;;A61F2250/0018;;A61F2250/0043;;A61F2250/0051;;A61F2250/0056;;A61F2310/00365;;A61L27/24;;A61L27/48;;A61L27/50;;A61L27/52;;A61L27/56;;A61L2430/06,A61F2/28;;A61F2/00;;A61F2/30,,0,0,,,,ACTIVE
469,US,B2,US 7157498 B2,099-999-907-698-469,2007-01-02,2007,US 34414604 A,2004-01-16,FR 0010427 A;;FR 0102562 W,2000-08-08,Diamines having a CaSR modulating activity,"The invention concerns diamines of general formula (I), wherein: A represents a group A1 or A2 of general formula (II); B represents a group B1 or B2 of general formula (III); X represents a SO 2 , CH 2 , C═O or COO; Y Z represents a group of formula CH(R25)—CH(R26) or CH(R27)═(R28), and R1 to R28, identical or different, represent independently of one another, a hydrogen or halogen atom or an alkyl, cycloalkyl, CN, NO 2 , hydroxy, aryl, aralkyl, alkoxy, aryloxy, amino, alkylamino, dialkylamino, cycloalkylamino, arylamino, arylalkylamino, diarylamino diarylalkylamino, trihalogenoalkyl or trihalogenoalkoxy group, provided that in the group A1, at least one of the radicals R1, R2, R3, R4 or R5 represents the hydrogen atom when the other four do not represent the hydrogen atom and in the group B1, at least one of the radicals R13, R14, R15, R16 or R17 represents the hydrogen atom when the other four do not represent the hydrogen atom, and their salts with a pharmaceutically acceptable acid, in the form of racemic mixture or their optically pore isomers. The invention also concerns their preparation, pharmaceutical compositions comprising them and their use as CaSR activity modulator and as medicine particularly designed for the treatment of psychological diseases and disorders involving CaSR activity modulation.",CENTRE NAT RECH SCIENT,DAUBAN PHILIPPE MARCEL;;DODD ROBERT HUGH;;FAURE HELENE VERONIQUE;;RUAT MARTIAL;;POTIER PIERRE JEAN-PAUL;;KESSLER ALBANE,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (2003-12-19),https://lens.org/099-999-907-698-469,Granted Patent,yes,10,25,9,9,0,A61P19/10;;A61P29/00;;A61P35/00;;C07C311/29;;C07C311/29;;C07B2200/07;;C07B2200/07;;C07C211/36;;C07C211/36;;C07C311/20;;C07C311/20;;C07C2601/14;;C07C2601/14;;C07D203/26;;C07D203/26,A61K31/18;;A61P19/10;;A61P29/00;;A61P35/00;;C07B53/00;;C07B55/00;;C07C209/60;;C07C211/36;;C07C303/00;;C07C303/40;;C07C311/20;;C07C311/29;;C07D203/26,514/602;;564/84,21,21,004-752-590-588-841;;027-230-470-821-73X;;025-738-507-876-844;;031-780-820-022-390;;006-374-663-346-34X;;080-106-548-907-87X;;034-674-846-789-178;;067-739-378-974-664;;095-490-749-475-288;;013-717-031-758-659;;031-816-227-505-983;;034-610-992-769-789;;016-159-301-798-016;;018-469-980-911-127;;036-473-270-821-164;;067-172-220-793-586;;098-127-415-391-554;;074-856-483-758-679;;094-439-806-281-288;;018-469-980-911-127;;016-159-301-798-016,10.1046/j.1523-1755.1998.00735.x;;9453023;;8255296;;10.1038/366575a0;;9509247;;10.1146/annurev.med.49.1.15;;8854047;;10.1210/edrv-17-4-289;;10.1210/er.17.4.289;;10.1006/bbrc.1997.7401;;9325183;;10.1002/hlca.19970800407;;10.1016/s1043-2760(98)00119-2;;10322397;;pmc19959;;9520489;;10.1073/pnas.95.7.4040;;7874174;;10.1038/ng1194-303;;07874174;;07916660;;10.1016/0092-8674(93)90617-y;;7916660;;10.1073/pnas.92.8.3161;;7724534;;pmc42125;;10.1074/jbc.271.11.5972;;8626377;;10.1002/ardp.19933260711;;10.1016/s0957-4166(00)80266-9;;10.1056/nejm199711203372104;;9366582;;10.1016/s0040-4039(97)01589-x;;10.1046/j.1523-1755.1998.00782.x;;9461105;;10.1172/jci119851;;pmc508509;;9399943;;9067864;;10.1002/(sici)1097-4547(19970301)47:5<547::aid-jnr10>3.0.co;2-v;;10.1016/s0957-4166(00)80266-9;;10.1002/ardp.19933260711,"Antonsen et al., ""A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure"", Kidney International, 1998, pp. 223-227, vol. 53, The International Society of Nephrology.;;Brown, ""Cloning and characterization of an extracellular Ca<SUP>2+</SUP>-sensing receptor from bovine parathyroid"", Nature, Dec. 9, 1993, pp. 575-580, vol. 366.;;Brown, ""The extracellular calcium sensing receptor: Its Role in Health and Disease"", Annu. Rev. Med., 1998, vol. 49, pp. 15-29, Annual Reviews, Inc.;;Chattopadhyay et al., ""The Calcium-Sensing Receptor: A Window into the Physiology and Pathophysiology of Mineral Ion Metabolism"", Endocrine Reviews, 1996, vol. 17, No. 4, pp. 289-307, The Endocrine Society, USA.;;Ferry et al., ""Effects of divalent Cations and of a Calcimimetic on Adrenocorticotropic Hormone Release in Pituitary Tumor Cells"", Biomedical and Biophysical Research Communication, 1997, pp. 866-873, vol. 238, No. 3, Academic Press.;;Nageli et al., ""81, Rhodium(II)-Catalyzed CH Insertions with {[(4-Nitrophenyl)sufonyl]imino}phenyl-lambda<SUP>3</SUP>-iodane,"" Helvetica Chimica Acta, Jun. 30, 1997, pp. 1087-1105, vol. 80, No. 4, Verlag Helvetica Chimica Acta, Bale, CH.;;Nemeth et al., ""Calcimimetic Compounds: a Direct Approach to Controlling Plasma Levels of Parathyroid Hormone in Hyperparathyroidism"", TEM, 1999, vol. 10, No. 2, pp. 66-71, Elsevier Science.;;Nemeth et al., ""Calcimimetics with potent and selective activity on the parathyroid calcium receptor"", Proc. Natl. Acad. Sci., Mar. 1998, pp. 4040-4045, vol. 95, Pharmacology, USA.;;Pollak et al., ""Autosomal dominant hypocalcaemia caused by a Ca<SUP>2+</SUP>-sensing receptor gene mutation"", Nature Genetics, Nov. 1994, pp. 303-307, vol. 8.;;Pollak et al., ""Mutations in the Human Ca<SUP>2+</SUP> -sensing Receptor Gene Cause Familial Hypocalciuric Hypercalcemia and Neanatal Severe Hyperparathyroidism"", Cell, Dec. 31, 1993, pp. 1297-1303, vol. 75, Cell Press.;;Ruat et al., ""Calcium sensing receptor: Molecular cloning in rat and localization to nerve terminals"", Proc. Natl. Acad. Sci., Apr. 1995, pp. 3161-3165, vol. 92, Neurobiology, USA.;;Ruat et al., ""Cloned and Expressed Rat Ca<SUP>2+</SUP> -sensing Receptor"", The Journal of Biological Chemistry, Mar. 15, 1996, pp. 5972-5975, vol. 271, No. 11, The American Society for Biochemistry and Molecular Biology, Inc., USA.;;Schlichter et al., ""Asymmetric Reductive Amination of Cycloalkanones, XIII: Enantioselective Amidoamination: A New Regiospecific Strategy for the Synthesis of Chiral Cyclohexane-1,2-diamino-Derivatives,"" Arch. Pharm., 1993, vol. 326, No. 7, pp. 429-436, VCH Verlagsgesellschaft, Weinheim, DE.;;Schlichter et al., ""Novel,Enantioselective Synthesis of Vicinal Cyclohexane-Diamines as Key-Intermediates for Highly Selective Opioid Kappa and Sigma Agonists,"" Tetrahedron: Asymmetry, 1992, pp. 3289-3333, vol. 3, No. 3, Elsevier Science Publishers, Amsterdam, NL.;;Silverberg et al., ""Short term inhibition of parathyroid hormone secretion by a calcium receptor agonist in patients with primary hyperparathyroidism"", New England Journal of Medicine, Nov. 20, 1997, pp. 1506-1510, vol. 337, No. 21.;;Sodergren et al., ""Preparation and Evaluation of Nitrene Precursors (Phl=NSO<SUB>2</SUB>Ar) for the Copper-Catalyzed Aziridination of Olefins,"" Tetrahedron Letters, Sep. 29, 1997, pp. 6897-6900, vol. 38, No. 39, Elsevier Science Publishers, Amsterdam, NL.;;Wada et al., ""NPS R-568 halts or reverses osteitis fibrosa in uremic rats"", Kidney International, 1998, pp. 448-453, vol. 53, The International Society of Nephrology.;;Wada et al., ""The calcimimetic Compound NPS R-568 suppresses Parathyroid Cell Proliferation in Rats with Renal Insufficiency"", J. Clin. Invest., pp. 2977-2983, vol. 100, No. 12, The American Society for Clinical Investigation, Inc.;;Ye et al., ""Amyloid-B Proteins Activate Ca<SUP>2+</SUP>-Permeable Channels Through Calcium-Sensing Receptors"", Journal of Neuroscience Research, 1997, pp. 547-554, vol. 47, Wiley-Liss, Inc.;;W. H. Schlichter et al.; ""Novel enantioselective synthesis of vicinal cyclohexanediamines as key-intermediates for highly selective opioid kappa and sigma agonists"", Tetrahedron: Asymmetry, vol. 3, No. 3, 1992, pp. 329-333, Elsevier Science Publishers, Amsterdan, NL.;;W. H. Schlichter et al., ""Asymmetric reductive animation of cycloakanones, XIII. Enantioselective amidoamination: a new regiospecific strategy for the synthesis of chiral cyclohexane-1,2-diamino-derivatives"", Archive Der Pharmazie, vol. 326, No. 7, 1993, pp. 429-436, VCH Verlagsgesellschaft, Weinheim, DE.",EXPIRED
470,US,A,US 5871718 A,170-628-535-688-824,1999-02-16,1999,US 87185397 A,1997-06-09,US 87185397 A,1997-06-09,Perfumed two phase compositions for reducing body odor,"The present invention relates to an odor absorbing composition, which is safe for use on skin, comprising from about 0.1% to about 5%, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from about 0.1% to about 36%, by weight of the composition, of an oil phase selected from the group consisting of emollients, moisturizers, skin protectants, and mixtures thereof; one or more surfactants; from about 0.004% to about 2%, by weight of the composition, of a perfume composition; and an aqueous carrier. The odor absorbing compositions of the present invention may also, preferably, contain an effective amount of hydrophobic antimicrobials. The present invention also relates to the odor absorbing compositions deposited on a flexible dispensing means.",PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;BARTOLO ROBERT GREGORY;;DODD MICHAEL THOMAS;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,PROCTER & GAMBLE COMPANY THE (1997-06-09),https://lens.org/170-628-535-688-824,Granted Patent,yes,33,32,1,21,0,A61Q15/00;;A61Q15/00;;A61K8/0208;;A61K8/0208;;A61K8/19;;A61K8/19;;A61K8/27;;A61K8/27;;A61K8/347;;A61K8/347;;A61K8/37;;A61K8/37;;A61K8/44;;A61K8/44;;A61K8/4973;;A61K8/4973;;A61K8/738;;A61K8/738;;A61K8/891;;A61K8/891;;A61K8/90;;A61K8/90;;A61Q13/00;;A61Q13/00,A61K8/02;;A61K8/19;;A61K8/27;;A61K8/34;;A61K8/37;;A61K8/44;;A61K8/49;;A61K8/73;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00,424/65;;422/5;;424/67;;424/69;;424/76.1;;424/76.2;;424/76.21;;424/76.4;;424/76.8;;424/78.03;;424/405;;424/642;;424/715;;424/717,30,0,,,"H. Matsuda, et al., Application of 2 Hydroxypropyl Cyclodextrin to Perfumes and Cosmetics , The 7th International Cyclodextrins Symposium, Tokyo, Japan, Apr. 25 28, 1994, pp. 516 519.;;Hashimoto, H., Studies on the Industrial Production and Application of Cyclodextrins , Starch Science, vol. 36, No. 1 (1989), pp. 35 42.;;U.S. application No. 08/736,469, Trinh et al., filed Oct. 24, 1996.;;U.S. application No. 08/736,093, Trinh et al., filed Oct. 24, 1996.;;U.S. application No. 08/889607, Trinh et al., filed Jul. 8, 1997.;;U.S. application No. 08/738,471, Lucas et al., filed Oct. 24, 1996.;;U.S. application No. 08/736,470, Lucas et al., filed Oct. 24, 1996.;;U.S. application No. 08/736,964, Dodd et al., filed Oct. 24, 1996.;;U.S. application No. 08/736,838, Peterson et al., filed Oct. 28, 1996.;;U.S. application No. 08/739,091, Peterson et al., filed Oct. 28, 1996.;;U.S. application No. 08/871,166, Lucas et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,854, Lucas et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,791, Dodd et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,855, Trinh et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,857, Lucas et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,790, Peterson et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,856, Peterson et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,858, Lucas et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,577, Lucas et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,860 Lucas et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,861, Peterson et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,092, Peterson et al., filed Jun. 9, 1997.;;U.S. application No. 08/289,732, Trinh et al., filed Aug. 12, 1994.;;U.S. application No. 08/289,733, Trinh et al., filed Aug. 12, 1994.;;U.S. application No. 08/289,734, Cappel et al., filed Aug. 12, 1994.;;U.S. application No. 08/289,735, Cappel et al., filed Aug. 12, 1994.;;U.S. application No. 08/289,969, Pilosof et al., filed Aug. 12, 1994.;;U.S. application No. 08/871,576, Woo et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,119, Woo et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,042, Woo et al., filed Jun. 9, 1997.",EXPIRED
471,EP,A1,EP 1409453 A1,195-600-938-047-952,2004-04-21,2004,EP 01963065 A,2001-08-07,FR 0102562 W;;FR 0010427 A,2000-08-08,NOVEL DIAMINES HAVING A CASR MODULATING ACTIVITY,,CENTRE NAT RECH SCIENT,DAUBAN PHILIPPE MARCEL;;DODD ROBERT HUGH;;FAURE HELENE VERONIQUE;;RUAT MARTIAL;;POTIER PIERRE JEAN-PAUL;;KESSLER ALBANE,,https://lens.org/195-600-938-047-952,Patent Application,yes,0,0,9,9,0,A61P19/10;;A61P29/00;;A61P35/00;;C07C311/29;;C07C311/29;;C07B2200/07;;C07B2200/07;;C07C211/36;;C07C211/36;;C07C311/20;;C07C311/20;;C07C2601/14;;C07C2601/14;;C07D203/26;;C07D203/26,A61P19/10;;A61K31/18;;A61P29/00;;A61P35/00;;C07B53/00;;C07B55/00;;C07C209/60;;C07C211/36;;C07C303/40;;C07C311/20;;C07C311/29;;C07D203/26,,1,0,,,See references of WO 0212181A1,DISCONTINUED
472,KR,A,KR 20000052768 A,198-361-968-786-696,2000-08-25,2000,KR 19997003576 A,1999-04-23,US 73647196 A;;US 73647096 A;;US 94707597 A;;US 95118497 A,1996-10-24,METHODS AND COMPOSITIONS FOR REDUCING BODY ODOR,"PURPOSE: A cyclodextrin-containing composition for the manufacture of an odor absorbing composition is provided, which is safe for use on skin, for controlling environmental malodors on skin and for reducing body odor and/or vaginal odor. CONSTITUTION: An aqueous odor absorbing composition comprises: a) from 0.1% to 5%, by weight of the composition, of solubilized, water soluble, uncomplexed cyclodextrin; b) an aqueous carrier; c) from 0.1% to 36%, by weight of the composition, of an oil phase selected from the group consisting of emollients, moisturizers, and skin protectants; and d. an emulsifier; and wherein the composition is safe for use on human skin.",PROCTER & GAMBLE,TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/198-361-968-786-696,Patent Application,no,0,0,24,28,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61Q15/00;;D06M13/005;;A61K8/73;;A61Q15/00,A61K8/02;;A61K8/00;;A61K8/04;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/44;;A61K8/73;;A61Q15/00;;D06M13/00,,0,0,,,,EXPIRED
473,WO,A1,WO 1991/007683 A1,074-274-279-522-28X,1991-05-30,1991,US 9006338 W,1990-10-31,US 43375789 A,1989-11-09,SPECIMEN REVIEW STATION,"A specimen review station (50) includes a vibration isolation table (64) that supports storage (80) and transportation (82, 84) equipments for a semiconductor wafer (54) and an optical system (58) for viewing microscopic regions of the patterned surface of the wafer. The optical system (58) includes an image extender (88) that enables an operator sitting on an adjustable chair (107) to view the wafer from a distance, thereby facilitating remote transportation and inspection of relatively large diameter wafers and reducing operator contamination of the wafer. An operator table (66) supports control equipments (96, 98, 100), which the operator uses to control the functions of the specimen review station. The vibration isolation table and the operator table are spatially isolated from each other in that they are connected only by the floor (70) that supports both of them. The vibration isolation table is, therefore, affected by neither floor vibrations resulting from normal building movement associated with manufacturing operations nor operator contact with the operator table.",INSYSTEMS INC,PAUL DAVID C;;CAVAN DANIEL L;;DODD BRIAN P;;GRAVES RICHARD E;;HOWE ROBERT B;;LAU ROBERT SHIN-SHUN;;LIN LAWRENCE H,,https://lens.org/074-274-279-522-28X,Patent Application,yes,4,17,1,1,0,G01N21/8803;;H01L21/67271,G01N21/88;;H01L21/00,H1K KMB           MB,3,0,,,"REFERENCE KLA-2600, Review Station, ""Product Description"", KLA Instruments Corporation, pages 1-4, 09 December 1988.;;INFORMATION BULLETIN, 517 Scanning Stage System, E. LEITZ, INC., pages 1-7, 01 January 1985.;;""Nikon Opstitation Model 2 & 2A Wafer Inspection System"", NIKON OPSTITATION, pages 1-6, October 1984.",PENDING
474,KR,A,KR 20010013611 A,010-829-648-273-018,2001-02-26,2001,KR 19997011621 A,1998-06-08,US 87185497 A;;US 87185797 A;;US 87186097 A;;US 9811787 W,1997-06-09,PERFUME-FREE TWO PHASE COMPOSITIONS AND METHODS FOR REDUCING BODY AND ENVIRONMENTAL ODOR,"The present invention relates to an aqueous odor-absorbing composition which is safe for use on human skin comprising solubilized, water-soluble, uncomplexed cyclodextrin; an oil phase selected from the group consisting of emollients, moisturizers, skin protectants, and mixtures thereof; one or more surfactants each having hydrophilic/lipophilic balance of about 8-18, and wherein each surfactant, when combined with an aqueous cyclodextrin solution, provides no less than about 25 % a level of odor capture as an aqueous cyclodextrin solution; and an aqueous carrier. The present invention also encompasses methods of controlling body and environmental odors on skin comprising the application to skin of these compositions.",PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/010-829-648-273-018,Patent Application,no,0,0,16,18,0,A61K8/19;;A61K8/27;;A61K8/347;;A61K8/37;;A61K8/39;;A61K8/44;;A61K8/4973;;A61K8/738;;A61K8/891;;A61K8/90;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61K8/39;;A61K8/37;;A61K8/90;;A61Q15/00;;A61K8/891;;A61K8/27;;A61K8/44;;A61K8/347;;A61K8/19;;A61K8/738;;A61K8/4973,A47K7/00;;A61K8/00;;A61K8/18;;A61K8/19;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/34;;A61K8/37;;A61K8/44;;A61K8/49;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;C08L83/10,,0,0,,,,DISCONTINUED
475,AU,A,AU 1986/066751 A,028-485-389-741-67X,1987-06-25,1987,AU 1986/066751 A,1986-12-19,US 81123385 A,1985-12-20,"SUBSTITUTED 5,6-DIALKOXYQUINAZOLINE DERIVATIVES",,ORTHO PHARMA CORP,BANDURCO VICTOR T;;TOBIA ALFONSO J;;BELL STANLEY C;;DODD JOHN H;;FALOTICO ROBERT;;SCHWENDER CHARLES F,,https://lens.org/028-485-389-741-67X,Patent Application,no,0,1,8,8,0,C07D239/95;;A61P9/04;;C07D239/95,C07D239/84;;A61K31/505;;A61K31/517;;A61P9/04;;C07D239/88;;C07D239/90;;C07D239/95,,0,0,,,,DISCONTINUED
476,DK,A,DK 615186 A,037-325-642-915-885,1987-06-21,1987,DK 615186 A,1986-12-18,US 81123385 A,1985-12-20,"SUBSTITUEREDE 5,6-DIALKOXYQUINAZOLINDERIVATER",,ORTHO PHARMA CORP,BANDURCO VICTOR T;;BELL STANLEY C;;DODD JOHN H;;FALOTICO ROBERT;;SCHWENDER CHARLES F;;TOBIA ALFONSO J,,https://lens.org/037-325-642-915-885,Patent Application,no,0,0,8,8,0,C07D239/95;;A61P9/04;;C07D239/95,A61K31/505;;A61K31/517;;A61P9/04;;C07D239/88;;C07D239/84;;C07D239/90;;C07D239/95,,0,0,,,,DISCONTINUED
477,CA,A1,CA 2766913 A1,090-362-572-676-827,2011-01-06,2011,CA 2766913 A,2010-06-30,US 49568809 A;;US 49565709 A;;US 49561109 A;;US 49553409 A;;US 2010/0001878 W,2009-06-30,MULTI-PHASIC IMPLANT DEVICE FOR THE REPAIR OR REPLACEMENT OF CARTILAGE TISSUE,"Tissue implants prepared for the repair of tissues, especially avascular tissues such as cartilage. One embodiment presents an electric potential capable of receiving and accumulating desirable factors or molecules from surrounding fluid when exposed to dynamic loading. In another embodiment the implant promotes tissue conduction by retarding, restricting and controlling cellular invasion through use of gradients until competent tissue forms. Further embodiments of the tissue implants may be formed into a multi-phasic device that provides deep tissue mechanical stimulus by conduction of mechanical and fluid forces experienced at the surface of the implant.",KENSEY NASH CORP,CASTIGLIONE-DODD EMME M;;BRADICA GINO;;EBRAHIMI ALI;;RINGEISEN TIMOTHY A;;WATTENGEL WILLIAM CHRISTIAN;;MCDADE ROBERT L,,https://lens.org/090-362-572-676-827,Patent Application,no,0,0,6,12,0,A61F2/28;;A61F2/30756;;A61F2002/30014;;A61F2002/30028;;A61F2002/30031;;A61F2002/30052;;A61F2002/30088;;A61F2002/30332;;A61F2002/3092;;A61F2002/30971;;A61F2002/4495;;A61F2210/008;;A61F2220/0033;;A61F2250/0018;;A61F2250/0043;;A61F2250/0051;;A61F2250/0056;;A61F2310/00365;;A61L27/24;;A61L27/48;;A61L27/50;;A61L27/52;;A61L27/56;;A61L2430/06,A61F2/28;;A61F2/00;;A61F2/30,,0,0,,,,DISCONTINUED
478,AU,B2,AU 721891 B2,161-335-809-647-97X,2000-07-13,2000,AU 1997/049108 A,1997-10-23,US 73647196 A;;US 73647096 A;;US 94707597 A;;US 95118497 A;;US 9718954 W,1996-10-24,Methods and compositions for reducing body odor,"The present invention relates to an odor absorbing composition, which is safe for use on human skin, comprising from 0.1 % to 5 %, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from 0.1 % to 36 %, by weight of the composition, of an oil phase selected from the group consisting of emollients, moisturizers, and skin protectants; an emulsifier; and an aqueous carrier. The odor absorbing compositions of the present invention may also contain an effective amount of hydrophobic antimicrobials. The present invention also relates to the use of cyclodextrin-containing compositions for the manufacture of an odor absorbing composition, which is safe for use on skin, for controlling environmental malodors on skin and for reducing body odor and/or vaginal odor.",PROCTER & GAMBLE,TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/161-335-809-647-97X,Granted Patent,no,0,0,24,28,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61Q15/00;;D06M13/005;;A61K8/73;;A61Q15/00,A61K8/00;;A61K8/02;;A61K8/04;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/44;;A61K8/73;;A61Q15/00;;D06M13/00,,0,0,,,,EXPIRED
479,TR,T2,TR 199903040 T2,160-544-842-460-300,2000-06-21,2000,TR 9903040 T,1998-06-08,US 87157797 A;;US 87185397 A;;US 87185597 A;;US 87185897 A,1997-06-09,Vücut kokusunun düsürülmesi için parfümlü bir ve iki fazli bilesimler ve bu bilesimlerin kullanim yöntemleri.,"Bu bulus, koku sogurucu bilesimler ve bunlarin deri üzerinde kullanimina iliskindir. Bilesimler, bilesimin agirligi ile %0.1-5 kadar çözündürülmüs, suda çözünür, komplekslenmemis siklodekstrini; bilesimin agirligi ile %0.004-2 kadar bir parfüm bilesimini; ve bir sulu tasiyici maddeyi içermektedir. Bilesimler, ayni zamanda, ya düsük molekül agirlikli bir dimetikon ya da yumusaticilar, nemlendiriciler, deri koruyucular ve bunlarin karisimlarindan seçilen bir yag fazini ve bir ya da daha çok sürfaktani içerebilmektedir. Bu bulusun koku sogurucu bilesimleri, ayni zamanda, tercihan, suda çözünür ve/veya hidrofobik antimikrobik maddelerin etkili bir miktarini da ihtiva edebilmektedir. Bu bulus, ayni zamanda bir bükülgen dagitma araci üzerinde biriktirilmis koku sogurucu bilesimlere de iliskindir.",PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/160-544-842-460-300,Patent Application,no,0,0,15,21,0,A61K8/0208;;A61K8/19;;A61K8/27;;A61K8/347;;A61K8/37;;A61K8/44;;A61K8/4973;;A61K8/738;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61Q15/00;;A61K8/891;;A61K8/19;;A61K8/347;;A61K8/738;;A61K8/27;;A61K8/44;;A61K8/90;;A61K8/4973;;A61K8/37;;A61K8/0208;;A61Q13/00,A61K8/02;;A61K8/00;;A61K8/19;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/34;;A61K8/37;;A61K8/44;;A61K8/49;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;A61Q19/00;;C08L83/04;;C08L83/12,,0,0,,,,PENDING
480,EP,A1,EP 0996414 A1,198-533-665-305-910,2000-05-03,2000,EP 98926415 A,1998-06-08,US 9811814 W;;US 87157797 A;;US 87185397 A;;US 87185597 A;;US 87185897 A,1997-06-09,PERFUMED ONE AND TWO PHASE COMPOSITIONS FOR REDUCING BODY ODOR AND METHODS OF USE THEREOF,,PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/198-533-665-305-910,Patent Application,yes,0,0,15,21,0,A61K8/0208;;A61K8/19;;A61K8/27;;A61K8/347;;A61K8/37;;A61K8/44;;A61K8/4973;;A61K8/738;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61Q15/00;;A61K8/891;;A61K8/19;;A61K8/347;;A61K8/738;;A61K8/27;;A61K8/44;;A61K8/90;;A61K8/4973;;A61K8/37;;A61K8/0208;;A61Q13/00,A61K8/00;;A61K8/02;;A61K8/19;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/34;;A61K8/37;;A61K8/44;;A61K8/49;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;A61Q19/00;;C08L83/04;;C08L83/12,,0,0,,,,DISCONTINUED
481,WO,A1,WO 1998/056342 A1,006-553-446-339-200,1998-12-17,1998,US 9811814 W,1998-06-08,US 87157797 A;;US 87185397 A;;US 87185597 A;;US 87185897 A,1997-06-09,PERFUMED ONE AND TWO PHASE COMPOSITIONS FOR REDUCING BODY ODOR AND METHODS OF USE THEREOF,"The present invention relates to odor absorbing compositions and their use on skin. The compositions comprise from about 0.1 % to about 5 % by weight of the compositions, of solubilized, water-soluble, uncomplexed cyclodextrin; from about 0.004 % to about 2 % by weight of the composition, of a perfume composition; and an aqueous carrier. The compositions may also comprise either a low molecular weight dimethicone or an oil phase selected from the group consisting of emollients, moisturizers, skin protectants, and mixtures thereof and one or more surfactants. The odor absorbing compositions of the present invention may also, preferably, contain an effective amount of water soluble and/or hydrophobic antimicrobials. The present invention also relates to the odor absorbing compositions deposited on a flexible dispensing means.",PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/006-553-446-339-200,Patent Application,yes,2,14,15,21,0,A61K8/0208;;A61K8/19;;A61K8/27;;A61K8/347;;A61K8/37;;A61K8/44;;A61K8/4973;;A61K8/738;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61Q15/00;;A61K8/891;;A61K8/19;;A61K8/347;;A61K8/738;;A61K8/27;;A61K8/44;;A61K8/90;;A61K8/4973;;A61K8/37;;A61K8/0208;;A61Q13/00,A61K8/02;;A61K8/00;;A61K8/19;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/34;;A61K8/37;;A61K8/44;;A61K8/49;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;A61Q19/00;;C08L83/04;;C08L83/12,,1,1,117-288-143-743-628,10.1002/star.19820341106,"SZETLI: ""CYCLODEXTRINS IN FOOD, COSMETICS AND TOILETRIES"", STÄRKE, vol. 34, no. 11, November 1982 (1982-11-01), WEINHEIM, DEUTSCHLAND, pages 382, XP002079065",PATENTED
482,HU,A2,HU P0002940 A2,004-455-498-909-787,2000-12-28,2000,HU P0002940 A,1997-10-23,US 95118497 A,1997-10-15,METHODS AND COMPOSITIONS FOR REDUCING BODY ODOR,"An aqueous odour absorbing composition (I), which is safe for use on human skin, comprises: (a) 0.1-5 wt.% solubilized, water-soluble, uncomplexed cyclodextrin; (b) an aqueous carrier; (c) 0.1-36 wt.% oil phase consisting of emollient, moisturiser and/or skin protectant; and (d) an emulsifier. Also claimed are: (1) use of (I) in manufacture of a composition for controlling environmental malodours and reducing body and/or vaginal odour; (2) production of an aqueous odour absorbing composition by mixing an emulsifier, an oil phase and an aqueous phase until homogeneous, and adding and dissolving cyclodextrin in the mixture.",The Procter & Gamble Co.,BARTOLO ROBERT GREGORY;;BUCKNER ROBIN YAGER;;DODD MICHAEL THOMAS;;KAJS THERESA MARIE;;LUCAS JULIET MARIE;;TRINH TOAN,,https://lens.org/004-455-498-909-787,Patent Application,no,0,0,2,28,0,,D06M15/03,,0,0,,,,PENDING
483,WO,A1,WO 1998/017240 A1,026-151-563-259-369,1998-04-30,1998,US 9718954 W,1997-10-23,US 73647196 A;;US 73647096 A;;US 94707597 A;;US 95118497 A,1996-10-24,METHODS AND COMPOSITIONS FOR REDUCING BODY ODOR,"The present invention relates to an odor absorbing composition, which is safe for use on human skin, comprising from 0.1 % to 5 %, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from 0.1 % to 36 %, by weight of the composition, of an oil phase selected from the group consisting of emollients, moisturizers, and skin protectants; an emulsifier; and an aqueous carrier. The odor absorbing compositions of the present invention may also contain an effective amount of hydrophobic antimicrobials. The present invention also relates to the use of cyclodextrin-containing compositions for the manufacture of an odor absorbing composition, which is safe for use on skin, for controlling environmental malodors on skin and for reducing body odor and/or vaginal odor.",PROCTER & GAMBLE,TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/026-151-563-259-369,Patent Application,yes,4,19,24,28,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61Q15/00;;D06M13/005;;A61K8/73;;A61Q15/00,A61K8/02;;A61K8/04;;A61K8/25;;A61K8/00;;A61K8/27;;A61K8/33;;A61K8/44;;A61K8/73;;A61Q15/00;;D06M13/00,,3,0,,,"DATABASE WPI Week 9241, Derwent World Patents Index; AN 92-334323, XP002059643;;DATABASE WPI Week 9331, Derwent World Patents Index; AN 93-249225, XP002059644;;STN, File Supplier, Karlsruhe, DE, File",PATENTED
484,CZ,A3,CZ 441099 A3,040-795-080-518-62X,2000-05-17,2000,CZ 441099 A,1998-06-08,CZ 441099 A,1998-06-08,"Bad smell absorbing preparation, process of its preparation, bad smell reducing method and cleansing agent",,PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/040-795-080-518-62X,Patent Application,no,0,0,1,1,0,,A61K8/19;;A61K8/27;;A61K8/34;;A61K8/37;;A61K8/44;;A61K8/49;;A61K8/73;;A61K8/891;;A61K8/90;;A61Q15/00,,0,0,,,,PENDING
485,AU,B2,AU 733865 B2,062-033-786-359-509,2001-05-31,2001,AU 1998/078259 A,1998-06-08,US 87157797 A;;US 87185397 A;;US 87185597 A;;US 87185897 A;;US 9811814 W,1997-06-09,Perfumed one and two phase compositions for reducing body odor and methods of use thereof,,PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/062-033-786-359-509,Granted Patent,no,1,0,15,21,0,A61K8/0208;;A61K8/19;;A61K8/27;;A61K8/347;;A61K8/37;;A61K8/44;;A61K8/4973;;A61K8/738;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61Q15/00;;A61K8/891;;A61K8/19;;A61K8/347;;A61K8/738;;A61K8/27;;A61K8/44;;A61K8/90;;A61K8/4973;;A61K8/37;;A61K8/0208;;A61Q13/00,A61K8/00;;A61K8/02;;A61K8/19;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/34;;A61K8/37;;A61K8/44;;A61K8/49;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;A61Q19/00;;C08L83/04;;C08L83/12,,0,0,,,,EXPIRED
486,HU,A2,HU P0003421 A2,074-252-877-768-709,2001-02-28,2001,HU P0003421 A,1998-06-08,US 87185497 A;;US 87185797 A;;US 87186097 A,1997-06-09,PERFUME-FREE TWO PHASE COMPOSITIONS AND METHODS FOR REDUCING BODY AND ENVIRONMENTAL ODOR,"A találmány tárgyát vizes szagelnyelő készítmény képezi, amely emberibőrre nézve biztonságos, és amely 0,1-5 t% szolubilizált, vízbenoldható, nem komplex ciklodextrint, 0,1-36 t% olajos fázist (puhítószert, nedvesítőszert, bőrvédő anyagot) tartalmaz, valamint egy vagytöbb felületaktív anyagot, amelyek hidrofil/lipofil egyensúlya 8-18. Afelületaktív anyagok mindegyike vizes ciklodextrinoldattal kombinálvalegalább 25% szagmegkötési szintet nyújt a vizes ciklodextrinoldatban.A készítmény vizes hordozót is magába foglal. Ó",PROCTER & GAMBLE,BARTOLO ROBERT GREGORY;;BUCKNER ROBIN YAGER;;DODD MICHAEL THOMAS;;KAJS THERESA MARIE;;LUCAS JULIET MARIE;;TRINH TOAN,,https://lens.org/074-252-877-768-709,Patent Application,no,0,0,16,18,0,A61K8/19;;A61K8/27;;A61K8/347;;A61K8/37;;A61K8/39;;A61K8/44;;A61K8/4973;;A61K8/738;;A61K8/891;;A61K8/90;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61K8/39;;A61K8/37;;A61K8/90;;A61Q15/00;;A61K8/891;;A61K8/27;;A61K8/44;;A61K8/347;;A61K8/19;;A61K8/738;;A61K8/4973,A61K8/00;;A61K8/18;;A47K7/00;;A61K8/19;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/34;;A61K8/37;;A61K8/44;;A61K8/49;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;C08L83/10,,0,0,,,,PENDING
487,EP,A1,EP 1006993 A1,156-737-036-389-497,2000-06-14,2000,EP 97911821 A,1997-10-23,US 9718954 W;;US 73647196 A;;US 73647096 A;;US 94707597 A;;US 95118497 A,1996-10-24,METHODS AND COMPOSITIONS FOR REDUCING BODY ODOR,"The present invention relates to an odor absorbing composition, which is safe for use on human skin, comprising from 0.1 % to 5 %, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from 0.1 % to 36 %, by weight of the composition, of an oil phase selected from the group consisting of emollients, moisturizers, and skin protectants; an emulsifier; and an aqueous carrier. The odor absorbing compositions of the present invention may also contain an effective amount of hydrophobic antimicrobials. The present invention also relates to the use of cyclodextrin-containing compositions for the manufacture of an odor absorbing composition, which is safe for use on skin, for controlling environmental malodors on skin and for reducing body odor and/or vaginal odor.",PROCTER & GAMBLE,TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/156-737-036-389-497,Patent Application,yes,0,2,24,28,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61Q15/00;;D06M13/005;;A61K8/73;;A61Q15/00,A61K8/00;;A61K8/02;;A61K8/04;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/44;;A61K8/73;;A61Q15/00;;D06M13/00,,0,0,,,,EXPIRED
488,NO,L,NO 996054 L,154-534-422-616-560,2000-02-04,2000,NO 996054 A,1999-12-08,US 87185497 A;;US 87185797 A;;US 87186097 A;;US 9811787 W,1997-06-09,Parfymefrie to-fase blandinger og fremgangsmåter for å redusere kropps- og omgivelseslukt,"Foreliggende oppfinnelse gjelder en vandig luktabsorberende blanding som er sikker til bruk på menneskelig hud, omfattende løseliggjort, vannløselig, ikke-komplekst syklo- dekstrin; en oljefase valgt fra gruppen bestående av myk- gjørere, fuktemidler, hudbeskyttende midler, og blandinger av disse; et eller flere overflateaktive stoff som hver har en hydrofil/ lipofil balanse på ca 8-18, og hvori hvert overflateaktivt stoff, når det kombineres med en vandig syklodekstrinløsning, gir ikke mindre enn 25% av luktfang- sten som en vandig syklodekstrin og en vandig bærer. Fore- liggende oppfinnelse innbefatter også metoder til å kontrollere kroppslukt og omgivende lukt på huden og omfatter appliseringen på huden av disse blandingene.",PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/154-534-422-616-560,Abstract,no,0,0,16,18,0,A61K8/19;;A61K8/27;;A61K8/347;;A61K8/37;;A61K8/39;;A61K8/44;;A61K8/4973;;A61K8/738;;A61K8/891;;A61K8/90;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61K8/39;;A61K8/37;;A61K8/90;;A61Q15/00;;A61K8/891;;A61K8/27;;A61K8/44;;A61K8/347;;A61K8/19;;A61K8/738;;A61K8/4973,A61K8/00;;A47K7/00;;A61K8/18;;A61K8/19;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/34;;A61K8/37;;A61K8/44;;A61K8/49;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;C08L83/10,,0,0,,,,DISCONTINUED
489,US,A,US 4672116 A,176-384-272-712-641,1987-06-09,1987,US 81123385 A,1985-12-20,US 81123385 A,1985-12-20,"Substituted 5,6-dialkoxyquinazoline derivatives",Quinazoline derivatives having an oxy substituent in 5 and 6 positions are described. The novel quinazoline derivatives are useful as cardiotonic agents.,ORTHO PHARMA CORP,BANDURCO VICTOR T;;BELL STANLEY C;;DODD JOHN H;;FALOTICO ROBERT;;SCHWENDER CHARLES F;;TOBIA ALFONSO J,ORTHO PHARMACEUTICAL CORPORATION (1985-12-18),https://lens.org/176-384-272-712-641,Granted Patent,yes,1,13,8,8,0,C07D239/95;;A61P9/04;;C07D239/95,A61K31/505;;A61K31/517;;C07D239/84;;A61P9/04;;C07D239/88;;C07D239/90;;C07D239/95,544/286;;544/116;;544/119;;544/250;;544/285;;544/287;;544/291;;544/292;;544/293,0,0,,,,EXPIRED
490,AU,A,AU 1997/049108 A,029-221-473-178-290,1998-05-15,1998,AU 1997/049108 A,1997-10-23,US 73647196 A;;US 73647096 A;;US 94707597 A;;US 95118497 A;;US 9718954 W,1996-10-24,Methods and compositions for reducing body odor,,PROCTER & GAMBLE,TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/029-221-473-178-290,Patent Application,no,0,0,24,28,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61Q15/00;;D06M13/005;;A61K8/73;;A61Q15/00,A61K8/00;;A61K8/02;;A61K8/04;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/44;;A61K8/73;;A61Q15/00;;D06M13/00,,0,0,,,,EXPIRED
491,US,A,US 5911976 A,035-244-452-322-715,1999-06-15,1999,US 94729997 A,1997-10-08,US 94729997 A;;US 73609396 A,1996-10-24,Compositions for reducing body odor,"The present invention relates to an aqueous odor-absorbing composition which is safe for use on human skin comprising from about 0.1% to about 5%, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from about 0.5% to about 30%, by weight of the composition, of a linear dimethicone having a nominal viscosity of 350 centistokes or less; from about 0.01% to about 1%, by weight of the composition, of low molecular weight polyols; and an aqueous carrier.",PROCTER & GAMBLE,TRINH TOAN;;BARTOLO ROBERT GREGORY;;DODD MICHAEL THOMAS;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,PROCTER & GAMBLE COMPANY THE (1997-10-28),https://lens.org/035-244-452-322-715,Granted Patent,yes,64,4,1,24,0,A61K8/0208;;A61K8/0208;;A61K8/046;;A61K8/046;;A61K8/27;;A61K8/27;;A61K8/44;;A61K8/44;;A61K8/738;;A61K8/738;;A61K8/891;;A61K8/891;;A61Q15/00;;A61Q15/00,A61K8/02;;A61K8/04;;A61K8/27;;A61K8/44;;A61K8/73;;A61K8/891;;A61Q15/00,424/65;;422/5;;424/67;;424/69;;424/76.1;;424/76.2;;424/76.21;;424/76.4;;424/76.8;;424/78.03;;424/405;;424/642;;424/715;;424/717,14,4,090-441-333-592-541;;014-996-805-444-655;;012-298-624-007-623;;095-848-985-388-657,10.3109/03639049209040853;;10.1080/10610279308035175;;10.1016/0378-5173(93)90178-i;;10.1111/j.2042-7158.1994.tb03775.x;;8027925,"Leyden, Bacteriology of the Human Axilla: Relationship to Axillary Odor , Antiperspirants & Deodorants, 1988, pp. 311 319.;;Lachman, et al., The Theory and Practice of Industrial Pharmacy, 1986, pp. 466 467; 520 522; 458 461.;;Loftsson, T., et al., Interactions Between Preservatives and 2 Hydroxypropyl Cyclodextrin , Drug Development and Industrial Pharmacy, 18(13) (1992), pp. 1477 1484.;;Furuta, T., Effects of Water and Alcohol on the Formation of Inclusion Complexes of d limonene and Cyclodextrins , Supramolecular Chemistry, vol. 1 (1993), pp. 321 325.;;Furuta, T., et al., Formation of Inclusion Complex Between Cyclodextrin and d limonene by a Twin Screw Kneader , The 7th International Cyclodextrins Symposium, Tokyo, Japan (Apr. 25 28, 1994), pp. 512 515.;;Hashimoto H., Studies on the Industrial Production and Application of Cyclodextrins , Starch Science, vol. 36, No. 1 (1989), pp. 35 42.;;Lehner, S. J., et al., Interactions Between p hydroxybenzoic Acid Esters and Hydroxypropyl Cyclodextrin and Their Antimicrobial Effect Against Candida Albicans , International Journal of Pharmaceuticals, 93 (1993), pp. 201 208.;;Djeda i ni Pilard, F., et al., Optimal Performances with Minimal Chemical Modifications of Cyclodextrins , The 7th International Cyclodextrins Symposium, Tokyo, Japan (Apr. 25 28, 1994), pp 94 97.;;Lehner, S. J., et al., Effect of Hydroxypropyl Cyclodexrin on the Antimicrobial Action of Preservatives , J. Pharm. Pharmacol, vol. 46 (1994), pp. 186 191.;;U.S. application No. 08/946,770, Trinh, et al., filed Oct. 8, 1997.;;U.S. application No. 08/947,075, Lucas, et al., filed Oct. 8, 1997.;;U.S. application No. 08/947,076, Trinh, et al., filed Oct. 8, 1997.;;U.S. application No. 08/951,184, Lucas, et al., filed Oct. 15, 1997.;;U.S. application No. 08/951,185 Dodd, et al., filed Oct. 15, 1997.",EXPIRED
492,US,A,US 5882638 A,064-393-242-718-763,1999-03-16,1999,US 95118597 A,1997-10-15,US 95118597 A;;US 73896496 A,1996-10-24,Methods using uncomplexed cyclodextrin solutions for controlling environmental odors,"The present invention encompasses methods of controlling environmental malodors on human skin comprising the application to the skin of a composition comprising from about 0.1% to about 5%, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; and an aqueous carrier. The compositions can also comprise one or more of the following optional components: a linear dimethicone having a nominal viscosity of about 350 ecentistokes or less; low molecular weight polyols; water-soluble antimicrobial preservatives; zinc salts; water-soluble polymers; soluble carbonate and/or bicarbonate salts; chelating agents; zeolites; activated carbon; and mixtures thereof. The compositions can be applied directly as a spray, poured from a bottle and applied by hand, or applied via a wipe.",PROCTER & GAMBLE,DODD MICHAEL THOMAS;;TRINH TOAN;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,PROCTER & GAMBLE COMPANY THE (1997-10-28),https://lens.org/064-393-242-718-763,Granted Patent,yes,63,61,1,24,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61K8/891;;A61Q15/00;;A61K8/0208;;A61K8/44;;A61K8/046;;A61K8/27;;A61K8/738;;A61K8/891;;A61Q15/00,A61K8/02;;A61K8/04;;A61K8/27;;A61K8/44;;A61K8/73;;A61K8/891;;A61Q15/00,424/65;;422/5;;424/67;;424/69;;424/76.1;;424/76.7;;424/76.21;;424/76.4;;424/76.8;;424/78.03;;424/405;;424/642;;424/715;;424/717,15,4,090-441-333-592-541;;014-996-805-444-655;;012-298-624-007-623;;095-848-985-388-657,10.3109/03639049209040853;;10.1080/10610279308035175;;10.1016/0378-5173(93)90178-i;;10.1111/j.2042-7158.1994.tb03775.x;;8027925,"T. Loftsson, et al. interactions Between Preservatives and 2 Hydroxypropyl Cyclodextrin , Drug Development and Industrial Pharmacy, 18(13), 1992, pp. 1477 1484.;;Leyden, Bacteriology of the Human Axilla: Relationship to Axillary Odor , Antiperspirants & Deodorants, 1988, pp. 311 319.;;Lachman, et al., The Theory and Practice of Industrial Pharmacy, 1986, pp. 466 467; 520 522; 458 461.;;Furuta, T., Effects of Water and Alcohol on the Formation of Inclusion Complexes of d limonene and Cyclodextrins , Supramolecular Chemistry, vol. 1 (1993), pp. 321 325.;;Furuta, T., et al., Formation of Inclusion Complex Between Cyclodextrin and d limonene by a Twin Screw Kneader , The 7th International Cyclodextrins Symposium, Tokyo, Japan (Apr. 25 28, 1994), pp. 512 515.;;Hashimoto, H., Studies on the Industrial Production and Application of Cyclodextrins , Starch Science, vol. 36, No. 1 (1989), pp. 35 42.;;Hashimoto, H., Application of Cyclodextrins to Foods, Toiletries and Other Products in Japan , Ensuiko Sugar Refining Co., Ltd., pp. 13 46.;;Lehner, S. J., et al. Interactions Between p hydroxybenzoic Acid Esters and Hydroxypropyl Cyclodextrin and Their Antimicrobial Effect Against Candida Albicans , International Journal of Pharmaceuticals, 93 (1993), pp. 201 208.;;Djeda i ni Pilard, F., et al., Optimal Performances with Minimal Chemical Modifications of Cyclodextrins , The 7th International Cyclodextrins Symposium, Tokyo, Japan (Apr. 25 28, 1994), pp. 94 97.;;Lehner, S. J., et al., Effect of Hydroxypropyl Cyclodextrin on the Antimicrobial Action of Preservatives , J. Pharm. Pharmacol, vol. 46 (1994), pp. 186 191.;;U.S. application No. 8/946,770, Trinh et al., filed Oct. 08, 1997.;;U.S. application No. 8/947,075, Lucas et al., filed Oct. 08, 1997.;;U.S. application No. 8/947,076, Trinh et al., filed Oct. 08, 1997.;;U.S. application No. 8/947,299, Trinh et al., filed Oct. 08, 1997.;;U.S. application No. 8/951,184, Lucas et al., filed Oct. 15, 1997.",EXPIRED
493,US,A,US 5871719 A,120-767-624-331-225,1999-02-16,1999,US 87185797 A,1997-06-09,US 87185797 A,1997-06-09,Perfume-free two phase compositions for reducing body odor,"The present invention relates to a perfume-free odor absorbing composition, which is safe for use on skin comprising from about 0.1% to about 5%, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from about 0.1% to about 36%, by weight of the composition, of an oil phase selected from the group consisting of emollients, moisturizers, skin protectants, and mixtures thereof; one or more surfactants each having a hydrophilic/lipophilic balance of about 8-18, and wherein each surfactant, when combined with an aqueous cyclodextrin solution, provides no less than about 25% a level of odor capture as an aqueous cyclodextrin solution; and an aqueous carrier. The odor absorbing compositions of the present invention may also contain an effective amount of hydrophobic antimicrobials.",PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;BARTOLO ROBERT GREGORY;;DODD MICHAEL THOMAS;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,PROCTER & GAMBLE COMPANY THE (1997-12-11),https://lens.org/120-767-624-331-225,Granted Patent,yes,31,17,1,18,0,A61K8/19;;A61K8/27;;A61K8/347;;A61K8/37;;A61K8/44;;A61K8/4973;;A61K8/738;;A61K8/891;;A61K8/90;;A61Q15/00;;A61K8/19;;A61K8/44;;A61K8/347;;A61K8/27;;A61K8/891;;A61Q15/00;;A61K8/37;;A61K8/4973;;A61K8/738;;A61K8/90,A61K8/19;;A61K8/27;;A61K8/34;;A61K8/37;;A61K8/44;;A61K8/49;;A61K8/73;;A61K8/891;;A61K8/90;;A61Q15/00,424/65;;422/5;;424/65;;424/67;;424/69;;424/76.1;;424/76.2;;424/76.21;;424/76.4;;424/76.8;;424/78.03;;424/405;;424/642;;424/715;;424/717,29,0,,,"Hashimoto, H., Studies on the Industrial Production and Application of cyclodextrins , Starch Science, vol. 36, No. 1 (1989), pp. 35 42.;;U.S. application No. 08/736,469, Trinh et al., filed Oct. 24, 1996.;;U.S. application No. 08/736,093, Trinh et al., filed Oct. 24, 1996.;;U.S. application No. 08/889,607, Trinh et al., filed Jul. 8, 1997.;;U.S. application No. 08/736,471, Lucas et al., filed Oct. 24, 1996.;;U.S. application No. 08/736,470, Lucas et al., filed Oct. 24, 1996.;;U.S. application No. 08/738,964, Dodd et al., filed Oct. 24, 1996.;;U.S. application No. 08/736,838, Peterson et al., filed Oct. 28, 1996.;;U.S. application No. 08/739,091, Peterson et al., filed Oct. 28, 1996.;;U.S. application No. 08/871,166, Lucas et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,854, Lucas et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,791, Dodd et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,855, Trinh et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,853, Lucas et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,790, Peterson et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,856, Peterson et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,858, Lucas et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,577, Lucas et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,860, Lucas et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,861, Peterson et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,092, Peterson et al., filed Jun. 9, 1997.;;U.S. application No. 08/289,732, Trinh et al., filed Aug. 12, 1994.;;U.S. application No. 08/289,733, Trinh et al., filed Aug. 12, 1994.;;U.S. application No. 08/289,734, Cappel et al., filed Aug. 12, 1994.;;U.S. application No. 08/289,735, Cappel et al., filed Aug. 12, 1994.;;U.S. application No. 08/289,969, Pilosof et al., filed Aug. 12, 1994.;;U.S. application No. 08/871,576, Woo et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,119, Woo et al., filed Jun. 9, 1997.;;U.S. application No. 08/871,042, Woo et al., filed Jun. 9, 1997.",EXPIRED
494,WO,A1,WO 2011/002511 A1,123-884-413-917-105,2011-01-06,2011,US 2010/0001878 W,2010-06-30,US 49568809 A;;US 49565709 A;;US 49561109 A;;US 49553409 A,2009-06-30,MULTI-PHASIC IMPLANT DEVICE FOR THE REPAIR OR REPLACEMENT OF CARTILAGE TISSUE,"Tissue implants prepared for the repair of tissues, especially avascular tissues such as cartilage. One embodiment presents an electric potential capable of receiving and accumulating desirable factors or molecules from surrounding fluid when exposed to dynamic loading. In another embodiment the implant promotes tissue conduction by retarding, restricting and controlling cellular invasion through use of gradients until competent tissue forms. Further embodiments of the tissue implants may be formed into a multi-phasic device that provides deep tissue mechanical stimulus by conduction of mechanical and fluid forces experienced at the surface of the implant.",KENSEY NASH CORP;;CASTIGLIONE-DODD EMME M;;BRADICA GINO;;EBRAHIMI ALI;;RINGEISEN TIMOTHY A;;WATTENGEL WILLIAM CHRISTIAN;;MCDADE ROBERT L,CASTIGLIONE-DODD EMME M;;BRADICA GINO;;EBRAHIMI ALI;;RINGEISEN TIMOTHY A;;WATTENGEL WILLIAM CHRISTIAN;;MCDADE ROBERT L,,https://lens.org/123-884-413-917-105,Patent Application,yes,5,3,6,12,0,A61F2/28;;A61F2/30756;;A61F2002/30014;;A61F2002/30028;;A61F2002/30031;;A61F2002/30052;;A61F2002/30088;;A61F2002/30332;;A61F2002/3092;;A61F2002/30971;;A61F2002/4495;;A61F2210/008;;A61F2220/0033;;A61F2250/0018;;A61F2250/0043;;A61F2250/0051;;A61F2250/0056;;A61F2310/00365;;A61L27/24;;A61L27/48;;A61L27/50;;A61L27/52;;A61L27/56;;A61L2430/06,A61F2/28;;A61F2/00;;A61F2/30,,1,0,,,See also references of EP 2448523A1,PENDING
495,DE,T2,DE 69717847 T2,122-576-932-928-964,2003-09-18,2003,DE 69717847 T,1997-10-23,US 73646996 A;;US 73609396 A;;US 73896496 A;;US 88960797 A;;US 94677097 A;;US 94729997 A;;US 94707697 A;;US 95118597 A;;US 9718852 W,1996-10-24,HAUTGERUCHSREDUZIERUNGSKOMPOSITIONEN,"The present invention relates to an aqueous odor-absorbing composition which is safe for use on human skin comprising from about 0.1 % to about 5 %, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from about 0.5 % to about 30 %, by weight of the composition, of a linear dimethicone having a nominal viscosity of 350 centistokes or less; and an aqueous carrier. The compositions can also comprise one or more of the following optional components: low molecular weight polyols; water-soluble antimicrobial preservatives; zinc salts; water-soluble polymers; soluble carbonate and/or bicarbonate salts; chelating agents; zeolites; activated carbon; and mixtures thereof. The present invention also relates the use of the aforementioned compositions in reducing body, vaginal, and or environmental odors on skin. The composition can be applied directly as a spray, poured from a bottle and applied by hand, or applied via a wipe.",PROCTER & GAMBLE,TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/122-576-932-928-964,Granted Patent,no,0,0,15,24,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61K8/891;;A61Q15/00;;A61K8/73;;A61Q15/00,A61K8/02;;A61K8/04;;A61K8/27;;A61K8/44;;A61K8/73;;A61K8/891;;A61Q15/00,,0,0,,,,EXPIRED
496,AU,A,AU 1997/049085 A,164-902-165-837-555,1998-05-15,1998,AU 1997/049085 A,1997-10-23,US 73646996 A;;US 73609396 A;;US 73896496 A;;US 88960797 A;;US 94677097 A;;US 94729997 A;;US 94707697 A;;US 95118597 A;;US 9718852 W,1996-10-24,Compositions for reducing odor on skin,,PROCTER & GAMBLE,TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/164-902-165-837-555,Patent Application,no,0,0,15,24,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61K8/891;;A61Q15/00;;A61K8/73;;A61Q15/00,A61K8/02;;A61K8/04;;A61K8/27;;A61K8/44;;A61K8/73;;A61K8/891;;A61Q15/00,,0,0,,,,EXPIRED
497,TR,T2,TR 199900876 T2,179-594-131-824-281,1999-07-21,1999,TR 9900876 T,1997-10-23,US 73647196 A;;US 73647096 A;;US 94707597 A;;US 95118497 A,1996-10-24,Vücut kokusunun azaltilmasi için yöntemler ve bilesimler,"The present invention relates to an odor absorbing composition, which is safe for use on human skin, comprising from 0.1 % to 5 %, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from 0.1 % to 36 %, by weight of the composition, of an oil phase selected from the group consisting of emollients, moisturizers, and skin protectants; an emulsifier; and an aqueous carrier. The odor absorbing compositions of the present invention may also contain an effective amount of hydrophobic antimicrobials. The present invention also relates to the use of cyclodextrin-containing compositions for the manufacture of an odor absorbing composition, which is safe for use on skin, for controlling environmental malodors on skin and for reducing body odor and/or vaginal odor.",PROCTER & GAMBLE,TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/179-594-131-824-281,Patent Application,no,0,0,24,28,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61Q15/00;;D06M13/005;;A61K8/73;;A61Q15/00,A61K8/02;;A61K8/04;;A61K8/00;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/44;;A61K8/73;;A61Q15/00;;D06M13/00,,0,0,,,,PENDING
498,US,A,US 5897855 A,197-251-895-809-995,1999-04-27,1999,US 94677097 A,1997-10-08,US 94677097 A;;US 73646996 A,1996-10-24,Methods and compositions for reducing body odor,"The present invention relates to an aqueous, odor absorbing composition, which is safe for use on human skin comprising from about 0.1% to about 5%, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from about 0.5% to about 30%, by weight of the composition, of a linear dimethicone having a nominal viscosity of about 350 centistokes or less; and an aqueous carrier. The odor absorbing compositions of the present invention may also contain an effective amount of solubilized, water-soluble, antimicrobial preservative having a water-solubility of greater than about 0.3%. The present invention also relates to methods of using the compositions of the present invention to reduce body odor and/or vaginal odor. The composition can be applied directly as a spray, poured from a bottle and applied by hand, or applied via a wipe.",PROCTER & GAMBLE,TRINH TOAN;;BARTOLO ROBERT GREGORY;;DODD MICHAEL THOMAS;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,PROCTER & GAMBLE COMPANY THE (1997-11-06),https://lens.org/197-251-895-809-995,Granted Patent,yes,64,24,1,24,0,A61K8/27;;A61K8/27;;A61K8/0208;;A61K8/0208;;A61K8/046;;A61K8/046;;A61K8/44;;A61K8/44;;A61K8/738;;A61K8/738;;A61K8/891;;A61K8/891;;A61Q15/00;;A61Q15/00,A61K8/02;;A61K8/04;;A61K8/27;;A61K8/44;;A61K8/73;;A61K8/891;;A61Q15/00,424/65;;422/5;;424/67;;424/69;;424/76.1;;424/76.2;;424/76.21;;424/76.4;;424/76.8;;424/78.03;;424/405;;424/642;;424/715;;424/717,10,4,090-441-333-592-541;;014-996-805-444-655;;012-298-624-007-623;;095-848-985-388-657,10.3109/03639049209040853;;10.1080/10610279308035175;;10.1016/0378-5173(93)90178-i;;10.1111/j.2042-7158.1994.tb03775.x;;8027925,"Leyden, Bacteriology of the Human Axilla: Relationship to Axillary Odor , Antiperspirants & Deodorants, 1988, pp. 311 319.;;Lachman, et al., The Theory and Practice of Industrial Pharmacy, 1986, pp. 466 467; 520 522; 458 461.;;Loftsson, T., et al., Interactions Between Preservatives and 2 Hydroxypropyl Cyclodextrin , Drug Development and Industrial Pharmacy, 18(13) (1992), pp. 1477 1484.;;Furuta, T., et al., Effects of Water and Alcohol on the Formation of Inclusion Complexes of d limonene and Cyclodextrins , Supramolecular Chemistry, vol. 1 (1993), pp. 321 325.;;Furuta, T., et al., Formation of Inclusion Complex Between Cyclodextrin and d limonene by a Twin Screw Kneader , The 7th International Cyclodextrins Symposium, Tokyo, Japan (Apr. 25 28, 1994), pp. 512 515.;;Hashimoto, H., Studies on the Industrial Production and Application of Cyclodextrins , Starch Science, vol. 36, No. 1 (1989), pp. 35 42.;;Hashimoti, H., Application of Cyclodextrins to Foods, Toiletries and Other Products in Japan , Ensuiko Sugar Refining Co., Ltd., pp. 13 46.;;Lehner, S.J., et al., Interactions Between p hydroxybenzoic Acid Esters and Hydroxypropyl Cyclodextrin and Their Antimicrobial Effect Against Candida Albicans , International Journal of Pharmaceuticals, 93 (1993), pp. 201 208.;;Djeda i ni Pilard, F., et al., Optimal Performances with Minimal Chemical Modifcations of Cyclodextrins , The 7th International Cyclodextrins Symposium, Tokyo, Japan (Apr. 25 28, 1994), pp. 94 97.;;Lehner, S. J., et al., Effect of Hydroxypropyl Cyclodextrin on the Antimicrobial Action of Preservatives , J. Pharm. Pharmacol, vol. 46 (1994), pp. 186 191.",EXPIRED
499,AU,B2,AU 731790 B2,046-619-987-478-22X,2001-04-05,2001,AU 1997/049085 A,1997-10-23,US 73646996 A;;US 73609396 A;;US 73896496 A;;US 88960797 A;;US 94677097 A;;US 94729997 A;;US 94707697 A;;US 95118597 A;;US 9718852 W,1996-10-24,Compositions for reducing odor on skin,"The present invention relates to an aqueous odor-absorbing composition which is safe for use on human skin comprising from about 0.1 % to about 5 %, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from about 0.5 % to about 30 %, by weight of the composition, of a linear dimethicone having a nominal viscosity of 350 centistokes or less; and an aqueous carrier. The compositions can also comprise one or more of the following optional components: low molecular weight polyols; water-soluble antimicrobial preservatives; zinc salts; water-soluble polymers; soluble carbonate and/or bicarbonate salts; chelating agents; zeolites; activated carbon; and mixtures thereof. The present invention also relates the use of the aforementioned compositions in reducing body, vaginal, and or environmental odors on skin. The composition can be applied directly as a spray, poured from a bottle and applied by hand, or applied via a wipe.",PROCTER & GAMBLE,TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/046-619-987-478-22X,Granted Patent,no,1,0,15,24,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61K8/891;;A61Q15/00;;A61K8/73;;A61Q15/00,A61K8/02;;A61K8/04;;A61K8/27;;A61K8/44;;A61K8/73;;A61K8/891;;A61Q15/00,,0,0,,,,EXPIRED
500,CZ,A3,CZ 145199 A3,084-563-393-212-369,1999-09-15,1999,CZ 145199 A,1997-10-23,US 73646996 A;;US 73609396 A;;US 73896496 A;;US 88960797 A;;US 94677097 A;;US 94729997 A;;US 94707697 A;;US 95118597 A,1996-10-24,BAD SMELL ABSORBING AQUEOUS PREPARATION AND ITS USE,"The present invention relates to an aqueous odor-absorbing composition which is safe for use on human skin comprising from about 0.1 % to about 5 %, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from about 0.5 % to about 30 %, by weight of the composition, of a linear dimethicone having a nominal viscosity of 350 centistokes or less; and an aqueous carrier. The compositions can also comprise one or more of the following optional components: low molecular weight polyols; water-soluble antimicrobial preservatives; zinc salts; water-soluble polymers; soluble carbonate and/or bicarbonate salts; chelating agents; zeolites; activated carbon; and mixtures thereof. The present invention also relates the use of the aforementioned compositions in reducing body, vaginal, and or environmental odors on skin. The composition can be applied directly as a spray, poured from a bottle and applied by hand, or applied via a wipe.",PROCTER & GAMBLE,TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/084-563-393-212-369,Patent Application,no,0,0,15,24,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61K8/891;;A61Q15/00;;A61K8/73;;A61Q15/00,A61K8/02;;A61K8/04;;A61K8/27;;A61K8/44;;A61K8/73;;A61K8/891;;A61Q15/00,,0,0,,,,PENDING
501,AU,B2,AU 2016/201883 B2,096-019-724-112-044,2017-11-02,2017,AU 2016/201883 A,2016-03-24,AU 2016/201883 A;;AU 2010/266713 A;;US 49561109 A;;US 49568809 A;;US 49553409 A;;US 49565709 A;;US 2010/0001878 W,2009-06-30,Multi-phasic implant device for the repair or replacement of cartilage tissue,"H:sxd\lnterwoven\NRPortbl\DCC\SXD\9883489 1docx-24/03/2016 Tissue implants prepared for the repair of tissues, especially avascular tissues such as cartilage. One embodiment presents an electric potential capable of receiving and accumulating desirable factors or molecules from surrounding fluid when exposed to dynamic loading. In another embodiment the implant promotes tissue conduction by retarding, restricting and controlling cellular invasion through use of gradients until competent tissue forms. Further embodiments of the tissue implants may be formed into a multi-phasic device that provides deep tissue mechanical stimulus by conduction of mechanical and fluid forces experienced at the surface of the implant. Fig. 3 Fig. 4",DSM IP ASSETS BV,CASTIGLIONE-DODD EMME M;;BRADICA GINO;;EBRAHIMI ALI;;RINGEISEN TIMOTHY A;;WATTENGEL WILLIAM CHRISTIAN;;MCDADE ROBERT L,DSM IP ASSETS B.V. (2017-11-02),https://lens.org/096-019-724-112-044,Granted Patent,no,6,0,6,12,0,A61F2/28;;A61F2/30756;;A61F2002/30014;;A61F2002/30028;;A61F2002/30031;;A61F2002/30052;;A61F2002/30088;;A61F2002/30332;;A61F2002/3092;;A61F2002/30971;;A61F2002/4495;;A61F2210/008;;A61F2220/0033;;A61F2250/0018;;A61F2250/0043;;A61F2250/0051;;A61F2250/0056;;A61F2310/00365;;A61L27/24;;A61L27/48;;A61L27/50;;A61L27/52;;A61L27/56;;A61L2430/06,A61F2/28;;A61F2/00;;A61F2/30,,0,0,,,,ACTIVE
502,CA,C,CA 2269808 C,122-681-029-053-991,2003-12-16,2003,CA 2269808 A,1997-10-23,US 73647196 A;;US 73647096 A;;US 94707597 A;;US 95118497 A;;US 9718954 W,1996-10-24,METHODS AND COMPOSITIONS FOR REDUCING BODY ODOR,"The present invention relates to an odor absorbing composition, which is saf e for use on human skin, comprising from 0.1 % to 5 %, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from 0 .1 % to 36 %, by weight of the composition, of an oil phase selected from the group consisting of emollients, moisturizers, and skin protectants; an emulsifier; and an aqueous carrier. The odor absorbing compositions of the present invention may also contain an effective amount of hydrophobic antimicrobials. The present invention also relates to the use of cyclodextri n- containing compositions for the manufacture of an odor absorbing composition , which is safe for use on skin, for controlling environmental malodors on ski n and for reducing body odor and/or vaginal odor.",PROCTER & GAMBLE,KAJS THERESA MARIE;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;BARTOLO ROBERT GREGORY;;TRINH TOAN;;DODD MICHAEL THOMAS,,https://lens.org/122-681-029-053-991,Granted Patent,no,0,0,24,28,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61Q15/00;;D06M13/005;;A61K8/73;;A61Q15/00,A61K8/00;;A61K8/02;;A61K8/04;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/44;;A61K8/73;;A61Q15/00;;D06M13/00,,0,0,,,,EXPIRED
503,US,A1,US 2003/0120588 A1,150-610-362-482-527,2003-06-26,2003,US 3660501 A,2001-12-21,US 3660501 A,2001-12-21,"Systems and methods for automatic submission, audit and adjustment of mortgage insurance claims","
   Systems and methods are described for automatically processing mortgage insurance claims. In one described system, a central server computer receives inputs from, and provides outputs to, a servicer terminal connected into a network. The servicer terminal captures data from a servicer submitting a mortgage insurance claim. A claims database is connected into the network, containing data relating to the mortgage insurance claim. A claim audit rulebase is connected into the network, for automatically performing an audit and adjustment of the submitted mortgage insurance claim. The system automatically provides results of the audit and adjustment to the servicer at the servicer terminal, and presents the servicer with an option to interact with a claim representative to resolve any issues. 
",GE MORTGAGE HOLDINGS LLC,DODD NANCY J;;PARKER CHARLA M;;POPE ALLISON N;;STEWART JOANNE A;;WHITNEY TRACI L;;JOHNSTON ROBERT,GENWORTH MORTGAGE HOLDINGS LLC (2001-12-13),https://lens.org/150-610-362-482-527,Patent Application,yes,6,64,2,2,0,G06Q20/10;;G06Q40/02;;G06Q40/08;;G06Q40/03;;G06Q40/02;;G06Q20/10;;G06Q40/08;;G06Q40/03,G06Q20/10,705/38;;705/4,0,0,,,,EXPIRED
504,CN,A,CN 113339228 A,148-206-042-748-22X,2021-09-03,2021,CN 202110232652 A,2021-03-02,US 202062983885 P,2020-03-02,FLUID SENSING SAFETY,"A fluid sensing safety may include a pump, and a prime mover configured to drive the pump. A fluid vessel may be associated with the pump. A sensing system may be configured to determine the presence of fluid within the fluid vessel.",FNA GROUP INC,ALEXANDER GUS;;CHRISTOPHER C ALEXANDER;;RICHARD J GILPATRICK;;JOSEPH PETER D;;ROBERT E DODD;;SHAWN M MULKINS,,https://lens.org/148-206-042-748-22X,Patent Application,no,0,0,3,3,0,F04B17/05;;F04B23/02;;F04B49/065;;F04B49/02;;F02D29/06;;F02D17/04;;F02N11/0818;;B08B3/02;;F04B17/05;;F04B49/02;;F04B49/10;;F04B23/02;;F04B49/02;;F04B49/10;;F04B17/05,F04B17/05;;B08B3/02;;F02D17/04;;F02D29/06;;F02N11/08;;F04B23/02;;F04B49/02;;F04B49/06,,0,0,,,,DISCONTINUED
505,US,A,US 5897856 A,176-868-465-490-863,1999-04-27,1999,US 94707697 A,1997-10-08,US 94707697 A;;US 88960797 A;;US 73609396 A,1996-10-24,Methods and compositions for reducing body odor,"The present invention relates to an odor-absorbing pre-formed wipe composition which is safe for use on human skin comprising from about 0.1% to about 5%, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from about 0.01% to about 1%, by weight of the composition, of low molecular weight polyols; and an aqueous carrier, wherein the composition is deposited on a wipe which comprises a flexible dispensing means. The present invention also relates to methods of using the compositions of the present invention to reduce body odor and/or vaginal odor.",PROCTER & GAMBLE,TRINH TOAN;;BARTOLO ROBERT GREGORY;;DODD MICHAEL THOMAS;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,PROCTER & GAMBLE COMPANY THE (1997-10-28),https://lens.org/176-868-465-490-863,Granted Patent,yes,31,10,1,24,0,A61K8/046;;A61K8/046;;A61K8/0208;;A61K8/0208;;A61K8/27;;A61K8/27;;A61K8/44;;A61K8/44;;A61K8/738;;A61K8/738;;A61K8/891;;A61K8/891;;A61Q15/00;;A61Q15/00,A61K8/02;;A61K8/04;;A61K8/27;;A61K8/44;;A61K8/73;;A61K8/891;;A61Q15/00,424/65;;422/5;;424/67;;424/69;;424/76.1;;424/76.2;;424/76.21;;424/76.4;;424/76.8;;424/78.03;;424/405;;424/642;;424/715;;424/717,6,0,,,"Hashimoto, H., Studies on the Industrial Production and Application of Cyclodextrins , Starch Science, vol. 36, No. 1 (1989), pp. 35 42.;;U.S. application No. 08/946,770, Trinh et al., filed Oct. 8, 1997.;;U.S. application No. 08/947,075, Lucas et al., filed Oct. 8, 1997.;;U.S. application No. 08/947,299, Trinh et al., filed Oct. 8, 1997.;;U.S. application No. 08/951,184, Lucas et al., filed Oct 15, 1997.;;U.S. application No. 08/951,185, Dodd et al., filed Oct. 15, 1997.",EXPIRED
506,RU,C2,RU 2286245 C2,015-877-711-763-385,2006-10-27,2006,RU 2004117873 A,2002-10-30,US 292001 A,2001-11-15,RAZOR AND RAZOR CASSETTE,"FIELD: hand-held cutting tools. ^ SUBSTANCE: razor comprises handle, head mounted on the handle, and member made of a material with phase transition for heat release and mounted inside the head. The razor cassette comprises housing, razor blade mounted in the housing, and member made of a material with phase transition for heat release and mounted inside the housing. ^ EFFECT: improved design. ^ 50 cl, 8 dwg",DZHILLETT KOMPANI,BRANDT KLAUS;;DEHVIS STJUART M;;DODD KENNET T;;PEHRENT CHARL Z ROBERT;;SHCHEPANOVSKI EHNDRJU;;VUDNORT DUGLAS DZH,,https://lens.org/015-877-711-763-385,Granted Patent,no,0,3,26,26,0,B26B21/40;;B26B21/4025;;B26B21/4087;;B26B21/48;;B26B21/4087;;B26B21/40;;B26B21/48;;B26B21/4025,B26B21/40;;B26B21/48;;B26B21/52,,0,0,,,,EXPIRED
507,AT,T1,AT E279173 T1,090-389-061-647-602,2004-10-15,2004,AT 97911821 T,1997-10-23,US 73647196 A;;US 73647096 A;;US 94707597 A;;US 95118497 A;;US 9718954 W,1996-10-24,VERFAHREN ZUR VERMINDERUNG VON KÖRPERGERUCH,"The present invention relates to an odor absorbing composition, which is safe for use on human skin, comprising from 0.1 % to 5 %, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from 0.1 % to 36 %, by weight of the composition, of an oil phase selected from the group consisting of emollients, moisturizers, and skin protectants; an emulsifier; and an aqueous carrier. The odor absorbing compositions of the present invention may also contain an effective amount of hydrophobic antimicrobials. The present invention also relates to the use of cyclodextrin-containing compositions for the manufacture of an odor absorbing composition, which is safe for use on skin, for controlling environmental malodors on skin and for reducing body odor and/or vaginal odor.",PROCTER & GAMBLE,TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/090-389-061-647-602,Granted Patent,no,0,0,24,28,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61Q15/00;;D06M13/005;;A61K8/73;;A61Q15/00,A61K8/00;;A61K8/02;;A61K8/04;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/44;;A61K8/73;;A61Q15/00;;D06M13/00,,0,0,,,,DISCONTINUED
508,AU,A,AU 1998/078259 A,102-377-053-507-509,1998-12-30,1998,AU 1998/078259 A,1998-06-08,US 87157797 A;;US 87185397 A;;US 87185597 A;;US 87185897 A;;US 9811814 W,1997-06-09,Perfumed one and two phase compositions for reducing body odor and methods of use thereof,,PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/102-377-053-507-509,Patent Application,no,0,0,15,21,0,A61K8/0208;;A61K8/19;;A61K8/27;;A61K8/347;;A61K8/37;;A61K8/44;;A61K8/4973;;A61K8/738;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61Q15/00;;A61K8/891;;A61K8/19;;A61K8/347;;A61K8/738;;A61K8/27;;A61K8/44;;A61K8/90;;A61K8/4973;;A61K8/37;;A61K8/0208;;A61Q13/00,A61K8/00;;A61K8/02;;A61K8/19;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/34;;A61K8/37;;A61K8/44;;A61K8/49;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;A61Q19/00;;C08L83/04;;C08L83/12,,0,0,,,,EXPIRED
509,US,A,US 5879666 A,113-018-001-305-90X,1999-03-09,1999,US 94707597 A,1997-10-08,US 94707597 A;;US 73647196 A,1996-10-24,Methods and compositions for reducing body odor,"The present invention relates to an odor absorbing composition, which is safe for use on human skin comprising from about 0.1% to about 5%, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from about 0.1% to about 36%, by weight of the composition, of an oil phase selected from the group consisting of emollients, moisturizers, and skin protectants; an emulsifier; and an aqueous carrier. The odor absorbing compositions of the present invention may also contain an effective amount of hydrophobic antimicrobials. The present invention also relates to methods of using the compositions of the present invention to reduce body odor and/or vaginal odor. The composition can be applied directly as a spray, poured from a bottle and applied by hand, or applied via a wipe.",PROCTER & GAMBLE,LUCAS JULIET MARIE;;BARTOLO ROBERT GREGORY;;DODD MICHAEL THOMAS;;TRINH TOAN;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,PROCTER & GAMMBLE COMPANY THE (1997-10-28),https://lens.org/113-018-001-305-90X,Granted Patent,yes,69,36,1,28,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61Q15/00;;D06M13/005;;A61K8/738;;A61K8/27;;D06M13/005;;A61Q15/00;;A61K8/44;;A61K8/0208;;A61K8/046,A61K8/02;;A61K8/04;;A61K8/27;;A61K8/44;;A61K8/73;;A61Q15/00;;D06M13/00,424/65;;422/5;;424/67;;424/69;;424/76.1;;424/76.2;;424/76.21;;424/76.4;;424/76.8;;424/78.03;;424/405;;424/642;;424/715;;424/717,10,4,090-441-333-592-541;;014-996-805-444-655;;012-298-624-007-623;;095-848-985-388-657,10.3109/03639049209040853;;10.1080/10610279308035175;;10.1016/0378-5173(93)90178-i;;10.1111/j.2042-7158.1994.tb03775.x;;8027925,"Leyden, Bacteriology of the Human Axilla: Relationship to Axillary Odor , Antiperspirants & Deodorants, 1988, pp. 311 319.;;Lachman, et al., The Theory and Practice of Industrial Pharmacy, 1986, pp. 466 467; 520 522; 458 461.;;Loftsson, T., et al., Interactions Between Preservatives and 2 Hydroxypropyl Cyclodextrin , Drug Development and Industrial Pharmacy, 18(13) (1992),pp. 1477 1484.;;Furuta, T., et al., Effects of Water and Alcohol on the Formation of Inclusion Complexes of d limonene and Cyclodextrins , Supramolecular Chemistry, vol. 1 (1993), pp. 321 325.;;Furuta, T., et al., Formation of Inclusion Complex Between Cyclodextrin and d limonene by a Twin Screw Kneader , The 7th International Cyclodextrins Symposium, Tokyo, Japan (Apr. 25 28, 1994), pp. 512 515.;;Hashimoto, H., Studies on the Industrial Production and Application of Cyclodextrins , Starch Science, vol. 36, No. 1 (1989), pp. 35 42.;;Hashimoti, H., Application of Cyclodextrins to Foods, Toiletries and Other Products in Japan , Ensuiko Sugar Refining Co., Ltd., pp. 13 46.;;Lehner, S. J., et al., Interactions Between p hydroxybenzoic Acid Esters and Hydroxypropyl Cyclodextrin and Their Antimicrobial Effect Against Candida Albicans , International Journal of Pharmaceuticals, 93 (1993), pp. 201 208.;;Djeda i ni Pilard, F., et al., Optimal Performances with Minimal Chemical Modifications of Cyclodextrins , The 7th International Cyclodextrins Symposium, Tokyo, Japan (Apr. 25 28, 1994) pp. 94 97.;;Lehner, S. J., et al., Effect of Hydroxypropyl Cyclodextrin on the Antimicrobial Action of Preservatives , J. Pharm. Pharmacol, vol. 46 (1994), pp. 186 191.",EXPIRED
510,WO,A1,WO 1998/017239 A1,174-919-690-630-601,1998-04-30,1998,US 9718852 W,1997-10-23,US 73646996 A;;US 73609396 A;;US 73896496 A;;US 88960797 A;;US 94677097 A;;US 94729997 A;;US 94707697 A;;US 95118597 A,1996-10-24,COMPOSITIONS FOR REDUCING ODOR ON SKIN,"The present invention relates to an aqueous odor-absorbing composition which is safe for use on human skin comprising from about 0.1 % to about 5 %, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from about 0.5 % to about 30 %, by weight of the composition, of a linear dimethicone having a nominal viscosity of 350 centistokes or less; and an aqueous carrier. The compositions can also comprise one or more of the following optional components: low molecular weight polyols; water-soluble antimicrobial preservatives; zinc salts; water-soluble polymers; soluble carbonate and/or bicarbonate salts; chelating agents; zeolites; activated carbon; and mixtures thereof. The present invention also relates the use of the aforementioned compositions in reducing body, vaginal, and or environmental odors on skin. The composition can be applied directly as a spray, poured from a bottle and applied by hand, or applied via a wipe.",PROCTER & GAMBLE,TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/174-919-690-630-601,Patent Application,yes,4,23,15,24,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61K8/891;;A61Q15/00;;A61K8/73;;A61Q15/00,A61K8/02;;A61K8/04;;A61K8/27;;A61K8/44;;A61K8/73;;A61K8/891;;A61Q15/00,,1,0,,,"DATABASE WPI Week 9241, Derwent World Patents Index; AN 92-334323, XP002059667",PATENTED
511,US,A,US 5874067 A,173-379-552-883-423,1999-02-23,1999,US 95118497 A,1997-10-15,US 95118497 A;;US 73647096 A,1996-10-24,Methods for controlling environmental odors on the body,"The present invention encompasses a method of controlling malodors on human skin comprising the application to the human skin of a composition comprising from about 0.1% to about 5%, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from about 0.1% to about 36%, by weight of the composition, of an oil phase selected from the group consisting of emollients, moisturizers, and skin protectants; an emulsifier; and an aqueous carrier. The compositions may also optionally comprise one or more of the following: hydrophobic antimicrobials; water-soluble antimicrobial preservatives; low molecular weight polyols; zinc salts; water-soluble polymers; soluble carbonate and/or bicarbonate salts; chelating agents; zeolites; activated carbon; and mixtures thereof. The compositions can be applied directly as a spray, poured from a bottle and applied by hand, or applied via a wipe.",PROCTER & GAMBLE,LUCAS JULIET MARIE;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;TRINH TOAN;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,PROCTER & GAMBLE COMPANY THE (1997-11-06),https://lens.org/173-379-552-883-423,Granted Patent,yes,62,87,1,28,0,A61K8/0208;;A61K8/0208;;A61K8/046;;A61K8/046;;A61K8/27;;A61K8/27;;A61K8/44;;A61K8/44;;A61K8/738;;A61K8/738;;A61Q15/00;;A61Q15/00;;D06M13/005;;D06M13/005,A61K8/02;;A61K8/04;;A61K8/27;;A61K8/44;;A61K8/73;;A61Q15/00;;D06M13/00,424/65;;422/5;;424/67;;424/69;;424/76.1;;424/76.2;;424/76.21;;424/76.4;;424/76.8;;424/78.03;;424/405;;424/642;;424/715;;424/717,9,4,090-441-333-592-541;;014-996-805-444-655;;012-298-624-007-623;;095-848-985-388-657,10.3109/03639049209040853;;10.1080/10610279308035175;;10.1016/0378-5173(93)90178-i;;10.1111/j.2042-7158.1994.tb03775.x;;8027925,"Leyden, Bacteriology of the Human Axilla: Relationship to Axillary Odor , Antiperspirants & Deodorants, 1988, pp. 311 319.;;Lachman, et al., The Theory and Practice of Industrial Pharmacy, 1986, pp. 466 467; 520 522; 458 461.;;Loftsson, T., et al., Interactions Between Preservatives and 2 Hydroxypropyl Cyclodextrin , Drug Development and Industrial Pharmacy, 18(13) (1992),pp. 1477 1484.;;Furuta, T., et al., Effects of Water and Alcohol on the Formation of Inclusion Complexes of d limonene and Cyclodextrins , Supramolecular Chemistry, vol. 1 (1993), pp. 321 325.;;Furuta, T., et al., Formation of Inclusion Complex Between Cyclodextrin and d limonene by a Twin Screw Kneader , The 7th International Cyclodextrins Symposium, Tokyo, Japan (Apr. 25 28, 1994), pp. 512 515.;;Hashimoto, H., Studies on the Industrial Production and Application of Cyclodextrins , Starch Science, vol. 36, No. 1 (1989), pp. 35 42.;;Lehner, S. J., et al., Interactions Between p hydroxybenzoic Acid Esters and Hydroxypropyl Cyclodextrin and Their Antimicrobial Effect Against Candida Albicans , International Journal of Pharmaceuticals, 93 (1993), pp. 201 208.;;Djeda i ni Pilard, F., et al., Optimal Performances with Minimal Chemical Modifcations of Cyclodextrins , The 7th International Cyclodextins Symposium, Tokyo, Japan (Apr. 25 28, 1994), pp. 94 97.;;Lehner, S. J., et al., Effect of Hydroxypropyl Cyclodextrin on the Antimicrobial Action of Preservatives , J. Pharm. Pharmacol. vol. 46 (1994), pp. 186 191.",EXPIRED
512,WO,A1,WO 2000/030600 A1,196-570-527-546-855,2000-06-02,2000,US 9927685 W,1999-11-22,US 10960298 P;;US 32129299 A,1998-11-23,SKIN DEODORIZING COMPOSITIONS,The present invention relates to aqueous gel compositions comprising an odor controlling agent for deodorizing skin surfaces. Articles of manufacture and methods of deodorizing the skin using disclosed compositions are also disclosed.,PROCTER & GAMBLE,DODD MICHAEL THOMAS;;WEI KARL SHIQING;;TRINH TOAN;;SINE MARK RICHARD;;BARTOLO ROBERT GREGORY;;JAKUBOVIC DAVID ANDREW,,https://lens.org/196-570-527-546-855,Patent Application,yes,10,8,6,21,0,A61K8/0208;;A61K8/042;;A61K8/27;;A61K8/347;;A61K8/40;;A61K8/416;;A61K8/43;;A61K8/4973;;A61K8/732;;A61K8/738;;A61K8/8147;;A61Q15/00;;A61Q17/005;;A61Q17/005;;A61Q15/00;;A61K8/40;;A61K8/738;;A61K8/4973;;A61K8/0208;;A61K8/8147;;A61K8/347;;A61K8/43;;A61K8/27;;A61K8/416;;A61K8/042;;A61K8/732,A61K8/02;;A61K8/27;;A61K8/00;;A61K8/34;;A61K8/35;;A61K8/37;;A61K8/40;;A61K8/41;;A61K8/43;;A61K8/49;;A61K8/73;;A61K8/81;;A61Q15/00;;A61Q17/00,,0,0,,,,PENDING
513,AU,A1,AU 2010/266713 A1,028-017-891-503-848,2012-01-19,2012,AU 2010/266713 A,2010-06-30,US 49561109 A;;US 49568809 A;;US 49553409 A;;US 49565709 A;;US 2010/0001878 W,2009-06-30,Multi-phasic implant device for the repair or replacement of cartilage tissue,"Tissue implants prepared for the repair of tissues, especially avascular tissues such as cartilage. One embodiment presents an electric potential capable of receiving and accumulating desirable factors or molecules from surrounding fluid when exposed to dynamic loading. In another embodiment the implant promotes tissue conduction by retarding, restricting and controlling cellular invasion through use of gradients until competent tissue forms. Further embodiments of the tissue implants may be formed into a multi-phasic device that provides deep tissue mechanical stimulus by conduction of mechanical and fluid forces experienced at the surface of the implant.",KENSEY NASH CORP,CASTIGLIONE-DODD EMME M;;BRADICA GINO;;EBRAHIMI ALI;;RINGEISEN TIMOTHY A;;WATTENGEL WILLIAM CHRISTIAN;;MCDADE ROBERT L,,https://lens.org/028-017-891-503-848,Patent Application,no,0,0,6,12,0,A61F2/28;;A61F2/30756;;A61F2002/30014;;A61F2002/30028;;A61F2002/30031;;A61F2002/30052;;A61F2002/30088;;A61F2002/30332;;A61F2002/3092;;A61F2002/30971;;A61F2002/4495;;A61F2210/008;;A61F2220/0033;;A61F2250/0018;;A61F2250/0043;;A61F2250/0051;;A61F2250/0056;;A61F2310/00365;;A61L27/24;;A61L27/48;;A61L27/50;;A61L27/52;;A61L27/56;;A61L2430/06,A61F2/28;;A61F2/00;;A61F2/30,,0,0,,,,DISCONTINUED
514,CO,A1,CO 4940389 A1,066-872-707-051-358,2000-07-24,2000,CO 98032884 A,1998-06-09,US 87185597 A;;US 87185397 A;;US 87185897 A;;US 87157797 A,1997-06-09,COMPOSICIONES DE PERFUME DE UNA Y DOS FASES PARA REDUCIR EL OLOR CORPORAL Y METODO PARA SU USO,"La presente invención se relaciona con una composiciónabsorbente del olor la cual comprende:a) de aproximadamente 0.1% hasta aproximadamente 5% del peso de la composición en ciclodextrina no-complejizada hidrosoluble y solubilizada;b) de aproximadamente O.1% hasta aproximadamente 36% del peso de la composición en una fase aceitosa seleccionada entre el grupo constituido por emolientes, humectantes y protectores de la piel;c) uno o más surfactantes;d) de aproximadamente O.OO4% hasta aproximadamente 2% del peso de la composición en una composición perfúmica; ye) un vehículo acuoso;en donde por lo menos aproximadamente 50% de la composición perfúmica comprende ingredientesperfúmicos seleccionados entre el grupo constituido por ingredientes perfúmicos hidrofílicos que tienen un punto de atascamiento menor de aproximadamente 3.5%; ingredientes perfúmicos que tienen valores deumbral de detección de olor significativamente bajos; y mezclas de los anteriores; y siendo la composiciónsegura para usar sobre la piel.",PROCTER & GAMBLE,LUCAS JULIET MARIE;;TOAN TRINH;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;BUCKINER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/066-872-707-051-358,Patent Application,no,0,0,15,21,0,A61K8/0208;;A61K8/19;;A61K8/27;;A61K8/347;;A61K8/37;;A61K8/44;;A61K8/4973;;A61K8/738;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61Q15/00;;A61K8/891;;A61K8/19;;A61K8/347;;A61K8/738;;A61K8/27;;A61K8/44;;A61K8/90;;A61K8/4973;;A61K8/37;;A61K8/0208;;A61Q13/00,A61K8/00;;A61K8/02;;A61K8/19;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/34;;A61K8/37;;A61K8/44;;A61K8/49;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;A61Q19/00;;C08L83/04;;C08L83/12,,0,0,,,,PENDING
515,NO,D0,NO 996054 D0,093-933-674-563-60X,1999-12-08,1999,NO 996054 A,1999-12-08,US 87185497 A;;US 87185797 A;;US 87186097 A;;US 9811787 W,1997-06-09,Parfymefrie to-fase blandinger og fremgangsmåter for å redusere kropps- og omgivelseslukt,,PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/093-933-674-563-60X,Patent Application,no,0,0,16,18,0,A61K8/19;;A61K8/27;;A61K8/347;;A61K8/37;;A61K8/39;;A61K8/44;;A61K8/4973;;A61K8/738;;A61K8/891;;A61K8/90;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61K8/39;;A61K8/37;;A61K8/90;;A61Q15/00;;A61K8/891;;A61K8/27;;A61K8/44;;A61K8/347;;A61K8/19;;A61K8/738;;A61K8/4973,A61K8/00;;A47K7/00;;A61K8/18;;A61K8/19;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/34;;A61K8/37;;A61K8/44;;A61K8/49;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;C08L83/10,,0,0,,,,DISCONTINUED
516,EP,B1,EP 1006993 B1,189-065-255-587-66X,2004-10-13,2004,EP 97911821 A,1997-10-23,US 9718954 W;;US 73647196 A;;US 73647096 A;;US 94707597 A;;US 95118497 A,1996-10-24,METHODS AND COMPOSITIONS FOR REDUCING BODY ODOR,"The present invention relates to an odor absorbing composition, which is safe for use on human skin, comprising from 0.1 % to 5 %, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from 0.1 % to 36 %, by weight of the composition, of an oil phase selected from the group consisting of emollients, moisturizers, and skin protectants; an emulsifier; and an aqueous carrier. The odor absorbing compositions of the present invention may also contain an effective amount of hydrophobic antimicrobials. The present invention also relates to the use of cyclodextrin-containing compositions for the manufacture of an odor absorbing composition, which is safe for use on skin, for controlling environmental malodors on skin and for reducing body odor and/or vaginal odor.",PROCTER & GAMBLE,TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/189-065-255-587-66X,Granted Patent,yes,4,1,24,28,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61Q15/00;;D06M13/005;;A61K8/73;;A61Q15/00,A61K8/00;;A61K8/02;;A61K8/04;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/44;;A61K8/73;;A61Q15/00;;D06M13/00,,3,0,,,"DATABASE WPI Week 9241 Derwent Publications Ltd., London, GB; AN 92-334323 XP002059643 & HU 60 127 A (SZIASZ SZOLGALTATO ES IPARI ALTALANOS);;DATABASE WPI Week 9331 Derwent Publications Ltd., London, GB; AN 93-249225 XP002059644 & TW 201 790 A (NAMCHOW CHEM IND CO.);;STN, File Supplier, Karlsruhe, DE, File XP002059642 & JP 04 163 372 A (TOYO INK MFG CO.)",EXPIRED
517,PE,A1,PE 100199 A1,018-000-829-369-381,1999-12-01,1999,PE 00048498 A,1998-06-09,US 87185497 A;;US 87185797 A;;US 87186097 A,1997-06-09,COMPOSICIONES SIN FRAGANCIA DE DOS FASES Y METODOS PARA REDUCIR EL MAL OLOR CORPORAL Y AMBIENTAL,"QUE COMPRENDEN: A) O,1% Y 5% APROXIMADAMENTE, EN PESO DE LA COMPOSICION, DE CICLODEXTRINA SOLUBILIZADA NO COMPLEJA SOLUBLE EN AGUA; B) DE 0,1% A 36% APROXIMADAMENTE, EN PESO DE LA COMPOSICION, DE UNA FASE DE ACEITE SELECCIONADA DE: EMOLIENTES, HUMECTANTES Y PROTECTORES DE LA PIEL; C) UNO O MAS SURFACTANTES, CADA UNO CON UN BALANCE HIDROFILO/LIPOFILO ALREDEDOR DE 8 A 18, DONDE CADA SURFACTANTE CUANDO SE COMBINA CON UNA SOLUCION DE CICLODEXTRINA ACUOSA, BRINDA NO MENOS DE 25% DE UN NIVEL DE CAPTURA DE MAL OLOR COMO SOLUCION DE CICLODEXTRINA ACUOSA; Y D) UN PORTADOR ACUOSO. UN METODO PARA REDUCIR EL MAL OLOR QUE COMPRENDE LA APLICACION EN LA PIEL DE LA COMPOSICION YA DESCRITA, LA CUAL ES DEPOSITADA EN UN LIMPIADOR CONFORMADO POR UN MEDIO DISPENSADOR FLEXIBLE. UN PROCESO PARA PREPARAR LA COMPOSICION ANTERIOR, QUE COMPRENDE: i) PREPARAR UNA MEZCLA COMBINANDO UNO O MAS SURFACTANTES, UNA FASE DE ACEITE Y UNA FASE ACUOSA HASTA QUE LA MEZCLA ESTE HOMOGENEA; ii) ANADIR CICLODEXTRINA A LA MEZCLA ANTERIOR, MEZCLANDO HASTA QUE LA CICLODEXTRINA SE DISUELVA Y LA MEZCLA ESTE HOMOGENEA",PROCTER & GAMBLE,DODD MICHAEL THOMAS;;BUCKNER ROBIN YAGER;;TRINH TOAN;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;KAJS THERESA MARIE,,https://lens.org/018-000-829-369-381,Patent Application,no,0,0,16,18,0,A61K8/19;;A61K8/27;;A61K8/347;;A61K8/37;;A61K8/39;;A61K8/44;;A61K8/4973;;A61K8/738;;A61K8/891;;A61K8/90;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61K8/39;;A61K8/37;;A61K8/90;;A61Q15/00;;A61K8/891;;A61K8/27;;A61K8/44;;A61K8/347;;A61K8/19;;A61K8/738;;A61K8/4973,A47K7/00;;A61K8/00;;A61K8/18;;A61K8/19;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/34;;A61K8/37;;A61K8/44;;A61K8/49;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;C08L83/10,,0,0,,,,DISCONTINUED
518,EP,A3,EP 0227450 A3,043-414-747-615-936,1988-01-07,1988,EP 86309957 A,1986-12-19,US 81123385 A,1985-12-20,"SUBSTITUTED 5,6-DIALKOXYQUINAZOLINE DERIVATIVES","Quinazoline derivatives having an oxy substituent in 5 and 6 positions are described. The novel quinazoline derivatives are useful as cardiotonic agents.  ",ORTHO PHARMACEUTICAL CORPORATION,"BANDURCO, VICTOR T.;;DODD, JOHN H.;;BELL, STALEY C.;;FALOTICO, ROBERT;;SCHWENDER, CHARLES F.;;TOBIA, ALFONSO J.",,https://lens.org/043-414-747-615-936,Search Report,yes,2,0,8,8,0,C07D239/95;;A61P9/04;;C07D239/95,A61K31/505;;A61K31/517;;C07D239/84;;A61P9/04;;C07D239/88;;C07D239/90;;C07D239/95,,1,1,064-212-479-045-24X,7097723;;10.1021/jm00348a018,"JOURNAL OF MEDICINAL CHEMISTRY, vol. 25, 1982, pages 703-708, American Chemical Society, Washington, US; J.A. GROSSO et al.: ""Synthesis of 2-(alkylamino)-5,6- and -6,7-dihydroxy-3,4-dihydroquinazolines and evaluation as potential dopamine agonists""",DISCONTINUED
519,CZ,A3,CZ 441199 A3,045-468-934-808-625,2000-05-17,2000,CZ 441199 A,1998-06-08,CZ 441199 A,1998-06-08,Single-phase or two-phase liquid perfume preparations absorbing body odors and method of their application,,PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/045-468-934-808-625,Patent Application,no,0,0,1,1,0,,A61K8/02;;A61K8/19;;A61K8/27;;A61K8/34;;A61K8/37;;A61K8/44;;A61K8/49;;A61K8/73;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00,,0,0,,,,PENDING
520,CZ,A3,CZ 145099 A3,098-221-122-880-574,1999-09-15,1999,CZ 145099 A,1997-10-23,US 73647196 A;;US 73647096 A;;US 94707597 A;;US 95118497 A,1996-10-24,"BAD SMELL ABSORBING AQUEOUS PREPARATION, ITS USE AND PROCESS OF ITS PREPARATION","The present invention relates to an odor absorbing composition, which is safe for use on human skin, comprising from 0.1 % to 5 %, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from 0.1 % to 36 %, by weight of the composition, of an oil phase selected from the group consisting of emollients, moisturizers, and skin protectants; an emulsifier; and an aqueous carrier. The odor absorbing compositions of the present invention may also contain an effective amount of hydrophobic antimicrobials. The present invention also relates to the use of cyclodextrin-containing compositions for the manufacture of an odor absorbing composition, which is safe for use on skin, for controlling environmental malodors on skin and for reducing body odor and/or vaginal odor.",PROCTER & GAMBLE,TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/098-221-122-880-574,Patent Application,no,0,0,24,28,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61Q15/00;;D06M13/005;;A61K8/73;;A61Q15/00,A61K8/00;;A61K8/02;;A61K8/04;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/44;;A61K8/73;;A61Q15/00;;D06M13/00,,0,0,,,,EXPIRED
521,KR,A,KR 20000052769 A,147-473-023-008-920,2000-08-25,2000,KR 19997003577 A,1999-04-23,US 73646996 A;;US 73609396 A;;US 73896496 A;;US 88960797 A;;US 94677097 A;;US 94729997 A;;US 94707697 A;;US 95118597 A,1996-10-24,COMPOSITIONS FOR REDUCING ODOR ON SKIN,"PURPOSE: An aqueous odor absorbing composition is provided for the use of the aforementioned compositions in reducing body, vaginal, and or environmental odors on skin. CONSTITUTION: An aqueous odor absorbing composition, comprises: a) 0.1% to 5%, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; b) 0.5% to 30%, by weight of the composition, of a linear dimethicone having a nominal viscosity of 350 centistokes or less; c) an effective amount of solubilized, water-soluble, antimicrobial preservative; and d) an aqueous carrier; and wherein the composition is safe for use on skin. The compositions can also comprise one or more of the following optional components: low molecular weight polyols; water-soluble antimicrobial preservatives; zinc salts; water-soluble polymers; soluble carbonate and/or bicarbonate salts; chelating agents; zeolites; activated carbon; and mixtures thereof.",PROCTER & GAMBLE,TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/147-473-023-008-920,Patent Application,no,0,0,15,24,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61K8/891;;A61Q15/00;;A61K8/73;;A61Q15/00,A61K8/02;;A61K8/04;;A61K8/27;;A61K8/44;;A61K8/73;;A61K8/891;;A61Q15/00,,0,0,,,,EXPIRED
522,US,B1,US 6344218 B1,028-960-610-289-556,2002-02-05,2002,US 32129299 A,1999-05-27,US 32129299 A;;US 19793398 A,1998-11-23,Skin deodorizing and santizing compositions,"
    The present invention relates to aqueous compositions comprising an odor controlling agent and select sanitizing agents for deodorizing and sanitizing skin surfaces. Articles of manufacture and methods of deodorizing and sanitizing the skin using disclosed compositions are also disclosed. 
",PROCTER & GAMBLE,DODD MICHAEL THOMAS;;WEI KARL SHIQING;;TRINH TOAN;;SINE MARK RICHARD;;BARTOLO ROBERT GREGORY;;JAKUBOVIC DAVID ANDREW,PROCTER & GAMBLE COMPANY THE (1999-07-14),https://lens.org/028-960-610-289-556,Granted Patent,yes,29,229,3,21,0,A61K8/0208;;A61K8/27;;A61K8/347;;A61K8/40;;A61K8/416;;A61K8/43;;A61K8/4973;;A61K8/738;;A61K8/8147;;A61Q15/00;;A61Q17/005;;A61Q17/005;;A61K8/347;;A61K8/8147;;A61K8/0208;;A61K8/40;;A61K8/43;;A61K8/738;;A61Q15/00;;A61K8/4973;;A61K8/416;;A61K8/27,A61K8/02;;A61K8/27;;A61K8/34;;A61K8/40;;A61K8/41;;A61K8/43;;A61K8/49;;A61K8/73;;A61K8/81;;A61Q15/00;;A61Q17/00,424/605;;424/76.2;;424/76.4;;424/405,0,0,,,,EXPIRED
523,NO,L,NO 996053 L,058-443-716-637-46X,2000-02-04,2000,NO 996053 A,1999-12-08,US 87157797 A;;US 87185397 A;;US 87185597 A;;US 87185897 A;;US 9811814 W,1997-06-09,"Parfymerte en- og to-fase blandinger for å redusere kroppslukt, samt fremgangsmåte ved anvendelse derav","Foreliggende oppfinnelse gjelder luktabsorberende blan- dinger og deres bruk på huden. Blandingene omfatter fra ca 0,1 til ca 5% av blandingens vekt, av løseliggjort, vann- løselig, ikke-komplekst syklodekstrin; fra 0,004 til ca 2% av blandingens vekt, av en parfymeblanding; og en vandig bærer. Blandingene kan også omfatte en lavmolekylær dime- tikon eller en oljefase valgt fra gruppen som består av mykgjørere, fuktemidler, hudbeskyttende midler, og blan- dinger av disse og en eller flere overflateaktive stoff. Den luktabsorberende blandingen i henhold til foreliggende oppfinnelse kan også ,foretrukket, inneholde en effektiv mengde av vannløselige og/eller hydrofobe antimikrobielle midler. Foreliggende oppfinnelse gjelder også luktabsor- berende blandinger avsatt på et elastisk middel til dis- pensering.",PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/058-443-716-637-46X,Abstract,no,0,0,15,21,0,A61K8/0208;;A61K8/19;;A61K8/27;;A61K8/347;;A61K8/37;;A61K8/44;;A61K8/4973;;A61K8/738;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61Q15/00;;A61K8/891;;A61K8/19;;A61K8/347;;A61K8/738;;A61K8/27;;A61K8/44;;A61K8/90;;A61K8/4973;;A61K8/37;;A61K8/0208;;A61Q13/00,A61K8/02;;A61K8/00;;A61K8/19;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/34;;A61K8/37;;A61K8/44;;A61K8/49;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;A61Q19/00;;C08L83/04;;C08L83/12,,0,0,,,,DISCONTINUED
524,TR,T2,TR 199903039 T2,111-450-939-945-465,2001-03-21,2001,TR 9903039 T,1998-06-08,US 87185497 A;;US 87185797 A;;US 87186097 A,1997-06-09,Parfüm barindirmayan iki fazli bilesimler ve vücut ve çevre kokusunun düsürülmesi için yöntemler.,"Bu bulus, insan derisi üzerinde kullanim için emin olan, bir sulu koku-sogurucu bilesime iliskindir, bu bilesim, çözündürülmüs, suda çözünür, komplekslenmemis siklodekstrini; yumusaticilar, nemlendiriciler, cilt koruyucular ve bunlarin karisimlarini kapsayan gruptan seçilen bir yagi fazini; her biri 8-18 arasinda hidrofilik/lipofilik dengeye sahip olan bir ya da daha çok sürfaktani ve bir sulu tasiyici maddeyi içermektedir; bu bilesimde, her sülfaktan, bir sulu siklodekstrin çözeltisi ile bir araya geldiginde, bir sulu siklodekstrin çözeltisi olarak % 25' den az olmayan bir koku tutma seviyesi temin etmektedir. Bu bulus, ayni zamanda, deri üzerindeki vücut ve çevre kokularinin kontrol edilmesi için yöntemleri de kapsamaktadir, bu yöntemler, bu bilesimlerin deriye uygulanmasini içermektedir.",PROCTER & GAMBLE,LUCAS JULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/111-450-939-945-465,Patent Application,no,0,0,16,18,0,A61K8/19;;A61K8/27;;A61K8/347;;A61K8/37;;A61K8/39;;A61K8/44;;A61K8/4973;;A61K8/738;;A61K8/891;;A61K8/90;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61K8/39;;A61K8/37;;A61K8/90;;A61Q15/00;;A61K8/891;;A61K8/27;;A61K8/44;;A61K8/347;;A61K8/19;;A61K8/738;;A61K8/4973,A61K8/00;;A47K7/00;;A61K8/18;;A61K8/19;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/34;;A61K8/37;;A61K8/44;;A61K8/49;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;C08L83/10,,0,0,,,,PENDING
525,AU,A,AU 2000/019188 A,196-892-254-673-681,2000-06-13,2000,AU 2000/019188 A,1999-11-22,US 19793398 A;;US 32129299 A;;US 9927688 W,1998-11-23,Skin deodorizing and sanitizing compositions,,PROCTER & GAMBLE,DODD MICHAEL THOMAS;;WEI KARL SHIQING;;TRINH TOAN;;SINE MARK RICHARD;;BARTOLO ROBERT GREGORY;;JAKUBOVIC DAVID ANDREW,,https://lens.org/196-892-254-673-681,Patent Application,no,0,0,7,21,0,A61Q17/005;;A61K8/0208;;A61K8/27;;A61K8/347;;A61K8/40;;A61K8/416;;A61K8/43;;A61K8/4973;;A61K8/738;;A61K8/8147;;A61Q15/00,A61K8/00;;A61K8/02;;A61K8/27;;A61K8/33;;A61K8/34;;A61K8/35;;A61K8/37;;A61K8/40;;A61K8/41;;A61K8/43;;A61K8/49;;A61K8/73;;A61K8/81;;A61K8/97;;A61Q15/00;;A61Q17/00;;A61Q19/10,,0,0,,,,DISCONTINUED
526,EP,B1,EP 0939614 B1,010-226-563-459-101,2002-12-11,2002,EP 97911792 A,1997-10-23,US 9718852 W;;US 73646996 A;;US 73609396 A;;US 73896496 A;;US 88960797 A;;US 94677097 A;;US 94729997 A;;US 94707697 A;;US 95118597 A,1996-10-24,COMPOSITIONS FOR REDUCING ODOR ON SKIN,"The present invention relates to an aqueous odor-absorbing composition which is safe for use on human skin comprising from about 0.1 % to about 5 %, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from about 0.5 % to about 30 %, by weight of the composition, of a linear dimethicone having a nominal viscosity of 350 centistokes or less; and an aqueous carrier. The compositions can also comprise one or more of the following optional components: low molecular weight polyols; water-soluble antimicrobial preservatives; zinc salts; water-soluble polymers; soluble carbonate and/or bicarbonate salts; chelating agents; zeolites; activated carbon; and mixtures thereof. The present invention also relates the use of the aforementioned compositions in reducing body, vaginal, and or environmental odors on skin. The composition can be applied directly as a spray, poured from a bottle and applied by hand, or applied via a wipe.",PROCTER & GAMBLE,TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/010-226-563-459-101,Granted Patent,yes,4,1,15,24,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61K8/891;;A61Q15/00;;A61K8/73;;A61Q15/00,A61K8/02;;A61K8/04;;A61K8/27;;A61K8/44;;A61K8/73;;A61K8/891;;A61Q15/00,,1,0,,,"DATABASE WPI Week 9241 Derwent Publications Ltd., London, GB; AN 92-334323 XP002059667 & HU 60 127 A (SZIASZ SZOLGALTATO ES IPARI ALTALANOS)",EXPIRED
527,DE,D1,DE 60003941 D1,033-750-481-052-24X,2003-08-21,2003,DE 60003941 T,2000-10-20,FR 9913232 A;;FR 0002927 W,1999-10-22,N-SUBSTITUIERTE 1-(BUTYROLACTON)-ISOCHINOLINE ZUR BEHANDLUNG VON NERVENSTÖRUNGEN,"The invention concerns compounds of general formula (I) wherein: Z represents a sulphur or oxygen atom, NH, N-alkyl or Nboc; group R', identical or different, represent each a hydrogen atom, a OCH3 group or a OCH2O group; group R'' represents a hydrogen or a CH3 group; group X represents a carbonyl, sulphonyl or CO2 group; and group R represents an alkyl, aryl, alkenyl or aralkyl group. The invention also concerns the preparation of said compounds, pharmaceutical compositions containing them and their use for stimulating gamma-amino-butyric acid activity and as medicine for treating nervous disorders.",CENTRE NAT RECH SCIENT;;INNOVATIONSAGENTUR GMBH BU TEC;;UNIV BERNE BERN,DODD ROBERT;;RAZET RODOLPHE;;POTIER JEAN-PAUL;;SIEGHART WERNER;;JURSKY FRANTISEK;;FURTMULLER ROMAN;;SIGEL ERWIN;;THOMET URS,,https://lens.org/033-750-481-052-24X,Granted Patent,no,0,0,12,12,0,C07D401/04;;C07D405/04;;C07D409/04;;A61P21/02;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/28;;A61P25/32;;A61P43/00;;C07D401/04;;C07D405/04;;C07D409/04,C07D491/056;;A61K31/4725;;A61K31/4741;;A61P21/02;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/28;;A61P25/32;;A61P43/00;;C07D401/04;;C07D405/04;;C07D409/04,,0,0,,,,EXPIRED
528,TR,T2,TR 199900877 T2,114-813-635-170-364,1999-07-21,1999,TR 9900877 T,1997-10-23,US 73646996 A;;US 73609396 A;;US 73896496 A;;US 88960797 A;;US 94677097 A;;US 94729997 A;;US 94707697 A;;US 95118597 A,1996-10-24,Cilt üzerindeki kokunun azaltilmasi için bilesimler.,"The present invention relates to an aqueous odor-absorbing composition which is safe for use on human skin comprising from about 0.1 % to about 5 %, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from about 0.5 % to about 30 %, by weight of the composition, of a linear dimethicone having a nominal viscosity of 350 centistokes or less; and an aqueous carrier. The compositions can also comprise one or more of the following optional components: low molecular weight polyols; water-soluble antimicrobial preservatives; zinc salts; water-soluble polymers; soluble carbonate and/or bicarbonate salts; chelating agents; zeolites; activated carbon; and mixtures thereof. The present invention also relates the use of the aforementioned compositions in reducing body, vaginal, and or environmental odors on skin. The composition can be applied directly as a spray, poured from a bottle and applied by hand, or applied via a wipe.",PROCTER & GAMBLE,TRINH TOAN;;DODD MICHAEL THOMAS;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;BUCKNER ROBIN YAGER;;KAJS THERESA MARIE,,https://lens.org/114-813-635-170-364,Patent Application,no,0,0,15,24,0,A61K8/0208;;A61K8/046;;A61K8/27;;A61K8/44;;A61K8/738;;A61K8/891;;A61Q15/00;;A61K8/73;;A61Q15/00,A61K8/02;;A61K8/04;;A61K8/27;;A61K8/44;;A61K8/73;;A61K8/891;;A61Q15/00,,0,0,,,,PENDING
529,CA,A1,CA 2293403 A1,186-359-764-558-466,1998-12-17,1998,CA 2293403 A,1998-06-08,US 87157797 A;;US 87185397 A;;US 87185597 A;;US 87185897 A;;US 9811814 W,1997-06-09,PERFUMED ONE AND TWO PHASE COMPOSITIONS FOR REDUCING BODY ODOR AND METHODS OF USE THEREOF,"The present invention relates to odor absorbing compositions and their use on skin. The compositions comprise from about 0.1 % to about 5 % by weight of the compositions, of solubilized, water-soluble, uncomplexed cyclodextrin; from about 0.004 % to about 2 % by weight of the composition, of a perfume composition; and an aqueous carrier. The compositions may also comprise either a low molecular weight dimethicone or an oil phase selected from the group consisting of emollients, moisturizers, skin protectants, and mixtures thereof and one or more surfactants. The odor absorbing compositions of the present invention may also, preferably, contain an effective amount of water soluble and/or hydrophobic antimicrobials. The present invention also relates to the odor absorbing compositions deposited on a flexible dispensing means.",PROCTER & GAMBLE,KAJS THERESA MARIE;;BUCKNER ROBIN YAGER;;BARTOLO ROBERT GREGORY;;LUCAS JULIET MARIE;;TRINH TOAN;;DODD MICHAEL THOMAS,,https://lens.org/186-359-764-558-466,Patent Application,no,0,0,15,21,0,A61K8/0208;;A61K8/19;;A61K8/27;;A61K8/347;;A61K8/37;;A61K8/44;;A61K8/4973;;A61K8/738;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;A61K8/73;;A61Q15/00;;A61Q15/00;;A61K8/891;;A61K8/19;;A61K8/347;;A61K8/738;;A61K8/27;;A61K8/44;;A61K8/90;;A61K8/4973;;A61K8/37;;A61K8/0208;;A61Q13/00,A61K8/00;;A61K8/02;;A61K8/19;;A61K8/25;;A61K8/27;;A61K8/33;;A61K8/34;;A61K8/37;;A61K8/44;;A61K8/49;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K8/90;;A61Q13/00;;A61Q15/00;;A61Q19/00;;C08L83/04;;C08L83/12,,0,0,,,,DISCONTINUED
530,FR,A1,FR 2999575 A1,002-279-436-634-922,2014-06-20,2014,FR 1262275 A,2012-12-18,FR 1262275 A,2012-12-18,"3,5-DIARYL-AZAINDOLES COMME INHIBITEURS DE LA PROTEINE DYRK1A POUR LE TRAITEMENT DES DEFICIENCES COGNITIVES LIEES AU SYNDROME DE DOWN ET A LA MALADIE D'ALZHEIMER","La présente invention concerne un composé de formule (I) et ses sels, solvates et hydrates pharmaceutiquement acceptables : dans lequel : 1 à 3 groupes parmi X1-X5 ne sont pas un atome d'hydrogène et les autres groupes X1-X5 sont des atomes d'hydrogène, et 1 à 3 groupes parmi Y1-Y5 ne sont pas un atome d'hydrogène et les autres groupes Y1-Y5 sont des atomes d'hydrogène, et son utilisation en tant que médicament, notamment pour le traitement des troubles cognitifs liés au dysfonctionnement de la protéine Dyrk1A.",CENTRE NAT RECH SCIENT;;UNIV REIMS CHAMPAGNE ARDENNE;;UNIV PARIS DIDEROT PARIS 7,DODD ROBERT;;CARIOU KEVIN;;GOURDAIN STEPHANIE;;DELABAR JEAN MAURICE;;JANEL NATHALIE;;RODRIGUES LIMA FERNANDO;;DAIROU JULIEN;;DENHEZ CLEMENT,,https://lens.org/002-279-436-634-922,Patent Application,no,6,0,7,7,0,A61P25/28;;C07D471/04;;C07D471/04,C07D471/04;;A61K31/437;;A61P25/28;;C07D207/20;;C07D213/30;;C12Q1/48,,0,0,,,,PENDING
531,EP,A1,EP 1309455 A1,097-830-256-702-017,2003-05-14,2003,EP 01968656 A,2001-09-07,US 0128081 W;;US 77318201 A,2001-01-30,NARROW INK JET PRINTHEAD,,HEWLETT PACKARD CO,"TORGERSON, JOSEPH, M.;;BROWNING, ROBERT, N., K.;;MACKENZIE, MARK, H.;;MILLER, MICHAEL, D.;;BAKKOM, ANGELA, WHITE;;DODD, SIMON","HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (2012-09-11)",https://lens.org/097-830-256-702-017,Patent Application,yes,0,0,34,34,0,B41J2/14072;;B41J2/15;;B41J2/14072;;B41J2/15,B41J2/15;;B41J2/05,,0,0,,,,EXPIRED
532,US,B1,US 6422676 B1,097-023-993-381-398,2002-07-23,2002,US 88339801 A,2001-06-19,US 88339801 A,2001-06-19,Compact ink jet printhead,"
    A compact thermal ink jet printhead including a printhead substrate, a plurality of side by side columnar arrays of drop generators formed in the printhead substrate, and drive circuits formed in the printhead substrate for energizing each ink drop generator. The printhead substrate has an ink drop generator packing density of at least 10.43 ink drop generators per square millimeter. 
",HEWLETT PACKARD CO,TORGERSON JOSEPH M;;BROWNING ROBERT N K;;MACKENZIE MARK H;;MILLER MICHAEL D;;BAKKOM ANGELA W;;DODD SIMON,HEWLETT-PACKARD COMPANY (2001-06-14);;HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2005-01-11),https://lens.org/097-023-993-381-398,Granted Patent,yes,1,25,23,23,0,B41J2/14072;;B41J2/15;;B41J2/145;;B41J2/14072;;B41J2/15,B41J2/14;;B41J2/15;;B41J2/05;;B41J2/175,347/13;;347/57,0,0,,,,EXPIRED
533,CA,A1,CA 2896209 A1,118-337-472-698-383,2014-06-26,2014,CA 2896209 A,2013-12-18,FR 1262275 A;;EP 2013077224 W,2012-12-18,"3,5-DIARYLAZAINDOLES AS DYRK1A PROTEIN INHIBITORS FOR THE TREATMENT OF COGNITIVE DEFICIENCES ASSOCIATED WITH DOWN'S SYNDROME AND WITH ALZHEIMER'S DISEASE","The present invention relates to a compound of formula (I') or a pharmaceutically acceptable salt, solvate or hydrate thereof, in which: X3 is F, OH or SH, Y3 is F, OH or SH, X1, X2, X4, X5, ?1, Y2, Y4 and Y5 are, independently of one another, H, F, Cl, Br, OH or SH, and 1 to 2 groups among the X1, X2, X4 and X5 radicals are other than H and/or 1 to 2 groups among the ?1, Y2, Y4 and Y5 radicals are other than H. The present invention also relates to a compound of formula (I') for use as a medicament, in particular in the prevention and/or treatment of cognitive disorders associated with a dysfunction of the Dyrk1A protein.",UNIV PARIS DIDEROT PARIS 7;;CENTRE NAT RECH SCIENT;;UNIV REIMS CHAMPAGNE ARDENNE,DODD ROBERT;;CARIOU KEVIN;;GOURDAIN STEPHANIE;;DELABAR JEAN MAURICE;;JANEL NATHALIE;;RODRIGUES LIMA FERNANDO;;DAIROU JULIEN;;DENHEZ CLEMENT,,https://lens.org/118-337-472-698-383,Patent Application,no,0,0,7,7,2,C07D471/04;;A61P25/28;;C07D471/04,C07D471/04;;A61K31/437;;A61P25/28,,0,0,,,,DISCONTINUED
534,PL,A1,PL 358619 A1,060-783-742-395-911,2004-08-09,2004,PL 35861901 A,2001-09-07,US 77318201 A,2001-01-30,NARROW INK JET PRINTHEAD,,HEWLETT PACKARD CO,TORGERSON JOSEPH M;;BROWNING ROBERT N K;;MACKENZIE MARK H;;MILLER MICHAEL D;;BAKKOMA ANGELA WHITE;;DODD SIMON,,https://lens.org/060-783-742-395-911,Patent Application,no,0,0,34,34,0,B41J2/14072;;B41J2/15;;B41J2/14072;;B41J2/15,B41J2/15;;B41J2/05,,0,0,,,,EXPIRED
535,HK,A1,HK 1052163 A1,095-877-736-616-623,2003-09-05,2003,HK 03104398 A,2003-06-18,US 77318201 A;;US 0128081 W,2001-01-30,Narrow ink jet printhead,,HEWLETT PACKARD CO,TORGERSON JOSEPH M;;BROWNING ROBERT N K;;MACKENZIE MARK H;;MILLER MICHAEL D;;BAKKOM ANGELA WHITE;;DODD SIMON,,https://lens.org/095-877-736-616-623,Patent Application,no,0,0,34,34,0,B41J2/14072;;B41J2/15;;B41J2/14072;;B41J2/15,B41J/;;B41J2/15;;B41J2/05,,0,0,,,,EXPIRED
536,US,A1,US 2003/0122893 A1,039-505-062-553-874,2003-07-03,2003,US 27808502 A,2002-10-22,US 27808502 A;;US 77318201 A,2001-01-30,Ink jet printhead,"
   A narrow ink jet printhead having four columnar arrays of ink drop generators configured for monochrome single-pass printing at a print resolution having a media axis dot spacing that is less than the columnar nozzle spacing of the ink drop generators. The ink jet printhead more particularly includes high resistance heater resistors and efficient FET drive circuits that are configured to compensate for variation in parasitic resistance presented by power traces. 
",TORGERSON JOSEPH M.;;BROWNING ROBERT N.K.;;MACKENZIE MARK H.;;MILLER MICHAEL D.;;BAKKOM ANGELA W.;;DODD SIMON,TORGERSON JOSEPH M;;BROWNING ROBERT N K;;MACKENZIE MARK H;;MILLER MICHAEL D;;BAKKOM ANGELA W;;DODD SIMON,HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2003-01-31),https://lens.org/039-505-062-553-874,Patent Application,yes,0,0,34,34,0,B41J2/14072;;B41J2/15;;B41J2/14072;;B41J2/15,B41J2/15;;B41J2/05,347 4,0,0,,,,EXPIRED
537,NZ,A,NZ 523869 A,034-341-268-330-078,2005-01-28,2005,NZ 52386901 A,2001-09-07,US 77318201 A;;US 0128081 W,2001-01-30,Narrow ink jet printhead,"A narrow ink jet printhead (100) having four columnar arrays (61) of ink drop generators (40) configured for monochrome single-pass printing at a print resolution having a media axis dot spacing that is less than the columnar nozzle spacing of the ink drop generators. The ink jet printhead more particularly includes high resistance heater resistors (56) and efficient FET drive circuits (85) that are configured to compensate for variation in parasitic resistance presented by power traces (86a, 86b, 86c and 86d).",HEWLETT PACKARD CO,TORGERSON JOSEPH M;;BROWNING ROBERT N K;;MACKENZIE MARK H;;MILLER MICHAEL D;;BAKKOM ANGELA WHITE;;DODD SIMON,,https://lens.org/034-341-268-330-078,Patent Application,no,0,0,34,34,0,B41J2/14072;;B41J2/15;;B41J2/14072;;B41J2/15,B41J2/15;;B41J2/05,,0,0,,,,DISCONTINUED
538,CA,C,CA 2451629 C,068-649-916-689-324,2008-11-18,2008,CA 2451629 A,2001-09-06,US 88339801 A;;US 0128151 W,2001-06-19,COMPACT INK JET PRINTHEAD,"A compact thermal ink jet printhead including a printhead substrate (11), a plurality of side by side columnar arrays (61) of drop generators (40) forme d in the printhead substrate, and drive circuits (85) formed in the printhead substrate for energizing each ink drop generator. The printhead substrate ha s an ink drop generator packing density of at least 10.43 ink drop generators per square millimeter.",HEWLETT PACKARD CO,MACKENZIE MARK H;;TORGERSON JOSEPH M;;BROWNING ROBERT N K;;MILLER MICHAEL D;;BAKKOM ANGELA W;;DODD SIMON,,https://lens.org/068-649-916-689-324,Granted Patent,no,0,0,23,23,0,B41J2/14072;;B41J2/15;;B41J2/145;;B41J2/14072;;B41J2/15,B41J2/05;;B41J2/15;;B41J2/04;;B41J2/14;;B41J2/175,,0,0,,,,EXPIRED
539,FR,A1,FR 2800072 A1,029-948-181-543-580,2001-04-27,2001,FR 9913232 A,1999-10-22,FR 9913232 A,1999-10-22,"New N-substituted 1-heterocyclyl-isoquinoline derivatives, are gamma-aminobutyric acid activity stimulants useful for treating nervous disorders e.g. epilepsy, anxiety, depression or pain","N-Acylated 1-(2,3,4,5-Tetrahydro-5-oxo-2-furyl, -thienyl or -pyrrolyl)-1,2,3,4-tetrahydro- or 3,4-dihydroisoquinoline derivatives (I) are new. N-Acylated 1-(2,3,4,5-Tetrahydro-5-oxo-2-furyl, -thienyl or -pyrrolyl)-1,2,3,4-tetrahydro- or 3,4-dihydroisoquinoline derivatives of formula (I), in racemate or pure optical isomer form, are new. Z' = O, S, NH-N-alkyl or N-Boc; R' = H or OMe, or Z' + R' = OCH2O; R'' = H or Me; X = CO, SO2 or COO, and R = alkyl, aryl, alkenyl or aralkyl. An Independent claim is included for the preparation of (I).",CENTRE NAT RECH SCIENT,DODD ROBERT;;RAZET RODOLPHE;;POTIER PIERRE JEAN PAUL;;SIEGHART WERNER;;JURSKY FRANTISEK;;FURTMULLER ROMAN;;SIGEL ERWIN;;THOMET URS,,https://lens.org/029-948-181-543-580,Patent Application,no,2,0,12,12,0,C07D401/04;;C07D405/04;;C07D409/04;;A61P21/02;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/28;;A61P25/32;;A61P43/00;;C07D401/04;;C07D405/04;;C07D409/04,A61K31/4725;;A61K31/4741;;A61P21/02;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/20;;A61P25/22;;C07D491/056;;A61P25/24;;A61P25/28;;A61P25/32;;A61P43/00;;C07D401/04;;C07D405/04;;C07D409/04,,1,1,098-025-051-359-723,8057295;;10.1021/jm00042a001,"P. KROGSGAARD-LARSEN ET AL: ""Gaba(A) receptor agonists, partial agonists and antagonists. Design and therapeutic prospects"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 37, no. 16, 1994, WASHINGTON US, pages 2489 - 2505, XP002141451",EXPIRED
540,PL,B1,PL 199531 B1,060-521-235-963-347,2008-09-30,2008,PL 35861901 A,2001-09-07,US 77318201 A,2001-01-30,NARROW INK JET PRINTHEAD,,HEWLETT PACKARD CO,TORGERSON JOSEPH M;;BROWNING ROBERT N K;;MACKENZIE MARK H;;MILLER MICHAEL D;;BAKKOM ANGELA WHITE;;DODD SIMON,,https://lens.org/060-521-235-963-347,Granted Patent,no,0,0,34,34,0,B41J2/14072;;B41J2/15;;B41J2/14072;;B41J2/15,B41J2/05;;B41J2/15,,0,0,,,,EXPIRED
541,MY,A,MY 130478 A,152-368-608-533-911,2007-06-29,2007,MY PI20014686 A,2001-10-09,US 88339801 A,2001-06-19,COMPACT INK JET PRINTHEAD,"A COMPACT THEREMAL INK JET PRINTHEAD INCLUDING PRINTHEAD SUBSTRATE (11), A PLURALITY OF SIDE BY SIDE COLUMNAR ARRAYS (61) OF DROP GENERATORS (40) FORMED IN THE PRINTHEAD SUBSTRATE, AND DRIVE CIRCUITS (85) FORMED IN THE PRINTHEAD SUBSTRATE FOR ENERGIZING EACH INK DROP GENERATOR. THE PRINTHEAD SUBSTRATE HAS AN INK DROP GENERATOR PACKING DENSITY OF AT LEAST 10.43 INK DROP GENERATORS PER SQUARE MILLIMETER.(FIG 1)",HEWLETT PACKARD CO,TORGERSON JOSEPH M;;BROWNING ROBERT N K;;MACKENZIE MARK H;;MILLER MICHAEL D;;BAKKOM ANGELA W;;DODD SIMON,,https://lens.org/152-368-608-533-911,Granted Patent,no,0,0,23,23,0,B41J2/14072;;B41J2/15;;B41J2/145;;B41J2/14072;;B41J2/15,B41J2/05;;B41J2/14;;B41J2/15;;B41J2/175,,0,0,,,,EXPIRED
542,US,B2,US 6523935 B2,151-629-353-925-193,2003-02-25,2003,US 77318201 A,2001-01-30,US 77318201 A,2001-01-30,Narrow ink jet printhead,"
    A narrow ink jet printhead having four columnar arrays of ink drop generators configured for monochrome single-pass printing at a print resolution having a media axis dot spacing that is less than the columnar nozzle spacing of the ink drop generators. The ink jet printhead more particularly includes high resistance heater resistors and efficient FET drive circuits that are configured to compensate for variation in parasitic resistance presented by power traces. 
",HEWLETT PACKARD CO,TORGERSON JOSEPH M;;BROWNING ROBERT N K;;MACKENZIE MARK H;;MILLER MICHAEL D;;BAKKOM ANGELA WHITE;;DODD SIMON,HEWLETT-PACKARD COMPANY (2002-01-23);;HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2005-01-11),https://lens.org/151-629-353-925-193,Granted Patent,yes,11,11,34,34,0,B41J2/14072;;B41J2/15;;B41J2/14072;;B41J2/15,B41J2/15;;B41J2/05,347/40,1,0,,,"International Search Report mailed Apr. 15, 2002, regarding International Application No. PCT/US 01/28081.",EXPIRED
543,AU,B2,AU 2001/288890 B2,116-673-666-318-975,2005-12-08,2005,AU 2001/288890 A,2001-09-07,US 77318201 A;;US 0128081 W,2001-01-30,Narrow ink jet printhead,,HEWLETT PACKARD DEVELOPMENT CO LP,DODD SIMON;;MACKENZIE MARK H;;BAKKOM ANGELA WHITE;;TORGERSON JOSEPH M;;MILLER MICHAEL D;;BROWNING ROBERT N K,"HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (2012-08-02)",https://lens.org/116-673-666-318-975,Granted Patent,no,0,0,34,34,0,B41J2/14072;;B41J2/15;;B41J2/14072;;B41J2/15,B41J2/05;;B41J2/15,,0,0,,,,EXPIRED
544,AT,T1,AT E245155 T1,171-019-302-692-649,2003-08-15,2003,AT 00969659 T,2000-10-20,FR 9913232 A;;FR 0002927 W,1999-10-22,N-SUBSTITUIERTE 1-(BUTYROLACTON)-ISOCHINOLINE ZUR BEHANDLUNG VON NERVENSTÖRUNGEN,"The invention concerns compounds of general formula (I) wherein: Z represents a sulphur or oxygen atom, NH, N-alkyl or Nboc; group R', identical or different, represent each a hydrogen atom, a OCH3 group or a OCH2O group; group R'' represents a hydrogen or a CH3 group; group X represents a carbonyl, sulphonyl or CO2 group; and group R represents an alkyl, aryl, alkenyl or aralkyl group. The invention also concerns the preparation of said compounds, pharmaceutical compositions containing them and their use for stimulating gamma-amino-butyric acid activity and as medicine for treating nervous disorders.",CENTRE NAT RECH SCIENT;;INNOVATIONSAGENTUR GMBH BU TEC;;UNIV BERNE,DODD ROBERT;;RAZET RODOLPHE;;POTIER PIERRE JEAN-PAUL;;SIEGHART WERNER;;JURSKY FRANTISEK;;FURTMULLER ROMAN;;SIGEL ERWIN;;THOMET URS,,https://lens.org/171-019-302-692-649,Granted Patent,no,0,0,12,12,0,C07D401/04;;C07D405/04;;C07D409/04;;A61P21/02;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/28;;A61P25/32;;A61P43/00;;C07D401/04;;C07D405/04;;C07D409/04,C07D491/056;;A61K31/4725;;A61K31/4741;;A61P21/02;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/28;;A61P25/32;;A61P43/00;;C07D401/04;;C07D405/04;;C07D409/04,,0,0,,,,DISCONTINUED
545,PL,A1,PL 365777 A1,008-437-147-922-564,2005-01-10,2005,PL 36577701 A,2001-09-06,US 0128151 W;;US 88339801 A,2001-06-19,COMPACT INK JET PRINTHEAD,,HEWLETT PACKARD CO,TORGERSON JOSEPH M;;BROWNING ROBERT N K;;MACKENZIE MARK H;;MILLER MICHAEL D;;BAKKOM ANGELA W;;DODD SIMON,,https://lens.org/008-437-147-922-564,Patent Application,no,0,0,23,23,0,B41J2/14072;;B41J2/15;;B41J2/145;;B41J2/14072;;B41J2/15,B41J2/14;;B41J2/05;;B41J2/15;;B41J2/175,,0,0,,,,EXPIRED
546,MY,A,MY 127429 A,111-026-432-004-428,2006-11-30,2006,MY PI20014689 A,2001-10-09,US 77318201 A,2001-01-30,NARROW INK JET PRINTHEAD,"A NARROE INK JET PRINTHEAD (100) HAVING FOUR COLUMNAR ARRAYS (61) OF INK DROP GENERATORS (40) CONFIGURED FOR MONOCHROME SINGLE-PASS PRINTING AT A PRINT RESOLUTION HAVING A MEDIA AXIS DOT SPACING THAT IS LESS THAN THE COLUMNAR NOZZLE SPACING OF THE INK DROP GENERATORS. THE INK JET PRINTHEAD MORE PARTICULARLY INCLUDES HIGH RESISTANCE HEATER RESISTORS (56) AND EFFICIENT FET DRIVE CIRCUITS (85) THAT ARE CONFIGURED TO COMPENSATE FOR VARIATION IN PARASITIC RESISTANCE PRESENTED BY POWER TRACES (86A, 86B, 86C, 86D, 181). (FIGURE 1)",HEWLETT PACKARD CO,JOSEPH M TORGERSON;;ROBERT N K BROWNING;;MARK H MACKENZIE;;MICHAEL D MILLER;;ANGELA W BAKKOM;;SIMON DODD,,https://lens.org/111-026-432-004-428,Granted Patent,no,0,0,34,34,0,B41J2/14072;;B41J2/15;;B41J2/14072;;B41J2/15,B41J2/05;;B41J2/15;;B41J2/145,,0,0,,,,EXPIRED
547,RU,C2,RU 2270760 C2,108-662-655-285-756,2006-02-27,2006,RU 2003102624 A,2001-09-07,US 77318201 A,2001-01-30,NARROW-SPRAY PRINTING HEAD,"FIELD: pray printing, in particular, narrow-spray printing head. ^ SUBSTANCE: the spray printing head (100) has four column matrices (61) of ink drop formers configurated for monochromatic single-pass printing with a printing resolution having a pitch of the points of the carrier axis that is less than the pitch of the column nozzles of the ink drop formers. The spray printing head has high-resistance heating resistors and control circuits , which are configurated so as to compensate for the parasitic resistance introduced by the power supply routes (86a, 86b, 86c, 86d). ^ EFFECT: provided compactness of the construction of the spray printing head at a great number of ink drop formers. ^ 22 cl, 11 dwg",,TORGERSON DZHOZEF M;;BRAUNING ROBERT N K;;MAKKENZI MARK G;;MILLER MAJKL D;;BEHKKOM ANDZHELA UAJT;;DODD SIMON,,https://lens.org/108-662-655-285-756,Granted Patent,no,0,1,34,34,0,B41J2/14072;;B41J2/15;;B41J2/14072;;B41J2/15,B41J2/05;;B41J2/15,,0,0,,,,EXPIRED
548,CA,A1,CA 2387972 A1,009-526-862-987-35X,2001-04-26,2001,CA 2387972 A,2000-10-20,FR 9913232 A;;FR 0002927 W,1999-10-22,N-SUBSTITUTED 1-(LACTONE) ISOQUINOLONES FOR TREATING NERVOUSDISORDERS,"The invention concerns compounds of general formula (I) wherein: Z represents a sulphur or oxygen atom, NH, N-alkyl or Nboc; group R', identical or different, represent each a hydrogen atom, a OCH3 group or a OCH2O group; group R'' represents a hydrogen or a CH3 group; group X represents a carbonyl, sulphonyl or CO2 group; and group R represents an alkyl, aryl, alkenyl or aralkyl group. The invention also concerns the preparation of said compounds, pharmaceutical compositions containing them and their use for stimulating gamma-amino-butyric acid activity and as medicine for treating nervous disorders.",CENTRE NAT RECH SCIENT;;UNIV BERN;;INNOVATIONSAGENTUR GMBH,THOMET URS;;JURSKY FRANTISEK;;FURTMULLER ROMAN;;SIGEL ERWIN;;SIEGHART WERNER;;POTIER PIERRE JEAN-PAUL;;RAZET RODOLPHE;;DODD ROBERT,,https://lens.org/009-526-862-987-35X,Patent Application,no,0,0,12,12,0,C07D401/04;;C07D405/04;;C07D409/04;;A61P21/02;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/28;;A61P25/32;;A61P43/00;;C07D401/04;;C07D405/04;;C07D409/04,C07D491/056;;A61K31/4725;;A61K31/4741;;A61P21/02;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/28;;A61P25/32;;A61P43/00;;C07D401/04;;C07D405/04;;C07D409/04,,0,0,,,,DISCONTINUED
549,WO,A1,WO 2002/060696 A1,041-990-640-555-93X,2002-08-08,2002,US 0128081 W,2001-09-07,US 77318201 A,2001-01-30,NARROW INK JET PRINTHEAD,"A narrow ink jet printhead (100) having four columnar arrays (61) of ink drop generators (40) configured for monochrome single-pass printing at a print resolution having a media axis dot spacing that is less than the columnar nozzle spacing of the ink drop generators. The ink jet printhead more particularly includes high resistance heater resistors (56) and efficient FET drive circuits (85) that are configured to compensate for variation in parasitic resistance presented by power traces (86a, 86b, 86c, 86d, 181).",HEWLETT PACKARD CO,TORGERSON JOSEPH M;;BROWNING ROBERT N K;;MACKENZIE MARK H;;MILLER MICHAEL D;;BAKKOM ANGELA WHITE;;DODD SIMON,,https://lens.org/041-990-640-555-93X,Patent Application,yes,12,0,34,34,0,B41J2/14072;;B41J2/15;;B41J2/14072;;B41J2/15,B41J2/15;;B41J2/05,,0,0,,,,PATENTED
550,PL,B1,PL 199677 B1,051-153-370-256-300,2008-10-31,2008,PL 36577701 A,2001-09-06,US 0128151 W;;US 88339801 A,2001-06-19,COMPACT INK JET PRINTHEAD,,HEWLETT PACKARD CO,TORGERSON JOSEPH M;;BROWNING ROBERT N K;;MACKENZIE MARK H;;MILLER MICHAEL D;;BAKKOM ANGELA W;;DODD SIMON,,https://lens.org/051-153-370-256-300,Granted Patent,no,0,0,23,23,0,B41J2/14072;;B41J2/15;;B41J2/145;;B41J2/14072;;B41J2/15,B41J2/05;;B41J2/14;;B41J2/15;;B41J2/175,,0,0,,,,EXPIRED
551,WO,A3,WO 2002/102597 A3,057-990-851-020-530,2003-03-27,2003,US 0128151 W,2001-09-06,US 88339801 A,2001-06-19,COMPACT INK JET PRINTHEAD,"A compact thermal ink jet printhead including a printhead substrate (11), a plurality of side by side columnar arrays (61) of drop generators (40) formed in the printhead substrate, and drive circuits (85) formed in the printhead substrate for energizing each ink drop generator. The printhead substrate has an ink drop generator packing density of at least 10.43 ink drop generators per square millimeter.",HEWLETT PACKARD CO,TORGERSON JOSEPH M;;BROWNING ROBERT N K;;MACKENZIE MARK H;;MILLER MICHAEL D;;BAKKOM ANGELA W;;DODD SIMON,,https://lens.org/057-990-851-020-530,Search Report,yes,12,0,23,23,0,B41J2/14072;;B41J2/15;;B41J2/145;;B41J2/14072;;B41J2/15,B41J2/14;;B41J2/05;;B41J2/15;;B41J2/175,,1,0,,,"UEDA D ET AL: ""DEEP-TRENCH POWER MOSFET WITH AN RON AREA PRODUCT OF 160 MOMEGA MM2"", INTERNATIONAL ELECTRON DEVICES MEETING. LOS ANGELES, DEC. 7 - 10, 1986, NEW YORK, IEEE, US, December 1986 (1986-12-01), pages 638 - 641, XP000842695",PENDING
552,EP,B1,EP 1224182 B1,067-197-870-156-096,2003-07-16,2003,EP 00969659 A,2000-10-20,FR 0002927 W;;FR 9913232 A,1999-10-22,N-SUBSTITUTED 1-(BUTYROLACTONE)-ISOQUINOLINES FOR TREATING NERVOUS DISORDERS,"The invention concerns compounds of general formula (I) wherein: Z represents a sulphur or oxygen atom, NH, N-alkyl or Nboc; group R', identical or different, represent each a hydrogen atom, a OCH3 group or a OCH2O group; group R'' represents a hydrogen or a CH3 group; group X represents a carbonyl, sulphonyl or CO2 group; and group R represents an alkyl, aryl, alkenyl or aralkyl group. The invention also concerns the preparation of said compounds, pharmaceutical compositions containing them and their use for stimulating gamma-amino-butyric acid activity and as medicine for treating nervous disorders.",CENTRE NAT RECH SCIENT;;INNOVATIONSAGENTUR GMBH BU TEC;;UNIV BERNE,DODD ROBERT;;RAZET RODOLPHE;;POTIER PIERRE JEAN-PAUL;;SIEGHART WERNER;;JURSKY FRANTISEK;;FURTMULLER ROMAN;;SIGEL ERWIN;;THOMET URS,,https://lens.org/067-197-870-156-096,Granted Patent,yes,2,0,12,12,0,C07D401/04;;C07D405/04;;C07D409/04;;A61P21/02;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/28;;A61P25/32;;A61P43/00;;C07D401/04;;C07D405/04;;C07D409/04,C07D491/056;;A61K31/4725;;A61K31/4741;;A61P21/02;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/28;;A61P25/32;;A61P43/00;;C07D401/04;;C07D405/04;;C07D409/04,,2,0,,,"P. KROGSGAARD-LARSEN ET AL: ""Gaba(A) receptor agonists, partial agonists and antagonists. Design and therapeutic prospects"" JOURNAL OF MEDICINAL CHEMISTRY, vol. 37, no. 16, 1994, pages 2489-2505, XP002141451 WASHINGTON US cité dans la demande;;CHEMICAL ABSTRACTS, vol. 117, no. 21, 23 novembre 1992 (1992-11-23) Columbus, Ohio, US; abstract no. 205616, MINCHIN M.C.W. ET AL: ""A novel GABA-like autoreceptor modulates GABA release"" XP002159129 & MOL. NEUROPHARMACOL., vol. 2, no. 2, 1992, pages 137-139,",EXPIRED
553,EP,A2,EP 1397256 A2,099-813-974-439-434,2004-03-17,2004,EP 01972965 A,2001-09-06,US 0128151 W;;US 88339801 A,2001-06-19,COMPACT INK JET PRINTHEAD,,HEWLETT PACKARD CO,TORGERSON JOSEPH M;;BROWNING ROBERT N K;;MACKENZIE MARK H;;MILLER MICHAEL D;;BAKKOM ANGELA W;;DODD SIMON,,https://lens.org/099-813-974-439-434,Patent Application,yes,0,0,23,23,0,B41J2/14072;;B41J2/15;;B41J2/145;;B41J2/14072;;B41J2/15,B41J2/05;;B41J2/14;;B41J2/15;;B41J2/175,,0,0,,,,DISCONTINUED
554,EP,A1,EP 2953947 A1,105-532-503-780-630,2015-12-16,2015,EP 13811495 A,2013-12-18,FR 1262275 A;;EP 2013077224 W,2012-12-18,"3,5-DIARYLAZAINDOLES AS DYRK1A PROTEIN INHIBITORS FOR THE TREATMENT OF COGNITIVE DEFICIENCES ASSOCIATED WITH DOWN'S SYNDROME AND WITH ALZHEIMER'S DISEASE",,CENTRE NAT RECH SCIENT;;UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE;;UNIV PARIS DIDEROT PARIS 7,DODD ROBERT;;CARIOU KEVIN;;GOURDAIN STÉPHANIE;;DELABAR JEAN MAURICE;;JANEL NATHALIE;;RODRIGUES LIMA FERNANDO;;DAIROU JULIEN;;DENHEZ CLÉMENT,,https://lens.org/105-532-503-780-630,Patent Application,yes,0,0,7,7,0,C07D471/04;;A61P25/28;;C07D471/04,A61K31/437;;C07D471/04;;A61P25/28,,1,1,025-601-187-378-100,10.1021/jm401049v;;24188002,"STÉPHANIE GOURDAIN ET AL: ""Development of DANDYs, New 3,5-Diaryl-7-azaindoles Demonstrating Potent DYRK1A Kinase Inhibitory Activity"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 56, no. 23, 12 December 2013 (2013-12-12), US, pages 9569 - 9585, XP055582476, ISSN: 0022-2623, DOI: 10.1021/jm401049v",DISCONTINUED
555,US,B1,US 6649626 B1,165-062-428-565-924,2003-11-18,2003,US 11108102 A,2002-08-15,FR 9913232 A;;FR 0002927 W,1999-10-22,N-substituted 1-(lactone) isoquinolones for treating nervous disorders,"
    The invention concerns compounds of general formula (I) wherein: Z represents a sulphur or oxygen atom, NH, N-alkyl or Nboc; group R, identical or different, represent each a hydrogen atom, a OCH _{ 3 } group or a OCH _{ 2 } O group; group R represents a hydrogen or a CH _{ 3 } group; group X represents a carbonyl, sulphonyl or CO _{ 2 } group; and group R represents an alkyl, aryl, alkenyl or aralkyl group. The invention also concerns the preparation of said compounds, pharmaceutical compositions containing them and their use for stimulating -amino-butyric acid activity and as medicine for treating nervous disorders. 
",CENTRE NAT RECH SCIENT;;UNIV BERN;;INNOVATIONSAGENTUR GMBH,DODD ROBERT;;RAZET RODOLPHE;;POTIER PIERRE JEAN-PAUL;;SIEGHART WERNER;;JURSKY FRANTISEK;;FURTMULLER ROMAN;;SIGEL ERWIN;;THOMET URS,INNOVATIONSAGENTUR GMBH (2002-06-17);;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (2002-06-17);;UNIVERSITE DE BERN (2002-06-17),https://lens.org/165-062-428-565-924,Granted Patent,yes,2,6,12,12,0,C07D401/04;;C07D405/04;;C07D409/04;;A61P21/02;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/28;;A61P25/32;;A61P43/00;;C07D401/04;;C07D405/04;;C07D409/04,A61K31/4725;;A61K31/4741;;C07D491/056;;A61P21/02;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/28;;A61P25/32;;A61P43/00;;C07D401/04;;C07D405/04;;C07D409/04,514/309;;546/141;;546/139;;546/89;;514/307;;514/291,26,24,177-210-894-714-920;;098-025-051-359-723;;059-973-250-012-525;;153-318-911-772-625;;018-128-863-484-298;;053-786-721-455-794;;069-067-203-713-730;;000-520-350-832-931;;091-460-052-972-29X;;044-087-415-240-593;;011-427-177-400-301;;017-978-665-181-899;;077-305-724-970-59X;;010-179-876-171-476;;011-349-211-797-920;;102-166-769-147-529;;101-116-596-950-505;;046-782-723-354-32X;;007-164-985-733-909;;058-428-465-760-192;;017-709-017-199-104;;003-450-863-278-508;;147-249-551-056-276;;002-804-265-384-529,10.1021/jm001049i;;11087560;;8057295;;10.1021/jm00042a001;;12646018;;10.1021/jm020409u;;10.1002/ddr.430190404;;10.1073/pnas.78.11.7180;;6273918;;pmc349220;;7568326;;6095867;;10.1016/0006-2952(84)90017-0;;10.1016/0896-6273(90)90224-4;;1699569;;2445971;;10.1113/jphysiol.1987.sp016523;;pmc1192451;;22026931;;10.1016/0223-5234(96)83969-9;;10.1071/ch9901259;;10.1021/jm960400q;;9003515;;10.1021/jo00040a006;;10.1016/s0040-4020(01)88589-6;;10.1016/s0040-4039(00)97946-2;;10.1016/s0040-4039(00)73857-3;;10.1016/0006-2952(84)90134-5;;6095852;;pmc1668104;;10.1111/j.1476-5381.1978.tb07803.x;;667493;;6273300;;10.1002/chin.199042313;;8773466;;10.1016/0014-2999(96)00066-0;;10.1016/0301-0082(93)90047-v;;8380934;;10.1039/jr9530001067;;2997631;;10.1007/bf00572441,"Razet, R. et al. : 5-[1'-(2'-N-Arylsulfonyl-1',2',3',4'-tetrahydroisoqunolyl)]-4,5-dihydro-2(3H)-furanones: Positive allosteric modulators of the GABA-A receptor with a new mode of action. J. Med. Chem. vol. 43, pp. 4363-4366, 2000.;;M.C.W. Minchin et al., ""A Novel GABAA-Like Autoreceptor Modulates GABA Release"", Chemical Abstracts, vol. 117, No. 21, Abstract No. 117:205616m, (Nov. 23, 1992).;;P. Krogsgaard-Larsen et al., ""GABAA Receptor Agonists, Partial Agonists, and Antagonists. Design and Therapeutic Prospects"", Journal of Medicinal Chemistry, vol. 37, No. 16, pp. 2489-2505, (Aug. 5, 1994).;;Wu et al., ""Synthesis and Biological Evaluation of Non-Peptide Cyclophilin Ligands,"" J. Med. Chem., 46:1112-1115 (2003).;;Wauquier et al.; Loreclezole (R72 063): An anticonvulsant chemically unrelated to prototype antiepileptic drugs; Drug Dev. Res. 19:375-292 (1990).;;Richard Manske; The alkaloids of fumaraceous plants II Dicentra cucullaria, Canadian Journal of Research, 265-269.;;Study et al.; Diazepam and (-)-pentobarbital Fluctuation analysis reveals different mechanisms for potentiation of gamma-aminobutyric acid responses in cultured central neurons; Proc. Natl. Acad. Sci. USA, 78(11) 7180-7184 (1981).;;Werner Sieghart; Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes; Pharmacological Reviews 47(2) 181-234 (1995).;;Sieghart et al.; Affinity of various ligands for benzodiazepine receptors in rat cerebellum and hippocampus; Biochem. Pharmacol. 33(24) 4033-4038 (1984).;;Sigel et al.' The effect of subunit composition of rat brain GABAA receptors on channel function; Neuron 5:703-711 (1990).;;Erwin Sigel; J. Physiol.; Properties of single sodium, channels translated by xenopus oocytes after injection with messenger ribonucleic acid; 386:73-90 (1987).;;Kardos et al.; Synthesis, anti-GABA activity and preferred conformation of bicuculline and norbicuculline enantiomers; Eur. J. Med. Chem. 31:761-765 (1996).;;Allan et al.; Synthesis of substituted (+)-bicuculline derivatives through chloromethylation; Aust. J. Chem; 43:1259-68 (1990).;;Rassu et al.; Expeditious Syntheses of sugar-modified nucleosides and collections thereof exploiting furan-, pyrrole-, and thiophene-based siloxy dienes; J. Med. Chem. 40:168-180 (1997).;;Casiraghi et al.; N-(tert-butoxycarbonyl)-2-(tert-butyldimethylsiloxy)pyrrole: A promising compound for synthesis of chiral nonracemic hydroxylated pyrrolidine derivatives; J. Org. Chem.; 57:3760-3763 (1992).;;Hillard et al.; Auxiliary silicon in regioselective cobalt catalyzed protoberberine syntheses; Tetrahedron, 39(6) 905-911 (1983).;;Jefford et al.; A short route to furanosesquiterpenes using a new siloxyfuran building block. The synthesis of freelingnite and dehydrolasiosperman; Tetrahedron Letters, 31(40) 5741-5744 (1990).;;Morimoto et al.; An efficient approach toward pyrrolidinyllactone system characteristic of the stemona alkaloids. Lewis acid catalyzed stereoselective reaction of n-benzyloxycarbonyl-2-methoxypyrrolidine with 3-methyl-2-trimethylsilyoxyfuran; Tetrahedron Letters 34(36) 5773-5776 (1993).;;Kardos et al.; Inhibition of [<3>H]GABA binding to rat brain synaptic membranes by bicuculline related alkaloids; Biochem. Pharmacol. 33(22) 3537-3545 (1984).;;M.A. Simmonds; Presynaptic actions of gamma-aminobutyric acid and some antagonists in a slice preparation of cuneate nucleus; Br. J. Pharmac. 63:495-502 (1978).;;Bhattacharyya et al.; Studies on the bicuculline-GABA interactions on neuronal membrane with fluroescent labeled anti-bicuculline antibodies; Indian J. of Biochem. & Biophysics 18:171-176 (1981).;;Casiraghi et al.; The four-carbon elongation of aldehydo sugars using 2-(trimethylsiloxy)furan: A butenolide route to higher monosaccharides; Journal of Organic Chemistry 55(9) 2565-2567 (1990).;;Zezula et al.; Interaction of allosteric ligands with GABAA receptors containing one, two, or three different subunits; European Journal of Pharmacology 301:207-214 (1996).;;Gardner et al.; The rapidly expanding range of neuronal benzodiazepine receptor ligands; Progress in Neurobiology 40:1-61 (1993).;;Whaley et al.; The synthesis and resolution of (±)-corlumine; 1067-1070.;;Arbilla et al.; Pharmacological profile of the imidazopyridine zolpidem at benzodiazepine receptors and electrocorticogram in rats; Naunyn-Schmiedeberg's Arch Pharmacol 330:248-251 (1985).",EXPIRED
556,DE,T2,DE 60009739 T2,176-932-055-588-263,2005-05-12,2005,DE 60009739 T,2000-10-20,FR 9913233 A;;FR 0002928 W,1999-10-22,"3-AMINO-2,2-DI-C-ALKYL-1,4-BUTYROLACTONE UND N-SUBSTITUIERTE 1,4-THIOBUTYROLACTONE DIE ZUR STIMULATION DER GAMMA-AMINOBUTANSÄUREAKTIVITÄT UND ZUR BEHANDLUNG VON NERVENERKRANKUNGEN VERWENDUNG FINDEN, SOWIE VERFAHREN ZU IHRER HERSTELLUNG","The invention concerns compounds represented by general formula (I) wherein: Z represents a sulfur or oxygen atom; the groups R1 and R2, identical or different, represent each a alkyl group or an alkenyl group; X represents a CO, a CO2, an SO, or an SO2 and the group R represents an alkyl, aryl, alkenyl, or aralkyl group, provided that when Z represents an oxygen atom, X an SO2 and R a group (a), R1 and R2 do not both represent the methyl group. The invention also concerns methods for preparing said compounds, pharmaceutical compositions containing them and their use as promoter of gamma-aminobutyric acid and as medicine particularly designed for treating nervous disorders.",CENTRE NAT RECH SCIENT;;INNOVATIONSAGENTUR GMBH BU TEC;;UNIV BERNE BERN,DODD ROBERT;;EL HADRI AHMED;;POTIER JEAN-PAUL;;SIEGHART WERNER;;JURSKY FRANTISEK;;FURTMULLER ROMAN;;SIGEL ERWIN;;THOMET URS,,https://lens.org/176-932-055-588-263,Granted Patent,no,0,0,12,12,0,A61K31/365;;C07D307/33;;A61P21/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/30;;A61P25/32;;C07D307/33;;A61K31/365,C07D333/36;;A61K31/341;;A61K31/365;;A61K31/381;;A61P21/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/30;;A61P25/32;;C07B61/00;;C07D307/33,,0,0,,,,EXPIRED
557,ZA,B,ZA 200208794 B,175-983-329-585-603,2004-02-03,2004,ZA 200208794 A,2002-10-30,US 77318201 A,2001-01-30,Narrow ink jet printhead.,,HEWLETT PACKARD CO,TORGERSON JOSEPH M;;BROWNING ROBERT N K;;MACKENZIE MARK H;;MILLER MICHAEL D;;BAKKOM ANGELA WHITE;;DODD SIMON,,https://lens.org/175-983-329-585-603,Granted Patent,no,0,0,34,34,0,B41J2/14072;;B41J2/15;;B41J2/14072;;B41J2/15,B41J2/15;;B41J2/05,,0,0,,,,EXPIRED
558,DE,D1,DE 60009739 D1,093-497-447-730-06X,2004-05-13,2004,DE 60009739 T,2000-10-20,FR 9913233 A;;FR 0002928 W,1999-10-22,"3-AMINO-2,2-DI-C-ALKYL-1,4-BUTYROLACTONE UND N-SUBSTITUIERTE 1,4-THIOBUTYROLACTONE DIE ZUR STIMULATION DER GAMMA-AMINOBUTANSÄUREAKTIVITÄT UND ZUR BEHANDLUNG VON NERVENERKRANKUNGEN VERWENDUNG FINDEN, SOWIE VERFAHREN ZU IHRER HERSTELLUNG","The invention concerns compounds represented by general formula (I) wherein: Z represents a sulfur or oxygen atom; the groups R1 and R2, identical or different, represent each a alkyl group or an alkenyl group; X represents a CO, a CO2, an SO, or an SO2 and the group R represents an alkyl, aryl, alkenyl, or aralkyl group, provided that when Z represents an oxygen atom, X an SO2 and R a group (a), R1 and R2 do not both represent the methyl group. The invention also concerns methods for preparing said compounds, pharmaceutical compositions containing them and their use as promoter of gamma-aminobutyric acid and as medicine particularly designed for treating nervous disorders.",CENTRE NAT RECH SCIENT;;INNOVATIONSAGENTUR GMBH BU TEC;;UNIV BERNE BERN,DODD ROBERT;;EL HADRI AHMED;;POTIER JEAN-PAUL;;SIEGHART WERNER;;JURSKY FRANTISEK;;FURTMULLER ROMAN;;SIGEL ERWIN;;THOMET URS,,https://lens.org/093-497-447-730-06X,Granted Patent,no,0,0,12,12,0,A61K31/365;;C07D307/33;;A61P21/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/30;;A61P25/32;;C07D307/33;;A61K31/365,C07D333/36;;A61K31/341;;A61K31/365;;A61K31/381;;A61P21/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/30;;A61P25/32;;C07B61/00;;C07D307/33,,0,0,,,,EXPIRED
559,US,B2,US 6722759 B2,114-170-970-868-763,2004-04-20,2004,US 27808502 A,2002-10-22,US 27808502 A;;US 77318201 A,2001-01-30,Ink jet printhead,"
    An ink jet printhead includes a printhead substrate having a plurality of thin film layers and four side by side columnar arrays of drop generators formed in the printhead substrate and extending along a longitudinal extent. Each columnar array has drop generators that are separated by a drop generator pitch P. The drop generators produce ink drops having a drop volume that enables single pass printing of a resolution that is 1/(4P) dpi along a print axis parallel to the longitudinal extent. Four columnar arrays of FET drive circuits formed in the printhead substrate are employed to energize corresponding columnar arrays of drop generators. 
",HEWLETT PACKARD DEVELOPMENT CO,TORGERSON JOSEPH M;;BROWNING ROBERT N K;;MACKENZIE MARK H;;MILLER MICHAEL D;;BAKKOM ANGELA W;;DODD SIMON,HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2003-01-31),https://lens.org/114-170-970-868-763,Granted Patent,yes,11,21,34,34,0,B41J2/14072;;B41J2/15;;B41J2/14072;;B41J2/15,B41J2/15;;B41J2/05,347/40;;347/62,1,0,,,"International Search Report mailed Apr. 15, 2002, regarding International Application No. PCT/US 01/28081.",EXPIRED
560,HK,A1,HK 1057514 A1,168-231-679-589-908,2004-04-08,2004,HK 04100441 A,2004-01-20,US 77318201 A;;US 0128081 W,2001-01-30,Ink jet printhead,,HEWLETT PACKARD CO,TORGERSON JOSEPH M;;BROWNING ROBERT N K;;MACKENZIE MARK H;;MILLER MICHAEL D;;BAKKOM ANGELA WHITE;;DODD SIMON,,https://lens.org/168-231-679-589-908,Patent Application,no,0,0,34,34,0,B41J2/14072;;B41J2/15;;B41J2/14072;;B41J2/15,B41J2/15;;B41J2/05,,0,0,,,,DISCONTINUED
561,HK,B,HK 1052163 B,199-097-055-956-888,2008-02-06,2008,HK 03104398 A,2003-06-18,US 77318201 A;;US 0128081 W,2001-01-30,NARROW INK JET PRINTHEAD,,HEWLETT PACKARD CO,TORGERSON JOSEPH M;;BROWNING ROBERT N K;;MACKENZIE MARK H;;MILLER MICHAEL D;;BAKKOM ANGELA WHITE;;DODD SIMON,,https://lens.org/199-097-055-956-888,Granted Patent,no,0,0,34,34,0,B41J2/14072;;B41J2/15;;B41J2/14072;;B41J2/15,B41J2/15;;B41J/;;B41J2/05,,0,0,,,,EXPIRED
562,CA,C,CA 2416599 C,014-234-438-140-383,2009-12-15,2009,CA 2416599 A,2001-09-07,US 77318201 A;;US 0128081 W,2001-01-30,NARROW INK JET PRINTHEAD,"A narrow ink jet printhead (100) having four columnar arrays (61) of ink dro p generators (40) configured for monochrome single-pass printing at a print resolution having a media axis dot spacing that is less than the columnar nozzle spacing of the ink drop generators. The ink jet printhead more particularly includes high resistance heater resistors (56) and efficient FE T drive circuits (85) that are configured to compensate for variation in parasitic resistance presented by power traces (86a, 86b, 86c, 86d, 181).",HEWLETT PACKARD CO,TORGERSON JOSEPH M;;DODD SIMON;;BROWNING ROBERT N K;;MACKENZIE MARK H;;MILLER MICHAEL D;;BAKKOM ANGELA WHITE,,https://lens.org/014-234-438-140-383,Granted Patent,no,0,0,34,34,0,B41J2/14072;;B41J2/15;;B41J2/14072;;B41J2/15,B41J2/05;;B41J2/15,,0,0,,,,EXPIRED
563,FR,B1,FR 2800072 B1,026-119-938-596-792,2002-01-11,2002,FR 9913232 A,1999-10-22,FR 9913232 A,1999-10-22,1-(2-BUTYROLACTONES ET 2-THIOBUTYROLACTONES)-ISOQUINOLINES N-SUBSTITUEES UTILES COMME STIMULANT DE L'ACTIVITE DE L'ACIDE GAMMA-AMINOBUTYRIQUE ET DANS LE TRAITEMENT DES TROUBLES NERVEUX ET LEUR PROCEDE DE PREPARATION,"The invention concerns compounds of general formula (I) wherein: Z represents a sulphur or oxygen atom, NH, N-alkyl or Nboc; group R', identical or different, represent each a hydrogen atom, a OCH3 group or a OCH2O group; group R'' represents a hydrogen or a CH3 group; group X represents a carbonyl, sulphonyl or CO2 group; and group R represents an alkyl, aryl, alkenyl or aralkyl group. The invention also concerns the preparation of said compounds, pharmaceutical compositions containing them and their use for stimulating gamma-amino-butyric acid activity and as medicine for treating nervous disorders.",CENTRE NAT RECH SCIENT,DODD ROBERT;;RAZET RODOLPHE;;POTIER PIERRE JEAN PAUL;;SIEGHART WERNER;;JURSKY FRANTISEK;;FURTMULLER ROMAN;;SIGEL ERWIN;;THOMET URS,,https://lens.org/026-119-938-596-792,Granted Patent,no,0,0,12,12,0,C07D401/04;;C07D405/04;;C07D409/04;;A61P21/02;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/28;;A61P25/32;;A61P43/00;;C07D401/04;;C07D405/04;;C07D409/04,A61K31/4725;;A61K31/4741;;A61P21/02;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/20;;A61P25/22;;C07D491/056;;A61P25/24;;A61P25/28;;A61P25/32;;A61P43/00;;C07D401/04;;C07D405/04;;C07D409/04,,0,0,,,,EXPIRED
564,WO,A1,WO 2001/029030 A1,141-962-512-680-557,2001-04-26,2001,FR 0002927 W,2000-10-20,FR 9913232 A,1999-10-22,N-SUBSTITUTED 1-(LACTONE) ISOQUINOLONES FOR TREATING NERVOUS DISORDERS,"The invention concerns compounds of general formula (I) wherein: Z represents a sulphur or oxygen atom, NH, N-alkyl or Nboc; groups R', identical or different, represent each a hydrogen atom, a OCH3 group or a OCH2O group; group R'' represents a hydrogen or a CH3 group; group X represents a carbonyl, sulphonyl or CO2 group; and group R represents an alkyl, aryl, alkenyl or aralkyl group. The invention also concerns the preparation of said compounds, pharmaceutical compositions containing them and their use for stimulating η-amino-butyric acid activity and as medicine for treating nervous disorders.",CENTRE NAT RECH SCIENT;;INNOVATIONSAGENTUR GMBH BU TEC;;UNIV BERN;;DODD ROBERT;;RAZET RODOLPHE;;POTIER PIERRE JEAN PAUL;;SIEGHART WERNER;;JURSKY FRANTISEK;;FURTMULLER ROMAN;;SIGEL ERWIN;;THOMET URS,DODD ROBERT;;RAZET RODOLPHE;;POTIER PIERRE JEAN-PAUL;;SIEGHART WERNER;;JURSKY FRANTISEK;;FURTMULLER ROMAN;;SIGEL ERWIN;;THOMET URS,,https://lens.org/141-962-512-680-557,Patent Application,yes,2,5,12,12,0,C07D401/04;;C07D405/04;;C07D409/04;;A61P21/02;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/28;;A61P25/32;;A61P43/00;;C07D401/04;;C07D405/04;;C07D409/04,A61K31/4725;;A61K31/4741;;A61P21/02;;A61P25/00;;A61P25/04;;C07D491/056;;A61P25/08;;A61P25/18;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/28;;A61P25/32;;A61P43/00;;C07D401/04;;C07D405/04;;C07D409/04,,2,1,098-025-051-359-723,8057295;;10.1021/jm00042a001,"P. KROGSGAARD-LARSEN ET AL: ""Gaba(A) receptor agonists, partial agonists and antagonists. Design and therapeutic prospects"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 37, no. 16, 1994, WASHINGTON US, pages 2489 - 2505, XP002141451;;CHEMICAL ABSTRACTS, vol. 117, no. 21, 23 November 1992, Columbus, Ohio, US; abstract no. 205616, MINCHIN M.C.W. ET AL: ""A novel GABA-like autoreceptor modulates GABA release"" XP002159129",PATENTED
565,HU,B1,HU 228020 B1,147-777-015-789-950,2012-08-28,2012,HU P0301018 A,2001-09-07,US 77318201 A;;US 0128081 W,2001-01-30,PRINTHEAD,,HEWLETT PACKARD CO,TORGERSON JOSEPH M;;BROWNING ROBERT N K;;MACKENZIE MARK H;;MILLER MICHAEL D;;BAKKOM ANGELA WHITE;;DODD SIMON,,https://lens.org/147-777-015-789-950,Granted Patent,no,0,0,34,34,0,B41J2/14072;;B41J2/15;;B41J2/14072;;B41J2/15,B41J2/05;;B41J2/15,,0,0,,,,EXPIRED
566,BR,A,BR 0117071 A,025-429-143-160-781,2004-07-27,2004,BR 0117071 A,2001-09-06,US 88339801 A;;US 0128151 W,2001-06-19,Cabeça de impressão de jato de tinta compacta,"""CABEçA DE IMPRESSãO DE JATO DE TINTA COMPACTA"". Cabeça de impressão de jato de tinta térmica compacta incluindo um substrato de cabeça de impressão (11), uma pluralidade de arranjos de coluna lado a lado (61) de geradores de gotas (40) formada no substrato de cabeça de impressão e circuitos de excitação (85) formados no substrato de cabeça de impressão para energizar cada gerador de gotas. O substrato de cabeça de impressão tem uma densidade de empacotamento de geradores de gotas de tinta de pelo menos 10,43 geradores de gotas de tinta per mm^ 2^.",HEWLETT PACKARD CO,TORGERSON JOSEPH M;;BROWNING ROBERT N K;;MACKENZIE MARK H;;MILLER MICHAEL D;;BAKKOM ANGELA W;;DODD SIMON,,https://lens.org/025-429-143-160-781,Patent Application,no,0,0,23,23,0,B41J2/14072;;B41J2/15;;B41J2/145;;B41J2/14072;;B41J2/15,B41J2/05;;B41J2/14;;B41J2/15;;B41J2/175,,0,0,,,,EXPIRED
567,AU,A,AU 2000/079320 A,192-444-857-134-519,2001-04-30,2001,AU 2000/079320 A,2000-10-20,FR 9913232 A;;FR 0002927 W,1999-10-22,N-substituted 1-(lactone) isoquinolones for treating nervous disorders,"The invention concerns compounds of general formula (I) wherein: Z represents a sulphur or oxygen atom, NH, N-alkyl or Nboc; group R', identical or different, represent each a hydrogen atom, a OCH3 group or a OCH2O group; group R'' represents a hydrogen or a CH3 group; group X represents a carbonyl, sulphonyl or CO2 group; and group R represents an alkyl, aryl, alkenyl or aralkyl group. The invention also concerns the preparation of said compounds, pharmaceutical compositions containing them and their use for stimulating gamma-amino-butyric acid activity and as medicine for treating nervous disorders.",CENTRE NAT RECH SCIENT;;INNOVATIONSAGENTUR GMBH BU TEC;;UNIV BERN,DODD ROBERT;;RAZET RODOLPHE;;POTIER PIERRE JEAN-PAUL;;SIEGHART WERNER;;JURSKY FRANTISEK;;FURTMULLER ROMAN;;SIGEL ERWIN;;THOMET URS,,https://lens.org/192-444-857-134-519,Patent Application,no,0,0,12,12,0,C07D401/04;;C07D405/04;;C07D409/04;;A61P21/02;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/28;;A61P25/32;;A61P43/00;;C07D401/04;;C07D405/04;;C07D409/04,C07D491/056;;A61K31/4725;;A61K31/4741;;A61P21/02;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/28;;A61P25/32;;A61P43/00;;C07D401/04;;C07D405/04;;C07D409/04,,0,0,,,,DISCONTINUED
568,CA,A1,CA 2416599 A1,042-058-988-528-249,2002-08-08,2002,CA 2416599 A,2001-09-07,US 77318201 A;;US 0128081 W,2001-01-30,NARROW INK JET PRINTHEAD,"A narrow ink jet printhead (100) having four columnar arrays (61) of ink dro p generators (40) configured for monochrome single-pass printing at a print resolution having a media axis dot spacing that is less than the columnar nozzle spacing of the ink drop generators. The ink jet printhead more particularly includes high resistance heater resistors (56) and efficient FE T drive circuits (85) that are configured to compensate for variation in parasitic resistance presented by power traces (86a, 86b, 86c, 86d, 181).</S DOAB>",HEWLETT PACKARD CO,BROWNING ROBERT N K;;TORGERSON JOSEPH M;;MACKENZIE MARK H;;MILLER MICHAEL D;;BAKKOM ANGELA WHITE;;DODD SIMON,,https://lens.org/042-058-988-528-249,Patent Application,no,0,0,34,34,0,B41J2/14072;;B41J2/15;;B41J2/14072;;B41J2/15,B41J2/05;;B41J2/15,,0,0,,,,EXPIRED
569,AU,B2,AU 2001/292592 B2,025-132-349-094-671,2006-04-06,2006,AU 2001/292592 A,2001-09-06,US 88339801 A;;US 0128151 W,2001-06-19,Compact ink jet printhead,,HEWLETT PACKARD DEVELOPMENT CO LP,BAKKOM ANGELA W;;TORGERSON JOSEPH M;;DODD SIMON;;MACKENZIE MARK H;;BROWNING ROBERT N K;;MILLER MICHAEL D,"HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (2012-08-02)",https://lens.org/025-132-349-094-671,Granted Patent,no,13,0,23,23,0,B41J2/14072;;B41J2/15;;B41J2/145;;B41J2/14072;;B41J2/15,B41J2/00;;B41J2/05;;B41J2/14;;B41J2/15;;B41J2/175,,0,0,,,,EXPIRED
570,CA,A1,CA 2451629 A1,085-127-505-727-451,2002-12-27,2002,CA 2451629 A,2001-09-06,US 88339801 A;;US 0128151 W,2001-06-19,COMPACT INK JET PRINTHEAD,"A compact thermal ink jet printhead including a printhead substrate (11), a plurality of side by side columnar arrays (61) of drop generators (40) forme d in the printhead substrate, and drive circuits (85) formed in the printhead substrate for energizing each ink drop generator. The printhead substrate ha s an ink drop generator packing density of at least 10.43 ink drop generators per square millimeter.",HEWLETT PACKARD CO,BAKKOM ANGELA W;;DODD SIMON;;MACKENZIE MARK H;;MILLER MICHAEL D;;TORGERSON JOSEPH M;;BROWNING ROBERT N K,,https://lens.org/085-127-505-727-451,Patent Application,no,0,2,23,23,0,B41J2/14072;;B41J2/15;;B41J2/145;;B41J2/14072;;B41J2/15,B41J2/05;;B41J2/14;;B41J2/15;;B41J2/175,,0,0,,,,EXPIRED
571,HU,A2,HU P0301018 A2,116-363-786-710-476,2003-09-29,2003,HU P0301018 A,2001-09-07,US 77318201 A;;US 0128081 W,2001-01-30,PRINTHEAD,"A találmány nyomtatófej, vékonyréteg-áramkörös alapréteggel, amelyalaprétegen, fúvókánként, cseppgenerátorok vannak kialakítva, amelycseppgenerátorok négy, egymással párhuzamos oszlopirányú sorban (61)vannak kialakítva az alaprétegben, annak hossziránya mentén, amelycseppgenerátorokból oszlopirányú soronként (61) legalább száz vanelrendezve egyforma fúvókatávolságokban, amely cseppgenerátorok elsőés második, valamint harmadik és negyedik oszlopirányú sora közöttitávolság legfeljebb 630 mikrométer, és amely cseppgenerátorok egyadott színű festékkel, hosszirányban legalább 1/4P dpi felbontástsingle-pass nyomtatási módban lehetővé tevő csepptérfogattalrendelkeznek, az alapréteg cseppgenerátorok sorával szomszédosterületein, négy oszlopirányú sorban, a cseppgenerátorokat meghajtóFET- áramkörök vannak kialakítva. Ó",HEWLETT PACKARD CO,BAKKOM ANGELA WHITE;;BROWNING ROBERT N K;;DODD SIMON;;MACKENZIE MARK H;;MILLER MICHAEL D;;TORGERSON JOSEPH M,,https://lens.org/116-363-786-710-476,Patent Application,no,0,0,34,34,0,B41J2/14072;;B41J2/15;;B41J2/14072;;B41J2/15,B41J2/15;;B41J2/05,,0,0,,,,EXPIRED
572,EP,A1,EP 1224182 A1,002-046-817-092-314,2002-07-24,2002,EP 00969659 A,2000-10-20,FR 0002927 W;;FR 9913232 A,1999-10-22,N-SUBSTITUTED 1-(LACTONE) ISOQUINOLONES FOR TREATING NERVOUS DISORDERS,"The invention concerns compounds of general formula (I) wherein: Z represents a sulphur or oxygen atom, NH, N-alkyl or Nboc; group R', identical or different, represent each a hydrogen atom, a OCH3 group or a OCH2O group; group R'' represents a hydrogen or a CH3 group; group X represents a carbonyl, sulphonyl or CO2 group; and group R represents an alkyl, aryl, alkenyl or aralkyl group. The invention also concerns the preparation of said compounds, pharmaceutical compositions containing them and their use for stimulating gamma-amino-butyric acid activity and as medicine for treating nervous disorders.",CENTRE NAT RECH SCIENT;;INNOVATIONSAGENTUR GMBH BU TEC;;UNIV BERNE,DODD ROBERT;;RAZET RODOLPHE;;POTIER PIERRE JEAN-PAUL;;SIEGHART WERNER;;JURSKY FRANTISEK;;FURTMULLER ROMAN;;SIGEL ERWIN;;THOMET URS,,https://lens.org/002-046-817-092-314,Patent Application,yes,0,0,12,12,0,C07D401/04;;C07D405/04;;C07D409/04;;A61P21/02;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/28;;A61P25/32;;A61P43/00;;C07D401/04;;C07D405/04;;C07D409/04,C07D491/056;;A61K31/4725;;A61K31/4741;;A61P21/02;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/28;;A61P25/32;;A61P43/00;;C07D401/04;;C07D405/04;;C07D409/04,,0,0,,,,EXPIRED
573,ES,T3,ES 2294027 T3,066-246-938-070-881,2008-04-01,2008,ES 01968656 T,2001-09-07,US 77318201 A,2001-01-30,CABEZA IMPRESORA DE CHORRO DE TINTA ESTRECHO.,"Una cabeza impresora de chorro de tinta, que comprende: un sustrato de cabeza de impresión (11) que incluye una pluralidad de capas de película delgadas; cuatro disposiciones en columnas (61), una al lado de otra, de generadores de gotas (40) formados en dicho sustrato de cabeza impresora y que se extienden a lo largo de una extensión longitudinal; cada disposición en columnas de generadores de gotas tiene al menos 100 generadores de gotas separados por una distancia P entre generadores de gotas; dichas cuatro disposiciones en columnas de generadores de gotas comprenden una primera disposición en columnas y una segunda disposición en columnas separadas entre sí por al menos 630 micrómetros, y una tercera disposición en columnas y una cuarta disposición en columnas separadas entre sí por como máximo 630 micrómetros; dichos generadores de gotas para producir gotas de tinta del mismo color predeterminado y con un volumen de gotas que permite una impresión de un solo color en un único paso de una resolución que es 1/(4P) dpi a lo largo de un eje de impresión paralelo a dicha extensión longitudinal; y cuatro disposiciones en columnas (81) de circuitos de excitación FET (85) formados en dicho sustrato de cabeza impresora respectivamente contigua a dichas disposiciones en columnas de generadores de gotas para energizar dichas disposiciones en columnas de generadores de gotas.",HEWLETT PACKARD CO,TORGERSON JOSEPH M;;BROWNING ROBERT N K;;MACKENZIE MARK H;;MILLER MICHAEL D;;BAKKOM ANGELA WHITE;;DODD SIMON,,https://lens.org/066-246-938-070-881,Granted Patent,no,0,0,34,34,0,B41J2/14072;;B41J2/15;;B41J2/14072;;B41J2/15,B41J2/05;;B41J2/15,,0,0,,,,EXPIRED
574,RU,C2,RU 2279983 C2,158-243-420-590-710,2006-07-20,2006,RU 2004101043 A,2001-09-06,US 88339801 A,2001-06-19,COMPACT PRINTING HEAD FOR INK-JET PRINTING,"FIELD: printing industry; ink-jet printing. ^ SUBSTANCE: proposed printing head for ink-jet printing is provided with printing head backing including great number of fine-film layers, four matrix-columns of droplet generator arranged side-by-side which are formatted in said backing of printing head and arranged longitudinal. Said printing head contains excitation circuits which are also formed in said backing to excite each generator of ink droplets at frequency in range approximately from 15 kHz to 18 kHz, and first ink feed slot, second ink feed slot. Backing of printing head has density of ink droplet generator equal to at least 10.43 ink droplet generators per square millimeter. First matrix-column of droplet generators and second matrix-column of droplet generators are arranged from each of two sides of said first ink-feed slot, and third matrix-column of droplet generators and fourth matrix-column of droplet generators are arranged at two sides of second ink-feed slot. ^ EFFECT: provision of compact printing head with great number of ink droplet generators. ^ 33 cl, 11 dwg",KH JULETT PAKKARD KOMPANI,TORDZHERSON DZHOZEF M;;BRAUNING ROBERT N K;;MAKKENZI MARK KH;;MILLER MAJKL D;;BEHKKOM ANDZHELA U;;DODD SAJMON,,https://lens.org/158-243-420-590-710,Granted Patent,no,0,0,23,23,0,B41J2/14072;;B41J2/15;;B41J2/145;;B41J2/14072;;B41J2/15,B41J2/05;;B41J2/14;;B41J2/15;;B41J2/175,,0,0,,,,EXPIRED
575,WO,A1,WO 2014/096093 A1,076-303-471-878-027,2014-06-26,2014,EP 2013077224 W,2013-12-18,FR 1262275 A,2012-12-18,"3,5-DIARYLAZAINDOLES AS DYRK1A PROTEIN INHIBITORS FOR THE TREATMENT OF COGNITIVE DEFICIENCES ASSOCIATED WITH DOWN'S SYNDROME AND WITH ALZHEIMER'S DISEASE","The present invention relates to a compound of formula (I') or a pharmaceutically acceptable salt, solvate or hydrate thereof, in which: X 3 is F, OH or SH, Y 3 is F, OH or SH, X 1 , X 2 , X 4 , X 5 , Υ 1 , Y 2 , Y 4 and Y 5 are, independently of one another, H, F, Cl, Br, OH or SH, and 1 to 2 groups among the X 1 , X 2 , X 4 and X 5 radicals are other than H and/or 1 to 2 groups among the Υ 1 , Y 2 , Y 4 and Y 5 radicals are other than H. The present invention also relates to a compound of formula (I') for use as a medicament, in particular in the prevention and/or treatment of cognitive disorders associated with a dysfunction of the Dyrk1A protein.",CENTRE NAT RECH SCIENT;;UNIV REIMS CHAMPAGNE ARDENNE;;UNIV PARIS DIDEROT PARIS 7,DODD ROBERT;;CARIOU KEVIN;;GOURDAIN STÉPHANIE;;DELABAR JEAN MAURICE;;JANEL NATHALIE;;RODRIGUES LIMA FERNANDO;;DAIROU JULIEN;;DENHEZ CLÉMENT,,https://lens.org/076-303-471-878-027,Patent Application,yes,9,0,7,7,2,A61P25/28;;C07D471/04;;C07D471/04,C07D471/04;;A61K31/437;;A61P25/28,,12,8,127-584-323-826-999;;102-151-915-708-207;;042-082-528-574-05X;;001-368-063-018-77X;;013-000-877-593-36X;;043-132-319-155-819;;015-697-198-346-776;;001-878-784-051-596,21615147;;10.1021/jm200274d;;10.1016/j.ejmech.2012.01.040;;22305342;;10.1021/jm700940h;;18232649;;10.1021/jm3002982;;22575050;;11311120;;10.1042/bj3550597;;pmc1221773;;10.1042/bj3550609;;pmc1221774;;11311121;;16760365;;10.1177/1087057106288444;;10.1021/ml200024y;;pmc4018049;;24900350,"See also references of EP 2953947A1;;DEBDAB ET AL., JOURNAL OF MEDICINAL CHEMISTRY, vol. 54, 2011, pages 4172 - 4186;;NEAGOIE ET AL., EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 49, 2012, pages 379 - 396;;MEIJER ET AL., J. MED. CHEM, vol. 51, 2008, pages 737 - 751;;HONG ET AL., JOURNAL OF MEDICINAL CHEMISTRY, vol. 55, 2012, pages 5337 - 5349;;GREENE: ""Protective Groups In Organic synthesis"", 1981, JOHN WILEY & SONS;;HARRISON ET AL.: ""Compendium of Synthetic Organic Méthods"", vol. 1-8, 1971, J. WILEY & SONS;;HARRISON ET AL.: ""Compendium of Synthetic Organic Methods"", vol. 1-8, 1971, J. WILEY & SONS;;WOODS, Y. ET AL., BIOCHEM. J., vol. 355, 2001, pages 597;;WOODS, Y. ET AL., BIOCHEM. J., vol. 355, 2001, pages 609;;KLUMPP, M. ET AL., J. BIOMOL. SCREEN., vol. 11, 2006, pages 617;;PONS ET AL., ACS MEDICINAL CHEMISTRY LETTERS, vol. 2, 2011, pages 565 - 570",PENDING
576,US,A1,US 2002/0140768 A1,112-646-106-255-452,2002-10-03,2002,US 77318201 A,2001-01-30,US 77318201 A,2001-01-30,NARROW INK JET PRINTHEAD,"
   A narrow ink jet printhead having four columnar arrays of ink drop generators configured for monochrome single-pass printing at a print resoluion having a media axis dot spacing that is less than the columnar nozzle spacing of the ink drop generators. The ink jet printhead more particularly includes high resistance heater resistors and efficient FET drive circuits that are configured to compensate for variation in parasitic resistance presented by power traces. 
",TORGERSON JOSEPH M.;;BROWNING ROBERT N.K.;;MACKENZIE MARK H.;;MILLER MICHAEL D.;;BAKKOM ANGELA WHITE,TORGERSON JOSEPH M;;BROWNING ROBERT N K;;MACKENZIE MARK H;;MILLER MICHAEL D;;BAKKOM ANGELA WHITE;;DODD SIMON,HEWLETT-PACKARD COMPANY (2002-01-23);;HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2005-01-11),https://lens.org/112-646-106-255-452,Patent Application,yes,0,0,34,34,0,B41J2/14072;;B41J2/15;;B41J2/14072;;B41J2/15,B41J2/15;;B41J2/05,347 4,0,0,,,,EXPIRED
577,BR,B1,BR 0117071 B1,182-112-001-835-330,2010-07-13,2010,BR 0117071 A,2001-09-06,US 88339801 A;;US 0128151 W,2001-06-19,cabeça de impressão de jato de tinta compacta.,,,TORGERSON JOSEPH M;;BROWNING ROBERT N K;;MACKENZIE MARK H;;MILLER MICHAEL D;;BAKKOM ANGELA W;;DODD SIMON,,https://lens.org/182-112-001-835-330,Granted Patent,no,0,0,23,23,0,B41J2/14072;;B41J2/15;;B41J2/145;;B41J2/14072;;B41J2/15,B41J2/05;;B41J2/15;;B41J2/14;;B41J2/175,,0,0,,,,EXPIRED
578,DE,B4,DE 102006030309 B4,076-662-279-715-249,2017-12-07,2017,DE 102006030309 A,2006-06-30,GB 0513318 A,2005-07-01,Zündverteiler für einen Motor mit Laserzündung,"Zündverteiler für einen lasergezündeten Mehrzylinder-Verbrennungsmotor, der eine durch den Motor drehbare Welle, mehrere ebene reflektierende Flächen (16a–16d) an dem Rotor (12), die in Ebenen senkrecht zur Drehachse der Welle liegen und entlang der Länge der Welle voneinander axial versetzt sind, einen optischen Sender (18) zum Lenken von Licht von einer Laserquelle, so dass es der Reihe nach auf den reflektierenden Flächen (16a–16d) bei einem Winkel auftrifft, wenn die Welle dreht, und mehrere voneinander beabstandete optische Empfänger (24a–24d) jeweils zum Empfangen des von einer jeweiligen der reflektierenden Flächen (16a–16d) reflektierten Lichts und zum Lenken des reflektierten Lichts zu einem jeweiligen der Motorzylinder umfasst.",FORD GLOBAL TECH LLC,SCARISBRICK ANDY DAVID;;CARROLL STEPH;;DODD ROBERT;;SHENTON TOM;;DEARDEN GEOFF;;KEEN STEVE;;CLISSOLD ROY;;MC CULLOCH JOHN,,https://lens.org/076-662-279-715-249,Granted Patent,no,5,0,7,7,0,F02P23/04;;H01S3/0071;;F02P7/03;;F02P23/04;;G02B6/3512;;G02B26/08;;F02P23/04;;H01S3/0071,F02P23/04;;F02P7/00,,0,0,,,,INACTIVE
579,MY,A,MY 130807 A,119-033-370-698-423,2007-07-31,2007,MY PI20055497 A,2001-10-09,US 88339801 A,2001-06-19,COMPACT INK JET PRINTHEAD,"A COMPACT THEREMAL INK JET PRINTHEAD INCLUDING PRINTHEAD SUBSTRATE (11), A PLURALITY OF SIDE BY SIDE COLUMNAR ARRAYS (61) OF DROP GENERATORS (40) FORMED IN THE PRINTHEAD SUBSTRATE, AND DRIVE CIRCUITS (85) FORMED IN THE PRINTHEAD SUBSTRATE FOR ENERGIZING EACH INK DROP GENERATOR. THE PRINTHEAD SUBSTRATE HAS AN INK DROP GENERATOR PACKING DENSITY OF AT LEAST 10.43 INK DROP GENERATORS PER SQUARE MILLIMETER.(FIG. 1)",HEWLETT PACKARD CO,TORGERSON JOSEPH M;;BROWNING ROBERT N K;;MACKENZIE MARK H;;MILLER MICHAEL D;;BAKKOM ANGELA W;;DODD SIMON,,https://lens.org/119-033-370-698-423,Granted Patent,no,0,0,23,23,0,B41J2/14072;;B41J2/15;;B41J2/145;;B41J2/14072;;B41J2/15,B41J2/14;;B41J2/05;;B41J2/15;;B41J2/175,,0,0,,,,EXPIRED
580,EP,B1,EP 1309455 B1,157-967-521-807-381,2007-11-14,2007,EP 01968656 A,2001-09-07,US 0128081 W;;US 77318201 A,2001-01-30,NARROW INK JET PRINTHEAD,,HEWLETT PACKARD CO,TORGERSON JOSEPH M;;BROWNING ROBERT N K;;MACKENZIE MARK H;;MILLER MICHAEL D;;BAKKOM ANGELA WHITE;;DODD SIMON,"HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (2012-09-11)",https://lens.org/157-967-521-807-381,Granted Patent,yes,9,0,34,34,0,B41J2/14072;;B41J2/15;;B41J2/14072;;B41J2/15,B41J2/05;;B41J2/15,,0,0,,,,EXPIRED
581,WO,A2,WO 2002/102597 A2,196-418-524-557-587,2002-12-27,2002,US 0128151 W,2001-09-06,US 88339801 A,2001-06-19,COMPACT INK JET PRINTHEAD,"A compact thermal ink jet printhead including a printhead substrate (11), a plurality of side by side columnar arrays (61) of drop generators (40) formed in the printhead substrate, and drive circuits (85) formed in the printhead substrate for energizing each ink drop generator. The printhead substrate has an ink drop generator packing density of at least 10.43 ink drop generators per square millimeter.",HEWLETT PACKARD CO,TORGERSON JOSEPH M;;BROWNING ROBERT N K;;MACKENZIE MARK H;;MILLER MICHAEL D;;BAKKOM ANGELA W;;DODD SIMON,,https://lens.org/196-418-524-557-587,Patent Application,yes,3,0,23,23,0,B41J2/14072;;B41J2/15;;B41J2/145;;B41J2/14072;;B41J2/15,B41J2/14;;B41J2/05;;B41J2/15;;B41J2/175,,0,0,,,,PENDING
582,DE,A1,DE 102006030309 A1,189-515-706-548-842,2007-01-04,2007,DE 102006030309 A,2006-06-30,GB 0513318 A,2005-07-01,Zündverteiler für einen Motor mit Laserzündung,"Es wird ein Zündverteiler für einen lasergezündeten Mehrzylinder-Verbrennungsmotor beschrieben. Der Zündverteiler umfasst eine durch den Motor drehbare Welle 12 und mehrere ebene reflektierende Flächen 16a bis 16d an der Welle 12. Die Flächen 16a bis 16d liegen in Ebenen senkrecht zur Drehachse der Welle 12 und sind entlang der Länge der Welle axial versetzt. Ein optischer Sender 18 lenkt Licht von einer Laserquelle, so dass es bei einem Winkel der Reihe nach auf den reflektierenden Flächen 16a bis 16d auftritt, wenn die Welle 12 dreht, und mehrere voneinander beabstandete optische Empfänger 24a bis 24d empfangen jeweils das von einer jeweiligen der Spiegelflächen reflektierte Licht und lenken das reflektierte Licht zu einem jeweiligen der Motorzylinder.",FORD GLOBAL TECH LLC,SCARISBRICK ANDY DAVID;;CARROLL STEPH;;DODD ROBERT;;SHENTON TOM;;DEARDEN GEOFF;;KEEN STEVE;;CLISSOLD ROY;;MC CULLOCH JOHN,,https://lens.org/189-515-706-548-842,Patent Application,no,0,0,7,7,0,F02P23/04;;H01S3/0071;;F02P7/03;;F02P23/04;;G02B6/3512;;G02B26/08;;F02P23/04;;H01S3/0071,F02P23/04;;F02P7/00,,0,0,,,,INACTIVE
583,WO,A2,WO 2001/029017 A2,191-985-097-456-026,2001-04-26,2001,FR 0002928 W,2000-10-20,FR 9913233 A,1999-10-22,"N-SUBSTITUTED 3-AMINO-2,2-DI-C-ALKYL-1,4-BUTYROLACTONES AND 1,4-THIOBUTYROLACTONES FOR USE AS PROMOTER OF gamma -AMINOBUTYRIC ACID ACTIVITY AND FOR TREATING NERVOUS DISORDERS AND PREPARATION METHOD","The invention concerns compounds represented by general formula (I) wherein: Z represents a sulphur or oxygen atom; the groups R1 and R2, identical or different, represent each an alkyl group or an alkenyl group; X represents a CO, a CO2, an SO or and SO2 and the group R represents an alkyl, aryl, alkenyl or aralkyl group, provided that when Z represents an oxygen atom, X an SO2 and R a group (a), R1 and R2 do not both represent the methyl group. The invention also concerns methods for preparing said compounds, pharmaceutical compositions containing them and their use as promoter of η-aminobutyric acid and as medicine particularly designed for treating nervous disorders.",CENTRE NAT RECH SCIENT;;INNOVATIONSAGENTUR GMBH;;UNIV BERN;;DODD ROBERT;;EL HADRI AHMED;;POTIER PIERRE JEAN PAUL;;SIEGHART WERNER;;JURSKY FRANTISEK;;FURTMULLER ROMAN;;SIGEL ERWIN;;THOMET URS,DODD ROBERT;;EL HADRI AHMED;;POTIER PIERRE JEAN-PAUL;;SIEGHART WERNER;;JURSKY FRANTISEK;;FURTMULLER ROMAN;;SIGEL ERWIN;;THOMET URS,,https://lens.org/191-985-097-456-026,Patent Application,yes,0,0,12,12,0,A61K31/365;;C07D307/33;;A61P21/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/30;;A61P25/32;;C07D307/33;;A61K31/365,A61K31/341;;A61K31/365;;A61K31/381;;C07D333/36;;A61P21/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/30;;A61P25/32;;C07B61/00;;C07D307/33,,0,0,,,,PATENTED
584,US,B1,US 6660769 B1,047-873-368-250-699,2003-12-09,2003,US 11109102 A,2002-06-26,FR 9913233 A;;FR 0002928 W,1999-10-22,"N substituted 3-amino-2,2-di-c-alkyl-1,4-butyrolactones and 1,4-thiobutyrolactones for use as promoter of gamma-aminobutyric acid activity and for treating nervous disorders and preparation method","
    The invention concerns compounds represented by general formula (I) wherein: Z represents a sulfur or oxygen atom; the groups R1 and R2, identical or different, represent each a alkyl group or an alkenyl group; X represents a CO, a CO _{ 2 } , an SO, or an SO _{ 2 } and the group R represents an alkyl, aryl, alkenyl, or aralkyl group, provided that when Z represents an oxygen atom, X an SO _{ 2 } and R a group (a), R1 and R2 do not both represent the methyl group. The invention also concerns methods for preparing said compounds, pharmaceutical compositions containing them and their use as promoter of -aminobutyric acid and as medicine particularly designed for treating nervous disorders. 
",CENTRE NAT RECH SCIENT;;INNOVATIONSAGENTUR GMBH;;UNIV BERN,DODD ROBERT;;EL HADRI AHMED;;POTIER JEAN-PAUL PIERRE;;SIEGHART WERNER;;JURSKY FRANTISEK;;FURTMULLER ROMAN;;SIGEL ERWIN;;THOMET URS,INNOVATIONSAGENTUR GMBH (2002-06-14);;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CRNS) (2002-06-14);;UNIVERSITE DE BERN (2002-06-14),https://lens.org/047-873-368-250-699,Granted Patent,yes,5,1,12,12,0,A61K31/365;;C07D307/33;;A61P21/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/30;;A61P25/32;;C07D307/33;;A61K31/365,A61K31/341;;A61K31/365;;C07D333/36;;A61K31/381;;A61P21/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/30;;A61P25/32;;C07B61/00;;C07D307/33,514/472;;514/445;;549/321;;549/68,21,21,008-377-922-483-880;;045-714-986-383-922;;069-067-203-713-730;;018-128-863-484-298;;053-786-721-455-794;;056-237-761-380-608;;029-705-321-947-290;;008-377-922-483-880;;005-665-418-428-441;;042-611-777-405-186;;055-355-035-770-688;;012-985-505-322-625;;002-804-265-384-529;;003-450-863-278-508;;017-709-017-199-104;;000-520-350-832-931;;153-318-911-772-625;;036-125-621-412-194;;098-025-051-359-723;;136-902-450-308-358;;070-848-880-387-327,10.1021/jm00108a034;;1849999;;10.1002/hlca.19940770807;;6095867;;10.1016/0006-2952(84)90017-0;;10.1073/pnas.78.11.7180;;6273918;;pmc349220;;7568326;;10.1016/0957-4166(96)00255-8;;pmc43827;;8183949;;10.1073/pnas.91.10.4569;;10.1021/jm00108a034;;1849999;;9224820;;10.1124/mol.52.1.114;;8395954;;10.1016/0006-8993(93)91128-f;;7909294;;10.1016/0014-2999(94)90180-5;;8734480;;10.1016/0028-3908(95)00180-8;;2997631;;10.1007/bf00572441;;10.1016/0301-0082(93)90047-v;;8380934;;8773466;;10.1016/0014-2999(96)00066-0;;10.1016/0896-6273(90)90224-4;;1699569;;10.1002/ddr.430190404;;10.1139/cjr32-078;;8057295;;10.1021/jm00042a001;;10.1021/ja00276a040;;6810462;;10.1126/science.6810462,"Canney et al., ""Synthesis and Structure-Activity Studies of Alkyl-substituted gamma-Butyrolactones and gamma-Thiobutyrolactones: Ligands for the Picrotoxin Receptor,"" Journal of Medicinal Chemistry (1991), vol. 34, pp. 1460-1467, XP002146077, Washington US, abstract, p. 1461, col. 2; table III.;;Jefford et al., ""185.A Practical Synthesis of (2S,3R)-3-Amino-2-Methylpentanoic Acidfrom L-Aspartic Acid,"" Helvetica Chimica ACTA, CH, Verlag Helvetica Chimca ACTA. Basel (1994), vol. 77, No. 8, pp. 2142-2146, XP002070485, ISSN: 0018-019X, p. 2145; examples 9,10.;;W. Sieghart et al., Affinity of Various Ligands for Benzodiazepine Receptors in Rat Cerebellum and Hippocampus, Biochemical Pharmacology, vol. 33, No. 24, pp. 4033-4038, 1984, Pergamon Press Ltd.;;R. Study et al., Diazepam and (-)-pentobarbital: Fluctuation analysis reveals different mechanisms for potentiation of gamma-aminobutyric acid responses in cultured central neurons, Neurobiology. vol. 78, No. 11, pp. 7180-7184, Nov. 1981, Proc. Natl. Acad. Sci. USA.;;W. Sieghart, Structure and Pharmacology of gamma-Aminobutyric AcidA Receptor Subtypes, Pharmacological Reviews, vol. 47, No. 2, 1995, Am. Society for Pharmacology and Experimental Therapeutics.;;M. Collis et al., A Stereodivergent Synthesis of 3,4-Disubstituted-2-Azetidinones, Tetrahedron: Asymmetry, vol. 7, No. 7, pp. 2117-2134, 1996, Elsevier Science Ltd.;;P. Wingrove et al., The modulatory action of lorecleole at the gamma-aminobutyric acid type A receptor is determined by a single amino acid in the beta2 and beta3 subunit, Neurobiology, vol. 91, pp. 4569-4573, May 194, Proc. Natl. Acad. Sci. USA.;;D. Canney et al., Synthesis and Structure-Activity Studies of Alkyl-Substituted gamma-Butyrolactones and gamma-Thiobutyrolactones: Ligands for the Picrotoxin Receptor, J. Med. Chem., vol. 34, No. 4, pp. 1460-1467, 1991, Am. Chemical Society.;;K. Williams et al., Lactone Modulation of the gamma-Aminobutyric AcidA Receptor: Evidence for a Positive Modulatory Site, Molecular Pharmacology, vol. 52, No. 1, pp. 114-119, 1997, Am. Society for Pharmacology and Experimental Therapeutics.;;K. Holland et al., Alkyl-substituted gamma-butyrolactones act at a distinct site allosterically linked to the TBS/picrotoxinin site on the GABAA receptor complex, Brain Research, vol. 615, No. 1, pp. 170-174, 1993, Elsevier Science Publishers B.V.;;G. Dawson et al., Lack of effect of flumazenil and CGS 8216 on the anxiolytic-like properties of loreclezole, European Journal of Pharmacology, vol. 252, No. 3, pp. 325-328, 1994, Elsevier-Science B.V.;;G. Mathews et al., Physiological Comparison of alpha-ethyl-alpha-methyl-gamma-thiobutyrolactone with Benzodiazepine and Barbiturate Modulators of GABAA Receptors, Neuropharmacology, vol. 35, No. 2, pp. 123-136, 1996, Elsevier Science Ltd.;;S. Arbilla et al., Pharmacological profile of the imidazopyridine zolpidem at benzodiazepine receptors and electrocorticogram in rats, Naunyn-Schmiedeberg's Arch. Pharmacol., vol. 330, No. 3, pp. 248-251, 1985, Springer-Verlag.;;C. Gardner et al., The Rapidly Expanding Range Of Neuronal Benzodiazepine Receptor Ligands, Progress in Neurobiology, vol. 40, No. 1, pp. 1-61, 1993, Pergamon Press Ltd.;;J. Zezula et al., Interaction of allosteric ligands with GABAA receptors containing one, two, or three different subunits, European J. of Pharmacology, vol. 301, Nos. 1-3, pp. 207-214, 1996, Elsevier Science B.V.;;E. Sigel et al., The Effect of Subunit Composition of Rat Brain GABAA Receptors on Channel Function, Neuron, vol. 5, No. 5, pp. 703-711, Nov. 1990, Cell Press.;;A. Wauquier et al., Loreclezole (R 72 063): An Anticonvulsant Chemically Unrelated to Prototype Antiepileptic Drugs, Drug Development Research, vol. 19, pp. 375-392, 1990, Wiley-Liss, Inc.;;R. Manske, The Alkaloids Of Fumaraceous Plants II. Dicentra Cucullaria (L.) Bemh, Can. J. Res., vol. VII, pp. 265-269, 1932, National Research Council of Canada.;;P. Krogsgaard-Larsen et al., GABAA Receptor Agonists, Partial Agonists, and Antagonists. Design and Therapeutic Prospects, J. of Medicinal Chemistry, vol. 37, No. 16, pp. 2489-2505, 1994, Am. Chemical Society.;;G. McGarvey et al., L-Aspartic Acid in Acyclic Stereoselective Synthesis. Synthetic Studies on Amphotericin B, J. Am. Chem. Soc., vol. 108, No. 16, pp. 4943-4952, 1986, Am. Chemical Society.;;W. Klunk et al., Alpha-Substitutted gamma-Butyrolactones: New Class of Anticonvulsant Drugs, Science, vol. 217, pp. 1040-1041, 1982, AAAS.",EXPIRED
585,EP,A2,EP 1226133 A2,078-209-845-207-757,2002-07-31,2002,EP 00969660 A,2000-10-20,FR 0002928 W;;FR 9913233 A,1999-10-22,"N-SUBSTITUTED 3-AMINO-2,2-DI-C-ALKYL-1,4-BUTYROLACTONES AND 1,4-THIOBUTYROLACTONES FOR USE AS PROMOTER OF $g(g)-AMINOBUTYRIC ACID ACTIVITY AND FOR TREATING NERVOUS DISORDERS AND PREPARATION METHOD","The invention concerns compounds represented by general formula (I) wherein: Z represents a sulfur or oxygen atom; the groups R1 and R2, identical or different, represent each a alkyl group or an alkenyl group; X represents a CO, a CO2, an SO, or an SO2 and the group R represents an alkyl, aryl, alkenyl, or aralkyl group, provided that when Z represents an oxygen atom, X an SO2 and R a group (a), R1 and R2 do not both represent the methyl group. The invention also concerns methods for preparing said compounds, pharmaceutical compositions containing them and their use as promoter of gamma-aminobutyric acid and as medicine particularly designed for treating nervous disorders.",CENTRE NAT RECH SCIENT;;INNOVATIONSAGENTUR GMBH BU TEC;;UNIV BERN,DODD ROBERT;;EL HADRI AHMED;;POTIER PIERRE JEAN-PAUL;;SIEGHART WERNER;;JURSKY FRANTISEK;;FURTMULLER ROMAN;;SIGEL ERWIN;;THOMET URS,,https://lens.org/078-209-845-207-757,Patent Application,yes,0,0,12,12,0,A61K31/365;;C07D307/33;;A61P21/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/30;;A61P25/32;;C07D307/33;;A61K31/365,C07D333/36;;A61K31/341;;A61K31/365;;A61K31/381;;A61P21/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/30;;A61P25/32;;C07B61/00;;C07D307/33,,0,0,,,,EXPIRED
586,AT,T1,AT E263760 T1,071-693-070-189-356,2004-04-15,2004,AT 00969660 T,2000-10-20,FR 9913233 A;;FR 0002928 W,1999-10-22,"3-AMINO-2,2-DI-C-ALKYL-1,4-BUTYROLACTONE UND N- SUBSTITUIERTE 1,4-THIOBUTYROLACTONE DIE ZUR STIMULATION DER GAMMA-AMINOBUTANSÄUREAKTIVITÄT UND ZUR BEHANDLUNG VON NERVENERKRANKUNGEN VERWENDUNG FINDEN, SOWIE VERFAHREN ZU IHRER HERSTELLUNG","The invention concerns compounds represented by general formula (I) wherein: Z represents a sulfur or oxygen atom; the groups R1 and R2, identical or different, represent each a alkyl group or an alkenyl group; X represents a CO, a CO2, an SO, or an SO2 and the group R represents an alkyl, aryl, alkenyl, or aralkyl group, provided that when Z represents an oxygen atom, X an SO2 and R a group (a), R1 and R2 do not both represent the methyl group. The invention also concerns methods for preparing said compounds, pharmaceutical compositions containing them and their use as promoter of gamma-aminobutyric acid and as medicine particularly designed for treating nervous disorders.",CENTRE NAT RECH SCIENT;;INNOVATIONSAGENTUR GMBH BU TEC;;UNIV BERN,DODD ROBERT;;EL HADRI AHMED;;POTIER PIERRE JEAN-PAUL;;SIEGHART WERNER;;JURSKY FRANTISEK;;FURTMULLER ROMAN;;SIGEL ERWIN;;THOMET URS,,https://lens.org/071-693-070-189-356,Granted Patent,no,0,0,12,12,0,A61K31/365;;C07D307/33;;A61P21/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/30;;A61P25/32;;C07D307/33;;A61K31/365,C07D333/36;;A61K31/341;;A61K31/365;;A61K31/381;;A61P21/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/30;;A61P25/32;;C07B61/00;;C07D307/33,,0,0,,,,DISCONTINUED
587,FR,A1,FR 2800069 A1,093-320-998-461-536,2001-04-27,2001,FR 9913233 A,1999-10-22,FR 9913233 A,1999-10-22,"Gamma-aminobutyric acid activity stimulants comprising new or known 3-amino-1,4-butyrolactone or thiolactone derivatives, useful for treating nervous disorders, e.g. epilepsy, anxiety, depression or pain","Pharmaceutical compositions contain 3-(N-substituted amino)-2,2-dialk(en)yl-1,4-butyrolactone or -thiolactone compounds (I), together with a carrier. Most of (I) are new compounds. Pharmaceutical compositions contain 3-(N-substituted amino)-2,2-dialk(en)yl-1,4-butyrolactone or -thiolactone compounds of formula (I), together with a carrier. Z' = O or S; R1, R2 = alkyl or alkenyl; X = CO, COO, SO or SO2 and R = alkyl, aryl, alkenyl or aralkyl. Independent claims are included for the following: (i) the preparation of (I) and (ii) (I) as new compounds, provided that if Z' = O, X = SO2 and R = p-tolyl, then R1 and R2 are not both Me.",CENTRE NAT RECH SCIENT,DODD ROBERT;;EL HADRI AHMED;;POTIER PIERRE JEAN PAUL;;SIEGHART WERNER;;JURSKY FRANTISEK;;FURTMULLER ROMAN;;SIGEL ERWIN;;THOMET URS,,https://lens.org/093-320-998-461-536,Patent Application,no,2,0,12,12,0,A61K31/365;;C07D307/33;;A61P21/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/30;;A61P25/32;;C07D307/33;;A61K31/365,A61K31/341;;A61K31/365;;A61K31/381;;C07D333/36;;A61P21/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/30;;A61P25/32;;C07B61/00;;C07D307/33,,2,2,045-714-986-383-922;;008-377-922-483-880,10.1002/hlca.19940770807;;10.1021/jm00108a034;;1849999,"JEFFORD C W ET AL: ""185.A PRACTICAL SYNTHESIS OF (2S,3R)-3-AMINO-2-METHYLPENTANOIC ACIDFROM L-ASPARTIC ACID"", HELVETICA CHIMICA ACTA,CH,VERLAG HELVETICA CHIMICA ACTA. BASEL, vol. 77, no. 8, 1994, pages 2142 - 2146, XP002070485, ISSN: 0018-019X;;D.J. CANNEY ET AL.: ""Synthesis and Structure-Activity Studies of Alkyl-Substituted gamma-Butyrolactones and gamma-Thiobutyrolactones: Ligands for the Picrotoxin Receptor"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 34, 1991, WASHINGTON US, pages 1460 - 1467, XP002146077",DISCONTINUED
588,EP,B1,EP 1226133 B1,097-392-725-889-594,2004-04-07,2004,EP 00969660 A,2000-10-20,FR 0002928 W;;FR 9913233 A,1999-10-22,"N-SUBSTITUTED 3-AMINO-2,2-DI-C-ALKYL-1,4-BUTYROLACTONES AND 1,4-THIOBUTYROLACTONES FOR USE AS PROMOTER OF $g(g)-AMINOBUTYRIC ACID ACTIVITY AND FOR TREATING NERVOUS DISORDERS AND PREPARATION METHOD","The invention concerns compounds represented by general formula (I) wherein: Z represents a sulfur or oxygen atom; the groups R1 and R2, identical or different, represent each a alkyl group or an alkenyl group; X represents a CO, a CO2, an SO, or an SO2 and the group R represents an alkyl, aryl, alkenyl, or aralkyl group, provided that when Z represents an oxygen atom, X an SO2 and R a group (a), R1 and R2 do not both represent the methyl group. The invention also concerns methods for preparing said compounds, pharmaceutical compositions containing them and their use as promoter of gamma-aminobutyric acid and as medicine particularly designed for treating nervous disorders.",CENTRE NAT RECH SCIENT;;INNOVATIONSAGENTUR GMBH BU TEC;;UNIV BERN,DODD ROBERT;;EL HADRI AHMED;;POTIER PIERRE JEAN-PAUL;;SIEGHART WERNER;;JURSKY FRANTISEK;;FURTMULLER ROMAN;;SIGEL ERWIN;;THOMET URS,,https://lens.org/097-392-725-889-594,Granted Patent,yes,2,0,12,12,0,A61K31/365;;C07D307/33;;A61P21/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/30;;A61P25/32;;C07D307/33;;A61K31/365,C07D333/36;;A61K31/341;;A61K31/365;;A61K31/381;;A61P21/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/30;;A61P25/32;;C07B61/00;;C07D307/33,,2,0,,,"D.J. CANNEY ET AL.: ""Synthesis and Structure-Activity Studies of Alkyl-Substituted gamma-Butyrolactones and gamma-Thiobutyrolactones: Ligands for the Picrotoxin Receptor"" JOURNAL OF MEDICINAL CHEMISTRY, vol. 34, 1991, pages 1460-1467, XP002146077 WASHINGTON US cité dans la demande;;JEFFORD C W ET AL: ""185.A PRACTICAL SYNTHESIS OF (2S,3R)-3-AMINO-2-METHYLPENTANOIC ACIDFROM L-ASPARTIC ACID"" HELVETICA CHIMICA ACTA,CH,VERLAG HELVETICA CHIMICA ACTA. BASEL, vol. 77, no. 8, 1994, pages 2142-2146, XP002070485 ISSN: 0018-019X",EXPIRED
589,WO,A3,WO 2001/029017 A3,013-384-131-753-449,2001-12-13,2001,FR 0002928 W,2000-10-20,FR 9913233 A,1999-10-22,"N-SUBSTITUTED 3-AMINO-2,2-DI-C-ALKYL-1,4-BUTYROLACTONES AND 1,4-THIOBUTYROLACTONES FOR USE AS PROMOTER OF gamma -AMINOBUTYRIC ACID ACTIVITY AND FOR TREATING NERVOUS DISORDERS AND PREPARATION METHOD","The invention concerns compounds represented by general formula (I) wherein: Z represents a sulphur or oxygen atom; the groups R1 and R2, identical or different, represent each an alkyl group or an alkenyl group; X represents a CO, a CO2, an SO or and SO2 and the group R represents an alkyl, aryl, alkenyl or aralkyl group, provided that when Z represents an oxygen atom, X an SO2 and R a group (a), R1 and R2 do not both represent the methyl group. The invention also concerns methods for preparing said compounds, pharmaceutical compositions containing them and their use as promoter of η-aminobutyric acid and as medicine particularly designed for treating nervous disorders.",CENTRE NAT RECH SCIENT;;INNOVATIONSAGENTUR GMBH;;UNIV BERN;;DODD ROBERT;;EL HADRI AHMED;;POTIER PIERRE JEAN PAUL;;SIEGHART WERNER;;JURSKY FRANTISEK;;FURTMULLER ROMAN;;SIGEL ERWIN;;THOMET URS,DODD ROBERT;;EL HADRI AHMED;;POTIER PIERRE JEAN-PAUL;;SIEGHART WERNER;;JURSKY FRANTISEK;;FURTMULLER ROMAN;;SIGEL ERWIN;;THOMET URS,,https://lens.org/013-384-131-753-449,Search Report,yes,2,0,12,12,0,A61K31/365;;C07D307/33;;A61P21/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/30;;A61P25/32;;C07D307/33;;A61K31/365,A61K31/341;;A61K31/365;;A61K31/381;;A61P21/00;;A61P25/00;;C07D333/36;;A61P25/04;;A61P25/08;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/30;;A61P25/32;;C07B61/00;;C07D307/33,,2,2,008-377-922-483-880;;045-714-986-383-922,10.1021/jm00108a034;;1849999;;10.1002/hlca.19940770807,"D.J. CANNEY ET AL.: ""Synthesis and Structure-Activity Studies of Alkyl-Substituted gamma-Butyrolactones and gamma-Thiobutyrolactones: Ligands for the Picrotoxin Receptor"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 34, 1991, WASHINGTON US, pages 1460 - 1467, XP002146077;;JEFFORD C W ET AL: ""185.A PRACTICAL SYNTHESIS OF (2S,3R)-3-AMINO-2-METHYLPENTANOIC ACIDFROM L-ASPARTIC ACID"", HELVETICA CHIMICA ACTA,CH,VERLAG HELVETICA CHIMICA ACTA. BASEL, vol. 77, no. 8, 1994, pages 2142 - 2146, XP002070485, ISSN: 0018-019X",PATENTED
590,CA,A1,CA 2387974 A1,021-314-019-639-423,2001-04-26,2001,CA 2387974 A,2000-10-20,FR 9913233 A;;FR 0002928 W,1999-10-22,"N-SUBSTITUTED 3-AMINO-2,2-DI-C-ALKYL-1,4-BUTYROLACTONES AND 1,4-THIOBUTYROLACTONES FOR USE AS PROMOTER OF .GAMMA.-AMINOBUTYRIC ACID ACTIVITY AND FOR TREATING NERVOUS DISORDERS ANDPREPARATION METHOD","The invention concerns compounds represented by general formula (I) wherein: Z represents a sulfur or oxygen atom; the groups R1 and R2, identical or different, represent each a alkyl group or an alkenyl group; X represents a CO, a CO2, an SO, or an SO2 and the group R represents an alkyl, aryl, alkenyl, or aralkyl group, provided that when Z represents an oxygen atom, X an SO2 and R a group (a), R1 and R2 do not both represent the methyl group. The invention also concerns methods for preparing said compounds, pharmaceutical compositions containing them and their use as promoter of gamma-aminobutyric acid and as medicine particularly designed for treating nervous disorders.",CENTRE NAT RECH SCIENT;;INNOVATIONSAGENTUR GMBH;;UNIV BERN,JURSKY FRANTISEK;;EL HADRI AHMED;;SIGEL ERWIN;;SIEGHART WERNER;;POTIER PIERRE JEAN-PAUL;;DODD ROBERT;;FURTMULLER ROMAN;;THOMET URS,,https://lens.org/021-314-019-639-423,Patent Application,no,0,0,12,12,0,A61K31/365;;C07D307/33;;A61P21/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/30;;A61P25/32;;C07D307/33;;A61K31/365,C07D333/36;;A61K31/341;;A61K31/365;;A61K31/381;;A61P21/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/30;;A61P25/32;;C07B61/00;;C07D307/33,,0,0,,,,DISCONTINUED
591,DE,C2,DE 2542203 C2,036-634-145-409-554,1985-01-24,1985,DE 2542203 A,1975-09-22,US 50803074 A,1974-09-23,DE 2542203 C2,,"SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V., DEN HAAG, NL","FOSTER, ELTON GORDON, HOUSTON, TEX., US;;GOLDING, ROBERT ALEXANDER, MISSOURI CITY, TEX., US;;DODD, DELWIN EARL, HOUSTON, TEX., US",,https://lens.org/036-634-145-409-554,Granted Patent,no,0,0,13,13,0,C07C29/76;;C07C29/76;;C07C29/86;;C07C29/86,C07C29/04;;C07C27/00;;C07C29/76;;C07C29/86;;C07C31/02;;C07C67/00,,0,0,,,,EXPIRED
592,AU,A,AU 2000/079321 A,044-707-755-098-030,2001-04-30,2001,AU 2000/079321 A,2000-10-20,FR 9913233 A;;FR 0002928 W,1999-10-22,"N-substituted 3-amino-2,2-di-c-alkyl-1,4-butyrolactones and 1,4-thiobutyrolactones for use as promoter of gamma-aminobutyric acid activity and for treating nervous disorders and preparation method","The invention concerns compounds represented by general formula (I) wherein: Z represents a sulfur or oxygen atom; the groups R1 and R2, identical or different, represent each a alkyl group or an alkenyl group; X represents a CO, a CO2, an SO, or an SO2 and the group R represents an alkyl, aryl, alkenyl, or aralkyl group, provided that when Z represents an oxygen atom, X an SO2 and R a group (a), R1 and R2 do not both represent the methyl group. The invention also concerns methods for preparing said compounds, pharmaceutical compositions containing them and their use as promoter of gamma-aminobutyric acid and as medicine particularly designed for treating nervous disorders.",CENTRE NAT RECH SCIENT;;INNOVATIONSAGENTUR GMBH;;UNIV BERN,DODD ROBERT;;HADRI AHMED EL;;POTIER PIERRE JEAN-PAUL;;SIEGHART WERNER;;JURSKY FRANTISEK;;FURTMULLER ROMAN;;SIGEL ERWIN;;THOMET URS,,https://lens.org/044-707-755-098-030,Patent Application,no,0,0,12,12,0,A61K31/365;;C07D307/33;;A61P21/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/30;;A61P25/32;;C07D307/33;;A61K31/365,C07D333/36;;A61K31/341;;A61K31/365;;A61K31/381;;A61P21/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/30;;A61P25/32;;C07B61/00;;C07D307/33,,0,0,,,,DISCONTINUED
593,US,A,US 4788382 A,026-604-928-372-129,1988-11-29,1988,US 5166487 A,1987-05-18,US 5166487 A,1987-05-18,Duplex glass preforms for hermetic glass-to-metal compression sealing,A duplex glass preform for forming hermetic glass-to-metal seals of the compression type. The duplex glass preform comprises a glass infrasturcture or matrix having at least one end thereof modified by the selective distribution therein of ceramic particles. The ceramic particles are selectively distributed to form a ceramic density gradient having the largest concentration of ceramic particles at the surface and gradually decreasing with depth. The duplex glass preform of the present invention has utility in forming glass-to-metal compression seals in hybrid metal packages containing microcircuit chips. The duplex glass preform may be used in the normal insulative fashion or as a conductive member.,ISOTRONICS INC,AHEARN JOHN E;;FRATES RAYMOND A;;GIRARD DENNIS;;KOEPKE RICHARD A;;O'HERN ROBERT M;;SCHMIDT JAMES K;;MANON C DODD,ISOTRONICS INC. INDUSTRIAL PARK NEW BEDFORD MASSACHUSETTS 02745 ANEW JERSEY CORP (1987-05-18);;ISOTRONICS INC. NEW BEDFORD MA. A DE. CORP (1989-05-26),https://lens.org/026-604-928-372-129,Granted Patent,yes,4,27,3,3,0,H01B17/305;;H01L23/10;;H01L2924/01079;;H01L2924/09701;;H01L2924/0002;;H01L23/10;;H01L2924/01079;;H01B17/305;;H01L2924/09701;;H01L2924/0002,H01B17/30;;C03C27/02;;H01L23/10,174 52FP;;174/50.61;;428/432;;501/32;;501/68,0,0,,,,EXPIRED
594,GB,B,GB 2445564 B,120-653-708-414-76X,2011-08-10,2011,GB 0700435 A,2007-01-10,GB 0700435 A,2007-01-10,Laser ignition system with redundant flash lamp trigger pulses,,FORD GLOBAL TECH LLC,SCARISBRICK ANDY DAVID;;CARROLL STEPHEN DAREN;;TRIANTOS GEORGIOS;;SHENTON TOM;;DEARDEN GEOFF;;DODD ROBERT;;NEARY DEREK;;MULLET JACK;;WATKINS KEN,,https://lens.org/120-653-708-414-76X,Granted Patent,no,2,0,3,3,0,F02P23/04;;F02P23/04,F02P23/04,,0,0,,,,INACTIVE
595,EP,A1,EP 0292388 A1,003-542-000-139-359,1988-11-23,1988,EP 88401210 A,1988-05-18,US 5166487 A,1987-05-18,Duplex glass preforms for hermetic glass-to-metal compression sealing.,"A duplex glass preform (30) for forming hermetic glass-to-metal seals of the compression type. The duplex glass preform (30) comprises a glass infrastructure or matrix having at least one end thereof modified by the selective distribution therein of ceramic particles (54). The ceramic particles (54) are selectively distributed to form a ceramic density gradient having the largest concentration of ceramic particles at the surface and gradually decreasing with depth. The duplex glass preform of the present invention has utility in forming glass-to-metal compression seals in hybrid metal packages containing microcircuit chips.  ",ISOTRONICS INC,AHEARN JOHN E;;FRATES RAYMOND A;;GIRARD DENNIS;;KOEPKE RICHARD A;;O'HERN ROBERT M;;SCHMIDT JAMES K;;MANON DODD C,,https://lens.org/003-542-000-139-359,Patent Application,yes,6,4,3,3,0,H01B17/305;;H01L23/10;;H01L2924/01079;;H01L2924/09701;;H01L2924/0002;;H01L23/10;;H01L2924/01079;;H01B17/305;;H01L2924/09701;;H01L2924/0002,C03C27/02;;H01B17/30;;H01L23/10,,0,0,,,,DISCONTINUED
596,GB,A,GB 2427896 A,063-157-773-646-737,2007-01-10,2007,GB 0513318 A,2005-07-01,GB 0513318 A,2005-07-01,Distributor for engine with laser ignition,"A distributor is described for a multi-cylinder laser ignited internal combustion engine. The distributor comprises a shaft 12 rotatable by the engine and a plurality of flat reflective surfaces 16a to 16d on the shaft 12. The surfaces 16a to 16d lie in planes normal to the axis of rotation of the shaft 12 and are axially staggered from one another along the length of the shaft. An optical transmitter 18 directs light from a laser source to impinge at an angle sequentially on the reflective surfaces 16a to 16d as the shaft 12 rotates, and a plurality of optical receivers 24a to 24d spaced from one another each receive the light reflected from a respective one of the mirror surfaces and direct the reflected light to a respective one of the engine cylinders.",FORD GLOBAL TECH LLC,SCARISBRICK ANDREW DAVID;;KEEN STEVE;;DEARDEN GEOFF;;WATKINS KENNETH GORDON;;CARROLL STEPP;;MCCULLOCH JOHN;;SHENTON TOM;;DODD ROBERT;;CLISSOLD ROY,,https://lens.org/063-157-773-646-737,Patent Application,no,4,0,7,7,0,F02P23/04;;H01S3/0071;;F02P7/03;;F02P23/04;;G02B6/3512;;G02B26/08;;F02P23/04;;H01S3/0071,F02P23/04;;F02P7/03;;G02B6/35;;G02B26/08,F1B BCCB          BCCB,0,0,,,,INACTIVE
597,GB,B,GB 2427896 B,123-636-661-116-97X,2010-06-16,2010,GB 0513318 A,2005-07-01,GB 0513318 A,2005-07-01,Distributor for engine with laser ignition,,FORD GLOBAL TECH LLC,SCARISBRICK ANDREW DAVID;;KEEN STEVE;;DEARDEN GEOFF;;WATKINS KENNETH GORDON;;CARROLL STEPP;;MCCULLOCH JOHN;;SHENTON TOM;;DODD ROBERT;;CLISSOLD ROY,,https://lens.org/123-636-661-116-97X,Granted Patent,no,4,0,7,7,0,F02P23/04;;H01S3/0071;;F02P7/03;;F02P23/04;;G02B6/3512;;G02B26/08;;F02P23/04;;H01S3/0071,F02P23/04;;F02P7/03;;G02B6/35;;G02B26/08,,0,0,,,,INACTIVE
598,TW,B,TW I680938 B,123-981-693-974-423,2020-01-01,2020,TW 107132019 A,2018-09-12,US 201715701558 A,2017-09-12,Child resistant aerosol actuator,,WD 40 MFG COMPANY,STARZMAN MICHAEL J;;FREUDENBERG JOHN W;;BATES KEVIN VICTOR;;KRUPP BENJAMIN THOMAS;;STATES ROBERT GERALD;;PARROTT DAVID A;;GOOD ROBERT J;;DODD JOSEPH K;;FALCON SARA DAWSON,,https://lens.org/123-981-693-974-423,Granted Patent,no,19,0,21,21,0,B05B1/1645;;B05B11/0094;;B65D83/303;;B65D83/20;;B65D83/22;;B05B1/1645;;B65D83/22;;B05B11/1059;;B65D83/20;;B65D83/22;;B65D83/24;;B65D83/30;;B65D50/046;;B65D2215/02;;B05B1/1645;;B05B11/0094;;B65D83/303;;B05B11/1059,,,0,0,,,,ACTIVE
599,RU,C1,RU 2745167 C1,141-216-577-923-164,2021-03-22,2021,RU 2020115050 A,2018-09-11,US 201715701558 A;;US 2018/0050424 W,2017-09-12,EXECUTIVE DEVICE OF AEROSOL CYLINDER WITH CHILD SAFE LOCK,"FIELD: aerosols; safe locks.SUBSTANCE: invention relates to an actuator of an aerosol can with protection against opening by children for use with a container of a fluid medium under pressure. The actuator includes a casing configured to be located on the aerosol container above the rod, and an executive element mounted on the casing and made with the ability to move in it to ensure that the rod is pressed by applying an external force applied to the upper surface of the executive element. The actuator includes a nozzle and a channel for connecting the stem and nozzle. The cap is normally positioned to block the movement of the actuator to push the stem. The blocking element normally crosses the path of movement of the cap with the possibility of blocking the cap in its locked position. The blocking element has two sections, both of which must be simultaneously moved to a position located at a distance from the path of movement of the cap, as a result of which the cap can be moved from its locked position, with the provision of movement of the actuator to push the stem.EFFECT: efficient child protection lock.71 cl, 9 dwg",WD 40 MFG COMPANY,STARZMAN MICHAEL J;;FREUDENBERG JOHN W;;BATES KEVIN VICTOR;;KRUPP BENJAMIN THOMAS;;STATES ROBERT GERALD;;PARROTT DAVID A;;GOOD ROBERT J;;DODD JOSEPH K;;FALCON SARA DAWSON,,https://lens.org/141-216-577-923-164,Granted Patent,no,4,0,21,21,0,B05B1/1645;;B05B11/0094;;B65D83/303;;B65D83/20;;B65D83/22;;B05B1/1645;;B65D83/22;;B05B11/1059;;B65D83/20;;B65D83/22;;B65D83/24;;B65D83/30;;B65D50/046;;B65D2215/02;;B05B1/1645;;B05B11/0094;;B65D83/303;;B05B11/1059,B05B1/16;;B65D83/20;;B05B11/00;;B65D50/04;;B65D83/22;;B65D83/24;;B65D83/30,,0,0,,,,ACTIVE
600,TW,A,TW 201919984 A,158-425-168-741-368,2019-06-01,2019,TW 107132019 A,2018-09-12,US 201715701558 A,2017-09-12,Child resistant aerosol actuator,"The actuator includes a shroud adapted to be situated on an aerosol container over the stem and an actuation member mounted on and moveable within the shroud to depress the stem by the application of an external force applied to the top surface of the actuation member. The actuation member includes a nozzle and a conduit for connecting the stem and the nozzle. A hood is normally positioned to block the actuation member from being moved to depress the stem. A locking member normally intersects the path of movement of the hood to lock the hood in its blocking position. The locking member has two sections both of which must be simultaneously moved to a position remote from the path of hood movement such that the hood may be moved from its blocking position, allowing the actuation member to be moved to depress the stem.",WD 40 MFG COMPANY,STARZMAN MICHAEL J;;FREUDENBERG JOHN W;;BATES KEVIN VICTOR;;KRUPP BENJAMIN THOMAS;;STATES ROBERT GERALD;;PARROTT DAVID A;;GOOD ROBERT J;;DODD JOSEPH K;;FALCON SARA DAWSON,,https://lens.org/158-425-168-741-368,Patent of Addition,no,0,0,21,21,0,B05B1/1645;;B05B11/0094;;B65D83/303;;B65D83/20;;B65D83/22;;B05B1/1645;;B65D83/22;;B05B11/1059;;B65D83/20;;B65D83/22;;B65D83/24;;B65D83/30;;B65D50/046;;B65D2215/02;;B05B1/1645;;B05B11/0094;;B65D83/303;;B05B11/1059,B67B5/00;;B65D83/20;;B65D83/22,,0,0,,,,ACTIVE
601,TW,A,TW 202016007 A,176-773-890-079-90X,2020-05-01,2020,TW 108145756 A,2018-09-12,US 201715701558 A,2017-09-12,Child resistant aerosol actuator,"The actuator includes a shroud adapted to be situated on an aerosol container over the stem and an actuation member mounted on and moveable within the shroud to depress the stem by the application of an external force applied to the top surface of the actuation member. The actuation member includes a nozzle and a conduit for connecting the stem and the nozzle. A hood is normally positioned to block the actuation member from being moved to depress the stem. A locking member normally intersects the path of movement of the hood to lock the hood in its blocking position. The locking member has two sections both of which must be simultaneously moved to a position remote from the path of hood movement such that the hood may be moved from its blocking position, allowing the actuation member to be moved to depress the stem.",WD-40 MFG COMPANY,STARZMAN MICHAEL J;;FREUDENBERG JOHN W;;BATES KEVIN VICTOR;;KRUPP BENJAMIN THOMAS;;STATES ROBERT GERALD;;PARROTT DAVID A;;GOOD ROBERT J;;DODD JOSEPH K;;FALCON SARA DAWSON,,https://lens.org/176-773-890-079-90X,Patent of Addition,no,0,0,21,21,0,B05B1/1645;;B05B11/0094;;B65D83/303;;B65D83/20;;B65D83/22;;B05B1/1645;;B65D83/22;;B05B11/1059;;B65D83/20;;B65D83/22;;B65D83/24;;B65D83/30;;B65D50/046;;B65D2215/02;;B05B1/1645;;B05B11/0094;;B65D83/303;;B05B11/1059,B65D83/20;;B67B5/00;;B65D83/22,,0,0,,,,ACTIVE
602,US,A1,US 2019/0119031 A1,102-590-352-045-300,2019-04-25,2019,US 201816229914 A,2018-12-21,US 201816229914 A;;US 201715701558 A,2017-09-12,CHILD RESISTANT AEROSOL ACTUATOR,"The actuator includes a shroud adapted to be situated on an aerosol container over the stem and an actuation member mounted on and moveable within the shroud to depress the stem by the application of an external force applied to the top surface of the actuation member. The actuation member includes a nozzle and a conduit for connecting the stem and the nozzle. A hood is normally positioned to block the actuation member from being moved to depress the stem. A locking member normally intersects the path of movement of the hood to lock the hood in its blocking position. The locking member has two sections both of which must be simultaneously moved to a position remote from the path of hood movement such that the hood may be moved from its blocking position, allowing the actuation member to be moved to depress the stem.",WD 40 COMPANY,STARZMAN MICHAEL J;;FREUDENBERG JOHN W;;BATES KEVIN VICTOR;;KRUPP BENJAMIN THOMAS;;STATES ROBERT GERALD;;PARROTT DAVID A;;GOOD ROBERT J;;DODD JOSEPH K;;FALCON SARA DAWSON,WD-40 COMPANY (2017-08-04),https://lens.org/102-590-352-045-300,Patent Application,yes,6,1,21,21,0,B05B1/1645;;B05B11/0094;;B65D83/303;;B65D83/20;;B65D83/22;;B05B1/1645;;B65D83/22;;B05B11/1059;;B65D83/20;;B65D83/22;;B65D83/24;;B65D83/30;;B65D50/046;;B65D2215/02;;B05B1/1645;;B05B11/0094;;B65D83/303;;B05B11/1059,B65D83/20;;B05B11/00;;B65D50/04;;B65D83/22;;B65D83/24;;B65D83/30,,0,0,,,,ACTIVE
603,TW,B,TW I716223 B,179-318-874-684-565,2021-01-11,2021,TW 108145756 A,2018-09-12,US 201715701558 A,2017-09-12,Child resistant aerosol actuator,,WD 40 MFG COMPANY,STARZMAN MICHAEL J;;FREUDENBERG JOHN W;;BATES KEVIN VICTOR;;KRUPP BENJAMIN THOMAS;;STATES ROBERT GERALD;;PARROTT DAVID A;;GOOD ROBERT J;;DODD JOSEPH K;;FALCON SARA DAWSON,,https://lens.org/179-318-874-684-565,Granted Patent,no,26,0,21,21,0,B05B1/1645;;B05B11/0094;;B65D83/303;;B65D83/20;;B65D83/22;;B05B1/1645;;B65D83/22;;B05B11/1059;;B65D83/20;;B65D83/22;;B65D83/24;;B65D83/30;;B65D50/046;;B65D2215/02;;B05B1/1645;;B05B11/0094;;B65D83/303;;B05B11/1059,,,0,0,,,,ACTIVE
604,EP,A1,EP 4043363 A1,107-460-092-726-420,2022-08-17,2022,EP 22154362 A,2018-09-11,US 201715701558 A;;EP 18857058 A;;US 2018/0050424 W,2017-09-12,CHILD RESISTANT AEROSOL ACTUATOR,"The actuator includes a shroud adapted to be situated on an aerosol container over the stem and an actuation member mounted on and moveable within the shroud to depress the stem by the application of an external force applied to the top surface of the actuation member. The actuation member includes a nozzle and a conduit for connecting the stem and the nozzle. A hood is normally positioned to block the actuation member from being moved to depress the stem. A locking member normally intersects the path of movement of the hood to lock the hood in its blocking position. The locking member has two sections both of which must be simultaneously moved to a position remote from the path of hood movement such that the hood may be moved from its blocking position, allowing the actuation member to be moved to depress the stem.
",WD 40 MFG COMPANY,STARZMAN MICHAEL J;;FREUDENBERG JOHN W;;BATES KEVIN VICTOR;;KRUPP BENJAMIN THOMAS;;STATES ROBERT GERALD;;PARROT DAVID A;;GOOD ROBERT J;;DODD JOSEPH K;;FALCON SARA DAWSON,,https://lens.org/107-460-092-726-420,Patent Application,yes,9,0,21,21,0,B05B1/1645;;B05B11/0094;;B65D83/303;;B65D83/20;;B65D83/22;;B05B1/1645;;B65D83/22;;B05B11/1059;;B65D83/20;;B65D83/22;;B65D83/24;;B65D83/30;;B65D50/046;;B65D2215/02;;B05B1/1645;;B05B11/0094;;B65D83/303;;B05B11/1059,B65D83/20;;B05B1/16;;B05B11/00;;B65D50/04;;B65D83/22;;B65D83/24;;B65D83/30,,0,0,,,,PENDING
605,CO,A2,CO 7131380 A2,158-919-438-264-136,2014-12-01,2014,CO 14252517 A,2014-11-14,US 201261647174 P;;US 201361790967 P,2012-05-15,"Derivados de benzamida para la inhibición de la actividad de abl1, abl2 y bcr-abl1","La presente invención se refiere a los compuestos de lafórmula (I),en donde Y, Y1, R1, R2, R3 y R4 se definen en la Breve Descripción dela Invención; capaces de inhibir la actividad de BCR-ABL1 y losmutantes de los mismos. La invención proporciona además unproceso para la preparación de los compuestos de la invención, laspreparaciones farmacéuticas que comprenden estos compuestos, ylos métodos para utilizar tales compuestos en el tratamiento decánceres.",NOVARTIS AG,DODD STEPHANIE;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JAHNKE WOLFGANG;;JONES DARRYL BRYNLEY;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS;;SALEM BAHAA;;SCHOEPFER JOSEPH,,https://lens.org/158-919-438-264-136,Patent Application,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,A61K31/4439;;A61P35/00;;C07D401/04,,0,0,,,,PENDING
606,CA,A1,CA 3075536 A1,013-732-109-535-451,2019-03-21,2019,CA 3075536 A,2018-09-11,US 201715701558 A;;US 2018/0050424 W,2017-09-12,CHILD RESISTANT AEROSOL ACTUATOR,"The actuator includes a shroud adapted to be situated on an aerosol container over the stem and an actuation member mounted on and moveable within the shroud to depress the stem by the application of an external force applied to the top surface of the actuation member. The actuation member includes a nozzle and a conduit for connecting the stem and the nozzle. A hood is normally positioned to block the actuation member from being moved to depress the stem. A locking member normally intersects the path of movement of the hood to lock the hood in its blocking position. The locking member has two sections both of which must be simultaneously moved to a position remote from the path of hood movement such that the hood may be moved from its blocking position, allowing the actuation member to be moved to depress the stem.",WD 40 MFG COMPANY,STARZMAN MICHAEL J;;FREUDENBERG JOHN W;;BATES KEVIN VICTOR;;KRUPP BENJAMIN THOMAS;;STATES ROBERT GERALD;;PARROT DAVID A;;GOOD ROBERT J;;DODD JOSEPH K;;FALCON SARA DAWSON,,https://lens.org/013-732-109-535-451,Patent Application,no,0,0,21,21,0,B05B1/1645;;B05B11/0094;;B65D83/303;;B65D83/20;;B65D83/22;;B05B1/1645;;B65D83/22;;B05B11/1059;;B65D83/20;;B65D83/22;;B65D83/24;;B65D83/30;;B65D50/046;;B65D2215/02;;B05B1/1645;;B05B11/0094;;B65D83/303;;B05B11/1059,B65D83/20;;B05B11/00;;B65D50/04;;B65D83/22;;B65D83/24;;B65D83/30,,0,0,,,,PENDING
607,CA,C,CA 3075536 C,061-620-455-815-741,2022-03-29,2022,CA 3075536 A,2018-09-11,US 201715701558 A;;US 2018/0050424 W,2017-09-12,CHILD RESISTANT AEROSOL ACTUATOR,"The actuator includes a shroud adapted to be situated on an aerosol container over the stem and an actuation member mounted on and moveable within the shroud to depress the stem by the application of an external force applied to the top surface of the actuation member. The actuation member includes a nozzle and a conduit for connecting the stem and the nozzle. A hood is normally positioned to block the actuation member from being moved to depress the stem. A locking member normally intersects the path of movement of the hood to lock the hood in its blocking position. The locking member has two sections both of which must be simultaneously moved to a position remote from the path of hood movement such that the hood may be moved from its blocking position, allowing the actuation member to be moved to depress the stem.",WD 40 MFG COMPANY,STARZMAN MICHAEL J;;FREUDENBERG JOHN W;;BATES KEVIN VICTOR;;KRUPP BENJAMIN THOMAS;;STATES ROBERT GERALD;;PARROT DAVID A;;GOOD ROBERT J;;DODD JOSEPH K;;FALCON SARA DAWSON,,https://lens.org/061-620-455-815-741,Granted Patent,no,0,0,21,21,0,B05B1/1645;;B05B11/0094;;B65D83/303;;B65D83/20;;B65D83/22;;B05B1/1645;;B65D83/22;;B05B11/1059;;B65D83/20;;B65D83/22;;B65D83/24;;B65D83/30;;B65D50/046;;B65D2215/02;;B05B1/1645;;B05B11/0094;;B65D83/303;;B05B11/1059,B65D83/20;;B05B11/00;;B65D50/04;;B65D83/22;;B65D83/24;;B65D83/30,,0,0,,,,PENDING
608,EP,A1,EP 3681819 A1,147-465-884-534-594,2020-07-22,2020,EP 18857058 A,2018-09-11,US 201715701558 A;;US 2018/0050424 W,2017-09-12,CHILD RESISTANT AEROSOL ACTUATOR,,WD 40 MFG COMPANY,STARZMAN MICHAEL J;;FREUDENBERG JOHN W;;BATES KEVIN VICTOR;;KRUPP BENJAMIN THOMAS;;STATES ROBERT GERALD III;;PARROT DAVID A;;GOOD ROBERT J;;DODD JOSEPH K;;FALCON SARA DAWSON,,https://lens.org/147-465-884-534-594,Patent Application,yes,0,0,21,21,0,B05B1/1645;;B05B11/0094;;B65D83/303;;B65D83/20;;B65D83/22;;B05B1/1645;;B65D83/22;;B05B11/1059;;B65D83/20;;B65D83/22;;B65D83/24;;B65D83/30;;B65D50/046;;B65D2215/02;;B05B1/1645;;B05B11/0094;;B65D83/303;;B05B11/1059,B65D83/20;;B05B11/00;;B65D50/04;;B65D83/22;;B65D83/24;;B65D83/30,,0,0,,,,PENDING
609,BR,A2,BR 112020004895 A2,072-939-393-637-671,2020-09-15,2020,BR 112020004895 A,2018-09-11,US 2018/0050424 W;;US 201715701558 A,2017-09-12,acionador de aerossol resistente a crianças,"a presente invenção refere-se a um acionador que inclui uma cobertura adaptada para ser situada em um recipiente aerossol sobre a haste e um membro de acionamento montado em e móvel dentro da cobertura para pressionar a haste pela aplicação de uma força externa aplicada na superfície de topo do membro de acionamento. o membro de acionamento inclui um bocal e um conduto para conectar a haste e o bocal. a cobertura de proteção é normalmente posicionada para impedir que o membro de acionamento seja movido para pressionar a haste. um membro de travamento normalmente intersecta o trajeto de movimento da cobertura de proteção para travar a cobertura de proteção em sua posição de bloqueio. o membro de travamento tem duas seções ambas as quais devem ser simultaneamente movidas para uma posição remota a partir do trajeto de movimento da cobertura de proteção de modo que a cobertura de proteção pode ser movida a partir de sua posição de bloqueio, permitindo que o membro de acionamento seja movido para pressionar a haste.",WD 40 MFG COMPANY,BENJAMIN THOMAS KRUPP;;DAVID A PARROTT;;JOHN W FREUDENBERG;;JOSEPH K DODD;;KEVIN VICTOR BATES;;MICHAEL J STARZMAN;;ROBERT GERALD STATES III;;ROBERT J GOOD;;SARA DAWSON FALCON,,https://lens.org/072-939-393-637-671,Patent Application,no,0,0,21,21,0,B05B1/1645;;B05B11/0094;;B65D83/303;;B65D83/20;;B65D83/22;;B05B1/1645;;B65D83/22;;B05B11/1059;;B65D83/20;;B65D83/22;;B65D83/24;;B65D83/30;;B65D50/046;;B65D2215/02;;B05B1/1645;;B05B11/0094;;B65D83/303;;B05B11/1059,B65D50/04;;B05B11/00;;B65D83/20;;B65D83/22;;B65D83/24;;B65D83/30,,0,0,,,,PENDING
610,US,B2,US 10752427 B2,015-651-147-374-300,2020-08-25,2020,US 201816229914 A,2018-12-21,US 201816229914 A;;US 201715701558 A,2017-09-12,Child resistant aerosol actuator,"The actuator includes a shroud adapted to be situated on an aerosol container over the stem and an actuation member mounted on and moveable within the shroud to depress the stem by the application of an external force applied to the top surface of the actuation member. The actuation member includes a nozzle and a conduit for connecting the stem and the nozzle. A hood is normally positioned to block the actuation member from being moved to depress the stem. A locking member normally intersects the path of movement of the hood to lock the hood in its blocking position. The locking member has two sections both of which must be simultaneously moved to a position remote from the path of hood movement such that the hood may be moved from its blocking position, allowing the actuation member to be moved to depress the stem.",WD-40 COMPANY,STARZMAN MICHAEL J;;FREUDENBERG JOHN W;;BATES KEVIN VICTOR;;KRUPP BENJAMIN THOMAS;;STATES III ROBERT GERALD;;PARROTT DAVID A;;GOOD ROBERT J;;DODD JOSEPH K;;FALCON SARA DAWSON,WD-40 COMPANY (2017-08-04),https://lens.org/015-651-147-374-300,Granted Patent,yes,6,0,21,21,0,B05B1/1645;;B05B11/0094;;B65D83/303;;B65D83/20;;B65D83/22;;B05B1/1645;;B65D83/22;;B05B11/1059;;B65D83/20;;B65D83/22;;B65D83/24;;B65D83/30;;B65D50/046;;B65D2215/02;;B05B1/1645;;B05B11/0094;;B65D83/303;;B05B11/1059,B65D83/20;;B05B1/16;;B05B11/00;;B65D50/04;;B65D83/22;;B65D83/24;;B65D83/30,,0,0,,,,ACTIVE
611,US,A1,US 2019/0077580 A1,164-782-009-133-042,2019-03-14,2019,US 201715701558 A,2017-09-12,US 201715701558 A,2017-09-12,CHILD RESISTANT AEROSOL ACTUATOR,"The actuator includes a shroud adapted to be situated on an aerosol container over the stem and an actuation member mounted on and moveable within the shroud to depress the stem by the application of an external force applied to the top surface of the actuation member. The actuation member includes a nozzle and a conduit for connecting the stem and the nozzle. A hood is normally positioned to block the actuation member from being moved to depress the stem. A locking member normally intersects the path of movement of the hood to lock the hood in its blocking position. The locking member has two sections both of which must be simultaneously moved to a position remote from the path of hood movement such that the hood may be moved from its blocking position, allowing the actuation member to be moved to depress the stem.",WD 40 COMPANY,STARZMAN MICHAEL J;;FREUDENBERG JOHN W;;BATES KEVIN VICTOR;;KRUPP BENJAMIN THOMAS;;STATES III ROBERT GERALD;;PARROTT DAVID A;;GOOD ROBERT J;;DODD JOSEPH K;;FALCON SARA DAWSON,WD-40 COMPANY (2017-08-04),https://lens.org/164-782-009-133-042,Patent Application,yes,8,6,21,21,0,B05B1/1645;;B05B11/0094;;B65D83/303;;B65D83/20;;B65D83/22;;B05B1/1645;;B65D83/22;;B05B11/1059;;B65D83/20;;B65D83/22;;B65D83/24;;B65D83/30;;B65D50/046;;B65D2215/02;;B05B1/1645;;B05B11/0094;;B65D83/303;;B05B11/1059,B65D83/20;;B05B11/00;;B65D50/04;;B65D83/22;;B65D83/24;;B65D83/30,,0,0,,,,ACTIVE
612,EP,A4,EP 3681819 A4,153-833-718-034-790,2021-06-16,2021,EP 18857058 A,2018-09-11,US 201715701558 A;;US 2018/0050424 W,2017-09-12,CHILD RESISTANT AEROSOL ACTUATOR,,WD 40 MFG COMPANY,STARZMAN MICHAEL J;;FREUDENBERG JOHN W;;BATES KEVIN VICTOR;;KRUPP BENJAMIN THOMAS;;STATES III ROBERT GERALD;;PARROT DAVID A;;GOOD ROBERT J;;DODD JOSEPH K;;FALCON SARA DAWSON,,https://lens.org/153-833-718-034-790,Search Report,no,4,0,21,21,0,B05B1/1645;;B05B11/0094;;B65D83/303;;B65D83/20;;B65D83/22;;B05B1/1645;;B65D83/22;;B05B11/1059;;B65D83/20;;B65D83/22;;B65D83/24;;B65D83/30;;B65D50/046;;B65D2215/02;;B05B1/1645;;B05B11/0094;;B65D83/303;;B05B11/1059,B65D83/20;;B05B1/16;;B05B11/00;;B65D50/04;;B65D83/22;;B65D83/24;;B65D83/30,,1,0,,,See also references of WO 2019055395A1,PENDING
613,US,B2,US 10370176 B2,021-339-885-673-055,2019-08-06,2019,US 201715701558 A,2017-09-12,US 201715701558 A,2017-09-12,Child resistant aerosol actuator,"The actuator includes a shroud adapted to be situated on an aerosol container over the stem and an actuation member mounted on and moveable within the shroud to depress the stem by the application of an external force applied to the top surface of the actuation member. The actuation member includes a nozzle and a conduit for connecting the stem and the nozzle. A hood is normally positioned to block the actuation member from being moved to depress the stem. A locking member normally intersects the path of movement of the hood to lock the hood in its blocking position. The locking member has two sections both of which must be simultaneously moved to a position remote from the path of hood movement such that the hood may be moved from its blocking position, allowing the actuation member to be moved to depress the stem.",WD 40 COMPANY,STARZMAN MICHAEL J;;FREUDENBERG JOHN W;;BATES KEVIN VICTOR;;KRUPP BENJAMIN THOMAS;;STATES III ROBERT GERALD;;PARROTT DAVID A;;GOOD ROBERT J;;DODD JOSEPH K;;FALCON SARA DAWSON,WD-40 COMPANY (2017-08-04),https://lens.org/021-339-885-673-055,Granted Patent,yes,26,1,21,21,0,B05B1/1645;;B05B11/0094;;B65D83/303;;B65D83/20;;B65D83/22;;B05B1/1645;;B65D83/22;;B05B11/1059;;B65D83/20;;B65D83/22;;B65D83/24;;B65D83/30;;B65D50/046;;B65D2215/02;;B05B1/1645;;B05B11/0094;;B65D83/303;;B05B11/1059,B65D83/20;;B05B1/16;;B05B11/00;;B65D50/04;;B65D83/22;;B65D83/24;;B65D83/30,,0,0,,,,ACTIVE
614,AU,A1,AU 2018/334523 A1,178-749-558-339-936,2020-06-04,2020,AU 2018/334523 A,2018-09-11,US 201715701558 A;;US 2018/0050424 W,2017-09-12,Child resistant aerosol actuator,"The actuator includes a shroud adapted to be situated on an aerosol container over the stem and an actuation member mounted on and moveable within the shroud to depress the stem by the application of an external force applied to the top surface of the actuation member. The actuation member includes a nozzle and a conduit for connecting the stem and the nozzle. A hood is normally positioned to block the actuation member from being moved to depress the stem. A locking member normally intersects the path of movement of the hood to lock the hood in its blocking position. The locking member has two sections both of which must be simultaneously moved to a position remote from the path of hood movement such that the hood may be moved from its blocking position, allowing the actuation member to be moved to depress the stem.",WD 40 MFG COMPANY,STARZMAN MICHAEL J;;FREUDENBERG JOHN W;;BATES KEVIN VICTOR;;KRUPP BENJAMIN THOMAS;;STATES III ROBERT GERALD;;PARROT DAVID A;;GOOD ROBERT J;;DODD JOSEPH K;;FALCON SARA DAWSON,,https://lens.org/178-749-558-339-936,Patent Application,no,0,0,21,21,0,B05B1/1645;;B05B11/0094;;B65D83/303;;B65D83/20;;B65D83/22;;B05B1/1645;;B65D83/22;;B05B11/1059;;B65D83/20;;B65D83/22;;B65D83/24;;B65D83/30;;B65D50/046;;B65D2215/02;;B05B1/1645;;B05B11/0094;;B65D83/303;;B05B11/1059,B65D83/20;;B05B11/00;;B65D50/04;;B65D83/22;;B65D83/24;;B65D83/30,,0,0,,,,DISCONTINUED
615,UY,A,UY 34811 A,066-591-517-291-763,2013-12-31,2013,UY 34811 A,2013-05-15,US 201261647174 P;;US 201361790967 P,2012-05-15,"COMPUESTOS Y COMPOSICIONES PARA INHIBIR LA ACTIVIDAD DE LA ABL1, ABL2 Y BCR-ABL1",Escanear fórmula I página 5/165.,NOVARTIS AG,PASCAL FURET;;DODD STEPHANIE KAY;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;PAUL MANLEY;;ANDREAS MARZINZIK;;PELLE XAVIER FRANCOIS ANDRE;;BAHAA SALEM;;JOSEPH SCHOEPFER,,https://lens.org/066-591-517-291-763,Patent Application,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D401/14;;A61K31/4155;;A61K31/4427;;A61P35/00;;C07D403/10;;C07D405/14,,0,0,,,,ACTIVE
616,MX,B,MX 351434 B,077-785-934-812-712,2017-10-13,2017,MX 2013010396 A,2012-03-16,US 201113068875 A;;US 201113285576 A;;US 2012/0029468 W,2011-03-15,DIP TUBE CONNECTORS AND PUMP SYSTEMS USING THE SAME.,"A pump system may include a blown-in dip tube connected to a valve body and having a connection which may include an improved blown-in dip tube connector having one or more of a lip for sealing with a blown-in dip tube, a seal ring configured to mate with a blown-in dip tube and seal therewith, a dip tube lock for mating with a blown-in dip tube, or an o-ring for providing an improved seal with a blown-in dip tube.",WESTROCK DISPENSING SYSTEMS INC,ROBERT J GOOD;;DENNIS KELLY;;JOSEPH K DODD;;JOSEPH R KRESTINE;;DAVID L DEJONG;;STEVEN SWEETON;;ERIC SCHEIER;;LLUIS COSTA QUINTAS;;ALEJANDRO ESPINOZA,KONINKLIJKE DOUWE EGBERTS B.V. (2017-03-15),https://lens.org/077-785-934-812-712,Granted Patent,no,0,0,27,27,0,B05B11/0037;;B05B15/30;;B05B11/0044;;B05B11/1011;;B05B11/0044;;B05B11/0037;;B05B15/30;;B05B11/1011;;B05B11/1045;;B05B11/1047;;B05B11/0089,B05B11/00,,0,0,,,,ACTIVE
617,MX,B,MX 359014 B,138-956-013-823-884,2018-09-12,2018,MX 2014013374 A,2013-05-09,US 201261647174 P;;US 201361790967 P;;IB 2013053768 W,2012-05-15,"BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1.","The present invention relates to compounds of formula (I): in which Y, Y1, R1, R2, R3 and R4 are defined in the Summary of the Invention; capable of inhibiting the activity of BCR-ABL1 and mutants thereof. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds in the treatment of cancers.",NOVARTIS AG,PASCAL FURET;;STEPHANIE KAY DODD;;ROBERT MARTIN GROTZFELD;;DARRYL BRYNLEY JONES;;PAUL MANLEY;;ANDREAS MARZINZIK;;XAVIER FRANCOIS ANDRE PELLE;;BAHAA SALEM;;JOSEPH SCHOEPFER,,https://lens.org/138-956-013-823-884,Granted Patent,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D401/14;;A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D403/10,,0,0,,,,ACTIVE
618,WO,A1,WO 2012/145105 A1,006-268-757-886-76X,2012-10-26,2012,US 2012/0029468 W,2012-03-16,US 201113068875 A;;US 201113285576 A,2011-03-15,DIP TUBE CONNECTORS AND PUMP SYSTEMS USING THE SAME,"A pump system may include a blown-in dip tube connected to a valve body and having a connection which may include an improved blown-in dip tube connector having one or more of a lip for sealing with a blown-in dip tube, a seal ring configured to mate with a blown-in dip tube and seal therewith, a dip tube lock for mating with a blown-in dip tube, or an o-ring for providing an improved seal with a blown-in dip tube.",MEADWESTVACO CALMAR INC;;GOOD ROBERT J;;KELLY DENNIS;;DODD JOSEPH K;;KRESTINE JOSEPH R;;DEJONG DAVID L;;SWEETON STEVEN;;SCHEIER ERIC;;COSTA QUINTAS LLUIS;;ESPINOZA ALEJANDRO,GOOD ROBERT J;;KELLY DENNIS;;DODD JOSEPH K;;KRESTINE JOSEPH R;;DEJONG DAVID L;;SWEETON STEVEN;;SCHEIER ERIC;;COSTA QUINTAS LLUIS;;ESPINOZA ALEJANDRO,,https://lens.org/006-268-757-886-76X,Patent Application,yes,14,4,27,27,0,B05B11/0037;;B05B15/30;;B05B11/0044;;B05B11/1011;;B05B11/0044;;B05B11/0037;;B05B15/30;;B05B11/1011;;B05B11/1045;;B05B11/1047;;B05B11/0089,B05B11/00,,1,0,,,See also references of EP 2686113A4,PENDING
619,JO,B1,JO 3453 B1,111-744-996-453-823,2020-07-05,2020,JO P20130150 A,2013-05-15,US 201261647174 P;;US 201361790967 P,2012-05-15,"Benzamide Derivatives FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1","<p>The present invention relates to compounds of formula (I): in which Y, Y1, R1, R2, R3andR4are defined in the Summary of the Invention; capable of inhibiting the activity of BCR-ABL1 and mutants thereof. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds in the treatment of cancers.</p>",NOVARTIS AG,DARRYL BRYNLEY JONES;;JOSEPH SCHOEPFER;;BAHAA SALEM;;XAVIER FRANCOIS ANDRE PELLE;;ANDREAS MARZINZIK;;PASCAL FURET;;ROBERT MARTIN GROTZFELD;;PAUL MANLEY;;STEPHANIE KAY DODD,,https://lens.org/111-744-996-453-823,Granted Patent,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D403/10;;A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D401/14,,0,0,,,,ACTIVE
620,MX,A,MX 2014013374 A,106-254-784-066-984,2015-01-16,2015,MX 2014013374 A,2013-05-09,US 201261647174 P;;US 201361790967 P;;IB 2013053768 W,2012-05-15,"BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1.","The present invention relates to compounds of formula (I): in which Y, Y1, R1, R2, R3 and R4 are defined in the Summary of the Invention; capable of inhibiting the activity of BCR-ABL1 and mutants thereof. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds in the treatment of cancers.",NOVARTIS AG,FURET PASCAL;;DODD STEPHANIE KAY;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH,,https://lens.org/106-254-784-066-984,Patent Application,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,A61K31/4439;;C07D401/14;;A61P35/00;;C07D213/82;;C07D401/04;;C07D403/10,,0,0,,,,ACTIVE
621,MX,A,MX 2013010396 A,008-031-463-339-696,2014-07-23,2014,MX 2013010396 A,2012-03-16,US 201113068875 A;;US 201113285576 A;;US 2012/0029468 W,2011-03-15,DIP TUBE CONNECTORS AND PUMP SYSTEMS USING THE SAME.,"A pump system may include a blown-in dip tube connected to a valve body and having a connection which may include an improved blown-in dip tube connector having one or more of a lip for sealing with a blown-in dip tube, a seal ring configured to mate with a blown-in dip tube and seal therewith, a dip tube lock for mating with a blown-in dip tube, or an o-ring for providing an improved seal with a blown-in dip tube.",MEADWESTVACO CALMAR INC,GOOD ROBERT J;;KELLY DENNIS;;DODD JOSEPH K;;KRESTINE JOSEPH R;;DEJONG DAVID L;;SWEETON STEVEN;;SCHEIER ERIC;;QUINTAS LLUIS COSTA;;ESPINOZA ALEJANDRO,KONINKLIJKE DOUWE EGBERTS B.V. (2017-03-15),https://lens.org/008-031-463-339-696,Patent Application,no,0,0,27,27,0,B05B11/0037;;B05B15/30;;B05B11/0044;;B05B11/1011;;B05B11/0044;;B05B11/0037;;B05B15/30;;B05B11/1011;;B05B11/1045;;B05B11/1047;;B05B11/0089,B05B11/00,,0,0,,,,ACTIVE
622,EP,A4,EP 2686113 A4,165-067-175-081-94X,2015-07-15,2015,EP 12774118 A,2012-03-16,US 201113068875 A;;US 201113285576 A;;US 2012/0029468 W,2011-03-15,DIP TUBE CONNECTORS AND PUMP SYSTEMS USING THE SAME,,MEADWESTVACO CALMAR INC,GOOD ROBERT J;;KELLY DENNIS;;DODD JOSEPH K;;KRESTINE JOSEPH R;;DEJONG DAVID L;;SWEETON STEVEN;;SCHEIER ERIC;;COSTA QUINTAS LLUIS;;ESPINOZA ALEJANDRO,"THE CLOROX COMPANY (2021-05-12);;WESTROCK DISPENSING SYSTEMS, INC. (2017-04-12);;SILGAN DISPENSING SYSTEMS CORPORATION (2017-09-27)",https://lens.org/165-067-175-081-94X,Search Report,no,3,0,27,27,0,B05B11/0037;;B05B15/30;;B05B11/0044;;B05B11/1011;;B05B11/0044;;B05B11/0037;;B05B15/30;;B05B11/1011;;B05B11/1045;;B05B11/1047;;B05B11/0089,B05B11/00;;B05B15/00,,1,0,,,See also references of WO 2012145105A1,ACTIVE
623,TN,A1,TN 2014000427 A1,189-997-683-533-190,2016-03-30,2016,TN 2014000427 A,2014-10-13,US 201261647174 P;;US 201361790967 P;;IB 2013053768 W,2012-05-15,"BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1","The present invention relates to compounds of formula (I): in which Y, Y1, R1, R2, R3 and R4 are defined in the Summary of the Invention; capable of inhibiting the activity of BCR-ABL1 and mutants thereof. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds in the treatment of cancers.",NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH,,https://lens.org/189-997-683-533-190,Patent Application,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10,,0,0,,,,PENDING
624,TW,B,TW I560183 B,080-811-203-867-204,2016-12-01,2016,TW 102117263 A,2013-05-15,US 201261647174 P;;US 201361790967 P,2012-05-15,"Compounds and compositions for inhibiting the activity of abl1, abl2 and bcr-abl1",,NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH,,https://lens.org/080-811-203-867-204,Granted Patent,no,2,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,,,0,0,,,,ACTIVE
625,AR,A1,AR 091063 A1,189-834-618-965-265,2014-12-30,2014,AR P130101692 A,2013-05-15,US 201261647174 P;;US 201361790967 P,2012-05-15,"COMPUESTOS Y COMPOSICIONES PARA INHIBIR LA ACTIVIDAD DE LA ABL1, ABL2 Y BCR-ABL1","Compuestos capaces de inhibir la actividad de BCR-ABL1 y mutantes de los mismos. Además se proporciona un proceso para la preparación de compuestos de la presente, preparaciones farmacéuticas que comprenden tales compuestos y métodos de utilizar tales compuestos en el tratamiento de cánceres. ABL Tirosina quinasa de la proteína de Abelson. Reivindicación 1: El compuesto de la reivindicación 1 de la fórmula (1) en el cual R¹ es pirazolilo; en donde dicho pirazolilo es sustituido o no sustituido con 1 a 2 grupos R⁶; R² es pirrolidinilo; en donde dicho pirrolidinilo es sustituido por un grupo R⁷; R³ se selecciona a partir de hidrógeno y halo; R⁴ se selecciona a partir de -SF₅ y -Y²-CF₂-Y³; R⁶ en cada ocurrencia es independientemente seleccionado a partir de hidrógeno, hidroxilo, metilo, metoxilo, ciano, trifluorometilo, hidroxi- metilo, halo, amino, fluoro-etilo, etilo y ciclopropilo; R⁷ se selecciona a partir de hidroxilo, metilo, halo, metoxilo, hidroxilo-metilo, amino, metilo-amino, amino-metilo, trifluorometilo, 2-hidroxipropan-2-ilo, metilocarbonil-amino, dimetil-amino, 2-amino-3-metilbutanoil)oxilo, carboxilo, metoxilo-carbonilo, fosfonooxilo, ciano y amino-carbonilo; Y se selecciona a partir de CH y N; Y¹ se selecciona a partir de CH y N; Y² se selecciona a partir de CF₂, O y S(O)₀₋₂; e Y³ se seleccionado a partir de hidrógeno, cloro, flúor, metilo, difluorometilo y trifluorometilo; o las sales farmacéuticamente aceptables de los mismos.",NOVARTIS AG,STEPHANIE KAY DODD;;PASCAL FURET;;ROBERT MARTIN GROTZFELD;;DARRYL BRYNLEY JONES;;PAUL MANLEY;;ANDREAS MARZINZIK;;XAVIER FRANCOIS ANDRE PELLE;;BAHAA SALEM;;JOSEPH SCHOEPFER,,https://lens.org/189-834-618-965-265,Patent Application,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D403/10;;A61K31/4155;;A61K31/4427;;A61P35/02;;C07D401/04;;C07D401/14;;C07F9/09,,0,0,,,,ACTIVE
626,TW,A,TW 201400471 A,143-573-435-730-066,2014-01-01,2014,TW 102117263 A,2013-05-15,US 201261647174 P;;US 201361790967 P,2012-05-15,"Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1","The present invention relates to compounds of formula (I): in which Y, Y1, R1, R2, R3 and R4 are defined in the Summary of the Invention; capable of inhibiting the activity of BCR-ABL1 and mutants thereof. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds in the treatment of cancers.",NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH,,https://lens.org/143-573-435-730-066,Patent of Addition,no,0,1,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,A61K31/4155;;C07D401/04;;A61K31/455;;A61P35/02;;C07D401/14;;C07D403/10;;C07D405/14,,0,0,,,,ACTIVE
627,EP,B1,EP 2686113 B1,178-061-010-430-341,2022-12-28,2022,EP 12774118 A,2012-03-16,US 201113068875 A;;US 201113285576 A;;US 2012/0029468 W,2011-03-15,DIP TUBE CONNECTORS AND PUMP SYSTEMS USING THE SAME,,CLOROX CO,GOOD ROBERT J;;KELLY DENNIS;;DODD JOSEPH K;;KRESTINE JOSEPH R;;DEJONG DAVID L;;SWEETON STEVEN;;SCHEIER ERIC;;COSTA QUINTAS LLUIS;;ESPINOZA ALEJANDRO,"THE CLOROX COMPANY (2021-05-12);;WESTROCK DISPENSING SYSTEMS, INC. (2017-04-12);;SILGAN DISPENSING SYSTEMS CORPORATION (2017-09-27)",https://lens.org/178-061-010-430-341,Granted Patent,yes,1,0,27,27,0,B05B11/0037;;B05B15/30;;B05B11/0044;;B05B11/1011;;B05B11/0044;;B05B11/0037;;B05B15/30;;B05B11/1011;;B05B11/1045;;B05B11/1047;;B05B11/0089,B05B11/00;;B05B15/00,,0,0,,,,ACTIVE
628,WO,A1,WO 2013/171639 A1,035-234-796-218-998,2013-11-21,2013,IB 2013053768 W,2013-05-09,US 201261647174 P;;US 201361790967 P,2012-05-15,"BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1","The present invention relates to compounds of formula (I): in which Y, Y 1 , R 1 , R 2 , R 3 and R 4 are defined in the Summary of the Invention; capable of inhibiting the activity of BCR-ABL1 and mutants thereof. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds in the treatment of cancers.",NOVARTIS AG;;DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH,,https://lens.org/035-234-796-218-998,Patent Application,yes,26,71,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,A61K31/4439;;C07D401/14;;A61P35/00;;C07D213/82;;C07D401/04;;C07D403/10,,61,47,049-997-490-538-87X;;094-055-108-080-726;;004-546-180-635-337;;065-615-513-012-189;;038-857-397-147-766;;045-353-430-616-937;;029-770-264-403-692;;004-612-905-249-779;;045-956-573-688-025;;093-945-784-743-386;;041-981-964-833-620;;018-806-825-558-137;;088-982-221-653-821;;025-668-588-533-438;;119-320-554-133-349;;095-445-815-198-969;;071-517-787-589-100;;078-056-191-591-782;;090-413-509-430-979;;037-344-681-635-660;;058-749-599-778-627;;092-530-441-612-463;;029-557-352-592-398;;112-317-399-448-33X;;039-909-541-957-56X;;083-453-620-359-077;;051-058-819-266-31X;;024-034-423-934-953;;041-861-351-785-754;;026-458-129-209-488;;000-458-056-018-977;;078-756-327-746-040;;098-653-150-994-279;;007-743-964-700-952;;122-280-374-736-315;;015-596-968-705-438;;042-502-466-246-154;;111-619-355-096-798;;028-477-762-606-039;;022-692-775-292-220;;045-300-544-902-393;;066-371-099-307-130;;077-295-491-167-117;;062-011-435-247-356;;015-048-246-604-291;;046-924-770-129-978;;006-062-994-561-578,19217274;;10.1016/j.ceb.2009.01.014;;10.1021/jm301188x;;23088644;;16205964;;10.1007/s11060-005-4570-9;;pmc2795431;;10.1038/sj.bjc.6605411;;19904263;;10.1158/1078-0432.ccr-08-1867;;19789313;;10.1093/annonc/mdi317;;16033874;;19768386;;10.1007/s11060-009-0008-0;;pmc3927643;;19491323;;10.1124/jpet.109.154781;;10.1016/j.ijrobp.2005.08.025;;16274936;;16921058;;10.1200/jco.2006.05.5608;;pmc3102501;;22379297;;10.1007/s12288-011-0055-5;;15160941;;10.1080/10428190310001625728;;pmc4794994;;22378924;;10.1126/scitranslmed.3003500;;20823226;;pmc2944759;;10.1073/pnas.1006083107;;10.1523/jneurosci.1833-10.2011;;21209200;;pmc3039694;;10.1073/pnas.1534745100;;14523244;;pmc218777;;20811458;;pmc2936959;;10.1038/nature09325;;pmc2982846;;21103325;;10.1371/journal.pone.0015503;;11279131;;10.1074/jbc.m100792200;;pmc3329755;;10.1007/s12031-011-9588-1;;21728062;;10.1096/fj.07-102715;;18591368;;10.1080/13550280701361516;;17849316;;10.1074/jbc.m405652200;;15247213;;19789182;;pmc2758807;;10.1242/jcs.048397;;pmc2717779;;19289603;;10.1096/fj.09-129833;;19116940;;10.1002/art.24186;;15735062;;10.1164/rccm.200404-531oc;;10.1159/000327719;;21659722;;pmc7068797;;19833721;;pmc2787359;;10.1074/jbc.m109.013771;;10.1016/s0083-6729(08)00604-3;;19251035;;19015530;;10.1073/pnas.0810246105;;pmc2596241;;10.1096/fj.06-6910com;;17135364;;10.3109/03639049109057315;;1941575;;10.1002/jps.2600800722;;10.1002/anie.199408031;;12196213;;10.1046/j.1468-0734.2002.00066.x;;12239143;;10.1182/blood-2002-03-0704;;10.1056/nejm199808273390907;;9718381;;10.1056/nejm200004063421402;;10749961;;10.3109/02841869409098463;;7818931;;10.1016/s0960-894x(01)80285-7;;18219308;;10.1038/nrd2468;;10.1002/0471220574;;10.1021/om00137a602;;15939018;;10.1016/j.str.2005.03.012;;10.2210/pdb1y57/pdb;;10.1007/3-540-26670-4_13;;pmc282729;;3143116;;10.1073/pnas.85.23.9312,"ECK M J ET AL: ""The interplay of structural information and functional studies in kinase drug design: insights from BCR-Abl"", CURRENT OPINION IN CELL BIOLOGY, CURRENT SCIENCE, LONDON, GB, vol. 21, no. 2, 1 April 2009 (2009-04-01), pages 288 - 295, XP026035462, ISSN: 0955-0674, [retrieved on 20090211], DOI: 10.1016/J.CEB.2009.01.014;;YUPENG LI ET AL: ""Design, Synthesis, and Biological Evaluation of 3-(1 H -1,2,3-Triazol-1-yl)benzamide Derivatives as Potent Pan Bcr-Abl Inhibitors Including the Threonine 315 ->Isoleucine 315 Mutant"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 55, no. 22, 26 November 2012 (2012-11-26), pages 10033 - 10046, XP055082710, ISSN: 0022-2623, DOI: 10.1021/jm301188x;;HABERLER C; GELPI E; MAROSI C; ROSSLER K; BIRNER P; BUDKA H; HAINFELLNER JA.: ""Immunohistochemical analysis of platelet-derived growth factor receptor-alpha, -beta, c-KIT, ABL1, and ABL2 proteins in glioblastoma: possible implications for patient selection for imatinib mesylate therapy"", J NEUROONCOL., vol. 76, no. 2, January 2006 (2006-01-01), pages 105 - 9, XP019260837;;REARDON DA; RESEMANN G; TAILLIBERT S; CAMPONE M; VAN DEN BENT M; CLEMENT P; BLOMQUIST E; GORDOWER L; SCHULTZ H; RAIZER J: ""Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma"", BR J CANCER., vol. 101, no. 12, 15 December 2009 (2009-12-15), pages 1995 - 2004;;RAZIS E; SELVIARIDIS P; LABROPOULOS S; NORRIS JL; ZHU MJ; SONG DD; KALEBIC T; TORRENS M; KALOGERA- FOUNTZILA A; KARKAVELAS G: ""Phase II study ofneoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment"", CLIN CANCER RES., vol. 15, no. 19, 1 October 2009 (2009-10-01), pages 6258 - 66;;DRESEMANN G.: ""Imatinib and hydroxyurea in pretreated progressive glioblastoma multiforme: a patient series."", ANN ONCOL., vol. 16, no. 10, October 2005 (2005-10-01), pages 1702 - 8;;HOLDHOFF ET AL., J NEUROONCOL., vol. 97, no. 2, 2010, pages 241 - 5;;CHEN Y; AGARWAL S; SHAIK NM; CHEN C; YANG Z; ELMQUIST WF.: ""P-glycoprotein and breast cancer resistance protein influence brain distribution of dasatinib"", J PHARMACOL EXP THER., vol. 330, no. 3, September 2009 (2009-09-01), pages 956 - 63;;GENG L; SHINOHARA ET; KIM D; TAN J; OSUSKY K; SHYR Y; HALLAHAN DE.: ""STI571 (Gleevec) improves tumor growth delay and survival in irradiated mouse models of glioblastoma"", INT J RADIAT ONCOL BIOL PHYS, vol. 64, no. 1, 1 January 2006 (2006-01-01), pages 263 - 71, XP024898131, DOI: doi:10.1016/j.ijrobp.2005.08.025;;KIM HJ; JUNG CW; KIM K; AHN JS; KIM WS; PARK K; KO YH; KANG WK; PARK K.: ""Isolated blast crisis in CNS in a patient with chronic myelogenous leukemia maintaining major cytogenetic response after imatinib"", J CLIN ONCOL., vol. 24, no. 24, 20 August 2006 (2006-08-20), pages 4028 - 9;;RADHIKA N; MINAKSHI M; RAJESH M; MANAS BR; DEEPAK KUMAR M.: ""Central nervous system blast crisis in chronic myeloid leukemia on imatinib mesylate therapy: report of two cases"", INDIAN J HEMATOL BLOOD TRANSFUS., vol. 27, no. L, March 2011 (2011-03-01), pages 51 - 4;;LEIS JF; STEPAN DE; CURTIN PT; FORD JM; PENG B; SCHUBACH S; DRUKER BJ; MAZIARZ RT.: ""Central nervous system failure in patients with chronic myelogenous leukemia lymphoid blast crisis and Philadelphia chromosome positive acute lymphoblastic leukemia treated with imatinib (STI-571"", LEUK LYMPHOMA., vol. 45, no. 4, April 2004 (2004-04-01), pages 695 - 8;;GARCIA MAYRA; COOPER ARIK; SHI WEI; BORNMANN WILLIAM; CARRION RICARDO; KALMAN DANIEL; NABEL GARY J.: ""Productive Replication of Ebola Virus Is Regulated by the ABL1 Tyrosine Kinase"", SCIENCE TRANSLATIONAL MEDICINE, vol. 4, 2012, pages 123RA24;;KO HS; LEE Y; SHIN JH; KARUPPAGOUNDER SS; GADAD BS; KOLESKE AJ; PLETNIKOVA O; TRONCOSO JC; DAWSON VL; DAWSON TM.: ""Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function."", PROC NATL ACAD SCI U S A, vol. 107, no. 38, 21 September 2010 (2010-09-21), pages 16691 - 6, XP055255293, DOI: doi:10.1073/pnas.1006083107;;IMAM SZ; ZHOU Q; YAMAMOTO A; VALENTE AJ; ALI SF; BAINS M; ROBERTS JL; KAHLE PJ; CLARK RA; LI S.: ""Novel regulation of parkin function through c-Abl- mediated tyrosine phosphorylation: implications for Parkinson's disease"", J NEUROSCI, vol. 31, no. 1, 5 January 2011 (2011-01-05), pages 157 - 63, XP055339898, DOI: doi:10.1523/JNEUROSCI.1833-10.2011;;NETZER WJ; DOU F; CAI D; VEACH D; JEAN S; LI Y; BORNMANN WG; CLARKSON B; XU H; GREENGARD P.: ""Gleevec inhibits beta-amyloid production but not Notch cleavage."", PROC NATL ACAD SCI U S A., vol. 100, no. 21, 14 October 2003 (2003-10-14), pages 12444 - 9, XP002669074, DOI: doi:10.1073/PNAS.1534745100;;HE G; LUO W; LI P; REMMERS C; NETZER WJ; HENDRICK J; BETTAYEB K; FLAJOLET M; GORELICK F; WENNOGLE LP: ""Gamma- secretase activating protein is a therapeutic target for Alzheimer's disease"", NATURE, vol. 467, no. 7311, 2 September 2010 (2010-09-02), pages 95 - 8;;BARBAGALLO AP; WELDON R; TAMAYEV R; ZHOU D; GILIBERTO L; FOREMAN O; D'ADAMIO L.: ""Tyr(682) in the intracellular domain of APP regulates amyloidogenic APP processing in vivo"", PLOS ONE., vol. 5, no. 11, 16 November 2010 (2010-11-16), pages E15503;;ZAMBRANO N; BRUNI P; MINOPOLI G; MOSCA R; MOLINO D; RUSSO C; SCHETTINI G; SUDOL M; RUSSO T.: ""The beta-amyloid precursor protein APP is tyrosine-phosphorylated in cells expressing a constitutively active form of the Abl protoncogene"", J BIOL CHEM., vol. 276, no. 23, 8 June 2001 (2001-06-08), pages 19787 - 92, XP002530714, DOI: doi:10.1074/JBC.M100792200;;SCHLATTERER SD; ACKER CM; DAVIES P.: ""c-Abl in neurodegenerative disease."", J MOL NEUROSCI., vol. 45, no. 3, November 2011 (2011-11-01), pages 445 - 52, XP019971746, DOI: doi:10.1007/s12031-011-9588-1;;SCHLATTERER SD; ACKER CM; DAVIES P.: ""c-Abl in neurodegenerative disease"", J MOL NEUROSCI., vol. 45, no. 3, November 2011 (2011-11-01), pages 445 - 52, XP019971746, DOI: doi:10.1007/s12031-011-9588-1;;ALVAREZ AR; KLEIN A; CASTRO J; CANCINO GI; AMIGO J; MOSQUEIRA M; VARGAS LM; YEVENES LF; BRONFMAN FC; ZANLUNGO S.: ""Imatinib therapy blocks cerebellar apoptosis and improves neurological symptoms in a mouse model of Niemann-Pick type C disease"", ASEB J., vol. 22, no. 10, October 2008 (2008-10-01), pages 3617 - 27, XP055255489, DOI: doi:10.1096/fj.07-102715;;YUN SW; ERTMER A; FLECHSIG E; GILCH S; RIEDERER P; GERLACH M; SCHATZL HM; KLEIN MA.: ""The tyrosine kinase inhibitor imatinib mesylate delays prion neuroinvasion by inhibiting prion propagation in the periphery"", J NEUROVIROL., vol. 13, no. 4, August 2007 (2007-08-01), pages 328 - 37;;ERTMER A; GILCH S; YUN SW; FLECHSIG E; KLEBL B; STEIN-GERLACH M; KLEIN MA; SCHATZL HM.: ""The tyrosine kinase inhibitor STI571 induces cellular clearance of PrPSc in prion-infected cells"", J BIOL CHEM., vol. 279, no. 40, 1 October 2004 (2004-10-01), pages 41918 - 27;;TIFFT KE; BRADBURY KA; WILSON KL.: ""Tyrosine phosphorylation of nuclear- membrane protein emerin by SRC, ABL and other kinases"", J CELL SCI., vol. 122, 15 October 2009 (2009-10-15), pages 3780 - 90;;HUANG P; ZHAO XS; FIELDS M; RANSOHOFF RM; ZHOU L.: ""Imatinib attenuates skeletal muscle dystrophy in mdx mice"", FASEB J., vol. 23, no. 8, August 2009 (2009-08-01), pages 2539 - 48;;AKHMETSHINA A; VENALIS P; DEES C; BUSCH N; ZWERINA J; SCHETT G; DISTLER O; DISTLER JH.: ""Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis"", ARTHRITIS RHEUM., vol. 60, no. 1, January 2009 (2009-01-01), pages 219 - 24, XP009144496;;AONO Y; NISHIOKA Y; INAYAMA M; UGAI M; KISHI J; UEHARA H; IZUMI K; SONE S.: ""Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice"", AM J RESPIR CRIT CARE MED., vol. 171, no. 11, 1 June 2005 (2005-06-01), pages 1279 - 85;;RHEE CK; LEE SH; YOON HK; KIM SC; LEE SY; KWON SS; KIM YK; KIM KH; KIM TJ; KIM JW.: ""Effect of nilotinib on bleomycin-induced acute lung injury and pulmonary fibrosis in mice"", RESPIRATION, vol. 82, no. 3, 2011, pages 273 - 87;;RHEE ET AL., RESPIRATION, vol. 82, no. 3, 2011, pages 273 - 87;;SINGLETON PA; PENDYALA S; GORSHKOVA IA; MAMBETSARIEV N; MOITRA J; GARCIA JG; NATARAJAN V.: ""Dynamin 2 and c-Abl are novel regulators of hyperoxia-mediated NADPH oxidase activation and reactive oxygen species production in caveolin-enriched microdomains of the endothelium"", J BIOL CHEM., vol. 284, no. 50, 11 December 2009 (2009-12-11), pages 34964 - 75, XP002748171, DOI: doi:10.1074/jbc.M109.013771;;GENUA M; PANDINI G; CASSARINO MF; MESSINA RL; FRASCA F.: ""c-Abl and insulin receptor signalling"", VITAM HORM, vol. 80, 2009, pages 77 - 105;;LOUVET C; SZOT GL; LANG J; LEE MR; MARTINIER N; BOLLAG G; ZHU S; WEISS A; BLUESTONE JA.: ""Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice"", PROC NATL ACAD SCI U S A., vol. 105, no. 48, 2 December 2008 (2008-12-02), pages 18895 - 900;;HAGERKVIST R; SANDLER S; MOKHTARI D; WELSH N.: ""Amelioration of diabetes by imatinib mesylate (Gleevec): role of beta-cell NF-kappaB activation and anti-apoptotic preconditioning"", FASEB J., vol. 21, no. 2, February 2007 (2007-02-01), pages 618 - 28;;BERGE ET AL.: ""Pharmaceutical Salts"", PHARM. SCI., vol. 66, 1977, pages 1 - 19, XP002675560, DOI: doi:10.1002/jps.2600660104;;DORDUNOO, S. K. ET AL., DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, vol. 17, no. 12, 1991, pages 1685 - 1713;;SHEEN, P. C. ET AL., J PHARM SCI, vol. 80, no. 7, 1991, pages 712 - 714;;VAN UDEN ET AL., PLANT CELL TISS. ORG. CULT., vol. 38, 1994, pages 1 - 3,113;;WENZ, AGNEW. CHEM. INT. ED. ENGL., vol. 33, 1994, pages 803 - 822;;""New RRC, Liposomes: A practical approach"", 1990, IRL PRESS, pages: 33 - 104;;LASIC DD: ""Liposomes from physics to applications"", 1993, ELSEVIER SCIENCE PUBLISHERS BV;;FADERL S; GARCIA-MANERO G; THOMAS D ET AL.: ""Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia- Current Concepts and Future Perspectives."", REV CLIN EXP HEMATOL, vol. 6, 2002, pages 142 - 160;;DOMBRET H; GALBERT J; BOIRON J ET AL.: ""Outcome of Treatment in Adults with Philadelphia chromosome-posititve acute lymphoblastic leukemia- Results of the prospective multicenter LALA-94 trial"", BLOOD, vol. 100, 2002, pages 2357 - 2366;;FADERL S; GARCIA-MANERO G; THOMAS D ET AL.: ""Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia- Current Concepts and Future Perspectives"", REV CLIN EXP HEMATOL, vol. 6, 2002, pages 142 - 160;;C. H. PUI; W. E. EVANS.: ""Acute Lymphoblastic"", LEUKEMIA NEW ENGL J MED, vol. 339, 1998, pages 605 - 615;;ARICO M; VALSECCHI M G; CAMITTA B; SCHRAPPE M; CHESSELLS J; BARUCHEL A; GAYNON P; SILVERMAN L; JANKA-SCHAUB G; KAMPS W ET AL., NEW ENGL J MED, vol. 342, 2000, pages 998 - 1006;;NANDY ET AL., ACTA ONCOLOGICA, vol. 33, 1994, pages 953 - 961;;HELLMAN ET AL.: ""Principles and Practice of Oncology"", vol. 1, 1993, article ""Principles of Radiation Therapy, Cancer"", pages: 248 - 275;;T.W. GREENE; P. G. M. WUTS: ""Protective Groups in Organic Chemistry"", 1991, JOHN WILEY AND SONS;;SAULNIER MG; LANGLEY DR; KADOW JF; SENTER PD; KNIPE JO; TUN MM; VYAS DM; DOYLE TW: ""Synthesis of etoposide phosphate, BMY-4048 1: a watersoluble clinically active prodrug of etoposide"", BIOORG MED CHEM LETT, vol. 4, 1994, pages 2567 - 2572, XP026637398, DOI: doi:10.1016/S0960-894X(01)80285-7;;RAUTIO J; KUMPULAINEN H; HEIMBACH T; OLIYAI R; OH D; JARVINEN T; SAVOLAINEN J: ""Prodrugs: design and clinical applications"", NAT REV DRUG DISCOV, vol. 7, 2008, pages 255 - 70, XP055227338, DOI: doi:10.1038/nrd2468;;J. F. W. MCOMIE: ""Protective Groups in Organic Chemistry"", 1973, PLENUM PRESS;;T. W. GREENE: ""Protective Groups in Organic Synthesis, Third edition,"", 1999, WILEY;;E. GROSS AND J. MEIENHOFER: ""The Peptides"", vol. 3, 1981, ACADEMIC PRESS;;HOUBEN WEYL: ""Methoden der organischen Chemie, 4th edition"", vol. 15/I, 1974, GEORG THIEME VERLAG;;H.-D. JAKUBKE; H. JESCHEIT: ""Aminosauren, Peptide, Proteine"", 1982, VERLAG CHEMIE;;JOCHEN LEHMANN: ""Chemie der Kohlenhydrate: Monosaccharide und Derivate"", 1974, GEORG THIEME VERLAG;;JEAN JACQUES; ANDRE COLLET; SAMUEL H. WILEN: ""Enantiomers, Racemates and Resolutions"", 1981, JOHN WILEY AND SONS, INC.;;S.W. COWAN-JACOB; G. FENDRICH; P.W. MANLEY; W. JAHNKE; D. FABBRO; J. LIEBETANZ; T. MEYER: ""c-Src crystal structure provides insights into c-Src activation"", STRUCTURE, vol. 13, 2005, pages 861 - 871;;D. FABBRO; G. FENDRICH; V. GUEZ; T. MEYER; P. FURET; J. MESTAN; J.D. GRIFFIN; P.W. MANLEY; S.W. COWAN-JACOB: ""Handbook of Experimental Pharmacology 167, Inhibitors of Protein Kinases and Protein Phosphates"", 2005, article ""Targeted therapy with imatinib: An exception or a rule?"", pages: 361 - 389;;DALEY, G.Q.; BALTIMORE, D.: ""Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myeloid leukemia-specific p210 BCR-ABL1 protein"", PNAS, vol. 85, 1988, pages 9312 - 9316",PENDING
629,CN,A,CN 103608122 A,101-075-212-332-25X,2014-02-26,2014,CN 201280023492 A,2012-03-16,US 2012/0029468 W;;US 201113285576 A,2011-10-31,Dip tube connectors and pump systems using the same,"A pump system may include a blown-in dip tube connected to a valve body and having a connection which may include an improved blown-in dip tube connector having one or more of a lip for sealing with a blown-in dip tube, a seal ring configured to mate with a blown-in dip tube and seal therewith, a dip tube lock for mating with a blown-in dip tube, or an O-ring for providing an improved seal with a blown-in dip tube.",MEADWESTVACO CALMAR INC,GOOD ROBERT J;;KELLY DENNIS;;DODD JOSEPH K;;KRESTINE JOSEPH R;;DEJONG DAVID L;;SWEETON STEVEN;;SCHEIER ERIC;;COSTA QUINTAS LLUIS;;ESPINOZA ALEJANDRO,,https://lens.org/101-075-212-332-25X,Patent Application,no,7,11,1,1,0,B05B15/30;;B05B11/0044;;B05B11/0037;;B05B11/1011;;B05B11/0037;;B05B15/30;;B05B11/0044;;B05B11/1011;;B05B11/1057;;B05B11/0037,B05B11/00,,0,0,,,,DISCONTINUED
630,CA,A1,CA 2829936 A1,122-096-851-845-881,2012-10-26,2012,CA 2829936 A,2012-03-16,US 201113068875 A;;US 201113285576 A;;US 2012/0029468 W,2011-03-15,DIP TUBE CONNECTORS AND PUMP SYSTEMS USING THE SAME,"A pump system may include a blown-in dip tube connected to a valve body and having a connection which may include an improved blown-in dip tube connector having one or more of a lip for sealing with a blown-in dip tube, a seal ring configured to mate with a blown-in dip tube and seal therewith, a dip tube lock for mating with a blown-in dip tube, or an o-ring for providing an improved seal with a blown-in dip tube.",MEADWESTVACO CALMAR INC,GOOD ROBERT J;;KELLY DENNIS;;DODD JOSEPH K;;KRESTINE JOSEPH R;;DEJONG DAVID L;;SWEETON STEVEN;;SCHEIER ERIC;;COSTA QUINTAS LLUIS;;ESPINOZA ALEJANDRO,,https://lens.org/122-096-851-845-881,Patent Application,no,0,0,27,27,0,B05B11/0037;;B05B15/30;;B05B11/0044;;B05B11/1011;;B05B11/0044;;B05B11/0037;;B05B15/30;;B05B11/1011;;B05B11/1045;;B05B11/1047;;B05B11/0089,B05B11/00;;B65D47/34,,0,0,,,,DISCONTINUED
631,ES,T3,ES 2937637 T3,015-675-087-319-487,2023-03-30,2023,ES 12774118 T,2012-03-16,US 201113068875 A;;US 201113285576 A;;US 2012/0029468 W,2011-03-15,Conectores de tubo de inmersión y sistemas de bombeo que utilizan los mismos,"Un sistema de bomba puede incluir un tubo de inmersión insuflado conectado a un cuerpo de válvula y que tiene una conexión que puede incluir un conector de tubo de inmersión insuflado mejorado que tiene uno o más labios para sellar con un tubo de inmersión insuflado, un sello anillo configurado para acoplarse con un tubo de inmersión insuflado y sellarlo, un bloqueo de tubo de inmersión para acoplarse con un tubo de inmersión insuflado, o una junta tórica para proporcionar un sellado mejorado con un tubo de inmersión insuflado. (Traducción automática con Google Translate, sin valor legal)",CLOROX CO,GOOD ROBERT J;;KELLY DENNIS;;DODD JOSEPH K;;KRESTINE JOSEPH R;;DEJONG DAVID L;;SWEETON STEVEN;;SCHEIER ERIC;;COSTA QUINTAS LLUIS;;ESPINOZA ALEJANDRO,,https://lens.org/015-675-087-319-487,Granted Patent,no,0,0,27,27,0,B05B11/0037;;B05B15/30;;B05B11/0044;;B05B11/1011;;B05B11/0044;;B05B11/0037;;B05B15/30;;B05B11/1011;;B05B11/1045;;B05B11/1047;;B05B11/0089,B05B11/00;;B05B15/00,,0,0,,,,ACTIVE
632,EP,A1,EP 2686113 A1,130-344-328-200-00X,2014-01-22,2014,EP 12774118 A,2012-03-16,US 201113068875 A;;US 201113285576 A;;US 2012/0029468 W,2011-03-15,DIP TUBE CONNECTORS AND PUMP SYSTEMS USING THE SAME,,MEADWESTVACO CALMAR INC,GOOD ROBERT J;;KELLY DENNIS;;DODD JOSEPH K;;KRESTINE JOSEPH R;;DEJONG DAVID L;;SWEETON STEVEN;;SCHEIER ERIC;;COSTA QUINTAS LLUIS;;ESPINOZA ALEJANDRO,"THE CLOROX COMPANY (2021-05-12);;WESTROCK DISPENSING SYSTEMS, INC. (2017-04-12);;SILGAN DISPENSING SYSTEMS CORPORATION (2017-09-27)",https://lens.org/130-344-328-200-00X,Patent Application,yes,0,0,27,27,0,B05B11/0037;;B05B15/30;;B05B11/0044;;B05B11/1011;;B05B11/0044;;B05B11/0037;;B05B15/30;;B05B11/1011;;B05B11/1045;;B05B11/1047;;B05B11/0089,B05B11/00;;B05B15/00,,0,0,,,,ACTIVE
633,US,A1,US 2014/0122504 A1,118-771-165-630-399,2014-05-01,2014,US 201313965519 A,2013-08-13,US 201313965519 A;;US 201261720130 P,2012-10-30,Systems and Methods for Collection and Automatic Analysis of Opinions on Various Types of Media,"Systems and methods for collection and automatic analysis of opinions of media are provided. A representative method includes: receiving, from a user, media for review; automatically distributing the media to a pool of reviewers based on reviewer profiles; receiving, from the reviewers, information corresponding to opinions pertaining to the media; automatically generating a report based, at least in part, on the information received from the reviewers; and providing the report to the user.",COURTIER-DUTTON DAVID ANTHONY;;SOPPER JAMES ALEXANDER MAURICE ERNEST;;DODD ANDREW JAMES;;AYERS MADELEINE REBECCA;;HAMMOND GRACE MARGARET;;REIMANN MARC WALTER;;SISCO JOEL ROBERT,COURTIER-DUTTON DAVID ANTHONY;;SOPPER JAMES ALEXANDER MAURICE ERNEST;;DODD ANDREW JAMES;;AYERS MADELEINE REBECCA;;HAMMOND GRACE MARGARET;;REIMANN MARC WALTER;;SISCO JOEL ROBERT,SLICETHEPIE LIMITED (2016-04-04),https://lens.org/118-771-165-630-399,Patent Application,yes,23,14,2,2,0,G06F16/48;;G06F16/48,G06F17/30,707/748,0,0,,,,ACTIVE
634,US,A1,US 2012/0234871 A1,026-604-327-962-545,2012-09-20,2012,US 201113285576 A,2011-10-31,US 201113285576 A;;US 201113068875 A,2011-03-15,DIP TUBE CONNECTORS AND PUMP SYSTEMS USING THE SAME,"A pump system may include a blown-in dip tube connected to a valve body and having a connection which may include an improved blown-in dip tube connector having one or more of a lip for sealing with a blown-in dip tube, a seal ring configured to mate with a blown-in dip tube and seal therewith, a dip tube lock for mating with a blown-in dip tube, or an o-ring for providing an improved seal with a blown-in dip tube.",GOOD ROBERT J;;KELLY DENNIS;;DODD JOSEPH K;;KRESTINE JOSEPH R;;DEJONG DAVID L;;SWEETON STEVEN L;;SCHEIER ERIC;;COSTA QUINTAS LLUIS;;ESPINOZA ALEJANDRO;;MEADWESTVACO CALMAR INC,GOOD ROBERT J;;KELLY DENNIS;;DODD JOSEPH K;;KRESTINE JOSEPH R;;DEJONG DAVID L;;SWEETON STEVEN L;;SCHEIER ERIC;;COSTA QUINTAS LLUIS;;ESPINOZA ALEJANDRO,THE CLOROX COMPANY (2020-10-22);;SILGAN DISPENSING SYSTEMS CORPORATION (2017-05-05),https://lens.org/026-604-327-962-545,Patent Application,yes,8,11,27,27,0,B05B11/0037;;B05B15/30;;B05B11/0044;;B05B11/1011;;B05B11/0044;;B05B11/0037;;B05B15/30;;B05B11/1011;;B05B11/1045;;B05B11/1047;;B05B11/0089,B67D7/58,222/382,0,0,,,,ACTIVE
635,US,A1,US 2013/0310395 A1,069-798-766-895-952,2013-11-21,2013,US 201313892769 A,2013-05-13,US 201313892769 A;;US 201361790967 P;;US 201261647174 P,2012-05-15,"COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1","The present invention relates to compounds of formula (I): in which Y, Y 1 , R 1 , R 2 , R 3 and R 4 are defined in the Summary of the Invention; capable of inhibiting the activity of BCR-ABL1 and mutants thereof. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds in the treatment of cancers.",DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL WILLIAM;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH;;NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL WILLIAM;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH,NOVARTIS AG (2012-11-05);;NOVARTIS PHARMA AG (2014-04-29);;NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC (2014-05-10),https://lens.org/069-798-766-895-952,Patent Application,yes,0,13,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,A61K31/4439;;C07D401/10;;A61K31/506;;A61K45/06;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/58,514/252.18;;514/275;;514/341;;546/22;;546/256;;546/275.4;;548/364.1,0,0,,,,ACTIVE
636,US,A1,US 2014/0367423 A1,188-886-748-012-09X,2014-12-18,2014,US 201414341951 A,2014-07-28,US 201414341951 A;;US 201113285576 A;;US 201113068875 A;;US 201161452854 P,2011-03-15,DIP TUBE CONNECTORS AND PUMP SYSTEMS USING THE SAME,"A pump system may include a blown-in dip tube connected to a valve body and having a connection which may include an improved blown-in dip tube connector having one or more of a lip for sealing with a blown-in dip tube, a seal ring configured to mate with a blown-in dip tube and seal therewith, a dip tube lock for mating with a blown-in dip tube, or an o-ring for providing an improved seal with a blown-in dip tube.",MEADWESTVACO CALMAR INC,GOOD ROBERT J;;KELLY DENNIS;;DODD JOSEPH K;;KRESTINE JOSEPH R;;DEJONG DAVID L;;SWEETON STEVEN L;;SCHEIER ERIC;;COSTA QUINTAS LLUIS;;ESPINOZA ALEJANDRO,THE CLOROX COMPANY (2020-10-22);;SILGAN DISPENSING SYSTEMS CORPORATION (2017-05-05),https://lens.org/188-886-748-012-09X,Patent Application,yes,9,1,27,27,0,B05B11/0037;;B05B15/30;;B05B11/0044;;B05B11/1011;;B05B11/0044;;B05B11/0037;;B05B15/30;;B05B11/1011;;B05B11/1045;;B05B11/1047;;B05B11/0089,B05B11/00,222/382,0,0,,,,ACTIVE
637,US,B2,US 8800822 B2,167-700-852-232-324,2014-08-12,2014,US 201113285576 A,2011-10-31,US 201113285576 A;;US 201113068875 A,2011-03-15,Dip tube connectors and pump systems using the same,"A pump system may include a blown-in dip tube connected to a valve body and having a connection which may include an improved blown-in dip tube connector having a swivel adaptor, or a rotatable connector, which creates a fluid path from a blown-in dip tube of a bottle to a trigger sprayer. The swivel adaptor, or rotatable connector, may also include a body or head which may be attached to a valve body, tube retainer, or valve retainer of a trigger sprayer.",GOOD ROBERT J;;KELLY DENNIS;;DODD JOSEPH K;;KRESTINE JOSEPH R;;DEJONG DAVID L;;SWEETON STEVEN L;;SCHEIER ERIC;;COSTA QUINTAS LLUIS;;ESPINOZA ALEJANDRO;;MEADWESTVACO CALMAR INC,GOOD ROBERT J;;KELLY DENNIS;;DODD JOSEPH K;;KRESTINE JOSEPH R;;DEJONG DAVID L;;SWEETON STEVEN L;;SCHEIER ERIC;;COSTA QUINTAS LLUIS;;ESPINOZA ALEJANDRO,THE CLOROX COMPANY (2020-10-22);;SILGAN DISPENSING SYSTEMS CORPORATION (2017-05-05),https://lens.org/167-700-852-232-324,Granted Patent,yes,18,8,27,27,0,B05B11/0037;;B05B15/30;;B05B11/0044;;B05B11/1011;;B05B11/0044;;B05B11/0037;;B05B15/30;;B05B11/1011;;B05B11/1045;;B05B11/1047;;B05B11/0089,B67D7/58;;B65D37/00,222/382;;222/383.1;;222/340;;222/464.1,3,0,,,"International Search Report dated Oct. 1, 2012 for PCT/US2012/029468.;;Unsolicited letter received from Mr. George T. Schooff, Esq. of Harness, Dickey & Pierce, P.L.C., dated Apr. 26, 2013 and related to U.S. Appl. No. 13/408,499.;;Unsolicited letter received from Mr. George T. Schooff, Esq. of Harness, Dickey & Pierce, P.L.C. dated Apr. 26, 2013 and related to U.S. Appl. No. 13/068,875.",ACTIVE
638,US,B2,US 11414315 B2,028-156-200-440-80X,2022-08-16,2022,US 201916583600 A,2019-09-26,US 201916583600 A;;US 201862737402 P,2018-09-27,Dispensing system including a dispensing tap and an integrated measuring cap/cup,"A dispensing system includes a liquid dispensing tap and an associated or integrated measuring cap/cup. The dispensing tap and cap/cup are configured such that the cap/cup is assembled with the tap prior to installation onto a container, and stays assembled with the tap during installation onto the container at the filling line, and which can later be removed for use and then reattached to the tap or container after use by the consumer.",SILGAN DISPENSING SYSTEMS CORP,DRISKELL WILLIAM L;;SMALLEY LEAH;;GOOD ROBERT;;VAN HOUTON BRIAN;;WANBAUGH LINN;;LE THANHHUNG;;CHOI DANIEL;;DODD JOSEPH;;TYLER ZACHARY;;FIELDS BRYAN;;RAMSUER BRANDON,SILGAN DISPENSING SYSTEMS CORPORATION (2021-09-16),https://lens.org/028-156-200-440-80X,Granted Patent,yes,25,0,2,3,0,B65D25/42;;B65D41/26;;B67D3/04;;G01F19/002;;D06F39/022;;G01F15/005;;B65D41/26;;B65D47/12;;B65D41/04;;B65D47/2025;;B67D3/043;;B65D47/248;;F16K21/04;;B67D3/04,F16K21/04;;B65D41/04;;B65D41/26;;B65D47/12;;B65D47/20;;B65D47/24;;B67D3/04,,0,0,,,,ACTIVE
639,US,B2,US 9387500 B2,109-793-235-048-275,2016-07-12,2016,US 201414341951 A,2014-07-28,US 201414341951 A;;US 201113285576 A;;US 201113068875 A;;US 201161452854 P,2011-03-15,Dip tube connectors and pump systems using the same,"A pump system may include a blown-in dip tube connected to a valve body and having a connection which may include an improved blown-in dip tube connector having one or more of a lip for sealing with a blown-in dip tube, a seal ring configured to mate with a blown-in dip tube and seal therewith, a dip tube lock for mating with a blown-in dip tube, or an o-ring for providing an improved seal with a blown-in dip tube.",MEADWESTVACO CALMAR INC;;WESTROCK DISPENSING SYSTEMS INC,GOOD ROBERT J;;KELLY DENNIS;;DODD JOSEPH K;;KRESTINE JOSEPH R;;DEJONG DAVID L;;SWEETON STEVEN L;;SCHEIER ERIC;;COSTA QUINTAS LLUIS;;ESPINOZA ALEJANDRO,THE CLOROX COMPANY (2020-10-22);;SILGAN DISPENSING SYSTEMS CORPORATION (2017-05-05),https://lens.org/109-793-235-048-275,Granted Patent,yes,9,3,27,27,0,B05B11/0037;;B05B15/30;;B05B11/0044;;B05B11/1011;;B05B11/0044;;B05B11/0037;;B05B15/30;;B05B11/1011;;B05B11/1045;;B05B11/1047;;B05B11/0089,B05B11/00;;B05B15/00,,0,0,,,,ACTIVE
640,US,B2,US 9336212 B2,131-633-991-055-846,2016-05-10,2016,US 201313965519 A,2013-08-13,US 201313965519 A;;US 201261720130 P,2012-10-30,Systems and methods for collection and automatic analysis of opinions on various types of media,"Systems and methods for collection and automatic analysis of opinions of media are provided. A representative method includes: receiving, from a user, media for review; automatically distributing the media to a pool of reviewers based on reviewer profiles; receiving, from the reviewers, information corresponding to opinions pertaining to the media; automatically generating a report based, at least in part, on the information received from the reviewers; and providing the report to the user.",COURTIER-DUTTON DAVID ANTHONY;;SOPPER JAMES ALEXANDER MAURICE ERNEST;;DODD ANDREW JAMES;;AYERS MADELEINE REBECCA;;HAMMOND GRACE MARGARET;;REIMANN MARC WALTER;;SISCO JOEL ROBERT;;SLICETHEPIE LTD,COURTIER-DUTTON DAVID ANTHONY;;SOPPER JAMES ALEXANDER MAURICE ERNEST;;DODD ANDREW JAMES;;AYERS MADELEINE REBECCA;;HAMMOND GRACE MARGARET;;REIMANN MARC WALTER;;SISCO JOEL ROBERT,SLICETHEPIE LIMITED (2016-04-04),https://lens.org/131-633-991-055-846,Granted Patent,yes,23,1,2,2,0,G06F16/48;;G06F16/48,G06F17/30,,0,0,,,,ACTIVE
641,US,A1,US 2020/0102124 A1,078-259-063-710-556,2020-04-02,2020,US 201916583600 A,2019-09-26,US 201916583600 A;;US 201862737402 P,2018-09-27,DISPENSING SYSTEM INCLUDING A DISPENSING TAP AND AN INTEGRATED MEASURING CAP/CUP,"A dispensing system includes a liquid dispensing tap and an associated or integrated measuring cap/cup. The dispensing tap and cap/cup are configured such that the cap/cup is assembled with the tap prior to installation onto a container, and stays assembled with the tap during installation onto the container at the filling line, and which can later be removed for use and then reattached to the tap or container after use by the consumer.",SILGAN DISPENSING SYSTEMS CORP,DRISKELL WILLIAM L;;SMALLEY LEAH;;GOOD ROBERT;;VAN HOUTON BRIAN;;WANBAUGH LINN;;LE THANHHUNG;;CHOI DANIEL;;DODD JOSEPH;;TYLER ZACHARY;;FIELDS BRYAN;;RAMSUER BRANDON,SILGAN DISPENSING SYSTEMS CORPORATION (2021-09-16),https://lens.org/078-259-063-710-556,Patent Application,yes,0,2,2,3,0,B65D25/42;;B65D41/26;;B67D3/04;;G01F19/002;;D06F39/022;;G01F15/005;;B65D41/26;;B65D47/12;;B65D41/04;;B65D47/2025;;B67D3/043;;B65D47/248;;F16K21/04;;B67D3/04,B65D41/26;;B65D41/04;;B65D47/12;;B65D47/20,,0,0,,,,ACTIVE
642,BR,A2,BR 112014026383 A2,104-078-416-399-563,2017-06-27,2017,BR 112014026383 A,2013-05-09,IB 2013053768 W;;US 201261647174 P;;US 201361790967 P,2012-05-15,"derivados de benzamida para inibir a atividade de abl1, abl2 e bcr-abl1","resumo patente de invenção: ""derivados de benzamida para inibir a atividade de abl1, abl2 e bcr-abl1"". a presente invenção refere-se aos compostos de fórmula (i): em que y, y1, r1, r2, r3 e r4 são definidos no sumário da invenção, capazes de inibir a atividade da bcr-abl1, e aos seus mutantes. a invenção adicionalmente proporciona um processo para a preparação dos compostos da invenção, as preparações farmacêuticas que compreendem tais compostos e os métodos de utilizar tais compostos no tratamento de cânceres.",NOVARTIS AG,ANDREAS MARZINZIK;;BAHAA SALEM;;DARRYL BRYNLEY JONES;;JOSEPH SCHOEPFER;;PASCAL FURET;;PAUL MANLEY;;ROBERT MARTIN GROTZFELD;;STEPHANIE KAY DODD;;WOLFGANG JAHNKE;;XAVIER FRANCOIS ANDRE PELLE,,https://lens.org/104-078-416-399-563,Patent Application,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D213/82;;A61K31/4439;;A61P35/00;;C07D401/04;;C07D401/14;;C07D403/10,,0,0,,,,ACTIVE
643,HU,T2,HU E039138 T2,166-660-065-396-194,2018-12-28,2018,HU E13730652 A,2013-05-09,US 201261647174 P;;US 201361790967 P,2012-05-15,"BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1",,NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH;;JAHNKE WOLFGANG,,https://lens.org/166-660-065-396-194,Amended Patent,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,A61P35/00,,0,0,,,,PENDING
644,CA,A1,CA 2868958 A1,086-984-596-471-561,2013-11-21,2013,CA 2868958 A,2013-05-09,US 201261647174 P;;US 201361790967 P;;IB 2013053768 W,2012-05-15,"BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1","The present invention relates to compounds of formula (I): in which Y, Y1, R1, R2, R3 and R4 are defined in the Summary of the Invention; capable of inhibiting the activity of BCR-ABL1 and mutants thereof. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds in the treatment of cancers.",NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH;;JAHNKE WOLFGANG,,https://lens.org/086-984-596-471-561,Patent Application,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D401/14;;A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D403/10,,0,0,,,,ACTIVE
645,CU,A7,CU 20140131 A7,191-882-144-953-913,2015-04-29,2015,CU 20140131 A,2013-05-09,US 201261647174 P;;US 201361790967 P;;IB 2013053768 W,2012-05-15,"DERIVADOS DE BENZAMIDA PARA LA INHIBICIÓN DE LA ACTIVIDAD DE ABL1, ABL2 Y BCR-ABL1","La presente invención se refiere a los compuestos de la fórmula (I): en donde Y, Y1, R1, R2, R3 y R4 se definen en la Breve Descripción de la Invención; capaces de inhibir la actividad de BCR-ABL1 y los mutantes de los mismos. La invención proporciona además un proceso para la preparación de los compuestos de la invención, las preparaciones farmacéuticas que comprenden estos compuestos, y los métodos para utilizar tales compuestos en el tratamiento de cánceres.",NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH;;JAHNKE WOLFGANG,,https://lens.org/191-882-144-953-913,Patent Application,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,A61K31/4439;;A61P35/00;;C07D401/14,,0,0,,,,PENDING
646,SG,A,SG 11201407152X A,193-862-585-157-167,2014-11-27,2014,SG 11201407152X A,2013-05-09,US 201261647174 P;;US 201361790967 P;;IB 2013053768 W,2012-05-15,"BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1",,NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JAHNKE WOLFGANG;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH,,https://lens.org/193-862-585-157-167,Unknown,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D401/14;;A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D403/10,,0,0,,,,PENDING
647,PL,T3,PL 2861579 T3,007-823-928-215-407,2018-07-31,2018,PL 13730652 T,2013-05-09,US 201261647174 P;;US 201361790967 P;;EP 13730652 A;;IB 2013053768 W,2012-05-15,"BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1",,NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH;;JAHNKE WOLFGANG,,https://lens.org/007-823-928-215-407,Patent Application,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,A61K31/4439;;C07D401/14;;A61P35/00;;C07D213/82;;C07D401/04;;C07D403/10,,0,0,,,,PENDING
648,PH,B1,PH 12014502531 B1,012-100-489-479-858,2015-01-12,2015,PH 12014502531 A,2014-11-13,US 201361790967 P;;US 201261647174 P;;IB 2013053768 W,2012-05-15,"BENZAMINE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1","The present invention relates to compounds of formula (I): in which Y, Y1, R1, R2, R3 and R4 are defined in the Summary of the Invention; capable of inhibiting the activity of BCR-ABL1 and mutants thereof. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds in the treatment of cancers.",NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JAHNKE WOLFGANG;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH,,https://lens.org/012-100-489-479-858,Granted Patent,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D401/04;;A61K9/14;;A61K31/4155;;A61K31/4439;;A61K47/32;;A61P35/00;;A61P43/00;;C07D213/82;;C07D401/14;;C07D403/10,,0,0,,,,ACTIVE
649,MA,B1,MA 37519 B1,024-063-660-621-451,2017-03-31,2017,MA 37519 A,2014-11-13,IB 2013053768 W;;US 201261647174 P;;US 201361790967 P,2012-05-15,"Composés et compositions pour inhiber l'activité d'abl1, abl2 et bcr-abl1","La présente invention concerne des composés de formule (i) : dans laquelle y, y",NOVARTIS AG,FURET PASCAL;;DODD STEPHANIE KAY;;GROTZFELD ROBERT MARTIN;;JAHNKE WOLFGANG;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH,,https://lens.org/024-063-660-621-451,Granted Patent,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10,,0,0,,,,ACTIVE
650,GE,B,GE P201606532 B,072-768-288-765-512,2016-08-25,2016,GE AP2013013621 A,2013-05-09,US 201261647174 P;;US 201361790967 P,2012-05-15,"BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1","Present invention relates to benzamide derivatives of formula (I), pharmaceutically acceptable salts thereof characterized with inhibition of ABL1, ABL2 and BCR-ABL1 activity; furthermore, to usage therefor cancer treatment, and leukemia, as well.",NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH;;JAHNKE WOLFGANG,,https://lens.org/072-768-288-765-512,Granted Patent,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D401/14;;A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D403/10,,0,0,,,,ACTIVE
651,ZA,B,ZA 201407065 B,139-665-012-859-160,2016-08-31,2016,ZA 201407065 A,2014-09-29,US 201261647174 P;;US 201361790967 P;;IB 2013053768 W,2012-05-15,"BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1",,NOVARTIS AG,JAHNKE WOLFGANG;;SCHOEPFER JOSEPH;;SALEM BAHAA;;PELLE XAVIER FRANCOIS ANDRE;;MARZINZIK ANDREAS;;MANLEY PAUL;;JONES DARRYL BRYNLEY;;GROTZFELD ROBERT MARTIN;;FURET PASCAL;;DODD STEPHANIE KAY,,https://lens.org/139-665-012-859-160,Granted Patent,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,,,0,0,,,,ACTIVE
652,BR,B1,BR 112014026383 B1,081-369-452-926-399,2020-11-17,2020,BR 112014026383 A,2013-05-09,IB 2013053768 W;;US 201261647174 P;;US 201361790967 P,2012-05-15,"derivados de benzamida, seu uso, e composição farmacêutica","derivados de benzamida para inibir a atividade de abl1, abl2 e bcr-abl1. a presente invenção refere-se aos compostos de fórmula (i): em que y, y1, r1, r2, r3 e r4 são definidos no sumário da invenção, capazes de inibir a atividade da bcr-abl1, e aos seus mutantes. a invenção adicionalmente proporciona um processo para a preparação dos compostos da invenção, as preparações farmacêuticas que compreendem tais compostos e os métodos de utilizar tais compostos no tratamento de cânceres.",NOVARTIS AG,ANDREAS MARZINZIK;;BAHAA SALEM;;DARRYL BRYNLEY JONES;;JOSEPH SCHOEPFER;;PASCAL FURET;;PAUL MANLEY;;ROBERT MARTIN GROTZFELD;;STEPHANIE KAY DODD;;WOLFGANG JAHNKE;;XAVIER FRANCOIS ANDRE PELLE,,https://lens.org/081-369-452-926-399,Granted Patent,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D213/82;;A61K31/4439;;A61P35/00;;C07D401/04;;C07D401/14;;C07D403/10,,0,0,,,,ACTIVE
653,SI,T1,SI 2861579 T1,140-366-377-681-241,2018-05-31,2018,SI 201330997 T,2013-05-09,US 201261647174 P;;US 201361790967 P;;IB 2013053768 W;;EP 13730652 A,2012-05-15,"BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1",,NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH;;JAHNKE WOLFGANG,,https://lens.org/140-366-377-681-241,Granted Patent,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D401/00;;A61K31/00;;A61P35/00;;C07D213/00;;C07D403/00,,0,0,,,,ACTIVE
654,PH,A1,PH 12014502531 A1,188-924-777-989-355,2015-01-12,2015,PH 12014502531 A,2014-11-13,US 201361790967 P;;US 201261647174 P;;IB 2013053768 W,2012-05-15,"BENZAMINE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1","The present invention relates to compounds of formula (I): in which Y, Y1, R1, R2, R3 and R4 are defined in the Summary of the Invention; capable of inhibiting the activity of BCR-ABL1 and mutants thereof. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds in the treatment of cancers.",NOVARTIS AG,KAY DODD STEPHANIE;;PASCAL FURET;;MARTIN GROTZFELD ROBERT;;WOLFGANG JAHNKE;;BRYNLEY JONES DARRYL;;PAUL MANLEY;;ANDREAS MARZINZIK;;ANDRE PELLE XAVIER FRANCOIS;;BAHAA SALEM;;JOSEPH SCHOEPFER,,https://lens.org/188-924-777-989-355,Patent Application,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10,,0,0,,,,ACTIVE
655,DK,T5,DK 2861579 T5,030-855-963-527-318,2022-10-24,2022,DK 13730652 T,2013-05-09,US 201261647174 P;;US 201361790967 P;;IB 2013053768 W,2012-05-15,"Benzamidderivater til at hæmme aktiviteten af ABL1, ABL2 og BCR-ABL1",,NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH;;JAHNKE WOLFGANG,,https://lens.org/030-855-963-527-318,Amended Patent,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D401/14;;A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D403/10,,0,0,,,,ACTIVE
656,HR,T1,HR P20180695 T1,196-140-394-296-660,2018-06-01,2018,HR P20180695 T,2018-05-03,US 201261647174 P;;US 201361790967 P;;EP 13730652 A;;IB 2013053768 W,2012-05-15,"BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1",,NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH;;JAHNKE WOLFGANG,,https://lens.org/196-140-394-296-660,Granted Patent,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D401/14;;A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D403/10,,0,0,,,,ACTIVE
657,GT,A,GT 201400253 A,038-425-941-257-282,2017-09-28,2017,GT 201400253 A,2014-11-14,US 201261647174 P;;US 201361790967 P,2012-05-15,"DERIVADOS DE BENZAMIDA PARA LA INHIBICIÓN DE LA ACTIVIDAD DE ABL1, ABL2 Y BCR-ABL1","LA PRESENTE INVENCIÓN SE REFIERE A COMPUESTOS CAPACES DE INHIBIR LA ACTIVIDAD ENZIMÁTICA DE CINASA DE TIROSINA DE LA PROTEÍNA DE ABELSON (ABL1), LA PROTEÍNA RELACIONADA CON ABELSON (ABL2), Y LAS PROTEÍNAS QUIMÉRICAS RELACIONADAS, EN PARTICULAR BCR-ABL1. LA INVENCIÓN PROPORCIONA ADEMÁS UN PROCESO PARA LA PREPARACIÓN DE LOS COMPUESTOS DE LA INVENCIÓN, LAS PREPARACIONES FARMACÉUTICAS QUE COMPRENDEN ESTOS COMPUESTOS, Y LOS MÉTODOS PARA UTILIZAR TALES COMPUESTOS EN EL TRATAMIENTO DE CÁNCERES.",NOVARTIS AG,STEPHANIE KAY DODD;;PASCAL FURET;;ROBERT MARTIN GROTZFELD;;DARRYL BRYNLEY JONES;;PAUL MANLEY;;ANDREAS MARZINZIK;;XAVIER FRANCOIS ANDRE PELLE;;BAHAA SALEM;;JOSEPH SCHOEPFER;;WOLFGANG JAHNKE,,https://lens.org/038-425-941-257-282,Amended Application,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D401/14;;A61K31/4439;;A61P35/00;;C07D401/04,,0,0,,,,PENDING
658,RS,B1,RS 57177 B1,086-898-986-849-274,2018-07-31,2018,RS P20180497 A,2013-05-09,US 201261647174 P;;US 201361790967 P;;IB 2013053768 W;;EP 13730652 A,2012-05-15,"BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1",,NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH;;JAHNKE WOLFGANG,,https://lens.org/086-898-986-849-274,Granted Patent,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,A61K31/4439;;C07D401/14;;A61P35/00;;C07D213/82;;C07D401/04;;C07D403/10,,0,0,,,,ACTIVE
659,PE,A1,PE 20161416 A1,161-222-966-053-20X,2017-01-08,2017,PE 2016001014 A,2013-05-09,US 201261647174 P;;US 201361790967 P,2012-05-15,"DERIVADOS DE BENZAMIDA PARA LA INHIBICION DE LA ACTIVIDAD ABL1, ABL2 Y BCR-ABL1","La presente invencion se refiere a compuestos derivados de benzamida de formula (I) o sales farmaceuticamente aceptables de los mismos, donde: R1 es pirazolilo opcionalmente sustituido con 1 a 2 grupos R6; R2 es pirrolidinilo sustituido con R7; R3 es H o halogeno; R4 es -SF5 o -Y2-CF2-Y3; R6 es H, hidroxilo, entre otros; R7 es hidroxilo, metilo, entre otros; Y e Y1 son CH o N; Y2 es CF2, -O- o S(O)0-2; Y3 es H, cloro, entre otros. Es un compuesto preferido: (R)-N-(4-(cloro-difluoro-metoxi)-fenil)-6-(3-hidroxi-pirrolidin-1-il)-5-(1H-pirazol-5-il)-nicotinamida, entre otros. Tambien se refiere a una composicion farmaceutica. Dichos compuestos inhiben la actividad enzimatica de cinasa de tirosina de la proteina de Abelson: ABL1, ABL2 y la proteina quimerica BCR-ABL1, siendo utiles en el tratamiento del cancer",NOVARTIS AG,JAHNKE WOLFGANG;;SCHOEPFER JOSEPH;;SALEM BAHAA;;PELLE XAVIER FRANCOIS ANDRE;;DODD STEPHANIE KAY;;MANLEY PAUL;;JONES DARRYL BRYNLEY;;GROTZFELD ROBERT MARTIN;;FURET PASCA;;MARZINZIK ANDREAS,,https://lens.org/161-222-966-053-20X,Patent Application,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,A61P35/00;;A61K31/4439;;C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10,,0,0,,,,PENDING
660,EP,B9,EP 2861579 B9,029-476-646-929-772,2018-08-29,2018,EP 13730652 A,2013-05-09,US 201261647174 P;;US 201361790967 P;;IB 2013053768 W,2012-05-15,"BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1",,NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH;;JAHNKE WOLFGANG,,https://lens.org/029-476-646-929-772,Amended Patent,yes,1,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D401/14;;A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D403/10,,2,0,,,"ECK M J ET AL: ""The interplay of structural information and functional studies in kinase drug design: insights from BCR-Abl"", CURRENT OPINION IN CELL BIOLOGY, CURRENT SCIENCE, LONDON, GB, vol. 21, no. 2, 1 April 2009 (2009-04-01), pages 288-295, XP026035462, ISSN: 0955-0674, DOI: 10.1016/J.CEB.2009.01.014 [retrieved on 2009-02-11];;YUPENG LI ET AL: ""Design, Synthesis, and Biological Evaluation of 3-(1 H -1,2,3-Triazol-1-yl)benzamide Derivatives as Potent Pan Bcr-Abl Inhibitors Including the Threonine 315 ->Isoleucine 315 Mutant"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 55, no. 22, 26 November 2012 (2012-11-26), pages 10033-10046, XP055082710, ISSN: 0022-2623, DOI: 10.1021/jm301188x",ACTIVE
661,ES,T9,ES 2670601 T9,049-035-529-136-089,2022-11-30,2022,ES 13730652 T,2013-05-09,US 201261647174 P;;US 201361790967 P;;IB 2013053768 W,2012-05-15,"Derivados de benzamida para la inhibición de la actividad de ABL1, ABL2 y BCR-ABL1",,NOVARTIS AG,FURET PASCAL;;GROTZFELD ROBERT MARTIN;;MANLEY PAUL;;DODD STEPHANIE KAY;;JONES DARRYL BRYNLEY;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH;;JAHNKE WOLFGANG,,https://lens.org/049-035-529-136-089,Unknown,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D401/14;;A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D403/10,,0,0,,,,ACTIVE
662,AP,A,AP 3613 A,068-777-888-327-639,2016-02-29,2016,AP 2014007992 A,2013-05-09,IB 2013053768 W;;US 201261647174 P;;US 201361790967 P,2012-05-15,"BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1 ABL1ABL2 BCR-ABL1",,NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH;;JAHNKE WOLFGANG,,https://lens.org/068-777-888-327-639,Granted Patent,no,1,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D401/14;;A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D403/10,,1,1,049-997-490-538-87X,19217274;;10.1016/j.ceb.2009.01.014,"ECK M J ET AL: ""The interplay of structural information and functional studies in kinase drug design: insights from BCR-Abl"", CURRENT OPINION IN CELL BIOLOGY, CURRENT SCIENCE, LONDON, GB, vol. 21, no. 2, 1 April 2009 (2009-04-01), pages 288 - 295, XP026035462",ACTIVE
663,MY,A,MY 169377 A,074-450-196-270-515,2019-03-26,2019,MY PI2014703394 A,2013-05-09,US 201261647174 P;;US 201361790967 P,2012-05-15,"BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1","The present invention relates to compounds of formula (I): in which Y, Y1, R1, R2, R3 and R4 are defined in the Summary of the Invention; capable of inhibiting the activity of BCR-ABLI and mutants thereof. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds in the treatment of cancers.",NOVARTIS AG,STEPHANIE KAY DODD;;PASCAL FURET;;ROBERT MARTIN GROTZFELD;;DARRYL BRYNLEY JONES;;PAUL MANLEY;;ANDREAS MARZINZIK;;XAVIER FRANCOIS ANDRE PELLE;;BAHAA SALEM;;JOSEPH SCHOEPFER;;WOLFGANG JAHNKE,,https://lens.org/074-450-196-270-515,Granted Patent,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,,,0,0,,,,ACTIVE
664,EP,A1,EP 2861579 A1,151-054-632-014-881,2015-04-22,2015,EP 13730652 A,2013-05-09,US 201261647174 P;;US 201361790967 P;;IB 2013053768 W,2012-05-15,"BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1",,NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH;;JAHNKE WOLFGANG,,https://lens.org/151-054-632-014-881,Patent Application,yes,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D401/14;;A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D403/10,,0,0,,,,ACTIVE
665,PT,T,PT 2861579 T,181-159-418-100-454,2018-04-27,2018,PT 13730652 T,2013-05-09,US 201261647174 P;;US 201361790967 P,2012-05-15,"BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1",,NOVARTIS AG,PASCAL FURET;;DARRYL BRYNLEY JONES;;ANDREAS MARZINZIK;;BAHAA SALEM;;JOSEPH SCHOEPFER;;WOLFGANG JAHNKE;;STEPHANIE KAY DODD;;ROBERT MARTIN GROTZFELD;;PAUL MANLEY;;XAVIER FRANCOIS ANDRE PELLE,,https://lens.org/181-159-418-100-454,Patent Application,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,A61K31/4439;;C07D401/14;;A61P35/00;;C07D213/82;;C07D401/04;;C07D403/10,,0,0,,,,PENDING
666,CU,B1,CU 24265 B1,036-352-212-553-287,2017-07-04,2017,CU 20140131 A,2013-05-09,US 201261647174 P;;US 201361790967 P;;IB 2013053768 W,2012-05-15,"COMPUESTOS DERIVADOS DE BENZAMIDA PARA INHIBIR LA ACTIVIDAD DE ABL1, ABL2 Y BCR-ABL1, ÚTILES EN EL TRATAMIENTO DEL CÁNCER","<p>La presente invención se refiere a los compuestos de la fórmula (I):</p> <p>ESPACIO PARA LA FÓRMULA I</p> <p>en donde Y, Y1, R1, R2, R3 y R4 están definidos de acuerdo a las reivindicaciones. Los compuestos de la invención son capaces de inhibir la actividad de BCR-ABL1 y mutantes de la misma, por lo que son útiles en el tratamiento del cáncer, en particular la leucemia mieloide crónica. La invención proporciona además un proceso para la preparación de los compuestos de la invención.</p>",NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JAHNKE WOLFGANG;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH,,https://lens.org/036-352-212-553-287,Unknown,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,A61K31/4439;;A61P35/00;;C07D401/14,,0,0,,,,PENDING
667,CA,C,CA 2868958 C,044-805-666-259-073,2020-09-01,2020,CA 2868958 A,2013-05-09,US 201261647174 P;;US 201361790967 P;;IB 2013053768 W,2012-05-15,"BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1","The present invention relates to compounds of formula (I): in which Y, Y1, R1, R2, R3 and R4 are defined in the Summary of the Invention; capable of inhibiting the activity of BCR-ABL1 and mutants thereof. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds in the treatment of cancers.",NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH;;JAHNKE WOLFGANG,,https://lens.org/044-805-666-259-073,Granted Patent,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D401/14;;A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D403/10,,0,0,,,,ACTIVE
668,HK,A1,HK 1203495 A1,199-241-005-405-037,2015-10-30,2015,HK 15103981 A,2015-04-24,IB 2013053768 W;;US 201261647174 P;;US 201361790967 P,2012-05-15,"BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1 ABL1ABL2 BCR-ABL1",,NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH;;JAHNKE WOLFGANG,,https://lens.org/199-241-005-405-037,Patent Application,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D/;;A61K/;;A61P/,,0,0,,,,PENDING
669,DK,T3,DK 2861579 T3,016-621-573-457-044,2018-05-28,2018,DK 13730652 T,2013-05-09,US 201261647174 P;;US 201361790967 P;;IB 2013053768 W,2012-05-15,"Benzamidderivater til at hæmme aktiviteten af ABL1, ABL2 og BCR-ABL1",,NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH;;JAHNKE WOLFGANG,,https://lens.org/016-621-573-457-044,Granted Patent,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D401/14;;A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D403/10,,0,0,,,,ACTIVE
670,AU,B2,AU 2013/261127 B2,032-373-040-375-37X,2015-03-12,2015,AU 2013/261127 A,2013-05-09,US 201261647174 P;;US 201361790967 P;;IB 2013053768 W,2012-05-15,"Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1","The present invention relates to compounds of formula (I): in which Y, Y",NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JAHNKE WOLFGANG;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH,,https://lens.org/032-373-040-375-37X,Granted Patent,no,1,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D401/14;;A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D403/10,,0,0,,,,ACTIVE
671,AU,A1,AU 2013/261127 A1,099-468-876-629-512,2014-11-20,2014,AU 2013/261127 A,2013-05-09,US 201261647174 P;;US 201361790967 P;;IB 2013053768 W,2012-05-15,"Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1","The present invention relates to compounds of formula (I): in which Y, Y",NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JAHNKE WOLFGANG;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH,,https://lens.org/099-468-876-629-512,Patent Application,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D401/14;;A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D403/10,,0,0,,,,ACTIVE
672,LT,T,LT 2861579 T,100-840-468-048-825,2018-05-10,2018,LT 13730652 T,2013-05-09,US 201261647174 P;;US 201361790967 P;;IB 2013053768 W,2012-05-15,"BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1",,NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH;;JAHNKE WOLFGANG,,https://lens.org/100-840-468-048-825,Unknown,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D401/14;;A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D403/10,,0,0,,,,PENDING
673,CY,T1,CY 1120235 T1,127-000-640-118-599,2019-07-10,2019,CY 181100518 T,2018-05-18,US 201261647174 P;;US 201361790967 P;;IB 2013053768 W,2012-05-15,"ΠΑΡΑΓΩΓΑ ΒΕΝΖΑΜΙΔΙΟΥ ΓΙΑ ΤΗΝ ΑΝΑΣΤΟΛΗ ΤΗΣ ΔΡΑΣΤΙΚΟΤΗΤΑΣ ΤΩΝ ABL1, ABL2 ΚΑΙ BCR-ABL1",,NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH;;JAHNKE WOLFGANG,,https://lens.org/127-000-640-118-599,Granted Patent,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D401/14;;A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D403/10,,0,0,,,,ACTIVE
674,EA,B1,EA 024391 B1,164-062-122-626-927,2016-09-30,2016,EA 201491824 A,2013-05-09,US 201261647174 P;;US 201361790967 P;;IB 2013053768 W,2012-05-15,"BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1","The present invention relates to compounds of formula (I)in which Y, Y, R, R, Rand Rare defined in the Summary of the Invention; capable of inhibiting the activity of BCR-ABL1 and mutants thereof. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds in the treatment of cancers.",NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JAHNKE WOLFGANG;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH,,https://lens.org/164-062-122-626-927,Granted Patent,no,1,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D401/14;;A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D403/10,,2,2,049-997-490-538-87X;;094-055-108-080-726,19217274;;10.1016/j.ceb.2009.01.014;;10.1021/jm301188x;;23088644,"ECK, M.J. ; MANLEY, P.W.: ""The interplay of structural information and functional studies in kinase drug design: insights from BCR-Abl"", CURRENT OPINION IN CELL BIOLOGY., CURRENT SCIENCE, LONDON., GB, vol. 21, no. 2, 1 April 2009 (2009-04-01), GB, pages 288 - 295, XP026035462, ISSN: 0955-0674, DOI: 10.1016/j.ceb.2009.01.014;;YUPENG LI, MENGJIE SHEN, ZHANG ZHANG, JINFENG LUO, XIAOFEN PAN, XIAOYUN LU, HUOYOU LONG, DONGHAI WEN, FENGXIANG ZHANG, FANG LENG, : ""Design, Synthesis, and Biological Evaluation of 3-(1 H -1,2,3-Triazol-1-yl)benzamide Derivatives as Potent Pan Bcr-Abl Inhibitors Including the Threonine 315 →Isoleucine 315 Mutant"", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, vol. 55, no. 22, 26 November 2012 (2012-11-26), pages 10033 - 10046, XP055082710, ISSN: 00222623, DOI: 10.1021/jm301188x",ACTIVE
675,EP,B1,EP 2861579 B1,197-635-307-163-220,2018-02-21,2018,EP 13730652 A,2013-05-09,US 201261647174 P;;US 201361790967 P;;IB 2013053768 W,2012-05-15,"BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1",,NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH;;JAHNKE WOLFGANG,,https://lens.org/197-635-307-163-220,Granted Patent,yes,1,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D401/14;;A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D403/10,,2,0,,,"ECK M J ET AL: ""The interplay of structural information and functional studies in kinase drug design: insights from BCR-Abl"", CURRENT OPINION IN CELL BIOLOGY, CURRENT SCIENCE, LONDON, GB, vol. 21, no. 2, 1 April 2009 (2009-04-01), pages 288-295, XP026035462, ISSN: 0955-0674, DOI: 10.1016/J.CEB.2009.01.014 [retrieved on 2009-02-11];;YUPENG LI ET AL: ""Design, Synthesis, and Biological Evaluation of 3-(1 H -1,2,3-Triazol-1-yl)benzamide Derivatives as Potent Pan Bcr-Abl Inhibitors Including the Threonine 315 ->Isoleucine 315 Mutant"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 55, no. 22, 26 November 2012 (2012-11-26), pages 10033-10046, XP055082710, ISSN: 0022-2623, DOI: 10.1021/jm301188x",ACTIVE
676,AR,A2,AR 117484 A2,027-505-329-318-481,2021-08-11,2021,AR P190103820 A,2019-12-20,US 201261647174 P,2012-05-15,"COMPUESTOS Y COMPOSICIONES PARA INHIBIR LA ACTIVIDAD DE LA ABL1, ABL2 Y BCR-ABL1","La presente se relaciona con compuestos de la fórmula (1), en los que Y, Y¹, R¹, R², R³ y R⁴ se definen en el resumen de la presente; capaces de inhibir la actividad de BCR-ABL1 y mutantes de los mismos. La presente además proporciona un proceso para la preparación de compuestos de la presente, preparaciones farmacéuticas que comprenden tales compuestos y métodos de utilizar tales compuestos en el tratamiento de cánceres. Reivindicación 1: El compuesto de la reivindicación 1 de la fórmula (1) caracterizado porque R¹ es pirazolilo; en donde dicho pirazolilo es sustituido o no sustituido con 1 a 2 grupos R⁶; R² es pirrolidinilo; en donde dicho pirrolidinilo es sustituido por un grupo R⁷; R³ se selecciona a partir de hidrógeno y halo; R⁴ se selecciona a partir de -SF₅ y -Y²-CF₂-Y³; R⁶ en cada ocurrencia es independientemente seleccionado a partir de hidrógeno, hidroxilo, metilo, metoxilo, ciano, trifluorometilo, hidroxi-metilo, halo, amino, fluoro-etilo, etilo y ciclopropilo; R⁷ se selecciona a partir de hidroxilo, metilo, halo, metoxilo, hidroxilo-metilo, amino, metilo-amino, amino-metilo, trifluorometilo, 2-hidroxipropan-2-ilo, metilo-carbonil-amino, dimetil-amino, 2-amino-3-metilbutanoil)oxilo, carboxilo, metoxilo-carbonilo, fosfonooxilo, ciano y amino-carbonilo; Y se selecciona a partir de CH y N; Y¹ se selecciona a partir de CH y N; Y² se selecciona a partir de CF₂, O y S(O)₀₋₂; y Y³ se seleccionado a partir de hidrógeno, cloro, flúor, metilo, difluorometilo y trifluorometilo; o las sales farmacéuticamente aceptables de los mismos.",NOVARTIS AG,JAHNKE WOLFGANG;;SCHOEPFER JOSEPH;;SALEM BAHAA;;PELLE XAVIER FRANCOIS ANDRE;;MARZINZIK ANDREAS;;MANLEY PAUL;;JONES DARRYL BRYNLEY;;GROTZFELD ROBERT MARTIN;;FURET PASCAL;;DODD STEPHANIE KAY,,https://lens.org/027-505-329-318-481,Amended Application,no,0,0,1,95,0,,C07D403/10;;A61K31/4155;;A61K31/4427;;A61P35/00;;C07D401/04;;C07D401/14;;C07F9/09,,0,0,,,,PENDING
677,CR,A,CR 20140519 A,024-808-091-515-539,2015-03-26,2015,CR 20140519 A,2014-11-14,US 201261647174 P;;US 201361790967 P;;IB 2013053768 W,2012-05-15,"DERIVADOS DE BENZAMIDA PARA LA INHIBICIÓN DE LA ACTIVIDAD DE ABL 1, ABL 2 Y BCR-ABL 1",La presente invención se refiere a los compuestos de lafórmula (I):,NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH;;JAHNKE WOLFGANG,,https://lens.org/024-808-091-515-539,Patent Application,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D401/14;;A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D403/10,,0,0,,,,PENDING
678,CN,A,CN 104302638 A,100-114-263-301-798,2015-01-21,2015,CN 201380025539 A,2013-05-09,IB 2013053768 W;;US 201261647174 P;;US 201361790967 P,2012-05-15,"Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1","The present invention relates to compounds of formula (I): in which Y, Y1, R1, R2, R3 and R4 are defined in the Summary of the Invention; capable of inhibiting the activity of BCR-ABL1 and mutants thereof. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds in the treatment of cancers.",NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JAHNKE WOLFGANG;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH,,https://lens.org/100-114-263-301-798,Patent Application,no,6,12,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D401/14;;A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D403/10,,0,0,,,,ACTIVE
679,PE,A1,PE 20210667 A1,099-167-335-520-793,2021-04-05,2021,PE 2020000185 A,2013-05-09,US 201261647174 P;;US 201361790967 P;;IB 2013053768 W,2012-05-15,"DERIVADOS DE BENZAMIDA PARA LA INHIBICION DE LA ACTIVIDAD ABL1, ABL2 Y BCR-ABL1","Referido a derivados de benzamida para la inhibicion de la actividad ABL1, ABL2 y BCR-ABL1; compuesto de formula I, en donde: R1 es pirazolilo insustituido o sustituido con 1 a 2 grupos R6; R2 es pirrolidinilo sustituido con un grupo R7; R3 es H o halogeno; R4 es -SF5 e -Y2-CF2-Y3. Tambien se refiere a un proceso para la preparacion de dichos compuestos, una composicion farmaceutica que comprende los comprende y su uso en el tratamiento del cancer.",NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH;;JAHNKE WOLFGANG,,https://lens.org/099-167-335-520-793,Patent Application,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D401/14;;A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D403/10,,0,0,,,,PENDING
680,TR,T4,TR 201807023 T4,131-291-541-541-727,2018-06-21,2018,TR 201807023 T,2013-05-09,US 201261647174 P;;US 201361790967 P,2012-05-15,"Abl1, abl2 ve bcr- abl1 aktivitesinin inhibe edilmesi için benzamid türevleri.","Mevcut buluş, Abelson proteini (ABL1), Abelson- ilişkili protein (ABL2) ve ilgili kimerik proteinlerin, özellikle BCR- ABL1'in tirosin kinaz enzimatik aktivitesini inhibe edebilen bileşikler ile ilgilidir. Buluş ayrıca buluşun bileşiklerinin hazırlanması için bir işlem, bu tür bileşikleri içeren farmasötik preparatlar ve bu tür bileşiklerin kanserlerin tedavisinde kullanılma yöntemleri ile ilgilidir.",NOVARTIS AG,STEPHANIE KAY DODD;;PASCAL FURET;;ROBERT MARTIN GROTZFELD;;DARRYL BRYNLEY JONES;;PAUL MANLEY;;ANDREAS MARZINZIK;;XAVIER FRANCOIS ANDRE PELLE;;BAHAA SALEM;;JOSEPH SCHOEPFER;;WOLFGANG JAHNKE,,https://lens.org/131-291-541-541-727,Granted Patent,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10,,0,0,,,,ACTIVE
681,US,A1,US 2018/0078264 A1,177-908-845-634-208,2018-03-22,2018,US 201715713816 A,2017-09-25,US 201715713816 A;;US 201413981949 A,2014-03-03,ROTARY MILL,"A rotary mill is disclosed comprising a body portion ( 4 ) having a milling surface ( 10 ) and a central bore ( 20 ) extending along an axis of rotation ( 18 ) of the body portion ( 4 ); and a guide portion ( 6 ) having a guide body ( 22 ) and a guide peg ( 24 ) extending from the guide body ( 22 ), the guide peg ( 24 ) operable to be received in the central bore ( 20 ) of the body portion ( 4 ), the guide body ( 22 ) having at least one alignment feature ( 28, 30 ) which is the same as that of a prosthesis component. A method of implanting a unicondylar femoral component is also disclosed, the method comprising, a) reaming the femoral condylar surface to accept the unicondylar femoral component; b) drilling peg holes for affixing the unicondylar femoral component; c) affixing a guide portion of a rotary mill onto the prepared condylar surface using the drilled peg holes; d) reaming a portion of bone anterior to the affixed guide portion; e) removing the guide portion from the bone; and f) affixing a unicondylar femoral component to the prepared condylar surface.",BIOMET UK HEALTHCARE LTD,GOODFELLOW JOHN;;MURRAY DAVID WYCLIFFE;;DODD CHRISTOPHER;;O'CONNOR JOHN JOSEPH;;ALINEJAD MONA;;LLOYD RUSSELL;;RIDLEY DUNCAN ANDREW;;HUNSLEY COLIN;;BURNSIDE ANNA ELIZABETH;;KIRTLAND ROBERT MAURICE,,https://lens.org/177-908-845-634-208,Patent Application,yes,0,2,3,3,0,A61B17/1637;;A61B2090/034;;A61F2/3859;;A61B17/1675;;A61B17/1764;;A61B17/1617;;A61B17/1613;;A61F2/3859;;A61F2002/3863;;A61B17/1675;;A61B17/1764;;A61B17/1615;;A61B17/17;;A61B17/1739;;A61B17/1662;;A61F2/4684;;A61B17/16;;A61B17/1617;;A61B2017/1602;;A61B17/56;;A61B2017/564;;A61B17/1637;;A61B2090/034,A61B17/16;;A61B17/17;;A61F2/38;;A61F2/46,,0,0,,,,DISCONTINUED
682,ME,B,ME 03095 B,178-569-271-934-406,2019-01-20,2019,ME P2018117 A,2013-05-09,US 201261647174 P;;US 201361790967 P;;EP 13730652 A;;IB 2013053768 W,2012-05-15,"BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1",,NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH;;JAHNKE WOLFGANG,,https://lens.org/178-569-271-934-406,Granted Patent,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10,,0,0,,,,ACTIVE
683,DO,A,DO P2014000256 A,139-695-299-725-81X,2015-02-27,2015,DO 2014000256 A,2014-11-12,US 201261647174 P;;US 201361790967 P,2012-05-15,"DERIVADOS DE BENZAMIDA PARA LA INHIBICIÓN DE LA ACTIVIDAD DE ABL1, ABL2 Y BCR-ABL1","La presente invención se refiere a los compuestos de la fórmula (I): en donde Y, Y1, R1, R2, R3 y R4 se definen en la Breve Descripción de la Invención; capaces de inhibir la actividad de BCR-ABL1 y los mutantes de los mismos. La invención proporciona además un proceso para la preparación de los compuestos de la invención, las preparaciones farmacéuticas que comprenden estos compuestos, y los procedimientos para utilizar tales compuestos en el tratamiento de cánceres.",NOVARTIS AG,FURET PASCAL;;DODD STEPHANIE KAY;;GROTZFELD ROBERT MARTIN;;JAHNKE WOLFGANG;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH,,https://lens.org/139-695-299-725-81X,Patent Application,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10,,0,0,,,,PENDING
684,PE,A1,PE 20150669 A1,131-743-488-753-388,2015-05-17,2015,PE 2014002006 A,2013-05-09,US 201261647174 P;;US 201361790967 P,2012-05-15,"DERIVADOS DE BENZAMIDA PARA LA INHIBICION DE LA ACTIVIDAD DE ABL1, ABL2 Y BCR-ABL1","La invencion describe compuestos derivados de benzamida de formula l, en la que R1, R2, R3, R4, Y y Y1 se definen en la presente solicitud. Estos compuestos son activos como inhibidores de la actividad de BCR-ABL1, por lo que son utiles en el tratamiento de enfermedades neurodegenerativas, enfermedades del sistema nervioso central, enfermedades autoinmunes e inflamatorias.",NOVARTIS AG;;NOVARTIS INST FOR BIOMEDICAL RES INC,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH;;JAHNKE WOLFGANG,,https://lens.org/131-743-488-753-388,Patent Application,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D401/14;;A61K31/4439;;C07D213/82;;C07D401/04;;C07D403/10,,0,0,,,,DISCONTINUED
685,CL,A1,CL 2014002757 A1,179-687-457-050-59X,2015-01-23,2015,CL 2014002757 A,2014-10-14,US 201261647174 P;;US 201361790967 P,2012-05-15,"Compuestos derivados de benzamida para inhibir la actividad de abl1, abl2 y bcr-abl1, composicion farmaceutica; y uso en el tratamiento del cancer.",,NOVARTIS AG,PASCAL FURET;;STEPHANIE KAY DODD;;ROBERT MARTIN GROTZFELD;;DARRYL BRYNLEY JONES;;PAUL MANLEY;;ANDREAS MARZINZIK;;XAVIER FRANCOIS ANDRE PELLE;;BAHAA SALEM;;JOSEPH SCHOEPFER;;WOLFGANG JAHNKE,,https://lens.org/179-687-457-050-59X,Patent Application,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D213/82;;A61K31/4439;;A61P35/00;;C07D401/04;;C07D401/14;;C07D403/10,,0,0,,,,PENDING
686,ES,T3,ES 2670601 T3,042-029-653-541-190,2018-05-31,2018,ES 13730652 T,2013-05-09,US 201261647174 P;;US 201361790967 P;;IB 2013053768 W,2012-05-15,"Derivados de benzamida para la inhibición de la actividad de ABL1, ABL2 y BCR-ABL1","El compuesto de la fórmula (I):**Fórmula** en donde: R1 es pirazolilo; en donde este pirazolilo está insustituido o sustituido con 1 a 2 grupos R6; R2 es pirrolidinilo; en donde este pirrolidinilo está sustituido con un grupo R7; R3 se selecciona a partir de hidrógeno y halógeno; R4 se selecciona a partir de -SF5 e -Y2-CF2-Y3; R6 en cada presentación se selecciona independientemente a partir de hidrógeno, hidroxilo, metilo, metoxilo, ciano, trifluoro-metilo, hidroxi-metilo, halógeno, amino, fluoro-etilo, etilo y ciclopropilo; R7 se selecciona a partir de hidroxilo, metilo, halógeno, metoxilo, hidroxi-metilo, amino, metil-amino, amino-metilo, trifluoro-metilo, 2-hidroxi-propan-2-ilo, metil-carbonil-amino, dimetil-amino, 2-amino-3-metil-butanoil)-oxilo, carboxilo, metoxi-carbonilo, fosfono-oxilo, ciano y amino-carbonilo; Y se selecciona a partir de CH y N; Y1 se selecciona a partir de CH y N; Y2 se selecciona a partir de CF2, O y S(O)0-2; y Y3 se selecciona a partir de hidrógeno, cloro, flúor, metilo, difluoro-metilo y trifluoro-metilo; o las sales farmacéuticamente aceptables de los mismos.",NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH;;JAHNKE WOLFGANG,,https://lens.org/042-029-653-541-190,Granted Patent,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D401/14;;A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D403/10,,0,0,,,,ACTIVE
687,MA,A1,MA 37519 A1,109-652-368-706-463,2016-06-30,2016,MA 37519 A,2014-11-13,IB 2013053768 W;;US 201261647174 P;;US 201361790967 P,2012-05-15,"Composés et compositions pour inhiber l'activité d'abl1, abl2 et bcr-abl1","يتعلق الاختراع الحالي بمركبات بالصيغة (i):و التي فيها y,₁y ,₁r,₂r,₃r و ₄r تكون معرفة كما في ملخص الاختراع و التي تكون قادرة تثبيط نشاط bcr-abl1 ومطفراته. ويوفر الاختراع ايضا و عملية لتحضير مركبات الاختراع و طرق استخدام تلك المركبات في علاج السرطان.",NOVARTIS AG,FURET PASCAL;;DODD STEPHANIE KAY;;GROTZFELD ROBERT MARTIN;;JAHNKE WOLFGANG;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH,,https://lens.org/109-652-368-706-463,Patent Application,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10,,0,0,,,,ACTIVE
688,SV,A,SV 2014004850 A,132-558-182-808-093,2018-04-04,2018,SV 2014004850 A,2014-11-14,US 201261647174 P;;US 201361790967 P,2012-05-15,"DERIVADOS DE BENZAMIDA PARA LA INHIBICIÓN DE LA ACTIVIDAD DE ABL1, ABL2 Y BCR-ABL1","LA PRESENTE INVENCIÓN SE REFIERE A LOS COMPUESTOS DE LA FÓRMULA (I): (VER FORMULA); EN DONDE Y, Y1, R1, R2, R3 Y R4 SE DEFINEN EN LA BREVE DESCRIPCIÓN DE LA INVENCIÓN; CAPACES DE INHIBIR LA ACTIVIDAD DE BCR-ABL1 Y LOS MUTANTES DE LOS MISMOS. LA INVENCIÓN PROPORCIONA ADEMÁS UN PROCESO PARA LA PREPARACIÓN DE LOS COMPUESTOS DE LA INVENCIÓN, LAS PREPARACIONES FARMACÉUTICAS QUE COMPRENDEN ESTOS COMPUESTOS, Y LOS MÉTODOS PARA UTILIZAR TALES COMPUESTOS EN EL TRATAMIENTO DE CÁNCERES",NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;JAHNKE WOLFGANG;;GROTZFELD ROBERT MARTIN;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINSIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH,,https://lens.org/132-558-182-808-093,Patent Application,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,A61K31/4439;;A61P35/00;;C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10,,0,0,,,,PENDING
689,NZ,A,NZ 701626 A,157-490-393-870-603,2016-02-26,2016,NZ 70162613 A,2013-05-09,IB 2013053768 W;;US 201261647174 P;;US 201361790967 P,2012-05-15,"Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1","The present invention relates to compounds of formula (I): in which Y, Y1, R1, R2, R3 and R4 are defined in the Summary of the Invention; capable of inhibiting the activity of BCR-ABL1 and mutants thereof. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds in the treatment of cancers.",NOVARTIS AG,FURET PASCAL;;DODD STEPHANIE KAY;;GROTZFELD ROBERT MARTIN;;JAHNKE WOLFGANG;;JONES DARRYL BRYNLEY;;MANLEY PAUL;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH,,https://lens.org/157-490-393-870-603,Patent Application,no,0,0,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,A61K31/402;;C07D401/14;;A61K31/4025;;A61K31/4155;;A61K31/4439;;A61P35/00;;C07D207/06;;C07D207/09;;C07D207/12;;C07D207/16;;C07D213/75;;C07D213/82;;C07D231/12;;C07D401/04;;C07D403/10,,0,0,,,,PENDING
690,US,B2,US 10870122 B2,190-977-401-410-30X,2020-12-22,2020,US 201916579710 A,2019-09-23,US 201916579710 A;;US 201615206758 A;;US 201414341951 A;;US 201113285576 A;;US 201113068875 A,2011-03-15,Dip tube connectors and pump systems using the same,"A pump system may include a blown-in clip tube connected to a valve body and having a connection which may include an improved blown-in clip tube connector having one or more of a lip for sealing with a blown-in clip tube, a seal ring configured to mate with a blown-in clip tube and seal therewith, a clip tube lock for mating with a blown-in clip tube, or an o-ring for providing an improved seal with a blown-in clip tube.",SILGAN DISPENSING SYSTEMS CORP;;CLOROX CO,DEJONG DAVID L;;SCHEIER ERIC C;;KRESTINE JOSEPH R;;DODD JOSEPH K;;ESPINOZA ALEJANDRO;;KELLY DENNIS J;;QUINTAS LLUIS COSTA;;GOOD ROBERT J;;SWEETON STEVEN L,THE CLOROX COMPANY (2020-10-22);;SILGAN DISPENSING SYSTEMS CORPORATION (2017-05-05),https://lens.org/190-977-401-410-30X,Granted Patent,yes,53,1,27,27,0,B05B11/0037;;B05B15/30;;B05B11/0044;;B05B11/1011;;B05B11/0044;;B05B11/0037;;B05B15/30;;B05B11/1011;;B05B11/1045;;B05B11/1047;;B05B11/0089,B05B11/00;;B05B15/30,,3,0,,,"International Search Report dated Oct. 1, 2012 for PCT/US2012/029468.;;Unsolicited letter received from Mr. George T. Schooff, Esq. of Harness, Dickey & Pierce, PLC, dated Apr. 26, 2013 and related to U.S. Appl. No. 13/408,499.;;Unsolicited letter received from Mr. George T. Schooff, Esq. of Harness, Dickey & Pierce, PLC, dated Apr. 26, 2013 and related to U.S. Appl. No. 13/068,875.",ACTIVE
691,US,B2,US 10421090 B2,052-552-278-667-152,2019-09-24,2019,US 201615206758 A,2016-07-11,US 201615206758 A;;US 201414341951 A;;US 201113285576 A;;US 201113068875 A,2011-03-15,Dip tube connectors and pump systems using the same,"A pump system may include a blown-in dip tube connected to a valve body and having a connection which may include an improved blown-in dip tube connector having one or more of a lip for sealing with a blown-in dip tube, a seal ring configured to mate with a blown-in dip tube and seal therewith, a dip tube lock for mating with a blown-in dip tube, or an o-ring for providing an improved seal with a blown-in dip tube.",SILGAN DISPENSING SYSTEMS CORP,DEJONG DAVID L;;SCHEIER ERIC C;;KRESTINE JOSEPH R;;DODD JOSEPH K;;ESPINOZA ALEJANDRO;;KELLY DENNIS J;;COSTA QUINTAS LLUIS;;GOOD ROBERT J;;SWEETON STEVEN L,THE CLOROX COMPANY (2020-10-22);;SILGAN DISPENSING SYSTEMS CORPORATION (2017-05-05),https://lens.org/052-552-278-667-152,Granted Patent,yes,6,4,27,27,0,B05B11/0037;;B05B15/30;;B05B11/0044;;B05B11/1011;;B05B11/0044;;B05B11/0037;;B05B15/30;;B05B11/1011;;B05B11/1045;;B05B11/1047;;B05B11/0089,B05B11/00;;B05B15/30,,0,0,,,,ACTIVE
692,US,A1,US 2020/0016615 A1,182-590-223-821-723,2020-01-16,2020,US 201916579710 A,2019-09-23,US 201916579710 A;;US 201615206758 A;;US 201414341951 A;;US 201113285576 A;;US 201113068875 A,2011-03-15,DIP TUBE CONNECTORS AND PUMP SYSTEMS USING THE SAME,"A pump system may include a blown-in clip tube connected to a valve body and having a connection which may include an improved blown-in clip tube connector having one or more of a lip for sealing with a blown-in clip tube, a seal ring configured to mate with a blown-in clip tube and seal therewith, a clip tube lock for mating with a blown-in clip tube, or an o-ring for providing an improved seal with a blown-in clip tube.",SILGAN DISPENSING SYSTEMS CORP,DEJONG DAVID L;;SCHEIER ERIC C;;KRESTINE JOSEPH R;;DODD JOSEPH K;;ESPINOZA ALEJANDRO;;KELLY DENNIS J;;QUINTAS LLUIS COSTA;;GOOD ROBERT J;;SWEETON STEVEN L,THE CLOROX COMPANY (2020-10-22);;SILGAN DISPENSING SYSTEMS CORPORATION (2017-05-05),https://lens.org/182-590-223-821-723,Patent Application,yes,0,1,27,27,0,B05B11/0037;;B05B15/30;;B05B11/0044;;B05B11/1011;;B05B11/0044;;B05B11/0037;;B05B15/30;;B05B11/1011;;B05B11/1045;;B05B11/1047;;B05B11/0089,B05B11/00;;B05B15/30,,0,0,,,,ACTIVE
693,US,A1,US 2016/0318052 A1,119-625-507-240-245,2016-11-03,2016,US 201615206758 A,2016-07-11,US 201615206758 A;;US 201414341951 A;;US 201113285576 A;;US 201113068875 A,2011-03-15,DIP TUBE CONNECTORS AND PUMP SYSTEMS USING THE SAME,"A pump system may include a blown-in dip tube connected to a valve body and having a connection which may include an improved blown-in dip tube connector having one or more of a lip for sealing with a blown-in dip tube, a seal ring configured to mate with a blown-in dip tube and seal therewith, a dip tube lock for mating with a blown-in dip tube, or an o-ring for providing an improved seal with a blown-in dip tube.",WESTROCK DISPENSING SYSTEMS INC,DEJONG DAVID L;;SCHEIER ERIC C;;KRESTINE JOSEPH R;;DODD JOSEPH K;;ESPINOZA ALEJANDRO;;KELLY DENNIS J;;COSTA QUINTAS LLUIS;;GOOD ROBERT J;;SWEETON STEVEN L,THE CLOROX COMPANY (2020-10-22);;SILGAN DISPENSING SYSTEMS CORPORATION (2017-05-05),https://lens.org/119-625-507-240-245,Patent Application,yes,13,2,27,27,0,B05B11/0037;;B05B15/30;;B05B11/0044;;B05B11/1011;;B05B11/0044;;B05B11/0037;;B05B15/30;;B05B11/1011;;B05B11/1045;;B05B11/1047;;B05B11/0089,B05B11/00;;B05B15/00,,0,0,,,,ACTIVE
694,US,A1,US 2021/0107022 A1,011-690-511-792-987,2021-04-15,2021,US 202017128440 A,2020-12-21,US 202017128440 A;;US 201916579710 A;;US 201615206758 A;;US 201414341951 A;;US 201113285576 A;;US 201113068875 A,2011-03-15,Dip Tube Connectors And Pump Systems Using The Same,"A pump system may include a blown-in dip tube connected to a valve body and having a connection which may include an improved blown-in dip tube connector having one or more of a lip for sealing with a blown-in dip tube, a seal ring configured to mate with a blown-in dip tube and seal therewith, a dip tube lock for mating with a blown-in dip tube, or an o-ring for providing an improved seal with a blown-in dip tube.",CLOROX CO,DEJONG DAVID L;;SCHEIER ERIC C;;KRESTINE JOSEPH R;;DODD JOSEPH K;;ESPINOZA ALEJANDRO;;KELLY DENNIS J;;QUINTAS LLUIS COSTA;;GOOD ROBERT J;;SWEETON STEVEN L,WESTROCK DISPENSING SYSTEMS INC (2015-08-19);;THE CLOROX COMPANY (2020-10-22);;MEADWESTVACO CALMAR INC (2011-12-12);;SILGAN DISPENSING SYSTEMS CORPORATION (2017-05-05),https://lens.org/011-690-511-792-987,Patent Application,yes,15,0,27,27,0,B05B11/0037;;B05B15/30;;B05B11/0044;;B05B11/1011;;B05B11/0044;;B05B11/0037;;B05B15/30;;B05B11/1011;;B05B11/1045;;B05B11/1047;;B05B11/0089,B05B11/00;;B05B15/30,,0,0,,,,ACTIVE
695,US,B2,US 11648575 B2,129-874-538-638-15X,2023-05-16,2023,US 202017128440 A,2020-12-21,US 202017128440 A;;US 201916579710 A;;US 201615206758 A;;US 201414341951 A;;US 201113285576 A;;US 201113068875 A,2011-03-15,Dip tube connectors and pump systems using the same,"A pump system may include a blown-in dip tube connected to a valve body and having a connection which may include an improved blown-in dip tube connector having one or more of a lip for sealing with a blown-in dip tube, a seal ring configured to mate with a blown-in dip tube and seal therewith, a dip tube lock for mating with a blown-in dip tube, or an o-ring for providing an improved seal with a blown-in dip tube.",CLOROX CO,DEJONG DAVID L;;SCHEIER ERIC C;;KRESTINE JOSEPH R;;DODD JOSEPH K;;ESPINOZA ALEJANDRO;;KELLY DENNIS J;;QUINTAS LLUIS COSTA;;GOOD ROBERT J;;SWEETON STEVEN L,WESTROCK DISPENSING SYSTEMS INC (2015-08-19);;THE CLOROX COMPANY (2020-10-22);;MEADWESTVACO CALMAR INC (2011-12-12);;SILGAN DISPENSING SYSTEMS CORPORATION (2017-05-05),https://lens.org/129-874-538-638-15X,Granted Patent,yes,68,0,27,27,0,B05B11/0037;;B05B15/30;;B05B11/0044;;B05B11/1011;;B05B11/0044;;B05B11/0037;;B05B15/30;;B05B11/1011;;B05B11/1045;;B05B11/1047;;B05B11/0089,B05B11/00;;B05B11/10;;B05B15/30,,4,0,,,"International Search Report dated Oct. 1, 2012 for PCT/US2012/029468.;;Unsolicited letter received from George T. Schoof, Esq. of Harness, Dickey & Pierce, PLC dated Apr. 26, 2013 and related to U.S. Appl. No. 13/068,875.;;Unsolicited letter received from George T. Schoof, Esq. of Harness, Dickey & Pierce, PLC dated Apr. 26, 2013 and related to U.S. Appl. No. 13/408,499.;;Mexican Office Action regarding Mexican Patent Application No. MX/a/2017/013208, dated Feb. 4, 2022.",ACTIVE
696,US,A1,US 2014/0343086 A1,169-295-179-011-05X,2014-11-20,2014,US 201414448363 A,2014-07-31,US 201414448363 A;;US 201313892769 A;;US 201361790967 P;;US 201261647174 P,2012-05-15,"COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1","The present invention relates to compounds of formula (I): in which Y, Y 1 , R 1 , R 2 , R 3 and R 4 are defined in the Summary of the Invention; capable of inhibiting the activity of BCR-ABL1 and mutants thereof. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds in the treatment of cancers.",DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JAHNKE WOLFGANG;;JONES DARRYL BRYNLEY;;MANLEY PAUL WILLIAM;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH;;NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JAHNKE WOLFGANG;;JONES DARRYL BRYNLEY;;MANLEY PAUL WILLIAM;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH,NOVARTIS AG (2012-11-05);;NOVARTIS PHARMA AG (2014-04-29);;NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC (2014-05-10),https://lens.org/169-295-179-011-05X,Patent Application,yes,1,4,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D213/82;;A61K31/4439;;A61K31/506;;C07D401/04;;C07D401/14;;C07D405/14,514/275;;514/341;;546/275.4;;546/278.4;;546/316,1,0,,,"Shin-Etsu Chemical Company Brochure for PHARMACOAT, 2005.",DISCONTINUED
697,US,B2,US 8829195 B2,011-881-623-809-546,2014-09-09,2014,US 201313892769 A,2013-05-13,US 201313892769 A;;US 201361790967 P;;US 201261647174 P,2012-05-15,"Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1","The present invention relates to compounds of formula (I): in which Y, Y 1 , R 1 , R 2 , R 3 and R 4 are defined in the Summary of the Invention; capable of inhibiting the activity of BCR-ABL1 and mutants thereof. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds in the treatment of cancers.",DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JAHNKE WOLFGANG;;JONES DARRYL BRYNLEY;;MANLEY PAUL WILLIAM;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH;;NOVARTIS AG,DODD STEPHANIE KAY;;FURET PASCAL;;GROTZFELD ROBERT MARTIN;;JAHNKE WOLFGANG;;JONES DARRYL BRYNLEY;;MANLEY PAUL WILLIAM;;MARZINZIK ANDREAS;;PELLE XAVIER FRANCOIS ANDRE;;SALEM BAHAA;;SCHOEPFER JOSEPH,NOVARTIS AG (2012-11-05);;NOVARTIS PHARMA AG (2014-04-29);;NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC (2014-05-10),https://lens.org/011-881-623-809-546,Granted Patent,yes,32,9,75,95,0,C07D213/82;;C07D401/04;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/65583;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07D213/82;;A61P35/00;;A61P35/02;;A61P43/00;;C07D401/10;;A61K31/506;;A61K31/4439;;C07F9/58;;C07D401/14;;C07D403/10;;A61K45/06;;C07D405/14;;C07D401/04;;C07D213/82,C07D401/00;;A01N43/40;;A61K31/44;;A61K31/4439;;A61K31/506;;A61K45/06;;C07D211/56;;C07D211/72;;C07D211/84;;C07D213/82;;C07D401/04;;C07D401/10;;C07D401/14;;C07D403/10;;C07D405/14;;C07F9/58,546/275.4;;546/275.7;;546/276.4;;546/316;;514/341;;514/343;;514/355,2,2,094-055-108-080-726;;049-997-490-538-87X,10.1021/jm301188x;;23088644;;19217274;;10.1016/j.ceb.2009.01.014,"Li, et al., ""Design, Synthesis, and Biologicl Evaluation of 3-(1H-1,2,3-Triazol-1-yl)benzamide Derivatives as Potent Pan Bcr-Abl Inhibitors Including the Threonin 315->Isoleucine315 Mutant"", Journal of Medicinal Chemistry, Nov. 26, 2012, pp. 10033-10046, vol. 55, No. 22, American Chemical Society, US.;;Eck, et al., ""The interplay of structural information and functional studies in kinase drug design: insights from BCR-Abl"", Current Opinion in Cell Biology, Apr. 1, 2009, pp. 288-295, vol. 21, No. 2.",ACTIVE
698,US,B2,US 7634195 B2,084-429-585-213-65X,2009-12-15,2009,US 93876107 A,2007-11-12,US 93876107 A;;US 26721202 A;;US 32820701 P;;US 32833201 P;;US 37034502 P;;US 36759502 P;;US 37801002 P;;US 39249402 P,2001-10-09,Digital optical network architecture,"A digital optical network (DON) is a new approach to low-cost, more compact optical transmitter modules and optical receiver modules for deployment in optical transport networks (OTNs). One important aspect of a digital optical network is the incorporation in these modules of transmitter photonic integrated circuit (TxPIC) chips and receiver photonic integrated circuit (TxPIC) chips in lieu of discrete modulated sources and detector sources with discrete multiplexers or demultiplexers.",INFINERA CORP,SINGH JAGDEEP;;PERKINS DREW;;WELCH DAVID F;;YIN MARK;;KISH JR FRED A;;GRUBB STEPHEN G;;TAYLOR ROBERT R;;DOMINIC VINCENT G;;MITCHELL MATTHEW L;;DODD JR JAMES R,,https://lens.org/084-429-585-213-65X,Granted Patent,yes,2,10,38,208,0,B82Y20/00;;G01R31/31728;;G01R31/318511;;G02B6/12004;;G02B6/12007;;G02B6/12011;;G02B6/12019;;G02B6/12021;;G02B6/12023;;G02B6/12026;;G02B6/12028;;G02B6/12033;;G02B6/131;;G02B6/136;;G02B6/4204;;G02F1/01725;;G02F2203/69;;H01L31/125;;H01S5/0014;;H01S5/0085;;H01S5/026;;H01S5/0262;;H01S5/0264;;H01S5/0265;;H01S5/0268;;H01S5/06256;;H01S5/06258;;H01S5/0683;;H01S5/06832;;H01S5/12;;H01S5/1228;;H01S5/2077;;H01S5/22;;H01S5/3408;;H01S5/4031;;H01S5/4087;;H01S5/50;;H04B10/2914;;H04B10/50;;H04J14/02;;H04J14/0282;;H04J14/0246;;H04J14/025;;H04J14/0258;;H04J14/0265;;H04J14/0276;;G02F1/01758;;G02F1/0175;;H01S5/02325;;G02B6/12011;;G01R31/318511;;G02B6/12026;;G02F2203/69;;H01S5/22;;H01S5/0085;;H01S5/0264;;H01L31/125;;G02B6/131;;G02B6/12023;;H01S5/026;;G02F1/01725;;H01S5/0265;;H01S5/50;;H01S5/4031;;G02B6/12028;;G02B6/12021;;G02B6/12033;;G02B6/4204;;B82Y20/00;;H01S5/06258;;H01S5/3408;;H01S5/4087;;G02B6/12007;;G02B6/12019;;G02B6/12004;;H01S5/1228;;G01R31/31728;;H01S5/06256;;H01S5/0268;;H01S5/06832;;H01S5/2077;;H04B10/2914;;H04J14/0282;;H01S5/0014;;H04J14/02;;H04B10/50;;H01S5/0262;;G02B6/136;;H01S5/0683;;H01S5/12;;H04J14/025;;H04J14/0246;;H04J14/0276;;H04J14/0265;;H04J14/0258;;G02F1/0175;;G02F1/01758;;H01S5/02325,H04J14/02;;G02B6/12;;G02B6/34;;G02F1/017;;H01L31/12;;H01S3/00;;H01S3/13;;H01S5/00;;H01S5/026;;H01S5/0625;;H01S5/0683;;H01S5/12;;H01S5/20;;H01S5/22;;H01S5/34;;H01S5/40;;H01S5/50;;H04B10/00;;H04B10/04;;H04B10/145;;H04B10/17,398/79;;398/82;;398/43,0,0,,,,EXPIRED
699,US,B2,US 7295783 B2,113-800-931-671-877,2007-11-13,2007,US 26721202 A,2002-10-08,US 26721202 A;;US 32820701 P;;US 32833201 P;;US 37034502 P;;US 36759502 P;;US 37801002 P;;US 39249402 P,2001-10-09,Digital optical network architecture,"A digital optical network (DON) is a new approach to low-cost, more compact optical transmitter modules and optical receiver modules for deployment in optical transport networks (OTNs). One important aspect of a digital optical network is the incorporation in these modules of transmitter photonic integrated circuit (TxPIC) chips and receiver photonic integrated circuit (RxPIC) chips in lieu of discrete modulated sources and detector sources with discrete multiplexers or demultiplexers.",INFINERA CORP,SINGH JAGDEEP;;PERKINS DREW D;;WELCH DAVID F;;YIN MARK;;KISH JR FRED A;;GRUBB STEPHEN G;;TAYLOR ROBERT R;;DOMINIC VINCENT G;;MITCHELL MATTHEW L;;DODD JR JAMES R,INFINERA CORPORATION (2002-10-24),https://lens.org/113-800-931-671-877,Granted Patent,yes,43,47,38,208,0,B82Y20/00;;G01R31/31728;;G01R31/318511;;G02B6/12004;;G02B6/12007;;G02B6/12011;;G02B6/12019;;G02B6/12021;;G02B6/12023;;G02B6/12026;;G02B6/12028;;G02B6/12033;;G02B6/131;;G02B6/136;;G02B6/4204;;G02F1/01725;;G02F2203/69;;H01L31/125;;H01S5/0014;;H01S5/0085;;H01S5/026;;H01S5/0262;;H01S5/0264;;H01S5/0265;;H01S5/0268;;H01S5/06256;;H01S5/06258;;H01S5/0683;;H01S5/06832;;H01S5/12;;H01S5/1228;;H01S5/2077;;H01S5/22;;H01S5/3408;;H01S5/4031;;H01S5/4087;;H01S5/50;;H04B10/2914;;H04B10/50;;H04J14/02;;H04J14/0282;;H04J14/0246;;H04J14/025;;H04J14/0258;;H04J14/0265;;H04J14/0276;;G02F1/01758;;G02F1/0175;;H01S5/02325;;G02B6/12011;;G01R31/318511;;G02B6/12026;;G02F2203/69;;H01S5/22;;H01S5/0085;;H01S5/0264;;H01L31/125;;G02B6/131;;G02B6/12023;;H01S5/026;;G02F1/01725;;H01S5/0265;;H01S5/50;;H01S5/4031;;G02B6/12028;;G02B6/12021;;G02B6/12033;;G02B6/4204;;B82Y20/00;;H01S5/06258;;H01S5/3408;;H01S5/4087;;G02B6/12007;;G02B6/12019;;G02B6/12004;;H01S5/1228;;G01R31/31728;;H01S5/06256;;H01S5/0268;;H01S5/06832;;H01S5/2077;;H04B10/2914;;H04J14/0282;;H01S5/0014;;H04J14/02;;H04B10/50;;H01S5/0262;;G02B6/136;;H01S5/0683;;H01S5/12;;H04J14/025;;H04J14/0246;;H04J14/0276;;H04J14/0265;;H04J14/0258;;G02F1/0175;;G02F1/01758;;H01S5/02325,H04J14/02;;G02B6/12;;G02B6/34;;G02F1/017;;H01L31/12;;H01S3/00;;H01S3/13;;H01S5/00;;H01S5/026;;H01S5/0625;;H01S5/0683;;H01S5/12;;H01S5/20;;H01S5/22;;H01S5/34;;H01S5/40;;H01S5/50;;H04B10/00;;H04B10/02;;H04B10/04;;H04B10/145;;H04B10/17,398/175;;398/87;;398/97;;398/164,19,10,135-237-212-545-354;;026-092-551-959-280;;120-264-501-449-093;;003-052-109-746-193;;106-421-325-931-399;;021-564-769-761-382;;120-264-501-449-093;;000-947-162-743-272;;064-630-231-090-92X;;003-052-109-746-193,10.1109/gaas.1995.528988;;10.1364/ipr.1993.iwa3;;10.1109/35.735876;;10.1109/49.510920;;10.1109/68.655362;;10.1109/68.554518;;10.1109/35.735876;;10.1049/el:19950402;;10.1109/68.826901;;10.1109/49.510920,"Sitch et al. ""The use of III-V ICs in WDM Optical Network Equipment"", Technical Digest of GaAs IC 17th Annual Symposium 1995, pp. 177-180, Oct. 29-Nov. 1, 1995).;;M.G. Young et al. ""A 16x1 WDM transmitter with Integrated DBR Lasers and Electroabsorption Modulators"", Integrated Photonics Research, Washington, DC., vol. 10, pp. 414-417, Mar. 22-24, 1993.;;Frank Tong ""Multiwavelength Receivers for WDM System"", IEEE Communications Magazine, pp. 42-49, Dec. 1998).;;Paul E. Green, Jr. ""WDM Protocol-Transparent Distance Extension Using R2 Remodulation"", IEEE Journal, vol. 14, No. 5, pp. 962-967, Jun. 1996).;;Rajiv Ramaswami and Kumar N. Sivarajan, ""Optical Networks"", Second Edition, pp. 24-26 and 217-218, Morgan Kaufmann Publishers, 2002.;;Raybon et al., ""Reconfigurable Optoelectronic Wavelength Translation based on an Integrated Electroabsorption Modulated Laser Array"", IEEE Photonics Technology Letters, vol. 10(2), pp. 215-217, Feb. 1998.;;K. Affolter, ""Integrating Active Components Improves System Design"", WDM Solutions, pp. 65-67, Jun. 2001.;;K. Inoue et al., ""Signal Improvement Effect in O/E-E/O Conversion Using an Electro-Absorption (EA) Modulator"", IEEE Photonics Technology Letters, vol. 9(1), pp. 109-111, Jan. 1997.;;Sitch et al., ""The USe of III-V . . . Network Equipment"", Technical Digest of GaAs IC 17TH Annual Symposium 1995, pp. 177-180, Oct. 29-Nov. 1, 1995.;;Young et al., ""A 16x1 WDM Transmitter . . . Modulators"", Integrated Photonics Research, Washington, D.C., vol. 10, pp. 414-417, Mar. 22-24, 1993.;;Sitch et al., ""Use of III-V. . . Network Equipment"", Technical Digest of GaAs IC 17TH Annual Symposium 1995, pp. 177-180, Oct. 29-Nov. 1, 1995.;;Young et al., ""A 16x1 WDM Transmitter . . . Modulators"", Integrated Photonics Research, Washington, D.C., vol. 10, pp. 414-417, Mar. 22-24, 1993.;;Thomas C. McDermott, ""Optical Networks in the Real World"", IEEE/LEOS Summer Topical Meetings, pp. 37-38, Jul. 20, 1998 Monterey, CA.;;U.S. Appl. No. 10/124,483, filed May 5, 2005, Welch et al.;;Tong, ""Mulitplewavelength Recivers for WDM Systems"", IEEE Communications Magazine, pp. 42-49, Dec. 1998.;;Zirngibl et al., ""WDM Reciver by Monolithic . . . Photodiode Array"", EWlectronic Letters, pp. 581-582, Mar. 30, 1995.;;Kudo et al., ""1.55-mm Wavelength . . . ES-Modulator"", IEEE Photonics Technology Letters, vol. 12(3), pp. 242-244, Mar. 2000.;;M. Bouda, ""Compact High-Power . . . WDM Applications"", Conference on Optical Fiber Communication, Technical Digest series, vol. 1, pp. 178-180, Mar. 7-10, 2000.;;Green et al., ""WDM Protocol-Transparent Distance Extension Using R2 Remodulation"", IEEE Journal on Selected Areas in Communications, vol. 14(5), pp. 962-967, Jun. 1996.",ACTIVE
700,CA,A1,CA 2463502 A1,028-651-914-915-203,2003-04-17,2003,CA 2463502 A,2002-10-08,US 32820701 P;;US 32833201 P;;US 36759502 P;;US 37034502 P;;US 37801002 P;;US 0232111 W,2001-10-09,DIGITAL OPTICAL NETWORK ARCHITECTURE,"A digital optical network (DON) is a new approach to low-cost, more compact optical transmitter modules and optical receiver modules for deployment in optical transport networks (OTNs). One important aspect of a digital optical network is the incorporation in these modules of transmitter photonic integrated circuit (TxPIC) chips and receiver photonic integrated circuit (TxPIC) chips in lieu of discrete modulated sources and detector sources wit h discrete multiplexers or demultiplexers.",INFINERA CORP,WELCH DAVID F;;DOMINIC VINCENT G;;PERKINS DREW D;;MITCHELL MATTHEW L;;SINGH JAGDEEP;;YIN MARK;;GRUBB STEPHEN G;;KISH FRED A JR;;TAYLOR ROBERT B;;DODD JAMES R JR,,https://lens.org/028-651-914-915-203,Patent Application,no,0,1,44,208,0,B82Y20/00;;G02B6/02204;;G02B6/12004;;G02B6/12007;;G02B6/12019;;G02B6/12023;;G02B6/12026;;G02B6/12028;;G02B6/124;;G02F1/01725;;H01S5/0085;;H01S5/02415;;H01S5/02453;;H01S5/02461;;H01S5/02476;;H01S5/026;;H01S5/0261;;H01S5/0264;;H01S5/0265;;H01S5/0268;;H01S5/0612;;H01S5/06256;;H01S5/06258;;H01S5/0683;;H01S5/0687;;H01S5/12;;H01S5/1228;;H01S5/2077;;H01S5/22;;H01S5/2214;;H01S5/2224;;H01S5/227;;H01S5/2272;;H01S5/2275;;H01S5/3408;;H01S5/34306;;H01S5/4025;;H01S5/4031;;H01S5/4087;;H01S5/50;;H04B10/2914;;H04B10/50;;H04B10/506;;H04B10/572;;H04J14/02;;G02B6/12033;;H01S5/04256;;G02F1/0175;;G02F1/01758;;B82Y20/00;;G02B6/02204;;G02B6/12004;;G02B6/12007;;G02B6/12019;;G02B6/12023;;G02B6/12026;;G02B6/12028;;G02B6/124;;G02F1/01725;;H01S5/0085;;H01S5/024;;H01S5/02415;;H01S5/02453;;H01S5/02461;;H01S5/02476;;H01S5/026;;H01S5/0261;;H01S5/0264;;H01S5/0265;;H01S5/0268;;H01S5/0612;;H01S5/06256;;H01S5/06258;;H01S5/0683;;H01S5/0687;;H01S5/12;;H01S5/1228;;H01S5/2077;;H01S5/22;;H01S5/2214;;H01S5/2224;;H01S5/227;;H01S5/2272;;H01S5/2275;;H01S5/3408;;H01S5/34306;;H01S5/4025;;H01S5/4031;;H01S5/4087;;H01S5/50;;H04B10/2914;;H04B10/50;;H04B10/506;;H04B10/572;;H04J14/02;;H01S5/04256;;G02F1/0175;;G02F1/01758;;G02B6/12033,G02B6/12;;G02B6/34;;G02F1/017;;H01S3/10;;H01S3/13;;H01S5/00;;H01S5/024;;H01S5/026;;H01S5/06;;H01S5/0625;;H01S5/0683;;H01S5/12;;H01S5/20;;H01S5/22;;H01S5/227;;H01S5/34;;H01S5/40;;H01S5/50;;H04B10/04;;H04B10/12;;H04B10/145;;H04B10/17;;H04B10/29;;H04J14/02,,0,0,,,,EXPIRED
701,CA,C,CA 2463502 C,192-813-791-010-679,2011-09-20,2011,CA 2463502 A,2002-10-08,US 32820701 P;;US 32833201 P;;US 36759502 P;;US 37034502 P;;US 37801002 P;;US 0232111 W,2001-10-09,DIGITAL OPTICAL NETWORK ARCHITECTURE,"A digital optical network (DON) is a new, approach to low-cost, more compact optical transmitter modules and optical receiver modules for deployment in optical transport networks (OTNs). One important aspect of a digital optical network is the incorporation in these modules of transmitter photonic integrated circuit (TxPIC) chips and receiver photonic integrated circuit (RxPIC) chips in lieu of discrete modulated sources and detector sources with discrete multiplexers or demultiplexers.",INFINERA CORP,SINGH JAGDEEP;;PERKINS DREW D;;WELCH DAVID F;;YIN MARK;;KISH FRED A JR;;GRUBB STEPHEN G;;TAYLOR ROBERT B;;DOMINIC VINCENT G;;MITCHELL MATTHEW L;;DODD JAMES R JR,,https://lens.org/192-813-791-010-679,Granted Patent,no,0,0,44,208,0,B82Y20/00;;G02B6/02204;;G02B6/12004;;G02B6/12007;;G02B6/12019;;G02B6/12023;;G02B6/12026;;G02B6/12028;;G02B6/124;;G02F1/01725;;H01S5/0085;;H01S5/02415;;H01S5/02453;;H01S5/02461;;H01S5/02476;;H01S5/026;;H01S5/0261;;H01S5/0264;;H01S5/0265;;H01S5/0268;;H01S5/0612;;H01S5/06256;;H01S5/06258;;H01S5/0683;;H01S5/0687;;H01S5/12;;H01S5/1228;;H01S5/2077;;H01S5/22;;H01S5/2214;;H01S5/2224;;H01S5/227;;H01S5/2272;;H01S5/2275;;H01S5/3408;;H01S5/34306;;H01S5/4025;;H01S5/4031;;H01S5/4087;;H01S5/50;;H04B10/2914;;H04B10/50;;H04B10/506;;H04B10/572;;H04J14/02;;G02B6/12033;;H01S5/04256;;G02F1/0175;;G02F1/01758;;B82Y20/00;;G02B6/02204;;G02B6/12004;;G02B6/12007;;G02B6/12019;;G02B6/12023;;G02B6/12026;;G02B6/12028;;G02B6/124;;G02F1/01725;;H01S5/0085;;H01S5/024;;H01S5/02415;;H01S5/02453;;H01S5/02461;;H01S5/02476;;H01S5/026;;H01S5/0261;;H01S5/0264;;H01S5/0265;;H01S5/0268;;H01S5/0612;;H01S5/06256;;H01S5/06258;;H01S5/0683;;H01S5/0687;;H01S5/12;;H01S5/1228;;H01S5/2077;;H01S5/22;;H01S5/2214;;H01S5/2224;;H01S5/227;;H01S5/2272;;H01S5/2275;;H01S5/3408;;H01S5/34306;;H01S5/4025;;H01S5/4031;;H01S5/4087;;H01S5/50;;H04B10/2914;;H04B10/50;;H04B10/506;;H04B10/572;;H04J14/02;;H01S5/04256;;G02F1/0175;;G02F1/01758;;G02B6/12033,G02B6/12;;G02B6/34;;G02F1/017;;H01S3/10;;H01S3/13;;H01S5/00;;H01S5/024;;H01S5/026;;H01S5/06;;H01S5/0625;;H01S5/0683;;H01S5/12;;H01S5/20;;H01S5/22;;H01S5/227;;H01S5/34;;H01S5/40;;H01S5/50;;H04B10/00;;H04B10/02;;H04B10/04;;H04B10/08;;H04B10/12;;H04B10/145;;H04B10/17;;H04B10/18;;H04B10/29;;H04J14/02,,0,0,,,,EXPIRED
702,ES,T3,ES 2641833 T3,007-876-941-132-98X,2017-11-14,2017,ES 11741554 T,2011-07-27,US 36882010 P;;EP 2011062933 W,2010-07-29,Inhibidores bicíclicos de la acetil-CoA carboxilasa,"Un compuesto, o una sal farmacéuticamente aceptable del mismo, representado por la fórmula IIa: **(Ver fórmula)** en la que ""*"" indica un carbono en el que el grupo sulfamoilo puede estar unido X4 es -NR4- u -O-; m es 0, 1 o 2; R1 puede sustituir un átomo de hidrógeno de cualquier enlace CH en el anillo de indol y, para cada aparición, es independientemente deutero, hidroxi, nitro, halo, ciano, carboxi, formilo, alquilo C1-7, carbociclilo C3-8, alquenilo C2-7, alquinilo C2-7, alcoxi C1-7, alquiltio C1-7, C3-8 cicloalcoxi, C6-10 arilo, C6-10 ariloC1-4 alquilo C6-10-ariloxi, amino, N-alquilamino C1-7, N,N-di-(alquil C1-7) amino, N-C6-10 arilamino, heterociclilo de 3 a 10 miembros, N-(heterociclilo de 3 a 10 miembros)amino, (heterociclilo de 3 a 10 miembros)oxi, heteroarilo de 5 a 10 miembros, (heteroaril de 5 a 10 miembros) alquilo C1-4, N-heteroarilo (amino de 5 a 10 miembros), heteroariloxi de 5 a 10 miembros, alcanoilo C1-7, alcoxicarbonilo C1-7, alcanoiloxi C1-7, alquilamido C1-7, arilamido C6-10, (heterociclilo de 3 a 10 miembros) amido, carbamoilo, N-alquil C1-7 carbamoilo, N,N-di-(alquil C1-7) carbamoilo, alcoxi C1-7 amido, alquil C1-7 ureido y arilo C6-10 ureido, en la que R1 está opcionalmente sustituido en unoo más átomos de carbono con uno o más R13 seleccionados independientemente; y en el que cuando R1 comprende un heterociclilo o un heteroarilo que comprende uno o más - NH-, el hidrógeno de cada grupo -NH- se puede sustituir independientemente opcionalmente con R22; o dos R1 en el mismo átomo de carbono juntos pueden formar un oxo; o dos R1 en el mismo átomo de carbono junto con el carbono al que están unidos forman un espiro C3-8 carbociclilo; o dos R1 en átomos de carbono adyacentes junto con los átomos de carbono a los que están unidos pueden formar un C3-8 carbociclilo condensado o fenilo que puede estar opcionalmente sustituido con uno o más R13; y R3 se selecciona del grupo que consiste en un alquilo C1-7, un C3-8carbociclilo, un C3-8carbociclilo C1-4alquilo, un C6-10 arilo, un C6-10arilC1-4alquilo, un heteroarilo de 5 a 10 miembros, un (5 a 10 miembros heteroaril) alquilo C1-4, un heterociclilo de 3 a 10 miembros y un (heterociclilo de 3 a 10 miembros) alquilo C1-4, en el que R3 está opcionalmente sustituido en uno o más átomos de carbono con uno o más R14; y en el que cuando R3 comprende un heteroarilo o heterociclilo que comprende uno o más -NH-, el hidrógeno de cada grupo -NH- se puede sustituir independientemente opcionalmente con un alquilo C1-7; R4 es hidrógeno, alquilo C1-7 o alcoxi C1-4 alquilo C1-4; o R3 y R4, junto con el átomo de nitrógeno al que están unidos, forman un heterociclilo de 3 a 7 miembros, donde el heterociclilo puede estar opcionalmente sustituido en uno o más átomos de carbono con uno o más R15; y en el que cuando el heterociclilo comprende uno o más -NH-, el hidrógeno de cada grupo -NH- puede sustituirse independientemente opcionalmente con R16; R13, para cada aparición, es independientemente deutero, nitro, halo, ciano, hidroxi, carboxi, alquilo C1-7, cicloalquilo C3-8, alcoxi C1-7, arilo C6-10, ariloxi C6-10, heterociclilo de 3 a 10 miembros, heteroarilo de 5 a 10 miembros, amino, C1- 7 alquilamino, di-(alquil C1-7)amino, alcanoilo C1-7, alcoxicarbonilo C1-7, alcanoiloxi C1-7, alquilamino C1-7, alcoxiamido C1-7, carbamoilo, N-alquil C1-7 carbamoilo, N,N-di-(alquil C1-7) carbamoilo, alquilsulfonilo C1-7, alquilsulfoniloxilo C1-7, alquilsulfonamido C1-7, sulfamoilo, N-alquil C1-7 sulfamoilo, o N,N-di-(alquil C1-7) sulfamoilo, donde R13 es opcionalmente sustituido en uno o más átomos de carbono con uno o más R17 seleccionados independientemente; y en el que cuando R13 es un heterociclilo o un heteroarilo que comprende uno o más -NH-, el hidrógeno de cada grupo -NH- puede estar independientemente opcionalmente sustituido con R20; o dos R13 en el mismo átomo de carbono juntos pueden formar un oxo o un espiro C3-8carbociclilo; o dos R13 en átomos de carbono adyacentes junto con los carbonos a los que están unidos pueden formar un heterociclilo de 3 a 7 miembros que puede estar opcionalmente sustituido en uno o más átomos de carbono con uno o más R17 y si el heterociclilo comprende uno o más grupos -NH-, el hidrógeno de cada grupo -NH- puede sustituirse independientemente opcionalmente con R20; ...",NOVARTIS AG,BARNES DAVID;;BEBERNITZ GREGORY;;CLAIRMONT KEVIN;;COHEN SCOTT;;DAMON ROBERT;;DAY ROBERT;;DODD STEPHANIE;;GAUL CHRISTOPH;;GULGEZE EFTHYMIOU HATICE;;JAIN MONISH;;KARKI RAJESHRI GANESH;;KIRMAN LOUISE;;LIN KAI;;MAO JUSTIN YIK CHING;;PATEL TAJESH JAYPRAKASH;;RAYMER BRIAN;;SU LIANSHENG,,https://lens.org/007-876-941-132-98X,Granted Patent,no,0,0,15,15,0,A61K9/0014;;A61K9/0019;;A61K9/0095;;A61K9/08;;A61K9/1075;;C07D215/36;;C07D235/18;;C07D263/57;;C07D401/04;;C07D401/12;;C07D403/04;;C07D405/04;;C07D413/12;;C07D471/04;;C07D513/04;;C12N9/93;;C12Y604/01002;;C07D209/24;;C07D235/08;;C07D235/12;;C07D235/16;;C07D235/30;;C07D405/14;;A61P13/02;;A61P19/06;;A61P3/00;;A61P3/04;;A61P31/12;;A61P31/14;;A61P35/00;;A61P3/06;;A61P3/08;;A61P43/00;;A61P5/50;;A61P7/02;;A61P9/12;;A61P3/10;;A61K9/0014;;A61K9/0019;;A61K9/0095;;A61K9/08;;A61K9/1075;;C07D215/36;;C07D235/18;;C07D263/57;;C07D401/04;;C07D401/12;;C07D403/04;;C07D405/04;;C07D413/12;;C07D471/04;;C07D513/04;;C12N9/93;;C12Y604/01002;;A61K31/404;;A61K31/4184;;A61K31/423;;A61K31/496;;A61K31/5377;;A61K31/542;;A61K45/06;;C07D209/24;;C07D235/08;;C07D235/12;;C07D235/16;;C07D235/30;;C07D405/14,C07D215/36;;A61K31/404;;A61K31/4184;;C07D235/18;;C07D263/57;;C07D401/04;;C07D401/12;;C07D403/04;;C07D405/04;;C07D413/12;;C07D471/04;;C07D513/04,,0,0,,,,ACTIVE
703,UY,A,UY 33536 A,030-833-695-581-694,2012-02-29,2012,UY 33536 A,2011-07-28,US 36882010 P,2010-07-29,INHIBIDORES BICÍCLICOS DE ACETIL-CoA-CARBOXILASA Y USOS DE LOS MISMOS,"La presente invención proporciona los compuestos de la fórmula (I) o las sales farmacéuticamente aceptables de los mismos, en donde las variables se definen como en la presente. La presente invención proporciona un método para la elaboración de los compuestos de la fórmula (I), sus usos terapéuticos, combinaciones con otros de los agentes farmacológicamente activos, y composiciones farmacéuticas.",NOVARTIS AG,RAJESHRI KARKI;;COHEN SCOTT LOUIS;;BARNES DAVID WENIGER;;BEBERNITZ GREGORY RAYMOND;;KEVIN CLAIRMONT;;DAMON ROBERT EDSON;;DAY ROBERT FRANCIS;;DODD STEPHANIE KAY;;CHRISTOPH GAUL;;EFTHYMIU HATICE BELGIN GULGEZE;;MONISH JAIN;;KIRMAN LOUISE CLARE;;KAI LIN;;MAO JUSTIN YIK CHING;;PATEL TAKESH JAYPRAKASH;;LIANSHENG SU;;RAYMER BRIAN KENNETH,,https://lens.org/030-833-695-581-694,Patent Application,no,0,0,15,15,0,A61K9/0014;;A61K9/0019;;A61K9/0095;;A61K9/08;;A61K9/1075;;C07D215/36;;C07D235/18;;C07D263/57;;C07D401/04;;C07D401/12;;C07D403/04;;C07D405/04;;C07D413/12;;C07D471/04;;C07D513/04;;C12N9/93;;C12Y604/01002;;C07D209/24;;C07D235/08;;C07D235/12;;C07D235/16;;C07D235/30;;C07D405/14;;A61P13/02;;A61P19/06;;A61P3/00;;A61P3/04;;A61P31/12;;A61P31/14;;A61P35/00;;A61P3/06;;A61P3/08;;A61P43/00;;A61P5/50;;A61P7/02;;A61P9/12;;A61P3/10;;A61K9/0014;;A61K9/0019;;A61K9/0095;;A61K9/08;;A61K9/1075;;C07D215/36;;C07D235/18;;C07D263/57;;C07D401/04;;C07D401/12;;C07D403/04;;C07D405/04;;C07D413/12;;C07D471/04;;C07D513/04;;C12N9/93;;C12Y604/01002;;A61K31/404;;A61K31/4184;;A61K31/423;;A61K31/496;;A61K31/5377;;A61K31/542;;A61K45/06;;C07D209/24;;C07D235/08;;C07D235/12;;C07D235/16;;C07D235/30;;C07D405/14,A61K31/404;;A61K31/4184;;A61K31/423;;A61K31/4245;;A61K31/437;;A61K31/4427;;A61K31/496;;A61K31/5377;;A61P3/00;;A61P3/10;;C07D209/04;;C07D235/04;;C07D263/58;;C07D401/12;;C07D413/12;;C07D413/14;;C07D471/04;;C07D487/04,,0,0,,,,DISCONTINUED
704,US,A1,US 2012/0028969 A1,019-496-114-448-105,2012-02-02,2012,US 201113189760 A,2011-07-25,US 201113189760 A;;US 36882010 P,2010-07-29,BICYCLIC ACETYL-COA CARBOXYLASE INHIBITORS AND USES THEREOF,"The present invention provides compounds of formula (I); or pharmaceutically acceptable salts thereof, wherein the variables are defined as herein. The present invention provides a method for manufacturing the compounds of formula (I), their therapeutic uses, combinations with other of pharmacologically active agents, and a pharmaceutical compositions.",BARNES DAVID WENINGER;;BEBERNITZ GREGORY RAYMOND;;CLAIRMONT KEVIN;;COHEN SCOTT LOUIS;;DAMON ROBERT EDSON;;DAY ROBERT FRANCIS;;DODD STEPHANIE KAY;;GAUL CHRISTOPH;;GULGEZE EFTHYMIOU HATICE BELGIN;;JAIN MONISH;;KARKI RAJESHRI GANESH;;KIRMAN LOUISE CLARE;;LIN KAI;;MAO JUSTIN YIK CHING;;PATEL TAJESH JAYPRAKASH;;RAYMER BRIAN KENNETH;;SU LIANSHENG;;NOVARTIS AG,BARNES DAVID WENINGER;;BEBERNITZ GREGORY RAYMOND;;CLAIRMONT KEVIN;;COHEN SCOTT LOUIS;;DAMON ROBERT EDSON;;DAY ROBERT FRANCIS;;DODD STEPHANIE KAY;;GAUL CHRISTOPH;;GULGEZE EFTHYMIOU HATICE BELGIN;;JAIN MONISH;;KARKI RAJESHRI GANESH;;KIRMAN LOUISE CLARE;;LIN KAI;;MAO JUSTIN YIK CHING;;PATEL TAJESH JAYPRAKASH;;RAYMER BRIAN KENNETH;;SU LIANSHENG,NOVARTIS AG (2011-06-23),https://lens.org/019-496-114-448-105,Patent Application,yes,0,8,15,15,0,A61K9/0014;;A61K9/0019;;A61K9/0095;;A61K9/08;;A61K9/1075;;C07D215/36;;C07D235/18;;C07D263/57;;C07D401/04;;C07D401/12;;C07D403/04;;C07D405/04;;C07D413/12;;C07D471/04;;C07D513/04;;C12N9/93;;C12Y604/01002;;C07D209/24;;C07D235/08;;C07D235/12;;C07D235/16;;C07D235/30;;C07D405/14;;A61P13/02;;A61P19/06;;A61P3/00;;A61P3/04;;A61P31/12;;A61P31/14;;A61P35/00;;A61P3/06;;A61P3/08;;A61P43/00;;A61P5/50;;A61P7/02;;A61P9/12;;A61P3/10;;A61K9/0014;;A61K9/0019;;A61K9/0095;;A61K9/08;;A61K9/1075;;C07D215/36;;C07D235/18;;C07D263/57;;C07D401/04;;C07D401/12;;C07D403/04;;C07D405/04;;C07D413/12;;C07D471/04;;C07D513/04;;C12N9/93;;C12Y604/01002;;A61K31/404;;A61K31/4184;;A61K31/423;;A61K31/496;;A61K31/5377;;A61K31/542;;A61K45/06;;C07D209/24;;C07D235/08;;C07D235/12;;C07D235/16;;C07D235/30;;C07D405/14,A61K31/542;;A61K31/405;;A61K31/4184;;A61K31/4245;;A61K31/47;;A61K31/4985;;A61K31/5365;;A61K31/5377;;A61P3/00;;A61P3/04;;A61P3/06;;A61P3/08;;A61P3/10;;A61P31/12;;C07D209/04;;C07D215/00;;C07D235/04;;C07D413/12;;C07D471/04;;C07D498/04;;C07D513/04;;C12N9/99,514/224.2;;435/184;;514/230.5;;514/235.2;;514/249;;514/311;;514/364;;514/394;;514/415;;544/48;;544/105;;544/144;;544/350;;546/152;;548/143;;548/304.4;;548/469,0,0,,,,INACTIVE
705,CN,A,CN 103339111 A,026-583-988-009-997,2013-10-02,2013,CN 201180035809 A,2011-07-27,EP 2011062933 W;;US 36882010 P,2010-07-29,Bicyclic acetyl-CoA carboxylase inhibitors,"The present invention provides compounds of formula (I); or pharmaceutically acceptable salts thereof, wherein the variables are defined as herein. The present invention provides a method for manufacturing the compounds of formula (I), their therapeutic uses, combinations with other of pharmacologically active agents, and a pharmaceutical compositions.",NOVARTIS AG,BARNES DAVID WENINGER;;BEBERNITZ GREGORY RAYMOND;;CLAIRMONT KEVIN;;COHEN SCOTT LOUIS;;DAMON ROBERT EDSON II;;DAY ROBERT FRANCIS;;DODD STEPHANIE KAY;;GAUL CHRISTOPH;;GULGEZE EFTHYMIOU HATICE BELGIN;;JAIN MONISH;;KARKI RAJESHRI GANESH;;KIRMAN LOUISE CLARE;;LIN KAI;;MAO JUSTIN YIK CHING;;PATEL TAJESH JAYPRAKASH;;RAYMER BRIAN KENNETH;;SU LIANSHENG,,https://lens.org/026-583-988-009-997,Patent Application,no,3,8,15,15,0,A61K9/0014;;A61K9/0019;;A61K9/0095;;A61K9/08;;A61K9/1075;;C07D215/36;;C07D235/18;;C07D263/57;;C07D401/04;;C07D401/12;;C07D403/04;;C07D405/04;;C07D413/12;;C07D471/04;;C07D513/04;;C12N9/93;;C12Y604/01002;;C07D209/24;;C07D235/08;;C07D235/12;;C07D235/16;;C07D235/30;;C07D405/14;;A61P13/02;;A61P19/06;;A61P3/00;;A61P3/04;;A61P31/12;;A61P31/14;;A61P35/00;;A61P3/06;;A61P3/08;;A61P43/00;;A61P5/50;;A61P7/02;;A61P9/12;;A61P3/10;;A61K9/0014;;A61K9/0019;;A61K9/0095;;A61K9/08;;A61K9/1075;;C07D215/36;;C07D235/18;;C07D263/57;;C07D401/04;;C07D401/12;;C07D403/04;;C07D405/04;;C07D413/12;;C07D471/04;;C07D513/04;;C12N9/93;;C12Y604/01002;;A61K31/404;;A61K31/4184;;A61K31/423;;A61K31/496;;A61K31/5377;;A61K31/542;;A61K45/06;;C07D209/24;;C07D235/08;;C07D235/12;;C07D235/16;;C07D235/30;;C07D405/14,C07D215/36;;A61K31/404;;A61K31/4184;;C07D235/18;;C07D263/57;;C07D401/04;;C07D401/12;;C07D403/04;;C07D405/04;;C07D413/12;;C07D471/04;;C07D513/04,,0,0,,,,INACTIVE
706,EP,B1,EP 2598486 B1,028-889-296-534-939,2017-06-28,2017,EP 11741554 A,2011-07-27,US 36882010 P;;EP 2011062933 W,2010-07-29,BICYCLIC ACETYL-COA CARBOXYLASE INHIBITORS,,NOVARTIS AG,BARNES DAVID WENINGER;;BEBERNITZ GREGORY RAYMOND;;CLAIRMONT KEVIN;;COHEN SCOTT LOUIS;;DAMON ROBERT EDSON II;;DAY ROBERT FRANCIS;;DODD STEPHANIE KAY;;GAUL CHRISTOPH;;GULGEZE EFTHYMIOU HATICE BELGIN;;JAIN MONISH;;KARKI RAJESHRI GANESH;;KIRMAN LOUISE CLARE;;LIN KAI;;MAO JUSTIN YIK CHING;;PATEL TAJESH JAYPRAKASH;;RAYMER BRIAN KENNETH;;SU LIANSHENG,,https://lens.org/028-889-296-534-939,Granted Patent,yes,2,0,15,15,0,A61K9/0014;;A61K9/0019;;A61K9/0095;;A61K9/08;;A61K9/1075;;C07D215/36;;C07D235/18;;C07D263/57;;C07D401/04;;C07D401/12;;C07D403/04;;C07D405/04;;C07D413/12;;C07D471/04;;C07D513/04;;C12N9/93;;C12Y604/01002;;C07D209/24;;C07D235/08;;C07D235/12;;C07D235/16;;C07D235/30;;C07D405/14;;A61P13/02;;A61P19/06;;A61P3/00;;A61P3/04;;A61P31/12;;A61P31/14;;A61P35/00;;A61P3/06;;A61P3/08;;A61P43/00;;A61P5/50;;A61P7/02;;A61P9/12;;A61P3/10;;A61K9/0014;;A61K9/0019;;A61K9/0095;;A61K9/08;;A61K9/1075;;C07D215/36;;C07D235/18;;C07D263/57;;C07D401/04;;C07D401/12;;C07D403/04;;C07D405/04;;C07D413/12;;C07D471/04;;C07D513/04;;C12N9/93;;C12Y604/01002;;A61K31/404;;A61K31/4184;;A61K31/423;;A61K31/496;;A61K31/5377;;A61K31/542;;A61K45/06;;C07D209/24;;C07D235/08;;C07D235/12;;C07D235/16;;C07D235/30;;C07D405/14,C07D215/36;;A61K31/404;;A61K31/4184;;C07D235/18;;C07D263/57;;C07D401/04;;C07D401/12;;C07D403/04;;C07D405/04;;C07D413/12;;C07D471/04;;C07D513/04,,0,0,,,,ACTIVE
707,US,B2,US 8697739 B2,058-510-015-166-949,2014-04-15,2014,US 201113189760 A,2011-07-25,US 201113189760 A;;US 36882010 P,2010-07-29,Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof,"The present invention provides compounds of formula (I); or pharmaceutically acceptable salts thereof, wherein the variables are defined as herein. The present invention provides a method for manufacturing the compounds of formula (I), their therapeutic uses, combinations with other of pharmacologically active agents, and a pharmaceutical compositions.",BARNES DAVID WENINGER;;BEBERNITZ GREGORY RAYMOND;;CLAIRMONT KEVIN;;COHEN SCOTT LOUIS;;DAMON ROBERT EDSON;;DAY ROBERT FRANCIS;;DODD STEPHANIE KAY;;GAUL CHRISTOPH;;GULGEZE EFTHYMIOU HATICE BELGIN;;JAIN MONISH;;KARKI RAJESHRI GANESH;;KIRMAN LOUISE CLARE;;LIN KAI;;MAO JUSTIN YIK CHING;;PATEL TAJESH JAYPRAKASH;;RAYMER BRIAN KENNETH;;SU LIANSHENG;;NOVARTIS AG,BARNES DAVID WENINGER;;BEBERNITZ GREGORY RAYMOND;;CLAIRMONT KEVIN;;COHEN SCOTT LOUIS;;DAMON ROBERT EDSON;;DAY ROBERT FRANCIS;;DODD STEPHANIE KAY;;GAUL CHRISTOPH;;GULGEZE EFTHYMIOU HATICE BELGIN;;JAIN MONISH;;KARKI RAJESHRI GANESH;;KIRMAN LOUISE CLARE;;LIN KAI;;MAO JUSTIN YIK CHING;;PATEL TAJESH JAYPRAKASH;;RAYMER BRIAN KENNETH;;SU LIANSHENG,NOVARTIS AG (2011-06-23),https://lens.org/058-510-015-166-949,Granted Patent,yes,8,3,15,15,0,A61K9/0014;;A61K9/0019;;A61K9/0095;;A61K9/08;;A61K9/1075;;C07D215/36;;C07D235/18;;C07D263/57;;C07D401/04;;C07D401/12;;C07D403/04;;C07D405/04;;C07D413/12;;C07D471/04;;C07D513/04;;C12N9/93;;C12Y604/01002;;C07D209/24;;C07D235/08;;C07D235/12;;C07D235/16;;C07D235/30;;C07D405/14;;A61P13/02;;A61P19/06;;A61P3/00;;A61P3/04;;A61P31/12;;A61P31/14;;A61P35/00;;A61P3/06;;A61P3/08;;A61P43/00;;A61P5/50;;A61P7/02;;A61P9/12;;A61P3/10;;A61K9/0014;;A61K9/0019;;A61K9/0095;;A61K9/08;;A61K9/1075;;C07D215/36;;C07D235/18;;C07D263/57;;C07D401/04;;C07D401/12;;C07D403/04;;C07D405/04;;C07D413/12;;C07D471/04;;C07D513/04;;C12N9/93;;C12Y604/01002;;A61K31/404;;A61K31/4184;;A61K31/423;;A61K31/496;;A61K31/5377;;A61K31/542;;A61K45/06;;C07D209/24;;C07D235/08;;C07D235/12;;C07D235/16;;C07D235/30;;C07D405/14,C07D215/00;;A61K31/47;;A61K31/4985;;C07D235/04,514/409;;514/414;;514/419;;548/407;;548/408;;548/409;;548/465;;548/503,0,0,,,,INACTIVE
708,WO,A1,WO 2012/013716 A1,161-093-253-845-989,2012-02-02,2012,EP 2011062933 W,2011-07-27,US 36882010 P,2010-07-29,BICYCLIC ACETYL-COA CARBOXYLASE INHIBITORS,"The present invention provides compounds of formula (I); or pharmaceutically acceptable salts thereof, wherein the variables are defined as herein. The present invention provides a method for manufacturing the compounds of formula (I), their therapeutic uses, combinations with other of pharmacologically active agents, and a pharmaceutical compositions.",NOVARTIS AG;;BARNES DAVID WENINGER;;BEBERNITZ GREGORY RAYMOND;;CLAIRMONT KEVIN;;COHEN SCOTT LOUIS;;DAMON ROBERT EDSON II;;DAY ROBERT FRANCIS;;DODD STEPHANIE KAY;;GAUL CHRISTOPH;;GULGEZE EFTHYMIOU HATICE BELGIN;;JAIN MONISH;;KARKI RAJESHRI GANESH;;KIRMAN LOUISE CLARE;;LIN KAI;;MAO JUSTIN YIK CHING;;PATEL TAJESH JAYPRAKASH;;RAYMER BRIAN KENNETH;;SU LIANSHENG,BARNES DAVID WENINGER;;BEBERNITZ GREGORY RAYMOND;;CLAIRMONT KEVIN;;COHEN SCOTT LOUIS;;DAMON ROBERT EDSON II;;DAY ROBERT FRANCIS;;DODD STEPHANIE KAY;;GAUL CHRISTOPH;;GULGEZE EFTHYMIOU HATICE BELGIN;;JAIN MONISH;;KARKI RAJESHRI GANESH;;KIRMAN LOUISE CLARE;;LIN KAI;;MAO JUSTIN YIK CHING;;PATEL TAJESH JAYPRAKASH;;RAYMER BRIAN KENNETH;;SU LIANSHENG,,https://lens.org/161-093-253-845-989,Patent Application,yes,43,22,15,15,0,A61K9/0014;;A61K9/0019;;A61K9/0095;;A61K9/08;;A61K9/1075;;C07D215/36;;C07D235/18;;C07D263/57;;C07D401/04;;C07D401/12;;C07D403/04;;C07D405/04;;C07D413/12;;C07D471/04;;C07D513/04;;C12N9/93;;C12Y604/01002;;C07D209/24;;C07D235/08;;C07D235/12;;C07D235/16;;C07D235/30;;C07D405/14;;A61P13/02;;A61P19/06;;A61P3/00;;A61P3/04;;A61P31/12;;A61P31/14;;A61P35/00;;A61P3/06;;A61P3/08;;A61P43/00;;A61P5/50;;A61P7/02;;A61P9/12;;A61P3/10;;A61K9/0014;;A61K9/0019;;A61K9/0095;;A61K9/08;;A61K9/1075;;C07D215/36;;C07D235/18;;C07D263/57;;C07D401/04;;C07D401/12;;C07D403/04;;C07D405/04;;C07D413/12;;C07D471/04;;C07D513/04;;C12N9/93;;C12Y604/01002;;A61K31/404;;A61K31/4184;;A61K31/423;;A61K31/496;;A61K31/5377;;A61K31/542;;A61K45/06;;C07D209/24;;C07D235/08;;C07D235/12;;C07D235/16;;C07D235/30;;C07D405/14,A61K31/404;;C07D215/36;;A61K31/4184;;C07D235/18;;C07D263/57;;C07D401/04;;C07D401/12;;C07D403/04;;C07D405/04;;C07D413/12;;C07D471/04;;C07D513/04,,10,3,102-282-992-482-029;;076-032-163-633-683;;011-257-407-545-225,16462891;;10.1139/o05-149;;10.1016/s0065-7743(00)35019-9;;10.1055/s-2004-815980,"DATABASE CHEMCATS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 4 April 2010 (2010-04-04), XP002664030, retrieved from STN Database accession no. 0065276084;;DATABASE CHEMCATS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 2 June 2004 (2004-06-02), XP002664039, retrieved from STN Database accession no. 0067952799;;SAGAN ET AL., BIOCHEM. CELL BIOL., vol. 84, 2006, pages 67 - 79;;BUNDGARD, H.: ""Design of Prodrugs"", 1985, ELSEVIER, pages: 7 - 9,21-24;;HIGUCHI, T.: ""Pro-drugs as Novel Delivery Systems"", A.C.S. SYMPOSIUM SERIES, vol. 14;;""Bioreversible Carriers in Drug Design"", 1987, PERGAMON PRESS;;J.O. SAUNDERS, S.A. RAYBUCK: ""Inosine Monophosphate Dehydrogenase: Consideration of Structure, Kinetics and Therapeutic Potential"", ANN. REP. MED. CHEM., vol. 35, 2000, pages 201 - 210;;J. F. W. MCOMIE: ""Protective Groups in Organic Chemistry"", 1973, PLENUM PRESS;;""Methods of Organic Synthesis"", vol. 21, 1952, THIEME;;RIKIMARU, K., SYNTHESIS, vol. 6, 2004, pages 909 - 917",PENDING
709,US,B2,US 9789118 B2,194-822-355-955-294,2017-10-17,2017,US 201414188647 A,2014-02-24,US 201414188647 A;;US 201113189760 A;;US 36882010 P,2010-07-29,Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof,"The present invention provides compounds of formula (IV); or pharmaceutically acceptable salts thereof, wherein the variables are defined as herein. The present invention provides a method for manufacturing the compounds of formula (IV), their therapeutic uses, combinations with other of pharmacologically active agents, and a pharmaceutical compositions.",BARNES DAVID WENINGER;;BEBERNITZ GREGORY RAYMOND;;CLAIRMONT KEVIN;;COHEN SCOTT LOUIS;;DAMON II ROBERT EDSON;;DAY ROBERT FRANCIS;;DODD STEPHANIE KAY;;GAUL CHRISTOPH;;GULGEZE EFTHYMIOU HATICE BELGIN;;JAIN MONISH;;KARKI RAJESHRI GANESH;;KIRMAN LOUISE CLARE;;LIN KAI;;MAO JUSTIN YIK CHING;;PATEL TAJESH JAYPRAKASH;;RAYMER BRIAN KENNETH;;LIANSHENG SU;;NOVARTIS AG,BARNES DAVID WENINGER;;BEBERNITZ GREGORY RAYMOND;;CLAIRMONT KEVIN;;COHEN SCOTT LOUIS;;DAMON II ROBERT EDSON;;DAY ROBERT FRANCIS;;DODD STEPHANIE KAY;;GAUL CHRISTOPH;;GULGEZE EFTHYMIOU HATICE BELGIN;;JAIN MONISH;;KARKI RAJESHRI GANESH;;KIRMAN LOUISE CLARE;;LIN KAI;;MAO JUSTIN YIK CHING;;PATEL TAJESH JAYPRAKASH;;RAYMER BRIAN KENNETH;;LIANSHENG SU,,https://lens.org/194-822-355-955-294,Granted Patent,yes,8,0,15,15,0,A61K9/0014;;A61K9/0019;;A61K9/0095;;A61K9/08;;A61K9/1075;;C07D215/36;;C07D235/18;;C07D263/57;;C07D401/04;;C07D401/12;;C07D403/04;;C07D405/04;;C07D413/12;;C07D471/04;;C07D513/04;;C12N9/93;;C12Y604/01002;;C07D209/24;;C07D235/08;;C07D235/12;;C07D235/16;;C07D235/30;;C07D405/14;;A61P13/02;;A61P19/06;;A61P3/00;;A61P3/04;;A61P31/12;;A61P31/14;;A61P35/00;;A61P3/06;;A61P3/08;;A61P43/00;;A61P5/50;;A61P7/02;;A61P9/12;;A61P3/10;;A61K9/0014;;A61K9/0019;;A61K9/0095;;A61K9/08;;A61K9/1075;;C07D215/36;;C07D235/18;;C07D263/57;;C07D401/04;;C07D401/12;;C07D403/04;;C07D405/04;;C07D413/12;;C07D471/04;;C07D513/04;;C12N9/93;;C12Y604/01002;;A61K31/404;;A61K31/4184;;A61K31/423;;A61K31/496;;A61K31/5377;;A61K31/542;;A61K45/06;;C07D209/24;;C07D235/08;;C07D235/12;;C07D235/16;;C07D235/30;;C07D405/14,C07D215/36;;A61K9/00;;A61K9/08;;A61K9/107;;A61K31/404;;A61K31/4184;;A61K31/423;;A61K31/496;;A61K31/5377;;A61K31/542;;A61K45/06;;C07D209/24;;C07D235/08;;C07D235/12;;C07D235/16;;C07D235/18;;C07D235/30;;C07D263/57;;C07D401/04;;C07D401/12;;C07D403/04;;C07D405/04;;C07D405/14;;C07D413/12;;C07D471/04;;C07D513/04;;C12N9/00,,0,0,,,,INACTIVE
710,US,A1,US 2014/0171363 A1,011-715-281-781-227,2014-06-19,2014,US 201414188647 A,2014-02-24,US 201414188647 A;;US 201113189760 A;;US 36882010 P,2010-07-29,BICYCLIC ACETYL-COA CARBOXYLASE INHIBITORS AND USES THEREOF,"The present invention provides compounds of formula (I); or pharmaceutically acceptable salts thereof, wherein the variables are defined as herein. The present invention provides a method for manufacturing the compounds of formula (I), their therapeutic uses, combinations with other of pharmacologically active agents, and a pharmaceutical compositions.",BARNES DAVID WENINGER;;BEBERNITZ GREGORY RAYMOND;;CLAIRMONT KEVIN;;COHEN SCOTT LOUIS;;DAMON II ROBERT EDSON;;DAY ROBERT FRANCIS;;DODD STEPHANIE KAY;;GAUL CHRISTOPH;;GULGEZE EFTHYMIOU HATICE BELGIN;;JAIN MONISH;;KARKI RAJESHRI GANESH;;KIRMAN LOUISE CLARE;;LIN KAI;;MAO JUSTIN YIK CHING;;PATEL TAJESH JAYPRAKASH;;RAYMER BRIAN KENNETH;;LIANSHENG SU;;NOVARTIS AG,BARNES DAVID WENINGER;;BEBERNITZ GREGORY RAYMOND;;CLAIRMONT KEVIN;;COHEN SCOTT LOUIS;;DAMON II ROBERT EDSON;;DAY ROBERT FRANCIS;;DODD STEPHANIE KAY;;GAUL CHRISTOPH;;GULGEZE EFTHYMIOU HATICE BELGIN;;JAIN MONISH;;KARKI RAJESHRI GANESH;;KIRMAN LOUISE CLARE;;LIN KAI;;MAO JUSTIN YIK CHING;;PATEL TAJESH JAYPRAKASH;;RAYMER BRIAN KENNETH;;LIANSHENG SU,,https://lens.org/011-715-281-781-227,Patent Application,yes,0,5,15,15,0,A61K9/0014;;A61K9/0019;;A61K9/0095;;A61K9/08;;A61K9/1075;;C07D215/36;;C07D235/18;;C07D263/57;;C07D401/04;;C07D401/12;;C07D403/04;;C07D405/04;;C07D413/12;;C07D471/04;;C07D513/04;;C12N9/93;;C12Y604/01002;;C07D209/24;;C07D235/08;;C07D235/12;;C07D235/16;;C07D235/30;;C07D405/14;;A61P13/02;;A61P19/06;;A61P3/00;;A61P3/04;;A61P31/12;;A61P31/14;;A61P35/00;;A61P3/06;;A61P3/08;;A61P43/00;;A61P5/50;;A61P7/02;;A61P9/12;;A61P3/10;;A61K9/0014;;A61K9/0019;;A61K9/0095;;A61K9/08;;A61K9/1075;;C07D215/36;;C07D235/18;;C07D263/57;;C07D401/04;;C07D401/12;;C07D403/04;;C07D405/04;;C07D413/12;;C07D471/04;;C07D513/04;;C12N9/93;;C12Y604/01002;;A61K31/404;;A61K31/4184;;A61K31/423;;A61K31/496;;A61K31/5377;;A61K31/542;;A61K45/06;;C07D209/24;;C07D235/08;;C07D235/12;;C07D235/16;;C07D235/30;;C07D405/14,A61K31/542;;A61K31/404;;A61K31/4184;;A61K31/423;;A61K31/496;;A61K31/5377;;A61K45/06;;C07D209/24;;C07D235/08;;C07D235/12;;C07D235/16;;C07D235/30;;C07D263/57;;C07D403/04;;C07D405/04;;C07D405/14;;C07D413/12;;C07D513/04,514/6.5;;548/310.7;;514/394;;548/306.1;;548/304.7;;548/307.4;;514/392;;544/367;;514/254.03;;548/224;;514/375;;548/469;;514/415;;544/144;;514/235.2;;544/48;;514/224.2,0,0,,,,INACTIVE
711,EP,A1,EP 2598486 A1,161-711-075-022-749,2013-06-05,2013,EP 11741554 A,2011-07-27,US 36882010 P;;EP 2011062933 W,2010-07-29,BICYCLIC ACETYL-COA CARBOXYLASE INHIBITORS,,NOVARTIS AG,BARNES DAVID WENINGER;;BEBERNITZ GREGORY RAYMOND;;CLAIRMONT KEVIN;;COHEN SCOTT LOUIS;;DAMON ROBERT EDSON II;;DAY ROBERT FRANCIS;;DODD STEPHANIE KAY;;GAUL CHRISTOPH;;GULGEZE EFTHYMIOU HATICE BELGIN;;JAIN MONISH;;KARKI RAJESHRI GANESH;;KIRMAN LOUISE CLARE;;LIN KAI;;MAO JUSTIN YIK CHING;;PATEL TAJESH JAYPRAKASH;;RAYMER BRIAN KENNETH;;SU LIANSHENG,,https://lens.org/161-711-075-022-749,Patent Application,yes,0,0,15,15,0,A61K9/0014;;A61K9/0019;;A61K9/0095;;A61K9/08;;A61K9/1075;;C07D215/36;;C07D235/18;;C07D263/57;;C07D401/04;;C07D401/12;;C07D403/04;;C07D405/04;;C07D413/12;;C07D471/04;;C07D513/04;;C12N9/93;;C12Y604/01002;;C07D209/24;;C07D235/08;;C07D235/12;;C07D235/16;;C07D235/30;;C07D405/14;;A61P13/02;;A61P19/06;;A61P3/00;;A61P3/04;;A61P31/12;;A61P31/14;;A61P35/00;;A61P3/06;;A61P3/08;;A61P43/00;;A61P5/50;;A61P7/02;;A61P9/12;;A61P3/10;;A61K9/0014;;A61K9/0019;;A61K9/0095;;A61K9/08;;A61K9/1075;;C07D215/36;;C07D235/18;;C07D263/57;;C07D401/04;;C07D401/12;;C07D403/04;;C07D405/04;;C07D413/12;;C07D471/04;;C07D513/04;;C12N9/93;;C12Y604/01002;;A61K31/404;;A61K31/4184;;A61K31/423;;A61K31/496;;A61K31/5377;;A61K31/542;;A61K45/06;;C07D209/24;;C07D235/08;;C07D235/12;;C07D235/16;;C07D235/30;;C07D405/14,C07D215/36;;A61K31/404;;A61K31/4184;;C07D235/18;;C07D263/57;;C07D401/04;;C07D401/12;;C07D403/04;;C07D405/04;;C07D413/12;;C07D471/04;;C07D513/04,,0,0,,,,ACTIVE
712,TW,A,TW 201206907 A,169-011-643-088-791,2012-02-16,2012,TW 100126860 A,2011-07-28,US 36882010 P,2010-07-29,Bicyclic acetyl-COA carboxylase inhibitors and uses thereof,"The present invention provides compounds of formula (I); or pharmaceutically acceptable salts thereof, wherein the variables are defined as herein. The present invention provides a method for manufacturing the compounds of formula (I), their therapeutic uses, combinations with other of pharmacologically active agents, and a pharmaceutical compositions.",NOVARTIS AG,BARNES DAVID WENINGER;;BEBERNITZ GREGORY RAYMOND;;CLAIRMONT KEVIN;;COHEN SCOTT LOUIS;;DAMON ROBERT EDSON;;DAY ROBERT FRANCIS;;DODD STEPHANIE KAY;;GAUL CHRISTOPH;;GULGEZE EFTHYMIOU HATICE BELGIN;;JAIN MONISH;;KARKI RAJESHRI GANESH;;KIRMAN LOUISE CLARE;;LIN KAI;;MAO JUSTIN YIK CHING;;PATEL TAJESH JAYPRAKASH;;RAYMER BRIAN KENNETH;;SU LIAN-SHENG,,https://lens.org/169-011-643-088-791,Patent of Addition,no,0,0,15,15,0,A61K9/0014;;A61K9/0019;;A61K9/0095;;A61K9/08;;A61K9/1075;;C07D215/36;;C07D235/18;;C07D263/57;;C07D401/04;;C07D401/12;;C07D403/04;;C07D405/04;;C07D413/12;;C07D471/04;;C07D513/04;;C12N9/93;;C12Y604/01002;;C07D209/24;;C07D235/08;;C07D235/12;;C07D235/16;;C07D235/30;;C07D405/14;;A61P13/02;;A61P19/06;;A61P3/00;;A61P3/04;;A61P31/12;;A61P31/14;;A61P35/00;;A61P3/06;;A61P3/08;;A61P43/00;;A61P5/50;;A61P7/02;;A61P9/12;;A61P3/10;;A61K9/0014;;A61K9/0019;;A61K9/0095;;A61K9/08;;A61K9/1075;;C07D215/36;;C07D235/18;;C07D263/57;;C07D401/04;;C07D401/12;;C07D403/04;;C07D405/04;;C07D413/12;;C07D471/04;;C07D513/04;;C12N9/93;;C12Y604/01002;;A61K31/404;;A61K31/4184;;A61K31/423;;A61K31/496;;A61K31/5377;;A61K31/542;;A61K45/06;;C07D209/24;;C07D235/08;;C07D235/12;;C07D235/16;;C07D235/30;;C07D405/14,C07D403/04;;A61K31/47;;A61K31/4985;;A61K31/5377;;A61K31/542;;A61P3/10;;A61P31/14;;A61P35/00;;C07D215/227;;C07D413/12;;C07D471/04;;C07D513/04,,0,0,,,,PENDING
713,US,A,US 4850750 A,150-405-554-339-036,1989-07-25,1989,US 9860287 A,1987-09-16,US 9860287 A;;US 75703285 A,1985-07-19,Integrated blending control system,"An integrated control system, specifically transportable on water between offshore wells, includes mixing and blending subsystems, a pumping subsystem, a proppant subsystem and a control subsystem for controlling the other subsystems in a unified manner from a common control location.",HALLIBURTON CO,COGBILL RANDALL B;;DODD TIMOTHY J;;HEILMAN PAUL W;;HERONEMUS DARYL L;;SEARS LESLIE R;;BERRYMAN LESLIE N;;BAKER ROBERT L;;GUFFEE LARRY E;;PRUCHA DAVID A;;ROBERTS DON M;;SHACKELFORD ELBERT L;;STEGEMOELLER CALVIN L;;WALKER LONNIE R,,https://lens.org/150-405-554-339-036,Granted Patent,yes,25,106,1,1,0,E21B21/062;;B01F33/502;;B01F33/80;;E21B43/2607;;E21B21/062;;B01F33/502;;B01F33/80;;E21B43/2607,B01F13/00;;B01F13/10;;E21B43/26,406/82;;406/39;;406/156;;114/72;;414/300,0,0,,,,EXPIRED
714,TW,A,TW 201941775 A,069-944-432-292-29X,2019-11-01,2019,TW 108103184 A,2019-01-28,US 201862623299 P,2018-01-29,GCN2 inhibitors and uses thereof,"The present invention provides compounds, compositions thereof, and methods of using the same.",VERTEX PHARMA;;MERCK PATENT GMBH,BAILEY ANDREW;;CHARRIER JEAN-DAMIEN;;DODD JAMES;;DURRANT STEVEN;;ETXEBARRIA I JARDI GORKA;;EVERITT SIMON;;FRAYSSE DAMIEN;;KEILY SHAZIA;;KNEGTEL RONALD;;MORTIMORE MIKE;;NORTH KIRI;;PULLIN ROBERT;;RUTHERFORD ALISTAIR;;STORCK PIERRE-HENRI;;TWIN HEATHER;;ENO MEREDITH SUZANNE;;MOCHALKIN IGOR;;XIAO YUFANG;;PORICHIS FILIPPOS,,https://lens.org/069-944-432-292-29X,Patent of Addition,no,0,0,25,25,0,C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00;;C07D487/04;;A61P35/00;;A61K31/5377;;A61P29/00;;A61K31/5025;;A61P9/00;;A61P37/00;;A61K31/4545;;A61P3/00;;A61K31/506;;A61P25/28;;C07D487/04;;A61K31/506;;A61K31/5377;;A61P35/00;;A61P19/02;;A61P9/10;;A61P3/10;;A61P25/28;;C07D513/04;;C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00,A61K31/495;;A61K31/505;;A61K31/519;;A61P35/00;;C07D487/00;;C07D487/02;;C07D487/04,,0,0,,,,ACTIVE
715,TW,B,TW I816742 B,098-903-220-709-525,2023-10-01,2023,TW 108103184 A,2019-01-28,US 201862623299 P,2018-01-29,Gcn2 inhibitors and uses thereof,,VERTEX PHARMA;;MERCK PATENT GMBH,BAILEY ANDREW;;CHARRIER JEAN-DAMIEN;;DODD JAMES;;DURRANT STEVEN;;ETXEBARRIA I JARDI GORKA;;EVERITT SIMON;;FRAYSSE DAMIEN;;KEILY SHAZIA;;KNEGTEL RONALD;;MORTIMORE MIKE;;NORTH KIRI;;PULLIN ROBERT;;RUTHERFORD ALISTAIR;;STORCK PIERRE-HENRI;;TWIN HEATHER;;ENO MEREDITH SUZANNE;;MOCHALKIN IGOR;;XIAO YUFANG;;PORICHIS FILIPPOS,,https://lens.org/098-903-220-709-525,Granted Patent,no,2,0,25,25,0,C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00;;C07D487/04;;A61P35/00;;A61K31/5377;;A61P29/00;;A61K31/5025;;A61P9/00;;A61P37/00;;A61K31/4545;;A61P3/00;;A61K31/506;;A61P25/28;;C07D487/04;;A61K31/506;;A61K31/5377;;A61P35/00;;A61P19/02;;A61P9/10;;A61P3/10;;A61P25/28;;C07D513/04;;C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00,,,0,0,,,,ACTIVE
716,US,A1,US 2022/0340577 A1,160-540-868-215-030,2022-10-27,2022,US 202017122543 A,2020-12-15,US 202017122543 A;;US 201916259979 A;;US 201862623299 P,2018-01-29,GCN2 INHIBITORS AND USES THEREOF,"The present invention provides compounds, compositions thereof, and methods of using the same.",MERCK PATENT GMBH;;VERTEX PHARMA,BAYLY ANDREW;;BLEICH MATTHEW;;CHARRIER JEAN-DAMIEN;;DODD JAMES;;DURRANT STEVEN;;ENO MEREDITH SUZANNE;;ETXEBARRIA I JARDI GORKA;;EVERITT SIMON;;FRAYSSE DAMIEN;;KELLY SHAZIA;;KNEGTEL RONALD;;MOCHALKIN IGOR;;MORTIMORE MICHAEL;;NORTH KIRI;;PORICHIS FILIPPOS;;PULLIN ROBERT;;RUTHERFORD ALISTAIR;;STORCK PIERRE-HENRI;;TWIN HEATHER CLARE,VERTEX PHARMACEUTICALS (EUROPE) LIMITED (2019-03-09);;MERCK PATENT GMBH (2019-03-05);;VERTEX PHARMACEUTICALS INCORPORATED (2019-03-18),https://lens.org/160-540-868-215-030,Patent Application,yes,0,0,25,25,0,C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00;;C07D487/04;;A61P35/00;;A61K31/5377;;A61P29/00;;A61K31/5025;;A61P9/00;;A61P37/00;;A61K31/4545;;A61P3/00;;A61K31/506;;A61P25/28;;C07D487/04;;A61K31/506;;A61K31/5377;;A61P35/00;;A61P19/02;;A61P9/10;;A61P3/10;;A61P25/28;;C07D513/04;;C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00,C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00,,0,0,,,,PENDING
717,EP,A2,EP 0906392 A2,139-938-742-092-986,1999-04-07,1999,EP 97924741 A,1997-05-16,US 9708314 W;;US 1788396 P,1996-05-17,DETERGENT COMPOSITION,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;FOLEY PETER ROBERT;;CRIPE THOMAS ANTHONY;;CURRY JOHN;;WILLMAN KENNETH WILLIAM;;DODD IAN MARTIN;;THOEN CHRISTIAAN ARTHUR JACQUE;;MOSS MICHAEL ALAN JOHN;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MURATA SUSUMU;;SARNAIK KHIZAR MOHAMED,,https://lens.org/139-938-742-092-986,Patent Application,yes,0,0,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,1,0,,,See references of WO 9744425A3,DISCONTINUED
718,KR,A,KR 20200116481 A,115-162-418-496-034,2020-10-12,2020,KR 20207025018 A,2019-01-28,US 201862623299 P;;US 2019/0015469 W,2018-01-29,GCN2 억제제 및 이의 용도,"본 발명은, 화합물, 이의 조성물 및 이의 사용 방법을 제공한다.",MERCK PATENT GMBH;;VERTEX PHARMA,BAYLY ANDREW;;BLEICH MATTHEW;;CHARRIER JEAN DAMIEN;;DODD JAMES;;DURRANT STEVEN;;ENO MEREDITH SUZANNE;;ETXEBARRIA I JARDI GORKA;;EVERITT SIMON;;FRAYSSE DAMIEN;;KELLY SHAZIA;;KNEGTEL RONALD;;MOCHALKIN IGOR;;MORTIMORE MICHAEL;;NORTH KIRI;;PORICHIS FILIPPOS;;PULLIN ROBERT;;RUTHERFORD ALISTAIR;;STORCK PIERRE HENRI;;TWIN HEATHER CLARE;;XIAO YUFANG,,https://lens.org/115-162-418-496-034,Patent Application,no,0,0,25,25,0,C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00;;C07D487/04;;A61P35/00;;A61K31/5377;;A61P29/00;;A61K31/5025;;A61P9/00;;A61P37/00;;A61K31/4545;;A61P3/00;;A61K31/506;;A61P25/28;;C07D487/04;;A61K31/506;;A61K31/5377;;A61P35/00;;A61P19/02;;A61P9/10;;A61P3/10;;A61P25/28;;C07D513/04;;C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00,C07D487/04;;A61K31/506;;A61K31/5377;;A61P3/10;;A61P9/10;;A61P19/02;;A61P25/28;;A61P35/00;;C07D513/04,,0,0,,,,DISCONTINUED
719,CA,A1,CA 2254829 A1,100-856-263-603-529,1997-11-20,1997,CA 2254829 A,1997-05-16,US 1788696 P;;US 9708438 W,1996-05-17,DETERGENT COMPOSITION,"A detergent composition comprising an aluminosilicate builder, a non-AQA surfactant and an alkoxylated quaternary ammonium (AQA) cationic surfactant.",PROCTER & GAMBLE,CRIPE THOMAS ANTHONY;;CRON LAURA;;ASANO KAORI;;CURRY JOHN DOWNING;;MINAMIKAWA KAORI;;MURATA SUSUMU;;WILLMAN KENNETH WILLIAM;;SCHEIBEL JEFFREY JOHN;;SARNAIK KHIZAR MOHAMED KHAN;;KATSUDA RINKO;;FOLEY PETER ROBERT;;KVIETOK FRANK ANDREJ;;DODD IAN MARTIN;;THOEN CHRISTIAAN ARTHUR JACQUE;;MOSS MICHAEL ALAN JOHN;;MAO MARK HSIANG-KUEN,,https://lens.org/100-856-263-603-529,Patent Application,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/835;;C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,DISCONTINUED
720,US,B2,US 10988477 B2,011-002-150-547-641,2021-04-27,2021,US 201916259979 A,2019-01-28,US 201916259979 A;;US 201862623299 P,2018-01-29,GCN2 inhibitors and uses thereof,"The present invention provides compounds inhibiting General amino acid Control Non-derepressible 2 kinase (“GCN2”), compositions thereof, and methods of using the same for treating various disorders, such as cancer.",MERCK PATENT GMBH;;VERTEX PHARMA,BAYLY ANDREW;;BLEICH MATTHEW;;CHARRIER JEAN-DAMIEN;;DODD JAMES;;DURRANT STEVEN;;ENO MEREDITH SUZANNE;;ETXEBARRIA I JARDI GORKA;;EVERITT SIMON;;FRAYSSE DAMIEN;;KELLY SHAZIA;;KNEGTEL RONALD;;MOCHALKIN IGOR;;MORTIMORE MICHAEL;;NORTH KIRI;;PORICHIS FILIPPOS;;PULLIN ROBERT;;RUTHERFORD ALISTAIR;;STORCK PIERRE-HENRI;;TWIN HEATHER CLARE;;XIAO YUFANG,VERTEX PHARMACEUTICALS (EUROPE) LIMITED (2019-03-09);;MERCK PATENT GMBH (2019-03-05);;VERTEX PHARMACEUTICALS INCORPORATED (2019-03-18),https://lens.org/011-002-150-547-641,Granted Patent,yes,73,1,25,25,0,C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00;;C07D487/04;;A61P35/00;;A61K31/5377;;A61P29/00;;A61K31/5025;;A61P9/00;;A61P37/00;;A61K31/4545;;A61P3/00;;A61K31/506;;A61P25/28;;C07D487/04;;A61K31/506;;A61K31/5377;;A61P35/00;;A61P19/02;;A61P9/10;;A61P3/10;;A61P25/28;;C07D513/04;;C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00,C07D487/04;;A61K31/5025;;A61P35/00;;C07D513/04;;C07D519/00,,36,30,069-358-879-722-143;;007-364-858-655-289;;066-063-067-951-832;;034-058-148-419-859;;062-454-538-072-176;;027-744-735-557-857;;004-852-224-980-155;;086-952-678-103-889;;081-397-071-138-944;;123-346-363-445-788;;091-564-829-860-147;;012-801-076-805-987;;014-543-743-870-605;;077-563-889-895-69X;;034-069-169-529-989;;062-851-990-951-379;;081-092-403-760-75X;;019-584-045-739-223;;120-631-877-018-330;;051-351-904-676-674;;004-616-072-707-912;;075-738-273-748-447;;021-712-582-065-143;;045-286-856-943-276;;104-567-149-697-802;;012-240-952-788-666;;012-144-043-742-206;;085-977-948-845-474;;026-365-423-140-482;;050-018-894-598-346,26228631;;10.1038/nrd4596;;10.1002/jps.2600660104;;833720;;24732012;;10.1016/j.bbamcr.2014.04.006;;24860567;;pmc4026755;;10.3389/fimmu.2014.00197;;10.1016/s1097-2765(00)00028-9;;10983975;;25406192;;pmc4297565;;10.1158/0008-5472.can-14-1491;;10.1084/jem.20130066;;23752227;;pmc3698523;;15254595;;10.1172/jci21583;;pmc449750;;10.1172/jci200421583;;15894280;;10.1016/j.immuni.2005.03.013;;10.1038/ni.2762;;24240160;;pmc3289319;;10.1073/pnas.1113873109;;22308364;;10.1016/j.leukres.2012.06.014;;22809693;;pmc3422406;;26261340;;pmc4553766;;10.1073/pnas.1504276112;;17023580;;pmc1794048;;10.1182/blood-2006-06-031856;;pmc3108892;;10.4049/jimmunol.1001224;;20889542;;28837681;;pmc5570333;;10.17504/protocols.io.ib8carw;;10.1371/journal.pone.0183390;;10.1002/1521-3773(20020715)41:14<2596::aid-anie2596>3.0.co;2-4;;12203546;;pmc4019906;;10.1186/2051-1426-2-3;;24829760;;10.1021/bc0502311.s001;;10.1021/bc0502311;;16417251;;29326017;;10.1016/j.bmcl.2017.12.044;;10.1038/nm934;;14502282;;15277680;;pmc509193;;10.1073/pnas.0400541101;;23908598;;10.1593/neo.13262;;pmc3730049;;2660141;;10.1073/pnas.86.12.4579;;pmc287314;;21628332;;10.1189/jlb.1110644;;pmc2892366;;10.1038/emboj.2010.81;;20473272;;15833831;;10.1158/0008-5472.can-04-4505;;pmc4859220;;10.1126/scitranslmed.aad7118;;26936508;;15993055;;10.1016/j.bmcl.2005.05.090;;pmc3744883;;19128055;;10.1021/jm801340z,"Lind et al. PLOS One p. 1-20 downloaded at https://doi.org/10.1371/journal.pone.0219774 (Year: 2019).;;International Search Report for PCT/US2019/015469.;;International Search Report for PCT/US2019/015473.;;Adams et al., “Big opportunities for small molecules in immuno-oncology”, Nature Reviews Drug Discovery, vol. 14, No. 9, 2015 (pp. 603-621).;;Berge, S. M. et al., “Pharmaceutical Salts”, J. Pharmaceutical Sciences, vol. 66, No. 1, Jan. 1977, (pp. 1-19).;;Castilho et al., “Keeping the eIF2 alpha kinase Gcn2 in check”, Biochimica et Biophysica Acta 1843, 2014, (pp. 1948-1968).;;Corthay, “Does the immune system naturally protect against cancer?”, Frontiers in Immunology, vol. 5, Article 197, May 2014, (pp. 1-8).;;Dong et al., “Uncharged tRNA Activates GCN2 by Displacing the Protein Kinase Moiety from a Bipartite tRNA-Binding Domain”, Molecular Cell, vol. 6, Aug. 2000, (pp. 269-279).;;Fallarino et al., “The Combined Effects of Tryptophan Starvation and Tryptophan Catabolites Down-Regulate T Cell Receptor ζ-Chain and Induce a Regulatory Phenotype in Naive T Cells”, J Immunol, 2006, 176, (pp. 6752-6761).;;Fletcher et al., “└-Arginine Depletion Blunts Antitumor T-cell Responses by Inducing Myeloid-Derived Suppressor Cells”, Cancer Res, 2015, (pp. 275-283).;;Holmgaard et al., “Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4”, Journal of Exp Med., vol. 210, No. 7, 2013, (pp. 1389-1402).;;Munn et al., “Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes”, J. Clin. Invest. 114(2), Jul. 2004, (pp. 280-290).;;Munn et al., “GCN2 Kinase in T Cells Mediates Proliferative Arrest and Anergy Induction in Response to Indoleamine 2,3-Dioxygenase”, Immunity, vol. 22, May 2005, (pp. 633-642).;;Okazaki, T et al., “A rheostat for immune responses—the unique properties of PD-1 and their advantage for clinical application”, Nat. Immunol 14(12), Dec. 2013, (pp. 1212-1218).;;Pilotte et al., “Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase”, Proc. Natl. Acad. Sci. U.S.A., vol. 109, No. 7, Feb. 2012, (pp. 2497-2502).;;Ramirez et al., “Defining causative factors contributing in the activation of hedgehog signaling in diffuse large B-cell lymphoma”, Leuk. Res., vol. 36(10), Oct. 2012 (pp. 1267-1273).;;Ravishankar et al., “The amino acid sensor GCN2 inhibits inflammatory responses to apoptotic cells promoting tolerance and suppressing systemic autoimmunity”, Proc. Natl. Acad. Sci. U.S.A., vol. 112(34), Aug. 2015, (pp. 10774-10779).;;Rodriguez et al., “└-arginine availability regulates T-lymphocyte cell-cycle progression”, Blood, vol. 109, No. 4, Feb. 2007, (pp. 1568-1573).;;Rodriguez et al., “└-Arginine Deprivation Regulates Cyclin D3 mRNA Stability in Human T Cells by Controlling HuR Expression”, J Immunol, vol. 185, 2010, (pp. 5198-5204).;;Ross et al., “Bispecific T cell engager (BiTE®) antibody constructs can mediate bystander tumor cell killing”, PLoS One vol. 12, No. 8, Aug. 2017, (pp. 1-24).;;Rostovtsev et al., “A Stepwise Huisgen Cycloaddition Process: Copper(I)-Catalyzed Regioselective “Ligation” of Azides and Terminal Alkynes” Angew. Chem. , vol. 41, 2002; (pp. 2708-2711).;;Spranger et al., “Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8+ T cells directly within the tumor microenvironment”, Journal for ImmunoTherapy of Cancer, 2:3, 2014, (pp. 1-14).;;Sun et al., “Carbohydrate and Protein Immobilization onto Solid Surfaces by Sequential Diels-Alder and Azide-Alkyne Cycloadditions”, Bioconjugate Chem., vol. 17, 2006, (pp. 52-57).;;Toogood, “Small molecule immuno-oncology therapeutic agents,” Bioorganic & Medicinal Chemistry Letters, vol. 28, 2018, (pp. 319-329).;;Uyttenhove et al., “Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase”, Nature Medicine, vol. 9, No. 10, Oct. 2003, (pp. 1269-1274).;;Vattern and Wek, “Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells”, Proc. Natl. Acad. Sci USA, vol. 101(31), Aug. 2004, (pp. 11269-11274).;;Wang et al., “Amino Acid Deprivation Promotes Tumor Angiogenesis through the GCN2/ATF4 Pathway”, NeoPlasia, vol. 15, No. 8, Aug. 2013, (pp. 989-997).;;Wek et al., “Juxtaposition of domains homologous to protein kinases and histidyl-tRNA synthetases in GCN2 protein suggest a mechanism for coupling GCN4 expression to amino acid availability”, Proc. Nat. Acad. Sci, U.S.A., vol. 86, Jun. 1989, (pp. 4579-4583).;;Whyte et al., “Suppressor of cytokine signaling (SOCS)1 is a key determinant of differential macrophage activation and function”, Journal of Leukocyte Biology, vol. 90, Nov. 2011, (pp. 845-854).;;Ye et al., “The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation”, the EMBO Journal, vol. 29, 2010, (pp. 2082-2096).;;Zea et al., “Arginase-Producing Myeloid Suppressor Cells in Renal Cell Carcinoma Patients: A Mechanism of Tumor Evasion”, Cancer Res., vol. 65 (8), 2005, (pp. 3044-3048).;;Zhang et al., “The GCN2 eIF2α Kinase is Required for Adaptation to Amino Acid Deprivation in Mice”, Molecular and Cellular Biology, vol. 22, No. 19, Oct. 2002, (pp. 6681-6688).;;Zou et al, “PD-L1 (B7-H1) and PD-01 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations”, Sci. Transl. Med. vol. 8, Issue 328 (pp. 1-16).;;Haning et al., “Comparison of different heterocyclic scaffolds as substrate analog PDE5 inhibitors”, Bioorganic & Medicinal Chemistry Letters 15, vol. 15, 2005, pp. 3900-3907.;;Popowycz, Inc., “Pyrazolo[1,5-a]=1,3,5-triazine as a Purine Bioisostere: Access to Potent Cyclin-Dependent Kinase Inhibitor (R)-Roscovitine Analogue”, J. Med. Chem 2009, vol. 52, pp. 655-663.;;Third Party Observation as submitted in PCT/US2019/015469 dated May 29, 2020.",ACTIVE
721,US,A1,US 2019/0233425 A1,149-038-987-394-762,2019-08-01,2019,US 201916259979 A,2019-01-28,US 201916259979 A;;US 201862623299 P,2018-01-29,GCN2 INHIBITORS AND USES THEREOF,"The present invention provides compounds, compositions thereof, and methods of using the same.",MERCK PATENT GMBH;;VERTEX PHARMA,BAYLY ANDREW;;BLEICH MATTHEW;;CHARRIER JEAN-DAMIEN;;DODD JAMES;;DURRANT STEVEN;;ENO MEREDITH SUZANNE;;ETXEBARRIA I JARDI GORKA;;EVERITT SIMON;;FRAYSSE DAMIEN;;KELLY SHAZIA;;KNEGTEL RONALD;;MOCHALKIN IGOR;;MORTIMORE MICHAEL;;NORTH KIRI;;PORICHIS FILIPPOS;;PULLIN ROBERT;;RUTHERFORD ALISTAIR;;STORCK PIERRE-HENRI;;TWIN HEATHER CLARE;;XIAO YUFANG,VERTEX PHARMACEUTICALS (EUROPE) LIMITED (2019-03-09);;MERCK PATENT GMBH (2019-03-05);;VERTEX PHARMACEUTICALS INCORPORATED (2019-03-18),https://lens.org/149-038-987-394-762,Patent Application,yes,0,8,25,25,0,C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00;;C07D487/04;;A61P35/00;;A61K31/5377;;A61P29/00;;A61K31/5025;;A61P9/00;;A61P37/00;;A61K31/4545;;A61P3/00;;A61K31/506;;A61P25/28;;C07D487/04;;A61K31/506;;A61K31/5377;;A61P35/00;;A61P19/02;;A61P9/10;;A61P3/10;;A61P25/28;;C07D513/04;;C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00,C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00,,0,0,,,,ACTIVE
722,SG,A,SG 11202006701T A,066-546-034-749-829,2020-08-28,2020,SG 11202006701T A,2019-01-28,US 201862623299 P;;US 2019/0015469 W,2018-01-29,GCN2 INHIBITORS AND USES THEREOF,,MERCK PATENT GMBH;;VERTEX PHARMA,BAYLY ANDREW;;BLEICH MATTHEW;;CHARRIER JEAN-DAMIEN;;DODD JAMES;;DURRANT STEVEN;;ENO MEREDITH SUZANNE;;ETXEBARRIA I JARDI GORKA;;EVERITT SIMON;;FRAYSSE DAMIEN;;KELLY SHAZIA;;KNEGTEL RONALD;;MOCHALKIN IGOR;;MORTIMORE MICHAEL;;NORTH KIRI;;PORICHIS FILIPPOS;;PULLIN ROBERT;;RUTHERFORD ALISTAIR;;STORCK PIERRE-HENRI;;TWIN HEATHER CLARE;;XIAO YUFANG,,https://lens.org/066-546-034-749-829,Unknown,no,0,0,25,25,0,C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00;;C07D487/04;;A61P35/00;;A61K31/5377;;A61P29/00;;A61K31/5025;;A61P9/00;;A61P37/00;;A61K31/4545;;A61P3/00;;A61K31/506;;A61P25/28;;C07D487/04;;A61K31/506;;A61K31/5377;;A61P35/00;;A61P19/02;;A61P9/10;;A61P3/10;;A61P25/28;;C07D513/04;;C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00,A61K31/495;;A61K31/505;;A61K31/519;;C07D487/00;;C07D487/02;;C07D487/04,,0,0,,,,PENDING
723,WO,A3,WO 1997/043371 A3,185-920-158-321-228,1997-12-24,1997,US 9708438 W,1997-05-16,US 1788696 P,1996-05-17,DETERGENT COMPOSITION,"A detergent composition comprising an aluminosilicate builder, a non-AQA surfactant and an alkoxylated quaternary ammonium (AQA) cationic surfactant.",PROCTER & GAMBLE;;ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;FOLEY PETER ROBERT;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;WILLMAN KENNETH WILLIAM;;DODD IAN MARTIN;;THOEN CHRISTIAAN ARTHUR JACQUE;;MOSS MICHAEL ALAN JOHN;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG KUEN;;MURATA SUSUMU;;SARNAIK KHIZAR MOHAMED KHAN,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;FOLEY PETER ROBERT;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;WILLMAN KENNETH WILLIAM;;DODD IAN MARTIN;;THOEN CHRISTIAAN ARTHUR JACQUE;;MOSS MICHAEL ALAN JOHN;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MURATA SUSUMU;;SARNAIK KHIZAR MOHAMED KHAN,,https://lens.org/185-920-158-321-228,Search Report,yes,7,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D1/835;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,PENDING
724,WO,A2,WO 1997/043371 A2,025-829-448-494-769,1997-11-20,1997,US 9708438 W,1997-05-16,US 1788696 P,1996-05-17,DETERGENT COMPOSITION,"A detergent composition comprising an aluminosilicate builder, a non-AQA surfactant and an alkoxylated quaternary ammonium (AQA) cationic surfactant.",PROCTER & GAMBLE;;ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;FOLEY PETER ROBERT;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;WILLMAN KENNETH WILLIAM;;DODD IAN MARTIN;;THOEN CHRISTIAAN ARTHUR JACQUE;;MOSS MICHAEL ALAN JOHN;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG KUEN;;MURATA SUSUMU;;SARNAIK KHIZAR MOHAMED KHAN,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;FOLEY PETER ROBERT;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;WILLMAN KENNETH WILLIAM;;DODD IAN MARTIN;;THOEN CHRISTIAAN ARTHUR JACQUE;;MOSS MICHAEL ALAN JOHN;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MURATA SUSUMU;;SARNAIK KHIZAR MOHAMED KHAN,,https://lens.org/025-829-448-494-769,Patent Application,no,0,7,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D1/835;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,PENDING
725,MX,A,MX 2020007799 A,055-782-947-840-841,2020-09-18,2020,MX 2020007799 A,2019-01-28,US 201862623299 P;;US 2019/0015469 W,2018-01-29,GCN2 INHIBITORS AND USES THEREOF.,"The present invention provides compounds, compositions thereof, and methods of using the same.",MERCK PATENT GMBH,TWIN HEATHER CLARE;;DURRANT STEVEN;;FRAYSSE DAMIEN;;XIAO YUFANG;;MORTIMORE MICHAEL;;EVERITT SIMON;;RUTHERFORD ALISTAIR;;KNEGTEL RONALD;;DODD JAMES;;ETXEBARRIA I JARDI GORKA;;MOCHALKIN IGOR;;CHARRIER JEAN-DAMIEN;;STORCK PIERRE-HENRI;;BAYLY ANDREW;;BLEICH MATTHEW;;ENO MEREDITH SUZANNE;;KELLY SHAZIA;;NORTH KIRI;;PORICHIS FILIPPOS;;PULLIN ROBERT,,https://lens.org/055-782-947-840-841,Patent Application,no,0,0,25,25,0,C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00;;C07D487/04;;A61P35/00;;A61K31/5377;;A61P29/00;;A61K31/5025;;A61P9/00;;A61P37/00;;A61K31/4545;;A61P3/00;;A61K31/506;;A61P25/28;;C07D487/04;;A61K31/506;;A61K31/5377;;A61P35/00;;A61P19/02;;A61P9/10;;A61P3/10;;A61P25/28;;C07D513/04;;C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00,A61K31/495;;A61K31/505;;A61K31/519;;C07D487/00;;C07D487/02;;C07D487/04,,0,0,,,,PENDING
726,BR,A,BR 9710672 A,052-016-368-366-741,1999-08-17,1999,BR 9710672 A,1997-05-16,US 1788696 P;;US 9708438 W,1996-05-17,Composi-Æo detergente,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;FOLEY PETER ROBERT;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;WILLMAN KENNETH WILLIAM;;DODD IAN MARTIN;;THOEN CHRISTIAAN ARTHUR JACQUE;;MOSS MICHAEL ALAN JOHN;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MURATA SUSUMU;;SARNAIK KHIZAR MOHAMED KHAN,,https://lens.org/052-016-368-366-741,Patent Application,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/835;;C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,DISCONTINUED
727,BR,A,BR 9710667 A,112-703-291-281-078,1999-08-17,1999,BR 9710667 A,1997-05-16,US 1788396 P;;US 9708314 W,1996-05-17,Composi-Æo detergente,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;FOLEY PETER ROBERT;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;WILLMAN KENNETH WILLIAM;;DODD IAN MARTIN;;THOEN CHRISTIAAN ARTHUR JACQUE;;MOSS MICHAEL ALAN JOHN;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MURATA SUSUMU;;SARNAIK KHIZAR MOHAMED KHAN,,https://lens.org/112-703-291-281-078,Patent Application,no,0,0,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,0,0,,,,DISCONTINUED
728,EP,A4,EP 3746075 A4,022-097-834-115-712,2021-09-08,2021,EP 19743925 A,2019-01-28,US 201862623299 P;;US 2019/0015469 W,2018-01-29,GCN2 INHIBITORS AND USES THEREOF,,MERCK PATENT GMBH;;VERTEX PHARMA,BAYLY ANDREW;;BLEICH MATTHEW;;CHARRIER JEAN-DAMIEN;;DODD JAMES;;DURRANT STEVEN;;ENO MEREDITH SUZANNE;;ETXEBARRIA I JARDI GORKA;;EVERITT SIMON;;FRAYSSE DAMIEN;;KELLY SHAZIA;;KNEGTEL RONALD;;MOCHALKIN IGOR;;MORTIMORE MICHAEL;;NORTH KIRI;;PORICHIS FILIPPOS;;PULLIN ROBERT;;RUTHERFORD ALISTAIR;;STORCK PIERRE-HENRI;;TWIN HEATHER CLARE;;XIAO YUFANG,,https://lens.org/022-097-834-115-712,Search Report,no,9,0,25,25,0,C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00;;C07D487/04;;A61P35/00;;A61K31/5377;;A61P29/00;;A61K31/5025;;A61P9/00;;A61P37/00;;A61K31/4545;;A61P3/00;;A61K31/506;;A61P25/28;;C07D487/04;;A61K31/506;;A61K31/5377;;A61P35/00;;A61P19/02;;A61P9/10;;A61P3/10;;A61P25/28;;C07D513/04;;C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00,A61K31/495;;A61K31/505;;A61K31/519;;A61P35/00;;C07D487/04;;C07D513/04;;C07D519/00,,1,0,,,See also references of WO 2019148132A1,PENDING
729,CA,A1,CA 2255003 A1,068-724-758-006-942,1997-11-27,1997,CA 2255003 A,1997-05-16,US 1788396 P,1996-05-17,DETERGENT COMPOSITION,"A detergent composition comprising an aluminosilicate builder, a non-AQA surfactant and a bis-alkoxylated quaternary ammonium (bis-AQA) cationic surfactant.",PROCTER & GAMBLE,MAO MARK HSIANG-KUEN;;CRON LAURA;;MINAMIKAWA KAORI;;MURATA SUSUMU;;THOEN CHRISTIAAN ARTHUR JACQUE;;DODD IAN MARTIN;;KVIETOK FRANK ANDREJ;;SCHEIBEL JEFFREY JOHN;;CURRY JOHN DOWNING;;WILLMAN KENNETH WILLIAM;;ASANO KAORI;;MOSS MICHAEL ALAN JOHN;;CRIPE THOMAS ANTHONY;;KATSUDA RINKO;;SARNAIK KHIZAR MOHAMED KHAN;;FOLEY PETER ROBERT,,https://lens.org/068-724-758-006-942,Patent Application,no,0,0,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,0,0,,,,DISCONTINUED
730,CZ,A3,CZ 371598 A3,124-901-663-290-550,1999-05-12,1999,CZ 371598 A,1997-05-16,US 1788696 P,1996-05-17,DETERGENT PREPARATION,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;FOLEY PETER ROBERT;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;WILLMAN KENNETH WILLIAM;;DODD IAN MARTIN;;THOEN CHRISTIAAN ARTHUR JACQUE;;MOSS MICHAEL ALAN JOHN;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MURATA SUSUMU;;SARNAIK KHIZAR MOHAMED KHAN,,https://lens.org/124-901-663-290-550,Patent Application,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D1/835;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,PENDING
731,CN,A,CN 111918651 A,158-181-247-825-764,2020-11-10,2020,CN 201980019860 A,2019-01-28,US 201862623299 P;;US 2019/0015469 W,2018-01-29,GCN2 INHIBITORS AND USES THEREOF,"The present invention provides compounds, compositions thereof, and methods of using the same.",MERCK PATENT GMBH;;VERTEX PHARMA,BAYLY ANDREW;;BLEICH MATTHEW;;CHARRIER JEAN-DAMIEN;;DODD JAMES;;DURRANT STEVEN;;ENO MEREDITH SUZANNE;;ETXEBARRIA I JARDI GORKA;;EVERITT SIMON;;FRAYSSE DAMIEN;;KELLY SHAZIA;;KNEGTEL RONALD;;MOCHALKIN IGOR;;MORTIMORE MICHAEL;;NORTH KIRI;;PORICHIS FILIPPOS;;PULLIN ROBERT;;RUTHERFORD ALISTAIR;;STORCK PIERRE-HENRI;;TWIN HEATHER CLARE;;XIAO YUFANG,,https://lens.org/158-181-247-825-764,Patent Application,no,2,1,25,25,0,C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00;;C07D487/04;;A61P35/00;;A61K31/5377;;A61P29/00;;A61K31/5025;;A61P9/00;;A61P37/00;;A61K31/4545;;A61P3/00;;A61K31/506;;A61P25/28;;C07D487/04;;A61K31/506;;A61K31/5377;;A61P35/00;;A61P19/02;;A61P9/10;;A61P3/10;;A61P25/28;;C07D513/04;;C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00,A61K31/495;;A61K31/505;;A61K31/519;;C07D487/00;;C07D487/02;;C07D487/04,,0,0,,,,ACTIVE
732,CA,A1,CA 3089762 A1,060-144-139-246-101,2019-08-01,2019,CA 3089762 A,2019-01-28,US 201862623299 P;;US 2019/0015469 W,2018-01-29,GCN2 INHIBITORS AND USES THEREOF,"The present invention provides compounds, compositions thereof, and methods of using the same.",MERCK PATENT GMBH;;VERTEX PHARMA,BAYLY ANDREW;;BLEICH MATTHEW;;CHARRIER JEAN-DAMIEN;;DODD JAMES;;DURRANT STEVEN;;ENO MEREDITH SUZANNE;;ETXEBARRIA I JARDI GORKA;;EVERITT SIMON;;FRAYSSE DAMIEN;;KELLY SHAZIA;;KNEGTEL RONALD;;MOCHALKIN IGOR;;MORTIMORE MICHAEL;;NORTH KIRI;;PORICHIS FILIPPOS;;PULLIN ROBERT;;RUTHERFORD ALISTAIR;;STORCK PIERRE-HENRI;;TWIN HEATHER CLARE;;XIAO YUFANG,,https://lens.org/060-144-139-246-101,Patent Application,no,0,0,25,25,0,C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00;;C07D487/04;;A61P35/00;;A61K31/5377;;A61P29/00;;A61K31/5025;;A61P9/00;;A61P37/00;;A61K31/4545;;A61P3/00;;A61K31/506;;A61P25/28;;C07D487/04;;A61K31/506;;A61K31/5377;;A61P35/00;;A61P19/02;;A61P9/10;;A61P3/10;;A61P25/28;;C07D513/04;;C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00,C07D487/04,,0,0,,,,PENDING
733,WO,A1,WO 2019/148132 A1,070-814-404-334-966,2019-08-01,2019,US 2019/0015469 W,2019-01-28,US 201862623299 P,2018-01-29,GCN2 INHIBITORS AND USES THEREOF,"The present invention provides compounds, compositions thereof, and methods of using the same.",MERCK PATENT GMBH;;VERTEX PHARMA,BAYLY ANDREW;;BLEICH MATTHEW;;CHARRIER JEAN-DAMIEN;;DODD JAMES;;DURRANT STEVEN;;ENO MEREDITH SUZANNE;;ETXEBARRIA I JARDI GORKA;;EVERITT SIMON;;FRAYSSE DAMIEN;;KELLY SHAZIA;;KNEGTEL RONALD;;MOCHALKIN IGOR;;MORTIMORE MICHAEL;;NORTH KIRI;;PORICHIS FILIPPOS;;PULLIN ROBERT;;RUTHERFORD ALISTAIR;;STORCK PIERRE-HENRI;;TWIN HEATHER CLARE;;XIAO YUFANG,,https://lens.org/070-814-404-334-966,Patent Application,yes,3,7,25,25,0,C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00;;C07D487/04;;A61P35/00;;A61K31/5377;;A61P29/00;;A61K31/5025;;A61P9/00;;A61P37/00;;A61K31/4545;;A61P3/00;;A61K31/506;;A61P25/28;;C07D487/04;;A61K31/506;;A61K31/5377;;A61P35/00;;A61P19/02;;A61P9/10;;A61P3/10;;A61P25/28;;C07D513/04;;C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00,A61K31/495;;A61K31/505;;A61K31/519;;C07D487/00;;C07D487/02;;C07D487/04,,1,0,,,See also references of EP 3746075A4,PENDING
734,EP,A1,EP 3746075 A1,183-209-345-293-480,2020-12-09,2020,EP 19743925 A,2019-01-28,US 201862623299 P;;US 2019/0015469 W,2018-01-29,GCN2 INHIBITORS AND USES THEREOF,,MERCK PATENT GMBH;;VERTEX PHARMA,BAYLY ANDREW;;BLEICH MATTHEW;;CHARRIER JEAN-DAMIEN;;DODD JAMES;;DURRANT STEVEN;;ENO MEREDITH SUZANNE;;ETXEBARRIA I JARDI GORKA;;EVERITT SIMON;;FRAYSSE DAMIEN;;KELLY SHAZIA;;KNEGTEL RONALD;;MOCHALKIN IGOR;;MORTIMORE MICHAEL;;NORTH KIRI;;PORICHIS FILIPPOS;;PULLIN ROBERT;;RUTHERFORD ALISTAIR;;STORCK PIERRE-HENRI;;TWIN HEATHER CLARE;;XIAO YUFANG,,https://lens.org/183-209-345-293-480,Patent Application,yes,0,0,25,25,0,C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00;;C07D487/04;;A61P35/00;;A61K31/5377;;A61P29/00;;A61K31/5025;;A61P9/00;;A61P37/00;;A61K31/4545;;A61P3/00;;A61K31/506;;A61P25/28;;C07D487/04;;A61K31/506;;A61K31/5377;;A61P35/00;;A61P19/02;;A61P9/10;;A61P3/10;;A61P25/28;;C07D513/04;;C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00,A61K31/495;;A61K31/505;;A61K31/519;;C07D487/00;;C07D487/02;;C07D487/04,,0,0,,,,PENDING
735,WO,A2,WO 1997/044425 A2,014-229-678-072-723,1997-11-27,1997,US 9708314 W,1997-05-16,US 1788396 P,1996-05-17,DETERGENT COMPOSITION,"A detergent composition comprising an aluminosilicate builder, a non-AQA surfactant and a bis-alkoxylated quaternary ammonium (bis-AQA) cationic surfactant.",PROCTER & GAMBLE;;ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;FOLEY PETER ROBERT;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;WILLMAN KENNETH WILLIAM;;DODD IAN MARTIN;;THOEN CHRISTIAAN ARTHUR JACQUE;;MOSS MICHAEL ALAN JOHN;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG KUEN;;MURATA SUSUMU;;SARNAIK KHIZAR MOHAMED KHAN,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;FOLEY PETER ROBERT;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;WILLMAN KENNETH WILLIAM;;DODD IAN MARTIN;;THOEN CHRISTIAAN ARTHUR JACQUE;;MOSS MICHAEL ALAN JOHN;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MURATA SUSUMU;;SARNAIK KHIZAR MOHAMED KHAN,,https://lens.org/014-229-678-072-723,Patent Application,no,0,1,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,0,0,,,,PENDING
736,AU,A1,AU 2019/211485 A1,067-030-596-286-01X,2020-08-06,2020,AU 2019/211485 A,2019-01-28,US 201862623299 P;;US 2019/0015469 W,2018-01-29,GCN2 inhibitors and uses thereof,"The present invention provides compounds, compositions thereof, and methods of using the same.",MERCK PATENT GMBH;;VERTEX PHARMA,BAYLY ANDREW;;BLEICH MATTHEW;;CHARRIER JEAN-DAMIEN;;DODD JAMES;;DURRANT STEVEN;;ENO MEREDITH SUZANNE;;ETXEBARRIA I JARDI GORKA;;EVERITT SIMON;;FRAYSSE DAMIEN;;KELLY SHAZIA;;KNEGTEL RONALD;;MOCHALKIN IGOR;;MORTIMORE MICHAEL;;NORTH KIRI;;PORICHIS FILIPPOS;;PULLIN ROBERT;;RUTHERFORD ALISTAIR;;STORCK PIERRE-HENRI;;TWIN HEATHER CLARE;;XIAO YUFANG,,https://lens.org/067-030-596-286-01X,Patent Application,no,0,0,25,25,0,C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00;;C07D487/04;;A61P35/00;;A61K31/5377;;A61P29/00;;A61K31/5025;;A61P9/00;;A61P37/00;;A61K31/4545;;A61P3/00;;A61K31/506;;A61P25/28;;C07D487/04;;A61K31/506;;A61K31/5377;;A61P35/00;;A61P19/02;;A61P9/10;;A61P3/10;;A61P25/28;;C07D513/04;;C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00,A61K31/495;;A61K31/505;;A61K31/519;;C07D487/00;;C07D487/02;;C07D487/04,,0,0,,,,PENDING
737,EP,A2,EP 0912675 A2,122-099-094-608-662,1999-05-06,1999,EP 97924762 A,1997-05-16,US 9708438 W;;US 1788696 P,1996-05-17,DETERGENT COMPOSITION,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;FOLEY PETER ROBERT;;CRIPE THOMAS ANTHONY;;CURRY JOHN;;WILLMAN KENNETH WILLIAM;;DODD IAN MARTIN;;THOEN CHRISTIAAN ARTHUR JACQUE;;MOSS MICHAEL ALAN JOHN;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MURATA SUSUMU;;SARNAIK KHIZAR MOHAMED KHAN,,https://lens.org/122-099-094-608-662,Patent Application,yes,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D1/835;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,DISCONTINUED
738,BR,A2,BR 112020015328 A2,146-576-162-000-035,2020-12-08,2020,BR 112020015328 A,2019-01-28,US 2019/0015469 W;;US 201862623299 P,2018-01-29,inibidores de gcn2 e usos dos mesmos,"a presente invenção refere-se a compostos, composições dos mesmos e métodos de uso dos mesmos.",MERCK PATENT GMBH;;VERTEX PHARMA,ALISTAIR RUTHERFORD;;ANDREW BAYLY;;DAMIEN FRAYSSE;;FILIPPOS PORICHIS;;GORKA ETXEBARRIA I JARDI;;HEATHER CLARE TWIN;;IGOR MOCHALKIN;;JAMES DODD;;JEAN-DAMIEN CHARRIER;;KIRI NORTH;;MATTHEW BLEICH;;MEREDITH SUZANNE ENO;;MICHAEL MORTIMORE;;PIERRE-HENRI STORCK;;ROBERT PULLIN;;RONALD KNEGTEL;;SHAZIA KELLY;;SIMON EVERITT;;STEVEN DURRANT;;YUFANG XIAO,,https://lens.org/146-576-162-000-035,Patent Application,no,0,0,25,25,0,C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00;;C07D487/04;;A61P35/00;;A61K31/5377;;A61P29/00;;A61K31/5025;;A61P9/00;;A61P37/00;;A61K31/4545;;A61P3/00;;A61K31/506;;A61P25/28;;C07D487/04;;A61K31/506;;A61K31/5377;;A61P35/00;;A61P19/02;;A61P9/10;;A61P3/10;;A61P25/28;;C07D513/04;;C07D487/04;;A61P35/00;;C07D513/04;;C07D519/00,A61K31/495;;A61K31/505;;A61K31/519;;C07D487/00;;C07D487/02;;C07D487/04,,0,0,,,,PENDING
739,WO,A1,WO 2023/205468 A1,029-849-939-271-002,2023-10-26,2023,US 2023/0019478 W,2023-04-21,US 202263333881 P,2022-04-22,HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN,"Compounds, and pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels are provided. Also provided are pharmaceutical compositions comprising the compounds or pharmaceutically acceptable salts and methods of using the compounds, pharmaceutically acceptable salts, and pharmaceutical compositions in the treatment of various disorders, including pain.",VERTEX PHARMA,MILLER MARK THOMAS;;HURLEY DENNIS JAMES;;NEUBERT TIMOTHY DONALD;;ARUMUGAM VIJAYALAKSMI;;HADIDA RUAH SARA SABINA;;MCCARTNEY JASON;;ZHOU JINGLAN;;CHAU JACLYN;;DEMORET ROBERT MARTIN;;GHIRMAI SENAIT G;;VALIULIN ROMAN ASKATOVICH;;KINTZER ALEXANDER FREDERIK;;SLOCHOWER DAVID ROBERT;;AERTGEERTS KATHLEEN;;BECK ELIZABETH MARY;;MUI JAMES JUN BON;;WRIGHT MIRANDA ADELE;;KNEGTEL RONALD MARCELLUS ALPHONSUS;;CHUDYK EWA IWONA;;PINDER JOANNE LOUISE;;JACQUES REECE;;DODD JAMES,,https://lens.org/029-849-939-271-002,Patent Application,yes,92,0,1,1,0,A61P9/06;;A61P25/02;;A61P29/00;;C07D401/04;;C07D213/70;;C07D401/14;;C07D213/80;;C07D213/69;;C07D213/85;;C07D213/68;;C07D413/14;;C07D491/048;;C07D405/14;;C07D405/04;;C07D413/04;;C07D495/04,A61K31/4427;;A61P9/06;;A61K31/4439;;A61K31/444;;A61K31/498;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K31/553;;A61P25/02;;A61P29/00;;C07D213/68;;C07D213/69;;C07D213/70;;C07D213/80;;C07D213/85;;C07D401/04;;C07D401/14;;C07D405/04;;C07D405/14;;C07D413/04;;C07D413/14;;C07D491/048;;C07D495/04,,40,30,058-348-862-479-038;;011-670-359-792-190;;019-905-324-201-535;;003-432-292-146-78X;;058-348-862-479-038;;048-739-017-964-226;;002-249-641-643-302;;032-258-978-889-474;;081-001-738-908-270;;116-388-299-398-826;;035-867-257-680-438;;039-124-108-066-758;;140-468-563-020-882;;025-012-153-359-707;;081-308-956-968-657;;039-644-522-243-747;;015-091-099-493-846;;011-853-331-771-066;;006-743-274-787-556;;004-651-227-961-899;;008-410-109-917-270;;002-538-222-031-88X;;026-916-898-963-990;;140-468-563-020-882;;047-633-914-386-647;;055-976-617-949-487;;084-965-079-491-373;;092-790-784-326-144;;029-966-049-767-156;;050-247-819-044-289,10.1016/j.coph.2007.09.007;;17964852;;18439759;;10.1016/j.pain.2008.03.002;;10.1124/mi.7.4.4;;17827438;;19012501;;10.1517/13543780802514559;;10.1016/j.coph.2007.09.007;;17964852;;10.1152/jn.2001.86.2.629;;11495938;;10.2174/187152708784083830;;18537643;;10.1053/eujp.2001.0315;;11888234;;10.1007/s00232-008-9103-y;;18418539;;10.1124/pr.57.4.4;;16382098;;8538791;;10.1038/379257a0;;12451128;;pmc6758735;;10.1523/jneurosci.22-23-10277.2002;;10.1113/jphysiol.2003.046110;;12824446;;pmc2343086;;17483457;;pmc1895982;;10.1073/pnas.0611364104;;10.1016/j.pain.2006.02.011;;16545521;;11790477;;10.1016/s0304-3959(01)00391-8;;10.1016/j.neuroscience.2007.01.054;;17367951;;pmc2525634;;10.1186/1744-8069-4-33;;18700027;;19107992;;10.1002/ana.21527;;10692601;;10.1016/s0304-3959(99)00251-1;;10.1016/s0014-5793(00)01166-2;;10675548;;pmc3220569;;21965668;;10.1074/jbc.m111.261701;;21940606;;10.1152/jn.00100.2011;;10.1113/jphysiol.2003.046110;;12824446;;pmc2343086;;pmc1472458;;16702558;;10.1073/pnas.0602813103;;10.1093/brain/awr345;;22271663;;17950013;;10.1016/j.ejpain.2007.09.001;;22342308;;10.1016/j.neulet.2012.01.069;;10.1016/b978-0-12-386009-5.00003-5;;10.1002/0470053488,"DATABASE Registry [online] Chemical Abstracts Service; 3 February 2011 (2011-02-03), ANONYMOUS: ""2-[2-(phenylmethoxy)phenyl]-4-pyridinol"", XP093057538, retrieved from STN Database accession no. 1262010-66-1;;DATABASE Registry [online] Chemical Abstracts Service; 27 July 2022 (2022-07-27), ANONYMOUS: ""5-fluoro-2-[5-fluoro-2-[(tetrahydro-3-furanyl)methoxy]phenyl]-4-pyridinol"", XP093057539, retrieved from STN Database accession no. 2797741-78-5;;DATABASE Registry [online] Chemical Abstracts Service; 16 August 2022 (2022-08-16), ANONYMOUS: ""5-fluoro-2-[2-[(4-methyl-1-piperazinyl)methyl]phenyl]-4-pyridinol"", XP093057542, retrieved from STN Database accession no. 2805387-34-0;;KRAFTE ET AL: ""Sodium channels and nociception: recent concepts and therapeutic opportunities"", CURRENT OPINION IN PHARMACOLOGY, ELSEVIER SCIENCE PUBLISHERS, NL, vol. 8, no. 1, 26 October 2007 (2007-10-26), pages 50 - 56, XP022450582, ISSN: 1471-4892, DOI: 10.1016/J.COPH.2007.09.007;;DIELEMAN, J.P. ET AL.: ""Incidence rates and treatment of neuropathic pain conditions in the general population"", PAIN, vol. 137, no. 3, 2008, pages 681 - 8, XP022853979, DOI: 10.1016/j.pain.2008.03.002;;RUSH, A.M.T.R. CUMMINS: ""Painful Research: Identification of a Small-Molecule Inhibitor that Selectively Targets Navl.8 Sodium Channels"", MOL. INTERV., vol. 7, no. 4, 2007, pages 192 - 5, XP009165204, DOI: 10.1124/mi.7.4.4;;ENGLAND, S.: ""Voltage-gated sodium channels: the search for subtypeselective analgesics"", EXPERT OPIN. INVESTIG. DRUGS, vol. 17, no. 12, 2008, pages 1849 - 64;;KRAFTE, D. S.BANNON, A. W.: ""Sodium channels and nociception: recent concepts and therapeutic opportunities"", CURR. OPIN. PHARMACOL., vol. 8, no. 1, 2008, pages 50 - 56, XP002540499, DOI: 10.1016/j.coph.2007.09.007;;RENGANATHAN, M., T.R. CUMMINS, S.G. WAXMAN: ""Contribution of Na(v) 1.8 sodium channels to action potential electrogenesis in DRG neurons"", J. NEUROPHYSIOL., vol. 86, no. 2, 2001, pages 629 - 40;;CHAHINC, M.CHATCLICR, A.BABICH, O.KRUPP, J. J.: ""Voltage-gated sodium channels in neurological disorders"", CNSNEUROL. DISORD. DRUG TARGETS, vol. 7, no. 2, 2008, pages 144 - 58;;SODERPALM, B.: ""Anticonvulsants: aspects of their mechanisms of action"", EUR. J. PAIN, 2002, pages 3 - 9;;WANG, G. K.MITCHELL, J.WANG, S. Y.: ""Block of persistent late Na+ currents by antidepressant sertraline and paroxetine"", J. MEMBR. BIOL., vol. 222, no. 2, 2008, pages 79 - 90, XP019622596;;CATTERALL, W. A.GOLDIN, A. L.WAXMAN, S. G.: ""International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels"", PHARMACOL. REV., vol. 57, no. 4, 2005, pages 397, XP055213863, DOI: 10.1124/pr.57.4.4;;AKOPIAN, A.N.L. SIVILOTTIJ.N. WOOD: ""A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons"", NATURE, vol. 379, no. 6562, 1996, pages 257 - 62, XP000605462, DOI: 10.1038/379257a0;;BLAIR, N.T.B.P. BEAN: ""Roles of tetrodotoxin (TTX)-sensitive Na+ current, TTX-resistant Na+ current, and Ca2+ current in the action potentials of nociceptive sensory neurons"", J. NEUROSCI., vol. 22, no. 23, 2002, pages 10277 - 90;;ROZA, C. ET AL.: ""The tetrodotoxin-resistant Na- channel Navl.8 is essential for the expression of spontaneous activity in damaged sensory axons of mice"", J. PHYSIOL., vol. 550, 2003, pages 921 - 6;;JARVIS, M.F. ET AL.: ""A-803467, a potent and selective Na 1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat"", PROC. NATL. ACAD. SCI. USA, vol. 104, no. 20, 2007, pages 8520 - 5, XP055030736, DOI: 10.1073/pnas.0611364104;;JOSHI, S.K. ET AL.: ""Involvement of the TTX-resistant sodium channel Na 1.8 in inflammatory and neuropathic, but not post-operative, pain states"", PAIN, vol. 123, no. 1-2, 2006, pages 75 - 82, XP025024615, DOI: 10.1016/j.pain.2006.02.011;;LAI, J. ET AL.: ""Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel"", NAV1.8. PAIN, vol. 95, no. 1-2, 2002, pages 143 - 52, XP002374879, DOI: 10.1016/S0304-3959(01)00391-8;;DONG, X.W. ET AL.: ""Small interfering RNA-mediated selective knockdown of Na 1.8 tetrodotoxin-resistant sodium channel reverses mechanical allodynia in neuropathic rats"", NEUROSCIENCE, vol. 146, no. 2, 2007, pages 812 - 21, XP022061734, DOI: 10.1016/j.neuroscience.2007.01.054;;HUANG, H.L. ET AL.: ""Proteomic profiling of neuromas reveals alterations in protein composition and local protein synthesis in hyper-excitable nerves"", MOL. PAIN, vol. 4, 2008, pages 33, XP021045080, DOI: 10.1186/1744-8069-4-33;;BLACK, J.A. ET AL.: ""Multiple sodium channel isoforms and mitogen-activated protein kinases are present in painful human neuromas"", ANN. NEUROL., vol. 64, no. 6, 2008, pages 644 - 53, XP009143330, DOI: 10.1002/ana.21527;;COWARD, K. ET AL.: ""Immunolocalization of SNS/PN3 and NaN/SNS2 sodium channels in human pain states"", PAIN, vol. 85, no. 1-2, 2000, pages 41 - 50;;YIANGOU, Y. ET AL.: ""SNS/PN3 and SNS2/NaN sodium channel-like immunoreactivity in human adult and neonate injured sensory nerves"", FEBSLETT., vol. 467, no. 2-3, 2000, pages 249 - 52, XP004260962, DOI: 10.1016/S0014-5793(00)01166-2;;RUANGSRI, S. ET AL.: ""Relationship of axonal voltage-gated sodium channel 1.8 (Na 1.8) mRNA accumulation to sciatic nerve injury-induced painful neuropathy in rats"", J. BIOL. CHEM., vol. 286, no. 46, pages 39836 - 47, XP055624203, DOI: 10.1074/jbc.M111.261701;;CHOI, J.S.S.G. WAXMAN: ""Physiological interactions between Navl.7 and Navl.8 sodium channels: a computer simulation study"", J. NEUROPHYSIOL., vol. 106, no. 6, pages 3173 - 84;;ROZA, C. ET AL.: ""The tetrodotoxin-resistant Na+ channel Na 1.8 is essential for the expression of spontaneous activity in damaged sensory axons of mice"", J. PHYSIOL., vol. 550, 2003, pages 921 - 6;;RUSH, A.M. ET AL.: ""A single sodium channel mutation produces hyper- or hypo excitability in different types of neurons"", PROC. NATL. ACAD. SCI. USA, vol. 103, no. 21, 2006, pages 8245 - 50;;SUN, W. ET AL.: ""Reduced conduction failure of the main axon of polymodal nociceptive C-fibers contributes to painful diabetic neuropathy in rats"", BRAIN, vol. 135, pages 359 - 75;;STRICKLAND, I.T. ET AL.: ""Changes in the expression of Na 1.7, Na 1.8 and Na 1.9 in a distinct population of dorsal root ganglia innervating the rat knee joint in a model of chronic inflammatory joint pain"", EUR. J. PAIN, vol. 12, no. 5, 2008, XP022632366, DOI: 10.1016/j.ejpain.2007.09.001;;QIU, F. ET AL.: ""Increased expression of tetrodotoxin-resistant sodium channels Nav 18 and Navl.9 within dorsal root ganglia in a rat model of bone cancer pain"", NEUROSCI. LETT., vol. 512, no. 2, pages 61 - 6;;""Handbook of Chemistry and Physics"", article ""Periodic Table of the Elements"";;THOMAS SORRELL: ""Organic Chemistry"", 1999, UNIVERSITY SCIENCE BOOKS;;""March's Advanced Organic Chemistry"", 2001, JOHN WILEY & SONS;;V.S. SHIRLEYC.M. LEDERER: ""Isotopes Project"", January 1980, NUCLEAR SCIENCE DIVISION, LAWRENCE BERKELEY LABORATORY;;S. L. HARBESONR. D. TUNG: ""Deuterium In Drug Discovery and Development"", ANN. REP. MED. CHEM., vol. 46, 2011, pages 403 - 417;;S. M. BERGE ET AL.: ""describe pharmaceutically acceptable salts in detail"", J. PHARMACEUTICAL SCIENCES, vol. 66, 1977, pages 1 - 19;;""Remington's Pharmaceutical Sciences"", 1980, MACK PUBLISHING CO.;;""The Merck Manual"", 2011, MERCK SHARP &DOHME CORP.;;T.G.M. WUTS ET AL.: ""Greene 's Protective Groups in Organic Synthesis"", 2006",PENDING
740,WO,A3,WO 1997/044425 A3,032-196-874-059-790,1997-12-24,1997,US 9708314 W,1997-05-16,US 1788396 P,1996-05-17,DETERGENT COMPOSITION,"A detergent composition comprising an aluminosilicate builder, a non-AQA surfactant and a bis-alkoxylated quaternary ammonium (bis-AQA) cationic surfactant.",PROCTER & GAMBLE;;ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;FOLEY PETER ROBERT;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;WILLMAN KENNETH WILLIAM;;DODD IAN MARTIN;;THOEN CHRISTIAAN ARTHUR JACQUE;;MOSS MICHAEL ALAN JOHN;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG KUEN;;MURATA SUSUMU;;SARNAIK KHIZAR MOHAMED KHAN,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;FOLEY PETER ROBERT;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;WILLMAN KENNETH WILLIAM;;DODD IAN MARTIN;;THOEN CHRISTIAAN ARTHUR JACQUE;;MOSS MICHAEL ALAN JOHN;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MURATA SUSUMU;;SARNAIK KHIZAR MOHAMED KHAN,,https://lens.org/032-196-874-059-790,Search Report,yes,8,0,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,0,0,,,,PENDING
741,US,A1,US 2023/0373925 A1,043-574-819-517-255,2023-11-23,2023,US 202318137939 A,2023-04-21,US 202318137939 A;;US 202263333875 P,2022-04-22,HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN,"Compounds, and pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels are provided. Also provided are pharmaceutical compositions comprising the compounds or pharmaceutically acceptable salts and methods of using the compounds, pharmaceutically acceptable salts, and pharmaceutical compositions in the treatment of various disorders, including pain.",VERTEX PHARMA,MILLER MARK THOMAS;;HURLEY DENNIS JAMES;;NEUBERT TIMOTHY DONALD;;ARUMUGAM VIJAYALAKSMI;;HADIDA RUAH SARA SABINA;;MCCARTNEY JASON;;ZHOU JINGLAN;;CHAU JACLYN;;DEMORET ROBERT MARTIN;;GHIRMAI SENAIT G;;VALIULIN ROMAN ASKATOVICH;;KINTZER ALEXANDER FREDERIK;;SLOCHOWER DAVID ROBERT;;AERTGEERTS KATHLEEN;;BECK ELIZABETH MARY;;MUI JAMES JUN BON;;WRIGHT MIRANDA ADELE;;KNEGTEL RONALD MARCELLUS ALPHONSUS;;CHUDYK EWA IWONA;;PINDER JOANNE LOUISE;;DODD JAMES,VERTEX PHARMACEUTICALS (SAN DIEGO) LLC (2023-04-18);;VERTEX PHARMACEUTICALS (EUROPE) LIMITED (2023-07-04);;VERTEX PHARMACEUTICALS INCORPORATED (2023-04-13),https://lens.org/043-574-819-517-255,Patent Application,yes,0,0,2,2,0,A61P9/06;;A61P25/02;;A61P29/00;;C07D471/04;;C07D215/233;;C07D239/91;;C07D401/04;;C07D401/14;;C07D519/00;;C07D405/14;;C07B2200/05;;C07D215/233;;C07D239/91;;C07D401/04;;C07D401/14;;C07D471/04;;C07D519/00,C07D215/233;;C07D239/91;;C07D401/04;;C07D401/14;;C07D471/04;;C07D519/00,,0,0,,,,PENDING
742,US,S,US D0906107 S,034-510-080-055-793,2020-12-29,2020,US 201729616998 F,2017-09-11,US 201729616998 F,2017-09-11,Child resistant aerosol actuator,,WD 40 COMPANY,BARRY STEPHANIE LYN;;CUMMARAGUNTA JAYASHREE;;STARZMAN MICHAEL J;;FREUDENBERG JOHN W;;COLE JEFFREY T;;UTLEY MICHAEL JOHN;;BALA ERIN;;OLIVERIO WENDE L;;BATES KEVIN VICTOR;;HOWELL CHRISTOPHER MICHAEL;;KRUPP BENJAMIN THOMAS;;PARROTT DAVID A;;LEEDY BRANDON CHRISTOPHER;;LEWIS RYAN ANDREW;;FALCON SARA DAWSON;;RAMSUER BRANDON LEE;;GOOD ROBERT J;;DODD JOSEPH K,WD-40 COMPANY (2017-08-04),https://lens.org/034-510-080-055-793,Design Right,no,11,0,4,4,0,,,0907;;D 9448,0,0,,,,ACTIVE
743,WO,A1,WO 1997/044433 A1,095-536-467-724-339,1997-11-27,1997,US 9708373 W,1997-05-16,US 1788396 P,1996-05-17,DETERGENT COMPOSITION,"Detergent composition comprising peroxygen bleach, a bleach catalyst, a non-AQA surfactant and a bis-alkoxylated quaternary ammonium (bis-AQA) cationic surfactant.",PROCTER & GAMBLE;;ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;FOLEY PETER ROBERT;;DODD IAN MARTIN;;MAO MARK HSIANG KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;SARNAIK KHIZAR MOHAMED KHAN;;HARTSHORN RICHARD TIMOTHY;;THOEN CHRISTIAAN ARTHUR JACQUE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;FOLEY PETER ROBERT;;DODD IAN MARTIN;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;SARNAIK KHIZAR MOHAMED KHAN;;HARTSHORN RICHARD TIMOTHY;;THOEN CHRISTIAAN ARTHUR JACQUE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU,,https://lens.org/095-536-467-724-339,Patent Application,yes,2,1,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,1,0,,,"DATABASE WPI Section Ch Week 8239, Derwent World Patents Index; Class A97, AN 82-82921E, XP002044559",PENDING
744,BR,A,BR 9709587 A,078-308-579-733-271,2000-04-25,2000,BR 9709587 A,1997-05-16,US 1788396 P;;US 9708373 W,1996-05-17,Composição detergente,"Patente de Invenção: <B>""COMPOSIçãO DETERGENTE""<D>. Composição detergente compreendendo agente de branqueamento de peroxigênio, um catalisador de branqueamento, um tenso-ativo não-AQA e um tenso-ativo de amónio quaternário (bis-AQA) catiónico bisalcoxilado.",PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;FOLEY PETER ROBERT;;DODD IAN MARTIN;;MAO MARK HSINAG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;SARNAIK KHIZAR MOHAMED KHAN;;HARTSHORN RICHARD TIMOTHY;;THOEN CHRISTIAAN ARTHUR JACQUE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU,,https://lens.org/078-308-579-733-271,Patent Application,no,0,0,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,0,0,,,,DISCONTINUED
745,CA,A1,CA 2254818 A1,043-981-859-393-531,1997-11-27,1997,CA 2254818 A,1997-05-16,US 1788396 P;;US 9708373 W,1996-05-17,DETERGENT COMPOSITION,"Detergent composition comprising peroxygen bleach, a bleach catalyst, a nonAQA surfactant and a bis-alkoxylated quaternary ammonium (bis-AQA) cationic surfactant.",PROCTER & GAMBLE,DODD IAN MARTIN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;CRON LAURA;;MINAMIKAWA KAORI;;SARNAIK KHIZAR MOHAMED KHAN;;KVIETOK FRANK ANDREJ;;PANANDIKER RAJAN KESHAV;;SCHEIBEL JEFFREY JOHN;;MAO MARK HSIANG-KUEN;;CURRY JOHN DOWNING;;MOSS MICHAEL ALAN JOHN;;CRIPE THOMAS ANTHONY;;HARTSHORN RICHARD TIMOTHY;;THOEN CHRISTIAAN ARTHUR JACQUE;;KATSUDA RINKO;;PRAMOD KAKUMANU;;ASANO KAORI;;WILLMAN KENNETH WILLIAM,,https://lens.org/043-981-859-393-531,Patent Application,no,0,0,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,0,0,,,,DISCONTINUED
746,EP,A1,EP 0907705 A1,186-409-497-670-957,1999-04-14,1999,EP 97926568 A,1997-05-16,US 9708373 W;;US 1788396 P,1996-05-17,DETERGENT COMPOSITION,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;FOLEY PETER ROBERT;;DODD IAN MARTIN;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;SARNAIK KHIZAR MOHAMED KHAN;;HARTSHORN RICHARD TIMOTHY;;THOEN CHRISTIAAN ARTHUR JACQUE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU,,https://lens.org/186-409-497-670-957,Patent Application,yes,0,0,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,1,0,,,See references of WO 9744433A1,DISCONTINUED
747,EP,A2,EP 0912693 A2,106-384-828-469-757,1999-05-06,1999,EP 97926588 A,1997-05-16,US 9708442 W;;US 1788696 P,1996-05-17,DETERGENT COMPOSITION,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;THOEN CHRISTIAAN ARTHUR JACQUE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;MANOHAR SANJEEV,,https://lens.org/106-384-828-469-757,Patent Application,yes,0,1,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/02;;C11D1/14;;C11D1/835;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,DISCONTINUED
748,EP,A2,EP 0912667 A2,197-732-876-279-949,1999-05-06,1999,EP 97924763 A,1997-05-16,US 9708440 W;;US 1788696 P,1996-05-17,DETERGENT COMPOSITION,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN;;MANOHAR SANJEEV;;DODD IAN MARTIN;;KOTT KEVIN LEE;;BABA HAJIME;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,,https://lens.org/197-732-876-279-949,Patent Application,yes,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/835;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,DISCONTINUED
749,BR,A,BR 9710677 A,109-239-655-669-950,1999-08-17,1999,BR 9710677 A,1997-05-16,US 1788696 P;;US 9708442 W,1996-05-17,Composi-Æo detergente,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;THOEN CHRISTIAAN ARTHUR JACQUE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;MANOHAR SANJEEV KRISHNADAS,,https://lens.org/109-239-655-669-950,Patent Application,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/835;;C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,DISCONTINUED
750,HU,A2,HU P9902976 A2,137-333-510-558-471,2000-01-28,2000,HU P9902976 A,1997-05-16,US 1788696 P,1996-05-17,Detergent composition,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;THOEN CHRISTIAN ARTHUR JACQUES;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;MANOHAR SANJEEV KRISHNADAS,,https://lens.org/137-333-510-558-471,Patent Application,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/835;;C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,PENDING
751,MX,A,MX 980962 A,195-837-366-273-609,1999-02-01,1999,MX 9809629 A,1998-11-17,US 1788696 P,1996-05-17,Detergent composition,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;THOEN CHRISTIAN ARTHUR JACQUES;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;MANOHAR SANJEEV KRISHNADAS,,https://lens.org/195-837-366-273-609,Patent Application,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/835;;C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,PENDING
752,CA,A1,CA 2254825 A1,029-183-158-004-480,1997-11-20,1997,CA 2254825 A,1997-05-16,US 1788696 P;;US 9708442 W,1996-05-17,DETERGENT COMPOSITION,"Detergent composition comprising peroxygen bleach, a bleach catalyst, a nonAQA surfactant and an alkoxylated quaternary ammonium (AQA) cationic surfactant.",PROCTER & GAMBLE,THOEN CHRISTIAAN ARTHUR JACQUE;;CRON LAURA;;KVIETOK FRANK ANDREJ;;KATSUDA RINKO;;MINAMIKAWA KAORI;;FOLEY PETER ROBERT;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;MANOHAR SANJEEV KRISHNADAS;;MAO MARK HSIANG-KUEN;;ASANO KAORI;;HARTSHORN RICHARD TIMOTHY;;PANANDIKER RAJAN KESHAV;;CRIPE THOMAS ANTHONY;;SCHEIBEL JEFFREY JOHN;;SARNAIK KHIZAR MOHAMMED KHAN;;CURRY JOHN DOWNING;;PRAMOD KAKUMANU;;WILLMAN KENNETH WILLIAM;;DODD IAN MARTIN,,https://lens.org/029-183-158-004-480,Patent Application,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/835;;C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,DISCONTINUED
753,EP,A2,EP 0912668 A2,076-258-977-285-982,1999-05-06,1999,EP 97924765 A,1997-05-16,US 9708443 W;;US 1788696 P,1996-05-17,DETERGENT COMPOSITION,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN;;MANOHAR SANJEEV;;DODD IAN MARTIN;;KOTT KEVIN LEE;;BABA HAJIME;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,,https://lens.org/076-258-977-285-982,Patent Application,yes,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/835;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,DISCONTINUED
754,HU,A2,HU P0500458 A2,186-038-102-351-258,2005-08-29,2005,HU P0500458 A,1997-05-16,US 1788696 P;;US 9708442 W,1996-05-17,DETERGENT COMPOSITION AND A PROCESS FOR ITS USE,"A találmány szerinti készítmények egy peroxigén fehérítő, egy fehérítőkatalizátor, egy nem-AQA felületaktív anyag és egy alábbi általánosképletű alkoxilezett kvaterner ammónium (AQA) kationos felületaktívanyag kombinációját tartalmazzák. A képletben R1 8-18 szénatomosalkil-, alkenil-, aril-, alkilaril-, éter- vagy glicitil-éter-csoport;R2 1-3 szénatomos alkilcsoport; R3 és R4 egymástól függetlenülhidrogénatom, metil- vagy etilcsoport; A 1-4 szénatomos alkoxicsoport;X anion és p értéke 2-30 egész szám. A találmány tárgya továbbá a 2illatanyagok vagy illatkomponensek textíliákon való lerakódásánakfokozására szolgáló eljárás.",PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;THOEN CHRISTIAN ARTHUR JACQUES;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;MANOHAR SANJEEV KRISHNADAS,,https://lens.org/186-038-102-351-258,Patent Application,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/02;;C11D1/835;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,DISCONTINUED
755,WO,A3,WO 1997/043391 A3,079-959-232-654-668,1997-12-24,1997,US 9708442 W,1997-05-16,US 1788696 P,1996-05-17,DETERGENT COMPOSITION,"Detergent composition comprising peroxygen bleach, a bleach catalyst, a non-AQA surfactant and an alkoxylated quaternary ammonium (AQA) cationic surfactant.",PROCTER & GAMBLE;;ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;THOEN CHRISTIAAN ARTHUR JACQUE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;MANOHAR SANJEEV KRISHNADAS,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;THOEN CHRISTIAAN ARTHUR JACQUE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;MANOHAR SANJEEV KRISHNADAS,,https://lens.org/079-959-232-654-668,Search Report,yes,2,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/02;;C11D1/14;;C11D1/835;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,1,0,,,"DATABASE WPI Section Ch Week 8239, Derwent World Patents Index; Class A97, AN 82-82921E, XP002044559",PENDING
756,EP,A2,EP 0912697 A2,155-798-996-923-880,1999-05-06,1999,EP 97924764 A,1997-05-16,US 9708441 W;;US 1788696 P,1996-05-17,DETERGENT COMPOSITION,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;MANOHAR SANJEEV;;CRIPE THOMAS ANTHONY;;CURRY JOHN;;KOTT KEVIN LEE;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;FOLEY PETER ROBERT;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;WILLMAN KENNETH WILLIAM;;PANANDIKER RAJAN;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,,https://lens.org/155-798-996-923-880,Patent Application,yes,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/835;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,DISCONTINUED
757,TW,S,TW D195537 S,040-110-852-907-138,2019-01-21,2019,TW 107301351 F,2018-03-09,US 201729616998 F,2017-09-11,CHILD RESISTANT AEROSOL ACTUATOR,【物品用途】;本設計係關於一種兒童安全噴霧致動器。;【設計說明】;圖式所揭露之虛線部分，為本案不主張設計之部分。,美商 WD 40 公司;;WD 40 COMPANY,BARRY STEPHANIE LYN;;CUMMARAGUNTA JAYASHREE;;J STARZMAN MICHAEL J;;W FREUDENBERG JOHN W;;T COLE JEFFREY T;;UTLEY MICHAEL JOHN;;BALA ERIN;;L OLIVERIO WENDE L;;BATES KEVIN VICTOR;;HOWELL CHRISTOPHER MICHAEL;;KRUPP BENJAMIN THOMAS;;A PARROTT DAVID A;;LEEDY BRANDON CHRISTOPHER;;LEWIS RYAN ANDREW;;FALCON SARA DAWSON;;RAMSUER BRANDON LEE;;J GOOD ROBERT J;;K DODD JOSEPH K,,https://lens.org/040-110-852-907-138,Design Right,no,0,0,4,4,0,,,09-07,0,0,,,,ACTIVE
758,EP,A1,EP 0906405 A1,089-356-548-165-73X,1999-04-07,1999,EP 97927653 A,1997-05-16,US 9708372 W;;US 1788396 P,1996-05-17,DETERGENT COMPOSITION,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;KOTT KEVIN LEE;;CRIPE THOMAS ANTHONY;;CURRY JOHN;;MANOHAR SANJEEV KRISHNADAS;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;FOLEY PETER ROBERT;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;WILLMAN KENNETH WILLIAM;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;THOEN CHRISTIAN ARTHUR JACQUES,,https://lens.org/089-356-548-165-73X,Patent Application,yes,0,0,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,1,0,,,See references of WO 9744432A1,DISCONTINUED
759,EP,A2,EP 0912669 A2,132-057-968-723-336,1999-05-06,1999,EP 97925602 A,1997-05-16,US 9708317 W;;US 1788396 P,1996-05-17,DETERGENT COMPOSITION,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN;;MANOHAR SANJEEV;;DODD IAN MARTIN;;KOTT KEVIN LEE;;BABA HAJIME;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN;;PRAMOD KAKUMANU;;SURNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,,https://lens.org/132-057-968-723-336,Patent Application,yes,0,0,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,1,0,,,See references of WO 9744419A3,DISCONTINUED
760,WO,A2,WO 1997/043391 A2,144-147-891-588-643,1997-11-20,1997,US 9708442 W,1997-05-16,US 1788696 P,1996-05-17,DETERGENT COMPOSITION,"Detergent composition comprising peroxygen bleach, a bleach catalyst, a non-AQA surfactant and an alkoxylated quaternary ammonium (AQA) cationic surfactant.",PROCTER & GAMBLE;;ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;THOEN CHRISTIAAN ARTHUR JACQUE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;MANOHAR SANJEEV KRISHNADAS,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;THOEN CHRISTIAAN ARTHUR JACQUE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;MANOHAR SANJEEV KRISHNADAS,,https://lens.org/144-147-891-588-643,Patent Application,no,0,6,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/02;;C11D1/14;;C11D1/835;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,PENDING
761,CA,A1,CA 2255009 A1,018-002-368-025-63X,1997-11-20,1997,CA 2255009 A,1997-05-16,US 1788696 P,1996-05-17,DETERGENT COMPOSITION,A detergent composition comprising a soil release agent a non-AQA surfactant and an alkoxylated quaternary ammonium (AQA) cationic surfactant.,PROCTER & GAMBLE,CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;SCHEIBEL JEFFREY JOHN;;ASANO KAORI;;MANOHAR SANJEEV KRISHNADAS;;THOEN CHRISTIAAN ARTHUR JACQUE;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;BABA HAJIME;;KATSUDA RINKO;;MURATA SUSUMU;;PANANDIKER RAJAN KESHAV;;FOLEY PETER ROBERT;;DODD IAN MARTIN;;KOTT KEVIN LEE;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN,,https://lens.org/018-002-368-025-63X,Patent Application,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/835;;C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,DISCONTINUED
762,CA,A1,CA 2254820 A1,035-624-326-061-723,1997-11-27,1997,CA 2254820 A,1997-05-16,US 1788396 P;;US 9708316 W,1996-05-17,DETERGENT COMPOSITION,"A detergent composition comprising a soil dispersant polymer, a non-bis AQA surfactant and a bis-alkoxylated quaternary ammonium (bis-AQA) cationic surfactant.",PROCTER & GAMBLE,MANOHAR SANJEEV KRISHNADAS;;CRON LAURA;;DODD IAN MARTIN;;KOTT KEVIN LEE;;THOEN CHRISTIAAN ARTHUR JACQUE;;CURRY JOHN DOWNING;;MINAMIKAWA KAORI;;MOSS MICHAEL ALAN JOHN;;PRAMOD KAKUMANU;;KATSUDA RINKO;;SARNAIK KHIZAR MOHAMED KHAN;;PANANDIKER RAJAN KESHAV;;ASANO KAORI;;KVIETOK FRANK ANDREJ;;FOLEY PETER ROBERT;;SCHEIBEL JEFFREY JOHN;;WILLMAN KENNETH WILLIAM;;MURATA SUSUMU;;BABA HAJIME;;CRIPE THOMAS ANTHONY;;MAO MARK HSIANG-KUEN,,https://lens.org/035-624-326-061-723,Patent Application,no,0,0,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,0,0,,,,DISCONTINUED
763,EP,A1,EP 0901518 A1,098-355-479-270-967,1999-03-17,1999,EP 97926587 A,1997-05-16,US 9708439 W;;US 1788696 P,1996-05-17,DETERGENT COMPOSITION,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;KOTT KEVIN LEE;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;WILLMAN KENNETH WILLIAM;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;MANOHAR SANJEEV KRISHNADAS;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,,https://lens.org/098-355-479-270-967,Patent Application,yes,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/835;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,DISCONTINUED
764,EP,A1,EP 0906403 A1,184-817-073-181-615,1999-04-07,1999,EP 97924742 A,1997-05-16,US 9708315 W;;US 1788396 P,1996-05-17,DETERGENT COMPOSITION,,PROCTER & GAMBLE,ASANO KAORI OHGI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;BETTIOL JEAN-LUC;;CRIPE THOMAS ANTHONY;;CURRY JOHN;;KOTT KEVIN LEE;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;THOEN CHRISTIAAN ARTHUR JACQUE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED;;WILLMAN KENNETH WILLIAM;;MANOHAR SANJEEV KRISHNADAS,,https://lens.org/184-817-073-181-615,Patent Application,yes,0,0,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,1,0,,,See references of WO 9744431A1,DISCONTINUED
765,CA,A1,CA 2255012 A1,036-172-591-320-847,1997-11-20,1997,CA 2255012 A,1997-05-16,US 1788696 P,1996-05-17,DETERGENT COMPOSITION,"A detergent composition comprising an alkoxylated quaternary ammonium (AQA) cationic surfactant, a non-AQA surfactant and a percarbonate bleach.",PROCTER & GAMBLE,SARNAIK KHIZAR MOHAMED KHAN;;MANOHAR SANJEEV KRISHNADAS;;KOTT KEVIN LEE;;MINAMIKAWA KAORI;;DODD IAN MARTIN;;MAO MARK HSIANG-KUEN;;MURATA SUSUMU;;CRIPE THOMAS ANTHONY;;MOSS MICHAEL ALAN JOHN;;THOEN CHRISTIAAN ARTHUR JACQUE;;KATSUDA RINKO;;FOLEY PETER ROBERT;;PRAMOD KAKUMANU;;PANANDIKER RAJAN KESHAV;;ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;CRON LAURA;;KVIETOK FRANK ANDREJ;;HARTSHORN RICHARD TIMOTHY;;CURRY JOHN DOWNING;;WILLMAN KENNETH WILLIAM,,https://lens.org/036-172-591-320-847,Patent Application,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/835;;C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,DISCONTINUED
766,BR,A,BR 9710670 A,052-678-129-596-34X,1999-08-17,1999,BR 9710670 A,1997-05-16,US 1788696 P;;US 9708441 W,1996-05-17,Composi-Æo detergente,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;MANOHAR SANJEEV KRISHNADAS;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;KOTT KEVIN LEE;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;FOLEY PETER ROBERT;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;WILLMAN KENNETH WILLIAM;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAAN ARTHUR JACQUE,,https://lens.org/052-678-129-596-34X,Patent Application,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/835;;C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,PENDING
767,WO,A2,WO 1997/043393 A2,136-983-531-956-071,1997-11-20,1997,US 9708441 W,1997-05-16,US 1788696 P,1996-05-17,DETERGENT COMPOSITION,"A detergent composition comprising an alkoxylated quaternary ammonium (AQA) cationic surfactant, a non-AQA surfactant and a photobleach.",PROCTER & GAMBLE;;ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;MANOHAR SANJEEV KRISHNADAS;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;KOTT KEVIN LEE;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;FOLEY PETER ROBERT;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;WILLMAN KENNETH WILLIAM;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;MANOHAR SANJEEV KRISHNADAS;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;KOTT KEVIN LEE;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;FOLEY PETER ROBERT;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;WILLMAN KENNETH WILLIAM;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,,https://lens.org/136-983-531-956-071,Patent Application,no,0,30,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/835;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,PENDING
768,CA,A1,CA 2255005 A1,159-708-269-033-463,1997-11-20,1997,CA 2255005 A,1997-05-16,US 1788396 P,1996-05-17,DETERGENT COMPOSITION,"A detergent composition comprising a bis-alkoxylated quaternary ammonium (bisAQA) cationic surfactant, a non-AQA surfactant and a photobleach.",PROCTER & GAMBLE,MAO MARK HSIANG-KUEN;;CRON LAURA;;KVIETOK FRANK ANDREJ;;MINAMIKAWA KAORI;;KATSUDA RINKO;;ASANO KAORI;;MOSS MICHAEL ALAN JOHN;;MANOHAR SANJEEV KRISHNADAS;;SCHEIBEL JEFFREY JOHN;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;WILLMAN KENNETH WILLIAM;;KOTT KEVIN LEE;;DODD IAN MARTIN;;CURRY JOHN DOWNING;;MURATA SUSUMU;;CRIPE THOMAS ANTHONY;;PANANDIKER RAJAN KESHAV;;THOEN CHRISTIAAN ARTHUR JACQUE;;HARTSHORN RICHARD TIMOTHY;;FOLEY PETER ROBERT,,https://lens.org/159-708-269-033-463,Patent Application,no,0,0,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,0,0,,,,DISCONTINUED
769,WO,A3,WO 1997/044419 A3,163-541-557-782-04X,1997-12-31,1997,US 9708317 W,1997-05-16,US 1788396 P,1996-05-17,DETERGENT COMPOSITION,"A detergent composition comprising a soil release agent, a non-AQA surfactant and a bis-alkoxylated quaternary ammonium (bis-AQA) cationic surfactant.",PROCTER & GAMBLE;;ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;MANOHAR SANJEEV KRISHNADAS;;DODD IAN MARTIN;;KOTT KEVIN LEE;;BABA HAJIME;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;MANOHAR SANJEEV KRISHNADAS;;DODD IAN MARTIN;;KOTT KEVIN LEE;;BABA HAJIME;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,,https://lens.org/163-541-557-782-04X,Search Report,yes,6,0,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,0,0,,,,PENDING
770,WO,A3,WO 1997/043364 A3,199-481-545-573-464,1997-12-24,1997,US 9708440 W,1997-05-16,US 1788696 P,1996-05-17,DETERGENT COMPOSITION,"A detergent composition comprising a soil dispersant polymer, a non-alkoxylated surfactant and an alkoxylated quaternary ammonium (AQA) surfactant.",PROCTER & GAMBLE;;ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;MANOHAR SANJEEV KRISHNADAS;;DODD IAN MARTIN;;KOTT KEVIN LEE;;BABA HAJIME;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;MANOHAR SANJEEV KRISHNADAS;;DODD IAN MARTIN;;KOTT KEVIN LEE;;BABA HAJIME;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,,https://lens.org/199-481-545-573-464,Search Report,yes,5,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/835;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,PENDING
771,AU,A,AU 2001/063063 A,091-010-589-956-048,2001-11-20,2001,AU 2001/063063 A,2001-05-10,US 20347200 P;;US 83886701 A;;US 0115275 W,2000-05-11,Laundry system having unitized dosing,,PROCTER & GAMBLE,WELCH ROBERT GARY;;RIDYARD MARK WILLIAM;;SAYERS EDWARD;;YORK DAVID WILLIAM;;DUFTON DANIEL JAMES;;HOWE SIMON;;ESHUIS JOHAN;;ROMERO ANGELINA PENA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMAN WUNDRIARI;;DECKNER GEORGE ENDEL;;CASEWELL DEBRA SUE;;WAHL ERROL HOFFMAN;;MURPHY RUTH ANNE;;HENSLEY CHARLES ALBERT;;TRINH TOAN;;DIHORA JITEN ODHAVJI;;BAKER ELLEN SCHMIDT;;LITTIG JANET SUE;;SCHROEDER TIMOTHY;;DIERSING STEVEN LOUIS;;DODD MALCOLM MCCLAREN;;GALLON LOIS SARA,,https://lens.org/091-010-589-956-048,Patent Application,no,0,0,26,26,0,A47F1/08;;C11D3/001;;C11D3/0015;;C11D3/0021;;C11D3/0026;;C11D3/0036;;C11D3/0052;;C11D3/0068;;C11D3/373;;C11D3/42;;C11D3/48;;C11D3/50;;C11D3/505;;C11D17/0039;;C11D17/041;;C11D17/042;;C11D17/043;;C11D17/046;;C11D2111/12;;C11D17/042;;C11D3/0052;;C11D17/043;;C11D3/0068;;C11D3/50;;A47F1/08;;C11D3/0015;;C11D3/48;;C11D3/373;;C11D3/0021;;C11D17/041;;C11D17/0039;;C11D3/42;;C11D3/0026;;C11D3/0036;;C11D3/505;;C11D17/046;;C11D3/001;;C11D2111/12,A47F1/08;;B65D65/46;;C11D1/62;;C11D1/72;;C11D3/00;;C11D3/37;;C11D3/42;;C11D3/48;;C11D3/50;;C11D11/00;;C11D17/04;;C11D17/06;;D06M15/03;;D06M15/11;;D06M15/15;;D06M15/333,,0,0,,,,PENDING
772,HU,A2,HU P9902832 A2,065-398-848-296-410,1999-12-28,1999,HU P9902832 A,1997-05-16,HU P9902832 A;;US 1788696 P,1996-05-17,DETERGENT COMPOSITIONS,"The composition comprises or is prepared by combining a percarbonate bleach, non-alkoxylated quaternary ammonium surfactant(s) (non-AQA) and AQA cationic surfactant of formula (I)R1 = substituted 8-18C alkyl, alkenyl, aryl, alkaryl, ether or glycidyl ether moiety; R2 = 1-3C alkyl; R3, R4 = H, Me or Et; X = anion; A = 1-4C alkoxy; p = 2-30. Also claimed are: (1) a method for removing soils and stains comprising contacting soils and stains with a detergent composition, or aqueous medium comprising the above detergent composition; and (2) a method for enhancing the deposition or substantivity of perfume or perfume ingredients onto fabrics or other surfaces comprising contacting the surfaces with perfume of perfume ingredient in the presence of compound (I).",The Procter & Gamble Co.,"Asano, Kaori;;Cripe, Thomas Anthony;;Cron, Laura;;Curry, John Downing;;Dodd, Ian Martin;;Foley, Peter Robert;;Hartshorn, Richard Timothy;;Katsuda, Rinko;;Kott, Kevin Lee;;Kvietok, Frank Andrej;;Manohar, Sanjeev Krishnadas;;Mao, Mark Hsiang-Kuen;;Minamikawa, Kaori;;Moss, Michael Alan John;;Murata, Susumu;;Panandiker, Rajan Keshav;;Pramod, Kakumanu;;Sarnaik, Khizar Mohamed Khan;;Scheibel, Jeffrey John;;Thoen, Christian Arthur Jacques Kamiel;;Willman, Kenneth William",,https://lens.org/065-398-848-296-410,Patent Application,no,0,0,1,507,0,,,,0,0,,,,PENDING
773,ZA,B,ZA 974225 B,064-138-965-233-737,1998-12-28,1998,ZA 974225 A,1997-05-15,US 1788696 P,1996-05-17,Detergent composition,,PROCTER & GAMBLE,SARNAIK KHIZAR MOHAMED KHAN;;SCHEIBEL JEFFREY JOHN;;WILLMAN KENNETH WILLIAM;;MINAMIKAWA KAORI;;KATSUDA RINKO;;ASANO KAORI;;CRON LAURA;;MURATA SUSUMU;;CRIPE THOMAS ANTHONY;;THOEN CHRISTIAAN ARTHUR JACQUE;;KVIETOK FRANK ANDREJ;;PANANDIKER RAJAN KESHAV;;CURRY JOHN DOWNING;;FOLEY PETER ROBERT;;HARTSHORN RICHARD TIMOTHY;;PRAMOD KAKUMANU;;MOSS MICHAEL ALAN JOHN;;DODD IAN MARTIN;;MANOHAR SANJEEV KRISHNADAS;;KOTT KEVIN LEE;;MAO MARK HSIANG-KUEN,,https://lens.org/064-138-965-233-737,Granted Patent,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/02;;C11D1/835;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,EXPIRED
774,WO,A2,WO 1997/044419 A2,114-637-260-295-768,1997-11-27,1997,US 9708317 W,1997-05-16,US 1788396 P,1996-05-17,DETERGENT COMPOSITION,"A detergent composition comprising a soil release agent, a non-AQA surfactant and a bis-alkoxylated quaternary ammonium (bis-AQA) cationic surfactant.",PROCTER & GAMBLE;;ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;MANOHAR SANJEEV KRISHNADAS;;DODD IAN MARTIN;;KOTT KEVIN LEE;;BABA HAJIME;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;MANOHAR SANJEEV KRISHNADAS;;DODD IAN MARTIN;;KOTT KEVIN LEE;;BABA HAJIME;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,,https://lens.org/114-637-260-295-768,Patent Application,no,0,2,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,0,0,,,,PENDING
775,WO,A3,WO 1997/043365 A3,102-500-351-285-124,1998-01-08,1998,US 9708443 W,1997-05-16,US 1788696 P,1996-05-17,DETERGENT COMPOSITION,A detergent composition comprising a soil release agent a non-AQA surfactant and an alkoxylated quaternary ammonium (AQA) cationic surfactant.,PROCTER & GAMBLE;;ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;MANOHAR SANJEEV KRISHNADAS;;DODD IAN MARTIN;;KOTT KEVIN LEE;;BABA HAJIME;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;MANOHAR SANJEEV KRISHNADAS;;DODD IAN MARTIN;;KOTT KEVIN LEE;;BABA HAJIME;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,,https://lens.org/102-500-351-285-124,Search Report,yes,6,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/835;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,PENDING
776,MA,A1,MA 25183 A1,117-858-815-727-607,2001-07-02,2001,MA 24610 A,1997-05-14,US 1788696 P,1996-05-17,COMPOSITIONS DETERGENTES,,CHRISTIAAN ARTHUR JACQUES KAMI,THOMAS ANTHONY CRIPE;;MICHAEL ALAN JOHN MOSS;;PETER ROBERT FOLEY;;IAN MARTIN DODD;;KEVIN LEE KOTT;;RAJAN KESHAV PANANDIKER;;MURATA SUSUMU;;JOHN DOWNING CURRY;;MARK HSIANG-KUEN MAO;;LAURA CRON;;RICHARD TIMOTHY HARTSHORN;;JEFFREY JOHN SCHEIBEL;;KENNETH WILLIAM WILLMAN;;KAKUMANU PRAMOD;;SANJEEV KRISHNADAS MANOHAR;;MINAMIKAWA KAORI;;KAORI ASANO;;RINKO KATSUDA;;FRANK ANDREJ KVIETOK;;KHIZAR MOHAMED KHAN SARNAIK;;CHRISTIAAN ARTHUR JACQUES KAMI,,https://lens.org/117-858-815-727-607,Granted Patent,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/02;;C11D1/14;;C11D1/835;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,EXPIRED
777,WO,A2,WO 1997/043394 A2,162-394-786-194-627,1997-11-20,1997,US 9708445 W,1997-05-16,US 1788396 P,1996-05-17,DETERGENT COMPOSITION,"A detergent composition comprising a bis-alkoxylated quaternary ammonium (bis-AQA) cationic surfactant, a non-AQA surfactant and a photobleach.",PROCTER & GAMBLE;;ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;MANOHAR SANJEEV KRISHNADAS;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;KOTT KEVIN LEE;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;FOLEY PETER ROBERT;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;WILLMAN KENNETH WILLIAM;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;MANOHAR SANJEEV KRISHNADAS;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;KOTT KEVIN LEE;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;FOLEY PETER ROBERT;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;WILLMAN KENNETH WILLIAM;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,,https://lens.org/162-394-786-194-627,Patent Application,no,0,1,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,0,0,,,,PENDING
778,WO,A2,WO 1997/043364 A2,199-406-157-268-003,1997-11-20,1997,US 9708440 W,1997-05-16,US 1788696 P,1996-05-17,DETERGENT COMPOSITION,"A detergent composition comprising a soil dispersant polymer, a non-alkoxylated surfactant and an alkoxylated quaternary ammonium (AQA) surfactant.",PROCTER & GAMBLE;;ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;MANOHAR SANJEEV KRISHNADAS;;DODD IAN MARTIN;;KOTT KEVIN LEE;;BABA HAJIME;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;MANOHAR SANJEEV KRISHNADAS;;DODD IAN MARTIN;;KOTT KEVIN LEE;;BABA HAJIME;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,,https://lens.org/199-406-157-268-003,Patent Application,no,0,12,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/835;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,PENDING
779,WO,A1,WO 1997/044418 A1,040-645-843-421-014,1997-11-27,1997,US 9708316 W,1997-05-16,US 1788396 P,1996-05-17,DETERGENT COMPOSITION,"A detergent composition comprising a soil dispersant polymer, a non-bis AQA surfactant and a bis-alkoxylated quaternary ammonium (bis-AQA) cationic surfactant.",PROCTER & GAMBLE;;ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;MANOHAR SANJEEV KRISHNADAS;;DODD IAN MARTIN;;KOTT KEVIN LEE;;BABA HAJIME;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;MANOHAR SANJEEV KRISHNADAS;;DODD IAN MARTIN;;KOTT KEVIN LEE;;BABA HAJIME;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,,https://lens.org/040-645-843-421-014,Patent Application,yes,5,1,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,0,0,,,,PENDING
780,BR,A,BR 9710669 A,072-522-197-038-061,1999-08-17,1999,BR 9710669 A,1997-05-16,US 1788696 P;;US 9708440 W,1996-05-17,Composi-Æo detergente,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;MANOHAR SANJEEV KRISHNADAS;;DODD IAN MARTIN;;KOTT KEVIN LEE;;BABA HAJIME;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAAN ARTHUR JACQUE,,https://lens.org/072-522-197-038-061,Patent Application,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/835;;C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,DISCONTINUED
781,WO,A1,WO 1997/043390 A1,192-782-911-481-880,1997-11-20,1997,US 9708439 W,1997-05-16,US 1788696 P,1996-05-17,DETERGENT COMPOSITION,"A detergent composition comprising an alkoxylated quaternary ammonium (AQA) cationic surfactant, a non-AQA surfactant and a percarbonate bleach.",PROCTER & GAMBLE;;ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;KOTT KEVIN LEE;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;WILLMAN KENNETH WILLIAM;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;MANOHAR SANJEEV KRISHNADAS;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;KOTT KEVIN LEE;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;WILLMAN KENNETH WILLIAM;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;MANOHAR SANJEEV KRISHNADAS;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,,https://lens.org/192-782-911-481-880,Patent Application,yes,3,8,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/835;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,1,0,,,"DATABASE WPI Section Ch Week 8420, Derwent World Patents Index; Class A97, AN 84-123539, XP002044147",PENDING
782,EP,A1,EP 0918833 A1,108-185-342-864-643,1999-06-02,1999,EP 97924743 A,1997-05-16,US 9708316 W;;US 1788396 P,1996-05-17,DETERGENT COMPOSITION,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;MANOHAR SANJEEV KRISHNADAS;;DODD IAN MARTIN;;KOTT KEVIN LEE;;BABA HAJIME;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,,https://lens.org/108-185-342-864-643,Patent Application,yes,0,0,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,1,0,,,See references of WO 9744418A1,DISCONTINUED
783,WO,A3,WO 1997/043393 A3,066-532-640-027-431,1997-12-31,1997,US 9708441 W,1997-05-16,US 1788696 P,1996-05-17,DETERGENT COMPOSITION,"A detergent composition comprising an alkoxylated quaternary ammonium (AQA) cationic surfactant, a non-AQA surfactant and a photobleach.",PROCTER & GAMBLE;;ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;MANOHAR SANJEEV KRISHNADAS;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;KOTT KEVIN LEE;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;FOLEY PETER ROBERT;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;WILLMAN KENNETH WILLIAM;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;MANOHAR SANJEEV KRISHNADAS;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;KOTT KEVIN LEE;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;FOLEY PETER ROBERT;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;WILLMAN KENNETH WILLIAM;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,,https://lens.org/066-532-640-027-431,Search Report,yes,8,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/835;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,PENDING
784,WO,A1,WO 1997/044432 A1,170-590-231-859-005,1997-11-27,1997,US 9708372 W,1997-05-16,US 1788396 P,1996-05-17,DETERGENT COMPOSITION,"A detergent composition comprising a non-AQA surfactant, bis-alkoxylated quaternary ammonium (bis-AQA) cationic surfactant, and a percarbonate bleach.",PROCTER & GAMBLE;;ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;KOTT KEVIN LEE;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;MANOHAR SANJEEV KRISHNADAS;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;FOLEY PETER ROBERT;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;WILLMAN KENNETH WILLIAM;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;KOTT KEVIN LEE;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;MANOHAR SANJEEV KRISHNADAS;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;FOLEY PETER ROBERT;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;WILLMAN KENNETH WILLIAM;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,,https://lens.org/170-590-231-859-005,Patent Application,yes,3,1,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,1,0,,,"DATABASE WPI Section Ch Week 8420, Derwent World Patents Index; Class A97, AN 84-123539, XP002044147",PENDING
785,WO,A3,WO 1997/043394 A3,169-978-599-156-565,1997-12-24,1997,US 9708445 W,1997-05-16,US 1788396 P,1996-05-17,DETERGENT COMPOSITION,"A detergent composition comprising a bis-alkoxylated quaternary ammonium (bis-AQA) cationic surfactant, a non-AQA surfactant and a photobleach.",PROCTER & GAMBLE;;ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;MANOHAR SANJEEV KRISHNADAS;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;KOTT KEVIN LEE;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;FOLEY PETER ROBERT;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;WILLMAN KENNETH WILLIAM;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;MANOHAR SANJEEV KRISHNADAS;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;KOTT KEVIN LEE;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;FOLEY PETER ROBERT;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;WILLMAN KENNETH WILLIAM;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,,https://lens.org/169-978-599-156-565,Search Report,yes,8,0,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,0,0,,,,PENDING
786,EP,A1,EP 0912692 A1,004-143-309-802-276,1999-05-06,1999,EP 97925633 A,1997-05-16,US 9708437 W;;US 1788696 P,1996-05-17,DETERGENT COMPOSITION,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;BETTIOL JEAN-LUC;;CRIPE THOMAS ANTHONY;;CURRY JOHN;;KOTT KEVIN LEE;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;THOEN CHRISTIAAN ARTHUR JACQUE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;WILLMAN KENNETH WILLIAM;;MANOHAR SANJEEV,,https://lens.org/004-143-309-802-276,Patent Application,yes,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/835;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,DISCONTINUED
787,CA,A1,CA 2255008 A1,056-035-264-590-692,1997-11-20,1997,CA 2255008 A,1997-05-16,US 1788696 P,1996-05-17,DETERGENT COMPOSITION,"A detergent composition comprising a soil dispersant polymer, a nonalkoxylated surfactant and an alkoxylated quaternary ammonium (AQA) surfactant.",PROCTER & GAMBLE,CURRY JOHN DOWNING;;CRIPE THOMAS ANTHONY;;MURATA SUSUMU;;FOLEY PETER ROBERT;;MANOHAR SANJEEV KRISHNADAS;;MAO MARK HSIANG-KUEN;;BABA HAJIME;;MINAMIKAWA KAORI;;SCHEIBEL JEFFREY JOHN;;KVIETOK FRANK ANDREJ;;PANANDIKER RAJAN KESHAV;;KOTT KEVIN LEE;;KATSUDA RINKO;;WILLMAN KENNETH WILLIAM;;CRON LAURA;;DODD IAN MARTIN;;SARNAIK KHIZAR MOHAMED KHAN;;ASANO KAORI;;THOEN CHRISTIAAN ARTHUR JACQUE;;PRAMOD KAKUMANU;;MOSS MICHAEL ALAN JOHN,,https://lens.org/056-035-264-590-692,Patent Application,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/835;;C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,DISCONTINUED
788,WO,A2,WO 2001/085888 A2,168-415-401-700-217,2001-11-15,2001,US 0115275 W,2001-05-10,US 20347200 P;;US 83886701 A,2000-05-11,LAUNDRY SYSTEM HAVING UNITIZED DOSING,"Compositions, articles and methods are provided for supplying fabric care benefits to clothing or fabrics in an automated washing machine and by manual washing. The fabric care compositions preferably have less than about 5% detergent surfactants, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. Similarly, the fabric care compositions preferably have less than about 5% fabric softener actives, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. The laundry articles can take a variety of forms in a variety of physical states all of which will rapidly dispense a unitized amount of one or more selected fabric care agents to a wash and/or rinse bath solution during the laundering process under a variety of conditions. The invention also pertains to laundry kits that contain a variety of such articles and instructions concerning their use. Likewise, methods for preparing a customized laundry solution to obtain a specific fabric care benefit selected based on the user's personal preferences and/or the fabric care needs of the fabrics being laundered are also provided. Further, the present invention also concerns methods for assisting a consumer in identifying the unitized articles to be used in preparing a laundry solution that will impart desired fabric care benefits as well as merchandising displays for dispensing the articles, assembling customized laundry kits and instructing the consumer on the selection and use of laundry articles.",PROCTER & GAMBLE,WELCH ROBERT GARY;;RIDYARD MARK WILLIAM;;SAYERS EDWARD;;YORK DAVID WILLIAM;;DUFTON DANIEL JAMES;;HOWE SIMON;;ESHUIS JOHAN;;ROMERO ANGELINA PENA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMAN WUNDRIARI;;DECKNER GEORGE ENDEL;;CASEWELL DEBRA SUE;;WAHL ERROL HOFFMAN;;MURPHY RUTH ANNE;;HENSLEY CHARLES ALBERT;;TRINH TOAN;;DIHORA JITEN ODHAVJI;;BAKER ELLEN SCHMIDT;;LITTIG JANET SUE;;SCHROEDER TIMOTHY;;DIERSING STEVEN LOUIS;;DODD MALCOLM MCLAREN;;GALLON LOIS SARAAREN,,https://lens.org/168-415-401-700-217,Patent Application,yes,0,74,26,26,0,A47F1/08;;C11D3/001;;C11D3/0015;;C11D3/0021;;C11D3/0026;;C11D3/0036;;C11D3/0052;;C11D3/0068;;C11D3/373;;C11D3/42;;C11D3/48;;C11D3/50;;C11D3/505;;C11D17/0039;;C11D17/041;;C11D17/042;;C11D17/043;;C11D17/046;;C11D2111/12;;C11D17/042;;C11D3/0052;;C11D17/043;;C11D3/0068;;C11D3/50;;A47F1/08;;C11D3/0015;;C11D3/48;;C11D3/373;;C11D3/0021;;C11D17/041;;C11D17/0039;;C11D3/42;;C11D3/0026;;C11D3/0036;;C11D3/505;;C11D17/046;;C11D3/001;;C11D2111/12,A47F1/08;;B65D65/46;;C11D1/62;;C11D1/72;;C11D3/00;;C11D3/37;;C11D3/42;;C11D3/48;;C11D3/50;;C11D11/00;;C11D17/04;;C11D17/06;;D06M15/03;;D06M15/11;;D06M15/15;;D06M15/333,,0,0,,,,PENDING
789,ZA,B,ZA 974226 B,020-962-456-463-672,1998-12-28,1998,ZA 974226 A,1997-05-15,US 1788396 P,1996-05-17,Detergent composition,,PROCTER & GAMBLE,SARNAIK KHIZAR MOHAMED KHAN;;SCHEIBEL JEFFREY JOHN;;WILLMAN KENNETH WILLIAM;;MINAMIKAWA KAORI;;KATSUDA RINKO;;ASANO KAORI;;CRON LAURA;;MURATA SUSUMU;;CRIPE THOMAS ANTHONY;;THOEN CHRISTIAAN ARTHUR JACQUE;;KVIETOK FRANK ANDREJ;;PANANDIKER RAJAN KESHAV;;CURRY JOHN DOWNING;;FOLEY PETER ROBERT;;HARTSHORN RICHARD TIMOTHY;;PRAMOD KAKUMANU;;MOSS MICHAEL ALAN JOHN;;DODD IAN MARTIN;;MANOHAR SANJEEV KRISHNADAS;;KOTT KEVIN LEE;;MAO MARK HSIANG-KUEN,,https://lens.org/020-962-456-463-672,Granted Patent,no,0,0,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,0,0,,,,EXPIRED
790,CA,A1,CA 2254961 A1,060-294-647-355-826,1997-11-27,1997,CA 2254961 A,1997-05-16,US 1788396 P;;US 9708317 W,1996-05-17,DETERGENT COMPOSITION,"A detergent composition comprising a soil release agent, a non-AQA surfactant and a bis-alkoxylated quaternary ammonium (bis-AQA) cationic surfactant.",PROCTER & GAMBLE,KVIETOK FRANK ANDREJ;;KATSUDA RINKO;;KOTT KEVIN LEE;;THOEN CHRISTIAAN ARTHUR JACQUE;;PANANDIKER RAJAN KESHAV;;MAO MARK HSIANG-KUEN;;BABA HAJIME;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;PRAMOD KAKUMANU;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;MOSS MICHAEL ALAN JOHN;;ASANO KAORI;;SARNAIK KHIZAR MOHAMED KHAN;;FOLEY PETER ROBERT;;MURATA SUSUMU;;DODD IAN MARTIN;;MANOHAR SANJEEV KRISHNADAS,,https://lens.org/060-294-647-355-826,Patent Application,no,0,0,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,0,0,,,,DISCONTINUED
791,HU,A2,HU P9902800 A2,146-717-619-950-687,1999-12-28,1999,HU P9902800 A,1997-05-16,HU P9902800 A;;US 1788696 P,1996-05-17,DETERGENT COMPOSITION AND ITS USE,"A composition comprises or is prepared by combining a soil dispersant polymer, a non alkoxylated quaternary ammonium surfactant and an alkoxylated quaternary ammonium surfactant of formula (I): (R1)(R2)N+(ApR4)(R3) (I) R1 = substituted 8-18C alkyl, alkenyl, aryl, alkaryl, ether or glycidyl ether moiety; R2 = 1-3C alkyl; R3, R4 = H, Me or Et; X = anion; A = 1-4C alkoxy; and p = 2-30. Also claimed are: (1) a method for removing soils and stains; and (2) a method for enhancing the deposition or substantivity of perfume or perfume ingredients onto fabrics or other surfaces comprising contacting the surfaces with perfume of perfume ingredient in the presence of compound (I).",The Procter & Gamble Co.,"Asano, Kaori;;Baba, Hajime;;Cripe, Thomas Anthony;;Cron, Laura;;Curry, John Downing;;Dodd, Ian Martin;;Foley, Peter Robert;;Katsuda, Rinko;;Kott, Kevin Lee;;Kvietok, Frank Andrej;;Manohar, Sanjeev Krishnadas;;Mao, Mark Hsiang-Kuen;;Minamikawa, Kaori;;Moss, Michael Alan John;;Murata, Susumu;;Panandiker, Rajan Keshav;;Pramod, Kakumanu;;Sarnaik, Khizar Mohamed Khan;;Scheibel, Jeffrey John;;Thoen, Christian Arthur Jacques Kamiel;;Willman, Kenneth William",,https://lens.org/146-717-619-950-687,Patent Application,no,0,0,1,507,0,,,,0,0,,,,PENDING
792,BR,A,BR 9710676 A,122-191-051-363-935,1999-08-17,1999,BR 9710676 A,1997-05-16,US 1788396 P;;US 9708445 W,1996-05-17,Composi-Æo detergente,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;MANOHAR SANJEEV KRISHNADAS;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;KOTT KEVIN LEE;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;FOLEY PETER ROBERT;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;WILLMAN KENNETH WILLIAM;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAAN ARTHUR JACQUE,,https://lens.org/122-191-051-363-935,Patent Application,no,0,0,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,0,0,,,,DISCONTINUED
793,CA,A1,CA 2254946 A1,023-331-783-023-47X,1997-11-20,1997,CA 2254946 A,1997-05-16,US 1788696 P;;US 9708441 W,1996-05-17,DETERGENT COMPOSITION,"A detergent composition comprising an alkoxylated quaternary ammonium (AQA) cationic surfactant, a non-AQA surfactant and a photobleach.",PROCTER & GAMBLE,MAO MARK HSIANG-KUEN;;SARNAIK KHIZAR MOHAMED KHAN;;MOSS MICHAEL ALAN JOHN;;SCHEIBEL JEFFREY JOHN;;MANOHAR SANJEEV KRISHNADAS;;MURATA SUSUMU;;DODD IAN MARTIN;;CRIPE THOMAS ANTHONY;;KOTT KEVIN LEE;;THOEN CHRISTIAAN ARTHUR JACQUE;;PANANDIKER RAJAN KESHAV;;KATSUDA RINKO;;MINAMIKAWA KAORI;;CRON LAURA;;HARTSHORN RICHARD TIMOTHY;;FOLEY PETER ROBERT;;ASANO KAORI;;KVIETOK FRANK ANDREJ;;CURRY JOHN DOWNING;;WILLMAN KENNETH WILLIAM;;PRAMOD KAKUMANU,,https://lens.org/023-331-783-023-47X,Patent Application,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/835;;C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,DISCONTINUED
794,BR,A,BR 9710671 A,111-708-773-322-334,1999-08-17,1999,BR 9710671 A,1997-05-16,US 1788696 P;;US 9708443 W,1996-05-17,Composi-Æo detergente,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;MANOHAR SANJEEV KRISHNADAS;;DODD IAN MARTIN;;KOTT KEVIN LEE;;BABA HAJIME;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAAN ARTHUR JACQUE,,https://lens.org/111-708-773-322-334,Patent Application,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/835;;C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,DISCONTINUED
795,BR,A,BR 9710675 A,185-708-309-423-910,1999-08-17,1999,BR 9710675 A,1997-05-16,US 1788396 P;;US 9708372 W,1996-05-17,Composi-Æo detergente,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;KOTT KEVIN LEE;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;MANOHAR SANJEEV KRISHNADAS;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;FOLEY PETER ROBERT;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;WILLMAN KENNETH WILLIAM;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAAN ARTHUR JACQUE,,https://lens.org/185-708-309-423-910,Patent Application,no,0,0,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,0,0,,,,DISCONTINUED
796,WO,A2,WO 1997/043365 A2,135-608-886-822-282,1997-11-20,1997,US 9708443 W,1997-05-16,US 1788696 P,1996-05-17,DETERGENT COMPOSITION,A detergent composition comprising a soil release agent a non-AQA surfactant and an alkoxylated quaternary ammonium (AQA) cationic surfactant.,PROCTER & GAMBLE;;ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;MANOHAR SANJEEV KRISHNADAS;;DODD IAN MARTIN;;KOTT KEVIN LEE;;BABA HAJIME;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;MANOHAR SANJEEV KRISHNADAS;;DODD IAN MARTIN;;KOTT KEVIN LEE;;BABA HAJIME;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES,,https://lens.org/135-608-886-822-282,Patent Application,no,0,12,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/835;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,PENDING
797,CA,A1,CA 2254948 A1,101-023-605-851-910,1997-11-27,1997,CA 2254948 A,1997-05-16,US 1788396 P;;US 9708372 W,1996-05-17,DETERGENT COMPOSITION,"A detergent composition comprising a non-AQA surfactant, bis-alkoxylated quaternary ammonium (bis-AQA) cationic surfactant, and a percarbonate bleach.",PROCTER & GAMBLE,MURATA SUSUMU;;MAO MARK HSIANG-KUEN;;KATSUDA RINKO;;MOSS MICHAEL ALAN JOHN;;KVIETOK FRANK ANDREJ;;MANOHAR SANJEEV KRISHNADAS;;PANANDIKER RAJAN KESHAV;;WILLMAN KENNETH WILLIAM;;CURRY JOHN DOWNING;;FOLEY PETER ROBERT;;THOEN CHRISTIAAN ARTHUR JACQUE;;SARNAIK KHIZAR MOHAMED KHAN;;ASANO KAORI;;HARTSHORN RICHARD TIMOTHY;;DODD IAN MARTIN;;PRAMOD KAKUMANU;;MINAMIKAWA KAORI;;CRON LAURA;;CRIPE THOMAS ANTHONY;;KOTT KEVIN LEE;;SCHEIBEL JEFFREY JOHN,,https://lens.org/101-023-605-851-910,Patent Application,no,0,0,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,0,0,,,,DISCONTINUED
798,CZ,A3,CZ 371498 A3,159-842-143-839-397,1999-04-14,1999,CZ 371498 A,1997-05-16,US 1788696 P,1996-05-17,DETERGENT PREPARATION,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;KOTT KEVIN LEE;;CRIPE THOMAS ANTHONY;;CUTTY JOHN DOWNING;;WILLMAN KENNETH WILLIAM;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;MANOHAR SANJEEV KRISHNADAS;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAAN ARTHUR JACQUE,,https://lens.org/159-842-143-839-397,Patent Application,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/835;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,PENDING
799,BR,A,BR 9710445 A,172-779-265-678-423,1999-08-17,1999,BR 9710445 A,1997-05-16,US 1788396 P;;US 9708317 W,1996-05-17,Composi-Æo detergente,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;WILLMAN KENNETH WILLIAM;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;MANOHAR SANJEEV KRISHNADAS;;DODD IAN MARTIN;;KOTT KEVIN LEE;;BABA HAJIME;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAAN ARTHUR JACQUE,,https://lens.org/172-779-265-678-423,Patent Application,no,0,0,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,0,0,,,,DISCONTINUED
800,CA,A1,CA 2707753 A1,001-461-680-963-693,2001-11-15,2001,CA 2707753 A,2001-05-10,US 20347200 P;;US 83886701 A;;CA 2405845 A,2000-05-11,LAUNDRY SYSTEM HAVING UNITIZED DOSING,"The present invention is directed to compositions, articles and methods for supplying fabric care benefits such as, improved cleaning, to clothing or fabrics in an automated washing machine and by manual washing. The fabric care compositions preferably have less than about 5% detergent surfactants, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. Similarly, the fabric care compositions preferably have less than about 5% fabric softener actives, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. The laundry articles can take a variety of forms in a variety of physical states all of which will rapidly dispense a unitized amount of one or more selected fabric care agents to a wash and/or rinse bath solution during the laundering process under a variety of conditions. The invention also pertains to laundry kits that contain a variety of such articles and instructions concerning their use. Likewise, methods for preparing a customized laundry solution to obtain a specific fabric care benefit selected based on the user's personal preferences and/or the fabric care needs of the fabrics being laundered are also provided. Further, the present invention also concerns methods for assisting a consumer in identifying the unitized articles to be used in preparing a laundry solution that will impart desired fabric care benefits as well as merchandising displays for dispensing the articles, assembling customized laundry kits and instructing the consumer on the selection and use of laundry articles.",PROCTER & GAMBLE,WELCH ROBERT GARY;;RIDYARD MARK WILLIAM;;SAYERS EDWARD;;YORK DAVID WILLIAM;;DUFTON DANIEL JAMES;;HOWE SIMON;;ESHUIS JOHAN;;ROMERO ANGELINA PENA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMAN WUNDRIARI;;DECKNER GEORGE ENDEL;;CASEWELL DEBRA SUE;;WAHL ERROL HOFFMAN;;MURPHY RUTH ANNE;;HENSLEY CHARLES ALBERT;;TRINH TOAN;;DIHORA JITEN ODHAVJI;;BAKER ELLEN SCHMIDT;;LITTIG JANET SUE;;SCHROEDER TIMOTHY JAMES;;DODD MALCOLM MCCLAREN;;GALLON LOIS SARA;;DIERSING STEVEN LOUIS,,https://lens.org/001-461-680-963-693,Patent Application,no,0,0,26,26,0,A47F1/08;;C11D3/001;;C11D3/0015;;C11D3/0021;;C11D3/0026;;C11D3/0036;;C11D3/0052;;C11D3/0068;;C11D3/373;;C11D3/42;;C11D3/48;;C11D3/50;;C11D3/505;;C11D17/0039;;C11D17/041;;C11D17/042;;C11D17/043;;C11D17/046;;C11D2111/12;;C11D17/042;;C11D3/0052;;C11D17/043;;C11D3/0068;;C11D3/50;;A47F1/08;;C11D3/0015;;C11D3/48;;C11D3/373;;C11D3/0021;;C11D17/041;;C11D17/0039;;C11D3/42;;C11D3/0026;;C11D3/0036;;C11D3/505;;C11D17/046;;C11D3/001;;C11D2111/12,C11D17/04;;A47F1/08;;B65D65/46;;C11D1/62;;C11D1/72;;C11D3/00;;C11D3/37;;C11D3/42;;C11D3/48;;C11D3/50;;C11D7/00;;C11D11/00;;C11D17/06;;D06M15/03;;D06M15/11;;D06M15/15;;D06M15/333,,0,0,,,,DISCONTINUED
801,US,A1,US 2010/0115708 A1,095-962-772-698-554,2010-05-13,2010,US 61361109 A,2009-11-06,US 61361109 A;;US 50859609 A;;US 33787506 A;;US 33787706 A;;US 12187605 A;;US 10579805 A;;US 92574904 A;;US 83886701 A;;US 20347200 P,2000-05-11,Laundry System Having Unitized Dosing,"Compositions, articles and methods are provided for supplying fabric care benefits to clothing or fabrics in an automated washing machine and by manual washing. The fabric care compositions preferably have less than about 5% detergent surfactants, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. Similarly, the fabric care compositions preferably have less than about 5% fabric softener actives, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. The laundry articles can take a variety of forms in a variety of physical states all of which will rapidly dispense a unitized amount of one or more selected fabric care agents to a wash and/or rinse bath solution during the laundering process under a variety of conditions. The invention also pertains to laundry kits that contain a variety of such articles and instructions concerning their use Likewise, methods for preparing a customized laundry solution to obtain a specific fabric care benefit selected based on the user's personal preferences and/or the fabric care needs of the fabrics being laundered are also provided. Further, the present invention also concerns methods for assisting a consumer in identifying the unitized articles to be used in preparing a laundry solution that will impart desired fabric care benefits as well as merchandising displays for dispensing the articles, assembling customized laundry kits and instructing the consumer on the selection and use of laundry articles.",CASWELL DEBRA SUE;;WELCH ROBERT GARY;;RIDYARD MARK WILLIAM;;SAYERS EDWARD;;YORK DAVID WILLIAM;;DUFTON DANIEL JAMES;;HOWE SIMON;;ESHUIS JOHAN;;PENA-ROMERO ANGELINA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMANN WUNDRIARI;;DECKNER GEORGE ENDEL;;WAHL ERROL HOFFMAN;;MURPHY RUTH ANNE;;HENSLEY CHARLES ALBERT;;TRINH TOAN;;DIHORA JITEN ODHAVJI;;BAKER ELLEN SCHMIDT;;LITTING JANET SUE;;SCHROEDER TIMOTHY JAMES;;DIERSING STEVEN LOUIS;;DODD MALCOLM MCCLAREN;;GALLON LOIS SARA,CASWELL DEBRA SUE;;WELCH ROBERT GARY;;RIDYARD MARK WILLIAM;;SAYERS EDWARD;;YORK DAVID WILLIAM;;DUFTON DANIEL JAMES;;HOWE SIMON;;ESHUIS JOHAN;;PENA-ROMERO ANGELINA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMANN WUNDRIARI;;DECKNER GEORGE ENDEL;;WAHL ERROL HOFFMAN;;MURPHY RUTH ANNE;;HENSLEY CHARLES ALBERT;;TRINH TOAN;;DIHORA JITEN ODHAVJI;;BAKER ELLEN SCHMIDT;;LITTING JANET SUE;;SCHROEDER TIMOTHY JAMES;;DIERSING STEVEN LOUIS;;DODD MALCOLM MCCLAREN;;GALLON LOIS SARA,,https://lens.org/095-962-772-698-554,Patent Application,yes,1,51,26,26,0,A47F1/08;;C11D3/001;;C11D3/0015;;C11D3/0021;;C11D3/0026;;C11D3/0036;;C11D3/0052;;C11D3/0068;;C11D3/373;;C11D3/42;;C11D3/48;;C11D3/50;;C11D3/505;;C11D17/0039;;C11D17/041;;C11D17/042;;C11D17/043;;C11D17/046;;C11D2111/12;;C11D17/042;;C11D3/0052;;C11D17/043;;C11D3/0068;;C11D3/50;;A47F1/08;;C11D3/0015;;C11D3/48;;C11D3/373;;C11D3/0021;;C11D17/041;;C11D17/0039;;C11D3/42;;C11D3/0026;;C11D3/0036;;C11D3/505;;C11D17/046;;C11D3/001;;C11D2111/12,C11D17/00;;A47F1/08;;B65D65/46;;C11D1/62;;C11D1/72;;C11D3/00;;C11D3/37;;C11D3/42;;C11D3/48;;C11D3/50;;C11D11/00;;C11D17/04;;C11D17/06;;D06M15/03;;D06M15/11;;D06M15/15;;D06M15/333,8/137;;510/295;;510/293,0,0,,,,DISCONTINUED
802,WO,A3,WO 2001/085888 A3,005-872-760-696-355,2002-07-11,2002,US 0115275 W,2001-05-10,US 20347200 P;;US 83886701 A,2000-05-11,LAUNDRY SYSTEM HAVING UNITIZED DOSING,"Compositions, articles and methods are provided for supplying fabric care benefits to clothing or fabrics in an automated washing machine and by manual washing. The fabric care compositions preferably have less than about 5% detergent surfactants, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. Similarly, the fabric care compositions preferably have less than about 5% fabric softener actives, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. The laundry articles can take a variety of forms in a variety of physical states all of which will rapidly dispense a unitized amount of one or more selected fabric care agents to a wash and/or rinse bath solution during the laundering process under a variety of conditions. The invention also pertains to laundry kits that contain a variety of such articles and instructions concerning their use. Likewise, methods for preparing a customized laundry solution to obtain a specific fabric care benefit selected based on the user's personal preferences and/or the fabric care needs of the fabrics being laundered are also provided. Further, the present invention also concerns methods for assisting a consumer in identifying the unitized articles to be used in preparing a laundry solution that will impart desired fabric care benefits as well as merchandising displays for dispensing the articles, assembling customized laundry kits and instructing the consumer on the selection and use of laundry articles.",PROCTER & GAMBLE,WELCH ROBERT GARY;;RIDYARD MARK WILLIAM;;SAYERS EDWARD;;YORK DAVID WILLIAM;;DUFTON DANIEL JAMES;;HOWE SIMON;;ESHUIS JOHAN;;ROMERO ANGELINA PENA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMAN WUNDRIARI;;DECKNER GEORGE ENDEL;;CASEWELL DEBRA SUE;;WAHL ERROL HOFFMAN;;MURPHY RUTH ANNE;;HENSLEY CHARLES ALBERT;;TRINH TOAN;;DIHORA JITEN ODHAVJI;;BAKER ELLEN SCHMIDT;;LITTIG JANET SUE;;SCHROEDER TIMOTHY JAMES;;DIERSING STEVEN LOUIS;;DODD MALCOLM MCCLAREN;;GALLON LOIS SARA,,https://lens.org/005-872-760-696-355,Search Report,yes,15,0,26,26,0,A47F1/08;;C11D3/001;;C11D3/0015;;C11D3/0021;;C11D3/0026;;C11D3/0036;;C11D3/0052;;C11D3/0068;;C11D3/373;;C11D3/42;;C11D3/48;;C11D3/50;;C11D3/505;;C11D17/0039;;C11D17/041;;C11D17/042;;C11D17/043;;C11D17/046;;C11D2111/12;;C11D17/042;;C11D3/0052;;C11D17/043;;C11D3/0068;;C11D3/50;;A47F1/08;;C11D3/0015;;C11D3/48;;C11D3/373;;C11D3/0021;;C11D17/041;;C11D17/0039;;C11D3/42;;C11D3/0026;;C11D3/0036;;C11D3/505;;C11D17/046;;C11D3/001;;C11D2111/12,A47F1/08;;B65D65/46;;C11D1/62;;C11D1/72;;C11D3/00;;C11D3/37;;C11D3/42;;C11D3/48;;C11D3/50;;C11D11/00;;C11D17/04;;C11D17/06;;D06M15/03;;D06M15/11;;D06M15/15;;D06M15/333,,0,0,,,,PENDING
803,US,B2,US 7056877 B2,162-665-244-498-96X,2006-06-06,2006,US 92574904 A,2004-08-25,US 92574904 A;;US 83886701 A;;US 20347200 P,2000-05-11,Laundry system having unitized dosing,"Compositions, articles and methods are provided for supplying fabric care benefits to clothing or fabrics in an automated washing machine and by manual washing. The fabric care compositions preferably have less than about 5% detergent surfactants, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. Similarly, the fabric care compositions preferably have less than about 5% fabric softener actives, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. The laundry articles can take a variety of forms in a variety of physical states all of which will rapidly dispense a unitized amount of one or more selected fabric care agents to a wash and/or rinse bath solution during the laundering process under a variety of conditions. The invention also pertains to laundry kits that contain a variety of such articles and instructions concerning their use. Likewise, methods for preparing a customized laundry solution to obtain a specific fabric care benefit selected based on the user's personal preferences and/or the fabric care needs of the fabrics being laundered are also provided. Further, the present invention also concerns methods for assisting a consumer in identifying the unitized articles to be used in preparing a laundry solution that will impart desired fabric care benefits as well as merchandising displays for dispensing the articles, assembling customized laundry kits and instructing the consumer on the selection and use of laundry articles.",PROCTER & GAMBLE,CASWELL DEBRA SUE;;WELCH ROBERT GARY;;RIDYARD MARK WILLIAM;;SAYERS EDWARD;;YORK DAVID WILLIAM;;DUFTON DANIEL JAMES;;HOWE SIMON;;ESHUIS JOHAN;;PENA-ROMERO ANGELINA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMANN WUNDRIARI;;DECKNER GEORGE ENDEL;;WAHL ERROL HOFFMAN;;MURPHY RUTH ANNE;;HENSLEY BETTY JEAN;;TRINH TOAN;;DIHORA JITEN ODHAVJI;;BAKER ELLEN SCHMIDT;;LITTIG JANET SUE;;SCHROEDER TIMOTHY JAMES;;DIERSING STEVEN LOUIS;;DODD MALCOLM MCCLAREN;;GALLON LOIS SARA,,https://lens.org/162-665-244-498-96X,Granted Patent,yes,26,63,26,26,0,A47F1/08;;C11D3/001;;C11D3/0015;;C11D3/0021;;C11D3/0026;;C11D3/0036;;C11D3/0052;;C11D3/0068;;C11D3/373;;C11D3/42;;C11D3/48;;C11D3/50;;C11D3/505;;C11D17/0039;;C11D17/041;;C11D17/042;;C11D17/043;;C11D17/046;;C11D2111/12;;C11D17/042;;C11D3/0052;;C11D17/043;;C11D3/0068;;C11D3/50;;A47F1/08;;C11D3/0015;;C11D3/48;;C11D3/373;;C11D3/0021;;C11D17/041;;C11D17/0039;;C11D3/42;;C11D3/0026;;C11D3/0036;;C11D3/505;;C11D17/046;;C11D3/001;;C11D2111/12,C11D3/37;;A47F1/08;;B65D65/46;;C11D1/62;;C11D1/72;;C11D3/00;;C11D3/42;;C11D3/48;;C11D3/50;;C11D11/00;;C11D17/04;;C11D17/06;;D06M15/03;;D06M15/11;;D06M15/15;;D06M15/333,510/439;;510/466,0,0,,,,EXPIRED
804,US,A1,US 2006/0123557 A1,036-556-289-429-043,2006-06-15,2006,US 33787706 A,2006-01-23,US 33787706 A;;US 12187605 A;;US 10579805 A;;US 92574904 A;;US 83886701 A;;US 20347200 P,2000-05-11,Laundry system having unitized dosing,"Compositions, articles and methods are provided for supplying fabric care benefits to clothing or fabrics in an automated washing machine and by manual washing. The fabric care compositions preferably have less than about 5% detergent surfactants, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. Similarly, the fabric care compositions preferably have less than about 5% fabric softener actives, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. The laundry articles can take a variety of forms in a variety of physical states all of which will rapidly dispense a unitized amount of one or more selected fabric care agents to a wash and/or rinse bath solution during the laundering process under a variety of conditions. The invention also pertains to laundry kits that contain a variety of such articles and instructions concerning their use. Likewise, methods for preparing a customized laundry solution to obtain a specific fabric care benefit selected based on the user's personal preferences and/or the fabric care needs of the fabrics being laundered are also provided. Further, the present invention also concerns methods for assisting a consumer in identifying the unitized articles to be used in preparing a laundry solution that will impart desired fabric care benefits as well as merchandising displays for dispensing the articles, assembling customized laundry kits and instructing the consumer on the selection and use of laundry articles.",CASWELL DEBRA S;;WELCH ROBERT G;;RIDYARD MARK W;;SAYERS EDWARD;;YORK DAVID W;;DUFTON DANIEL J;;HOWE SIMON;;ESHUIS JOHAN;;PENA-ROMERO ANGELINA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMANN WUNDRIARI;;DECKNER GEORGE E;;WAHL ERROL H;;MURPHY RUTH A;;HENSLEY CHARLES A;;TRINH TOAN;;DIHORA JITEN O;;BAKER ELLEN S;;LITTIG JANET S;;SCHROEDER TIMOTHY J;;DIERSING STEVEN L;;DODD MALCOLM M;;GALLON LOIS S,CASWELL DEBRA S;;WELCH ROBERT G;;RIDYARD MARK W;;SAYERS EDWARD;;YORK DAVID W;;DUFTON DANIEL J;;HOWE SIMON;;ESHUIS JOHAN;;PENA-ROMERO ANGELINA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMANN WUNDRIARI;;DECKNER GEORGE E;;WAHL ERROL H;;MURPHY RUTH A;;HENSLEY CHARLES A;;TRINH TOAN;;DIHORA JITEN O;;BAKER ELLEN S;;LITTIG JANET S;;SCHROEDER TIMOTHY J;;DIERSING STEVEN L;;DODD MALCOLM M;;GALLON LOIS S,,https://lens.org/036-556-289-429-043,Patent Application,yes,24,6,26,26,0,A47F1/08;;C11D3/001;;C11D3/0015;;C11D3/0021;;C11D3/0026;;C11D3/0036;;C11D3/0052;;C11D3/0068;;C11D3/373;;C11D3/42;;C11D3/48;;C11D3/50;;C11D3/505;;C11D17/0039;;C11D17/041;;C11D17/042;;C11D17/043;;C11D17/046;;C11D2111/12;;C11D17/042;;C11D3/0052;;C11D17/043;;C11D3/0068;;C11D3/50;;A47F1/08;;C11D3/0015;;C11D3/48;;C11D3/373;;C11D3/0021;;C11D17/041;;C11D17/0039;;C11D3/42;;C11D3/0026;;C11D3/0036;;C11D3/505;;C11D17/046;;C11D3/001;;C11D2111/12,C11D3/00;;A47F1/08;;B65D65/46;;C11D1/62;;C11D1/72;;C11D3/37;;C11D3/42;;C11D3/48;;C11D3/50;;C11D11/00;;C11D17/04;;C11D17/06;;D06M15/03;;D06M15/11;;D06M15/15;;D06M15/333,8/115.51;;510/515;;510/295,0,0,,,,EXPIRED
805,TR,T2,TR 199802353 T2,172-790-067-306-95X,1999-02-22,1999,TR 9802353 T,1997-05-16,US 1788696 P,1996-05-17,Deterjan bilesimi,"Bir peroksijen agartma maddesi, bir agartma maddesi etkinlestiricisi, AKA olmayan bir yüzey aktif madde ve bir alkoksilatli kuaterner amonyum (AKA) katyonik yüzey aktif maddesi içeren bir deterjan bilesimi.",PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;BETTIOL JEAN-LUC;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;KOTT KEVIN LEE;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;THOEN CHRISTIAN ARTHUR JACQUES;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;MOSS MICHAEL ALAN JOHN;;FOLEY RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;WILLMAN KENNETH WILLIAM;;MANOHAR SANJEEV KRISHNADAS,,https://lens.org/172-790-067-306-95X,Patent Application,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/835;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,PENDING
806,CA,A1,CA 2254827 A1,029-338-655-907-027,1997-11-20,1997,CA 2254827 A,1997-05-16,US 1788696 P;;US 9708437 W,1996-05-17,DETERGENT COMPOSITION,"Detergent composition comprising a peroxygen bleach, a bleach activator, a nonAQA surfactant and an alkoxylated quaternary ammonium (AQA) cationic surfactant.",PROCTER & GAMBLE,PANANDIKER RAJAN KESHAV;;SCHEIBEL JEFFREY JOHN;;THOEN CHRISTIAAN ARTHUR JACQUE;;KATSUDA RINKO;;HARTSHORN RICHARD TIMOTHY;;DODD IAN MARTIN;;CRON LAURA;;ASANO KAORI;;MINAMIKAWA KAORI;;PRAMOD KAKUMANU;;WILLMAN KENNETH WILLIAM;;MURATA SUSUMU;;MAO MARK HSIANG-KUEN;;CRIPE THOMAS ANTHONY;;BETTIOL JEAN-LUC;;MOSS MICHAEL ALAN JOHN;;KVIETOK FRANK ANDREJ;;FOLEY PETER ROBERT;;SARNAIK KHIZAR MOHAMED KHAN;;KOTT KEVIN LEE;;MANOHAR SANJEEV KRISHNADAS;;CURRY JOHN DOWNING,,https://lens.org/029-338-655-907-027,Patent Application,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/835;;C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,DISCONTINUED
807,US,A1,US 2008/0009432 A1,073-684-172-341-177,2008-01-10,2008,US 82303007 A,2007-06-26,US 82303007 A;;US 39652106 A;;US 33787506 A;;US 33787706 A;;US 12187605 A;;US 10579805 A;;US 92574904 A;;US 83886701 A;;US 20347200 P,2000-05-11,Laundry system having unitized dosing,"Compositions, articles and methods are provided for supplying fabric care benefits to clothing or fabrics in an automated washing machine and by manual washing. The fabric care compositions preferably have less than about 5% detergent surfactants, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. Similarly, the fabric care compositions preferably have less than about 5% fabric softener actives, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. The laundry articles can take a variety of forms in a variety of physical states all of which will rapidly dispense a unitized amount of one or more selected fabric care agents to a wash and/or rinse bath solution during the laundering process under a variety of conditions. The invention also pertains to laundry kits that contain a variety of such articles and instructions concerning their use. Likewise, methods for preparing a customized laundry solution to obtain a specific fabric care benefit selected based on the user's personal preferences and/or the fabric care needs of the fabrics being laundered are also provided. Further, the present invention also concerns methods for assisting a consumer in identifying the unitized articles to be used in preparing a laundry solution that will impart desired fabric care benefits as well as merchandising displays for dispensing the articles, assembling customized laundry kits and instructing the consumer on the selection and use of laundry articles.",CASWELL DEBRA S;;WELCH ROBERT G;;RIDYARD MARK W;;SAYERS EDWARD;;YORK DAVID W;;DUFTON DANIEL J;;HOWE SIMON;;ESHUIS JOHAN;;PENA-ROMERO ANGELINA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMANN WUNDRIARI;;DECKNER GEORGE E;;WAHL ERROL H;;MURPHY RUTH A;;HENSLEY CHARLES A;;TRINH TOAN;;DIHORA JITEN O;;BAKER ELLEN S;;LITTIG JANET S;;SCHROEDER TIMOTHY J;;DIERSING STEVEN L;;DODD MALCOLM M;;GALLON LOIS S,CASWELL DEBRA S;;WELCH ROBERT G;;RIDYARD MARK W;;SAYERS EDWARD;;YORK DAVID W;;DUFTON DANIEL J;;HOWE SIMON;;ESHUIS JOHAN;;PENA-ROMERO ANGELINA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMANN WUNDRIARI;;DECKNER GEORGE E;;WAHL ERROL H;;MURPHY RUTH A;;HENSLEY CHARLES A;;TRINH TOAN;;DIHORA JITEN O;;BAKER ELLEN S;;LITTIG JANET S;;SCHROEDER TIMOTHY J;;DIERSING STEVEN L;;DODD MALCOLM M;;GALLON LOIS S,,https://lens.org/073-684-172-341-177,Patent Application,yes,26,6,26,26,0,A47F1/08;;C11D3/001;;C11D3/0015;;C11D3/0021;;C11D3/0026;;C11D3/0036;;C11D3/0052;;C11D3/0068;;C11D3/373;;C11D3/42;;C11D3/48;;C11D3/50;;C11D3/505;;C11D17/0039;;C11D17/041;;C11D17/042;;C11D17/043;;C11D17/046;;C11D2111/12;;C11D17/042;;C11D3/0052;;C11D17/043;;C11D3/0068;;C11D3/50;;A47F1/08;;C11D3/0015;;C11D3/48;;C11D3/373;;C11D3/0021;;C11D17/041;;C11D17/0039;;C11D3/42;;C11D3/0026;;C11D3/0036;;C11D3/505;;C11D17/046;;C11D3/001;;C11D2111/12,C11D17/00;;A47F1/08;;B65D65/46;;C11D1/62;;C11D1/72;;C11D3/00;;C11D3/37;;C11D3/42;;C11D3/48;;C11D3/50;;C11D11/00;;C11D17/04;;C11D17/06;;D06M15/03;;D06M15/11;;D06M15/15;;D06M15/333,510/439,0,0,,,,EXPIRED
808,TW,A,TW 202313593 A,128-907-520-304-508,2023-04-01,2023,TW 111120776 A,2022-06-03,US 202163196946 P,2021-06-04,N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels,"Compounds, and pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels are provided. Also provided are pharmaceutical compositions comprising the compounds or pharmaceutically acceptable salts and methods of using the compounds, pharmaceutically acceptable salts, and pharmaceutical compositions in the treatment of various disorders, including pain.",VERTEX PHARMA,PULLIN ROBERT;;ETXEBARRIA I JARDI GORKA;;STAMOS DEAN;;SCHMIDT YVONNE;;PONTILLO JOSEPH;;THOMSON STEPHEN ANDREW;;SHAW DAVID MATTHEW;;AHMAD NADIA;;CARVALHO MEIRELES LIDIO;;SKERRATT SARAH;;HADIDA RUAH SARA S;;NEUBERT TIMOTHY DONALD;;HURLEY DENNIS JAMES;;ZHOU JINGLAN;;DURRANT STEVEN JOHN;;BECK ELIZABETH MARY;;WRAY CHRISTOPHER;;VIRANI ANISA NIZARALI;;NORTH KIRI;;DODD JAMES;;O'DONNELL MICHAEL EDWARD;;GALAN BHAIRAVI;;KNEGTEL RONALD MARCELLUS;;CHUDYK EWA IWONA;;PINDER JOANNE LOUISE,,https://lens.org/128-907-520-304-508,Patent of Addition,no,0,0,10,10,0,A61P29/00;;C07D405/12;;C07D405/12;;A61P29/00;;C07D405/12,C07D405/12;;A61K31/443;;A61P29/00,,0,0,,,,PENDING
809,HU,A2,HU P9902657 A2,043-916-073-814-153,1999-12-28,1999,HU P9902657 A,1997-05-16,HU P9902657 A;;US 1788696 P,1996-05-17,DETERGENT COMPOSITION,"A detergent composition comprises or is prepared by combining a peroxygen bleach, a bleach activator, a non-alkoxylated quaternary ammonium (non-AQA) surfactant and an AQA cationic surfactant of formula (I) R1 = substituted 8-18C alkyl, alkenyl, aryl, alkaryl, ether or glycidyl ether moiety; R2 = 1-3C alkyl; R3, R4 = H, Me or Et; X = anion; A = 1-4C alkoxy; p = 2-30. Also claimed are: (1) a method for removing soils and stains comprising contacting soils and stains with a detergent composition, or aqueous medium comprising the above detergent composition; and (2) a method for enhancing the deposition or substantivity of perfume or perfume ingredients onto fabrics or other surfaces comprising contacting the surfaces with perfume of perfume ingredient in the presence of compound (I). Use - The composition is useful for removing a variety of soils, especially hydrophobic soils, bleach sensitive soils, greasy soils or surfactant sensitive soils and stains from a variety of fabrics. The composition is in the form of granules, bar, aqueous liquid or non-aqueous liquid or tablet form. Advantage - The compositions provide superior cleaning and whiteness and also provide improved fabric care. The AQA surfactants are compatible with anionic surfactants, and perfume ingredients. The compositions can be formulated as concentrates and provide economic advantage in transportation/storage costs.",The Procter & Gamble Co.,"Asano, Kaori;;Bettiol, Jean-Luc;;Cripe, Thomas Anthony;;Cron, Laura;;Curry, John Downing;;Dodd, Ian Martin;;Foley, Peter Robert;;Hartshorn,Richard Timothy;;Katsuda, Rinko;;Kott, Kevin Lee;;Kvietok, Frank Andrej;;Manohar, Sanjeev Krishnadas;;Mao, Mark Hsiang-Kuen;;Minamikawa, Kaori;;Moss, Michael Alan John;;Murata, Susumu;;Panandiker, Rajan Keshav;;Pramod, Kakumanu;;Sarnaik, Khizar Mohamed Khan;;Scheibel, Jeffrey John;;Thoen, Christiaan Arthur Jacques Kamiel;;Willman, Kenneth William",,https://lens.org/043-916-073-814-153,Patent Application,no,0,0,1,507,0,,,,0,0,,,,PENDING
810,US,B2,US 7091171 B2,159-697-944-737-560,2006-08-15,2006,US 12187605 A,2005-05-04,US 12187605 A;;US 10579805 A;;US 92574904 A;;US 83886701 A;;US 20347200 P,2000-05-11,Laundry system having unitized dosing,"Compositions, articles and methods are provided for supplying fabric care benefits to clothing or fabrics in an automated washing machine and by manual washing. The fabric care compositions preferably have less than about 5% detergent surfactants, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. Similarly, the fabric care compositions preferably have less than about 5% fabric softener actives, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. The laundry articles can take a variety of forms in a variety of physical states all of which will rapidly dispense a unitized amount of one or more selected fabric care agents to a wash and/or rinse bath solution during the laundering process under a variety of conditions. The invention also pertains to laundry kits that contain a variety of such articles and instructions concerning their use. Likewise, methods for preparing a customized laundry solution to obtain a specific fabric care benefit selected based on the user's personal preferences and/or the fabric care needs of the fabrics being laundered are also provided. Further, the present invention also concerns methods for assisting a consumer in identifying the unitized articles to be used in preparing a laundry solution that will impart desired fabric care benefits as well as merchandising displays for dispensing the articles, assembling customized laundry kits and instructing the consumer on the selection and use of laundry articles.",PROCTER & GAMBLE,CASWELL DEBRA SUE;;WELCH ROBERT GARY;;RIDYARD MARK WILLIAM;;SAYERS EDWARD;;YORK DAVID WILLIAM;;DUFTON DANIEL JAMES;;HOWE SIMON;;ESHUIS JOHAN;;PENA-ROMERO ANGELINA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMANN WUNDRIARI;;DECKNER GEORGE ENDEL;;WAHL ERROL HOFFMAN;;MURPHY RUTH ANNE;;HENSLEY LEGAL REPRESENTATIVE B;;TRINH TOAN;;DIHORA JITEN ODHAVJI;;BAKER ELLEN SCHMIDT;;LITTIG JANET SUE;;SCHROEDER TIMOTHY JAMES;;DIERSING STEVEN LOUIS;;DODD MALCOLM MCCLAREN;;GALLON LOIS SARA,,https://lens.org/159-697-944-737-560,Granted Patent,yes,33,38,26,26,0,A47F1/08;;C11D3/001;;C11D3/0015;;C11D3/0021;;C11D3/0026;;C11D3/0036;;C11D3/0052;;C11D3/0068;;C11D3/373;;C11D3/42;;C11D3/48;;C11D3/50;;C11D3/505;;C11D17/0039;;C11D17/041;;C11D17/042;;C11D17/043;;C11D17/046;;C11D2111/12;;C11D17/042;;C11D3/0052;;C11D17/043;;C11D3/0068;;C11D3/50;;A47F1/08;;C11D3/0015;;C11D3/48;;C11D3/373;;C11D3/0021;;C11D17/041;;C11D17/0039;;C11D3/42;;C11D3/0026;;C11D3/0036;;C11D3/505;;C11D17/046;;C11D3/001;;C11D2111/12,C11D17/00;;A47F1/08;;B65D65/46;;C11D1/62;;C11D1/72;;C11D3/00;;C11D3/37;;C11D3/42;;C11D3/48;;C11D3/50;;C11D11/00;;C11D17/04;;C11D17/06;;D06M15/03;;D06M15/11;;D06M15/15;;D06M15/333,510/439;;510/431,0,0,,,,EXPIRED
811,US,B2,US 7166565 B2,168-765-984-351-29X,2007-01-23,2007,US 10579805 A,2005-04-14,US 10579805 A;;US 92574904 A;;US 83886701 A;;US 20347200 P,2000-05-11,Laundry system having unitized dosing,"Compositions, articles and methods are provided for supplying fabric care benefits to clothing or fabrics in an automated washing machine and by manual washing. The fabric care compositions preferably have less than about 5% detergent surfactants, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. Similarly, the fabric care compositions preferably have less than about 5% fabric softener actives, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. The laundry articles can take a variety of forms in a variety of physical states all of which will rapidly dispense a unitized amount of one or more selected fabric care agents to a wash and/or rinse bath solution during the laundering process under a variety of conditions. The invention also pertains to laundry kits that contain a variety of such articles and instructions concerning their use. Likewise, methods for preparing a customized laundry solution to obtain a specific fabric care benefit selected based on the user's personal preferences and/or the fabric care needs of the fabrics being laundered are also provided. Further, the present invention also concerns methods for assisting a consumer in identifying the unitized articles to be used in preparing a laundry solution that will impart desired fabric care benefits as well as merchandising displays for dispensing the articles, assembling customized laundry kits and instructing the consumer on the selection and use of laundry articles.",PROCTER & GAMBLE,CASWELL DEBRA SUE;;WELCH ROBERT GARY;;RIDYARD MARK WILLIAM;;SAYERS EDWARD;;YORK DAVID WILLIAM;;DUFTON DANIEL JAMES;;HOWE SIMON;;ESHUIS JOHAN;;PENA-ROMERO ANGELINA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMANN WUNDRIARI;;DECKNER GEORGE ENDEL;;WAHL ERROL HOFFMAN;;MURPHY RUTH ANNE;;HENSLEY LEGAL REPRESENTATIVE B;;TRINH TOAN;;DIHORA JITEN ODHAVJI;;BAKER ELLEN SCHMIDT;;LITTIG JANET SUE;;SCHROEDER TIMOTHY JAMES;;DIERSING STEVEN LOUIS;;DODD MALCOLM MCCLAREN;;GALLON LOIS SARA,,https://lens.org/168-765-984-351-29X,Granted Patent,yes,32,30,26,26,0,A47F1/08;;C11D3/001;;C11D3/0015;;C11D3/0021;;C11D3/0026;;C11D3/0036;;C11D3/0052;;C11D3/0068;;C11D3/373;;C11D3/42;;C11D3/48;;C11D3/50;;C11D3/505;;C11D17/0039;;C11D17/041;;C11D17/042;;C11D17/043;;C11D17/046;;C11D2111/12;;C11D17/042;;C11D3/0052;;C11D17/043;;C11D3/0068;;C11D3/50;;A47F1/08;;C11D3/0015;;C11D3/48;;C11D3/373;;C11D3/0021;;C11D17/041;;C11D17/0039;;C11D3/42;;C11D3/0026;;C11D3/0036;;C11D3/505;;C11D17/046;;C11D3/001;;C11D2111/12,A47F1/08;;B65D65/46;;C11D1/62;;C11D1/72;;C11D3/00;;C11D3/37;;C11D3/42;;C11D3/48;;C11D3/50;;C11D11/00;;C11D17/04;;C11D17/06;;D06M15/03;;D06M15/11;;D06M15/15;;D06M15/333,510/438;;510/439;;512/4,0,0,,,,EXPIRED
812,CA,C,CA 2405845 C,110-447-758-795-409,2011-10-04,2011,CA 2405845 A,2001-05-10,US 20347200 P;;US 83886701 A;;US 0115275 W,2000-05-11,LAUNDRY UNIT DOSE ARTICLE,"The present invention is directed to compositions, articles and methods for supplying fabric care benefits such as, improved cleaning, to clothing or fabrics in an automated washing machine and by manual washing. The fabric care compositions preferably have less than about 5% detergent surfactants, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. Similarly, the fabric care compositions preferably have less than about 5% fabric softener actives, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. The laundry articles can take a variety of forms in a variety of physical states all of which will rapidly dispense a unitized amount of one or more selected fabric care agents to a wash and/or rinse bath solution during the laundering process under a variety of conditions. The invention also pertains to laundry kits that contain a variety of such articles and instructions concerning their use. Likewise, methods for preparing a customized laundry solution to obtain a specific fabric care benefit selected based on the user's personal preferences and/or the fabric care needs of the fabrics being laundered are also provided. Further, the present invention also concerns methods for assisting a consumer in identifying the unitized articles to be used in preparing a laundry solution that will impart desired fabric care benefits as well as merchandising displays for dispensing the articles, assembling customized laundry kits and instructing the consumer on the selection and use of laundry articles.",PROCTER & GAMBLE,WELCH ROBERT GARY;;RIDYARD MARK WILLIAM;;SAYERS EDWARD;;YORK DAVID WILLIAM;;DUFTON DANIEL JAMES;;HOWE SIMON;;ESHUIS JOHAN;;ROMERO ANGELINA PENA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMANN WUNDRIARI;;DECKNER GEORGE ENDEL;;CASWELL DEBRA SUE;;WAHL ERROL HOFFMAN;;MURPHY RUTH ANNE;;HENSLEY CHARLES ALBERT;;TRINH TOAN;;DIHORA JITEN ODHAVJI;;BAKER ELLEN SCHMIDT;;LITTIG JANET SUE;;SCHROEDER TIMOTHY JAMES;;DIERSING STEVEN LOUIS;;DODD MALCOLM MCCLAREN;;GALLON LOIS SARA,,https://lens.org/110-447-758-795-409,Granted Patent,no,0,0,26,26,0,A47F1/08;;C11D3/001;;C11D3/0015;;C11D3/0021;;C11D3/0026;;C11D3/0036;;C11D3/0052;;C11D3/0068;;C11D3/373;;C11D3/42;;C11D3/48;;C11D3/50;;C11D3/505;;C11D17/0039;;C11D17/041;;C11D17/042;;C11D17/043;;C11D17/046;;C11D2111/12;;C11D17/042;;C11D3/0052;;C11D17/043;;C11D3/0068;;C11D3/50;;A47F1/08;;C11D3/0015;;C11D3/48;;C11D3/373;;C11D3/0021;;C11D17/041;;C11D17/0039;;C11D3/42;;C11D3/0026;;C11D3/0036;;C11D3/505;;C11D17/046;;C11D3/001;;C11D2111/12,C11D3/00;;A47F1/08;;A47F7/28;;B65D65/46;;C11D1/62;;C11D1/72;;C11D3/37;;C11D3/386;;C11D3/42;;C11D3/48;;C11D3/50;;C11D11/00;;C11D17/04;;C11D17/06;;D06M15/03;;D06M15/11;;D06M15/15;;D06M15/333,,0,0,,,,EXPIRED
813,US,B2,US 7534758 B2,164-053-034-477-189,2009-05-19,2009,US 26508008 A,2008-11-05,US 26508008 A;;US 33787506 A;;US 12187605 A;;US 10579805 A;;US 92574904 A;;US 83886701 A;;US 20347200 P,2000-05-11,Laundry system having unitized dosing,"Compositions, articles and methods are provided for supplying fabric care benefits to clothing or fabrics in an automated washing machine and by manual washing. The fabric care compositions preferably have less than about 5% detergent surfactants, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. Similarly, the fabric care compositions preferably have less than about 5% fabric softener actives, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. The laundry articles can take a variety of forms in a variety of physical states all of which will rapidly dispense a unitized amount of one or more selected fabric care agents to a wash and/or rinse bath solution during the laundering process under a variety of conditions. The invention also pertains to laundry kits that contain a variety of such articles and instructions concerning their use. Likewise, methods for preparing a customized laundry solution to obtain a specific fabric care benefit selected based on the user's personal preferences and/or the fabric care needs of the fabrics being laundered are also provided. Further, the present invention also concerns methods for assisting a consumer in identifying the unitized articles to be used in preparing a laundry solution that will impart desired fabric care benefits as well as merchandising displays for dispensing the articles, assembling customized laundry kits and instructing the consumer on the selection and use of laundry articles.",PROCTER & GAMBLE,CASWELL DEBRA SUE;;WELCH ROBERT GARY;;RIDYARD MARK WILLIAM;;SAYERS EDWARD;;YORK DAVID WILLIAM;;DUFTON DANIEL JAMES;;HOWE SIMON;;ESHUIS JOHAN;;PENA-ROMERO ANGELINA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMANN WUNDRIARI;;DECKNER GEORGE ENDEL;;WAHL ERROL HOFFMAN;;MURPHY RUTH ANNE;;HENSLEY LEGAL REPRESENTATIVE B;;TRINH TOAN;;DIHORA JITEN ODHAVJI;;BAKER ELLEN SCHMIDT;;LITTIG JANET SUE;;SCHROEDER TIMOTHY JAMES;;DIERSING STEVEN LOUIS;;DODD MALCOLM MCCLAREN;;GALLON LOIS SARA,,https://lens.org/164-053-034-477-189,Granted Patent,yes,34,6,26,26,0,A47F1/08;;C11D3/001;;C11D3/0015;;C11D3/0021;;C11D3/0026;;C11D3/0036;;C11D3/0052;;C11D3/0068;;C11D3/373;;C11D3/42;;C11D3/48;;C11D3/50;;C11D3/505;;C11D17/0039;;C11D17/041;;C11D17/042;;C11D17/043;;C11D17/046;;C11D2111/12;;C11D17/042;;C11D3/0052;;C11D17/043;;C11D3/0068;;C11D3/50;;A47F1/08;;C11D3/0015;;C11D3/48;;C11D3/373;;C11D3/0021;;C11D17/041;;C11D17/0039;;C11D3/42;;C11D3/0026;;C11D3/0036;;C11D3/505;;C11D17/046;;C11D3/001;;C11D2111/12,C11D3/50;;A47F1/08;;B65D65/46;;C11D1/62;;C11D1/72;;C11D3/00;;C11D3/37;;C11D3/42;;C11D3/48;;C11D11/00;;C11D17/04;;C11D17/06;;D06M15/03;;D06M15/11;;D06M15/15;;D06M15/333,510/418;;512/4,0,0,,,,EXPIRED
814,US,B2,US 7494965 B2,141-333-299-415-305,2009-02-24,2009,US 82303007 A,2007-06-26,US 82303007 A;;US 39652106 A;;US 33787506 A;;US 33787706 A;;US 12187605 A;;US 10579805 A;;US 92574904 A;;US 83886701 A;;US 20347200 P,2000-05-11,Laundry system having unitized dosing,"Compositions, articles and methods are provided for supplying fabric care benefits to clothing or fabrics in an automated washing machine and by manual washing. The fabric care compositions preferably have less than about 5% detergent surfactants, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. Similarly, the fabric care compositions preferably have less than about 5% fabric softener actives, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. The laundry articles can take a variety of forms in a variety of physical states all of which will rapidly dispense a unitized amount of one or more selected fabric care agents to a wash and/or rinse bath solution during the laundering process under a variety of conditions. The invention also pertains to laundry kits that contain a variety of such articles and instructions concerning their use. Likewise, methods for preparing a customized laundry solution to obtain a specific fabric care benefit selected based on the user's personal preferences and/or the fabric care needs of the fabrics being laundered are also provided. Further, the present invention also concerns methods for assisting a consumer in identifying the unitized articles to be used in preparing a laundry solution that will impart desired fabric care benefits as well as merchandising displays for dispensing the articles, assembling customized laundry kits and instructing the consumer on the selection and use of laundry articles.",PROCTER & GAMBLE,CASWELL DEBRA SUE;;WELCH ROBERT GARY;;RIDYARD MARK WILLIAM;;SAYERS EDWARD;;YORK DAVID WILLIAM;;DUFTON DANIEL JAMES;;HOWE SIMON;;ESHUIS JOHAN;;PENA-ROMERO ANGELINA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMANN WUNDRIARI;;DECKNER GEORGE ENDEL;;WAHL ERROL HOFFMAN;;MURPHY RUTH ANNE;;HENSLEY LEGAL REPRESENTATIVE B;;TRINH TOAN;;DIHORA JITEN ODHAVJI;;BAKER ELLEN SCHMIDT;;LITTIG JANET SUE;;SCHROEDER TIMOTHY JAMES;;DIERSING STEVEN LOUIS;;DODD MALCOLM MCCLAREN;;GALLON LOIS SARA,,https://lens.org/141-333-299-415-305,Granted Patent,yes,44,10,26,26,0,A47F1/08;;C11D3/001;;C11D3/0015;;C11D3/0021;;C11D3/0026;;C11D3/0036;;C11D3/0052;;C11D3/0068;;C11D3/373;;C11D3/42;;C11D3/48;;C11D3/50;;C11D3/505;;C11D17/0039;;C11D17/041;;C11D17/042;;C11D17/043;;C11D17/046;;C11D2111/12;;C11D17/042;;C11D3/0052;;C11D17/043;;C11D3/0068;;C11D3/50;;A47F1/08;;C11D3/0015;;C11D3/48;;C11D3/373;;C11D3/0021;;C11D17/041;;C11D17/0039;;C11D3/42;;C11D3/0026;;C11D3/0036;;C11D3/505;;C11D17/046;;C11D3/001;;C11D2111/12,C11D17/08;;A47F1/08;;B65D65/46;;C11D1/62;;C11D1/72;;C11D3/00;;C11D3/37;;C11D3/42;;C11D3/48;;C11D3/50;;C11D11/00;;C11D17/04;;C11D17/06;;D06M15/03;;D06M15/11;;D06M15/15;;D06M15/333,510/406,0,0,,,,EXPIRED
815,BR,A,BR 9710444 A,098-709-799-295-114,1999-08-17,1999,BR 9710444 A,1997-05-16,US 1788396 P;;US 9708315 W,1996-05-17,Composi-Æo de detergente,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;THOEN CHRISTIAAN ARTHUR JACQUE;;KATSUDA RINKO;;MINAMIKAWA KAORI;;CRON LAURA;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG KUEN;;BETTIOL JEAN-LUC;;MOSS MICHAEL ALAN JOHN;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;MURATA SUSUMU;;KOTT KEVIN LEE;;FOLEY PETER ROBERT;;DODD IAN MARTIN;;PANANDIKER RAJAN KESHAV;;HARTSHORN RICHARD TIMOTHY;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;WILLMAN KENNETH WILLIAM;;MANOHAR SANJEEV KRISHNADAS,,https://lens.org/098-709-799-295-114,Patent Application,no,0,0,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,0,0,,,,DISCONTINUED
816,IL,A,IL 308953 A,156-791-844-264-251,2024-01-01,2024,IL 30895323 A,2023-11-29,US 202163196946 P;;US 2022/0032116 W,2021-06-04,N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels,,VERTEX PHARMA;;BECK ELIZABETH MARY;;PULLIN ROBERT;;ETXEBARRIA JARDI GORKA;;STAMOS DEAN;;SCHMIDT YVONNE;;PONTILLO JOSEPH;;THOMSON STEPHEN ANDREW;;SHAW DAVID MATTHEW;;AHMAD NADIA M;;CARVALHO MEIRELES LIDIO MARX;;SKERRATT SARAH;;HADIDA RUAH SARA S;;NEUBERT TIMOTHY DONALD;;HURLEY DENNIS JAMES;;ZHOU JINGLAN;;DURRANT STEVEN JOHN;;WRAY CHRISTOPHER;;VIRANI ANISA NIZARALI;;NORTH KIRI;;DODD JAMES;;ODONNELL MICHAEL EDWARD;;GALAN BHAIRAVI;;KNEGTEL RONALD MARCELLUS;;CHUDYK EWA IWONA;;PINDER JOANNE LOUISE,BECK ELIZABETH MARY;;PULLIN ROBERT;;ETXEBARRIA JARDI GORKA;;STAMOS DEAN;;SCHMIDT YVONNE;;PONTILLO JOSEPH;;THOMSON STEPHEN ANDREW;;SHAW DAVID MATTHEW;;AHMAD NADIA M;;CARVALHO MEIRELES LIDIO MARX;;SKERRATT SARAH;;HADIDA RUAH SARA S;;NEUBERT TIMOTHY DONALD;;HURLEY DENNIS JAMES;;ZHOU JINGLAN;;DURRANT STEVEN JOHN;;WRAY CHRISTOPHER;;VIRANI ANISA NIZARALI;;NORTH KIRI;;DODD JAMES;;O'DONNELL MICHAEL EDWARD;;GALAN BHAIRAVI;;KNEGTEL RONALD MARCELLUS;;CHUDYK EWA IWONA;;PINDER JOANNE LOUISE,,https://lens.org/156-791-844-264-251,Patent Application,no,0,0,10,10,0,A61P29/00;;C07D405/12;;C07D405/12;;A61P29/00;;C07D405/12,A61P29/00,,0,0,,,,PENDING
817,WO,A1,WO 1997/043389 A1,089-823-044-553-560,1997-11-20,1997,US 9708437 W,1997-05-16,US 1788696 P,1996-05-17,DETERGENT COMPOSITION,"Detergent composition comprising a peroxygen bleach, a bleach activator, a non-AQA surfactant and an alkoxylated quaternary ammonium (AQA) cationic surfactant.",PROCTER & GAMBLE;;ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;BETTIOL JEAN LUC;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;KOTT KEVIN LEE;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;THOEN CHRISTIAAN ARTHUR JACQUE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;WILLMAN KENNETH WILLIAM;;MANOHAR SANJEEV KRISHNADAS,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;BETTIOL JEAN-LUC;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;KOTT KEVIN LEE;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;THOEN CHRISTIAAN ARTHUR JACQUE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;WILLMAN KENNETH WILLIAM;;MANOHAR SANJEEV KRISHNADAS,,https://lens.org/089-823-044-553-560,Patent Application,yes,5,8,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/835;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,PENDING
818,US,B2,US 7544651 B2,091-472-188-147-246,2009-06-09,2009,US 39652106 A,2006-04-03,US 39652106 A;;US 33787506 A;;US 12187605 A;;US 10579805 A;;US 92574904 A;;US 83886701 A;;US 20347200 P,2000-05-11,Laundry system having unitized dosing,"Compositions, articles and methods are provided for supplying fabric care benefits to clothing or fabrics in an automated washing machine and by manual washing. The fabric care compositions preferably have less than about 5% detergent surfactants, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. Similarly, the fabric care compositions preferably have less than about 5% fabric softener actives, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. The laundry articles can take a variety of forms in a variety of physical states all of which will rapidly dispense a unitized amount of one or more selected fabric care agents to a wash and/or rinse bath solution during the laundering process under a variety of conditions. The invention also pertains to laundry kits that contain a variety of such articles and instructions concerning their use. Likewise, methods for preparing a customized laundry solution to obtain a specific fabric care benefit selected based on the user's personal preferences and/or the fabric care needs of the fabrics being laundered are also provided. Further, the present invention also concerns methods for assisting a consumer in identifying the unitized articles to be used in preparing a laundry solution that will impart desired fabric care benefits as well as merchandising displays for dispensing the articles, assembling customized laundry kits and instructing the consumer on the selection and use of laundry articles.",PROCTER & GAMBLE,CASWELL DEBRA SUE;;WELCH ROBERT GARY;;RIDYARD MARK WILLIAM;;SAYERS EDWARD;;YORK DAVID WILLIAM;;DUFTON DANIEL JAMES;;HOWE SIMON;;ESHUIS JOHAN;;PENA-ROMERO ANGELINA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMANN WUNDRIARI;;DECKNER GEORGE ENDEL;;WAHL ERROL HOFFMAN;;MURPHY RUTH ANNE;;HENSLEY LEGAL REPRESENTATIVE B;;TRINH TOAN;;DIHORA JITEN ODHAVJI;;BAKER ELLEN SCHMIDT;;LITTIG JANET SUE;;SCHROEDER TIMOTHY JAMES;;DIERSING STEVEN LOUIS;;DODD MALCOLM MCCLAREN;;GALLON LOIS SARA,,https://lens.org/091-472-188-147-246,Granted Patent,yes,46,12,26,26,0,A47F1/08;;C11D3/001;;C11D3/0015;;C11D3/0021;;C11D3/0026;;C11D3/0036;;C11D3/0052;;C11D3/0068;;C11D3/373;;C11D3/42;;C11D3/48;;C11D3/50;;C11D3/505;;C11D17/0039;;C11D17/041;;C11D17/042;;C11D17/043;;C11D17/046;;C11D2111/12;;C11D17/042;;C11D3/0052;;C11D17/043;;C11D3/0068;;C11D3/50;;A47F1/08;;C11D3/0015;;C11D3/48;;C11D3/373;;C11D3/0021;;C11D17/041;;C11D17/0039;;C11D3/42;;C11D3/0026;;C11D3/0036;;C11D3/505;;C11D17/046;;C11D3/001;;C11D2111/12,C11D17/00;;A47F1/08;;B65D65/46;;C11D1/62;;C11D1/72;;C11D3/00;;C11D3/37;;C11D3/42;;C11D3/48;;C11D3/50;;C11D11/00;;C11D17/04;;C11D17/06;;D06M15/03;;D06M15/11;;D06M15/15;;D06M15/333,510/439,0,0,,,,EXPIRED
819,US,A1,US 2007/0111918 A1,000-766-265-285-89X,2007-05-17,2007,US 39652106 A,2006-04-03,US 39652106 A;;US 33787506 A;;US 12187605 A;;US 10579805 A;;US 92574904 A;;US 83886701 A;;US 20347200 P,2000-05-11,Laundry system having unitized dosing,"Compositions, articles and methods are provided for supplying fabric care benefits to clothing or fabrics in an automated washing machine and by manual washing. The fabric care compositions preferably have less than about 5% detergent surfactants, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. Similarly, the fabric care compositions preferably have less than about 5% fabric softener actives, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. The laundry articles can take a variety of forms in a variety of physical states all of which will rapidly dispense a unitized amount of one or more selected fabric care agents to a wash and/or rinse bath solution during the laundering process under a variety of conditions. The invention also pertains to laundry kits that contain a variety of such articles and instructions concerning their use. Likewise, methods for preparing a customized laundry solution to obtain a specific fabric care benefit selected based on the user's personal preferences and/or the fabric care needs of the fabrics being laundered are also provided. Further, the present invention also concerns methods for assisting a consumer in identifying the unitized articles to be used in preparing a laundry solution that will impart desired fabric care benefits as well as merchandising displays for dispensing the articles, assembling customized laundry kits and instructing the consumer on the selection and use of laundry articles.",CASWELL DEBRA S;;WELCH ROBERT G;;RIDYARD MARK W;;SAYERS EDWARD;;YORK DAVID W;;DUFTON DANIEL J;;HOWE SIMON;;ESHUIS JOHAN;;PENA-ROMERO ANGELINA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMANN WUNDRIARI;;DECKNER GEORGE E;;WAHL ERROL H;;MURPHY RUTH A;;HENSLEY CHARLES A;;HENSLEY BETTY J;;TRINH TOAN;;DIHORA JITEN O;;BAKER ELLEN S;;LITTIG JANET S;;SCHROEDER TIMOTHY J;;DIERSING STEVEN L;;DODD MALCOLM M;;GALLON LOIS S,CASWELL DEBRA S;;WELCH ROBERT G;;RIDYARD MARK W;;SAYERS EDWARD;;YORK DAVID W;;DUFTON DANIEL J;;HOWE SIMON;;ESHUIS JOHAN;;PENA-ROMERO ANGELINA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMANN WUNDRIARI;;DECKNER GEORGE E;;WAHL ERROL H;;MURPHY RUTH A;;HENSLEY CHARLES A;;HENSLEY BETTY J;;TRINH TOAN;;DIHORA JITEN O;;BAKER ELLEN S;;LITTIG JANET S;;SCHROEDER TIMOTHY J;;DIERSING STEVEN L;;DODD MALCOLM M;;GALLON LOIS S,,https://lens.org/000-766-265-285-89X,Patent Application,yes,29,14,26,26,0,A47F1/08;;C11D3/001;;C11D3/0015;;C11D3/0021;;C11D3/0026;;C11D3/0036;;C11D3/0052;;C11D3/0068;;C11D3/373;;C11D3/42;;C11D3/48;;C11D3/50;;C11D3/505;;C11D17/0039;;C11D17/041;;C11D17/042;;C11D17/043;;C11D17/046;;C11D2111/12;;C11D17/042;;C11D3/0052;;C11D17/043;;C11D3/0068;;C11D3/50;;A47F1/08;;C11D3/0015;;C11D3/48;;C11D3/373;;C11D3/0021;;C11D17/041;;C11D17/0039;;C11D3/42;;C11D3/0026;;C11D3/0036;;C11D3/505;;C11D17/046;;C11D3/001;;C11D2111/12,C11D17/00;;A47F1/08;;B65D65/46;;C11D1/62;;C11D1/72;;C11D3/00;;C11D3/37;;C11D3/42;;C11D3/48;;C11D3/50;;C11D11/00;;C11D17/04;;C11D17/06;;D06M15/03;;D06M15/11;;D06M15/15;;D06M15/333,510/439,0,0,,,,EXPIRED
820,CA,A1,CA 2254947 A1,066-290-144-472-158,1997-11-27,1997,CA 2254947 A,1997-05-16,US 1788396 P;;US 9708315 W,1996-05-17,DETERGENT COMPOSITION,"Detergent composition comprising a peroxygen bleach, a bleach activator, a nonAQA surfactant and a bis-alkoxylated quaternary ammonium (bis-AQA) cationic surfactants.",PROCTER & GAMBLE,CRIPE THOMAS ANTHONY;;KATSUDA RINKO;;MURATA SUSUMU;;ASANO KAORI;;HARTSHORN RICHARD TIMOTHY;;CURRY JOHN DOWNING;;THOEN CHRISTIAAN ARTHUR JACQUE;;MOSS MICHAEL ALAN JOHN;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;CRON LAURA;;FOLEY PETER ROBERT;;MINAMIKAWA KAORI;;PRAMOD KAKUMANU;;MANOHAR SANJEEV KRISHNADAS;;WILLMAN KENNETH WILLIAM;;SARNAIK KHIZAR MOHAMED KHAN;;DODD IAN MARTIN;;BETTIOL JEAN-LUC;;PANANDIKER RAJAN KESHAV;;SCHEIBEL JEFFREY JOHN;;KOTT KEVIN LEE,,https://lens.org/066-290-144-472-158,Patent Application,no,0,0,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,0,0,,,,DISCONTINUED
821,US,B2,US 7186680 B2,185-523-177-374-860,2007-03-06,2007,US 33787706 A,2006-01-23,US 33787706 A;;US 12187605 A;;US 10579805 A;;US 92574904 A;;US 83886701 A;;US 20347200 P,2000-05-11,Laundry system having unitized dosing,"Compositions, articles and methods are provided for supplying fabric care benefits to clothing or fabrics in an automated washing machine and by manual washing. The fabric care compositions preferably have less than about 5% detergent surfactants, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. Similarly, the fabric care compositions preferably have less than about 5% fabric softener actives, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. The laundry articles can take a variety of forms in a variety of physical states all of which will rapidly dispense a unitized amount of one or more selected fabric care agents to a wash and/or rinse bath solution during the laundering process under a variety of conditions. The invention also pertains to laundry kits that contain a variety of such articles and instructions concerning their use. Likewise, methods for preparing a customized laundry solution to obtain a specific fabric care benefit selected based on the user's personal preferences and/or the fabric care needs of the fabrics being laundered are also provided. Further, the present invention also concerns methods for assisting a consumer in identifying the unitized articles to be used in preparing a laundry solution that will impart desired fabric care benefits as well as merchandising displays for dispensing the articles, assembling customized laundry kits and instructing the consumer on the selection and use of laundry articles.",PROCTER & GAMBLE,CASWELL DEBRA SUE;;WELCH ROBERT GARY;;RIDYARD MARK WILLIAM;;SAYERS EDWARD;;YORK DAVID WILLIAM;;DUFTON DANIEL JAMES;;HOWE SIMON;;ESHUIS JOHAN;;PENA-ROMERO ANGELINA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMANN WUNDRIARI;;DECKNER GEORGE ENDEL;;WAHL ERROL HOFFMAN;;MURPHY RUTH ANNE;;HENSLEY LEGAL REPRESENTATIVE B;;TRINH TOAN;;DIHORA JITEN ODHAVJI;;BAKER ELLEN SCHMIDT;;LITTIG JANET SUE;;SCHROEDER TIMOTHY JAMES;;DIERSING STEVEN LOUIS;;DODD MALCOLM MCCLAREN;;GALLON LOIS SARA,,https://lens.org/185-523-177-374-860,Granted Patent,yes,42,80,26,26,0,A47F1/08;;C11D3/001;;C11D3/0015;;C11D3/0021;;C11D3/0026;;C11D3/0036;;C11D3/0052;;C11D3/0068;;C11D3/373;;C11D3/42;;C11D3/48;;C11D3/50;;C11D3/505;;C11D17/0039;;C11D17/041;;C11D17/042;;C11D17/043;;C11D17/046;;C11D2111/12;;C11D17/042;;C11D3/0052;;C11D17/043;;C11D3/0068;;C11D3/50;;A47F1/08;;C11D3/0015;;C11D3/48;;C11D3/373;;C11D3/0021;;C11D17/041;;C11D17/0039;;C11D3/42;;C11D3/0026;;C11D3/0036;;C11D3/505;;C11D17/046;;C11D3/001;;C11D2111/12,A47F1/08;;B65D65/46;;C11D1/62;;C11D1/72;;C11D3/00;;C11D3/37;;C11D3/42;;C11D3/48;;C11D3/50;;C11D11/00;;C11D17/04;;C11D17/06;;D06M15/03;;D06M15/11;;D06M15/15;;D06M15/333,512/4,0,0,,,,EXPIRED
822,CA,A1,CA 3221259 A1,042-276-639-991-097,2022-12-08,2022,CA 3221259 A,2022-06-03,US 202163196946 P;;US 2022/0032116 W,2021-06-04,N-(HYDROXYALKYL (HETERO)ARYL) TETRAHYDROFURAN CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS,"Compounds of formula I and pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels are provided. Also provided are pharmaceutical compositions comprising the compounds or pharmaceutically acceptable salts and methods of using the compounds, pharmaceutically acceptable salts, and pharmaceutical compositions in the treatment of various disorders, including pain.",VERTEX PHARMA,BECK ELIZABETH MARY;;PULLIN ROBERT;;ETXEBARRIA JARDI GORKA;;STAMOS DEAN;;SCHMIDT YVONNE;;PONTILLO JOSEPH;;THOMSON STEPHEN ANDREW;;SHAW DAVID MATTHEW;;AHMAD NADIA M;;CARVALHO MEIRELES LIDIO MARX;;SKERRATT SARAH;;HADIDA RUAH SARA S;;NEUBERT TIMOTHY DONALD;;HURLEY DENNIS JAMES;;ZHOU JINGLAN;;DURRANT STEVEN JOHN;;WRAY CHRISTOPHER;;VIRANI ANISA NIZARALI;;NORTH KIRI;;DODD JAMES;;O'DONNELL MICHAEL EDWARD;;GALAN BHAIRAVI;;KNEGTEL RONALD MARCELLUS;;CHUDYK EWA IWONA;;PINDER JOANNE LOUISE,,https://lens.org/042-276-639-991-097,Patent Application,no,0,0,10,10,0,A61P29/00;;C07D405/12;;C07D405/12;;A61P29/00;;C07D405/12,A61K31/443;;A61P29/00;;C07D405/12,,0,0,,,,PENDING
823,US,A1,US 2005/0202990 A1,160-339-751-858-10X,2005-09-15,2005,US 12187605 A,2005-05-04,US 12187605 A;;US 10579805 A;;US 92574904 A;;US 83886701 A;;US 20347200 P,2000-05-11,Laundry system having unitized dosing,"Compositions, articles and methods are provided for supplying fabric care benefits to clothing or fabrics in an automated washing machine and by manual washing. The fabric care compositions preferably have less than about 5% detergent surfactants, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. Similarly, the fabric care compositions preferably have less than about 5% fabric softener actives, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. The laundry articles can take a variety of forms in a variety of physical states all of which will rapidly dispense a unitized amount of one or more selected fabric care agents to a wash and/or rinse bath solution during the laundering process under a variety of conditions. The invention also pertains to laundry kits that contain a variety of such articles and instructions concerning their use. Likewise, methods for preparing a customized laundry solution to obtain a specific fabric care benefit selected based on the user's personal preferences and/or the fabric care needs of the fabrics being laundered are also provided. Further, the present invention also concerns methods for assisting a consumer in identifying the unitized articles to be used in preparing a laundry solution that will impart desired fabric care benefits as well as merchandising displays for dispensing the articles, assembling customized laundry kits and instructing the consumer on the selection and use of laundry articles.",PROCTER & GAMBLE,CASWELL DEBRA S;;WELCH ROBERT G;;RIDYARD MARK W;;SAYERS EDWARD;;YORK DAVID W;;DUFTON DANIEL J;;HOWE SIMON;;ESHUIS JOHAN;;PENA-ROMERO ANGELINA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMANN WUNDRIARI;;DECKNER GEORGE E;;WAHL ERROL H;;MURPHY RUTH A;;HENSLEY CHARLES A;;HENSLEY BETTY J;;TRINH TOAN;;DIHORA JITEN O;;BAKER ELLEN S;;LITTIG JANET S;;SCHROEDER TIMOTHY J;;DIERSING STEVEN L;;DODD MALCOLM M;;GALLON LOIS S,,https://lens.org/160-339-751-858-10X,Patent Application,yes,17,29,26,26,0,A47F1/08;;C11D3/001;;C11D3/0015;;C11D3/0021;;C11D3/0026;;C11D3/0036;;C11D3/0052;;C11D3/0068;;C11D3/373;;C11D3/42;;C11D3/48;;C11D3/50;;C11D3/505;;C11D17/0039;;C11D17/041;;C11D17/042;;C11D17/043;;C11D17/046;;C11D2111/12;;C11D17/042;;C11D3/0052;;C11D17/043;;C11D3/0068;;C11D3/50;;A47F1/08;;C11D3/0015;;C11D3/48;;C11D3/373;;C11D3/0021;;C11D17/041;;C11D17/0039;;C11D3/42;;C11D3/0026;;C11D3/0036;;C11D3/505;;C11D17/046;;C11D3/001;;C11D2111/12,A47F1/08;;B65D65/46;;C11D1/62;;C11D1/72;;C11D3/00;;C11D3/37;;C11D3/42;;C11D3/48;;C11D3/50;;C11D11/00;;C11D17/04;;C11D17/06;;D06M15/03;;D06M15/11;;D06M15/15;;D06M15/333,510/295,0,0,,,,EXPIRED
824,AU,A1,AU 2022/284886 A1,012-114-038-318-374,2023-11-30,2023,AU 2022/284886 A,2022-06-03,US 202163196946 P;;US 2022/0032116 W,2021-06-04,N-(HYDROXYALKYL (HETERO)ARYL) TETRAHYDROFURAN CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS,"Compounds of formula I and pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels are provided. Also provided are pharmaceutical compositions comprising the compounds or pharmaceutically acceptable salts and methods of using the compounds, pharmaceutically acceptable salts, and pharmaceutical compositions in the treatment of various disorders, including pain.",VERTEX PHARMA,BECK ELIZABETH;;PULLIN ROBERT;;ETXEBARRIA JARDI GORKA;;STAMOS DEAN;;SCHMIDT YVONNE;;PONTILLO JOSEPH;;THOMSON STEPHEN ANDREW;;SHAW DAVID MATTHEW;;AHMAD NADIA M;;CARVALHO MEIRELES LIDIO MARX;;SKERRATT SARAH;;HADIDA RUAH SARA S;;NEUBERT TIMOTHY DONALD;;HURLEY DENNIS JAMES;;ZHOU JINGLAN;;DURRANT STEVEN JOHN;;WRAY CHRISTOPHER;;VIRANI ANISA NIZARALI;;NORTH KIRI;;DODD JAMES;;O'DONNELL MICHAEL EDWARD;;GALAN BHAIRAVI;;KNEGTEL RONALD MARCELLUS;;CHUDYK EWA IWONA;;PINDER JOANNE LOUISE,,https://lens.org/012-114-038-318-374,Patent Application,no,0,0,10,10,0,A61P29/00;;C07D405/12;;C07D405/12;;A61P29/00;;C07D405/12,A61P29/00;;A61K31/443;;C07D405/12,,0,0,,,,PENDING
825,US,A1,US 2005/0176611 A1,009-573-484-222-035,2005-08-11,2005,US 10579805 A,2005-04-14,US 10579805 A;;US 92574904 A;;US 83886701 A;;US 20347200 P,2000-05-11,Laundry system having unitized dosing,"Compositions, articles and methods are provided for supplying fabric care benefits to clothing or fabrics in an automated washing machine and by manual washing. The fabric care compositions preferably have less than about 5% detergent surfactants, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. Similarly, the fabric care compositions preferably have less than about 5% fabric softener actives, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. The laundry articles can take a variety of forms in a variety of physical states all of which will rapidly dispense a unitized amount of one or more selected fabric care agents to a wash and/or rinse bath solution during the laundering process under a variety of conditions. The invention also pertains to laundry kits that contain a variety of such articles and instructions concerning their use. Likewise, methods for preparing a customized laundry solution to obtain a specific fabric care benefit selected based on the user's personal preferences and/or the fabric care needs of the fabrics being laundered are also provided. Further, the present invention also concerns methods for assisting a consumer in identifying the unitized articles to be used in preparing a laundry solution that will impart desired fabric care benefits as well as merchandising displays for dispensing the articles, assembling customized laundry kits and instructing the consumer on the selection and use of laundry articles.",CASWELL DEBRA S.;;WELCH ROBERT G.;;RIDYARD MARK W.;;SAYERS EDWARD;;YORK DAVID W.;;DUFTON DANIEL J.;;HOWE SIMON;;ESHUIS JOHAN;;PENA-ROMERO ANGELINA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMANN WUNDRIARI;;DECKNER GEORGE E.;;WAHL ERROL H.;;MURPHY RUTH A.;;HENSLEY CHARLES A.;;TRINH TOAN;;DIHORA JITEN O.;;BAKER ELLEN S.;;LITTIG JANET S.;;SCHROEDER TIMOTHY J.;;DIERSING STEVEN L.;;DODD MALCOLM M.;;GALLON LOIS S.,CASWELL DEBRA S;;WELCH ROBERT G;;RIDYARD MARK W;;SAYERS EDWARD;;YORK DAVID W;;DUFTON DANIEL J;;HOWE SIMON;;ESHUIS JOHAN;;PENA-ROMERO ANGELINA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMANN WUNDRIARI;;DECKNER GEORGE E;;WAHL ERROL H;;MURPHY RUTH A;;HENSLEY CHARLES A;;TRINH TOAN;;DIHORA JITEN O;;BAKER ELLEN S;;LITTIG JANET S;;SCHROEDER TIMOTHY J;;DIERSING STEVEN L;;DODD MALCOLM M;;GALLON LOIS S,,https://lens.org/009-573-484-222-035,Patent Application,yes,16,12,26,26,0,A47F1/08;;C11D3/001;;C11D3/0015;;C11D3/0021;;C11D3/0026;;C11D3/0036;;C11D3/0052;;C11D3/0068;;C11D3/373;;C11D3/42;;C11D3/48;;C11D3/50;;C11D3/505;;C11D17/0039;;C11D17/041;;C11D17/042;;C11D17/043;;C11D17/046;;C11D2111/12;;C11D17/042;;C11D3/0052;;C11D17/043;;C11D3/0068;;C11D3/50;;A47F1/08;;C11D3/0015;;C11D3/48;;C11D3/373;;C11D3/0021;;C11D17/041;;C11D17/0039;;C11D3/42;;C11D3/0026;;C11D3/0036;;C11D3/505;;C11D17/046;;C11D3/001;;C11D2111/12,A47F1/08;;B65D65/46;;C11D1/62;;C11D1/72;;C11D3/00;;C11D3/37;;C11D3/42;;C11D3/48;;C11D3/50;;C11D11/00;;C11D17/04;;C11D17/06;;D06M15/03;;D06M15/11;;D06M15/15;;D06M15/333,510/295,0,0,,,,EXPIRED
826,US,A1,US 2006/0123556 A1,131-802-350-195-27X,2006-06-15,2006,US 33787506 A,2006-01-23,US 33787506 A;;US 12187605 A;;US 10579805 A;;US 92574904 A;;US 83886701 A;;US 20347200 P,2000-05-11,Laundry system having unitized dosing,"Compositions, articles and methods are provided for supplying fabric care benefits to clothing or fabrics in an automated washing machine and by manual washing. The fabric care compositions preferably have less than about 5% detergent surfactants, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. Similarly, the fabric care compositions preferably have less than about 5% fabric softener actives, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. The laundry articles can take a variety of forms in a variety of physical states all of which will rapidly dispense a unitized amount of one or more selected fabric care agents to a wash and/or rinse bath solution during the laundering process under a variety of conditions. The invention also pertains to laundry kits that contain a variety of such articles and instructions concerning their use. Likewise, methods for preparing a customized laundry solution to obtain a specific fabric care benefit selected based on the user's personal preferences and/or the fabric care needs of the fabrics being laundered are also provided. Further, the present invention also concerns methods for assisting a consumer in identifying the unitized articles to be used in preparing a laundry solution that will impart desired fabric care benefits as well as merchandising displays for dispensing the articles, assembling customized laundry kits and instructing the consumer on the selection and use of laundry articles.",CASWELL DEBRA S;;WELCH ROBERT G;;RIDYARD MARK W;;SAYERS EDWARD;;YORK DAVID W;;DUFTON DANIEL J;;HOWE SIMON;;ESHUIS JOHAN;;PENA-ROMERO ANGELINA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMANN WUNDRIARI;;DECKNER GEORGE E;;WAHL ERROL H;;HENSLEY CHARLES A;;MURPHY RUTH A;;TRINH TOAN;;DIHORA JITEN O;;BAKER ELLEN S;;LITTIG JANET S;;SCHROEDER TIMOTHY J;;DIERSING STEVEN L;;DODD MALCOLM M;;GALLON LOIS S,CASWELL DEBRA S;;WELCH ROBERT G;;RIDYARD MARK W;;SAYERS EDWARD;;YORK DAVID W;;DUFTON DANIEL J;;HOWE SIMON;;ESHUIS JOHAN;;PENA-ROMERO ANGELINA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMANN WUNDRIARI;;DECKNER GEORGE E;;WAHL ERROL H;;HENSLEY CHARLES A;;MURPHY RUTH A;;TRINH TOAN;;DIHORA JITEN O;;BAKER ELLEN S;;LITTIG JANET S;;SCHROEDER TIMOTHY J;;DIERSING STEVEN L;;DODD MALCOLM M;;GALLON LOIS S,,https://lens.org/131-802-350-195-27X,Patent Application,yes,21,16,26,26,0,A47F1/08;;C11D3/001;;C11D3/0015;;C11D3/0021;;C11D3/0026;;C11D3/0036;;C11D3/0052;;C11D3/0068;;C11D3/373;;C11D3/42;;C11D3/48;;C11D3/50;;C11D3/505;;C11D17/0039;;C11D17/041;;C11D17/042;;C11D17/043;;C11D17/046;;C11D2111/12;;C11D17/042;;C11D3/0052;;C11D17/043;;C11D3/0068;;C11D3/50;;A47F1/08;;C11D3/0015;;C11D3/48;;C11D3/373;;C11D3/0021;;C11D17/041;;C11D17/0039;;C11D3/42;;C11D3/0026;;C11D3/0036;;C11D3/505;;C11D17/046;;C11D3/001;;C11D2111/12,C11D3/00;;A47F1/08;;B65D65/46;;C11D1/62;;C11D1/72;;C11D3/37;;C11D3/42;;C11D3/48;;C11D3/50;;C11D11/00;;C11D17/00;;C11D17/04;;C11D17/06;;D06M15/03;;D06M15/11;;D06M15/15;;D06M15/333,8/115.51;;510/296,0,0,,,,DISCONTINUED
827,US,B2,US 11827627 B2,050-476-998-995-969,2023-11-28,2023,US 202217831842 A,2022-06-03,US 202217831842 A;;US 202163196946 P,2021-06-04,N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels,"Compounds, and pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels are provided. Also provided are pharmaceutical compositions comprising the compounds or pharmaceutically acceptable salts and methods of using the compounds, pharmaceutically acceptable salts, and pharmaceutical compositions in the treatment of various disorders, including pain.",VERTEX PHARMA,BECK ELIZABETH MARY;;DURRANT STEVEN JOHN;;SKERRATT SARAH;;PULLIN ROBERT;;ETXEBARRIA JARDI GORKA;;SHAW DAVID MATTHEW;;AHMAD NADIA M;;WRAY CHRISTOPHER;;VIRANI ANISA NIZARALI;;NORTH KIRI;;DODD JAMES;;O'DONNELL MICHAEL EDWARD;;GALAN BHAIRAVI;;KNEGTEL RONALD MARCELLUS;;CHUDYK EWA IWONA;;PINDER JOANNE LOUISE;;THOMSON STEPHEN ANDREW;;CARVALHO MEIRELES LIDIO MARX;;STAMOS DEAN;;SCHMIDT YVONNE;;PONTILLO JOSEPH;;HADIDA RUAH SARA S;;NEUBERT TIMOTHY DONALD;;HURLEY DENNIS JAMES;;ZHOU JINGLAN,VERTEX PHARMACEUTICALS (SAN DIEGO) LLC (2022-10-07);;VERTEX PHARMACEUTICALS (EUROPE) LIMITED (2022-08-15);;VERTEX PHARMACEUTICALS INCORPORATED (2022-07-15),https://lens.org/050-476-998-995-969,Granted Patent,yes,520,0,10,10,0,A61P29/00;;C07D405/12;;C07D405/12;;A61P29/00;;C07D405/12,C07D405/12,,43,34,035-867-257-680-438;;006-743-274-787-556;;039-124-108-066-758;;116-388-299-398-826;;002-249-641-643-302;;026-916-898-963-990;;004-651-227-961-899;;011-670-359-792-190;;015-192-349-156-432;;015-091-099-493-846;;003-432-292-146-78X;;072-135-896-348-317;;040-954-007-621-052;;018-528-636-825-26X;;029-966-049-767-156;;110-518-998-264-258;;011-853-331-771-066;;025-012-153-359-707;;081-308-956-968-657;;100-213-476-331-142;;058-348-862-479-038;;039-644-522-243-747;;048-449-774-363-270;;092-790-784-326-144;;048-739-017-964-226;;140-468-563-020-882;;002-538-222-031-88X;;019-905-324-201-535;;047-633-914-386-647;;032-258-978-889-474;;084-965-079-491-373;;055-976-617-949-487;;081-001-738-908-270;;008-410-109-917-270,8538791;;10.1038/379257a0;;19107992;;10.1002/ana.21527;;12451128;;pmc6758735;;10.1523/jneurosci.22-23-10277.2002;;10.1124/pr.57.4.4;;16382098;;10.2174/187152708784083830;;18537643;;21940606;;10.1152/jn.00100.2011;;10692601;;10.1016/s0304-3959(99)00251-1;;18439759;;10.1016/j.pain.2008.03.002;;10.1021/jm400487c;;23808545;;10.1016/j.neuroscience.2007.01.054;;17367951;;19012501;;10.1517/13543780802514559;;10.1007/978-1-4939-3043-2_5;;10.1007/978-1-59745-457-5_5;;26820855;;17951767;;10.1016/s1074-5521(97)90070-3;;9195864;;8534797;;10.1016/s0006-3495(95)80029-9;;pmc1236357;;10.1016/b978-0-12-386009-5.00003-5;;10.1038/nbt1194;;16550174;;pmc2525634;;10.1186/1744-8069-4-33;;18700027;;17483457;;pmc1895982;;10.1073/pnas.0611364104;;10.1016/j.pain.2006.02.011;;16545521;;925860;;10.1248/yakushi1947.97.6_676;;10.1016/j.coph.2007.09.007;;17964852;;11790477;;10.1016/s0304-3959(01)00391-8;;10.1021/acs.joc.5b00489;;25849746;;22342308;;10.1016/j.neulet.2012.01.069;;10.1152/jn.2001.86.2.629;;11495938;;10.1113/jphysiol.2003.046110;;12824446;;pmc2343086;;pmc3220569;;21965668;;10.1074/jbc.m111.261701;;10.1124/mi.7.4.4;;17827438;;pmc1472458;;16702558;;10.1073/pnas.0602813103;;10.1053/eujp.2001.0315;;11888234;;17950013;;10.1016/j.ejpain.2007.09.001;;10.1093/brain/awr345;;22271663;;10.1007/s00232-008-9103-y;;18418539;;10.1016/s0014-5793(00)01166-2;;10675548,"Akopian, A.N., L. Sivilotti, and J.N. Wood, A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature, 1996. 379(6562): p. 257-62.;;Berge et al. describe pharmaceutically acceptable salts in detail in J. Pharmaceutical Sciences, 1977, 66, 1-19.;;Black, J.A., et al., Multiple sodium channel isoforms and mitogen-activated protein kinases are present in painful human neuromas. Ann. Neurol., 2008. 64(6): p. 644-53.;;Blair, N.T. and B.P. Bean, Roles of tetrodotoxin (TTX)-sensitive Na+ current, TTX-resistant Na+ current, and Ca2+ current in the action potentials of nociceptive sensory neurons. J. Neurosci., 2002. 22(23): p. 10277-90.;;CAS No. 169211-44-3; 5-[3-(1,3-dihexylhexahydro-4,6-dioxo-2-thioxo-5-pyrimidinyl)-2-propen-1-ylidene]-1,3-dihexyldihydro-2-thioxo-4,6(1H,5H)-pyrimidinedione.;;CAS No. 393782-57-5; tetradecanoic acid, 1,1′-[(1R)-1-[8-(6-chloro-7-hydroxy-2-oxo-2H-1-benzopyran-3-yl)-3-hydroxy-3-oxido-8-oxo-2,4-dioxa-7-aza-3-phosphaoct-1-yl]-1,2-ethanediyl] ester).;;CAS Registry Compounds, database entry dates no later than Oct. 2017.;;CAS Registry Compounds, database entry dates no later than Sep. 2018.;;Catterall, W. A., Goldin, A. L., and Waxman, S. G., International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol. Rev. 57 (4), p. 397 (2005).;;Chahine, M., Chatelier, A., Babich, O., and Krupp, J. J., Voltage-gated sodium channels in neurological disorders. CNS Neurol. Disord. Drug Targets 7 (2), p. 144-58 (2008).;;Choi, J.S. and S.G. Waxman, Physiological interactions between Nav1.7 and Nav1.8 sodium channels: a computer simulation study. J. Neurophysiol. 106(6): p. 3173-84.;;Coward, K., et al., Immunolocalization of SNS/PN3 and NaN/SNS2 sodium channels in human pain states. Pain, 2000. 85(1-2): p. 41-50.;;Dieleman, J.P., et al., Incidence rates and treatment of neuropathic pain conditions in the general population. Pain, 2008. 137(3): p. 681-8.;;Ding, Qingjie et al., “Discovery of RG7388, a Potent and Selective p53-MDM2 Inhibitor in Clinical Development,” J. Med. Chem., 56(14), pp. 5979-5983 (2013).;;Dong, X.W., et al., Small interfering RNA-mediated selective knockdown of Nav1.8 tetrodotoxin-resistant sodium channel reverses mechanical allodynia in neuropathic rats. Neuroscience, 2007. 146(2): p. 812-21.;;England, S., Voltage-gated sodium channels: the search for subtype-selective analgesics. Expert Opin. Investig. Drugs 17 (12), p. 1849-64 (2008).;;Fornwald et al., Gene Expression in Mammalian Cells Using BacMam, a Modified Baculovirus System, 1350 Methods in Molecular Biology 95-116 (2016).;;Gonzalez, J.E. and Tsien, R.Y. “Improved indicators of cell membrane potential that use fluorescence resonance energy transfer,” (1997) Chem. Biol. 4, 269-277.;;Gonzalez, J.E. and Tsien, R.Y., “Voltage Sensing by Fluorescence Resonance Energy Transfer in Single Cells,” (1995) Biophys. J. 69, 1272-1280.;;Harbeson, S. L. and Tung, R. D., Deuterium In Drug Discovery and Development, Ann. Rep. Med. Chem. 2011, 46, 403-417.;;Huang et al. Characterization of voltage-gated sodium channel blockers by electrical stimulation and fluorescence detection of membrane potential, 24 Nature Biotech. 439-46 (2006).;;Huang, H.L., et al., Proteomic profiling of neuromas reveals alterations in protein composition and local protein synthesis in hyper-excitable nerves. Mol. Pain, 2008. 4: p. 33.;;International Search Report and Written Opinion for PCT/US2020/063290, dated Feb. 2, 2021, 13 pgs.;;International Search Report and Written Opinion for PCT/US2022/032116, dated Sep. 23, 2022, 13 pgs.;;Jarvis, M.F., et al., A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Proc. Natl. Acad. Sci. USA, 2007. 104(20): p. 8520-5.;;Joshi, S.K., et al., Involvement of the TTX-resistant sodium channel Nav1.8 in inflammatory and neuropathic, but not post-operative, pain states. Pain, 2006. 123(1-2): pp. 75-82.;;Kato, Tetsuzo et al., “Antitumor activity of compounds derived from diketene and their related compounds,” Pharm. Inst., 97(6), pp. 676-684 (1977).;;Krafte, D. S. and Bannon, A. W., Sodium channels and nociception: recent concepts and therapeutic opportunities. Curr. Opin. Pharmacol. 8 (1), p. 50-56 (2008).;;Lai, J., et al., Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, Nav1.8. Pain, 2002. 95(1-2): p. 143-52.;;Liu, Jianzhong et al.,“Pd(II)—Catalyzed Pyridine N-Oxides Directed Arylation of Unactivated Csp3-H Bonds,” Am. Chem. Society, 80(9), pp. 4618-4626 (2015).;;National Center for Biotechnology Information (2022); Pub Chem Compound Summary for CID 136583999, Created Jan. 24, 2019; Retrieved Apr. 1, 2022 from https://pubchem.ncbi.nim.nih.gov/compound/136583999 (Year: 2019).;;Qiu, F., et al., Increased expression of tetrodotoxin-resistant sodium channels Nav1.8 and Nav1.9 within dorsal root ganglia in a rat model of bone cancer pain. Neurosci. Lett., 512(2): p. 61-6.;;Renganathan, M., T.R. Cummins, and S.G. Waxman, Contribution of Na(v)1.8 sodium channels to action potential electrogenesis in DRG neurons. J. Neurophysiol., 2001. 86(2): p. 629-40.;;Roza, C., et al., The tetrodotoxin-resistant Na+ channel Nav1.8 is essential for the expression of spontaneous activity in damaged sensory axons of mice. J. Physiol., 2003. 550(Pt 3): p. 921-6.;;Ruangsri, S., et al., Relationship of axonal voltage-gated sodium channel 1.8 (Nav1.8) mRNA accumulation to sciatic nerve injury-induced painful neuropathy in rats. J. Biol. Chem. 286(46): p. 39836-47).;;Rush, A.M. and T.R. Cummins, Painful Research: Identification of a Small-Molecule Inhibitor that Selectively Targets Nav1.8 Sodium Channels. Mol. Interv., 2007. 7(4): p. 192-5).;;Rush, A.M., et al., A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons. Proc. Natl. Acad. Sci. USA, 2006. 103(21): p. 8245-50).;;Soderpalm, B., Anticonvulsants: aspects of their mechanisms of action. Eur. J. Pain 6 Suppl. A, p. 3-9 (2002).;;Strickland, I.T., et al., Changes in the expression of Nav1.7, Nav1.8 and Nav1.9 in a distinct population of dorsal root ganglia innervating the rat knee joint in a model of chronic inflammatory joint pain. Eur. J. Pain, 2008. 12(5): p. 564-72.;;Sun, W., et al., Reduced conduction failure of the main axon of polymodal nociceptive C-fibers contributes to painful diabetic neuropathy in rats. Brain, 135(Pt 2): p. 359-75.;;Wang et al., “NHC-Catalyzed Asymmetric Synthesis of Functionalized Succinimides from Enals and α-Ketoamides,” Chem. A EP Jour. 21(22), (2015), pp. 8033-8037.;;Wang, G. K., Mitchell, J., and Wang, S. Y., Block of persistent late Na+ currents by antidepressant sertraline and paroxetine. J. Membr. Biol. 222 (2), p. 79-90 (2008).;;Yiangou, Y., et al., SNS/PN3 and SNS2/NaN sodium channel-like immunoreactivity in human adult and neonate injured sensory nerves. FEBS Lett., 2000. 467(2-3): p. 249-52.",ACTIVE
828,US,A1,US 2010/0035789 A1,067-837-981-711-34X,2010-02-11,2010,US 50859609 A,2009-07-24,US 50859609 A;;US 33787506 A;;US 33787706 A;;US 12187605 A;;US 10579805 A;;US 92574904 A;;US 83886701 A;;US 20347200 P,2000-05-11,Laundry System Having Unitized Dosing,"Compositions, articles and methods are provided for supplying fabric care benefits to clothing or fabrics in an automated washing machine and by manual washing. The fabric care compositions preferably have less than about 5% detergent surfactants, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. Similarly, the fabric care compositions preferably have less than about 5% fabric softener actives, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. The laundry articles can take a variety of forms in a variety of physical states all of which will rapidly dispense a unitized amount of one or more selected fabric care agents to a wash and/or rinse bath solution during the laundering process under a variety of conditions. The invention also pertains to laundry kits that contain a variety of such articles and instructions concerning their use. Likewise, methods for preparing a customized laundry solution to obtain a specific fabric care benefit selected based on the user's personal preferences and/or the fabric care needs of the fabrics being laundered are also provided. Further, the present invention also concerns methods for assisting a consumer in identifying the unitized articles to be used in preparing a laundry solution that will impart desired fabric care benefits as well as merchandising displays for dispensing the articles, assembling customized laundry kits and instructing the consumer on the selection and use of laundry articles.",CASWELL DEBRA SUE;;WELCH ROBERT GARY;;RIDYARD MARK WILLIAM;;SAYERS EDWARD;;YORK DAVID WILLIAM;;DUFTON DANIEL JAMES;;HOWE SIMON;;ESHUIS JOHAN;;PENA-ROMERO ANGELINA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMANN WUNDRIARI;;DECKNER GEORGE ENDEL;;WAHL ERROL HOFFMAN;;MURPHY RUTH ANNE;;HENSLEY CHARLES ALBERT;;HENSLEY BETTY JEAN;;TRINH TOAN;;DIHORA JITEN ODHAVJI;;BAKER ELLEN SCHMIDT;;LITTIG JANET SUE;;SCHROEDER TIMOTHY JAMES;;DIERSING STEVEN LOUIS;;DODD MALCOLM MCCLAREN;;GALLON LOIS SARA,CASWELL DEBRA SUE;;WELCH ROBERT GARY;;RIDYARD MARK WILLIAM;;SAYERS EDWARD;;YORK DAVID WILLIAM;;DUFTON DANIEL JAMES;;HOWE SIMON;;ESHUIS JOHAN;;PENA-ROMERO ANGELINA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMANN WUNDRIARI;;DECKNER GEORGE ENDEL;;WAHL ERROL HOFFMAN;;MURPHY RUTH ANNE;;HENSLEY CHARLES ALBERT;;HENSLEY BETTY JEAN;;TRINH TOAN;;DIHORA JITEN ODHAVJI;;BAKER ELLEN SCHMIDT;;LITTIG JANET SUE;;SCHROEDER TIMOTHY JAMES;;DIERSING STEVEN LOUIS;;DODD MALCOLM MCCLAREN;;GALLON LOIS SARA,,https://lens.org/067-837-981-711-34X,Patent Application,yes,3,17,26,26,0,A47F1/08;;C11D3/001;;C11D3/0015;;C11D3/0021;;C11D3/0026;;C11D3/0036;;C11D3/0052;;C11D3/0068;;C11D3/373;;C11D3/42;;C11D3/48;;C11D3/50;;C11D3/505;;C11D17/0039;;C11D17/041;;C11D17/042;;C11D17/043;;C11D17/046;;C11D2111/12;;C11D17/042;;C11D3/0052;;C11D17/043;;C11D3/0068;;C11D3/50;;A47F1/08;;C11D3/0015;;C11D3/48;;C11D3/373;;C11D3/0021;;C11D17/041;;C11D17/0039;;C11D3/42;;C11D3/0026;;C11D3/0036;;C11D3/505;;C11D17/046;;C11D3/001;;C11D2111/12,C11D17/00;;A47F1/08;;B65D65/46;;C11D1/62;;C11D1/72;;C11D3/00;;C11D3/37;;C11D3/42;;C11D3/48;;C11D3/50;;C11D11/00;;C11D17/04;;C11D17/06;;D06M15/03;;D06M15/11;;D06M15/15;;D06M15/333,510/296,0,0,,,,DISCONTINUED
829,WO,A1,WO 1997/044431 A1,100-432-540-695-793,1997-11-27,1997,US 9708315 W,1997-05-16,US 1788396 P,1996-05-17,DETERGENT COMPOSITION,"Detergent composition comprising a peroxygen bleach, a bleach activator, a non-AQA surfactant and a bis-alkoxylated quaternary ammonium (bis-AQA) cationic surfactants.",PROCTER & GAMBLE;;ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;BETTIOL JEAN LUC;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;KOTT KEVIN LEE;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;THOEN CHRISTIAAN ARTHUR JACQUE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;WILLMAN KENNETH WILLIAM;;MANOHAR SANJEEV KRISHNADAS,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;BETTIOL JEAN-LUC;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;KOTT KEVIN LEE;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;THOEN CHRISTIAAN ARTHUR JACQUE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;WILLMAN KENNETH WILLIAM;;MANOHAR SANJEEV KRISHNADAS,,https://lens.org/100-432-540-695-793,Patent Application,yes,5,1,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,1,0,,,"DATABASE WPI Section Ch Week 8420, Derwent World Patents Index; Class A97, AN 84-123539, XP002044147",PENDING
830,US,A1,US 2009/0062173 A1,136-075-034-549-05X,2009-03-05,2009,US 26508008 A,2008-11-05,US 26508008 A;;US 33787506 A;;US 12187605 A;;US 10579805 A;;US 92574904 A;;US 83886701 A;;US 20347200 P,2000-05-11,Laundry System Having Unitized Dosing,"Compositions, articles and methods are provided for supplying fabric care benefits to clothing or fabrics in an automated washing machine and by manual washing. The fabric care compositions preferably have less than about 5% detergent surfactants, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. Similarly, the fabric care compositions preferably have less than about 5% fabric softener actives, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. The laundry articles can take a variety of forms in a variety of physical states all of which will rapidly dispense a unitized amount of one or more selected fabric care agents to a wash and/or rinse bath solution during the laundering process under a variety of conditions. The invention also pertains to laundry kits that contain a variety of such articles and instructions concerning their use. Likewise, methods for preparing a customized laundry solution to obtain a specific fabric care benefit selected based on the user's personal preferences and/or the fabric care needs of the fabrics being laundered are also provided. Further, the present invention also concerns methods for assisting a consumer in identifying the unitized articles to be used in preparing a laundry solution that will impart desired fabric care benefits as well as merchandising displays for dispensing the articles, assembling customized laundry kits and instructing the consumer on the selection and use of laundry articles.",CASWELL DEBRA SUE;;WELCH ROBERT GARY;;RIDYARD MARK WILLIAM;;SAYERS EDWARD;;YORK DAVID WILLIAM;;DUFTON DANIEL JAMES;;HOWE SIMON;;ESHUIS JOHAN;;PENA-ROMERO ANGELINA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMANN WUNDRIARI;;DECKNER GEORGE ENDEL;;WAHL ERROL HOFFMAN;;MURPHY RUTH ANNE;;HENSLEY CHARLES ALBERT;;TRINH TOAN;;DIHORA JITEN ODHAVJI;;BAKER ELLEN SCHMIDT;;LITTIG JANET SUE;;SCHROEDER TIMOTHY JAMES;;DIERSING STEVEN LOUIS;;DODD MALCOLM MCCLAREN;;GALLON LOIS SARA,CASWELL DEBRA SUE;;WELCH ROBERT GARY;;RIDYARD MARK WILLIAM;;SAYERS EDWARD;;YORK DAVID WILLIAM;;DUFTON DANIEL JAMES;;HOWE SIMON;;ESHUIS JOHAN;;PENA-ROMERO ANGELINA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMANN WUNDRIARI;;DECKNER GEORGE ENDEL;;WAHL ERROL HOFFMAN;;MURPHY RUTH ANNE;;HENSLEY CHARLES ALBERT;;TRINH TOAN;;DIHORA JITEN ODHAVJI;;BAKER ELLEN SCHMIDT;;LITTIG JANET SUE;;SCHROEDER TIMOTHY JAMES;;DIERSING STEVEN LOUIS;;DODD MALCOLM MCCLAREN;;GALLON LOIS SARA,,https://lens.org/136-075-034-549-05X,Patent Application,yes,31,5,26,26,0,A47F1/08;;C11D3/001;;C11D3/0015;;C11D3/0021;;C11D3/0026;;C11D3/0036;;C11D3/0052;;C11D3/0068;;C11D3/373;;C11D3/42;;C11D3/48;;C11D3/50;;C11D3/505;;C11D17/0039;;C11D17/041;;C11D17/042;;C11D17/043;;C11D17/046;;C11D2111/12;;C11D17/042;;C11D3/0052;;C11D17/043;;C11D3/0068;;C11D3/50;;A47F1/08;;C11D3/0015;;C11D3/48;;C11D3/373;;C11D3/0021;;C11D17/041;;C11D17/0039;;C11D3/42;;C11D3/0026;;C11D3/0036;;C11D3/505;;C11D17/046;;C11D3/001;;C11D2111/12,C11D17/00;;A47F1/08;;B65D65/46;;C11D1/62;;C11D1/72;;C11D3/00;;C11D3/37;;C11D3/42;;C11D3/48;;C11D3/50;;C11D11/00;;C11D17/04;;C11D17/06;;D06M15/03;;D06M15/11;;D06M15/15;;D06M15/333,510/295,0,0,,,,EXPIRED
831,BR,A,BR 9710674 A,068-438-426-756-985,1999-08-17,1999,BR 9710674 A,1997-05-16,US 1788696 P;;US 9708437 W,1996-05-17,Composi-Æo detergente,,PROCTER & GAMBLE,ASANO KAORI;;MINAMIKAWA KAORI;;DODD IAN MARTIN;;SCHEIBEL JOHN JEFFREY;;HARTSHORN RICHARD TIMOTHY;;THOEN CHRISTIAAN ARTHUR JACQUE;;CRON LAURA;;BETTIOL JEAN-LUC;;KATSUDA RINKO;;CRIPE THOMAS ANTHONY;;KVIETOK FRANK ANDREJ;;CURRY JOHN DOWNING;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;KOTT KEVIN LEE;;MURATA SUSUMU;;FOLEY PETER ROBERT;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;WILLMAN KENNETH WILLIAM;;MANOHAR SANJEEV KRISHNADAS,,https://lens.org/068-438-426-756-985,Patent Application,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/835;;C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,DISCONTINUED
832,US,A1,US 2003/0104969 A1,071-009-731-562-08X,2003-06-05,2003,US 83886701 A,2001-04-20,US 83886701 A;;US 20347200 P,2000-05-11,Laundry system having unitized dosing,"
   Compositions, articles and methods are provided for supplying fabric care benefits to clothing or fabrics in an automated washing machine and by manual washing. The fabric care compositions preferably have less than about 5% detergent surfactants, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. Similarly, the fabric care compositions preferably have less than about 5% fabric softener actives, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. The laundry articles can take a variety of forms in a variety of physical states all of which will rapidly dispense a unitized amount of one or more selected fabric care agents to a wash and/or rinse bath solution during the laundering process under a variety of conditions. The invention also pertains to laundry kits that contain a variety of such articles and instructions concerning their use. Likewise, methods for preparing a customized laundry solution to obtain a specific; fabric care benefit selected based on the user's personal preferences and/or the fabric care needs of the fabrics being laundered are also provided. Further, the present invention also concerns methods for assisting a consumer in identifying the unitized articles to be used in preparing a laundry solution that will impart desired fabric care benefits as well as merchandising displays for dispensing the articles, assembling customized laundry kits and instructing the consumer on the selection and use of laundry articles. 
",CASWELL DEBRA SUE;;WELCH ROBERT GARY;;RIDYARD MARK WILLIAM;;SAYERS EDWARD;;YORK DAVID WILLIAM;;DUFTON DANIEL JAMES;;HOWE SIMON;;ESHUIS JOHAN;;PENA-ROMERO ANGELINA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMAN WUNDRIARI;;DECKNER GEORGE ENDEL;;WAHL ERROL HOFFMAN;;MURPHY RUTH ANNE;;HENSLEY CHARLES ALBERT;;TRINH TOAN;;DIHORA JITEN ODHAVJI;;BAKER ELLEN SCHMIDT;;LITTIG JANET SUE;;SCHROEDER TIMOTHY JAMES;;DIERSING STEVEN LOUIS;;DODD MALCOLM MCCLAREN;;GALLON LOIS SARA,CASWELL DEBRA SUE;;WELCH ROBERT GARY;;RIDYARD MARK WILLIAM;;SAYERS EDWARD;;YORK DAVID WILLIAM;;DUFTON DANIEL JAMES;;HOWE SIMON;;ESHUIS JOHAN;;PENA-ROMERO ANGELINA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMAN WUNDRIARI;;DECKNER GEORGE ENDEL;;WAHL ERROL HOFFMAN;;MURPHY RUTH ANNE;;HENSLEY CHARLES ALBERT;;TRINH TOAN;;DIHORA JITEN ODHAVJI;;BAKER ELLEN SCHMIDT;;LITTIG JANET SUE;;SCHROEDER TIMOTHY JAMES;;DIERSING STEVEN LOUIS;;DODD MALCOLM MCCLAREN;;GALLON LOIS SARA,PROCTER & GAMBLE COMPANY THE (2001-07-16),https://lens.org/071-009-731-562-08X,Patent Application,yes,0,125,26,26,0,A47F1/08;;C11D3/001;;C11D3/0015;;C11D3/0021;;C11D3/0026;;C11D3/0036;;C11D3/0052;;C11D3/0068;;C11D3/373;;C11D3/42;;C11D3/48;;C11D3/50;;C11D3/505;;C11D17/0039;;C11D17/041;;C11D17/042;;C11D17/043;;C11D17/046;;C11D2111/12;;C11D17/042;;C11D3/0052;;C11D17/043;;C11D3/0068;;C11D3/50;;A47F1/08;;C11D3/0015;;C11D3/48;;C11D3/373;;C11D3/0021;;C11D17/041;;C11D17/0039;;C11D3/42;;C11D3/0026;;C11D3/0036;;C11D3/505;;C11D17/046;;C11D3/001;;C11D2111/12,A47F1/08;;B65D65/46;;C11D1/62;;C11D1/72;;C11D3/00;;C11D3/37;;C11D3/42;;C11D3/48;;C11D3/50;;C11D11/00;;C11D17/04;;C11D17/06;;D06M15/03;;D06M15/11;;D06M15/15;;D06M15/333,510/513;;510/439,0,0,,,,DISCONTINUED
833,CO,A2,CO 2023017899 A2,080-866-406-342-545,2023-12-29,2023,CO 2023017899 A,2023-12-20,US 2022/0032116 W;;US 202163196946 P,2021-06-04,N-(hidroxialquil(hetero)aril) tetrahidrofurano carboxamidas como moduladores de canales de sodio,"Se proporcionan compuestos de la fórmula I, y sales farmacéuticamente aceptables de estos, útiles como inhibidores de canales de sodio. También se proporcionan composiciones farmacéuticas que comprenden los compuestos o sales farmacéuticamente aceptables y métodos de uso de los compuestos, sales farmacéuticamente aceptables y composiciones farmacéuticas en el tratamiento de diversos trastornos, incluido el dolor.",VERTEX PHARMA,ZHOU JINGLAN;;SCHMIDT YVONNE;;THOMSON STEPHEN ANDREW;;DURRANT STEVEN JOHN;;BECK ELIZABETH MARY;;CHUDYK EWA IWONA;;ETXEBARRIA JARDI GORKA;;GALAN BHAIRAVI;;HADIDA RUAH SARA S;;HURLEY DENNIS JAMES;;KNEGTEL RONALD MARCELLUS;;NEUBERT TIMOTHY DONALD;;PINDER JOANNE LOUISE;;PONTILLO JOSEPH;;PULLIN ROBERT;;SHAW DAVID MATTHEW;;SKERRATT SARAH;;STAMOS DEAN;;VIRANI ANISA NIZARALI;;WRAY CHRISTOPHER;;AHMAD NADIA M;;CARVALHO MEIRELES LIDIO MARX;;NORTH KIRI;;DODD JAMES;;O'DONNELL MICHAEL EDWARD,,https://lens.org/080-866-406-342-545,Patent Application,no,0,0,10,10,0,A61P29/00;;C07D405/12;;C07D405/12;;A61P29/00;;C07D405/12,A61P29/00;;A61K31/443;;C07D405/12,,0,0,,,,PENDING
834,US,A1,US 2005/0026793 A1,076-348-921-425-498,2005-02-03,2005,US 92574904 A,2004-08-25,US 92574904 A;;US 83886701 A;;US 20347200 P,2000-05-11,Laundry system having unitized dosing,"Compositions, articles and methods are provided for supplying fabric care benefits to clothing or fabrics in an automated washing machine and by manual washing. The fabric care compositions preferably have less than about 5% detergent surfactants, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. Similarly, the fabric care compositions preferably have less than about 5% fabric softener actives, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. The laundry articles can take a variety of forms in a variety of physical states all of which will rapidly dispense a unitized amount of one or more selected fabric care agents to a wash and/or rinse bath solution during the laundering process under a variety of conditions. The invention also pertains to laundry kits that contain a variety of such articles and instructions concerning their use. Likewise, methods for preparing a customized laundry solution to obtain a specific fabric care benefit selected based on the user's personal preferences and/or the fabric care needs of the fabrics being laundered are also provided. Further, the present invention also concerns methods for assisting a consumer in identifying the unitized articles to be used in preparing a laundry solution that will impart desired fabric care benefits as well as merchandising displays for dispensing the articles, assembling customized laundry kits and instructing the consumer on the selection and use of laundry articles.",PROCTER & GAMBLE,CASWELL DEBRA SUE;;WELCH ROBERT GARY;;RIDYARD MARK WILLIAM;;SAYERS EDWARD;;YORK DAVID WILLIAM;;DUFTON DANIEL JAMES;;HOWE SIMON;;ESHUIS JOHAN;;PENA-ROMERO ANGELINA;;LAUDAMIEL-PELLET CHRISTOPHE;;HOFFMANN WUNDRIARI;;DECKNER GEORGE ENDEL;;WAHL ERROL HOFFMAN;;MURPHY RUTH ANNE;;HENSLEY CHARLES ALBERT;;TRINH TOAN;;DIHORA JITEN ODHAVJI;;BAKER ELLEN SCHMIDT;;LITTIG JANET SUE;;SCHROEDER TIMOTHY JAMES;;DIERSING STEVEN LOUIS;;DODD MALCOLM MCCLAREN;;GALLON LOIS SARA,,https://lens.org/076-348-921-425-498,Patent Application,yes,4,39,26,26,0,A47F1/08;;C11D3/001;;C11D3/0015;;C11D3/0021;;C11D3/0026;;C11D3/0036;;C11D3/0052;;C11D3/0068;;C11D3/373;;C11D3/42;;C11D3/48;;C11D3/50;;C11D3/505;;C11D17/0039;;C11D17/041;;C11D17/042;;C11D17/043;;C11D17/046;;C11D2111/12;;C11D17/042;;C11D3/0052;;C11D17/043;;C11D3/0068;;C11D3/50;;A47F1/08;;C11D3/0015;;C11D3/48;;C11D3/373;;C11D3/0021;;C11D17/041;;C11D17/0039;;C11D3/42;;C11D3/0026;;C11D3/0036;;C11D3/505;;C11D17/046;;C11D3/001;;C11D2111/12,A47F1/08;;B65D65/46;;C11D1/62;;C11D1/72;;C11D3/00;;C11D3/37;;C11D3/42;;C11D3/48;;C11D3/50;;C11D11/00;;C11D17/04;;C11D17/06;;D06M15/03;;D06M15/11;;D06M15/15;;D06M15/333,510/101,0,0,,,,EXPIRED
835,CA,A1,CA 2405845 A1,190-030-085-335-624,2001-11-15,2001,CA 2405845 A,2001-05-10,US 20347200 P;;US 83886701 A;;US 0115275 W,2000-05-11,LAUNDRY SYSTEM HAVING UNITIZED DOSING,"Compositions, articles and methods are provided for supplying fabric care benefits to clothing or fabrics in an automated washing machine and by manua l washing. The fabric care compositions preferably have less than about 5% detergent surfactants, more preferably less than 3%, even more preferably le ss than 1% and are most preferably free of detergent surfactants. Similarly, th e fabric care compositions preferably have less than about 5% fabric softener actives, more preferably less than 3%, even more preferably less than 1% and are most preferably free of detergent surfactants. The laundry articles can take a variety of forms in a variety of physical states all of which will rapidly dispense a unitized amount of one or more selected fabric care agent s to a wash and/or rinse bath solution during the laundering process under a variety of conditions. The invention also pertains to laundry kits that contain a variety of such articles and instructions concerning their use. Likewise, methods for preparing a customized laundry solution to obtain a specific fabric care benefit selected based on the user's personal preferenc es and/or the fabric care needs of the fabrics being laundered are also provide d. Further, the present invention also concerns methods for assisting a consume r in identifying the unitized articles to be used in preparing a laundry solution that will impart desired fabric care benefits as well as merchandising displays for dispensing the articles, assembling customized laundry kits and instructing the consumer on the selection and use of laundr y articles.",PROCTER & GAMBLE,DODD MALCOLM MCCLAREN;;LAUDAMIEL-PELLET CHRISTOPHE;;DIHORA JITEN ODHAVJI;;SCHROEDER TIMOTHY JAMES;;HOWE SIMON;;LITTIG JANET SUE;;BAKER ELLEN SCHMIDT;;ESHUIS JOHAN;;DIERSING STEVEN LOUIS;;ROMERO ANGELINA PENA;;GALLON LOIS SARA;;TRINH TOAN;;MURPHY RUTH ANNE;;HENSLEY CHARLES ALBERT;;SAYERS EDWARD;;DUFTON DANIEL JAMES;;HOFFMAN WUNDRIARI;;WAHL ERROL HOFFMAN;;CASEWELL DEBRA SUE;;WELCH ROBERT GARY;;DECKNER GEORGE ENDEL;;RIDYARD MARK WILLIAM;;YORK DAVID WILLIAM,,https://lens.org/190-030-085-335-624,Patent Application,no,0,2,26,26,0,A47F1/08;;C11D3/001;;C11D3/0015;;C11D3/0021;;C11D3/0026;;C11D3/0036;;C11D3/0052;;C11D3/0068;;C11D3/373;;C11D3/42;;C11D3/48;;C11D3/50;;C11D3/505;;C11D17/0039;;C11D17/041;;C11D17/042;;C11D17/043;;C11D17/046;;C11D2111/12;;C11D17/042;;C11D3/0052;;C11D17/043;;C11D3/0068;;C11D3/50;;A47F1/08;;C11D3/0015;;C11D3/48;;C11D3/373;;C11D3/0021;;C11D17/041;;C11D17/0039;;C11D3/42;;C11D3/0026;;C11D3/0036;;C11D3/505;;C11D17/046;;C11D3/001;;C11D2111/12,A47F1/08;;B65D65/46;;C11D1/62;;C11D1/72;;C11D3/00;;C11D3/37;;C11D3/42;;C11D3/48;;C11D3/50;;C11D11/00;;C11D17/04;;C11D17/06;;D06M15/03;;D06M15/11;;D06M15/15;;D06M15/333,,0,0,,,,EXPIRED
836,CZ,A3,CZ 371398 A3,148-191-274-021-178,1999-04-14,1999,CZ 371398 A,1997-05-16,US 1788696 P,1996-05-17,DETERGENT PREPARATION,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;MINAMIKAWA KAORI;;CRON LAURA;;BETTIOL JEAN-LUC;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;KOTT KEVIN LEE;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;THOEN CHRISTIAAN ARTHUR JACQUE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;FOLEY PETER ROBERT;;WILLAMAN KENNETH WILLIAM;;MANOHAR SANJEEV KRISHNADAS,,https://lens.org/148-191-274-021-178,Patent Application,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/835;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,PENDING
837,MX,A,MX 9809624 A,168-037-723-349-559,1999-03-01,1999,MX 9809624 A,1998-11-17,US 1788396 P,1996-05-17,Detergent composition,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;THOEN CHRISTIAAN ARTHUR JACQUE;;KATSUDA RINKO;;MINAMIKAWA KAORI;;CRON LAURA;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG KUEN;;BETTIOL JEAN-LUC;;MOSS MICHAEL ALAN JOHN;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;MURATA SUSUMU;;KOTT KEVIN LEE;;FOLEY PETER ROBERT;;DODD IAN MARTIN;;PANANDIKER RAJAN KESHAV;;HARTSHORN RICHARD TIMOTHY;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;WILLMAN KENNETH WILLIAM;;MANOHAR SANJEEV KRISHNADAS,,https://lens.org/168-037-723-349-559,Patent Application,no,0,0,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,0,0,,,,PENDING
838,US,A,US 6136769 A,044-917-197-162-653,2000-10-24,2000,US 29542199 A,1999-04-21,US 29542199 A;;US 1788696 P,1996-05-17,Alkoxylated cationic detergency ingredients,"Alkoxylated cationic surfactants, and mixtures thereof, are used in detergent compositions.",PROCTER & GAMBLE,ASANO KAORI;;ASKEW STUART CLIVE;;BABA HAJIME;;BAECK ANDRECESAR;;BETTIOL JEAN-LUC;;CRIPE THOMAS ANTHONY;;CRON LAURA;;DODD IAN MARTIN;;FOLEY PETER ROBERT;;HARTSHORN RICHARD TIMOTHY;;JONES SPEED LYNDA ANNE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MINAMIKAWA KAORI;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;OHTANI ROYOHEI;;OKAMOTO MITSUYO;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KAHN;;SCHEIBEL JEFFREY JOHN;;THOEN CHRISTIAAN ARTHUR JACQUE;;WILLMAN KENNETH WILLIAM,PROCTER & GAMBLE COMPANY THE (1999-05-06),https://lens.org/044-917-197-162-653,Granted Patent,yes,62,475,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/835;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,510/329;;510/235;;510/276;;510/320;;510/327;;510/330;;510/332;;510/504,0,0,,,,EXPIRED
839,EP,A2,EP 0906400 A2,199-974-594-861-775,1999-04-07,1999,EP 97924761 A,1997-05-16,US 9708436 W;;US 1788696 P,1996-05-17,DETERGENT COMPOSITION,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;BABA HAJIME;;BAECK ANDRE CESAR;;MINAMIKAWA KAORI;;CRIPE THOMAS ANTHONY;;CURRY JOHN;;CRON LAURA;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;SPEED JONES LYNDA ANNE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;OHTANI ROYOHEI;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED;;THOEN CHRISTIAN ARTHUR J K;;KOTT KEVIN LEE;;WILLMAN KENNETH WILLIAM;;FOLEY PETER ROBERT;;MANOHAR SANJEEV KRISHNADAS,,https://lens.org/199-974-594-861-775,Patent Application,yes,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/835;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,DISCONTINUED
840,HU,A2,HU P9902671 A2,071-093-697-359-014,1999-12-28,1999,HU P9902671 A,1997-05-16,HU P9902671 A;;US 1788696 P,1996-05-17,DETERGENT COMPOSITION,"A detergent composition comprises or is prepared by combining an enzyme, a non-alkoxylated quaternary ammonium surfactant (non-AQA) and an AQA cationic surfactant of formula (I). R1R2N+ApR3(A'qR4) X- (I) R1 = substituted 8-18C alkyl, alkenyl, aryl, ether or glycidyl ether; R2 = 1-3C alkyl; R3, R4 = H, Me or Et; X = anion; A, A' = 1-4C alkoxy; p, q = 1-30. Also claimed are: (1) a method for removing soils and stains comprising contacting soils and stains with a detergent composition, or aqueous medium comprising the above detergent composition; and (2) a method for enhancing the deposition or substantivity of perfume or perfume ingredients onto fabrics or other surfaces comprising contacting the surfaces with perfume of perfume ingredient in the presence of compound (I).",The Procter & Gamble Co.,"Asano, Kaori;;Baba, Hajime;;Baeck, Andre Cesar;;Cripe, Thomas Anthony;;Cron, Laura;;Curry, John Downing;;Dodd, Ian Martin;;Foley, Peter Robert;;Hartshorn, Richard Timothy;;Katsuda, Rinko;;Kott, Kevin Lee;;Kvietok, Frank Andrej;;Manohar, Sanjeev Krishnadas;;Mao, Mark Hsiang-Kuen;;Minamikawa, Kaori;;Moss, Michael Alan John;;Murata, Susumu;;Ohtani, Royohei;;Okamoto, Mitsuyo;;Panandiker, Rajan Keshav;;Pramod, Kakumanu;;Sarnaik, Khizar Mohamed Khan;;Scheibel, Jeffry John;;Speed, (Jones) Lynda Anne;;Thoen, Christian Arthur Jacques Kamiel;;Willman, Kenneth William",,https://lens.org/071-093-697-359-014,Patent Application,no,0,0,1,507,0,,,,0,0,,,,PENDING
841,HU,A2,HU P9902979 A2,005-160-292-884-455,2000-01-28,2000,HU P9902979 A,1997-05-16,US 1788496 P,1996-05-17,Detergent composition,,PROCTER & GAMBLE,BAECK ANDRE CESAR;;DODD IAN MARTIN;;ASKEW STUART CLIVE;;BABA HAJIME;;BETTIOL JEAN-LUC;;HARTSHORN RICHARD TIMOTHY;;SPEED JONES LYNDA ANNE;;CURRY JOHN DOWNING;;CRIPE THOMAS ANTHONY;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;ASANO KAORI;;KVIETOK FRANK ANDREJ;;KATSUDA RINKO;;MAO MARK HSIANG-KUEN;;THOEN CHRISTIAAN ARTHUR JACQUE;;SCHMIDT DE ROSSETT COREY ELIZA;;FOLEY PETER ROBERT;;SARNAIK KHIZAR MOHAMED KHAN;;OHTANI ROYOHEI;;MANOHAR SANJEEV KRISHNADAS;;OKAMOTO MITSUYO;;WILLMAN KENNETH WILLIAM;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU,,https://lens.org/005-160-292-884-455,Patent Application,no,0,0,13,507,0,C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/645;;C11D1/65;;C11D3/042;;C11D3/10;;C11D3/2086;;C11D1/65,C11D1/22;;C11D1/14;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/645;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/10;;C11D3/20,,0,0,,,,PENDING
842,MX,A,MX 9809632 A,020-173-178-870-822,1999-02-01,1999,MX 9809632 A,1998-11-17,US 1788696 P,1996-05-17,Detergent composition,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;BABA HAJIME;;BAECK ANDRE CESAR;;MINAMIKAWA KAORI;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;CRON LAURA;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;SPEED LYNDA ANNE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;OHTANI ROYOHEI;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAAN ARTHUR JACQUE;;KOTT KEVIN LEE;;WILLMAN KENNETH WILLIAM;;OKAMOTO MITSUYO;;FOLEY PETER ROBERT;;MANOHAR SANJEEV KRISHNADAS,,https://lens.org/020-173-178-870-822,Patent Application,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/835;;C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,PENDING
843,CA,A1,CA 2254955 A1,103-652-079-179-494,1997-11-27,1997,CA 2254955 A,1997-05-16,US 1788496 P;;US 9708279 W,1996-05-17,DETERGENT COMPOSITION,"Alkoxylated cationic surfactants, and mixtures thereof, are used in detergent compositions comprising a mixture of alkyl sulfate and alkylbenzene sulfonate surfactants.",PROCTER & GAMBLE,BAECK ANDRE CESAR;;DODD IAN MARTIN;;ASKEW STUART CLIVE;;BABA HAJIME;;BETTIOL JEAN-LUC;;HARTSHORN RICHARD TIMOTHY;;SPEED JONES LYNDA ANNE;;CURRY JOHN DOWNING;;CRIPE THOMAS ANTHONY;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;ASANO KAORI;;KVIETOK FRANK ANDREJ;;KATSUDA RINKO;;MAO MARK HSIANG-KUEN;;THOEN CHRISTIAAN ARTHUR JACQUE;;SCHMIDT DE ROSSETT COREY ELIZA;;FOLEY PETER ROBERT;;SARNAIK KHIZAR MOHAMED KHAN;;OHTANI ROYOHEI;;MANOHAR SANJEEV KRISHNADAS;;OKAMOTO MITSUYO;;WILLMAN KENNETH WILLIAM;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU,,https://lens.org/103-652-079-179-494,Patent Application,no,0,0,13,507,0,C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/645;;C11D1/65;;C11D3/042;;C11D3/10;;C11D3/2086;;C11D1/65,C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/645;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/10;;C11D3/20,,0,0,,,,DISCONTINUED
844,WO,A3,WO 1997/043388 A3,169-331-943-988-540,1998-02-12,1998,US 9708444 W,1997-05-16,US 1788396 P,1996-05-17,Detergent composition,"A detergent composition comprising an enzyme, a non-AQA surfactant and a bis-alkoxylated quaternary ammonium (bis-AQA) cationic surfactant.",PROCTER & GAMBLE;;ASOANO KAORI;;SCHEIBEL JEFFREY JOHN;;BABA HAJIME;;BEACK ANDRE CESAR;;MINAMIKAWA KAORI;;HARTSHORN RICHARD TIMOTHY;;SPEED JONES LYNDA ANNE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;OHTANI ROYOHEI;;PANADIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES;;KOTT KEVIN LEE;;WILLMAN KENNETH WILLIAM;;CRON LAURA;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;FOLEY PETER ROBERT;;DODD IAN MARTIN;;MANOHAR SANJEEV KRISHNADAS;;OKAMOTO MITSUYO,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;BABA HAJIME;;BAECK ANDRE CESAR;;MINAMIKAWA KAORI;;HARTSHORN RICHARD TIMOTHY;;SPEED JONES LYNDA ANNE;;KATSUDA RINKO;;KVIETOK FRAKN ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;OHTANI RYOHEI;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES;;KOTT KEVIN LEE;;WILLMAN KENNETH WILLIAM;;CRON LAURA;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;FOLEY PETER ROBERT;;DODD IAN MARTIN;;MANOHAR SANJEEV RISHNADAS;;OKAMOTO MITSUYO,,https://lens.org/169-331-943-988-540,Search Report,yes,8,0,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,0,0,,,,PENDING
845,TR,T2,TR 199802348 T2,078-728-783-857-803,1999-03-22,1999,TR 9802348 T,1997-05-16,US 1788696 P,1996-05-17,Deterjan bilesimi.,"Bir enzim, AKA olmayan bir yüzey aktif madde ve bir alkoksilatli kuaterner amonyum (AKA) katyonik yüzey aktif maddesi içeren bir deterjan bilesimi.",PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;BABA HAJIME;;BAECK ANDRE CESAR;;MINAMIKAWA KAORI;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;CRON LAURA;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;SPEED JONES LYNDA ANNE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;OHTANI ROYOHEI;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES;;KOTT KEVIN LEE;;WILLMAN KENNETH WILLIAM;;OKAMOTO MITSUYO;;FOLEY PETER ROBERT;;MANOHAR SANJEEV KRISHNADAS,,https://lens.org/078-728-783-857-803,Patent Application,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/835;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,PENDING
846,MX,A,MX 9809676 A,017-831-305-373-807,1999-03-01,1999,MX 9809676 A,1998-11-17,US 1788696 P,1996-05-17,Detergent composition,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;BABA HAJIME;;BAECK ANDRE CESAR;;MINAMIKAWA KAORI;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;CRON LAURA;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;SPEED LYNDA ANNE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;OHTANI ROYOHEI;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAAN ARTHUR JACQUE;;KOTT KEVIN LEE;;WILLMAN KENNETH WILLIAM;;OKAMOTO MITSUYO;;FOLEY PETER ROBERT;;MANOHAR SANJEEV KRISHNADAS,,https://lens.org/017-831-305-373-807,Patent Application,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/835;;C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,PENDING
847,MX,A,MX 9809680 A,013-542-469-444-45X,1999-03-01,1999,MX 9809680 A,1998-11-17,US 1788696 P,1996-05-17,Detergent composition,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;BABA HAJIME;;BAECK ANDRE CESAR;;MINAMIKAWA KAORI;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;CRON LAURA;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;SPEED LYNDA ANNE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;OHTANI ROYOHEI;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAAN ARTHUR JACQUE;;KOTT KEVIN LEE;;WILLMAN KENNETH WILLIAM;;OKAMOTO MITSUYO;;FOLEY PETER ROBERT;;MANOHAR SANJEEV KRISHNADAS,,https://lens.org/013-542-469-444-45X,Patent Application,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/835;;C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,PENDING
848,ZA,B,ZA 974222 B,075-424-165-594-645,1998-12-28,1998,ZA 974222 A,1997-05-15,US 1788496 P,1996-05-17,Detergent composition,,PROCTER & GAMBLE,ASANO KAORI;;BABA HAJIME;;BAECK ANDRE CESAR;;DODD IAN MARTIN;;BETTIOL JEAN-LUC;;ASKEW STUART CLIVE;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;SCHMIDT COREY ELIZABETH;;FOLEY PETER ROBERT;;MANOHAR SANJEEV KRISHNADAS;;KATSUDA RINKO;;SPEED LYNDA ANNE;;HARTSHORN RICHARD TIMOTHY;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;OHTANI RYOHEI;;OKAMOTO MITSUYO;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAAN ARTHUR JACQUE;;WILLMAN KENNETH WILLIAM,,https://lens.org/075-424-165-594-645,Granted Patent,no,0,0,13,507,0,C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/645;;C11D1/65;;C11D3/042;;C11D3/10;;C11D3/2086;;C11D1/65,C11D1/22;;C11D1/29;;C11D1/14;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/645;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/10;;C11D3/20,,0,0,,,,EXPIRED
849,MX,A,MX 9809634 A,109-384-225-725-01X,1999-02-01,1999,MX 9809634 A,1998-11-17,US 1788696 P,1996-05-17,Detergent composition,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;BABA HAJIME;;BAECK ANDRE CESAR;;MINAMIKAWA KAORI;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;CRON LAURA;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;SPEED LYNDA ANNE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;OHTANI ROYOHEI;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAAN ARTHUR JACQUE;;KOTT KEVIN LEE;;WILLMAN KENNETH WILLIAM;;OKAMOTO MITSUYO;;FOLEY PETER ROBERT;;MANOHAR SANJEEV KRISHNADAS,,https://lens.org/109-384-225-725-01X,Patent Application,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/835;;C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,PENDING
850,CZ,A3,CZ 371298 A3,138-447-556-607-189,1999-05-12,1999,CZ 371298 A,1997-05-16,US 1788696 P,1996-05-17,CLEANSING PREPARATIONS,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;BABA HAJIME;;BAECK ANDRE CESAR;;MINAMIKAWA KAORI;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;CRON LAURA;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;SPEED JONES LYNDA ANNE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;OHTANI ROYOHEI;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAAN ARTHUR JACQUE;;KOTT KEVIN LEE;;WILLAMAN KENNETH WILLIAM;;OKAMOTO MITSUYO;;FOLEY PETER ROBERT;;MANOHAR SANJEEV KRISHNADAS,,https://lens.org/138-447-556-607-189,Patent Application,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/835;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,PENDING
851,EP,A2,EP 0918834 A2,139-375-390-491-951,1999-06-02,1999,EP 97925591 A,1997-05-16,US 9708279 W;;US 1788496 P,1996-05-17,DETERGENT COMPOSITION,,PROCTER & GAMBLE,ASANO KAORI;;ASKEW STUART CLIVE;;BABA HAJIME;;BAECK ANDRE CESAR;;BETTIOL JEAN-LUC;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;SCHMIDT DE ROSSETT COREY ELIZA;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;SPEED JONES LYNDA ANNE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;OHTANI ROYOHEI;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES;;FOLEY PETER ROBERT;;MANOHAR SANJEEV KRISHNADAS;;OKAMOTO MITSUYO;;WILLMAN KENNETH WILLIAM,,https://lens.org/139-375-390-491-951,Patent Application,yes,0,0,13,507,0,C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/645;;C11D1/65;;C11D3/042;;C11D3/10;;C11D3/2086;;C11D1/65,C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/14;;C11D1/62;;C11D1/645;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/10;;C11D3/20,,0,0,,,,DISCONTINUED
852,MX,A,MX 9809625 A,146-234-580-669-276,1999-03-01,1999,MX 9809625 A,1998-11-17,US 1788496 P,1996-05-17,Detergent composition,,PROCTER & GAMBLE,BAECK ANDRE CESAR;;DODD IAN MARTIN;;ASKEW STUART CLIVE;;BABA HAJIME;;BETTIOL JEAN-LUC;;HARTSHORN RICHARD TIMOTHY;;SPEED JONES LYNDA ANNE;;CURRY JOHN DOWNING;;CRIPE THOMAS ANTHONY;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;ASANO KAORI;;KVIETOK FRANK ANDREJ;;KATSUDA RINKO;;MAO MARK HSIANG-KUEN;;THOEN CHRISTIAAN ARTHUR JACQUE;;SCHMIDT DE ROSSETT COREY ELIZA;;FOLEY PETER ROBERT;;SARNAIK KHIZAR MOHAMED KHAN;;OHTANI ROYOHEI;;MANOHAR SANJEEV KRISHNADAS;;OKAMOTO MITSUYO;;WILLMAN KENNETH WILLIAM;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU,,https://lens.org/146-234-580-669-276,Patent Application,no,0,0,13,507,0,C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/645;;C11D1/65;;C11D3/042;;C11D3/10;;C11D3/2086;;C11D1/65,C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/645;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/10;;C11D3/20,,0,0,,,,PENDING
853,KR,A,KR 20000011102 A,186-606-726-103-378,2000-02-25,2000,KR 19980709261 A,1998-11-17,US 1788496 P,1996-05-17,DETERGENT COMPOSITION,"PURPOSE: A detergent composition is provided to include a selected mixture of a cationic surfactant and a selected ethoxy fourth grade ammonium compound. CONSTITUTION: Alkoxylated cationic surfactants, and mixtures thereof, are used in detergent compositions comprising a mixture of alkyl sulfate and alkylbenzene sulfonate surfactants. Herein, the composition is manufactured by including or mixing a bis-alcove AQA cationic surfactant of chemical formula I and an anionic surfactant of chemical formula II and III and a mixture of non-ionic surfactant.",PROCTER & GAMBLE,ASANO KAORI;;ASKEW STUART CLIVE;;BABA HAJIME;;BAECK ANDRE CESAR;;BETTIOL JEAN-LUC;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;SCHMIDT DE ROSSETT COREY ELIZA;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;SPEED JONES LYNDA ANNE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;OHTANI ROYOHEI;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR JACQUES;;FOLEY PETER ROBERT;;MANOHAR SANJEEV KRISHNADAS;;OKAMOTO MITSUYO;;WILLMAN KENNETH WILLIAM,,https://lens.org/186-606-726-103-378,Patent Application,no,0,1,13,507,0,C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/645;;C11D1/65;;C11D3/042;;C11D3/10;;C11D3/2086;;C11D1/65,C11D1/22;;C11D1/14;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/645;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/10;;C11D3/20,,0,0,,,,DISCONTINUED
854,BR,A,BR 9709320 A,006-500-314-816-58X,1999-08-10,1999,BR 9709320 A,1997-05-16,US 1788496 P;;US 9708279 W,1996-05-17,Composição detergente,,PROCTER & GAMBLE,ASANO KAORI;;ASKEW STUART CLIVE;;BABA HAJIME;;BAECK ANDRE CESAR;;BETTIOL JEAN LUC;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;SCHMIDT COREY ELIZABETH;;DODD IAN MARTIN;;HARTSHOR RICHARD TIMOTHY;;SPEED LYINDA ANNE;;KATSUDA RINKO;;KVIETOK FRANK ANDREW;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;OHTANI ROYOHEI;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAAN ARTHUR JACQUE;;FOLEY PETER ROBERT;;MANOHAR SANJEEV KRISHNADAS;;OKAMOTO MITSUYO;;WILLMAN KENNETH WILLIAM,,https://lens.org/006-500-314-816-58X,Patent Application,no,0,0,13,507,0,C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/645;;C11D1/65;;C11D3/042;;C11D3/10;;C11D3/2086;;C11D1/65,C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/645;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/10;;C11D3/20,,0,0,,,,DISCONTINUED
855,MX,A,MX 9809678 A,127-533-163-519-18X,1999-03-01,1999,MX 9809678 A,1998-11-17,US 1788696 P,1996-05-17,Detergent composition,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;BABA HAJIME;;BAECK ANDRE CESAR;;MINAMIKAWA KAORI;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;CRON LAURA;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;SPEED LYNDA ANNE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;OHTANI ROYOHEI;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAAN ARTHUR JACQUE;;KOTT KEVIN LEE;;WILLMAN KENNETH WILLIAM;;OKAMOTO MITSUYO;;FOLEY PETER ROBERT;;MANOHAR SANJEEV KRISHNADAS,,https://lens.org/127-533-163-519-18X,Patent Application,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/835;;C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,PENDING
856,MX,A,MX 9809630 A,039-191-891-002-894,1999-02-01,1999,MX 9809630 A,1998-11-17,US 1788696 P,1996-05-17,Detergent composition,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;BABA HAJIME;;BAECK ANDRE CESAR;;MINAMIKAWA KAORI;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;CRON LAURA;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;SPEED LYNDA ANNE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;OHTANI ROYOHEI;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAAN ARTHUR JACQUE;;KOTT KEVIN LEE;;WILLMAN KENNETH WILLIAM;;OKAMOTO MITSUYO;;FOLEY PETER ROBERT;;MANOHAR SANJEEV KRISHNADAS,,https://lens.org/039-191-891-002-894,Patent Application,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/835;;C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,PENDING
857,BR,A,BR 9710668 A,117-092-566-096-923,1999-08-17,1999,BR 9710668 A,1997-05-16,US 1788696 P;;US 9708436 W,1996-05-17,Composi-Æo detergente,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;BABA HAJIME;;BAECK ANDRE CESAR;;MINAMIKAWA KAORI;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;CRON LAURA;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;SPEED LYNDA ANNE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;OHTANI ROYOHEI;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAAN ARTHUR JACQUE;;KOTT KEVIN LEE;;WILLMAN KENNETH WILLIAM;;OKAMOTO MITSUYO;;FOLEY PETER ROBERT;;MANOHAR SANJEEV KRISHNADAS,,https://lens.org/117-092-566-096-923,Patent Application,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/835;;C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,DISCONTINUED
858,EP,A2,EP 0912686 A2,168-488-982-667-618,1999-05-06,1999,EP 97924766 A,1997-05-16,US 9708444 W;;US 1788396 P,1996-05-17,DETERGENT COMPOSITION,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;BABA HAJIME;;BAECK ANDRE CESAR;;MINAMIKAWA KAORI;;HARTSHORN RICHARD TIMOTHY;;SPEED JONES LYNDA ANNE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;OHTANI ROYOHEI;;PANANDIKER RAJAN;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAN ARTHUR J K;;KOTT KEVIN LEE;;WILLMAN KENNETH WILLIAM;;CRON LAURA;;CRIPE THOMAS ANTHONY;;CURRY JOHN;;FOLEY PETER ROBERT;;DODD IAN MARTIN;;MANOHAR SANJEEV;;OKAMOTO MITSUYO,,https://lens.org/168-488-982-667-618,Patent Application,yes,0,0,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,1,0,,,See references of WO 9743388A3,DISCONTINUED
859,CA,A1,CA 2255006 A1,064-067-327-494-582,1997-11-20,1997,CA 2255006 A,1997-05-16,US 1788396 P,1996-05-17,DETERGENT COMPOSITION,"A detergent composition comprising an enzyme, a non-AQA surfactant and a bisalkoxylated quaternary ammonium (bis-AQA) cationic surfactant.",PROCTER & GAMBLE,BABA HAJIME;;KATSUDA RINKO;;OHTANI ROYOHEI;;BAECK ANDRE CESAR;;MURATA SUSUMU;;MINAMIKAWA KAORI;;KOTT KEVIN LEE;;SARNAIK KHIZAR MOHAMED KHAN;;DODD IAN MARTIN;;THOEN CHRISTIAAN ARTHUR JACQUE;;FOLEY PETER ROBERT;;MOSS MICHAEL ALAN JOHN;;CURRY JOHN DOWNING;;PRAMOD KAKUMANU;;OKAMOTO MITSUYO;;MAO MARK HSIANG-KUEN;;SPEED JONES LYNDA ANNE;;CRON LAURA;;CRIPE THOMAS ANTHONY;;WILLMAN KENNETH WILLIAM;;HARTSHORN RICHARD TIMOTHY;;KVIETOK FRANK ANDREJ;;MANOHAR SANJEEV KRISHNADAS;;ASANO KAORI;;SCHEIBEL JAFFREY JOHN;;PANANDIKER RAJAN KESHAV,,https://lens.org/064-067-327-494-582,Patent Application,no,0,0,61,507,0,C11D3/042;;C11D1/02;;C11D1/143;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0052;;C11D3/0063;;C11D3/06;;C11D3/10;;C11D3/1273;;C11D3/128;;C11D3/2086;;C11D3/3715;;C11D3/3723;;C11D3/386;;C11D3/3907;;C11D3/3932;;C11D3/3942;;C11D3/42;;C11D3/50;;D06L4/60;;D06M13/005,C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/02;;C11D3/06;;C11D3/08;;C11D3/10;;C11D3/12;;C11D3/20;;C11D3/30;;C11D3/34;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;C11D17/06;;C11D17/08;;D06L3/12;;D06M13/00,,0,0,,,,DISCONTINUED
860,MX,A,MX 9809633 A,131-455-490-746-498,1999-02-01,1999,MX 9809633 A,1998-11-17,US 1788696 P,1996-05-17,Detergent composition,,PROCTER & GAMBLE,ASANO KAORI;;SCHEIBEL JEFFREY JOHN;;BABA HAJIME;;BAECK ANDRE CESAR;;MINAMIKAWA KAORI;;CRIPE THOMAS ANTHONY;;CURRY JOHN DOWNING;;CRON LAURA;;DODD IAN MARTIN;;HARTSHORN RICHARD TIMOTHY;;SPEED LYNDA ANNE;;KATSUDA RINKO;;KVIETOK FRANK ANDREJ;;MAO MARK HSIANG-KUEN;;MOSS MICHAEL ALAN JOHN;;MURATA SUSUMU;;OHTANI ROYOHEI;;PANANDIKER RAJAN KESHAV;;PRAMOD KAKUMANU;;SARNAIK KHIZAR MOHAMED KHAN;;THOEN CHRISTIAAN ARTHUR JACQUE;;KOTT KEVIN LEE;;WILLMAN KENNETH WILLIAM;;OKAMOTO MITSUYO;;FOLEY PETER ROBERT;;MANOHAR SANJEEV KRISHNADAS,,https://lens.org/131-455-490-746-498,Patent Application,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/835;;C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,PENDING
861,CA,A1,CA 2254945 A1,118-801-100-532-055,1997-11-20,1997,CA 2254945 A,1997-05-16,US 1788696 P;;US 9708436 W,1996-05-17,DETERGENT COMPOSITION,"A detergent composition comprising an enzyme, a non-AQA surfactant and an alkoxylated quaternary ammonium (AQA) cationic surfactant.",PROCTER & GAMBLE,OHTANI ROYOHEI;;DODD IAN MARTIN;;CRON LAURA;;SARNAIK KHIZAR MOHAMED KHAN;;PANANDIKER RAJAN KESHAV;;SPEED JONES LYNDA ANNE;;CURRY JOHN DOWNING;;MURATA SUSUMU;;THOEN CHRISTIAAN ARTHUR JACQUE;;CRIPE THOMAS ANTHONY;;SCHEIBEL JEFFREY JOHN;;HARTSHORN RICHARD TIMOTHY;;KATSUDA RINKO;;MINAMIKAWA KAORI;;BABA HAJIME;;KOTT KEVIN LEE;;WILLMAN KENNETH WILLIAM;;BAECK ANDRE CESAR;;ASANO KAORI;;FOLEY PETER ROBERT;;MANOHAR SANJEEV KRISHNADAS;;PRAMOD KAKUMANU;;MOSS MICHAEL ALAN JOHN;;MAO MARK HSIANG-KUEN;;KVIETOK FRANK ANDREJ;;OKAMOTO MITSUYO,,https://lens.org/118-801-100-532-055,Patent Application,no,0,0,79,507,0,C11D1/02;;C11D1/146;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/0036;;C11D3/0063;;C11D3/128;;C11D3/3715;;C11D3/3723;;C11D3/3932;;C11D3/50;;D06L4/60;;C11D3/50;;C11D3/0036;;C11D3/128;;C11D1/44;;C11D1/29;;C11D1/22;;C11D1/62;;C11D3/3715;;C11D1/146;;C11D3/3932;;C11D3/0063;;C11D1/40;;C11D1/65;;C11D3/3723;;C11D1/02;;D06L4/60,C11D1/835;;C11D1/02;;C11D1/14;;C11D1/22;;C11D1/29;;C11D1/40;;C11D1/44;;C11D1/62;;C11D1/65;;C11D3/00;;C11D3/06;;C11D3/08;;C11D3/12;;C11D3/37;;C11D3/386;;C11D3/39;;C11D3/395;;C11D3/42;;C11D3/50;;C11D17/00;;D06L3/12,,0,0,,,,DISCONTINUED
862,AU,A1,AU 2022/286438 A1,169-266-909-079-249,2023-11-30,2023,AU 2022/286438 A,2022-06-03,US 202163196970 P;;US 2022/0032202 W,2021-06-04,N-(HYDROXYALKYL (HETERO)ARYL) TETRAHYDROFURAN CARBOXAMIDE ANALOGS AS MODULATORS OF SODIUM CHANNELS,"Compounds of formula (I) and pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels are provided. Also provided are pharmaceutical compositions comprising the compounds or pharmaceutically acceptable salts and methods of using the compounds, pharmaceutically acceptable salts, and pharmaceutical compositions in the treatment of various disorders, including pain.",VERTEX PHARMA,BECK ELIZABETH;;PULLIN ROBERT;;ETXEBARRIA JARDI GORKA;;STAMOS DEAN;;SCHMIDT YVONNE;;PONTILLO JOSEPH;;THOMSON STEPHEN ANDREW;;SHAW DAVID MATTHEW;;AHMAD NADIA M;;CARVALHO MEIRELES LIDIO MARX;;SKERRATT SARAH;;HADIDA RUAH SARA S;;MILLER MARK THOMAS;;NEUBERT TIMOTHY DONALD;;HURLEY DENNIS JAMES;;ZHOU JINGLAN;;KINTZER ALEXANDER;;DURRANT STEVEN JOHN;;WRAY CHRISTOPHER;;VIRANI ANISA NIZARALI;;NORTH KIRI;;DODD JAMES;;JACQUES REECE;;O'DONNELL MICHAEL EDWARD;;GALAN BHAIRAVI;;KNEGTEL RONALD MARCELLUS;;CHUDYK EWA IWONA;;PINDER JOANNE LOUISE;;SOUSA BRUNO ARTUR;;STEVENS REBECCA E,,https://lens.org/169-266-909-079-249,Patent Application,no,0,0,3,3,0,C07D491/048;;C07D405/12;;C07D405/14;;A61P29/00,C07D405/12;;A61K31/443;;A61P29/00;;C07D405/14;;C07D491/048,,0,0,,,,PENDING
863,CA,A1,CA 3221939 A1,045-599-718-938-847,2022-12-08,2022,CA 3221939 A,2022-06-03,US 202163196970 P;;US 2022/0032202 W,2021-06-04,N-(HYDROXYALKYL (HETERO)ARYL) TETRAHYDROFURAN CARBOXAMIDE ANALOGS AS MODULATORS OF SODIUM CHANNELS,"Compounds of formula (I) and pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels are provided. Also provided are pharmaceutical compositions comprising the compounds or pharmaceutically acceptable salts and methods of using the compounds, pharmaceutically acceptable salts, and pharmaceutical compositions in the treatment of various disorders, including pain.",VERTEX PHARMA,BECK ELIZABETH MARY;;STAMOS DEAN;;PINDER JOANNE LOUISE;;STEVENS REBECCA E;;MILLER MARK THOMAS;;SKERRATT SARAH;;ETXEBARRIA JARDI GORKA;;DODD JAMES;;CARVALHO MEIRELES LIDIO MARX;;PONTILLO JOSEPH;;DURRANT STEVEN JOHN;;SHAW DAVID MATTHEW;;KNEGTEL RONALD MARCELLUS;;SCHMIDT YVONNE;;GALAN BHAIRAVI;;JACQUES REECE;;AHMAD NADIA M;;NEUBERT TIMOTHY DONALD;;THOMSON STEPHEN ANDREW;;PULLIN ROBERT;;SOUSA BRUNO ARTUR;;WRAY CHRISTOPHER;;KINTZER ALEXANDER;;HADIDA RUAH SARA S;;HURLEY DENNIS JAMES;;O'DONNELL MICHAEL EDWARD;;NORTH KIRI;;CHUDYK EWA IWONA;;VIRANI ANISA NIZARALI;;ZHOU JINGLAN,,https://lens.org/045-599-718-938-847,Patent Application,no,0,0,3,3,0,C07D491/048;;C07D405/12;;C07D405/14;;A61P29/00,C07D405/12;;A61K31/443;;A61P29/00;;C07D405/14;;C07D491/048,,0,0,,,,PENDING
864,AU,A1,AU 2022/283934 A1,076-158-843-564-646,2023-11-30,2023,AU 2022/283934 A,2022-06-03,US 202163197253 P;;US 2022/0032238 W,2021-06-04,SUBSTITUTED TETRAHYDROFURAN-2-CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS,"Compounds of formula I and pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels are provided. Also provided are pharmaceutical compositions comprising the compounds or pharmaceutically acceptable salts and methods of using the compounds, pharmaceutically acceptable salts, and pharmaceutical compositions in the treatment of various disorders, including pain.",VERTEX PHARMA,BECK ELIZABETH MARY;;PULLIN ROBERT;;ETXEBARRIA JARDI GORKA;;STAMOS DEAN;;SCHMIDT YVONNE;;PONTILLO JOSEPH;;THOMSON STEPHEN ANDREW;;SHAW DAVID MATTHEW;;AHMAD NADIA M;;CARVALHO MEIRELES LIDIO MARX;;SKERRATT SARAH;;HADIDA RUAH SARA S;;MILLER MARK THOMAS;;NEUBERT TIMOTHY DONALD;;HURLEY DENNIS JAMES;;ZHOU JINGLAN;;KINTZER ALEXANDER;;DURRANT STEVEN JOHN;;WRAY CHRISTOPHER;;VIRANI ANISA NIZARALI;;NORTH KIRI;;DODD JAMES;;JACQUES REECE;;GEDDIS STEPHEN MICHAEL;;GALAN BHAIRAVI;;KNEGTEL RONALD MARCELLUS;;CHUDYK EWA IWONA;;PINDER JOANNE LOUISE;;SOUSA BRUNO ARTUR;;STEVENS REBECCA E;;WRIGHT MIRANDA ADELE;;TWIN HEATHER CLARE;;MUI JAMES JUN BON,,https://lens.org/076-158-843-564-646,Patent Application,no,0,0,3,3,0,C07D405/12;;C07D471/04;;C07D405/14;;C07D413/14;;C07D407/14;;C07D498/04;;C07D417/12;;C07D409/12;;C07D491/052;;C07D471/08;;C07D487/08;;C07D491/10;;C07D521/00;;C07D491/08;;A61P29/00,A61P29/00;;A61K31/443;;C07D405/12;;C07D405/14;;C07D407/14;;C07D409/12;;C07D413/14;;C07D417/12;;C07D471/04;;C07D471/08;;C07D487/08;;C07D491/052;;C07D491/08;;C07D491/10;;C07D498/04;;C07D521/00,,0,0,,,,PENDING
865,CA,A1,CA 3221788 A1,182-344-664-702-769,2022-12-08,2022,CA 3221788 A,2022-06-03,US 202163197253 P;;US 2022/0032238 W,2021-06-04,SUBSTITUTED TETRAHYDROFURAN-2-CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS,"Compounds of formula I and pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels are provided. Also provided are pharmaceutical compositions comprising the compounds or pharmaceutically acceptable salts and methods of using the compounds, pharmaceutically acceptable salts, and pharmaceutical compositions in the treatment of various disorders, including pain.",VERTEX PHARMA,BECK ELIZABETH MARY;;PULLIN ROBERT;;ETXEBARRIA JARDI GORKA;;STAMOS DEAN;;SCHMIDT YVONNE;;PONTILLO JOSEPH;;THOMSON STEPHEN ANDREW;;SHAW DAVID MATTHEW;;AHMAD NADIA M;;CARVALHO MEIRELES LIDIO MARX;;SKERRATT SARAH;;HADIDA RUAH SARA;;MILLER MARK THOMAS;;NEUBERT TIMOTHY DONALD;;HURLEY DENNIS JAMES;;ZHOU JUNGLAN;;KINTZER ALEXANDER;;DURRANT STEVEN JOHN;;WRAY CHRISTOPHER;;VIRANI ANISA NIZARALI;;NORTH KIRI;;DODD JAMES;;JACQUES REECE;;GEDDIS STEPHEN MICHAEL;;GALAN BHAIRAVI;;KNEGTEL RONALD MARCELLUS;;CHUDYK EWA IWONA;;PINDER JOANNE LOUISE;;SOUSA BRUNO ARTUR;;STEVENS REBECCA E;;WRIGHT MIRANDA ADELE;;TWIN HEATHER CLARE;;MUI JAMES JUN BON,,https://lens.org/182-344-664-702-769,Patent Application,no,0,0,3,3,0,C07D405/12;;C07D471/04;;C07D405/14;;C07D413/14;;C07D407/14;;C07D498/04;;C07D417/12;;C07D409/12;;C07D491/052;;C07D471/08;;C07D487/08;;C07D491/10;;C07D521/00;;C07D491/08;;A61P29/00,A61K31/443;;A61P29/00;;C07D405/12;;C07D405/14;;C07D407/14;;C07D409/12;;C07D413/14;;C07D417/12;;C07D471/04;;C07D471/08;;C07D487/08;;C07D491/052;;C07D491/08;;C07D491/10;;C07D498/04;;C07D521/00,,0,0,,,,PENDING
